Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,embryonic skeletal system development (GO:0048706),-0.7585660066923609,-2.3353266229864698,0.0,0.0,0.0,18/35,10.79%,SULF1;COL1A1;PDGFRA;HOXC4;OSR1;SULF2;HOXA3;PCSK5;RBP4;DYNC2I1;WNT9A;HOXB4;SIX1;HOXB3;KIAA1217;XYLT1;SLC2A10;FUZ
prerank,retinoid metabolic process (GO:0001523),-0.613005373710162,-2.097347632792476,0.0,0.004103191153969636,0.008,25/71,16.33%,GPC6;ALDH1A1;LRP1;ALDH1A2;SDC2;GPC3;RBP1;HSPG2;ABCA4;RBP4;CYP26B1;AKR1B1;DHRS3;CYP1B1;GPC5;SDC4;APOE;GPC4;STRA6;SCPEP1;RDH13;SDC1;RARRES2;GPC1;RDH10
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.7957466029957355,-2.0832307326718253,0.0,0.0033433409402715553,0.01,11/20,12.50%,ATP1A2;ANK2;CACNA1C;DMD;ATP1B1;SLC8A1;PRKACA;ATP2A2;RYR2;SLC9A1;GSTM2
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.8365757457240834,-2.0812375359290827,0.0,0.002735460769313091,0.011,9/17,7.21%,ATP1A2;ANK2;CACNA1C;CACNA2D1;CACNA1D;SLC8A1;CACNB2;CACNA1G;KCNJ2
prerank,collagen fibril organization (GO:0030199),-0.5755592557382029,-2.060734405180841,0.0,0.004194373179613405,0.021,43/88,11.64%,COL1A2;COL3A1;COL4A5;COL1A1;ADAMTS2;COL8A1;COL4A6;COL5A1;COL12A1;COL22A1;COL25A1;COL4A3;COL4A4;LOXL1;COL6A2;COL6A3;COL11A1;COL6A1;PLOD2;COL8A2;TGFBR1;COL26A1;SERPINH1;COL13A1;COL18A1;COL23A1;LOXL3;COL27A1;CYP1B1;COL5A3;NF1;COL16A1;P4HB;LUM;LOX;COL14A1;COL9A2;COL20A1;DDR2;DPT;ADAMTS14;P4HA1;TGFB2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.7603573614562278,-2.03793616980707,0.002398081534772182,0.006252481758429922,0.042,4/21,1.86%,EYA2;EYA1;BCL2;EYA4
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.7603573614562278,-2.03793616980707,0.002398081534772182,0.006252481758429922,0.042,4/21,1.86%,EYA2;EYA1;BCL2;EYA4
prerank,diterpenoid metabolic process (GO:0016101),-0.6338996187422175,-2.0260678582716,0.0,0.006610696859173302,0.05,20/55,16.33%,GPC6;ALDH1A1;LRP1;SDC2;GPC3;RBP1;HSPG2;ABCA4;RBP4;AKR1B1;DHRS3;GPC5;SDC4;APOE;GPC4;STRA6;SDC1;RARRES2;GPC1;RDH10
prerank,cotranslational protein targeting to membrane (GO:0006613),0.6902515105669752,2.0193420392503656,0.0,0.032589699468304305,0.028,62/91,22.73%,RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPS20;RPL39;RPL34;RPS7;SEC63;RPS24;RPL37A;RPS18;RPL36;TRAM1;RPL15;RPL14;RPS8;RPL23;RPL17;RPL9;RPL4;RPL13A;RPS11;RPL32;RPL22;RPL31;RPS27;RPS23;RPL13;SRP9;RPS12;RPL6;RPL10;RPS29;RPS6;RPS25;RPL35A;RPL29;RPS13;RPL18;RPL27A;RPS21;RPL27;RPS10;RPL11;ARL6IP1;RPLP2;SEC62;RPL8;SIL1;RPL18A;SSR1;RPS3;RPL21;RPL3;RPS28;RPL7;RPL26;SRP19
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.6112742930752645,-2.0128351971666336,0.0,0.007193248689675164,0.06,22/55,12.38%,GPC6;SDC2;DCN;GPC3;OGN;CEMIP;FMOD;HSPG2;BGN;FGF2;CSPG4;PRELP;LUM;VCAN;CD44;ARSB;GPC5;SDC4;OMD;GPC4;HEXA;SLC9A1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.7981722394754888,-1.9798709858914008,0.0,0.012491937513196447,0.119,7/16,8.88%,ATP1A2;ANK2;CACNA1C;DMD;SLC8A1;PRKACA;RYR2
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.6783324520181002,1.9792739968261084,0.0,0.042576865434397565,0.071,58/87,22.73%,RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPS20;RPL39;RPL34;RPS7;SEC63;RPS24;RPL37A;RPS18;RPL36;RPL15;RPL14;RPS8;RPL23;RPL17;RPL9;ZFAND2B;RPL4;RPL13A;RPS11;RPL32;RPL22;RPL31;RPS27;RPS23;RPL13;SRP9;RPS12;RPL6;RPL10;RPS29;RPS6;RPS25;RPL35A;RPL29;RPS13;RPL18;RPL27A;RPS21;RPL27;RPS10;RPL11;RPLP2;RPL8;RPL18A;RPS3;RPL21;RPL3;RPS28;RPL7;RPL26;SRP19
prerank,establishment of endothelial barrier (GO:0061028),0.7930505939112164,1.966227029507372,0.0,0.04240165199639593,0.103,14/29,7.67%,TJP1;PECAM1;PPP1R16B;ICAM1;F11R;TJP2;PDE2A;MSN;PDE4D;RAP1B;SOX18;ROBO4;RAPGEF2;RAP1A
prerank,regulation of striated muscle contraction (GO:0006942),-0.69944325896256,-1.9542336868384194,0.0,0.018733761632265408,0.185,7/27,8.88%,ATP1A2;ANK2;DMD;SLC8A3;P2RX4;PRKACA;RYR2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.7711219446573305,-1.946111101498516,0.0,0.019680120534780292,0.21,6/16,3.77%,IGF1;IGFBP2;BMP5;IGFBP5;IGFBP6;IGFBP3
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.6511942270543415,1.9456671425025598,0.0,0.053878132185503094,0.159,60/110,20.40%,RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPS20;RPL39;RPL34;RPS7;RPS24;RPL37A;RPS18;RPL36;RPL15;RPL14;RPS8;RPL23;RPL17;SMG7;RPL9;RPL4;RPL13A;RPS11;RPL32;RPL22;RPL31;RPS27;RNPS1;RPS23;RPL13;RPS12;RPL6;PNRC2;RPL10;UPF2;RPS29;RPS6;RPS25;RPL35A;RPL29;RPS13;RPL18;RPL27A;RPS21;RPL27;CTIF;RPS10;RPL11;RPLP2;PPP2R2A;HELZ2;RPL8;RPL18A;DHX34;RPS3;PPP2R1A;RPL21;RPL3
prerank,negative regulation of peptidase activity (GO:0010466),-0.6066441101484608,-1.9447786132599485,0.0,0.018727385266835775,0.214,13/47,12.13%,LRP1;TIMP3;VTN;SERPING1;TIMP2;SERPINH1;SERPINE2;SERPIND1;ECM1;SERPINF1;SERPINE1;CST3;SPOCK3
prerank,protein targeting to ER (GO:0045047),0.656013474079556,1.9413402162737,0.0,0.04751788438604371,0.175,59/99,20.40%,RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPS20;RPL39;RPL34;RPS7;SEC63;RPS24;RPL37A;RPS18;RPL36;RPL15;CHMP4A;CHMP4B;RPL14;RPS8;RPL23;RPL17;RPL9;ZFAND2B;RPL4;RPL13A;RPS11;RPL32;RPL22;RPL31;RPS27;RPS23;RPL13;SRP9;RPS12;RPL6;RPL10;SPCS1;RPS29;RPS6;RPS25;RPL35A;RPL29;RPS13;RPL18;RPL27A;RPS21;RPL27;RPS10;RPL11;RPLP2;SEC62;RPL8;ZFAND2A;RPL18A;RPS3;RPL21;RPL3
prerank,membrane lipid biosynthetic process (GO:0046467),0.7044410589582807,1.9208779149919755,0.0,0.06552982581261191,0.266,17/58,5.88%,ACER2;CERT1;ELOVL7;SPTLC2;SGMS1;DEGS2;PRKD1;SPNS2;PLPP1;SGPP2;PRKD2;PRKD3;CERS4;SPTLC3;ELOVL5;SPTSSA;PPM1L
prerank,cardiac muscle cell action potential (GO:0086001),-0.6769494777725389,-1.9111714067602508,0.0,0.03380247950651176,0.366,11/30,7.21%,ATP1A2;ANK2;CACNA1C;DMD;CACNA2D1;CACNA1D;ATP1B1;SLC8A1;KCND3;CACNA1G;KCNJ2
prerank,skeletal system morphogenesis (GO:0048705),-0.6090531590062139,-1.9093460873285208,0.0,0.03240001311208616,0.374,16/42,10.79%,FGFR2;PDGFRA;HOXC4;TGFBR1;HOXA3;WWOX;CYP26B1;DYNC2I1;FBN2;HOXB4;SIX1;SFRP4;HOXB3;LRP6;HHIP;FUZ
prerank,cytoplasmic translation (GO:0002181),0.6517897828094275,1.8937832877719973,0.0,0.1006225743952253,0.402,52/91,20.40%,RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPS20;RPL39;RPL34;RPS7;RPS24;RPL37A;RPS18;RPL36;RPL15;RPL14;RPS8;RPL23;RPL17;RPL9;RPL4;RPL13A;RPS11;RPL32;RPL22;DRG2;RPL31;RPS27;RPS23;RPL13;RPS12;RPL6;RPL10;RPS29;RPS6;RPS25;RPL35A;RPL29;RPS13;RPL18;RPL27A;RPS21;RPL27;RPS10;RPL11;RPL8;RPL18A;RWDD1;RPS3;RPL21;RPL3
prerank,renal system development (GO:0072001),-0.5741859512001058,-1.8901910603374508,0.0031446540880503146,0.041715776732024624,0.468,28/52,18.05%,SULF1;GLI2;WNT4;SULF2;GREB1L;TGFBR1;BMP4;PKD1;PCSK5;RBP4;SALL1;SIX1;AGTR1;IFT88;TBX18;PYGO1;ARL3;VEGFA;TGFB2;STRA6;PYGO2;TRAF3IP1;PAX8;MYOCD;NPHP3;FOXC1;ITGA8;IFT27
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.7150572812781455,-1.8894798827335633,0.0,0.0395300899408578,0.47,8/21,8.88%,ATP1A2;ANK2;CACNA1C;DMD;SLC8A1;AKAP6;PRKACA;RYR2
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.8463827926993516,-1.8788225930653346,0.002197802197802198,0.04442590916088112,0.524,6/10,5.02%,PID1;PRKCB;APPL2;ENPP1;GRB10;SELENOS
prerank,positive regulation of acute inflammatory response (GO:0002675),0.888169528348157,1.8784231547048873,0.001736111111111111,0.12549662496867184,0.501,3/14,2.25%,IL6ST;PTGS2;OSMR
prerank,membrane depolarization during action potential (GO:0086010),-0.685438199123976,-1.8738177729385057,0.0,0.04568699390150986,0.546,7/26,7.21%,ATP1A2;CACNA1C;SCN7A;CACNA1D;SLC8A1;CACNA1G;KCNJ2
prerank,sphingolipid metabolic process (GO:0006665),0.6272806200130726,1.8717878426611738,0.0,0.1280226186998621,0.544,23/108,5.88%,ST6GALNAC3;ACER2;CERT1;ELOVL7;SPTLC2;SGMS1;UGCG;DEGS2;PRKD1;SPNS2;PLPP1;SGPP2;PRKD2;PRKD3;CERS4;ESYT2;SPTLC3;ELOVL5;SPTSSA;GLTP;ENPP2;ASAH2;PPM1L
prerank,mesonephric tubule development (GO:0072164),-0.7416079255849448,-1.858026406841778,0.002364066193853428,0.05584899070680894,0.645,10/15,10.49%,FGFR2;BMP7;OSR1;BMP4;PKD1;ROBO2;SALL1;SIX1;NPNT;SLIT2
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.5676375840024173,-1.8458607609915674,0.0,0.06348005785294823,0.705,22/50,15.64%,ZIC1;FGFR2;GLI3;GPC3;DCDC2;IFT81;GAS1;TULP3;EVC;GLIS2;RORA;ARMC9;BTRC;GLI1;SFRP1;HHIP;SMO;FUZ;SUFU;INTU;KIF7;PTCH2
prerank,synaptic membrane adhesion (GO:0099560),-0.761068704188423,-1.8361212911624785,0.0,0.07021015974570266,0.764,7/14,5.93%,GPC6;PTPRS;PTPRF;PTPRD;LRRC4C;LRFN5;NTNG1
prerank,ureteric bud development (GO:0001657),-0.7283405392616907,-1.8335853135493339,0.0,0.06965513872004492,0.777,10/17,10.49%,FGFR2;GPC3;BMP7;OSR1;BMP4;ROBO2;SALL1;SIX1;NPNT;SLIT2
prerank,dermatan sulfate metabolic process (GO:0030205),-0.7698495528038198,-1.8308448821572554,0.0021231422505307855,0.0696022795747442,0.79,7/13,9.44%,UST;DSE;DCN;BGN;CSPG4;VCAN;DSEL
prerank,endodermal cell differentiation (GO:0035987),-0.6226797814960658,-1.8296929069740724,0.0029239766081871343,0.06765706302767711,0.794,13/31,10.16%,COL8A1;COL12A1;VTN;COL11A1;ITGB5;COL6A1;MMP14;ITGAV;CTR9;PAF1;LEO1;INHBA;MMP2
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.7931991813875188,-1.8207625420763756,0.002197802197802198,0.07441856092926126,0.828,7/12,9.44%,UST;DSE;DCN;BGN;CSPG4;VCAN;DSEL
prerank,sphingolipid biosynthetic process (GO:0030148),0.648096878367393,1.8200512177361612,0.0,0.30844573625808014,0.863,18/71,5.88%,ACER2;CERT1;ELOVL7;SPTLC2;SGMS1;DEGS2;PRKD1;SPNS2;PLPP1;SGPP2;PRKD2;PRKD3;CERS4;SPTLC3;ELOVL5;SPTSSA;ASAH2;PPM1L
prerank,digestive tract development (GO:0048565),-0.6215584940221835,-1.8192212892370974,0.0,0.07314824723866857,0.833,17/32,15.54%,FGFR2;GLI3;CLMP;RARB;GLI2;KIT;PKD1;PCSK5;COBL;SALL1;GLI1;SMO;TGFB2;STRA6;CCDC39;PKDCC;RARRES2
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.6638596441608932,-1.8115820509949383,0.0,0.07831884702616647,0.86,10/25,9.89%,ANK2;DMD;ACTN2;SLC6A9;ATP1B1;WNK4;ANK3;TRPC6;WNK1;ATP1B2
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.8443537600305594,1.809048750543604,0.0017667844522968198,0.31205513308091387,0.905,2/14,0.43%,SLCO2B1;ABCG2
prerank,heme catabolic process (GO:0042167),0.8443537600305594,1.809048750543604,0.0017667844522968198,0.31205513308091387,0.905,2/14,0.43%,SLCO2B1;ABCG2
prerank,regulation of cell junction assembly (GO:1901888),0.748344212549815,1.8083298205672846,0.0016181229773462784,0.29185167588364824,0.907,12/27,11.15%,PRKCH;TJP1;MEF2C;CLDN5;OCLN;F11R;RAP1B;RAPGEF2;RAP1A;APLNR;MYO1C;CBFB
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.7092623804508275,-1.8067164883053766,0.0,0.08162363399007797,0.882,8/17,9.89%,ATP1A2;CACNA1C;GJA1;ATP1B1;SLC8A1;PRKACA;RYR2;ATP1B2
prerank,relaxation of cardiac muscle (GO:0055119),-0.7510247187976475,-1.8058534136338862,0.002136752136752137,0.08048333463490072,0.884,6/13,7.21%,ATP1A2;GSN;ATP1B1;SLC8A1;P2RX4;KCNJ2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.8021705628458385,1.8047380524403507,0.003395585738539898,0.2878256176544019,0.922,6/18,5.49%,JAM2;SLC39A8;VCAM1;SELE;SELP;CX3CR1
prerank,embryonic digestive tract development (GO:0048566),-0.7247668935608343,-1.8034741693442655,0.0024813895781637717,0.08056373168976942,0.895,12/18,15.54%,FGFR2;GLI3;RARB;GLI2;PDGFRA;PCSK5;SALL1;RBPMS2;TGFB2;STRA6;PKDCC;RARRES2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.6264615727607664,1.8016028777872624,0.0,0.2820936351826341,0.93,18/75,6.71%,NRP2;TEK;EGFL7;BMPR2;KDR;PPP1R16B;PRKD1;PLCG1;PDGFB;VEGFC;GATA2;PRKD2;JCAD;HIF1A;FLT4;VEGFD;WNT5A;NRAS
prerank,negative regulation of blood pressure (GO:0045776),0.8665825289297566,1.7957299795652617,0.0,0.29074479868396486,0.953,3/13,1.81%,NOS3;BMPR2;PRCP
prerank,extracellular structure organization (GO:0043062),-0.4472298152041094,-1.789112451064078,0.0,0.09519973364869828,0.939,78/204,7.56%,LAMA2;COL1A2;COL3A1;COL4A5;FBN1;SMOC1;ADAMTS12;THSD4;COL1A1;ADAMTS2;COL8A1;DCN;COL4A6;ADAMTSL3;COL5A1;NID1;COL22A1;ADAMTS6;VTN;COL4A3;ADAMTSL5;LAMC3;COL4A4;ITGA9;LOXL1;COL6A2;COL6A3;COL11A1;ITGB5;HSPG2;COL6A1;NID2;ADAMTS10;ADAMTS5;SPARC;COL8A2;TGFBR1;BGN;MFAP5;VIT;COL13A1;DAG1;ITGA10;FBLN5;COL18A1;COL23A1;ITGA11;THBS1;ADAMTSL1;DDR1;SMOC2;FGF2;CDH1;COL27A1;NDNF;RECK;ADAMTS17;ITGA1;ADAMTSL4;MMP14;MMP16;FBN2;COL5A3;ITGB8;ITGAV;SPP1;NF1;ADAMTS15;ADAM19;TGFBI;COL16A1;LUM;LOX;VCAN;ST7;ADAMTS1;COL14A1;CD44
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.7169746334737866,1.7886687439403324,0.004746835443037975,0.30555162252920604,0.963,6/30,3.61%,NOS3;TNFSF10;ICAM1;ARHGEF2;FAS;CASP8
prerank,regulation of potassium ion transport (GO:0043266),-0.631965900304293,-1.7886344982911262,0.0,0.09300566615664509,0.941,12/31,10.27%,ANK2;FHL1;ACTN2;KCNIP3;CACNA1D;KCNIP4;ANK3;DLG1;DPP6;ADRA2A;KCNAB1;CD63
prerank,bile acid and bile salt transport (GO:0015721),0.7669071135742745,1.7837867911614402,0.001692047377326565,0.3116463017255767,0.972,6/24,5.16%,ABCC4;SLCO2B1;ATP8B1;STARD5;NCOA1;CEACAM1
prerank,relaxation of muscle (GO:0090075),-0.7417890855485894,-1.7824727033901577,0.0021645021645021645,0.09804749580988882,0.952,6/13,7.21%,ATP1A2;GSN;ATP1B1;SLC8A1;P2RX4;KCNJ2
prerank,external encapsulating structure organization (GO:0045229),-0.4447697428258796,-1.7811063526489728,0.0,0.09667899918972266,0.957,77/205,7.56%,LAMA2;COL1A2;COL3A1;COL4A5;FBN1;SMOC1;ADAMTS12;THSD4;COL1A1;ADAMTS2;COL8A1;DCN;COL4A6;ADAMTSL3;COL5A1;NID1;COL22A1;ADAMTS6;VTN;COL4A3;ADAMTSL5;LAMC3;COL4A4;ITGA9;LOXL1;COL6A2;COL6A3;COL11A1;ITGB5;HSPG2;COL6A1;NID2;ADAMTS10;ADAMTS5;SPARC;COL8A2;BGN;MFAP5;VIT;COL13A1;DAG1;ITGA10;FBLN5;COL18A1;COL23A1;ITGA11;THBS1;ADAMTSL1;DDR1;SMOC2;FGF2;CDH1;COL27A1;NDNF;RECK;ADAMTS17;ITGA1;ADAMTSL4;MMP14;MMP16;FBN2;COL5A3;ITGB8;ITGAV;SPP1;NF1;ADAMTS15;ADAM19;TGFBI;COL16A1;LUM;LOX;VCAN;ST7;ADAMTS1;COL14A1;CD44
prerank,sulfur compound catabolic process (GO:0044273),-0.5813486868089238,-1.7809751591665706,0.006289308176100629,0.09412011313673561,0.957,14/38,11.52%,DCN;OGN;FMOD;BGN;CSPG4;GGT5;PRELP;LUM;VCAN;ARSB;OMD;NUDT7;ACAT1;HEXA
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.7115715970171784,1.7782109371265697,0.0,0.3226878222396447,0.975,16/34,9.65%,SEMA6A;FLT1;KDR;ERN1;PRKD1;VEGFC;DAB2IP;PRKD2;NOTCH1;FLT4;VEGFD;DLL4;RAMP2;GAB1;EGR3;MAP2K3
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.6629257960581755,1.7690663768522554,0.001488095238095238,0.3538084953567037,0.984,18/48,7.90%,NOS3;HDAC9;KDR;PTGS2;PRKD1;PLCG1;PDGFB;GATA2;PRKD2;JCAD;HDAC7;HIF1A;PIK3C2A;TMSB4X;RHOJ;CD40;TGFB1;MAP3K3
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.6434069962998497,-1.7666408057790823,0.005235602094240838,0.10996059416824334,0.971,4/26,1.86%,EYA2;EYA1;BCL2;EYA4
prerank,leukocyte cell-cell adhesion (GO:0007159),0.7457045288319913,1.7631070107654203,0.004885993485342019,0.3705513908823172,0.986,7/24,3.96%,PECAM1;ICAM1;VCAM1;F11R;MSN;SELE;SELP
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.5996389564309151,-1.7619085405360744,0.002890173410404624,0.1137135840857433,0.977,7/37,7.07%,PHLDB2;EPHA3;EFNA5;PHLDB1;BICD1;PRKAA2;MAP6
prerank,striated muscle cell development (GO:0055002),0.8183225460634994,1.7586259846745849,0.001890359168241966,0.37956009219463505,0.992,3/14,4.00%,PGM5;FLII;TMOD3
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.7358829066351833,1.7571438491230837,0.004792332268370607,0.3702336124730223,0.993,6/26,5.59%,NOS3;ACER2;SPTLC2;GCH1;SPTLC3;ASAH2
prerank,granulocyte differentiation (GO:0030851),0.7840154990962153,1.7567697250916388,0.00505902192242833,0.3568221664903319,0.993,4/18,3.48%,LEF1;CBFA2T3;TAL1;LBR
prerank,extracellular matrix organization (GO:0030198),-0.41746574315876417,-1.7535228423467502,0.0,0.12297883458621245,0.983,92/276,7.56%,LAMA2;COL1A2;COL3A1;COL4A5;FBN1;SMOC1;ADAMTS12;THSD4;COL1A1;ADAMTS2;COL8A1;DCN;GSN;COL4A6;ADAMTSL3;COL5A1;COL12A1;NID1;COL22A1;ADAMTS6;VTN;COL25A1;COL4A3;TIMP2;ADAMTSL5;LAMC3;COL4A4;ITGA9;LOXL1;COL6A2;COL6A3;COL11A1;ITGB5;HSPG2;COL6A1;NID2;ADAMTS10;ADAMTS5;PLOD2;SPARC;COL8A2;TGFBR1;BGN;MFAP5;COL26A1;SERPINH1;VIT;COL13A1;DAG1;ITGA10;GPM6B;FBLN5;COL18A1;COL23A1;ITGA11;THBS1;ADAMTSL1;DDR1;LOXL3;SMOC2;FGF2;CDH1;COL27A1;SH3PXD2B;NDNF;RECK;SCUBE1;ADAMTS17;HTRA1;ITGA1;ADAMTSL4;MMP14;MMP16;FBN2;CYP1B1;COL5A3;ITGB8;ITGAV;SPP1;NF1;ADAMTS15;ADAM19;TGFBI;COL16A1;P4HB;LUM;LOX;VCAN;ST7;ADAMTS1;COL14A1;CD44
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.6676239160644761,-1.7480765785519985,0.012135922330097087,0.1280423595102636,0.987,11/20,10.49%,IGF1;LRP1;BMPR1A;PDGFRB;VTN;NRP1;IGFBP5;IGFBP3;CCN4;SERPINE1;SLIT2
prerank,embryonic limb morphogenesis (GO:0030326),-0.5920305413655893,-1.7464898265316544,0.0,0.12763259638282784,0.987,11/34,13.50%,CACNA1C;AFF3;GLI3;OSR1;CYP26B1;SALL1;LRP6;TGFB2;TBX2;WDPCP;INTU
prerank,regulation of endothelial cell proliferation (GO:0001936),0.5995593522402829,1.7441601695036202,0.001326259946949602,0.40861175449485543,0.996,20/88,6.71%,NRP2;TEK;EGFL7;BMPR2;KDR;CAV1;TIE1;PPP1R16B;ACVRL1;PRKD1;PTPRM;PDGFB;VEGFC;PRKD2;HIF1A;FLT4;CAV2;VEGFD;WNT5A;NRAS
prerank,carboxylic acid metabolic process (GO:0019752),0.7051582313281034,1.7405606504245716,0.006211180124223602,0.4129915513266256,0.996,6/33,4.22%,CSGALNACT1;SLC2A1;ST6GAL1;ST3GAL1;PLA2G4A;GLYAT
prerank,kidney development (GO:0001822),-0.5100194300427383,-1.7358771811624822,0.0,0.14085451961351853,0.993,31/65,18.05%,SULF1;GLI2;WNT4;BMP7;OSR1;SULF2;GREB1L;TGFBR1;BMP4;PKD1;PCSK5;KANK2;ROBO2;SALL1;SIX1;NF1;AGTR1;IFT88;PYGO1;ARL3;VEGFA;TGFB2;STRA6;PYGO2;TRAF3IP1;PAX8;FGF10;NPHP3;FOXC1;ITGA8;IFT27
prerank,neurotransmitter uptake (GO:0001504),-0.7509212306364665,-1.7348945604316113,0.004597701149425287,0.13916921727908385,0.993,4/12,4.14%,ATP1A2;SLC1A3;GLUL;SNAP25
prerank,cell-substrate junction assembly (GO:0007044),0.7072948762778813,1.7336843294453024,0.004608294930875576,0.4361257153458501,0.997,10/33,5.24%,THSD1;ITGA6;PEAK1;BCR;DST;TAOK2;LAMA3;ACTN1;SORBS1;PTPRK
prerank,amino sugar metabolic process (GO:0006040),0.8624860648902759,1.7335125346723415,0.005555555555555556,0.42148844035850713,0.997,3/10,1.47%,CSGALNACT1;ST6GAL1;ST3GAL1
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.7674162406879363,1.7301574150894343,0.00684931506849315,0.42642117335446456,0.997,6/19,4.82%,PRKCH;TJP1;CLDN5;OCLN;F11R;IKBKB
prerank,cellular response to increased oxygen levels (GO:0036295),0.8411301473778472,1.730154263743657,0.00530035335689046,0.4122772196178497,0.997,3/11,2.44%,FOXO1;CAV1;FAS
prerank,regulation of gastrulation (GO:0010470),-0.7321095681392005,-1.7264829366098096,0.008888888888888889,0.14928984380402655,0.994,4/14,2.99%,PHLDB2;OSR1;PHLDB1;DAG1
prerank,keratan sulfate catabolic process (GO:0042340),-0.7526996459785966,-1.7257966669329392,0.011389521640091117,0.14716778938904426,0.995,6/11,11.52%,OGN;FMOD;PRELP;LUM;OMD;HEXA
prerank,intestinal absorption (GO:0050892),0.8228570929963899,1.7227431426744881,0.003738317757009346,0.44221610933058086,0.999,4/13,2.45%,UGCG;F11R;TJP2;KCNQ1
prerank,dicarboxylic acid transport (GO:0006835),-0.6082009810989031,-1.7191963716821022,0.0024330900243309003,0.15554464244057842,0.997,13/28,15.75%,SLC1A3;SLC13A3;PDPN;SLC26A7;GJA1;SLC22A6;SLC1A2;SLC25A12;SLC25A13;SLC26A6;SLC19A1;SLC1A1;SLC25A18
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.6238506166059407,1.7186890227759497,0.001375515818431912,0.4526748679171019,1.0,20/67,6.19%,NRP2;CLEC14A;FLT1;KDR;PRKD1;VEGFC;DOCK1;ELMO1;WASF2;DAB2IP;PRKD2;PTK2B;FYN;NCK1;PXN;FLT4;PAK2;NCKAP1;VEGFD;RAC1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.6333986818550845,1.7177032390497762,0.0014184397163120568,0.44395899490741825,1.0,15/54,7.19%,NOS3;KDR;MEF2C;ACVRL1;PRKD1;PRCP;PLCG1;PDGFB;GATA2;PRKD2;HIF1A;TMSB4X;ATP2B4;CD40;TGFB1
prerank,actomyosin structure organization (GO:0031032),0.6049349726266634,1.7155123678127908,0.0028089887640449437,0.4420944240965987,1.0,12/75,5.48%,PGM5;FRMD5;FLII;TJP1;FAM171A1;EPB41;F11R;MYH9;TMOD3;PDLIM1;SORBS1;CDC42BPB
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.5510044215999502,-1.7153954109935132,0.0,0.1585597224652191,0.997,12/47,12.13%,TIMP3;VTN;SERPING1;TIMP2;SERPINH1;RECK;SERPINE2;SERPIND1;SERPINF1;BIN1;SERPINE1;SPOCK3
prerank,modulation by symbiont of entry into host (GO:0052372),0.7723558543873655,1.7147144493496227,0.010889292196007259,0.43378842370622195,1.0,6/16,7.94%,CAV1;TRIM14;NECTIN2;FUCA2;TRIM68;TRIM25
prerank,lipid transport (GO:0006869),0.5785608743045054,1.7139070098735119,0.0,0.42588546330264343,1.0,17/97,5.80%,ABCC4;SLCO2B1;ATP8B1;CERT1;PPARD;UGCG;PLTP;ATP8A1;SPNS2;SLCO2A1;SCARB1;PRELID2;STARD5;NCOA1;GLTP;CEACAM1;ABCA3
prerank,heart contraction (GO:0060047),-0.5485859574712203,-1.7137639852512738,0.008379888268156424,0.15783988564043383,0.999,9/41,8.88%,ATP1A2;DMD;SGCD;ATP1B1;SLC8A1;TPM1;SGCZ;GAA;RYR2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.7028373132627542,-1.7136981025942644,0.0069124423963133645,0.1546744892144926,0.999,5/15,5.98%,PIEZO2;ADGRV1;COL11A1;KIT;WHRN
prerank,odontogenesis (GO:0042476),-0.5727379777121023,-1.713212487903541,0.0061162079510703364,0.15236516485073917,0.999,13/35,11.64%,COL1A2;FGFR2;GLI2;EDA;OSR1;WNT6;BMP4;LRP6;BCOR;AXIN2;INHBA;TGFB3;TGFB2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.6400405636721358,-1.7121843025005545,0.007792207792207792,0.15112973779740885,0.999,11/21,10.33%,SULF1;SULF2;EXT1;HS6ST3;HS3ST3B1;HS2ST1;HS3ST4;HS6ST2;XYLT1;HS6ST1;HS3ST5
prerank,tight junction assembly (GO:0120192),0.6391454815350206,1.7063650330175886,0.002828854314002829,0.45543181584782017,1.0,9/49,5.78%,PECAM1;ESAM;LSR;CLDN5;OCLN;F11R;PARD3;PAK2;RAMP2
prerank,regulation of Notch signaling pathway (GO:0008593),0.6024904400014742,1.705780492313485,0.002785515320334262,0.4461579654714292,1.0,19/76,8.56%,EGFL7;NOS3;IL6ST;LFNG;MAML2;EPN2;GATA2;STAT3;PRAG1;MFNG;FBXW7;NOTCH1;TSPAN5;DLL1;DLL4;TSPAN14;ARRB1;ARRDC1;LLGL1
prerank,ceramide metabolic process (GO:0006672),0.6341220418174532,1.705543845366082,0.004424778761061947,0.435984945575148,1.0,10/49,5.59%,ST6GALNAC3;ACER2;SPTLC2;SGMS1;DEGS2;PLPP1;CERS4;SPTLC3;SPTSSA;ASAH2
prerank,embryonic eye morphogenesis (GO:0048048),-0.7505440274212938,-1.7055074273261561,0.00904977375565611,0.16026994507385672,0.999,7/11,14.90%,FBN1;EFEMP1;MFAP5;FBN2;LRP6;TBX2;MFAP2
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.7220085967705396,-1.705029404709914,0.004694835680751174,0.1582782331929587,0.999,4/14,9.89%,ANK2;ACTN2;ATP1B1;ATP1B2
prerank,regulation of protein neddylation (GO:2000434),0.8588969209298107,1.7012542033698062,0.003861003861003861,0.4473987532652776,1.0,3/10,2.78%,EPAS1;DCUN1D3;HIF1A
prerank,regulation of hydrolase activity (GO:0051336),0.5940669522213246,1.700339894482247,0.0013679890560875513,0.4414609407913417,1.0,11/71,4.32%,PRKG1;CHN2;FGD5;PLXNA4;CAV1;RASIP1;FGD6;DAB2IP;PLXND1;ARHGAP27;TBC1D15
prerank,filopodium assembly (GO:0046847),0.7803583829822094,1.699904105800579,0.007155635062611807,0.433302832178046,1.0,6/16,4.45%,FGD5;DNM3;FGD6;SRGAP2;SPATA13;PPP1R9B
prerank,organic hydroxy compound transport (GO:0015850),0.6735345376763118,1.6989860183666787,0.007776049766718507,0.4281645962403701,1.0,6/36,5.16%,ABCC4;SLCO2B1;ATP8B1;STARD5;NCOA1;CEACAM1
prerank,protein localization to synapse (GO:0035418),-0.7411315138890976,-1.6989632717256713,0.0,0.1665929379632281,0.999,8/12,15.21%,NLGN2;DLG4;PCLO;NRXN1;NLGN1;SHANK1;NRXN2;BSN
prerank,cardiac muscle contraction (GO:0060048),-0.5747617444430883,-1.6969589464491879,0.0079155672823219,0.1668133712777474,0.999,8/34,8.88%,ATP1A2;DMD;GSN;ATP1B1;SLC8A1;TPM1;GAA;RYR2
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.6664633318853562,-1.691704335066848,0.011547344110854504,0.1735389338055888,0.999,7/17,1.53%,IGF1;DOCK7;DOCK5;PDGFRB;VTN;NRP1;IGFBP5
prerank,positive regulation of endothelial cell migration (GO:0010595),0.5866895829837788,1.69093728938364,0.002699055330634278,0.46208562149340565,1.0,23/84,7.54%,NRP2;TEK;NOS3;BMPR2;KDR;PRKD1;PLCG1;PDGFB;FOXP1;GATA2;SCARB1;EDN1;PRKD2;PTK2B;HIF1A;FLT4;TMSB4X;WNT5A;CD40;RAC1;SASH1;TGFB1;PIK3CG
prerank,hematopoietic stem cell proliferation (GO:0071425),0.8237356076503857,1.6894876584537875,0.014388489208633094,0.45999367923362866,1.0,5/11,8.41%,MECOM;ETV6;CD34;WNT5A;SFRP2
prerank,response to lipid (GO:0033993),0.5751686598934682,1.688548761994631,0.0,0.4549759726612919,1.0,33/105,15.53%,FOXO1;NOS3;ACER2;ESR1;PPARD;GCH1;FOXP1;SOCS2;STAT3;TNFRSF11A;SELE;SELP;SOX9;TIRAP;RPS6KA3;IFNAR1;PELI1;WNT9B;HNRNPA0;TGFB1;CITED1;CYP27B1;MAPKAPK3;OVCA2;ASXL1;ABCG1;TRIB1;ADAM17;S100A9;IRAK3;STRN3;PAQR8;TRIM16
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6675397681858005,1.6881296917283888,0.011272141706924315,0.44768897382162715,1.0,12/32,5.29%,HDAC9;KDR;PTGS2;MMRN2;GATA2;JCAD;HDAC7;NOTCH1;PIK3C2A;CARD10;RHOJ;DLL4
prerank,sulfation (GO:0051923),-0.7316605936274301,-1.6852724295594368,0.023504273504273504,0.18210810174187267,0.999,1/11,0.08%,UST
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.6944343483548719,-1.6848099985248963,0.017582417582417582,0.17989584817959595,0.999,8/15,10.76%,LRP1;PDPN;DPP4;DDR1;FAP;DDR2;FGFR4;CST3
prerank,leukocyte tethering or rolling (GO:0050901),0.7632930168808987,1.6848004244981736,0.010291595197255575,0.45612438247775916,1.0,5/17,5.49%,JAM2;VCAM1;SELE;SELP;CX3CR1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.5660240530393845,1.6841093054240615,0.002607561929595828,0.45039865762877707,1.0,28/94,18.67%,IL1R1;RPS6KA5;NOD1;NFKBIA;PLCB1;IKBKB;PELI1;NFKB1;PSMA2;MAP3K3;IKBKG;PSMA8;PSMA6;CUL1;IRAK4;RELA;RIPK2;IL1RAP;TRAF6;IRAK3;PSME1;RPS6KA4;TAB3;IRAK2;PSMA4;MAP3K8;PSMF1;PELI2
prerank,amide transport (GO:0042886),0.7022631236180281,1.682343859468328,0.011023622047244094,0.44984298072540047,1.0,7/26,5.82%,ABCG2;CERT1;PLTP;SLC38A5;AQP11;GLTP;TAP2
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.7842843593924267,1.6821673244335957,0.01916376306620209,0.4419089039857734,1.0,6/13,9.08%,EPN2;MMRN2;DAB2IP;HHEX;NEDD4;PTPN1
prerank,translation (GO:0006412),0.5293573305481183,1.682138693394728,0.0011587485515643105,0.43355217437827914,1.0,89/208,20.44%,GARS1;RPS15;IGF2BP3;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;FARS2;RPS20;RPL39;RPL34;IARS1;RPS7;RPS24;RPL37A;SRBD1;RPS18;RPL36;RSL24D1;RPL15;RPL14;RPS8;MRPS18A;RPL23;RPL17;NDUFA7;TNIP1;RPL9;RPL4;DHPS;RPL13A;LARS1;RPS11;RPL32;RPL22;DRG2;RPL31;RPS27;RPS23;MRPL13;RPL13;EEF2K;MRPS12;RPS12;MRPL35;HBS1L;APEH;RPL6;WARS1;MRRF;RPL10;FASTKD2;MRPL41;RARS1;MRPL52;RPS29;RPS6;RPS25;AIMP1;RPL35A;RPL29;QRSL1;RPS13;RPL18;RPL27A;MRPS16;RPS21;RPL27;MRPS5;MRPL23;KARS1;EEFSEC;RPS10;MRPL37;RPL11;RPLP2;EEF2;MRPL11;RPL8;PTCD3;WARS2;RPL18A;RWDD1;RPS3;RPL21;RPL3;MRPL43
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.6474540745278838,-1.680010693600981,0.009876543209876543,0.18567133153970322,0.999,10/19,14.11%,OBSL1;CUX2;PTPRD;CAPRIN2;IL1RAPL1;CUX1;FBXW8;CDKL3;DBN1;CAMK2B
prerank,apical junction assembly (GO:0043297),0.625451587012895,1.679899794640215,0.005633802816901409,0.4370352089988733,1.0,10/53,5.78%,PECAM1;ESAM;CLDN5;OCLN;F11R;PARD3;PKN2;PAK2;CTNNA1;RAMP2
prerank,regulation of sprouting angiogenesis (GO:1903670),0.6679214053194716,1.6797836055497837,0.009404388714733543,0.4294870728615659,1.0,11/33,7.81%,SEMA6A;TJP1;PPP1R16B;EPN2;SMAD1;RHOJ;DLL1;KLF2;CEACAM1;JAK1;ITGA5
prerank,T cell proliferation (GO:0042098),0.794500022212089,1.6789566627884742,0.019963702359346643,0.4260171388560507,1.0,5/13,7.54%,CADM1;CTPS1;MSN;PPP3CB;PIK3CG
prerank,regulation of cation transmembrane transport (GO:1904062),-0.5858103818270405,-1.6779020675425584,0.005479452054794521,0.18710551662101538,0.999,13/29,15.79%,SNTA1;KCNIP3;CACNA1D;KCNIP4;DLG1;SLMAP;DPP6;KCNAB1;WNK1;CD63;KCNN2;WNK3;DPP10
prerank,positive regulation of epithelial cell migration (GO:0010634),0.5775104212387534,1.6762360388383883,0.001349527665317139,0.4317759722183174,1.0,23/92,6.29%,NRP2;TEK;BMPR2;KDR;PRKD1;PLCG1;DOCK1;FOXP1;RAB11A;SCARB1;EDN1;PRKD2;PTK2B;HIF1A;PPM1F;RREB1;PLCG2;FLT4;SOX9;ENPP2;WNT5A;RAC1;SASH1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.5394750373210597,1.6741999768627538,0.0,0.43382847249205087,1.0,41/149,14.67%,PRKCH;RPS6KA5;NOD1;CAV1;APP;PRKD1;ARHGEF2;PRKD2;STAT3;AIM2;TNFRSF11A;TRIM14;NFKBIA;TRAF1;TIRAP;IKBKB;CX3CR1;TRIM68;WNT5A;CD40;MID2;NFKB1;TRIM25;MALT1;IKBKG;PSMA6;MAP3K13;RIPK1;CARD16;RELA;RIPK2;RNF25;RAB7B;MTPN;NFKB2;IL1RAP;NPM1;TRAF6;S100A9;ERC1;IRAK3
prerank,skeletal system development (GO:0001501),-0.44162231910288025,-1.6738584549109337,0.0,0.19178121131304343,0.999,41/148,8.06%,BMP6;COL1A2;SOX5;IGF1;SULF1;FBN1;FGFR2;COL1A1;GLI2;CDH11;AKAP13;BMP5;TRPS1;BMP7;GJA1;SULF2;NPR3;TGFBR1;WWOX;COL13A1;PKD1;PCSK5;RBP4;SOX6;EXT1;SH3PXD2B;GNAS;MMP14;TNFRSF11B;MMP16;IGF2;ALPL;EVC;ITGB8;PRELP;KIAA1217;PAPSS2;VCAN;NOTUM;CD44;COL9A2
prerank,modified amino acid transport (GO:0072337),-0.6829247495477406,-1.6720621250076813,0.015659955257270694,0.19251172833499117,0.999,3/15,1.61%,SLC6A13;SLC16A12;PDPN
prerank,endothelial cell development (GO:0001885),0.6965926095969677,1.6717034155268535,0.011164274322169059,0.4383477708239552,1.0,11/25,7.67%,PECAM1;PPP1R16B;ICAM1;PDE2A;MSN;PDE4D;RAP1B;SOX18;ROBO4;RAPGEF2;RAP1A
prerank,actin filament depolymerization (GO:0030042),-0.7410809264056903,-1.6699874403973995,0.0117096018735363,0.19333484103959928,0.999,3/11,1.04%,MICAL3;GSN;MICAL2
prerank,blood vessel morphogenesis (GO:0048514),0.6183395532833302,1.6689138511559032,0.01002865329512894,0.4436760616516005,1.0,18/54,7.48%,EGFL7;FLT1;KDR;ENG;CAV1;TBX1;RASIP1;LRP5;SOX17;SOX18;FLT4;CDH2;LAMA1;ID1;SMAD7;RAMP2;TGFB1;RASA1
prerank,monocyte chemotaxis (GO:0002548),0.6858600955768276,1.6684784372142292,0.00473186119873817,0.4383139365048928,1.0,5/32,4.46%,FLT1;PDGFB;IL6R;TNFRSF11A;RPS19
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.5128178529833348,-1.6681523421042426,0.003424657534246575,0.1940182539401337,0.999,25/54,18.65%,GPC6;SDC2;GPC3;HSPG2;HS3ST3A1;EXT1;PXYLP1;HS3ST3B1;HS2ST1;GPC5;HS6ST2;SDC4;GCNT2;XYLT1;HS6ST1;HS3ST5;GPC4;HEXA;B4GALT7;SDC1;GPC1;HGSNAT;UGDH;B3GAT2;IDUA
prerank,L-serine metabolic process (GO:0006563),0.8189665278723206,1.6661577046712501,0.007366482504604052,0.4426063785007886,1.0,2/10,2.42%,SERINC3;SERINC5
prerank,cytosolic calcium ion transport (GO:0060401),-0.585269995542361,-1.6661058667189275,0.002638522427440633,0.1946666107474757,0.999,15/28,18.22%,CACNA1C;CACNA2D1;JPH1;SLC8A1;MCU;SLC35G1;ATP2A2;RYR2;MICU1;ADRA1A;JPH2;SLC25A23;CACNB3;SLC8A2;ATP2A3
prerank,regulation of GTPase activity (GO:0043087),0.5321986497416933,1.6654727360491248,0.001182033096926714,0.43894357447242127,1.0,38/177,10.72%,PRKG1;CHN2;LRCH1;FGD5;DOCK9;PKP4;TGM2;PLXNA4;NET1;ITGA6;F11R;TBC1D30;RASIP1;SH3BP4;FGD6;DAB2IP;SRGAP2;PLXND1;ARHGAP27;CAV2;ADRB1;TBC1D15;RAP1GDS1;CD40;RAPGEF2;BCAR3;PTK2;RAP1A;TBC1D2;AGRN;RSU1;RASA4;ARHGEF7;CRK;OCRL;LARS1;CCL14;SEMA4D
prerank,growth hormone receptor signaling pathway (GO:0060396),0.7792271665753467,1.6643926030318754,0.009074410163339383,0.4370657493465573,1.0,8/14,9.08%,SOCS2;LYN;STAT3;PXN;JAK3;GHR;PTK2;PTPN1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.6562939426140777,1.664005191233985,0.015748031496062992,0.4321913219307231,1.0,11/36,6.02%,LEF1;NFATC1;FZD6;FZD4;PPP3CA;GNB1;PLCB1;TCF7L2;WNT5A;TNRC6C;PPP3CB
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.5646965042005478,-1.6635705755206216,0.005934718100890208,0.19692554447368077,0.999,21/37,20.23%,DYNC2H1;IFT81;WDR35;DYNC2I1;KIF3C;KIF3A;IFT80;IFT88;IFT46;IFT20;DYNC2LI1;IFT43;IFT22;TRAF3IP1;PCM1;KIFAP3;IFT140;IFT74;IFT27;TTC21B;IFT57
prerank,calcium ion transmembrane transport (GO:0070588),-0.4685151691195668,-1.663089314661717,0.0,0.1950478793323145,0.999,25/86,13.39%,SLC24A3;TRPM3;CACNA1C;NALCN;SLC8A3;CACNA2D1;CACNA1D;PKD1;SLC8A1;P2RX4;MCU;SLC35G1;CACNA1G;ITGAV;TRPC3;TRPC6;TRPC1;ATP2A2;SLC24A2;TRPC4;MICU1;GRIN2A;YME1L1;TRPC5;GRIN2D
prerank,positive regulation of angiogenesis (GO:0045766),0.5575348266155424,1.6624805686333355,0.0,0.43201164391954167,1.0,27/108,8.41%,TEK;TJP1;NOS3;FLT1;KDR;TIE1;PRKD1;SMAD1;PLCG1;VEGFC;GATA2;PRKD2;HIF1A;CD34;PIK3R6;DLL1;XBP1;HIPK1;VEGFD;RAMP2;WNT5A;CD40;SASH1;JAK1;ITGA5;GAB1;SFRP2
prerank,inositol lipid-mediated signaling (GO:0048017),-0.5192639679537994,-1.6616676092982963,0.0,0.19484794332788488,0.999,15/50,7.60%,PLCL1;IGF1;PLCE1;PDGFRB;PDGFRA;ADAP2;IRS1;PI4KA;GAB2;OGT;PLCD3;NGF;PLCB3;PLCD1;EZR
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.5341295055993658,1.6576419054298401,0.001183431952662722,0.44813226043072996,1.0,31/151,9.99%,ACER2;CERT1;ELOVL7;SPTLC2;SGMS1;DEGS2;PRKD1;GCH1;SPNS2;PLA2G4A;PLPP1;SGPP2;PRKD2;PRKD3;ALAS1;CERS4;LPCAT3;SPTLC3;ELOVL5;GPHN;SPTSSA;CEPT1;PAM;LPIN3;PPM1L;B4GALT5;GSTO2;GSTA4;B3GNT6;TNIP1;MOCOS
prerank,regulation of endothelial cell migration (GO:0010594),0.5666004117564372,1.6554392192590623,0.005383580080753701,0.4524743204465534,1.0,23/85,7.54%,NRP2;TEK;BMPR2;KDR;ACVRL1;PRKD1;PTPRM;PRCP;FOXP1;DAB2IP;SCARB1;EDN1;PRKD2;PTK2B;FLT4;RHOJ;CEACAM1;DLL4;WNT5A;RAC1;SASH1;PTK2;PIK3CG
prerank,T-helper cell differentiation (GO:0042093),0.7870135895725009,1.6537688872698568,0.010471204188481676,0.4542459913556534,1.0,4/14,9.32%,LEF1;FOXP1;TMEM98;ZFPM1
prerank,lymphocyte differentiation (GO:0030098),0.5915363177817494,1.6526085426553496,0.005633802816901409,0.4532847820857978,1.0,22/68,13.49%,HDAC9;PBX1;LFNG;VCAM1;HHEX;TPD52;PTPRJ;ADGRG3;CHD7;PLCG2;TOX;JAK3;DLL4;LYL1;LCK;TCF3;RELB;SOX4;JAG2;DCAF1;KLF6;ADAM17
prerank,regulation of lymphocyte migration (GO:2000401),0.8187041085006386,1.6506505620166207,0.02394106813996317,0.45609059131471597,1.0,3/10,2.75%,JAM2;STK10;MSN
prerank,regulation of macrophage migration (GO:1905521),0.8070019544516215,1.6503368025378904,0.01876172607879925,0.45096977587739406,1.0,6/10,11.02%,MTUS1;CD200;PTK2B;CX3CR1;CSF1;P2RY12
prerank,hippo signaling (GO:0035329),0.6885722669973625,1.6500646483686572,0.019672131147540985,0.446297828829834,1.0,7/26,5.98%,TJP1;TEAD4;TJP2;WWTR1;STK3;STK4;TEAD2
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.5671120183566613,-1.6491187959803004,0.008982035928143712,0.21674892530566817,1.0,10/31,5.93%,FGFR2;PDGFRA;HOXC4;OSR1;TGFBR1;HOXA3;DYNC2I1;HOXB4;SIX1;HOXB3
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.804224669375217,1.647717118456749,0.012939001848428836,0.45143142255100976,1.0,7/12,11.44%,ERN1;DAB2IP;XBP1;BOK;BCL2L11;PTPN1;ATF6
prerank,embryonic organ morphogenesis (GO:0048562),-0.508859582387945,-1.6441157111146574,0.0,0.2241254190323859,1.0,15/42,8.88%,FBN1;FGFR2;PDGFRA;HOXC4;EFEMP1;MFAP5;HOXA3;RBP4;DYNC2I1;FBN2;HOXB4;SIX1;HOXB3;RBPMS2;RYR2
prerank,response to interleukin-4 (GO:0070670),0.8166759967041064,1.6407586398759266,0.0196078431372549,0.4789293585333369,1.0,5/10,8.44%,LEF1;JAK3;XBP1;DCSTAMP;CITED1
prerank,hemopoiesis (GO:0030097),0.5700074377592471,1.6406537640237289,0.007853403141361256,0.47304824845433713,1.0,20/87,7.29%,MECOM;TEK;FLT1;KDR;SNRK;ZBTB16;ETV6;KITLG;PDGFB;TAL1;FLT4;CD34;TOX;TIRAP;DLL1;HIPK1;WNT5A;LYL1;TGFB1;LCK
prerank,regulation of T cell migration (GO:2000404),0.7400573994299704,1.6392967375162852,0.020654044750430294,0.4734359312403155,1.0,3/18,1.50%,LRCH1;APP;CD200
prerank,regulation of plasminogen activation (GO:0010755),-0.7062901318781813,-1.6386737126976638,0.016985138004246284,0.23320766248805827,1.0,6/12,14.45%,CLEC3B;THBS1;SERPINE2;SERPINE1;RUNX1;CTSZ
prerank,diol biosynthetic process (GO:0034312),0.7592804912448233,1.6377724591071114,0.020202020202020204,0.4750013549232405,1.0,5/15,5.59%,ACER2;SPTLC2;GCH1;SPTLC3;ASAH2
prerank,adenine nucleotide transport (GO:0051503),0.7423068678970255,1.637053280632138,0.024154589371980676,0.4723349949821028,1.0,2/17,0.56%,ABCC4;LRRC8C
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.6952711977781079,1.636308358101858,0.0128,0.46981598192261476,1.0,4/23,3.91%,CADM1;NECTIN2;PVR;PIK3R6
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.5848912126543679,1.634845615738745,0.009817671809256662,0.47077660623064593,1.0,23/70,14.15%,WIPF3;PLCG1;DOCK1;ELMO1;WASF2;LYN;YES1;FYN;NCK1;PLCG2;ARPC3;NCKAP1;ARPC1B;RAC1;PTK2;CRK;FCGR1A;MYO1C;ACTR2;CYFIP1;PLD2;HSP90AB1;ACTR3
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.5020471489581415,-1.63356272212377,0.012618296529968454,0.24097383110411802,1.0,9/53,4.98%,EYA2;EGFR;EYA1;DDX5;EYA4;PLA2R1;PRKCD;SPRED1;FXR2
prerank,maintenance of blood-brain barrier (GO:0035633),0.6666694527546463,1.6333429536381106,0.012738853503184714,0.47162266000766306,1.0,9/30,1.96%,TJP1;PECAM1;JAM2;ESAM;LSR;CLDN5;OCLN;F11R;TJP2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.7981106523488476,1.6331751373808276,0.012773722627737226,0.4666403938817231,1.0,3/11,4.50%,SEMA6A;EPN2;KLF2
prerank,negative regulation of protein processing (GO:0010955),-0.7175252857589995,-1.6324323687154054,0.006564551422319475,0.24019593878488918,1.0,7/12,20.49%,GAS1;THBS1;SERPINE2;LRRK2;SERPINE1;CTSZ;TMEM59
prerank,heart morphogenesis (GO:0003007),0.6133393205412414,1.6291891679301391,0.010130246020260492,0.48066323557041596,1.0,13/50,7.32%,NOS3;ENG;TBX1;EPHB4;ACVRL1;INSR;NOTCH1;SOX17;CHD7;FKBP1A;SOX9;ACVR1;PTK2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.7036822072653429,1.6290489845572187,0.015254237288135594,0.47566693843772734,1.0,4/21,2.30%,PRKCH;FOXP1;ELF2;LYN
prerank,regulation of transferase activity (GO:0051338),0.7407303773392225,1.6282503676310767,0.01559792027729636,0.47391730710682517,1.0,4/17,8.33%,LDB2;NLRC5;HMBOX1;PINX1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.5814029731695854,1.6263686564561597,0.009831460674157303,0.47755033737013364,1.0,23/71,14.15%,WIPF3;PLCG1;DOCK1;ELMO1;WASF2;LYN;YES1;FYN;NCK1;PLCG2;ARPC3;NCKAP1;ARPC1B;RAC1;PTK2;CRK;FCGR1A;MYO1C;ACTR2;CYFIP1;PLD2;HSP90AB1;ACTR3
prerank,bicellular tight junction assembly (GO:0070830),0.6192774732372073,1.6262628177685703,0.010071942446043165,0.47262918624537875,1.0,8/46,5.78%,PECAM1;ESAM;CLDN5;OCLN;F11R;PARD3;PAK2;RAMP2
prerank,glial cell differentiation (GO:0010001),0.6696394734528306,1.6260331756219848,0.01732283464566929,0.4684291443737831,1.0,8/28,11.25%,ADGRG6;STAT3;CDH2;SOX9;EIF2B5;SOX4;NFIB;PICK1
prerank,lipid translocation (GO:0034204),0.6980538007488276,1.6248992620709384,0.01692047377326565,0.4684341108425314,1.0,5/21,2.92%,ATP8B1;ATP8A1;ATP10A;ATP11C;ATP11B
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.7227594101438655,1.6245181163496796,0.017452006980802792,0.4652150396860774,1.0,8/18,4.17%,HDAC9;KDR;PTGS2;GATA2;JCAD;HDAC7;PIK3C2A;RHOJ
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.5741308100726022,1.6240938175143762,0.012413793103448275,0.462355530705592,1.0,23/73,14.15%,WIPF3;PLCG1;DOCK1;ELMO1;WASF2;LYN;YES1;FYN;NCK1;PLCG2;ARPC3;NCKAP1;ARPC1B;RAC1;PTK2;CRK;FCGR1A;MYO1C;ACTR2;CYFIP1;PLD2;HSP90AB1;ACTR3
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.6042729691835512,-1.623049749270747,0.035046728971962614,0.25931428779366666,1.0,6/19,11.24%,WNT4;BMP4;LARP6;RGCC;TGFB3;RUNX1
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.7157060038597206,1.62118367805367,0.027868852459016394,0.4710879909818771,1.0,10/18,16.88%,RNF125;SEC14L1;USP15;PUM1;OASL;PUM2;BIRC3;NOP53;GPATCH3;BIRC2
prerank,angiogenesis involved in wound healing (GO:0060055),0.801764594554754,1.621121334982851,0.02564102564102564,0.4662486105687408,1.0,5/11,3.88%,ADIPOR2;KDR;PRCP;GATA2;CD34
prerank,regulation of microtubule-based process (GO:0032886),-0.544187971923662,-1.6197849319812683,0.0029239766081871343,0.2637105757652011,1.0,8/36,7.07%,PHLDB2;EPHA3;EFNA5;PHLDB1;BICD1;PRKAA2;ATF5;MAP6
prerank,L-glutamate transmembrane transport (GO:0015813),-0.733006053571178,-1.617907035886776,0.0262582056892779,0.2647398128757134,1.0,7/10,18.25%,SLC1A3;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18;PRAF2
prerank,phosphorylation (GO:0016310),0.48636523457730607,1.6173803902970663,0.0,0.47703536071415653,1.0,99/384,13.03%,PRKG1;PRKCH;ERG;RPS6KA5;CDK17;BMPR2;APP;SNRK;ERN1;ACVRL1;PRKD1;CDK6;INSR;DAPK1;NEK7;PDGFB;PEAK1;DGKZ;LYN;PRKD2;STAT3;BCR;PIM3;PRAG1;ADAM10;PTK2B;STK10;FNIP2;MAP4K3;SIK1;FYN;TAOK2;STK24;STK3;PKN3;LIPE;PKN2;PAK2;PKN1;STK4;LMTK2;MARK3;JAK3;IKBKB;MAP3K9;DGKH;HIPK1;ACVR2A;CDC42BPB;MAST2;MAPK8;PLK2;RET;ULK1;LIMK2;PPP3CB;AURKA;ACVR1;SIK3;TSSK6;DYRK1A;JAK1;STK26;TNIK;TGFB1;BMX;LCK;PIK3CG;NEK6;CERKL;CTBP1;PXK;SGK3;HASPIN;CREB1;PANK2;AURKC;MAP3K11;CDK2;COPS2;NUAK1;PRKAB1;CDK18;AKT3;GAS6;GK5;PICK1;DGKE;GMFG;STK38;MAP3K13;PIM1;SIK2;MKNK2;GNPTAB;TOP1;TGFBR2;TRIB1;EIF2AK4
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.6633510009495084,-1.6166622393685963,0.022004889975550123,0.26466471079717563,1.0,7/16,9.13%,FOXD1;FGF1;BMP4;FGF2;SALL1;SIX1;NPNT
prerank,aminoglycan biosynthetic process (GO:0006023),-0.5047134868602455,-1.616444430833158,0.012987012987012988,0.2617859336239203,1.0,21/49,13.16%,GPC6;SDC2;B3GALT1;GPC3;HSPG2;HS3ST3A1;EXT1;PXYLP1;HS3ST3B1;HS2ST1;GPC5;HS6ST2;SDC4;GCNT2;XYLT1;HS6ST1;HS3ST5;GPC4;HEXA;B3GALT5;B4GALT7
prerank,peripheral nervous system development (GO:0007422),0.6941088106617083,1.615367518908725,0.023923444976076555,0.4814201309572532,1.0,1/23,0.01%,ADGRG6
prerank,myeloid cell differentiation (GO:0030099),0.5910101064369135,1.6145640829626815,0.023121387283236993,0.4802162302029841,1.0,10/47,5.07%,SNRK;ZBTB16;LYN;TAL1;MFHAS1;TIRAP;RPS19;JAK3;RPS14;KMT2E
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.6301480849904971,1.6145354136312389,0.015384615384615385,0.4753305750850982,1.0,11/38,7.67%,CAV1;PTGS2;INSR;EDN1;CD34;KLF2;CX3CR1;ATP2B4;RAC1;NOS1AP;PKD2
prerank,receptor clustering (GO:0043113),-0.5725963723906047,-1.614450553125038,0.019704433497536946,0.2631467091964943,1.0,14/27,20.30%,MAGI2;PTN;DLG2;DLG4;DLG1;NRXN1;NLGN1;DLG3;NRXN2;LRRC7;DVL1;ITGA4;MUSK;ITGB2
prerank,aminoglycan catabolic process (GO:0006026),-0.5688371040555583,-1.6142669662460876,0.013812154696132596,0.2602562966937296,1.0,11/28,18.65%,GPC6;SDC2;GPC3;HSPG2;GPC5;SDC4;GPC4;SDC1;GPC1;HGSNAT;IDUA
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.6279124365519859,1.6130608641541342,0.015479876160990712,0.47723849570306853,1.0,6/38,3.61%,NOS3;TNFSF10;ICAM1;ARHGEF2;FAS;CASP8
prerank,brain morphogenesis (GO:0048854),0.7731658200867737,1.6125143120660888,0.027124773960216998,0.4748921309618888,1.0,1/12,0.09%,SHANK3
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.7105329860530263,1.610995685807327,0.024822695035460994,0.47683986725269256,1.0,4/18,7.96%,GNAQ;GNB1;PLCB1;AGRN
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.7221959641397302,1.6102402085271204,0.023529411764705882,0.4753870182422212,1.0,3/17,3.19%,CADM1;NECTIN2;PVR
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.7602305180733883,1.6098441906941465,0.03046594982078853,0.4725506422904125,1.0,3/12,7.19%,ESR1;STAT3;TGFB1
prerank,cellular response to sterol (GO:0036315),-0.6744713375059799,-1.6095949726502183,0.029082774049217,0.2686605214832355,1.0,9/13,21.10%,GRAMD1B;GRAMD1C;INSIG2;RORA;LRP6;SMO;INSIG1;GPLD1;PTCH1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.6609638250971368,-1.6085419941442987,0.013824884792626729,0.26769708357903793,1.0,4/14,3.92%,SULF1;SULF2;THBS1;FGF2
prerank,metanephros development (GO:0001656),-0.5705255585888038,-1.608525117140878,0.020588235294117647,0.26450477487048707,1.0,8/26,5.87%,FOXD1;BMP7;OSR1;BMP4;PKD1;ROBO2;SIX1;NF1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.7306505517411839,1.6071612897170275,0.02707275803722504,0.48049648664871963,1.0,3/16,3.19%,CADM1;NECTIN2;PVR
prerank,regulation of angiogenesis (GO:0045765),0.507764724066445,1.6060935134298542,0.001177856301531213,0.48071828409264267,1.0,37/192,6.82%,SEMA6A;TEK;NOS3;FLT1;KDR;TIE1;PPP1R16B;PRKD1;CLDN5;PTPRM;PLCG1;VEGFC;ECSCR;GATA2;DAB2IP;HHEX;PRKD2;STAB1;NPR1;ADGRA2;HIF1A;PLXND1;CD34;PIK3R6;GTF2I;RHOJ;TSPAN12;XBP1;HIPK1;CEACAM1;VEGFD;ATP2B4;RAMP2;WNT5A;CD40;SASH1;EGLN1
prerank,alpha-amino acid catabolic process (GO:1901606),-0.554081836195352,-1.6042358053692505,0.012953367875647668,0.2712122512749507,1.0,10/29,16.51%,DDO;ACADSB;ALDH4A1;PRODH;FAH;ACAT1;CBS;HOGA1;GSTZ1;BLMH
prerank,nitric oxide metabolic process (GO:0046209),0.75035348808881,1.6030280160597155,0.035211267605633804,0.4901370653675481,1.0,2/14,1.56%,NOS3;GCH1
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.6899741683067707,-1.6029792617718788,0.014018691588785047,0.27098225291614897,1.0,6/13,9.35%,MGAT3;LARGE1;RENBP;PGM3;NAGK;CHST3
prerank,regulation of neurotransmitter transport (GO:0051588),0.7348577740764827,1.6019160011536409,0.012280701754385965,0.4906406032856003,1.0,6/16,12.99%,MCTP1;MEF2C;KCNMB4;SNCAIP;MCTP2;FMR1
prerank,purine ribonucleotide transport (GO:0015868),0.7432190925478472,1.601506354673119,0.03140495867768595,0.48793176213293,1.0,2/16,0.56%,ABCC4;LRRC8C
prerank,vasculogenesis (GO:0001570),0.640354400347211,1.6011316294420965,0.03317535545023697,0.48516600982653024,1.0,11/32,7.48%,EGFL7;KDR;ENG;CAV1;RASIP1;NOTCH1;SOX17;SOX18;RAMP2;TGFB1;RASA1
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.6489981999072363,-1.5997519157381053,0.021377672209026127,0.2755817686666119,1.0,8/17,18.45%,IGF1;NTRK2;RTN1;BIN1;APOE;RTN4;ABCA7;CHRNA7
prerank,regulation of chemokine production (GO:0032642),0.6361815918937707,1.5997110544249769,0.018808777429467086,0.48709014271908035,1.0,8/36,7.31%,APP;FOXP1;IL6R;HIF1A;ACKR1;SIGIRR;WNT5A;LPL
prerank,cellular response to interleukin-4 (GO:0071353),0.7988468368446993,1.5995731411298624,0.023668639053254437,0.4833692756622953,1.0,4/10,6.57%,LEF1;JAK3;XBP1;DCSTAMP
prerank,cardiac muscle cell contraction (GO:0086003),-0.6188624212433108,-1.5991273323196764,0.01978021978021978,0.2736928066277473,1.0,6/19,7.21%,CACNA1C;GSN;CACNA2D1;CACNA1D;CACNA1G;KCNJ2
prerank,nitric oxide biosynthetic process (GO:0006809),0.7553473985165382,1.597914318218811,0.0374331550802139,0.4867145177785988,1.0,2/13,1.56%,NOS3;GCH1
prerank,hemidesmosome assembly (GO:0031581),0.7900211485348512,1.5977816092889605,0.024528301886792454,0.4829508113603667,1.0,3/11,3.66%,ITGA6;DST;LAMA3
prerank,regulation of cellular component biogenesis (GO:0044087),0.618754526468846,1.5976161830833793,0.02147239263803681,0.47935605626730793,1.0,9/39,7.67%,TJP1;TIE1;DAB2IP;MSN;NOTCH1;RAP1B;RAPGEF2;SNCAIP;RAP1A
prerank,regulation of B cell proliferation (GO:0030888),0.6093136356278124,1.5973522023535234,0.016541353383458645,0.47622090272855205,1.0,11/44,11.05%,CD38;MEF2C;AHR;LYN;BST1;TIRAP;CD40;TNFRSF13C;IL7;CD320;RC3H1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.5106571741030256,1.5973313067976993,0.0024067388688327317,0.47215298396590444,1.0,76/168,20.50%,CNOT6;PAN3;CNOT6L;RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPS20;RPL39;RPL34;RPS7;RPS24;RPL37A;RPS18;RPL36;RPL15;RPL14;RPS8;RPL23;RPL17;SMG7;RPL9;RPL4;NBDY;CNOT1;RPL13A;RPS11;RPL32;RPL22;DCP2;RC3H1;CNOT2;RPL31;RPS27;RNPS1;RPS23;RPL13;RPS12;RPL6;ZFP36;PNRC2;RPL10;CNOT7;UPF2;MTPAP;RPS29;RPS6;RPS25;ZFP36L1;RPL35A;RPL29;RPS13;XRN2;RPL18;RPL27A;RPS21;RPL27;CTIF;RPS10;RPL11;CSDE1;RPLP2;PPP2R2A;HELZ2;RPL8;RPL18A;DHX34;RPS3;PPP2R1A;RPL21;RPL3;PAN2;LSM1
prerank,regulation of T cell proliferation (GO:0042129),0.5717227854742196,1.5965396029728323,0.002857142857142857,0.4716262403588867,1.0,10/61,9.76%,IL6ST;VCAM1;IL15;TNFRSF1B;NCK1;JAK3;TNFSF8;PLA2G2D;TNFRSF13C;IL23A
prerank,endocardial cushion development (GO:0003197),0.6970141115404672,1.5943617345784447,0.0390015600624025,0.47687706641337596,1.0,8/21,6.15%,NOS3;BMPR2;ENG;ACVRL1;NOTCH1;SOX9;FOXF1;ACVR1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.5826185281494209,1.5943517605367474,0.009971509971509971,0.4728713719735342,1.0,14/63,10.91%,CD38;IL6ST;MEF2C;VCAM1;IL15;BST1;NCK1;TIRAP;JAK3;CD40;TNFRSF13C;IL23A;IL7;CD320
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.7602863254928268,1.593167337937587,0.0297951582867784,0.47410106035945215,1.0,1/12,0.05%,IL1R1
prerank,negative regulation of wound healing (GO:0061045),-0.5612136656946416,-1.5924696663048585,0.023255813953488372,0.28673638586818617,1.0,11/28,10.31%,PHLDB2;VTN;TFPI;SLC12A2;FGF2;SERPINE2;CD109;CASK;AJAP1;SERPINE1;APOE
prerank,regulation of immune response (GO:0050776),0.522914553955398,1.5922447490386726,0.00125,0.47419764860762786,1.0,22/135,6.03%,CLEC2D;ICAM1;VCAM1;IL15;CD200;B2M;AHR;FOXP1;LYN;SAMHD1;NECTIN2;ICAM2;DENND1B;PVR;CASP8;FKBP1A;CD34;TIRAP;SPPL2A;N4BP1;XIAP;CD40
prerank,regulation of defense response (GO:0031347),0.5623607394340363,1.5910423436571624,0.006887052341597796,0.47550899810725006,1.0,19/76,8.92%,IL1R1;PTGS2;SEMA7A;FOXP1;SAMHD1;CASP4;NLRP6;BST1;SELE;CASP8;TMSB4X;TIRAP;SBNO2;N4BP1;XIAP;WNT5A;CASP1;ERAP1;BRD4
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.632544387996238,-1.590560826812549,0.023696682464454975,0.28871917580528916,1.0,8/18,13.12%,ASPA;NAALAD2;SMS;SLC25A12;ASPG;GOT1;MTHFD1;SLC25A13
prerank,heterochromatin organization (GO:0070828),0.7254093569100981,1.589264450627813,0.05026929982046679,0.4791771570686055,1.0,3/14,8.64%,MECOM;SMCHD1;EZH1
prerank,regulation of response to external stimulus (GO:0032101),0.5306307360134607,1.5891364650773654,0.0038314176245210726,0.4757600396547839,1.0,32/121,12.24%,IL1R1;CAV1;PTGS2;SEMA7A;FOXP1;NMT2;SAMHD1;ADGRA2;CASP4;NLRP6;CNGB1;BST1;SELE;STK24;CASP8;TMSB4X;TIRAP;SBNO2;N4BP1;XIAP;WNT5A;GNAT1;CASP1;GUCA1B;ERAP1;BRD4;CYRIB;CXCR4;PSMA6;P2RY12;BIRC3;RELA
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.6434757631166531,-1.589066900263355,0.03225806451612903,0.28895583926510615,1.0,6/16,11.10%,ANK2;LRRK2;RYR2;GBF1;SEC16B;MIA3
prerank,homeostasis of number of cells (GO:0048872),0.762061457676872,1.5887930987069812,0.04638218923933209,0.4733560589005813,1.0,4/12,5.49%,NOS3;NOTCH1;LPCAT3;CX3CR1
prerank,B cell activation (GO:0042113),0.5650972959737817,1.5884095733576375,0.017591339648173207,0.47119238771902383,1.0,15/68,8.38%,HDAC9;MEF2C;VCAM1;HHEX;CTPS1;TPD52;PTPRJ;ADGRG3;CASP8;PLCG2;JAK3;CD40;LYL1;TCF3;MALT1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.6841622958424949,-1.5873414631197325,0.021413276231263382,0.28980854150491764,1.0,8/12,14.64%,DMD;ATP1B1;WNK4;ANK3;WNK1;ATP1B2;WNK3;FXYD1
prerank,monocarboxylic acid transport (GO:0015718),0.5835286137460548,1.5863872990682504,0.01023391812865497,0.47630521596187614,1.0,10/51,5.16%,ABCC4;SLCO2B1;ABCG2;ATP8B1;SLCO2A1;STARD5;SLC16A2;SLC16A9;NCOA1;CEACAM1
prerank,platelet degranulation (GO:0002576),0.5313629554761079,1.5857398287996094,0.0,0.4753526776650686,1.0,20/118,7.27%,VWF;ABCC4;PECAM1;PCDH7;APP;PDGFB;VEGFC;LYN;ACTN4;SELENOP;SELP;TMSB4X;ACTN1;PROS1;QSOX1;VEGFD;TAGLN2;PPBP;TGFB1;SRGN
prerank,positive regulation of vasculature development (GO:1904018),0.5412251170211682,1.585097819438045,0.005256241787122208,0.4741193501025209,1.0,20/94,6.29%,TEK;NOS3;FLT1;KDR;TIE1;PRKD1;PLCG1;VEGFC;GATA2;PRKD2;HIF1A;CD34;PIK3R6;XBP1;HIPK1;VEGFD;RAMP2;WNT5A;CD40;SASH1
prerank,regulation of cell killing (GO:0031341),0.7278911558733148,1.58502099638425,0.03986135181975736,0.4707210880191861,1.0,6/16,7.56%,CFH;ICAM1;MAPK8;WNT5A;RAC1;CR1L
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.6815643362028042,-1.5821089566825892,0.023094688221709007,0.3001276196244167,1.0,4/13,4.82%,ANK2;CACNA1C;GJA1;CACNB2
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.5597927859871871,-1.581339428351361,0.016042780748663103,0.2988417356582903,1.0,10/28,9.15%,PID1;PRKCB;APPL2;IRS1;ENPP1;GRB10;PRKCD;TNS2;PRKCZ;TSC2
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.6075773451714171,-1.581198082289519,0.04028436018957346,0.2959438745069967,1.0,9/19,18.45%,IGF1;NTRK2;RTN1;BIN1;APOE;FLOT2;RTN4;ABCA7;CHRNA7
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.624885988520274,-1.580675715868339,0.034324942791762014,0.29422040148253853,1.0,6/16,11.24%,WNT4;BMP4;LARP6;RGCC;TGFB3;RUNX1
prerank,regulation of integrin activation (GO:0033623),0.7240405295053154,1.580304823048964,0.024734982332155476,0.4874788272081519,1.0,5/15,6.24%,PIEZO1;RASIP1;RAP1B;SELP;SKAP1
prerank,endothelial cell proliferation (GO:0001935),0.7056944725766894,1.5792658752872817,0.04258943781942078,0.48804298772837396,1.0,5/17,3.88%,TEK;BMPR2;ERN1;ACVRL1;CD34
prerank,mRNA splice site selection (GO:0006376),-0.5488412193711537,-1.5785374552071871,0.014044943820224719,0.2965030515126624,1.0,7/30,12.93%,CELF2;SRSF5;CELF4;LUC7L3;PSIP1;SF1;CELF1
prerank,sodium ion transmembrane transport (GO:0035725),-0.44339019931462,-1.5783881597993026,0.0,0.2937283252877187,1.0,13/84,3.34%,ATP1A2;SLC24A3;NALCN;SLC6A13;SLC8A3;SLC12A2;SLC6A1;SCN7A;SLC9A9;SLC6A12;SLC6A9;ATP1B1;SLC8A1
prerank,rRNA metabolic process (GO:0016072),0.5109314966786159,1.5767419701773455,0.001201923076923077,0.495121318803896,1.0,87/160,27.97%,DDX54;RPS15;IMP3;RPS19;RPLP1;RPS14;RPS16;RPL38;RPL39;RPL34;RPS7;RPS24;MTREX;FCF1;RPL37A;RPF1;RPL36;RPL15;RPL14;RPL23;RPL17;NIFK;RPL9;RPL4;RPL13A;RPL32;RPL22;EXOSC1;RPL31;RPS27;RPL13;UTP4;RPL6;NOP53;RPL10;RPS6;PELP1;RPS25;RRP9;TRIR;RPL35A;RPL29;XRN2;RPL18;RPL27A;RPL27;EMG1;RRP1B;UTP6;PIH1D1;RPL11;PDCD11;WDR18;ESF1;NOP14;RPLP2;HEATR1;RPL8;RPL18A;RPL21;RPL3;DIS3L;RPS28;DDX47;SBDS;RPL7;RPL26;NOL6;TEX10;LYAR;RRP12;LAS1L;WDR74;NOLC1;EXOSC4;RPS9;WDR46;RPS17;RPS2;DIS3;RPL28;RPL41;RPL36A;RRP1;RPL37;UTP20;UTP18
prerank,regulation of epithelial cell differentiation (GO:0030856),0.709417222795758,1.5754947883137067,0.04054054054054054,0.4967024314549538,1.0,7/17,5.16%,CAV1;APOLD1;KLF7;MAFF;SOX9;DLL1;CEACAM1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.7082021024854837,1.5753011438245648,0.027960526315789474,0.49379592542959594,1.0,5/18,2.34%,RPS6KA5;CRTC1;PRKD1;CD200;PRKD2
prerank,determination of bilateral symmetry (GO:0009855),0.6763721776006311,1.5747778081271728,0.033444816053511704,0.4922874626733079,1.0,6/24,8.52%,TBX1;ZIC3;NOTCH1;DLL1;PKD2;CFAP53
prerank,myeloid leukocyte differentiation (GO:0002573),0.5641581332673161,1.5743901321078404,0.009575923392612859,0.490461062989668,1.0,12/65,9.40%,LEF1;CBFA2T3;IL15;PIR;MYH9;FOXP1;TNFRSF11A;CASP8;SBNO2;DCSTAMP;CDK2;CSF1
prerank,lung development (GO:0030324),-0.5439023975331204,-1.5742673778196827,0.0106951871657754,0.30025868872960115,1.0,18/33,17.34%,FGFR2;GLI2;FGF1;PDPN;ERRFI1;BMP4;PKD1;RBP4;LOXL3;FGF2;RCN3;VEGFA;STRA6;CCDC39;FGF7;WNT11;FGF10;NPHP3
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.7340571983750246,1.574173608067699,0.041666666666666664,0.4878095585590075,1.0,5/13,10.08%,NECTIN2;PVR;STX7;IL23A;CYRIB
prerank,lung epithelium development (GO:0060428),-0.709172738551868,-1.572773775605033,0.023554603854389723,0.30115857318181627,1.0,6/10,17.09%,ERRFI1;BMP4;PKD1;RCN3;STRA6;FGF10
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.4015876905375271,-1.572345014176254,0.0,0.2990679259090002,1.0,32/152,11.76%,RNF220;EGFR;SULF1;ZEB2;WLS;LGR4;FGFR2;COL1A1;GPC3;PTK7;SULF2;SEMA5A;DAAM2;RSPO3;RSPO2;DACT1;CAPRIN2;LYPD6;LRRK1;PLEKHA4;SALL1;PSME4;SFRP4;AXIN2;GPC5;LRRK2;SFRP1;WNK1;SMARCA4;DKK2;SCEL;GPRC5B
prerank,positive regulation of neuron migration (GO:2001224),0.7700249612532094,1.570525495458829,0.029159519725557463,0.499998208252147,1.0,4/11,6.24%,SEMA6A;DAB2IP;ARHGEF2;RAPGEF2
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.7129067250004693,1.5686272792019562,0.03636363636363636,0.5044785643849696,1.0,2/14,2.22%,NOS3;EDN1
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.6708044995986701,1.568602057914447,0.04280821917808219,0.5009427283940204,1.0,4/20,7.96%,GNAQ;GNB1;PLCB1;AGRN
prerank,cardiac conduction system development (GO:0003161),-0.5800625591860844,-1.5685310181699843,0.027855153203342618,0.3054327021366352,1.0,7/24,6.24%,NOTCH2;BMPR1A;GJB6;GJA1;BMP4;CACNA1G;TBX18
prerank,membrane fusion (GO:0061025),0.6159081321428306,1.5681798052985723,0.0297029702970297,0.4993732100866204,1.0,2/33,0.34%,DNM3;MYOF
prerank,positive regulation of cellular senescence (GO:2000774),0.7805669427386531,1.5673302215152718,0.047186932849364795,0.49926205430350695,1.0,3/10,9.33%,ABI3;B2M;CGAS
prerank,protein autophosphorylation (GO:0046777),0.5065211648236411,1.5663941168998845,0.0048250904704463205,0.49948327572197865,1.0,43/157,12.28%,TEK;FLT1;KDR;EPHB4;ERN1;PRKD1;INSR;DAPK1;PEAK1;LYN;PRKD2;PIM3;PTK2B;STK10;SIK1;TAOK2;STK24;SRMS;FLT4;PAK2;STK4;LMTK2;MARK3;MAP3K9;ULK1;AURKA;DYRK1A;STK26;TNIK;BMX;PTK2;NEK6;MAP3K3;SLK;MAP3K11;MAPKAPK3;EPHA4;MAP3K13;RIPK1;EEF2K;PIM1;SIK2;MKNK2
prerank,cellular response to interleukin-15 (GO:0071350),0.7377093823232047,1.5654171009153715,0.03942652329749104,0.4968497252198945,1.0,5/13,6.74%,IL15;STAT3;PLCB1;JAK3;JAK1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.7377093823232047,1.5654171009153715,0.03942652329749104,0.4968497252198945,1.0,5/13,6.74%,IL15;STAT3;PLCB1;JAK3;JAK1
prerank,ceramide biosynthetic process (GO:0046513),0.6074846326343757,1.5651696243272413,0.029641185647425898,0.49439711780672607,1.0,9/40,7.18%,ST6GALNAC3;SPTLC2;SGMS1;DEGS2;CERS4;SPTLC3;SPTSSA;ASAH2;ST8SIA4
prerank,glycerophospholipid catabolic process (GO:0046475),0.6571105805137063,1.5641369076794718,0.03538461538461538,0.4953605712906663,1.0,8/27,15.41%,GPCPD1;PLA2G4A;ENPP6;ENPP2;GDPD1;INPP5F;PNPLA6;PNPLA8
prerank,focal adhesion assembly (GO:0048041),0.6893897527917523,1.5634390307714603,0.042692939244663386,0.4950040075954059,1.0,7/21,5.24%,THSD1;PEAK1;BCR;TAOK2;ACTN1;SORBS1;PTPRK
prerank,positive regulation of developmental growth (GO:0048639),0.5908921404056615,1.563096744141292,0.01744186046511628,0.49305767011128854,1.0,14/49,12.14%,NTN1;INSR;SEMA7A;SMURF1;NEDD4L;ITSN2;PLCB1;DLL1;GHR;AGRN;TWF2;SEMA4D;MAP3K13;DBNL
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.7791389788172569,1.5626617039984223,0.026022304832713755,0.49157882165739014,1.0,1/10,0.04%,PRKCH
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.5836435825193952,-1.561760627588624,0.031331592689295036,0.31943209042439435,1.0,7/22,6.27%,CACNA1C;ADGRV1;CACNA1D;GRM3;NF1;CAP2;STIM1
prerank,sphingosine biosynthetic process (GO:0046512),0.7630729486990862,1.5589584735468753,0.04440497335701599,0.5003058341338559,1.0,4/11,5.59%,ACER2;SPTLC2;SPTLC3;ASAH2
prerank,sphingoid biosynthetic process (GO:0046520),0.7630729486990862,1.5589584735468753,0.04440497335701599,0.5003058341338559,1.0,4/11,5.59%,ACER2;SPTLC2;SPTLC3;ASAH2
prerank,cAMP-mediated signaling (GO:0019933),0.6661929376309463,1.5583130763037443,0.028764805414551606,0.49939265388074155,1.0,7/24,6.24%,ADGRG6;AHR;PDE2A;PDE7B;PDE4D;SOX9;RAPGEF2
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.7139055432710484,-1.5575164921143263,0.040268456375838924,0.3271310090887593,1.0,5/10,16.80%,ADGRV1;WHRN;IFT88;PLS1;TSKU
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.5981928693769198,1.556905509723969,0.022727272727272728,0.501952367386765,1.0,9/42,6.24%,TEK;KDR;UTRN;CDK6;PTK2B;PTPRJ;PPM1F;RAC1;SKAP1
prerank,regulation of glucose import (GO:0046324),-0.5553860629849566,-1.5547433306483216,0.02356020942408377,0.3313677556929111,1.0,10/30,6.05%,PID1;IGF1;APPL2;IRS1;RHOQ;ENPP1;GRB10;SELENOS;PRKAG2;OSBPL8
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.49908590722864143,-1.5545454558280205,0.012048192771084338,0.3287068604445686,1.0,13/40,6.81%,BMP6;BMPR1A;PTN;WNT4;BMP7;ADGRV1;OSR1;WNT6;BMP4;GPM6B;SLC8A1;FBN2;CCN1
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.7559959017906502,1.5537905057148735,0.039399624765478425,0.5114310693876143,1.0,5/11,9.77%,TJP1;F11R;TJP2;RAPGEF2;TJP3
prerank,regulation of phospholipase activity (GO:0010517),-0.715622435716102,-1.550758132579399,0.03571428571428571,0.33536921073336307,1.0,2/10,0.66%,LRP1;FGFR2
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.6054363447122583,1.5506515098837805,0.045941807044410414,0.5213812796657916,1.0,8/35,6.19%,NRP2;SEMA6A;PLXNA4;SEMA5B;SEMA7A;PLXND1;SEMA6B;RAC1
prerank,glucose transmembrane transport (GO:1904659),0.6842437564678596,1.550494548823624,0.044563279857397504,0.5186831129061682,1.0,4/18,6.89%,SLC2A1;PPARD;SLC2A9;PPBP
prerank,innate immune response (GO:0045087),0.4846900545570012,1.5493103107230524,0.0023148148148148147,0.5205169843620755,1.0,37/217,9.69%,SERINC3;APP;GCH1;B2M;NLRC5;NRROS;LYN;SERINC5;MFHAS1;PTK2B;YES1;TRIM14;FYN;SRMS;PLCG2;LCN2;IKBKB;CX3CR1;TRIM68;RPL39;PTX3;CD40;MID2;ADAM15;PGLYRP2;CFB;LCK;PTK2;PIK3CG;TRIM25;MALT1;CITED1;ANG;RELB;DEFA6;CYP27B1;IKBKG
prerank,lamellipodium assembly (GO:0030032),0.6455796926072046,1.5490867333530898,0.040783034257748776,0.5181821721911027,1.0,10/26,11.57%,PARVB;ABLIM1;SRGAP2;S1PR1;SPATA13;CCDC88A;RAC1;ARHGEF7;P2RY12;CYFIP1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.6604702804752272,1.5490258143512032,0.04186795491143317,0.5152063537719108,1.0,7/21,9.69%,PRKCH;FOXP1;PRKD2;NECTIN2;TESPA1;LCK;IKBKG
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.7178224891530758,1.548612894124538,0.03411131059245961,0.513899925376575,1.0,2/15,2.21%,PLTP;SCARB1
prerank,regulation of platelet activation (GO:0010543),0.6718340844588229,1.5485209408382727,0.04753820033955857,0.5111235561971431,1.0,5/21,3.96%,NOS3;PLA2G4A;PDGFB;LYN;SELP
prerank,regulation of inflammatory response (GO:0050727),0.48531168808688746,1.5479339785224295,0.002336448598130841,0.5102967764954889,1.0,35/190,12.24%,IL1R1;TEK;PTGS2;APP;PPARD;IL15;CD200;SEMA7A;FOXP1;PDE2A;MFHAS1;CASP4;NFKBIZ;TNFRSF1B;NFKBIA;NLRP6;BST1;SELE;LPCAT3;TMSB4X;SBNO2;XIAP;WNT5A;TNFRSF1A;LPL;CASP1;BRD4;TNIP1;IL23A;PSMA6;NMI;RB1;RIPK1;BIRC3;RELA
prerank,spermatid development (GO:0007286),0.6219767695874728,1.547702173321426,0.04146730462519936,0.5081787991835744,1.0,7/32,11.50%,JAM2;GALNTL5;NECTIN2;CDYL;CEP57;TTC21A;TDRD5
prerank,peptide biosynthetic process (GO:0043043),0.5010533599315858,1.5475614817074115,0.007272727272727273,0.5057615530389044,1.0,72/153,20.44%,RPS15;IGF2BP3;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPS20;RPL39;RPL34;RPS7;RPS24;RPL37A;SRBD1;RPS18;RPL36;RSL24D1;RPL15;RPL14;RPS8;MRPS18A;RPL23;RPL17;TNIP1;RPL9;RPL4;DHPS;RPL13A;RPS11;RPL32;RPL22;RPL31;RPS27;RPS23;MRPL13;RPL13;MRPS12;RPS12;MRPL35;HBS1L;RPL6;WARS1;MRRF;RPL10;MRPL41;MRPL52;RPS29;RPS6;RPS25;RPL35A;RPL29;RPS13;RPL18;RPL27A;MRPS16;RPS21;RPL27;MRPS5;MRPL23;RPS10;MRPL37;RPL11;RPLP2;MRPL11;RPL8;RPL18A;GGTA1;RPS3;RPL21;RPL3;MRPL43
prerank,regulation of cell morphogenesis (GO:0022604),-0.5360186355595848,-1.5470170407684236,0.0213903743315508,0.34200076964125314,1.0,13/30,16.33%,EFNA5;PDPN;SPARC;NTNG1;CD44;ZMYM6;ZMYM3;ZMYM4;MOV10;MFSD2A;MACF1;CAPZB;MYO9A
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.7731359878355891,1.5467745861363202,0.037300177619893425,0.506033296990942,1.0,4/11,6.74%,IL6ST;STAT3;IL27RA;JAK1
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.7556869554051819,1.5453167907969487,0.0595903165735568,0.5088764797989792,1.0,3/11,5.19%,AHR;CEACAM1;SMAD7
prerank,response to lipopolysaccharide (GO:0032496),0.5044732132315832,1.5451440666668197,0.0036991368680641184,0.5065858526222303,1.0,37/138,14.67%,NOS3;MEF2C;GCH1;FOXP1;DAB2IP;SCARB1;TNFRSF11A;TNFRSF1B;SELE;SELP;TIRAP;RPS6KA3;XBP1;SBNO2;CX3CR1;MAPK8;IFNAR1;PELI1;WNT5A;IL36G;PPBP;HNRNPA0;NFKB1;CASP1;CITED1;DEFA6;CYP27B1;MAPKAPK3;CARD16;RELA;GSTP1;ZFP36;TRIB1;ADAM17;TRAF6;S100A9;IRAK3
prerank,neuron projection regeneration (GO:0031102),-0.697677470880856,-1.5425675923790159,0.04504504504504504,0.3508312864445561,1.0,3/10,11.77%,PTN;GAP43;NREP
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.6194729526617861,1.5421430123729172,0.03930817610062893,0.515600272977643,1.0,6/29,10.08%,CADM1;NECTIN2;PVR;STX7;IL23A;CYRIB
prerank,acidic amino acid transport (GO:0015800),-0.6207840653328366,-1.5420169513431237,0.04096385542168675,0.34906821707002034,1.0,10/17,18.25%,SLC6A13;SLC1A3;GJA1;SLC6A1;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18;PRAF2
prerank,neuron projection organization (GO:0106027),0.7097957337332181,1.5406277552457157,0.05008635578583765,0.5182937176162278,1.0,7/15,12.13%,APP;INSR;ATP1A3;PSEN1;PICK1;LGMN;ABCD1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.6576393119913089,-1.5405908130907902,0.04608294930875576,0.34983227529491023,1.0,6/13,4.99%,FSTL1;FBN1;LTBP1;NBL1;GREM2;FBN2
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.5803198241860351,1.5398408661363634,0.026905829596412557,0.5184534891268762,1.0,9/45,8.38%,APP;STAT3;GBP5;AIM2;CASP8;WNT5A;LPL;CASP1;MALT1
prerank,neuron cell-cell adhesion (GO:0007158),-0.6554407658885006,-1.5395112869538126,0.03611738148984198,0.34947359612278317,1.0,9/14,12.33%,NLGN2;NRXN1;NLGN1;NRXN3;NCAM2;ASTN1;NLGN3;CNTN4;NRXN2
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.6671711862916571,1.5391841915699975,0.04251700680272109,0.51815910767535,1.0,11/20,14.13%,ADAM10;SPPL2A;TGFB1;NFKB1;PSEN1;RHBDD1;MBTPS2;APH1A;RELA;ADAM17;TRAF6
prerank,negative regulation of platelet activation (GO:0010544),0.6977224472598995,1.5372907709265318,0.04424778761061947,0.5230637649512888,1.0,4/16,5.16%,PRKG1;NOS3;PDGFB;CEACAM1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.5475663650260747,-1.5362901785591068,0.03,0.35517027238706217,1.0,10/23,15.64%,GLI3;GPC3;ENPP1;TULP3;GLIS2;BTRC;HHIP;SUFU;KIF7;PTCH2
prerank,protein depolymerization (GO:0051261),-0.5420242769198429,-1.5357029389668966,0.03581267217630854,0.3534796296770774,1.0,3/27,1.04%,MICAL3;GSN;MICAL2
prerank,cellular response to drug (GO:0035690),0.65186697602489,1.5329735116321395,0.047217537942664416,0.5388659076526869,1.0,7/25,7.12%,ACER2;MEF2C;KCNQ1;AIM2;PPM1F;FBP1;KCNE2
prerank,cellular response to mechanical stimulus (GO:0071260),0.5870575879704811,1.5326435410573043,0.033973412112259974,0.5371022765091523,1.0,14/46,11.08%,PIEZO1;F11R;PDE2A;FAS;CASP8;SOX9;MAPK8;CD40;TNFRSF1A;NFKB1;CASP1;CRADD;TNFRSF8;BNIP3
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.40157431299804747,-1.532407971013951,0.0,0.3594091510791922,1.0,28/129,13.01%,RNF220;EGFR;ZEB2;WLS;LGR4;FGFR2;COL1A1;GPC3;PTK7;SEMA5A;DAAM2;DACT1;CAPRIN2;LYPD6;LRRK1;PLEKHA4;PSME4;SFRP4;AXIN2;GPC5;LRRK2;SFRP1;WNK1;DKK2;SCEL;GPRC5B;PSMD12;UBE2B
prerank,cytokine-mediated signaling pathway (GO:0019221),0.4544899388181101,1.5321924408102399,0.0,0.5359440587964817,1.0,105/532,12.26%,IL1R1;RPS6KA5;FOXO1;ADIPOR2;NOD1;IL6ST;LIFR;INPP5D;PTGS2;MAOA;UGCG;LCP1;ICAM1;VCAM1;IL15;STX3;B2M;PDGFB;IRF2;IL6R;OSMR;SOCS2;STAT3;AIM2;PTK2B;TNFRSF11A;SAMHD1;MSN;HIF1A;S1PR1;PTPRJ;TNFRSF1B;NFKBIA;RAP1B;FYN;ACTN4;PLCB1;TRAF1;PAK2;TMSB4X;TNFRSF25;EDAR;LCN2;JAK3;IKBKB;GHR;ISG20;CEACAM1;CSF2RB;IL27RA;TRIM68;IFNAR1;PELI1;CD40;HNRNPF;IFNAR2;CISH;TNFSF8;JUNB;CA1;IL36G;CDKN1B;MTAP;JAK1;BCL2L11;PPBP;TNFRSF1A;TGFB1;LCK;NFKB1;STX1A;CASP1;PSMA2;MAP3K3;TRIM25;TNFRSF13C;IL7R;CRK;CSF1;IKBKG;TNFRSF9;TNFRSF8;IL23A;PSMA8;BCL2L1;FCGR1A;POU2F1;PSMA6;CCL14;CBL;IL7;IL4R;FSCN1;CEBPD;ABL2;CUL1;IRAK4;ADAR;OASL;RIPK1;BIRC3;IL17RB;PIM1;RELA;MUC1
prerank,stress-activated MAPK cascade (GO:0051403),0.5607230370729779,1.5319189382264933,0.019886363636363636,0.5340505590289867,1.0,26/61,17.93%,NOD1;TNFRSF19;MAP4K3;TAOK2;SH2D3C;IKBKB;MAPK8;NFKB1;MAP3K11;MAP2K3;MAPK11;IKBKG;CCM2;CUL1;MAP3K13;RIPK2;ZFP36;TRIB1;TRAF6;MAP3K20;ZFP36L1;MAP4K2;TAB3;MAP2K4;IRAK2;MAP3K8
prerank,regulation of mitochondrial fusion (GO:0010635),-0.6841350491284292,-1.531386248608453,0.043478260869565216,0.3592096078056819,1.0,2/11,1.14%,PID1;PRKN
prerank,ceramide transport (GO:0035627),0.7489993160653003,1.5312046209188068,0.058931860036832415,0.5340682772418184,1.0,4/12,9.26%,CERT1;PLTP;GLTP;PLEKHA8
prerank,protein localization to cell-cell junction (GO:0150105),0.7110592708727743,1.530896225215348,0.05194805194805195,0.5324178438636977,1.0,7/15,9.77%,TJP1;LSR;F11R;TJP2;PAK2;JAK1;TJP3
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.6337817808775174,-1.530787382804783,0.04484304932735426,0.3576614955876866,1.0,2/15,1.14%,IGF1;PRKN
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.5448399823325513,1.5301946995760158,0.02086230876216968,0.5321524134506357,1.0,18/67,7.32%,TEK;FLT1;ABI3;KDR;IL15;INSR;PDGFB;LYN;PTK2B;FYN;SRMS;FLT4;JAK3;GHR;DYRK1A;BMX;LCK;PTK2
prerank,camera-type eye development (GO:0043010),-0.5497810474998667,-1.5296359399068997,0.029177718832891247,0.35779982729325727,1.0,10/25,12.68%,CACNA1C;FBN1;EFEMP1;TENM3;FBN2;CYP1B1;NF1;VEGFA;STRA6;NES
prerank,cellular response to interleukin-1 (GO:0071347),0.4961698052474921,1.529120887369829,0.007263922518159807,0.5338646972604988,1.0,36/143,18.12%,IL1R1;RPS6KA5;NOD1;DAB2IP;HIF1A;NFKBIA;PLCB1;SOX9;IKBKB;PELI1;CD40;NFKB1;PSMA2;MAP3K3;MAPK11;IKBKG;PSMA8;PSMA6;CCL14;RC3H1;CUL1;IRAK4;RELA;RIPK2;GBP3;HAS2;IL1RAP;TRAF6;IRAK3;PSME1;RPS6KA4;TAB3;IRAK2;PSMA4;MAP3K8;PSMF1
prerank,protein hydroxylation (GO:0018126),-0.6387373046519322,-1.5287295974483268,0.03619909502262444,0.35724808555616616,1.0,7/15,18.61%,PLOD2;ASPH;P3H3;EGLN3;P3H4;P3H1;VIPAS39
prerank,cellular response to fluid shear stress (GO:0071498),0.7400413943443842,1.528668758834769,0.055350553505535055,0.5326989125072599,1.0,6/12,17.24%,MEF2C;MTSS1;KLF2;PKD2;HAS2;MAP2K5
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.7529284880948208,1.528611470075097,0.0642361111111111,0.5299603305746534,1.0,2/10,2.16%,RNF125;SEC14L1
prerank,regulation of epithelial cell migration (GO:0010632),0.5714565580220514,1.527981130125626,0.021613832853025938,0.5295026276165095,1.0,17/51,7.32%,PTPRG;BMPR2;PLCG1;DOCK1;DAB2IP;RAB11A;HIF1A;PPM1F;RREB1;PLCG2;EVL;RHOJ;SOX9;CEACAM1;ENPP2;SASH1;PTK2
prerank,positive regulation of lymphocyte migration (GO:2000403),0.7470555083611145,1.5274331276792334,0.061567164179104475,0.5290157772105182,1.0,2/12,1.05%,JAM2;APP
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.616006420415771,1.5270629940297527,0.04,0.5276354863795721,1.0,6/35,2.55%,TEK;TJP1;ABI3;ESAM;F11R;PTK2B
prerank,chordate embryonic development (GO:0043009),-0.4715613545712341,-1.5268523161449334,0.02666666666666667,0.35912692099981863,1.0,18/55,10.39%,SULF1;ALDH1A2;FGFR2;COL1A1;ARNT2;BMP5;BMP7;SULF2;TGFBR1;PKD1;PCSK5;RBP4;DACT1;IGF2;KIAA1217;VEGFA;XYLT1;TGFB3
prerank,phospholipid catabolic process (GO:0009395),0.6477124248029555,1.5266616668585031,0.06312292358803986,0.5263205544112675,1.0,5/24,10.21%,GPCPD1;PLA2G4A;ENPP6;ENPP2;GDPD1
prerank,phospholipid transport (GO:0015914),0.5614988516826813,1.5261378755532415,0.03879310344827586,0.5255620271496309,1.0,12/52,10.58%,ATP8B1;PLTP;ATP8A1;SCARB1;PRELID2;ATP10A;ATP11C;ATP11B;ABCA3;ATP11A;PITPNC1;SCARB2
prerank,B cell differentiation (GO:0030183),0.578979257532422,1.5257799695557848,0.03529411764705882,0.524271980489086,1.0,10/46,7.44%,HDAC9;VCAM1;HHEX;TPD52;PTPRJ;ADGRG3;PLCG2;JAK3;LYL1;TCF3
prerank,protein phosphorylation (GO:0006468),0.4562651761710428,1.524150268372171,0.0,0.5279752636102775,1.0,107/478,11.94%,PRKG1;PRKCH;ERG;TEK;RPS6KA5;CDK17;FLT1;BMPR2;ABI3;KDR;APP;SNRK;EPHB4;ERN1;ACVRL1;PRKD1;CDK6;INSR;DAPK1;NEK7;PDGFB;PEAK1;DAB2IP;LYN;PRKD2;BCR;PIM3;PRAG1;ADAM10;PTK2B;STK10;FNIP2;MAP4K3;SIK1;FYN;TAOK2;STK24;STK3;PKN3;SRMS;FLT4;LIPE;PKN2;PAK2;RPS6KA3;PKN1;STK4;LMTK2;MARK3;JAK3;IKBKB;MAP3K9;RPS6KA1;HIPK1;ACVR2A;SMAD7;CDC42BPB;MAST2;MAPK8;PLK2;USP15;RET;ULK1;LIMK2;PPP3CB;AURKA;ACVR1;SIK3;TSSK6;DYRK1A;JAK1;STK26;TNIK;TGFB1;BMX;LCK;PTK2;NEK6;MAP3K3;CTBP1;PXK;SGK3;HASPIN;CREB1;AKT2;SLK;AURKC;MAP3K11;RICTOR;CDK2;COPS2;MAPKAPK3;NUAK1;PRKAB1;CDK18;AKT3;GAS6;ABL2;PICK1;EPHA4;GMFG;STK38;MAP3K13;RIPK1;EEF2K;PIM1;SIK2
prerank,energy reserve metabolic process (GO:0006112),-0.5927811230890948,-1.5218717398830428,0.04878048780487805,0.36988748552608874,1.0,9/19,12.46%,PID1;LEPR;PHKB;PYGM;PRKAG2;GFPT1;PPP1R3C;UGP2;GFPT2
prerank,negative regulation of DNA metabolic process (GO:0051053),0.6541328630073386,1.5217791432157568,0.052969502407704656,0.534617479995924,1.0,3/24,1.37%,DACH1;BMPR2;ACVRL1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.5890843888879204,1.5212781503062496,0.0391566265060241,0.533694656733046,1.0,8/39,6.03%,TEK;KDR;ICAM1;PLCG1;ECSCR;GATA2;RAMP2;CD40
prerank,regulation of blood circulation (GO:1903522),-0.5058726697557584,-1.521044950715102,0.031161473087818695,0.3693474894940565,1.0,11/34,14.64%,CELF2;DMPK;TPM1;PER2;AGTR1;KCNMB2;BDKRB2;DES;S100A1;TBX2;FXYD1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.6179704799704159,1.5210408086976606,0.05379746835443038,0.5319262095734228,1.0,8/28,8.26%,CTSC;SMURF1;ECSCR;DAB2IP;FBXW7;KCNE2;PTK2;RNF139
prerank,glycolipid metabolic process (GO:0006664),0.575569919208689,1.520969119485477,0.034023668639053255,0.5294661084552944,1.0,6/47,4.87%,ST3GAL6;ST6GALNAC3;UGCG;PGAP1;ESYT2;GLTP
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.6379945600401283,-1.5199775057862308,0.03761061946902655,0.3690854075710064,1.0,6/13,12.48%,RENBP;PGM3;NAGK;GFPT1;GFPT2;GNPDA1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.7496503469224627,1.5198203036471971,0.054613935969868174,0.5312147969247141,1.0,2/11,1.56%,NOS3;GCH1
prerank,nuclear migration (GO:0007097),-0.6470653668600596,-1.5193512244323473,0.06415929203539823,0.36772302439297166,1.0,6/13,18.57%,DOCK7;CLMN;SYNE3;SYNE2;PCM1;DYNC1H1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.7063841741919841,1.5192996772450174,0.0582010582010582,0.5306499880179754,1.0,4/15,9.40%,PRKCH;LPL;NFKB1;CSF1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.6946015528340899,1.5190562596635613,0.05779334500875657,0.526266834783217,1.0,7/15,14.46%,NANOS3;NANOS2;TNRC6C;CNOT1;ZFP36;CNOT7;ZFP36L1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.6946015528340899,1.5190562596635613,0.05779334500875657,0.526266834783217,1.0,7/15,14.46%,NANOS3;NANOS2;TNRC6C;CNOT1;ZFP36;CNOT7;ZFP36L1
prerank,regulation of programmed cell death (GO:0043067),0.4883644257834124,1.5186299328740913,0.003575685339690107,0.5254237184986348,1.0,35/161,12.88%,MECOM;ACER2;TGM2;PPP1R13B;DAPK1;HIP1;FAS;ANP32A;GLS2;ACTN4;AMIGO2;ACTN1;TNFRSF25;SOX9;JAK3;BCL3;TOX3;BCL2L11;STK26;TIGAR;CASP1;NF2;MALT1;CITED1;RBM25;CRADD;TRIM24;SLK;BNIP3;RIPK1;BIRC3;BID;NOP53;OMA1;PRDX2
prerank,sodium ion import across plasma membrane (GO:0098719),-0.590948680408314,-1.517797041995706,0.04488778054862843,0.3689048276206966,1.0,4/17,3.34%,SLC12A2;SLC6A1;SLC9A9;SLC8A1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.5802895313942907,-1.5177424036255325,0.020671834625323,0.3660848911166581,1.0,8/22,13.29%,ANK2;ATP1B1;AKAP6;RYR2;SLC9A1;GSTM2;HTT;JPH2
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.6667396431500042,1.5173106913242944,0.05360134003350084,0.5280109518210703,1.0,6/18,6.89%,ERN1;NCK1;XBP1;BOK;BCL2L11;ATXN3
prerank,regulation of actomyosin structure organization (GO:0110020),-0.6592923601534151,-1.5160685143244457,0.05502392344497608,0.36746356334439184,1.0,7/13,17.29%,ROCK2;AKAP13;ALMS1;FHOD1;ASAP3;SLC9A1;TSC1
prerank,presynapse assembly (GO:0099054),-0.6166722717999407,-1.514916183331839,0.040865384615384616,0.36776511020085156,1.0,10/16,16.11%,NLGN2;LRRTM3;PTPRD;IL1RAPL1;PCLO;NLGN1;NLGN3;FZD1;BSN;DVL1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.5990062239972757,1.5137429991813356,0.038461538461538464,0.5398404478608617,1.0,9/36,7.46%,NOS3;CAV1;GCH1;SCARB1;HIF1A;NOSTRIN;ATP2B4;NOS1AP;NOSIP
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.581118915041454,1.5137037005738188,0.042899408284023666,0.5373709404184436,1.0,10/39,5.31%,NOS3;IL6ST;MAML2;EPN2;STAT3;NOTCH1;TSPAN5;DLL1;DLL4;TSPAN14
prerank,apical protein localization (GO:0045176),0.777608932343967,1.513396574467658,0.07550644567219153,0.5360547245612025,1.0,4/10,4.34%,ATP8B1;CELSR1;SHROOM2;MAL
prerank,lymphocyte proliferation (GO:0046651),0.6487869229210615,1.5130852781477442,0.05956112852664577,0.5346380393799334,1.0,6/22,7.54%,MEF2C;CTPS1;MSN;PPP3CB;CD40;PIK3CG
prerank,"phototransduction, visible light (GO:0007603)",0.7048336623442139,1.5127476261010748,0.06713780918727916,0.5333069702921017,1.0,4/14,7.02%,GNAQ;GNB1;CNGB1;GNAT1
prerank,regulation of trophoblast cell migration (GO:1901163),-0.6463570507088223,-1.5126817393335668,0.03286384976525822,0.37099686683808786,1.0,10/14,29.44%,GJA1;VEGFA;ACVR1B;SYDE1;ARHGDIB;TIMP1;CALR;C1QBP;SMURF2;ACVR1C
prerank,ethanol metabolic process (GO:0006067),-0.6492355937226726,-1.5117041086292096,0.057777777777777775,0.37083517778098707,1.0,2/12,6.00%,ALDH1A1;ALDH2
prerank,myeloid cell development (GO:0061515),0.6650050273988191,1.5112415096621052,0.0657672849915683,0.536586901126661,1.0,4/18,2.95%,APP;FOXP1;NRROS;ALAS1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.6326060897886948,-1.5110069184858912,0.041189931350114416,0.3698623520190203,1.0,6/15,28.07%,MOXD1;SAT1;ASMT;DDC;SRM;SAT2
prerank,amino sugar biosynthetic process (GO:0046349),-0.6480160438513852,-1.5107655805702722,0.04893617021276596,0.36765149576365763,1.0,6/12,12.48%,RENBP;PGM3;NAGK;GFPT1;GFPT2;GNPDA1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.731400245179441,1.5106440728254313,0.06133828996282528,0.536452760657241,1.0,5/11,12.99%,STAT3;PUM1;PUM2;ZFP36;FMR1
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.6313955486556997,1.5101098304256548,0.050080775444264945,0.5359509509334661,1.0,5/29,3.63%,SHANK3;TJP1;KANK3;HIP1R;SSH2
prerank,glycerolipid catabolic process (GO:0046503),0.6806383390212996,1.5093562093714405,0.059322033898305086,0.5363090518614098,1.0,4/19,5.49%,GPCPD1;PLA2G4A;ABHD2;ENPP6
prerank,positive regulation of cell migration (GO:0030335),0.46677113532643394,1.5064911475810419,0.001152073732718894,0.5446084201931425,1.0,51/253,8.88%,SEMA6A;LEF1;TJP1;PECAM1;FLT1;BMPR2;KDR;CAV1;ITGA6;SEMA5B;PODXL;INSR;SEMA7A;PLCG1;PDGFB;DOCK1;NEDD9;DAB2IP;RAB11A;EDN1;ARHGEF2;STAT3;ADAM10;PTK2B;PDGFD;PPP3CA;HIF1A;NOTCH1;PPM1F;RREB1;ACTN4;PLCG2;NUMB;SOX9;F7;SDCBP;XBP1;ENPP2;SEMA6B;RET;ACVR1;RAPGEF2;CBLL1;TGFB1;PDGFC;PTK2;GRB7;GAB1;SEMA6D;AKT2;ARHGEF7
prerank,negative regulation of RNA metabolic process (GO:0051253),0.6650852934078018,1.5059612573406174,0.06129032258064516,0.5439604982190888,1.0,7/18,15.00%,ESR1;TMBIM6;PTBP3;TGFB1;NUDT16;KAT2B;RPS13
prerank,response to molecule of bacterial origin (GO:0002237),0.5367686479832244,1.505644988700333,0.02384105960264901,0.54259469356701,1.0,19/69,14.67%,NOS3;GCH1;FOXP1;TNFRSF11A;SELE;SELP;TIRAP;RPS6KA3;IFNAR1;PELI1;HNRNPA0;CITED1;CYP27B1;MAPKAPK3;CYRIB;TRIB1;ADAM17;S100A9;IRAK3
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.5314877296043029,-1.5050289894663305,0.046875,0.381279021775266,1.0,9/27,9.15%,PID1;PRKCB;IRS1;ENPP1;GRB10;PRKCD;TNS2;PRKCZ;TSC2
prerank,cardiac myofibril assembly (GO:0055003),-0.6224543894044753,-1.504750005575756,0.04328018223234624,0.37924866876406405,1.0,4/15,11.06%,PDGFRB;PDGFRA;OBSL1;FHOD3
prerank,nuclear transport (GO:0051169),0.6729558268949691,1.504523364471496,0.06925675675675676,0.5445288161804649,1.0,7/16,14.08%,ANP32A;RSRC1;XPO1;CITED1;NUP98;NUP205;NPM1
prerank,negative regulation of GTPase activity (GO:0034260),0.6595324195741026,1.5040267770461382,0.051666666666666666,0.5439345619427988,1.0,4/22,2.15%,LRCH1;F11R;SH3BP4;DAB2IP
prerank,cellular response to cytokine stimulus (GO:0071345),0.4531028461137656,1.5034575854245507,0.0021008403361344537,0.5435658711318105,1.0,85/416,12.26%,IL1R1;LEF1;ST3GAL6;LRCH1;FOXO1;PTPN14;IL6ST;LIFR;INPP5D;PTGS2;MAOA;ICAM1;VCAM1;STX3;DAPK1;PTPN12;IL6R;DAB2IP;OSMR;ARHGEF2;SOCS2;PDE2A;STAT3;GBP5;AIM2;GBP4;HIF1A;S1PR1;PTPRJ;TNFRSF1B;FYN;SIGIRR;SOX9;GBP7;LCN2;JAK3;IKBKB;XBP1;GHR;SBNO2;CSF2RB;IL27RA;MAPK8;IFNAR1;ASAH2;WNT5A;CD40;IFNAR2;JUNB;IL36G;DCSTAMP;CDKN1B;JAK1;INPP5K;BCL2L11;TNFRSF1A;TGFB1;LCK;NFKB1;STX1A;CASP1;YBX3;CRK;CSF1;MAPK11;IL23A;BCL2L1;CXCR4;POU2F1;RPL13A;CCL14;CBL;IL7;IL4R;FSCN1;RC3H1;GAS6;CEBPD;ABL2;RO60;IRAK4;RIPK1;PIM1;RELA;MUC1
prerank,embryonic digit morphogenesis (GO:0042733),-0.5912198593598845,-1.5032051741722836,0.06870229007633588,0.3808278542671055,1.0,7/18,15.83%,GLI3;OSR1;SALL1;TBX2;WDPCP;INTU;TBX3
prerank,smooth muscle cell differentiation (GO:0051145),0.7080624675177924,1.5024490596117672,0.05964912280701754,0.5448845899454212,1.0,3/12,4.33%,MRTFB;MEF2C;MRTFA
prerank,regulation of neuron migration (GO:2001222),0.6294510789885903,1.5019507525184543,0.03912363067292645,0.5444519392517382,1.0,7/26,6.24%,SEMA6A;NEXMIF;DAB2IP;ARHGEF2;SRGAP2;ADGRG1;RAPGEF2
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.693604066661758,1.5013326534987232,0.03866432337434095,0.5443463578400003,1.0,2/17,1.15%,PRKG1;MEF2C
prerank,cation transmembrane transport (GO:0098655),-0.48095478537479647,-1.5003196641359793,0.0438871473354232,0.38627407752349546,1.0,7/44,4.11%,ATP1A2;TRPM3;SLC7A2;SLC6A9;ATP1B1;SFXN2;ABCC9
prerank,positive regulation of cell motility (GO:2000147),0.4704581233512458,1.499860472615896,0.004672897196261682,0.5477076064567855,1.0,37/205,7.72%,SEMA6A;LEF1;TJP1;PECAM1;FLT1;NTN1;KDR;CAV1;ITGA6;SEMA5B;PODXL;INSR;SEMA7A;PDGFB;NEDD9;EDN1;STAT3;ADAM10;PTK2B;PDGFD;PPP3CA;NOTCH1;PPM1F;ACTN4;NUMB;F7;SDCBP;XBP1;CAVIN1;SEMA6B;RET;ACVR1;CBLL1;TGFB1;PDGFC;PTK2;GRB7
prerank,sphingosine metabolic process (GO:0006670),0.6826345706797101,1.4985098556198087,0.05782312925170068,0.5505652219853592,1.0,6/17,5.59%,ACER2;SPTLC2;PLPP1;SGPP2;SPTLC3;ASAH2
prerank,copper ion homeostasis (GO:0055070),0.668905907193972,1.4976992290380078,0.06655290102389079,0.5512801447061431,1.0,4/17,10.44%,APP;SLC31A1;XIAP;ATP7B
prerank,sodium ion transport (GO:0006814),-0.4271840432263551,-1.497602647697413,0.011811023622047244,0.3913586177116267,1.0,12/85,3.34%,ATP1A2;SLC24A3;NALCN;SLC6A13;SLC8A3;SLC12A2;SLC6A1;SCN7A;SLC6A12;SLC6A9;ATP1B1;SLC8A1
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.6686824758279498,-1.4968927069030589,0.05995203836930456,0.39048536091386626,1.0,6/11,15.00%,BMPR1A;BMP4;ZFPM2;JAG1;TGFB2;HEY2
prerank,heart trabecula morphogenesis (GO:0061384),0.6658156931614974,1.4963300670800304,0.08116883116883117,0.5544368793153933,1.0,7/18,5.29%,ADGRG6;TEK;ENG;NOTCH1;S1PR1;FKBP1A;DLL4
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.5044218591484068,1.4954835766445358,0.017632241813602016,0.5551515997956771,1.0,14/110,6.24%,ADGRG6;ADGRL4;CALCRL;GNAQ;ADGRL2;ADCY4;S1PR1;GNB1;ADGRG3;ADGRE5;ADGRG1;ADRB1;RAMP2;RAPGEF2
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.6221616850937988,1.495230756477162,0.05737704918032787,0.5536728996794735,1.0,5/24,5.78%,TEK;KDR;ICAM1;GATA2;RAMP2
prerank,regulation of cardiac conduction (GO:1903779),-0.4660558126780946,-1.495152686029126,0.025236593059936908,0.3923470059947133,1.0,15/54,9.89%,ATP1A2;ANK2;SLC8A3;ATP1B1;SLC8A1;ASPH;DMPK;ABCC9;STIM1;PRKACA;TRPC1;ATP2A2;RYR2;TMEM65;ATP1B2
prerank,respiratory tube development (GO:0030323),-0.5330114356862429,-1.4947002116911026,0.032663316582914576,0.3905936225112934,1.0,13/28,12.67%,FGFR2;GLI2;FGF1;PDPN;BMP4;PCSK5;RBP4;LOXL3;FGF2;VEGFA;STRA6;CCDC39;FGF7
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.7561677418464211,1.4945543036533442,0.056838365896980464,0.5538660307773852,1.0,2/10,1.05%,SHANK3;APP
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.6376905547259847,-1.4935859838988348,0.045023696682464455,0.3912164810245939,1.0,5/13,11.74%,DDX5;PLA2R1;SPRED1;SPRED3;SPRED2
prerank,positive regulation of integrin activation (GO:0033625),0.7413789188599671,1.4934820915066311,0.054307116104868915,0.5556715871661091,1.0,5/11,11.02%,PIEZO1;RASIP1;RAP1B;SKAP1;P2RY12
prerank,positive regulation of T cell activation (GO:0050870),0.5348147966844355,1.4930431245573768,0.04384724186704385,0.554927973438979,1.0,12/62,10.63%,IL6ST;VCAM1;IL15;NCK1;JAK3;XBP1;LCK;TNFRSF13C;IL23A;CYRIB;ZMIZ1;IL7
prerank,negative regulation of locomotion (GO:0040013),0.7065574668184614,1.4929284505246394,0.07330827067669173,0.5529597776933212,1.0,2/12,2.31%,FRMD5;CCDC125
prerank,ATP transport (GO:0015867),-0.6685277590410643,-1.4928233193197364,0.0651685393258427,0.3906147443234482,1.0,4/10,18.45%,ABCC6;SLC25A42;SLC17A9;SLC25A4
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.731933358462705,1.4927015945548434,0.06043956043956044,0.5514678459402061,1.0,3/11,4.33%,LYN;MFHAS1;TIRAP
prerank,regulation of cellular protein metabolic process (GO:0032268),0.5725830909575887,1.4921929911651168,0.030303030303030304,0.5510447389200325,1.0,13/47,13.24%,NANOS3;APP;EDN1;NFKBIA;EIF4E;TGFB1;NFKB1;PM20D2;CSF1;RBM3;CYFIP1;RPL10;MTPN
prerank,diol metabolic process (GO:0034311),0.6750818536834589,1.4920778565008197,0.06462585034013606,0.5490688537148414,1.0,6/19,5.59%,NOS3;DEGS2;GCH1;PLPP1;SGPP2;ASAH2
prerank,negative regulation of lymphocyte migration (GO:2000402),0.7511813943030918,1.4918946059959668,0.0595903165735568,0.5474090732159391,1.0,2/10,1.50%,LRCH1;CD200
prerank,peptidyl-tyrosine modification (GO:0018212),0.5477227302702304,1.4906985248819253,0.04040404040404041,0.5497926968449792,1.0,16/56,7.32%,TEK;FLT1;ABI3;KDR;INSR;PDGFB;LYN;TPST2;PTK2B;FYN;SRMS;FLT4;JAK3;DYRK1A;LCK;PTK2
prerank,positive regulation of bone mineralization (GO:0030501),-0.497243264674695,-1.4902552075447095,0.04142011834319527,0.3951199706998648,1.0,12/35,6.81%,BMP6;BMPR1A;PTN;WNT4;BMP7;ADGRV1;OSR1;BMP4;GPM6B;SLC8A1;FBN2;CCN1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.7310027018165405,1.4902293491318035,0.06463195691202872,0.5493615179189759,1.0,4/10,4.96%,PLPP1;PARD3;PRKD3;DGKH
prerank,regulation of DNA biosynthetic process (GO:2000278),0.6180180029206476,1.4896592074038972,0.05815831987075929,0.5491800530031535,1.0,6/27,4.01%,DACH1;BMPR2;ACVRL1;PDGFB;PRKD2;HMBOX1
prerank,regulated exocytosis (GO:0045055),0.4769842597986305,1.4896582709647443,0.006002400960384154,0.5468530188802588,1.0,36/173,12.45%,VWF;ABCC4;PECAM1;PCDH7;APP;PDGFB;VEGFC;MYH9;LYN;ACTN4;RAB11FIP1;SELENOP;SELP;TMSB4X;ACTN1;PROS1;QSOX1;VEGFD;RAB11FIP5;ARHGAP17;TAGLN2;PPP3CB;PPBP;TGFB1;SRGN;STX1A;APOOL;TMX3;APLP2;CYRIB;GAS6;SYT15;ITGB3;RAB26;MMRN1;RAB11B
prerank,receptor metabolic process (GO:0043112),0.5530758620159991,1.4889841712578868,0.038011695906432746,0.5470429681405512,1.0,16/53,13.17%,DNM3;CALCRL;CAV1;SMURF1;LMTK2;RAMP2;SH3GLB1;SNX25;TGFB1;NEDD4;PICALM;EHD3;LGMN;KIF16B;RAB11B;RAB31
prerank,T cell activation involved in immune response (GO:0002286),0.7165713560101319,1.488640577857479,0.06315789473684211,0.5459856861587452,1.0,2/12,1.25%,LCP1;ICAM1
prerank,hexose biosynthetic process (GO:0019319),-0.48090225015774624,-1.4879038292750557,0.018633540372670808,0.3989245503742072,1.0,17/42,18.41%,RBP4;AKR1B1;PPARGC1A;SLC39A14;CHST15;PER2;ENO2;SLC25A12;GOT1;TPI1;SLC25A13;G6PC3;ENO3;PFKFB1;MDH1;CRY1;PCK2
prerank,endothelial cell differentiation (GO:0045446),0.7108833492609631,1.487841342867134,0.08376963350785341,0.5466307372553804,1.0,5/12,3.75%,BMPR2;KDR;TIE1;ACVRL1;SOX18
prerank,axonal fasciculation (GO:0007413),-0.6371763232055367,-1.4872769468051164,0.06607929515418502,0.39802853819039713,1.0,7/12,18.26%,EPHA3;SEMA5A;NRCAM;CNTN4;RTN4;ARHGAP35;EPHB3
prerank,lipoprotein transport (GO:0042953),-0.6578427011500924,-1.4866077295942415,0.058333333333333334,0.39705055856190474,1.0,4/10,14.98%,LRP1;PRKCB;MIA3;UNC119B
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.4708178638723124,-1.4864548845647356,0.022857142857142857,0.3947120001857457,1.0,12/43,9.15%,PID1;PRKCB;IRS1;ENPP1;GRB10;PRKCD;OGT;TNS2;IGF2;PRKCZ;NUCKS1;TSC2
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.7328651825280903,1.4860184381660333,0.08608058608058608,0.5513528860316483,1.0,1/10,0.83%,KDR
prerank,aortic valve development (GO:0003176),0.592608546412968,1.4853828035472425,0.0444104134762634,0.5515777190428599,1.0,12/34,7.19%,NOS3;BMPR2;TIE1;NFATC1;EFNA1;NOTCH1;TNFRSF1B;ELN;SOX9;DLL4;TNFRSF1A;TGFB1
prerank,smoothened signaling pathway (GO:0007224),-0.505203346286854,-1.484603312743763,0.054878048780487805,0.3970325916603,1.0,16/32,18.74%,GLI3;GLI2;EVC2;CC2D2A;GLI1;HIPK2;SMO;TMEM231;DISP2;TTBK2;DISP3;PTCH2;TCTN2;IFT27;ULK3;TMEM17
prerank,cellular response to fatty acid (GO:0071398),-0.6454893021933064,-1.4841836476087489,0.04925053533190578,0.3954465877007433,1.0,2/12,1.44%,PID1;IRS1
prerank,apoptotic process (GO:0006915),0.46595811279290406,1.4840444368379475,0.00585480093676815,0.5543376686686803,1.0,46/203,13.11%,SEMA6A;FOXO1;TBX1;APP;PPARD;ZBTB16;TNFRSF19;AHR;DAPK1;ELMO1;HIP1;PAEP;FAS;PTK2B;DDIT4;CASP4;BIK;NFKBIA;TAOK2;STK3;CASP8;TNFRSF25;MAL;STK4;IER3;NCKAP1;BOK;ADAM15;JADE1;BCL2L11;CASP7;CASP1;BNIP2;IKBKG;BCL2L1;CXCR4;SIAH1;BNIP3;CSRNP1;RIPK1;BID;GLRX2;RHOB;MAGI3;TGFBR2;FASTKD2
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.5836194918440218,-1.4835963517521227,0.0589622641509434,0.3944877126895521,1.0,6/17,11.24%,WNT4;BMP4;LARP6;RGCC;TGFB3;RUNX1
prerank,receptor catabolic process (GO:0032801),0.6285760525982478,1.4828189737287851,0.06156405990016639,0.5567590858455445,1.0,11/24,12.38%,SMURF1;ZNRF3;AP2B1;SH3GLB1;SNX25;TGFB1;AP2A1;NEDD4;MYLIP;LGMN;KIF16B
prerank,activation of adenylate cyclase activity (GO:0007190),-0.48734003466632536,-1.482741293292007,0.03488372093023256,0.3942528424785314,1.0,8/35,5.90%,LGR4;ADCY5;ADCY1;ADCY2;EDNRA;ADCY7;ADCY6;CAP2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.5374357504969915,-1.4824391968450317,0.0390625,0.39242690731865304,1.0,8/25,9.63%,ANK2;CACNA1C;CXADR;DLG1;TBX18;ATP2A2;RYR2;CTNNA3
prerank,lipoxygenase pathway (GO:0019372),0.6918712902768068,1.4823184386333332,0.08141592920353982,0.5563299529938996,1.0,4/14,8.78%,PTGS2;ALOX5AP;PON2;LTC4S
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.6146661667100273,1.48227939452535,0.05214723926380368,0.5541493282599989,1.0,8/28,7.49%,EGFL7;LFNG;GATA2;FBXW7;DLL1;DLL4;ARRB1;ARRDC1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.5334788014753243,-1.481742867209337,0.029649595687331536,0.3918907481089596,1.0,13/30,15.71%,ANK2;CACNA1C;SNTA1;GJA1;CACNA2D1;CACNA1D;CACNA1G;KCNJ2;RYR2;GPD1L;SCN2B;SCN1A;GJC1
prerank,mesenchyme morphogenesis (GO:0072132),0.6766404189976377,1.481318286510888,0.06991869918699187,0.5556103589001637,1.0,6/17,6.15%,NOS3;ENG;ACVRL1;NOTCH1;SOX9;ACVR1
prerank,regulation of cell adhesion (GO:0030155),0.49338188484993367,1.481315261966563,0.01838235294117647,0.5533651804456206,1.0,33/129,11.35%,FRMD5;PKP4;TGM2;PLXNA4;STX3;ACVRL1;PODXL;CYTH1;LYN;PRKD2;ADAM10;EFNA1;PTK2B;PPP3CA;PLXND1;PTPRJ;PPP1R12A;ADGRG1;DLL1;RET;CBLL1;ADAMDEC1;ATXN3;PTK2;RASA1;PIK3CG;RSU1;DSCAM;NUAK1;CXCR4;SEMA4D;ABL2;EPHA4
prerank,regulation of cell migration (GO:0030334),0.44409071552183044,1.4809584725082083,0.002150537634408602,0.5525030774714332,1.0,73/382,8.71%,FRMD5;SEMA6A;LEF1;TJP1;LIMCH1;MCTP1;PECAM1;FLT1;DACH1;PLXNA4;ABI3;LDB2;KDR;ENG;CAV1;ITGA6;SEMA5B;ACVRL1;CLDN5;PODXL;INSR;SEMA7A;PDGFB;NEDD9;ADARB1;EDN1;STAT3;ADAM10;PTK2B;PDGFD;SRGAP3;SRGAP2;PPP3CA;PLXND1;NOTCH1;PTPRJ;PPM1F;ADGRG3;SPATA13;ACTN4;SRGAP1;STK24;NUMB;ROBO4;TMSB4X;FGF23;F7;SDCBP;XBP1;CEACAM1;SMAD7;PTPRK;ENPP2;SEMA6B;RET;PRR5L;DUSP22;ACVR1;RAC1;CBLL1;SASH1;ADAM15;STK26;TGFB1;PDGFC;PTK2;GRB7;NF2;GNA12;SFRP2;SEMA6D;SGK3;AKT2
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.6567526624481852,1.4809492314660961,0.0766721044045677,0.550313743683982,1.0,5/19,6.19%,TEK;KDR;PTPRJ;PPM1F;RAC1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.6443107626768533,1.480916454881558,0.06741573033707865,0.5482680782421915,1.0,5/23,8.63%,PLA2G4A;LPCAT3;PLA2G2D;MBOAT1;PLAAT3
prerank,positive regulation of cell adhesion (GO:0045785),0.523001155812395,1.4808741473387734,0.0267022696929239,0.5462387129234432,1.0,15/74,8.41%,FRMD5;TGM2;STX3;MAGI1;PDGFB;PRKD2;PPP3CA;PTPRJ;PPM1F;ADGRG1;SMAD7;RET;RAC1;RSU1;SFRP2
prerank,cellular response to interferon-gamma (GO:0071346),0.5108797253019558,1.478452145866703,0.022911051212938006,0.5529736103331635,1.0,19/88,13.23%,ICAM1;VCAM1;B2M;DAPK1;IRF2;GBP5;GBP4;GBP7;TRIM68;WNT5A;JAK1;CASP1;TRIM25;FCGR1A;RPL13A;CCL14;OASL;MID1;GBP3
prerank,striated muscle tissue development (GO:0014706),0.6240767927113395,1.478234799109377,0.05501618122977346,0.551577443175016,1.0,4/29,1.15%,PGM5;BMPR2;CAV1;MEF2C
prerank,actin filament polymerization (GO:0030041),-0.525585334909913,-1.4778356332062854,0.037037037037037035,0.3996752527956713,1.0,5/29,3.76%,ARHGAP6;GAS7;GSN;SPIRE1;COBL
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5825729644636156,1.4776545458183976,0.05112781954887218,0.5516533011979858,1.0,6/36,7.88%,SHANK3;EDN1;FBXW7;HIF1A;GREM1;TGFA
prerank,establishment of epithelial cell polarity (GO:0090162),0.6480380333458999,1.477303224812255,0.08542713567839195,0.5507514916723898,1.0,5/19,5.74%,PARD3;CYTH1;MSN;SIPA1L3;OPHN1
prerank,negative regulation of angiogenesis (GO:0016525),0.5046553317845806,1.477057328598,0.026420079260237782,0.5496062270715695,1.0,13/84,5.58%,SEMA6A;TEK;CLDN5;EPN2;PTPRM;ECSCR;DAB2IP;HHEX;STAB1;NPR1;GTF2I;KLF2;ATP2B4
prerank,bone development (GO:0060348),-0.4808175562472213,-1.4765451151874882,0.06441717791411043,0.4004963244526121,1.0,12/39,7.06%,RANBP3L;SULF1;FGFR2;AKAP13;GJA1;SULF2;CYP26B1;SH3PXD2B;GNAS;SFRP4;LRP6;NOTUM
prerank,negative regulation of cell activation (GO:0050866),0.676516165973236,1.4761712108813763,0.07922535211267606,0.5509405890408643,1.0,3/14,1.90%,NOS3;CD200;PDGFB
prerank,regulation of interleukin-13 production (GO:0032656),0.6975475198108739,1.4760594655869748,0.08768971332209106,0.5492085587816864,1.0,1/13,0.13%,LEF1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.6227705213846889,1.4758468454392961,0.06734006734006734,0.5478470951471542,1.0,6/25,7.67%,PTGS2;INSR;EDN1;KLF2;NOS1AP;PKD2
prerank,regulation of platelet aggregation (GO:0090330),0.6659565265006918,1.4758388211642057,0.057245080500894455,0.5457602078702039,1.0,4/17,5.16%,PRKG1;F11R;LYN;CEACAM1
prerank,neuron projection morphogenesis (GO:0048812),-0.38173283998270474,-1.4737303610499966,0.0051813471502590676,0.4059953225680494,1.0,36/137,8.66%,ALCAM;DCLK1;GAS7;DOCK7;SDC2;FGFR2;NBL1;CTNND2;EPB41L3;BMP7;DCDC2;DLG4;NRK;MAP2;BRSK1;CNTNAP2;IMPACT;ALS2;S100A6;ANK3;FARP1;SHTN1;TAOK3;DOCK10;NGF;RYK;NLGN1;NTNG1;MAP6;S100B;CTNNA2;LRRK2;DCC;FLRT1;PLXNB1;NRCAM
prerank,regulation of osteoblast proliferation (GO:0033688),-0.586359008251888,-1.4735903837412434,0.053488372093023255,0.40383700857395455,1.0,6/17,8.83%,FGFR2;NPR3;MN1;CCN1;PLXNB1;SFRP1
prerank,ribosome assembly (GO:0042255),0.5628457139230791,1.4730188876710386,0.048600883652430045,0.554226285717497,1.0,18/47,21.43%,RPS15;RPS19;RPS14;RPSA;RSL24D1;RRS1;EIF6;RPS27;RPL6;NOP53;RPL10;NPM1;RPL11;MTERF3;RPL3;TRAF7;RPS28;SBDS
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.5836199710586969,-1.4729437734848103,0.045454545454545456,0.40317555542614597,1.0,6/17,10.49%,FSTL1;SULF1;TWSG1;SFRP4;CASK;SLIT2
prerank,muscle tissue development (GO:0060537),0.6933349111764537,1.4728880386590588,0.09217391304347826,0.5525803832280299,1.0,3/13,5.71%,PGM5;ENG;SRPK3
prerank,protein localization to cilium (GO:0061512),-0.5000950617464008,-1.4728385904118693,0.04419889502762431,0.4008950490756803,1.0,19/32,29.43%,TULP3;WDR35;INVS;ARL3;IFT20;RAB29;EHD1;BBS9;TCTN1;IFT140;TULP1;TCTN2;TTC21B;IFT122;TULP2;BBS1;ARL6;NPHP4;ODAD4
prerank,hydrogen peroxide catabolic process (GO:0042744),0.7141431659170826,1.472700456343685,0.06741573033707865,0.5512068193157477,1.0,4/11,16.72%,PXDN;CAT;PRDX2;PRDX1
prerank,striated muscle contraction (GO:0006941),-0.46934112345176726,-1.4725597551373029,0.03215434083601286,0.3991765571689231,1.0,8/53,8.88%,ATP1A2;DMD;ATP1B1;SLC8A1;DTNA;TPM1;GAA;RYR2
prerank,inorganic cation transmembrane transport (GO:0098662),-0.36067439789554073,-1.4724413825396092,0.0,0.3969723463933568,1.0,44/268,8.41%,ATP1A2;SLC24A3;TRPM3;CACNA1C;KCNK2;NALCN;SLC6A13;SLC1A3;SLC8A3;SLC41A1;SLC12A2;SLC6A1;SCN7A;KCNB2;CACNA1D;SCARA5;SLC9A9;KCNK5;SLC6A12;SLC30A10;SLC6A9;PKD1;ATP1B1;SLC8A1;P2RX4;KCNQ3;ABCC9;KCND2;KCND3;ATP6V0A4;SLC39A14;CACNA1G;ITGAV;TRPC3;KCNC2;SLC39A13;SLC6A15;KCNJ2;KCNS3;TRPC6;TRPC1;KCNQ4;KCNAB1;ATP2A2
prerank,regulation of heart contraction (GO:0008016),-0.422421356817244,-1.472294124581958,0.016260162601626018,0.3948011805979618,1.0,22/90,12.33%,CELF2;ATP1A2;ANK2;SLC8A3;ATP1B1;SLC8A1;P2RX4;ASPH;DMPK;ABCC9;TPM1;STIM1;PRKACA;TRPC1;ATP2A2;RYR2;TMEM65;ATP1B2;DES;TGFB2;S100A1;TBX2
prerank,positive regulation of T cell cytokine production (GO:0002726),0.6630769284941986,1.4719768098088264,0.05653710247349823,0.551675438042515,1.0,3/20,3.14%,IL1R1;B2M;DENND1B
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.6492917003867138,-1.4717573573513567,0.04741379310344827,0.39367558145692494,1.0,6/11,12.48%,RENBP;PGM3;NAGK;GFPT1;GFPT2;GNPDA1
prerank,regulation of adaptive immune response (GO:0002819),0.6527014390628444,1.4709803068940037,0.08934707903780069,0.5533782541975295,1.0,4/18,8.20%,IL6ST;AHR;SKAP1;SAMSN1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.540206737736944,-1.4701044667660121,0.0661764705882353,0.3957188033153538,1.0,5/23,9.02%,ATP1A2;ANK2;CACNA2D1;UBASH3B;CACNB1
prerank,potassium ion transport (GO:0006813),-0.3946363801451178,-1.4695226237922328,0.0,0.3948960093520967,1.0,28/120,14.18%,ATP1A2;SLC24A3;KCNK2;NALCN;SLC1A3;KCNB2;SLC9A9;KCNK5;KCNMA1;KCNQ3;ABCC9;KCND2;KCND3;KCNC2;KCNMB2;KCNJ2;KCNS3;KCNQ4;KCNJ13;KCNAB1;SLC24A2;KCNQ5;KCNA6;ABCB8;SLC9A1;KCNJ10;KCNN2;CCDC51
prerank,calcium ion transport into cytosol (GO:0060402),-0.5573794846563533,-1.4678644493744657,0.03896103896103896,0.3971502204206543,1.0,9/21,13.39%,CACNA1C;CACNA2D1;JPH1;SLC8A1;RYR2;GRIN2A;ADRA1A;JPH2;GRIN2D
prerank,positive regulation of B cell proliferation (GO:0030890),0.6000635328296408,1.4671365099204547,0.062111801242236024,0.5660158136129846,1.0,8/29,10.91%,CD38;MEF2C;BST1;TIRAP;CD40;TNFRSF13C;IL7;CD320
prerank,rRNA processing (GO:0006364),0.4720096915849144,1.466969327206687,0.015384615384615385,0.5645888831894517,1.0,90/172,27.21%,DDX54;RPS15;IMP3;RPS19;RPLP1;RPS14;RPS16;RPL38;RPL39;RPL34;RPS7;RPS24;MTREX;FCF1;RPL37A;RPF1;RPL36;RPL15;RPL14;RPL23;RPL17;RPL9;RPL4;RPL13A;RPL32;RPL22;EXOSC1;EIF6;RPL31;RPS27;RPL13;UTP4;RPL6;NOP53;RPL10;RPS6;PELP1;RPS25;SRFBP1;RIOK1;RRP9;RPL35A;RPL29;XRN2;RPL18;RPL27A;MAK16;RPL27;EMG1;RRP1B;UTP6;PIH1D1;RPL11;PDCD11;WDR18;ESF1;NOP14;RPLP2;HEATR1;RPL8;RPL18A;RPL21;SART1;RPL3;RIOK2;RPS28;DDX47;SBDS;RPL7;THUMPD1;MRPL1;RPL26;NOL6;TEX10;RIOK3;LYAR;RRP12;LAS1L;WDR74;NOLC1;EXOSC4;RPS9;WDR46;RPS17;RPS2;DIS3;RPL28;RPL41;RPL36A;RRP1
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.5621572945005358,-1.46623747479234,0.05623471882640587,0.3988774190466038,1.0,5/19,10.36%,DDO;ASPA;ALDH7A1;PHYKPL;GOT1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.7352845302602731,1.4654864654443944,0.09090909090909091,0.5682250248171268,1.0,4/10,13.32%,GNB1;CNGB1;GNAT1;PDE6B
prerank,positive regulation of interleukin-1 production (GO:0032732),0.5444350552344064,1.464887057455503,0.0463768115942029,0.5684262631329806,1.0,9/51,8.38%,APP;STAT3;GBP5;AIM2;CASP8;WNT5A;LPL;CASP1;MALT1
prerank,cardiac muscle tissue development (GO:0048738),-0.44716809586588924,-1.4643655932728457,0.037162162162162164,0.4013810928832599,1.0,13/50,7.62%,NOTCH2;BMPR1A;GJB6;AKAP13;BMP5;SGCD;BMP7;GJA1;BMP4;RBP4;CACNA1G;TBX18;SGCZ
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.5700852124582025,-1.4641246016265275,0.04228855721393035,0.39964864739603195,1.0,4/21,2.52%,ANK2;SNTA1;CACNA2D1;CACNA1D
prerank,epithelial structure maintenance (GO:0010669),-0.6458852377351036,-1.463863063488812,0.07918552036199095,0.39802842578651937,1.0,2/11,3.21%,CXADR;RBP4
prerank,ribosomal small subunit biogenesis (GO:0042274),0.5802127011586735,1.4626979468188954,0.0594679186228482,0.5748713964514124,1.0,19/39,21.28%,RPS15;RPS19;RPS14;RPSA;RPS16;RPS7;RPS24;RPS27;UTP4;RPS6;NPM1;RPS25;SRFBP1;RIOK1;EMG1;NOP14;NOM1;RIOK2;RPS28
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.6271281703904404,1.4626657570368662,0.07814992025518341,0.57282768507174,1.0,5/24,6.19%,TEK;KDR;PTPRJ;PPM1F;RAC1
prerank,negative regulation of potassium ion transport (GO:0043267),0.6939505634312266,1.462510647279149,0.08534322820037106,0.5713903463348795,1.0,3/13,2.55%,CAV1;NEDD4L;PTK2B
prerank,regulation of fatty acid metabolic process (GO:0019217),0.6608530096721311,1.4625057666223138,0.07214765100671142,0.5693165956272062,1.0,3/17,1.05%,ADIPOR2;CAV1;PPARD
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.6991054069019227,1.4617265667027546,0.08545454545454545,0.5701816162332511,1.0,5/11,18.29%,NFKBIZ;MALT1;IL23A;NFKBID;CARD9
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.41177041845361617,-1.4611066298712199,0.01809954751131222,0.4032069173967496,1.0,39/95,13.16%,GPC6;UST;DSE;SDC2;DCN;ANGPT1;GPC3;OGN;CEMIP;FMOD;HSPG2;HS3ST3A1;BGN;CSPG4;EXT1;CHST15;PRELP;PXYLP1;HS3ST3B1;HS2ST1;LUM;VCAN;CHSY3;GPC5;HS6ST2;CHSY1;SDC4;GCNT2;CHST3;DSEL;OMD;XYLT1;HS6ST1;HS3ST5;GPC4;HEXA;B4GALT6;ABCC5;B4GALT7
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.6146423780482612,1.4606904879922824,0.06902356902356903,0.5721222091175313,1.0,6/26,7.67%,PTGS2;INSR;EDN1;KLF2;NOS1AP;PKD2
prerank,regulation of cell communication (GO:0010646),-0.487187938058035,-1.4599305145292831,0.06629834254143646,0.4038243956756705,1.0,13/35,9.09%,ANK2;CXADR;GRK3;SLC8A1;ANXA1;YWHAG;MTCH1;IGFBP7;TBX18;MGLL;RYR2;GRK5;SCG5
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.5989866918697687,-1.4597942929052583,0.08333333333333333,0.4018476690609901,1.0,6/15,8.83%,GPC3;DAAM2;RSPO3;DACT1;SFRP4;SFRP1
prerank,stabilization of membrane potential (GO:0030322),-0.5732009153369371,-1.4596867493135641,0.052132701421800945,0.39982000585462896,1.0,2/16,2.70%,KCNK2;KCNK5
prerank,heart looping (GO:0001947),0.5702965290793708,1.4594050159378928,0.062111801242236024,0.5748829080589332,1.0,13/39,13.78%,ENG;MEF2C;ZIC3;NOTCH1;SOX17;SOX18;DLL1;PKD2;IHH;APLNR;VANGL2;TGFBR2;SETDB2
prerank,cation transport (GO:0006812),-0.3731514921685942,-1.458489424010898,0.006024096385542169,0.40049870642820357,1.0,46/167,18.98%,ATP1A2;TRPM3;PIEZO2;SLC47A1;SLC8A3;SLC41A1;SLC12A2;SCN7A;KCNB2;KCNK5;SLC6A9;ATP1B1;SLC8A1;SLC22A4;KCNMA1;ANO1;ABCC9;KCND3;KCNMB2;KCNJ2;KCNS3;TRPC6;SLC5A5;KCNQ4;KCNJ13;KCNAB1;SLC66A1;SLC7A6;SLC5A6;KCNA6;KCNJ10;KCNN2;SLC1A1;SCN1A;SLC22A2;SLC22A18;SLC9B2;KCNJ8;NDFIP1;KCNJ15;SLC8A2;KCNJ6;SLC36A1;SCN8A;SCN2A;SLC8B1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.703133141447394,1.4578578979502683,0.08791208791208792,0.5784320596208524,1.0,2/12,2.89%,CAV1;PDE4D
prerank,myelination in peripheral nervous system (GO:0022011),0.7068302310417217,1.4569340392234884,0.0782122905027933,0.5799627824270701,1.0,2/13,1.93%,ADGRG6;PARD3
prerank,epithelial cell-cell adhesion (GO:0090136),-0.6398910906540088,-1.4568877475270783,0.07142857142857142,0.4025243548047876,1.0,4/11,11.79%,ITGB5;KIT;CCN3;PLEKHA7
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.7162761404804532,1.4568493933291768,0.10218978102189781,0.5782005773744743,1.0,5/10,9.08%,LYN;STAT3;JAK3;GHR;PTPN1
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.6184088518208057,-1.4565979300562493,0.08816705336426914,0.4010403081283277,1.0,5/13,10.36%,ADHFE1;IDH2;GPT2;IDH1;GOT1
prerank,regulation of AMPA receptor activity (GO:2000311),0.6052988219177097,1.4565141691626056,0.07550077041602465,0.5774121303607203,1.0,2/25,1.15%,SHANK3;MEF2C
prerank,dephosphorylation (GO:0016311),0.4708168644125173,1.4563235497061493,0.015476190476190477,0.576142937483572,1.0,27/147,9.08%,PTPRB;PTPRG;PTPN14;CTTNBP2NL;PTPRM;PLPP1;PPP2R5A;PTPN12;SGPP2;PPP3CA;PTPRJ;PPM1F;MTM1;SSH2;PPP1R12A;PTPRK;PPM1L;PPP3CB;MTMR6;FBP1;INPP5K;PPM1D;DUSP23;PPP2R5E;DUSP16;PPP2R5B;PTPN1
prerank,ncRNA processing (GO:0034470),0.46010804746057493,1.4545809124375326,0.010477299185098952,0.5807430762836782,1.0,77/200,21.91%,SMAD1;DDX54;RPS15;IMP3;RPS19;RPLP1;RPS14;RPS16;RPL38;FARS2;RPL39;RPL34;DROSHA;RPS7;RPS24;MTREX;FCF1;RPL37A;RPF1;RPL36;RPL15;RPL14;DICER1;RPL23;RPL17;RPL9;RPL4;RPL13A;RPL32;RPL22;EXOSC1;INTS11;RPL31;RPS27;ADAR;RPL13;RPP30;UTP4;RPL6;NOP53;RPL10;INTS12;RPS6;PELP1;RPS25;RRP9;RPL35A;RPL29;ADAT1;XRN2;RPL18;RPL27A;RPL27;EMG1;KARS1;RRP1B;UTP6;PIH1D1;RPL11;PDCD11;WDR18;ESF1;NOP14;RPLP2;HEATR1;RPL8;SMAD2;RPL18A;RPL21;RPL3;INTS8;MRPL44;RPS28;DDX47;SBDS;PRKRA;RPL7
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.6805057788710156,-1.4542083858973809,0.07399103139013453,0.40552304387863874,1.0,4/10,9.36%,CPEB1;CPEB3;PAF1;LEO1
prerank,positive regulation of chromatin organization (GO:1905269),0.7022726459376024,1.453397318465926,0.08957952468007313,0.5830669826565117,1.0,6/12,16.46%,TAL1;H3-3A;ACD;MIER1;ATRX;TERF1
prerank,regulation of protein localization to membrane (GO:1905475),-0.5022819940690474,-1.453079672664237,0.07142857142857142,0.4062722726858075,1.0,8/28,7.75%,GPC6;GSN;PRKN;GPC3;AR;MMP14;SLC5A3;GPC5
prerank,clathrin coat assembly (GO:0048268),0.6586197837230805,1.4529669680157116,0.1026936026936027,0.5825760440732849,1.0,4/15,3.94%,HIP1;HIP1R;PIK3C2A;FCHO2
prerank,positive regulation of cell projection organization (GO:0031346),-0.3958893665889349,-1.4527783314247176,0.01834862385321101,0.4048023481471199,1.0,45/115,15.47%,ROBO1;PLXNA2;MAGI2;NTRK3;ROR1;DPYSL3;CAMK1D;EPHA3;PTN;PTK7;GRIP1;TIAM2;DLG4;NDNF;OBSL1;TENM3;CUX2;PTPRD;NTRK2;CARMIL1;CAPRIN2;IL1RAPL1;ROBO2;NGF;CUX1;ROR2;KIDINS220;MAP6;ARSB;PLXNB1;ATP1B2;FBXW8;APOE;SLIT2;FZD1;CAMK1;PLK5;CDKL3;PRKCI;CAMK2B;FUT9;P3H1;PLPPR5;CBFA2T2;LRRC7
prerank,mesoderm development (GO:0007498),0.6387524841902954,1.4523731422584958,0.08377896613190731,0.5828631785042636,1.0,5/18,9.49%,TBX1;TIE1;MESD;BMX;TCF15
prerank,macromolecule catabolic process (GO:0009057),0.6133732568240922,1.451916047906695,0.07234726688102894,0.5826226646881536,1.0,11/26,12.38%,SMURF1;SH3GLB1;SNX25;TGFB1;NEDD4;CTRL;TRIM24;SIAH1;CLN6;LGMN;KIF16B
prerank,negative regulation of cell adhesion (GO:0007162),0.5137834731546479,1.4515703929021446,0.04429530201342282,0.5818746701066737,1.0,17/72,8.99%,SEMA6A;ACER2;PLXNA4;NEXMIF;ACVRL1;PODXL;FZD4;ADAM10;PLXND1;NOTCH1;CBLL1;ADAMDEC1;TGFB1;PTK2;RASA1;NF2;DSCAM
prerank,regulation of acute inflammatory response (GO:0002673),0.6642747365604673,1.4514930834823276,0.07325383304940375,0.5802083491025428,1.0,3/18,6.41%,IL6ST;OSMR;PLA2G2D
prerank,positive regulation of vasculogenesis (GO:2001214),0.736657672618216,1.451352585910131,0.09157509157509157,0.5787245292455562,1.0,5/10,7.67%,KDR;CD34;CEACAM1;RAPGEF2;RAP1A
prerank,hexose transmembrane transport (GO:0008645),0.6291668360256137,1.4509835043903718,0.08404802744425385,0.5781753445604885,1.0,4/21,6.89%,SLC2A1;PPARD;SLC2A9;PPBP
prerank,phospholipid translocation (GO:0045332),0.5931781883293292,1.4508885721521416,0.07728706624605679,0.5765027881002697,1.0,5/28,2.92%,ATP8B1;ATP8A1;ATP10A;ATP11C;ATP11B
prerank,regulation of leukocyte activation (GO:0002694),0.6852178923191576,1.4502798056551327,0.1003584229390681,0.5769514493144833,1.0,4/14,7.29%,CD200;LYN;MFHAS1;LCK
prerank,positive regulation of cytokine production (GO:0001819),0.44613461627429896,1.4501050614718631,0.006557377049180328,0.5755743498411288,1.0,42/292,10.08%,IL1R1;NOD1;IL6ST;CADM1;PTGS2;APP;IL15;SPTBN1;CD200;LRRFIP1;FOXP1;IL6R;ARHGEF2;PAEP;PRKD2;STAT3;GBP5;HIF1A;PDE4D;AFAP1L2;PLCB1;PLCG2;FLT4;CD34;TIRAP;XBP1;WNT5A;CD40;TIGIT;TGFB1;LPL;AGPAT1;PIK3CG;NFKB1;RFTN1;MALT1;ZFPM1;CGAS;G3BP1;MAPK11;IL23A;CYRIB
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.6917819537945942,1.448898528839447,0.09369676320272573,0.5781328297164188,1.0,2/13,1.05%,SHANK3;APP
prerank,pteridine-containing compound metabolic process (GO:0042558),0.6945046271727582,1.447591554746057,0.08163265306122448,0.5809768753328284,1.0,3/13,5.61%,NOS3;GCH1;MTHFD1L
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.6034617289765287,1.4464685321739748,0.0749185667752443,0.583215686507162,1.0,10/30,16.46%,DACH1;BMPR2;ACVRL1;PINX1;DCP2;ACD;HNRNPC;ERCC4;NIBAN2;TERF1
prerank,embryonic heart tube morphogenesis (GO:0003143),0.5553103606103922,1.4463960586163243,0.0578386605783866,0.5815387102255514,1.0,14/43,13.78%,ENG;MEF2C;ZIC3;NOTCH1;SOX17;SOX18;DLL1;ACVR1;PKD2;IHH;APLNR;VANGL2;TGFBR2;SETDB2
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.6200418677963483,1.4463087777121273,0.07394957983193277,0.5799329612031333,1.0,8/21,6.76%,CAV1;CNKSR3;DDIT4;PDE4D;PPM1F;NCK1;SMAD7;INPP5K
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.584839579085579,1.4458611492736286,0.0778816199376947,0.579719736544771,1.0,5/29,6.38%,DCUN1D3;FBXW7;DTX3L;SMAD7;TRIB3
prerank,positive regulation of cholesterol transport (GO:0032376),0.5993758205647839,1.4457815227246575,0.07640067911714771,0.5780606703862377,1.0,6/27,5.80%,CAV1;PLTP;NFKBIA;LPCAT3;EEPD1;ABCA3
prerank,intraciliary retrograde transport (GO:0035721),-0.633090763564868,-1.4456548911912441,0.06373626373626373,0.4219042983218137,1.0,7/12,20.09%,DYNC2H1;WDR35;DYNC2I1;DYNC2LI1;IFT43;IFT140;TTC21B
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.6390781228104,1.4450650142923132,0.09507640067911714,0.5788539739662291,1.0,5/19,7.58%,APP;PDGFB;KLF2;MAPK8;NFKB1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.6564816164885272,1.444776423282827,0.09330985915492958,0.5780233301979271,1.0,3/14,3.25%,PRKD1;LIMS2;BST1
prerank,endoderm development (GO:0007492),0.675975717407746,1.4445393637398405,0.09700176366843033,0.5770350992943782,1.0,4/13,12.38%,SOX7;SOX17;DUSP2;KIF16B
prerank,positive regulation of cell aging (GO:0090343),0.7146408645372959,1.4441383125470328,0.10649819494584838,0.5766205081434632,1.0,2/11,1.56%,ABI3;B2M
prerank,regulation of metal ion transport (GO:0010959),-0.5847610293384103,-1.443949526674735,0.07493540051679587,0.4243289061878655,1.0,7/16,6.27%,ANK2;BCL2;CACNA2D1;SLC30A10;IL16;DLG1;STIM1
prerank,cellular potassium ion homeostasis (GO:0030007),-0.6052665339983806,-1.4438977775109285,0.0782608695652174,0.4221176687151547,1.0,6/13,9.89%,ATP1A2;SLC12A2;ATP1B1;KCNMA1;KCNJ2;ATP1B2
prerank,amide biosynthetic process (GO:0043604),0.5362434376295021,1.4412787044936406,0.06060606060606061,0.5851531380154573,1.0,8/47,5.59%,SPTLC2;SGMS1;DEGS2;CERS4;SPTLC3;SPTSSA;PAM;ASAH2
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.5164698451426796,-1.4411838745319414,0.05089058524173028,0.4271852988288849,1.0,8/26,9.89%,ANK2;FHL1;ACTN2;CACNA1D;ATP1B1;DLG1;KCNAB1;ATP1B2
prerank,positive regulation of ion transport (GO:0043270),-0.46110776912401863,-1.4406412308996612,0.046511627906976744,0.4262908365192391,1.0,10/48,8.20%,ANK2;FHL1;ACTN2;CACNA1D;P2RX4;ANK3;DLG1;CACNB2;TRPC6;ADRA2A
prerank,glial cell development (GO:0021782),0.6137384669106576,1.4405548454027006,0.07377049180327869,0.5859309144655104,1.0,11/25,14.48%,APP;CDK6;NRROS;DLL1;EIF2B5;PRDM8;SOX4;PICK1;CSPG5;EIF2B2;S100A9
prerank,vasodilation (GO:0042311),0.6865417608794797,1.4404462846924966,0.10849909584086799,0.584392176333131,1.0,3/13,4.50%,NOS3;ADRB1;KLF2
prerank,lipoprotein localization (GO:0044872),-0.6254876182330992,-1.4401509715947023,0.07423580786026202,0.42534689897468536,1.0,4/11,14.98%,LRP1;PRKCB;MIA3;UNC119B
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.5658186257713695,1.4399292869104943,0.06288343558282208,0.584341366733846,1.0,2/36,0.30%,MECOM;FOXO1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.5475850894386362,-1.4396852252389756,0.061124694376528114,0.4243346751451108,1.0,5/20,3.92%,SULF1;SULF2;THBS1;SMOC2;FGF2
prerank,limb morphogenesis (GO:0035108),-0.5533558335470896,-1.439075192776701,0.05721393034825871,0.4237672451683816,1.0,9/20,21.10%,GLI3;PCSK5;CYP26B1;LRP6;TGFB2;TBX3;IQCE;SKI;PTCH1
prerank,response to interleukin-1 (GO:0070555),0.5146568403230748,1.438654498986892,0.04704301075268817,0.5872814221546877,1.0,18/73,14.67%,IL1R1;APP;DAB2IP;TNFRSF11A;HIF1A;SELE;SOX9;CD40;NFKB1;CITED1;MAPK11;CCL14;RC3H1;RELA;GBP3;HAS2;TRAF6;IRAK3
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.5313847172350208,-1.4385594564998248,0.03836317135549872,0.4228372434919939,1.0,10/24,20.25%,PID1;LEPR;PPARGC1A;GFPT1;GFPT2;SLC25A13;MT3;SDHAF4;NR4A3;MRAP2
prerank,protein localization to chromatin (GO:0071168),0.6566191411875858,1.4384022902895939,0.10380622837370242,0.5862279904565966,1.0,9/18,22.09%,ESR1;TASOR;PPHLN1;MCM9;PIH1D1;RAD21;PLK1;MSH2;NIPBL
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.6470381692645056,1.4383937163543852,0.10552763819095477,0.5843768162309486,1.0,4/17,2.79%,PBX1;MAML2;PLXND1;NOTCH1
prerank,determination of heart left/right asymmetry (GO:0061371),0.5586162206886952,1.4375781437107398,0.06317411402157165,0.5854015743202355,1.0,13/42,13.78%,ENG;MEF2C;ZIC3;NOTCH1;SOX17;SOX18;DLL1;PKD2;IHH;APLNR;VANGL2;TGFBR2;SETDB2
prerank,positive regulation of lipid kinase activity (GO:0090218),0.5878434246310591,1.4375591209095553,0.07849293563579278,0.5836253260239544,1.0,8/29,7.32%,TEK;FLT1;PRKD1;PDGFB;DGKZ;PTK2B;TGFB1;PTK2
prerank,JNK cascade (GO:0007254),0.5617906773514434,1.437137746907665,0.06738131699846861,0.5832799550616502,1.0,15/40,17.16%,NOD1;TNFRSF19;MAP4K3;SH2D3C;MAPK8;MAP3K11;IKBKG;MAP3K13;RIPK2;TRIB1;TRAF6;MAP4K2;TAB3;MAP2K4;IRAK2
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.42878536204439877,1.4369336844941725,0.004166666666666667,0.5821157768213593,1.0,64/417,11.49%,MECOM;LEF1;ELK3;RPS6KA5;FOXO1;ATP8B1;CD38;HDAC9;DACH1;ZHX3;SMARCA2;PPARD;CBFA2T3;ZBTB16;SOX7;AHR;PDGFB;FOXP1;DAB2IP;SOX13;HHEX;NR3C1;NOTCH1;PPM1F;PLCB1;SOX18;HMBOX1;SOX9;SCMH1;VGLL4;SBNO2;FOXL2;ID1;EPC1;PTPRK;TCF7L2;WNT5A;RCOR1;KLF10;ATF7IP;BCL3;TRIB3;CDKN1B;INPP5K;TGFB1;GATAD2A;CTBP1;SFRP2;KAT6B;CITED1;FOXK1;MYBBP1A;YEATS2;COPS2;POU2F1;FOXN3;SMARCE1;RBM15;SPEN;TFAP4;GAS6;EID1;ZMYND11;SP3
prerank,adherens junction organization (GO:0034332),0.548965682390098,1.4367947389965239,0.06095791001451379,0.5807427223648024,1.0,11/48,8.96%,TJP1;CADM1;NECTIN2;PVR;PAK2;CDH2;SMAD7;CTNNA1;RAMP2;CDH15;ANG
prerank,myelination (GO:0042552),0.5484131422574716,1.4366688203862892,0.052552552552552555,0.5793816470550631,1.0,13/46,14.16%,ADGRG6;MPZ;PARD3;MAL;MALL;B4GALT5;EIF2B5;PLLP;CXCR4;DEGS1;ABCD1;CMTM8;EIF2B2
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.6941889681188771,1.4364042257747318,0.09872029250457039,0.5784754303472128,1.0,2/12,3.83%,RAB27A;PLCG2
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.6672102755456258,1.4347842872399177,0.08727272727272728,0.5822578725917693,1.0,3/15,2.78%,STAT3;GBP5;HIF1A
prerank,organic substance transport (GO:0071702),0.4809552799938217,1.4343042984351906,0.02822085889570552,0.5822813430908995,1.0,31/121,15.84%,CALCRL;SLCO2B1;ABCG2;SLC6A2;PLTP;ATP8A1;SPNS2;SLCO2A1;MYH9;SCAMP1;RAMP2;ABCA3;TAP2;CHMP2B;ARRDC1;RAB38;PLEKHA8;SLCO1B1;CD320;PICK1;ABCD1;RILP;ABCG1;RAB7A;TCN2;CHKA;TXNIP;SLC22A5;SLC18A2;CEP290;ABCA1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.6617326754402431,1.4342939839957596,0.12169312169312169,0.5805099577484486,1.0,2/15,1.45%,STOX2;NR5A2
prerank,long-term memory (GO:0007616),-0.5610035183800253,-1.4342653580323017,0.06802721088435375,0.43227999268428846,1.0,9/19,24.07%,RASGRF1;CPEB3;LDLR;APOE;SHANK1;NFATC4;PJA2;CAMK4;CALB1
prerank,response to axon injury (GO:0048678),-0.5596142462668754,-1.4336459857797084,0.07524271844660194,0.4317036999374182,1.0,5/18,11.77%,DPYSL3;P2RX4;APOD;GAP43;NREP
prerank,establishment of skin barrier (GO:0061436),0.6670993713944262,1.4324820158975908,0.09743589743589744,0.5834672580230209,1.0,5/15,15.51%,UGCG;LSR;SFN;MET;FA2H
prerank,regulation of water loss via skin (GO:0033561),0.6670993713944262,1.4324820158975908,0.09743589743589744,0.5834672580230209,1.0,5/15,15.51%,UGCG;LSR;SFN;MET;FA2H
prerank,skeletal muscle tissue development (GO:0007519),0.5796211586278519,1.432464693021686,0.08265802269043761,0.5817345717118023,1.0,4/32,5.01%,CAV1;MEF2C;CAV2;FOXL2
prerank,regulation of anoikis (GO:2000209),0.6280670081353734,1.4323527743622348,0.09715242881072027,0.5803069066614187,1.0,6/19,9.33%,CAV1;NOTCH1;SIK1;PTK2;ITGA5;MYBBP1A
prerank,multivesicular body organization (GO:0036257),0.5666881161001562,1.4320430642634683,0.0816,0.5795136090096077,1.0,6/31,10.07%,RAB27A;RAB11A;CHMP2B;CHMP4A;CHMP4B;VPS28
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.5961773252857403,-1.432033401908975,0.10232558139534884,0.4338545806547534,1.0,5/13,14.28%,DDO;GLUL;ASPA;GOT1;QPRT
prerank,O-glycan processing (GO:0016266),0.5384918163549405,1.4314958854453619,0.06158357771260997,0.5796671364933026,1.0,12/54,12.26%,ST6GAL1;ST3GAL1;GALNT14;GALNT15;B3GNT3;B3GNT4;B4GALT5;ST6GALNAC2;B3GNT6;ST6GALNAC4;C1GALT1;MUC1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.7114634862071942,1.431216280471402,0.08318264014466546,0.5789575495138817,1.0,4/11,9.00%,FOXO1;NOTCH1;ATP2B4;GLRX3
prerank,positive regulation of protein binding (GO:0032092),0.5257333364747744,1.431070398168318,0.0715307582260372,0.5777410150374312,1.0,15/56,6.38%,CAV1;APP;EPB41;CLDN5;B2M;HIP1R;STK3;FKBP1A;STK4;MARK3;RALB;DTX3L;TCF7L2;RAPGEF2;TRIB3
prerank,regulation of muscle contraction (GO:0006937),-0.5169915565278412,-1.430566849387986,0.07179487179487179,0.43562212751310975,1.0,7/26,9.00%,ATP1A2;PLCE1;KCNB2;TPM1;ANXA6;MYL9;PPP1R12B
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.4793650483755311,1.4305103886462789,0.027989821882951654,0.5779781607854333,1.0,30/113,17.06%,UNC13B;ESR1;PIEZO1;LCP1;RASIP1;DAB2IP;TAL1;GBP5;FNIP2;BIK;RAP1B;TIRAP;SKAP1;SH3GLB1;BCL2L11;RPA1;TGFB1;CDT1;FSCN1;BID;WARS1;RACK1;ERCC4;CDH5;ABCA1;BMF;PIH1D1;TERF1;GTF2H4;SPIDR
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.6100780836175974,-1.4304420230539592,0.08200455580865604,0.43370517896881117,1.0,8/13,18.65%,DCN;BGN;CSPG4;VCAN;ARSB;HEXA;HYAL1;IDUA
prerank,cell junction assembly (GO:0034329),0.48525003382181575,1.43006135015015,0.03501945525291829,0.5779566116018198,1.0,10/100,4.17%,SHANK3;DNM3;TJP1;PKP4;ITGA6;CLDN5;LIMS2;PLXND1;PCDHB4;CDH2
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.6064091873128997,1.4300042480767279,0.09320695102685624,0.5764437670042741,1.0,8/26,6.76%,PDE8A;PLCG1;PTPN12;IQGAP1;DAB2IP;SOX9;DUSP22;INPP5K
prerank,serine family amino acid biosynthetic process (GO:0009070),0.6881434202540646,1.4298511661052546,0.09811320754716982,0.5752336094565785,1.0,2/12,2.42%,SERINC3;SERINC5
prerank,cellular copper ion homeostasis (GO:0006878),0.6677257342168151,1.4297993798199964,0.11413043478260869,0.573684468214315,1.0,3/14,10.44%,APP;SLC31A1;ATP7B
prerank,negative regulation of proteolysis (GO:0045861),-0.4845597425192927,-1.4297792953405826,0.05929919137466307,0.43335902723746667,1.0,9/34,10.76%,TIMP3;TIMP2;GAS1;SERPINE2;ECM1;CAMK2N1;LRRK2;PLAT;CST3
prerank,plasma membrane tubulation (GO:0097320),0.6911029221263192,1.4289765902402172,0.11827956989247312,0.574818280337869,1.0,4/13,8.74%,FNBP1L;CAVIN2;EHD2;CHMP4A
prerank,neurotransmitter secretion (GO:0007269),-0.4594237701404952,-1.4286729469983566,0.029940119760479042,0.4341012580853847,1.0,16/44,16.70%,SYT1;BRSK1;SNAP25;NAAA;PCLO;NRXN1;LIN7A;SNPH;PTPRN2;NRXN2;GAD2;SNCA;RIMS1;SYN1;DVL1;PDZD11
prerank,cellular protein modification process (GO:0006464),0.4180515495521475,1.4281853502608406,0.0,0.5759578588253067,1.0,193/982,13.10%,PTPRB;PRKG1;PRKCH;ERG;ST3GAL6;RPS6KA5;PTPRG;EPAS1;CDK17;PTPN14;BMPR2;TGM2;DCUN1D3;KLHL3;APP;UGCG;SNRK;KLHL5;ZBTB16;ERN1;ACVRL1;CTTNBP2NL;PRKD1;ST3GAL1;CDK6;INSR;MGAT4A;DAPK1;PTPRM;STT3B;GALNTL5;NEK7;PDGFB;PPP2R5A;PEAK1;PTPN12;RAB11A;SOCS2;LYN;PRKD2;BCR;PIM3;KLHL2;PRAG1;ADAM10;PTK2B;STK10;PPP3CA;FNIP2;NEURL2;YES1;FBXW7;HIF1A;PTPRJ;MAP4K3;PPM1F;SIK1;MAN2A1;MTM1;PGAP1;BTBD1;FYN;TAOK2;B3GNT3;FUCA2;STK24;STK3;SSH2;PKN3;PPP1R12A;LIPE;PKN2;PAK2;FGF23;CPE;CDH2;PTP4A2;UBA7;PKN1;STK4;LMTK2;MARK3;JAK3;IKBKB;PADI4;MAP3K9;HIPK1;ACVR2A;QSOX1;PTPRK;ALG10B;CDC42BPB;MAST2;MAPK8;PLK2;SPARCL1;FBXL4;RET;ULK1;LIMK2;PPM1L;KCTD6;PPP3CB;MTMR6;AURKA;ACVR1;SIK3;CISH;VWA1;TSSK6;B3GNT4;DYRK1A;JAK1;STK26;B4GALT5;PPM1D;TNIK;ST8SIA4;TGFB1;BMX;LCK;SIRT5;RNF7;GOLM1;ST6GALNAC2;FBXL7;NEK6;PSMA2;RAB2A;PPP2R5E;DUSP16;PIGU;CTBP1;PXK;RAB38;PPP2R5B;SGK3;HASPIN;CREB1;AKT2;B3GNT6;PGGT1B;PTPN1;AURKC;RHBDD1;MAP3K11;CDK2;CSF1;APLP2;FBXL2;FBXW2;ERO1A;PDXP;PSMA8;COPS2;PTAR1;NUAK1;PARP2;PSMA6;UBE2D3;ASB10;PRKAB1;CDK18;AKT3;FBXO30;ICMT;PIGK;GAS6;COPS4;ABL2;CUL1;PICK1;PPP2R3A;GMFG;STK38;MAP3K13;NUS1;PIM1;SIK2;COP1;DUSP2;MKNK2;RAB11B;SIRT6;PMM2;TGM4;LAMB1;PARP6;CTDSP2;TGFBR2;TRIB1;EIF2AK4;ASB11
prerank,ganglioside biosynthetic process (GO:0001574),0.6458107008894663,1.4279915895257262,0.10273972602739725,0.5748882881128933,1.0,5/15,10.36%,ST6GALNAC3;ST3GAL1;B4GALT5;ST8SIA4;ST6GALNAC4
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.5219551043663835,1.4276894545928738,0.05346820809248555,0.5742884805809483,1.0,13/57,8.38%,NOD1;TNFSF10;SOX7;DAPK1;AIM2;PPM1F;FYN;CASP8;FOXL2;CYCS;GRAMD4;CASP1;MALT1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.4783582224864701,-1.427589984216153,0.03825136612021858,0.43476148084249244,1.0,10/38,9.63%,ANK2;CACNA1C;CACNA2D1;CACNA1D;KCND3;CACNB2;CACNA1G;KCNJ2;BIN1;CTNNA3
prerank,response to muramyl dipeptide (GO:0032495),0.6892159073423729,1.4273402954174264,0.0990990990990991,0.5737883465431985,1.0,2/12,2.26%,NOD1;ARHGEF2
prerank,regulation of cytokine production (GO:0001817),0.47324103148280816,1.4269345288622817,0.03593556381660471,0.5735354226162966,1.0,18/126,8.25%,RPS6KA5;HDAC9;CADM1;IL15;FOXP1;LYN;TNFRSF1B;AFAP1L2;CASP8;ACKR1;IGF2BP3;N4BP1;MAST2;BTN2A2;SRGN;AGPAT1;PIK3CG;POLA1
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.5920460220734665,-1.4266359699872533,0.08254716981132075,0.4350956323142782,1.0,6/15,12.48%,MGAT3;LARGE1;RENBP;NAGK;CHST3;GNPDA1
prerank,positive regulation of DNA repair (GO:0045739),-0.4513874892391404,-1.426455203413073,0.046583850931677016,0.4334507979630573,1.0,5/46,3.01%,EYA2;EGFR;EYA1;EYA4;SPIRE1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.5804637369706794,1.4259523945184795,0.07623318385650224,0.5754173727141355,1.0,9/32,13.24%,NANOS3;APP;EIF4E;TIGAR;RBM3;CYFIP1;PICALM;RPL10;MTPN
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.5045664253774879,-1.4257922807150336,0.07368421052631578,0.4330321456038061,1.0,9/27,13.29%,ANK2;DMD;JPH1;CACNB2;PRKACA;ADRA2A;CACNB1;AHNAK;JPH2
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.453850392238354,1.4253823592018873,0.021052631578947368,0.5757851703929905,1.0,45/163,18.22%,CD38;INPP5D;MEF2C;PLCG1;PRKD2;PTPRJ;PDE4D;NFKBIZ;DENND1B;FYN;NCK1;PLCG2;SH2B2;PAK2;IKBKB;SKAP1;BTN2A2;BMX;LCK;NFKB1;PSMA2;EIF2B5;RFTN1;MALT1;IKBKG;ICOSLG;PSMA8;PSMA6;RC3H1;CUL1;RELA;RIPK2;BTN3A3;SLA2;TRAF6;EIF2B2;PSME1;SPPL3;ERMAP;LAT;NFKBID;CD276;PSMA4;PSMF1;PAK1
prerank,positive regulation of hydrolase activity (GO:0051345),0.4651551579973204,1.4252396962014493,0.027160493827160494,0.5746520589684796,1.0,27/137,10.72%,DOCK9;PKP4;TGM2;NET1;ITGA6;F11R;CD200;TBC1D30;SRGAP2;ARHGAP27;CAV2;ADRB1;PLIN5;RAP1GDS1;MAPK8;CD40;CHP2;RAPGEF2;BCAR3;RAP1A;TBC1D2;AGRN;RSU1;ARHGEF7;LARS1;CCL14;SEMA4D
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.5761022013261233,1.424811551464549,0.09316770186335403,0.574451518047271,1.0,9/34,7.32%,TEK;FLT1;PRKD1;PDGFB;DAB2IP;PTK2B;PIK3IP1;TGFB1;PTK2
prerank,pyroptosis (GO:0070269),0.64080510245526,1.4246376243355623,0.11627906976744186,0.5734293983210762,1.0,4/15,7.68%,AIM2;CASP4;CASP8;CASP1
prerank,protein oxidation (GO:0018158),-0.6399381937226396,-1.4240566570078674,0.10823529411764705,0.43535769963874277,1.0,3/11,6.85%,LOXL1;LOXL3;LOX
prerank,cochlea morphogenesis (GO:0090103),0.7192259562300124,1.4239303585151182,0.10873440285204991,0.5742635622420212,1.0,2/10,4.24%,TBX1;SOX9
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.4245436145959279,1.4231631465573622,0.0020833333333333333,0.5752625774232736,1.0,86/476,10.39%,MECOM;LEF1;FLI1;FOXO1;CD38;TBX1;ESR1;SMARCA2;PPARD;MEF2C;ZBTB16;ACVRL1;NR5A2;AHR;ZIC3;NFATC1;PDGFB;ELF2;MLLT3;FZD4;LRP5;HHEX;STAT3;TAL1;HIF1A;NOTCH1;RREB1;AFAP1L2;KDM3A;SOX17;PLCB1;SOX18;SOX9;NCOA1;FOXF1;KLF2;IKBKB;DTX3L;RPS6KA1;FOXL2;KMT2E;EPC1;TCF4;SPIN1;ARID1B;FOXF2;RET;WNT5A;PITX3;TEAD2;ESRRG;PPP3CB;ATF7IP;CNBP;ACVR1;ATMIN;SKAP1;BCL3;DYRK1A;SOST;HNF1B;ETS2;INPP5K;LYL1;TGFB1;TCF3;NFKB1;HNRNPD;PCBD2;ARID1A;NEUROD1;KAT6B;PSEN1;CITED1;CREB1;FOXK1;BRD4;MAFB;SOX4;MAP2K3;EDRF1;RNF4;SMAD5;NFIB;MAD2L2;ZMIZ1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.5274374779203161,-1.4231032557312575,0.07932692307692307,0.43565048013302377,1.0,12/22,23.81%,DMD;CACNB2;GNB5;CACNB1;AHNAK;PDE4B;CACNB3;STAC3;CBARP;CACNB4;HPCA;GPR35
prerank,epithelial tube morphogenesis (GO:0060562),0.5680442538054379,1.4229740141330316,0.08620689655172414,0.5742348547582585,1.0,12/32,13.08%,MEF2C;ACVRL1;PODXL;RASIP1;PRKD2;MTSS1;SOX17;ACVR1;PKD2;CCM2;RHOB;MET
prerank,organic anion transport (GO:0015711),0.5101905647508532,1.422274978717142,0.0444743935309973,0.5750746016446477,1.0,7/76,3.98%,ABCC4;SLCO2B1;ABCG2;LRRC8C;SLC39A8;SLCO2A1;SLC16A2
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.4184670759760013,-1.4219277851211123,0.014035087719298246,0.43657231644370437,1.0,16/69,7.60%,PLCL1;IGF1;PLCE1;PDGFRB;PDGFRA;IRS1;PI4KA;GAB2;OGT;PLCD3;SIRT2;NGF;NF1;PLCB3;PLCD1;EZR
prerank,metanephric mesenchyme development (GO:0072075),-0.6415509428243107,-1.421782260583195,0.0970873786407767,0.4348708864397638,1.0,3/10,5.73%,WNT4;OSR1;SIX1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4709685340046607,1.4215744869301792,0.04648241206030151,0.5759065463184633,1.0,19/113,5.81%,NRP2;TEK;EGFL7;BMPR2;KDR;TBX1;PPP1R16B;PRKD1;PDGFB;VEGFC;PRKD2;HIF1A;RREB1;FLT4;SOX9;XBP1;VEGFD;TCF7L2;WNT5A
prerank,glucose import (GO:0046323),0.6573757660315694,1.4215563968181633,0.12545454545454546,0.5743466546678587,1.0,1/13,0.53%,SLC2A1
prerank,endocardial cushion morphogenesis (GO:0003203),0.635730757347729,1.4204166767069546,0.10935023771790808,0.5762899394890515,1.0,6/18,6.15%,NOS3;ENG;ACVRL1;NOTCH1;SOX9;ACVR1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.5414390626610763,1.4203809030150634,0.07339449541284404,0.5747646028406644,1.0,8/41,7.29%,TJP1;PIEZO1;PODXL;MAGI1;SMAD7;SKAP1;JAK1;LCK
prerank,positive regulation of protein phosphorylation (GO:0001934),0.4299660360265623,1.4194833126283781,0.006342494714587738,0.576259179271652,1.0,62/348,8.41%,TEK;RPS6KA5;LIMCH1;PECAM1;BMPR2;KDR;ENG;CAV1;TBX1;APP;PDE8A;RBPMS;IL15;ACVRL1;PRKD1;INSR;PDGFB;VEGFC;IQGAP1;IL6R;ARHGEF2;LYN;PRKD2;FAS;EFNA1;PTK2B;PDGFD;FNIP2;PTPRJ;TAOK2;PLCG2;FLT4;PAK2;FGF23;SOX9;STK4;SH2D3C;RALB;SDCBP;GHR;ACVR2A;VEGFD;CX3CR1;ENPP2;ATP2B4;LIMK2;CD40;ACVR1;RAC1;RAPGEF2;KRAS;ARRB1;BCAR3;TNIK;TGFB1;PDGFC;PTK2;NIBAN1;RAP1A;ITGA5;RPTOR;SFRP2
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.5378488974388118,-1.4184876363749173,0.0857843137254902,0.44147297415858483,1.0,12/19,12.33%,BMPR1A;FGFR2;TGFBR3;TGFBR1;RBP4;ERBB4;FGF2;ZFPM2;RBPJ;GLI1;RUNX1;TBX2
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.5072949992995963,-1.4184012071650443,0.07216494845360824,0.4395462905435592,1.0,14/27,25.57%,DDX5;PLA2R1;SPRED1;KMT5A;CD44;MDM2;SPRED3;SPRED2;SNAI1;CD74;ATR;MSX1;TWIST1;ATM
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.5030178427832868,1.418270145068609,0.0594059405940594,0.5787906934739792,1.0,15/67,13.51%,TBC1D8;ATP8B1;CAV1;PPP1R16B;PODXL;TBC1D22A;TBC1D15;RAC1;TBC1D2;TWF2;FSCN1;TBC1D5;FMR1;RAB5A;EVI5
prerank,regulation of cellular senescence (GO:2000772),0.5873496118083119,1.4180209627575129,0.08359133126934984,0.5780419284544425,1.0,12/28,18.30%,ABI3;CDK6;B2M;NEK6;MAP3K3;CGAS;NUAK1;AKT3;YBX1;PNPT1;YPEL3;RBL1
prerank,positive regulation of synapse assembly (GO:0051965),-0.4986135783677178,-1.4179842502405255,0.07692307692307693,0.43855898547498545,1.0,10/27,12.11%,NLGN2;CLSTN2;CUX2;PTPRD;IL1RAPL1;NRXN1;NLGN1;NLGN3;SRPX2;GRID2
prerank,negative regulation of reproductive process (GO:2000242),-0.5622875216847434,-1.4179627792532485,0.08275862068965517,0.43648879724960304,1.0,3/17,1.99%,IGF1;SULF1;GJA1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5955436295880391,1.417874737501176,0.09563758389261745,0.5768880360476388,1.0,10/26,18.23%,NOD1;CASP8;IKBKG;RIPK2;IFIH1;TRAF6;TAB3;TIFA;IRAK2;AAMP
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.5465611020365547,1.4178036810136065,0.07488986784140969,0.5755320957643686,1.0,11/45,13.24%,NANOS3;APP;EIF4E;PUM1;RBM3;YTHDC1;RC3H1;CYFIP1;PUM2;RPL10;MTPN
prerank,signal release from synapse (GO:0099643),-0.46073858540824114,-1.416912432252151,0.03592814371257485,0.43713452168845107,1.0,16/43,16.70%,SYT1;BRSK1;SNAP25;NAAA;PCLO;NRXN1;LIN7A;SNPH;PTPRN2;NRXN2;GAD2;SNCA;RIMS1;SYN1;DVL1;PDZD11
prerank,regulation of phagocytosis (GO:0050764),0.5245345820245313,1.416670665978413,0.06569343065693431,0.5780374289825674,1.0,5/53,2.21%,RAB27A;TGM2;IL15;GATA2;SCARB1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.6406063880550432,-1.416296263742014,0.08874458874458875,0.4366833728594181,1.0,3/10,2.48%,ATP1A2;OSR1;HECW2
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.5727733990991963,-1.4159536594344748,0.08924485125858124,0.43565903452348936,1.0,6/16,10.15%,OGT;ARHGAP24;RASGRF1;ALS2;AUTS2;CADM4
prerank,T cell receptor signaling pathway (GO:0050852),0.45920071012458197,1.4155464061670493,0.02997601918465228,0.5802543426300182,1.0,40/138,18.22%,INPP5D;PLCG1;PRKD2;PTPRJ;PDE4D;NFKBIZ;DENND1B;FYN;NCK1;PLCG2;PAK2;IKBKB;SKAP1;BTN2A2;LCK;NFKB1;PSMA2;EIF2B5;RFTN1;MALT1;IKBKG;ICOSLG;PSMA8;PSMA6;RC3H1;CUL1;RELA;RIPK2;BTN3A3;TRAF6;EIF2B2;PSME1;SPPL3;ERMAP;LAT;NFKBID;CD276;PSMA4;PSMF1;PAK1
prerank,ribosome biogenesis (GO:0042254),0.4520063844046467,1.4146036868884075,0.0282021151586369,0.5817950074949727,1.0,90/187,27.21%,DDX54;RPS15;IMP3;RPS19;RPLP1;RPS14;RPS16;RPL38;RPL39;RPL34;RPS7;RPS24;MTREX;FCF1;RPL37A;RPF1;RPL36;XPO1;RPL15;RRS1;RPL14;RPL23;RPL17;RPL9;RPL4;RPL13A;RPL32;RPL22;EXOSC1;EIF6;RPL31;RPS27;RPL13;UTP4;RPL6;NOP53;NOP16;RPL10;RPS6;NPM1;PELP1;RPS25;RIOK1;RRP9;RPL35A;RPL29;XRN2;RPL18;RPL27A;RPL27;EMG1;RRP1B;UTP6;PIH1D1;RPL11;PDCD11;WDR18;ESF1;NOP14;RPLP2;HEATR1;RPL8;RPL18A;NOM1;RPL21;RPL3;RIOK2;RPS28;DDX47;SBDS;RPL7;RPL26;NOL6;TEX10;CUL4B;LYAR;RRP12;LAS1L;WDR74;NOLC1;EXOSC4;RPS9;WDR46;RPS17;RPS2;DIS3;RPL28;RPL41;RPL36A;RRP1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.4396088563928286,1.4136579992076004,0.0091324200913242,0.5835943366915488,1.0,53/234,14.73%,PRKCH;RPS6KA5;NOD1;CAV1;ESR1;APP;CRTC1;PRKD1;CD200;EDN1;FZD4;ARHGEF2;PRKD2;STAT3;AIM2;TNFRSF11A;TRIM14;NFKBIA;STK3;JMY;TRAF1;PLCG2;TIRAP;IKBKB;CX3CR1;TRIM68;WNT5A;CD40;MID2;TCF3;NFKB1;TRIM25;NEUROD1;MALT1;IKBKG;PSMA6;MBTPS2;MAP3K13;RIPK1;CARD16;RELA;RIPK2;RNF25;RAB7B;MTPN;NFKB2;IL1RAP;NPM1;TRAF6;S100A9;ERC1;IRAK3;ARID5B
prerank,embryonic hemopoiesis (GO:0035162),0.6759588306347608,1.412352635959852,0.12454873646209386,0.5862902283624333,1.0,3/12,2.36%,KDR;KITLG;TAL1
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.6149677773470325,-1.4114530610758194,0.1038374717832957,0.4451929991384433,1.0,2/12,2.47%,NUPR1;IL18
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.6308831937893308,-1.4110948020850684,0.09955752212389381,0.44410377631355835,1.0,3/11,2.91%,EGFR;DDX5;BMP4
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.556382215476307,1.4110356790365919,0.0794392523364486,0.5892485682666889,1.0,7/35,6.24%,ADGRG6;AHR;PDE2A;PDE7B;PDE4D;SOX9;RAPGEF2
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.6671530250642393,1.4107527833967604,0.12792792792792793,0.5886797088138147,1.0,2/13,2.22%,KDR;EDN1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.6276199387381483,1.4103281947997006,0.10638297872340426,0.5885706617619221,1.0,5/18,10.53%,IL6ST;IL6R;STAT3;JAK1;CBL
prerank,regulation of interleukin-1 beta production (GO:0032651),0.5056262383681472,1.4091916436451537,0.06415620641562064,0.5908569517648523,1.0,15/66,13.65%,APP;FOXP1;STAT3;GBP5;AIM2;CASP8;CX3CR1;WNT5A;LPL;CASP1;MALT1;CARD16;RIPK2;GSTP1;PANX1
prerank,icosanoid biosynthetic process (GO:0046456),0.7211310695558639,1.4089853759598197,0.12432432432432433,0.5900398226930205,1.0,3/10,8.78%,PLA2G4A;ALOX5AP;LTC4S
prerank,ameboidal-type cell migration (GO:0001667),0.5196962755538932,1.40884867650636,0.0847953216374269,0.5889194306139218,1.0,10/51,5.69%,SEMA6A;TBX1;SEMA5B;SEMA7A;SRGAP2;PKN3;PKN2;PDLIM1;PKN1;SEMA6B
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.6055858317380494,1.4087088375504846,0.10204081632653061,0.5877994121102347,1.0,8/23,18.43%,NMT2;CNGB1;GNAT1;GUCA1B;PDE6B;CALM1;FNTA;CAMKMT
prerank,gluconeogenesis (GO:0006094),-0.46338638236125224,-1.408161380243891,0.03951367781155015,0.4494674545759435,1.0,19/39,26.52%,RBP4;PPARGC1A;SLC39A14;PER2;ENO2;SLC25A12;GOT1;TPI1;SLC25A13;G6PC3;ENO3;PFKFB1;MDH1;CRY1;PCK2;ALDOA;GOT2;ENO1;ALDOC
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.41665477109112226,1.4080868467061398,0.0010395010395010396,0.5884082848702598,1.0,105/509,12.24%,VWF;TEK;FLT1;NOD1;TNFSF10;TGM2;KDR;ENG;CAV1;TBX1;ESR1;APP;TNFRSF19;PRKD1;INSR;KITLG;PDGFB;HIP1;IQGAP1;DAB2IP;LYN;PRKD2;JCAD;MFHAS1;PDGFD;RASD2;TRIM14;PTPRJ;FYN;ACTN4;CASP8;FKBP1A;PLCG2;FLT4;CAV2;SELP;RPS15;FGF23;PLEKHG5;SOX9;TIRAP;EDAR;F7;IKBKB;TCF7L2;CX3CR1;TRIM68;PELI1;PLK2;USP15;RET;WNT5A;BOK;RPS20;CD40;RAC1;MID2;RAPGEF2;SASH1;TRIB3;BCL2L11;BCAR3;TNFRSF1A;ATP2C1;TGFB1;NOS1AP;PDGFC;LCK;PTK2;PIK3CG;NEK6;CASP1;NEDD4;TGFA;MAP3K3;TRIM25;RPTOR;GAB1;MALT1;AKT2;BRD4;RICTOR;PUM1;RPL23;CGAS;IKBKG;IL23A;BCL2L1;SIAH1;LARS1;CBL;SEMA4D;MC1R;NMI;P2RY12;GAS6;IRAK4;OASL;PUM2;RIPK1;BIRC3;CARD16;MIER1;BID;RELA
prerank,regulation of vasculogenesis (GO:2001212),0.6696668802666461,1.407504606537968,0.11151079136690648,0.5887397598710459,1.0,7/14,13.55%,KDR;CD34;CEACAM1;RAPGEF2;RAP1A;XDH;ASB4
prerank,positive regulation by host of viral transcription (GO:0043923),0.6434816117526573,1.406949049871765,0.13036020583190394,0.589018725484953,1.0,6/15,16.14%,LEF1;CHD1;TFAP4;SNW1;RRP1B;CTDP1
prerank,regulation of endopeptidase activity (GO:0052548),-0.4293895620136668,-1.4056768943349414,0.01935483870967742,0.4541333569714908,1.0,11/59,12.13%,TIMP3;VTN;SERPING1;TIMP2;SERPINH1;SERPINE2;SERPIND1;APH1B;SERPINF1;SERPINE1;SPOCK3
prerank,muscle cell migration (GO:0014812),-0.6413641995461339,-1.4056149985004571,0.09473684210526316,0.452203472850818,1.0,4/10,8.54%,DDR1;SIX1;CCN3;PLAT
prerank,macrophage activation (GO:0042116),0.5538570514827242,1.405262566842403,0.0875796178343949,0.5933158017053476,1.0,5/34,4.99%,APP;CD93;FOXP1;PLCG2;SBNO2
prerank,regulation of cell motility (GO:2000145),0.4661575915507895,1.4043380554970457,0.04358974358974359,0.5948874681181628,1.0,28/121,10.43%,FRMD5;PLXNA4;ABI3;NTN1;LDB2;CDK6;CCDC125;PRAG1;PLXND1;ADGRG3;SPATA13;PKN2;ROBO4;TMSB4X;FGF23;PKN1;CAVIN1;CEACAM1;ENPP2;RAC1;TGFB1;SGK3;AKT2;SLK;CRK;SST;CYRIB;INPP5F
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.6451012425108966,1.4039548703321145,0.09734513274336283,0.5946557688501058,1.0,1/15,0.04%,PRKCH
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.6066832662094434,-1.4026703280896922,0.0891566265060241,0.45806303715765967,1.0,8/13,23.03%,SLC4A10;GRIK2;SHISA7;SYP;SLC8A2;PPFIA3;RAB3GAP1;CLN3
prerank,lamellipodium organization (GO:0097581),0.5801856329075388,1.402660843977595,0.10260586319218241,0.5976488542094108,1.0,9/29,11.57%,PARVB;ABLIM1;S1PR1;SPATA13;CCDC88A;RAC1;ARHGEF7;P2RY12;CYFIP1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.5799317484582583,1.4025772276835253,0.10327022375215146,0.5964181994605214,1.0,11/28,18.23%,NOD1;CASP8;IKBKG;RELA;RIPK2;TRAF6;IRGM;OTULIN;TAB3;IRAK2;AAMP
prerank,cellular glucose homeostasis (GO:0001678),0.5375441741379677,1.4023847514325538,0.0791044776119403,0.5954520048907949,1.0,13/41,15.26%,FOXO1;UNC13B;ERN1;HIF1A;KCNB1;XBP1;FOXA3;FOXK1;SOX4;GAS6;RACK1;IGF1R;LRRC8A
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.6978302557209464,1.4016878343452601,0.12781954887218044,0.5962199755359252,1.0,2/10,5.16%,PRKG1;CEACAM1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5424340720482252,1.4016043081160439,0.07566765578635015,0.5949889649859337,1.0,16/40,17.98%,SMURF1;PTK2B;FBXW7;FOXF2;RPS7;PTK2;XPO1;RNF139;GNA12;RPL23;RAD23A;UBE3A;RPL11;DESI1;CSNK2A1;CSNK2A2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.659149384404401,1.4010458531916528,0.09540636042402827,0.5952835275452654,1.0,7/15,17.33%,JMY;ARPC3;ARPC1B;ACTR2;ACTR3;ARPC2;WHAMM
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.4173218343355645,1.400818669037159,0.0030991735537190084,0.5945499750132279,1.0,84/497,13.14%,MECOM;LEF1;ELK3;RPS6KA5;FOXO1;NANOS3;ATP8B1;CD38;HDAC9;DACH1;ZHX3;BMPR2;SMARCA2;PPARD;CBFA2T3;ZBTB16;ACVRL1;SOX7;AHR;DAPK1;PDGFB;FOXP1;DAB2IP;SOX13;HHEX;NR3C1;NOTCH1;PPM1F;PLCB1;SOX18;HMBOX1;SOX9;IGF2BP3;SCMH1;VGLL4;SBNO2;FOXL2;ID1;EPC1;PTPRK;TCF7L2;NANOS2;WNT5A;RCOR1;KLF10;ATF7IP;BCL3;TRIB3;CDKN1B;INPP5K;TGFB1;GRB7;GATAD2A;RNF139;CTBP1;SFRP2;KAT6B;CITED1;FOXK1;MYBBP1A;YEATS2;BTG2;POU2F1;FOXN3;CNOT1;RPL13A;SMARCE1;RBM15;SPEN;TFAP4;GAS6;EID1;ZMYND11;SP3;MRPL13;RB1;SAMD1;RELA;PRICKLE1;PA2G4;RACK1;MIDEAS;FMR1;CNOT7
prerank,triglyceride biosynthetic process (GO:0019432),-0.5514951168549529,-1.400771748267238,0.07579462102689487,0.46117515486085964,1.0,5/18,6.93%,AGMO;MOGAT3;LPGAT1;GK;LPIN1
prerank,negative regulation of cell junction assembly (GO:1901889),-0.516131618623416,-1.4005940364654694,0.0654911838790932,0.4595657745680528,1.0,6/25,5.34%,ARHGAP6;PHLDB2;ROCK2;THBS1;APOD;ROBO2
prerank,cellular response to interleukin-6 (GO:0071354),0.5900621755548517,1.4004791875894875,0.09569377990430622,0.594307555441737,1.0,7/26,7.58%,ST3GAL6;IL6ST;IL6R;STAT3;SBNO2;JAK1;NFKB1
prerank,positive regulation of potassium ion transport (GO:0043268),-0.46860575693963535,-1.4002530053780307,0.06976744186046512,0.45844157441023714,1.0,16/38,18.12%,ANK2;FHL1;ACTN2;KCNMA1;DLG1;AKAP6;KCNMB2;KCNJ2;ADRA2A;GABBR1;KCNJ10;KCNN2;GNG2;KCNJ15;KCNJ6;KCNN3
prerank,positive regulation of neuron projection development (GO:0010976),-0.3928427777332246,-1.3997774009801347,0.042735042735042736,0.45764673134360934,1.0,33/85,15.47%,MAGI2;NTRK3;ROR1;DPYSL3;CAMK1D;EPHA3;PTN;PTK7;BMP5;BMP7;COBL;NDNF;TENM3;CUX2;NTRK2;CAPRIN2;ROR2;KIDINS220;ARSB;ALK;ATP1B2;APOE;FZD1;CAMK1;PLK5;DBN1;PRKCI;CAMK2B;FUT9;P3H1;PLPPR5;CBFA2T2;LRRC7
prerank,defense response to protozoan (GO:0042832),0.6780168340685047,1.3997605626708245,0.12062256809338522,0.595262397569496,1.0,3/12,6.03%,GBP4;GBP7;CD40
prerank,response to cytokine (GO:0034097),0.45922101773207064,1.3997507602904742,0.035108958837772396,0.5937420552053887,1.0,30/141,10.12%,IL1R1;LEF1;PTPN14;IL6ST;LIFR;APP;GCH1;PTPN12;IL6R;OSMR;STAT3;ADAM10;TNFRSF11A;MAP4K3;SELE;CASP8;SIGIRR;SELP;JAK3;MAPK8;ASAH2;CD40;IFNAR2;CASP1;CITED1;RELB;CYP27B1;MAPKAPK3;BCL2L1;CXCR4
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.6427594474879497,1.3997239177929397,0.12195121951219512,0.5923056315552672,1.0,1/15,0.26%,ENTPD1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.6958863870521532,1.3995587446626176,0.1303538175046555,0.5912992919908925,1.0,3/11,6.24%,MEF2C;LYN;RAPGEF2
prerank,positive regulation of locomotion (GO:0040017),0.5833692517100342,1.3993490328216018,0.11093247588424437,0.5904386574953745,1.0,8/27,11.02%,NTN1;STX3;PDGFB;PPM1F;CAVIN1;TGFB1;AKT2;P2RY12
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.5078671182013946,-1.398492884554482,0.09375,0.45895090436814523,1.0,5/22,10.31%,AEBP1;AKAP13;MAP2;EFEMP2;APOE
prerank,amino acid import (GO:0043090),-0.5175952810053285,-1.3979160855615451,0.09295774647887324,0.45867434007732844,1.0,6/21,3.64%,SLC6A13;SLC1A3;SLC47A1;SLC6A1;SFXN2;SLC22A4
prerank,eye morphogenesis (GO:0048592),-0.5320809881455262,-1.3974906601710209,0.07920792079207921,0.4577051465712078,1.0,8/19,9.33%,FBN1;COL5A1;EFEMP1;MFAP5;TENM3;FBN2;NF1;VEGFA
prerank,regulation of dendrite development (GO:0050773),-0.46525728001419253,-1.3972128555651981,0.041791044776119404,0.45650036900984603,1.0,9/37,3.76%,CAMK1D;SDC2;PTN;BMP5;BMP7;HECW2;ADGRB3;CSMD3;COBL
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.657132744368031,1.3961680025665117,0.11870503597122302,0.5999200293521865,1.0,7/14,19.72%,ENTPD1;NUDT16;NUDT15;ENTPD3;NUDT1;ADPRM;NUDT9
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.5982591550613278,-1.3958313559273654,0.12895927601809956,0.4581228120411372,1.0,5/12,13.83%,NINL;BICD1;KIF3A;BICD2;PCM1
prerank,positive regulation of dendrite development (GO:1900006),-0.6289609702288479,-1.3955954862669806,0.08558558558558559,0.45672915260848057,1.0,5/10,9.65%,PTN;BMP5;BMP7;COBL;ALK
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.5195262824883793,-1.3955545825975237,0.0794044665012407,0.45481353381352907,1.0,7/22,13.29%,MAGI2;NTRK3;NTRK2;NGF;KIDINS220;WASF1;EHD1
prerank,regulation of intracellular signal transduction (GO:1902531),0.41661057410113506,1.3954429160932373,0.002109704641350211,0.6008082232562392,1.0,88/420,12.85%,VWF;CHN2;TEK;ARHGAP31;NET1;SGMS1;PPP1R16B;PPP1R13B;MCF2L;ARHGEF3;ARAP3;RASGRF2;PIP5K1B;DAB2IP;ARHGEF2;PDE2A;LYN;PRKD2;BCR;SRGAP3;SRGAP2;DDIT4;RASD2;NFKBIA;BST1;TAOK2;SRGAP1;STK3;PRKAR2B;JMY;TRAF1;PLCG2;PAK2;TMSB4X;RHOJ;PLEKHG5;KALRN;STK4;IER3;ARHGAP8;PREX1;HIPK1;CEACAM1;ARHGAP17;PHF20;XIAP;OPHN1;WNT5A;AURKA;RAC1;BCL3;RPA1;TNIK;PTPMT1;NF2;GNA12;SLC15A2;WWC2;PPP2R5B;TAF3;RRS1;TAF4B;DEPDC1B;BRIP1;ARHGEF7;ARHGEF26;RICTOR;CRK;CDK2;FBXL2;MAPK11;IKBKG;ARHGAP28;NUAK1;PRKAB1;OCRL;ARAP2;HUS1;RMI1;BIRC3;ARHGAP23;TMBIM4;TRIO;RELA;NOP53;RHOB;ARHGEF9;GNA13
prerank,cell-cell junction maintenance (GO:0045217),0.6819181686195828,1.3949989831753924,0.13221601489757914,0.6007425147875279,1.0,1/11,0.28%,TJP1
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.3957628385791926,-1.3948216110123923,0.02834008097165992,0.454646377337119,1.0,19/85,8.37%,EYA1;ROR1;COL1A1;PIEZO2;COL4A3;CEMIP;ADGRV1;EML2;COL11A1;DCDC2;CACNA1D;GRM7;P2RX4;GSDME;ATP6V0A4;PCDH15;WHRN;ALDH7A1;RIPOR2
prerank,negative regulation of protein kinase activity (GO:0006469),0.48332038576711633,1.3947873688386871,0.0520694259012016,0.5999575618608083,1.0,22/88,13.02%,PTPRB;GNAQ;CAV1;ADARB1;DAB2IP;LRP5;PPM1F;WWTR1;PAK2;CEACAM1;TRIB3;CDKN1B;INPP5K;PTPN1;SFN;ADAR;RB1;CORO1C;GSKIP;WARS1;GSTP1;TRIB1
prerank,muscle cell differentiation (GO:0042692),0.5619087969068415,1.394605418605574,0.09235668789808917,0.5990325093197255,1.0,5/32,6.78%,MRTFB;TBX1;MEF2C;MRTFA;SYNE1
prerank,cellular metal ion homeostasis (GO:0006875),-0.3829990838032738,-1.3943092143019005,0.015748031496062992,0.4541103781930413,1.0,19/102,10.27%,ATP1A2;SLC24A3;ANK2;ATP13A5;ATP13A3;SLC8A3;SLC41A1;SLC12A2;ATP1B1;SLC8A1;KCNMA1;DMPK;STIM1;KCNJ2;ATP2A2;RYR2;SLC24A2;ATP1B2;CXCL12
prerank,regulation of protein import into nucleus (GO:0042306),-0.46333084782742034,-1.3935722578421248,0.05337078651685393,0.4539675546290464,1.0,15/36,22.78%,ZIC1;PRKCD;BMP4;CDH1;APOD;SMAD3;RAB23;SUFU;MAVS;PIK3R2;TRIM28;UBR5;HDAC3;JUP;BAG3
prerank,cellular response to inorganic substance (GO:0071241),0.60376198267393,1.3927203198606934,0.11869918699186992,0.6039380982971128,1.0,9/21,17.06%,FOXO1;CDK2;FMR1;AOC1;DDI1;ATRX;MTR;DDI2;SPIDR
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.48570520064978906,1.392686870886139,0.05320600272851296,0.6025457395423233,1.0,11/75,5.58%,SEMA6A;TEK;CLDN5;PTPRM;ECSCR;DAB2IP;HHEX;STAB1;NPR1;GTF2I;ATP2B4
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.5470834576268275,-1.3923359989611477,0.11380145278450363,0.45526277530951603,1.0,4/18,5.09%,IGF1;IGFBP2;IL18;IGF2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.5305159103244979,-1.3921009922310998,0.0896551724137931,0.4539607193947402,1.0,9/20,20.25%,GRK3;BICD1;GPRASP1;RPGRIP1L;SNCA;PLEK;CRY1;RNF157;MRAP2
prerank,negative regulation of cell death (GO:0060548),0.4838158648682166,1.39209883269867,0.04847645429362881,0.6029504851251767,1.0,18/88,10.07%,MECOM;PDE8A;PRKD1;CD200;SRGAP2;TNFRSF1B;FYN;NCK1;CD34;AMIGO2;TIGAR;CHMP4A;CHMP4B;CSF1;SOX4;IKBKG;BTBD10;RAD18
prerank,regulation of interleukin-4 production (GO:0032673),0.6086372985695915,1.3919457789411542,0.11986301369863013,0.6020007956007267,1.0,1/21,0.13%,LEF1
prerank,vesicle transport along actin filament (GO:0030050),0.6249280693828984,1.3917394597828645,0.12345679012345678,0.6011849710632978,1.0,5/19,10.90%,FNBP1L;MYO1D;ACTN4;MYO1E;MYO1C
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.6805937667066893,1.3914046350451845,0.12260536398467432,0.6007648276824897,1.0,2/10,1.47%,ST6GAL1;ST3GAL1
prerank,negative regulation of cellular component movement (GO:0051271),0.6276788173462975,1.391076661404075,0.11607142857142858,0.6003415364849873,1.0,3/15,4.18%,FRMD5;CCDC125;ACTN1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.5321341174217434,1.3907428409612494,0.0745814307458143,0.6000092654958116,1.0,10/47,7.58%,CAV1;FBXW7;SIK1;FYN;CD34;CEACAM1;ATP2B4;RAPGEF2;TRIB3;NFKB1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.5180968744782799,-1.3891663785745045,0.07398568019093078,0.45952610211133094,1.0,9/20,12.77%,ATP1A2;SLC12A2;ATP1B1;SLC8A1;KCNMA1;KCNJ2;ATP1B2;SLC9A1;LACC1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.5745682699042725,1.3881487155189045,0.09646302250803858,0.6071576051827711,1.0,7/27,12.83%,PRKCH;NFKBIA;LPL;NFKB1;CSF1;ITGB3;ABCG1
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.6435126536632421,1.3879533368053312,0.12199312714776632,0.606261047710354,1.0,2/16,1.81%,BMPR2;PRCP
prerank,anion transport (GO:0006820),0.5708772406884592,1.3876069079284796,0.1058282208588957,0.606077558698163,1.0,4/33,2.49%,SLCO2B1;ABCG2;LRRC8C;LRRC8B
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.5216089973937622,1.3874034881982868,0.08211143695014662,0.6052994205076028,1.0,9/46,6.74%,LCP1;MSN;RAP1B;PLCB1;PAK2;HNRNPF;CA1;MTAP;JAK1
prerank,regulation of erythrocyte differentiation (GO:0045646),0.5532406351988186,1.386849088136404,0.10631741140215717,0.6057055366742455,1.0,9/35,9.68%,CDK6;LYN;STAT3;TAL1;HIF1A;ACVR2A;MAFB;ZFPM1;MAPK11
prerank,defense response to bacterium (GO:0042742),0.46281280948599596,1.3867892619985922,0.055916775032509754,0.6043884477138199,1.0,16/105,9.76%,NOD1;IL6R;STAB1;GBP4;SELP;TIRAP;RPS19;GBP7;LCN2;RPL39;DROSHA;PGLYRP2;LYG2;ANG;DEFA6;IL23A
prerank,positive regulation of cholesterol efflux (GO:0010875),0.6029742221291832,1.3867769770163523,0.109375,0.6029698438182953,1.0,5/21,5.80%,CAV1;PLTP;NFKBIA;EEPD1;ABCA3
prerank,neural crest cell development (GO:0014032),0.5198476028033022,1.3859078269155372,0.09447674418604651,0.6044632842138101,1.0,10/44,11.77%,SEMA6A;TBX1;SEMA5B;SEMA7A;CDH2;SEMA6B;CYP26C1;SEMA6D;SEMA4D;CORO1C
prerank,glutamine family amino acid catabolic process (GO:0009065),0.6330051880171962,1.3854369545291845,0.1338432122370937,0.6045656547783168,1.0,3/13,3.41%,NOS3;GLS2;GLS
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.45528588820871435,1.3847990149435594,0.059186189889025895,0.6051829621043014,1.0,24/138,5.73%,TEK;PTPRG;FLT1;BMPR2;IL6ST;KDR;TIE1;LIFR;EPHB4;INSR;NEDD9;LYN;PTK2B;NPR1;YES1;MPZL1;MTSS1;FYN;SRMS;FLT4;LMTK2;JAK3;ACVR2A;RET
prerank,regulation of myotube differentiation (GO:0010830),0.580970080103344,1.384526337551078,0.11073825503355705,0.6046212712104495,1.0,6/24,8.06%,HDAC9;PIEZO1;NOTCH1;SIK1;XBP1;ATP11A
prerank,Golgi localization (GO:0051645),-0.616655124758763,-1.3841000403403685,0.10480349344978165,0.4709707491211206,1.0,3/11,13.42%,ARHGAP21;COPG1;ARCN1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.42824301232982803,-1.3840273251284003,0.05245901639344262,0.4691645026698747,1.0,19/51,14.56%,DCLK1;GAS7;NBL1;EPB41L3;BMP7;NRK;CNTNAP2;ALS2;SHTN1;TAOK3;NGF;LRRK2;PLXNB1;DTNBP1;WASF1;DBN1;ANKRD27;CTTN;CNTNAP1
prerank,response to estrogen (GO:0043627),0.5686973009708929,1.3830652207240994,0.10344827586206896,0.6082928095631003,1.0,10/31,14.22%,CAV1;ESR1;SERPINB9;NCOA4;TRIM25;CITED1;TRIM24;CYP27B1;ASH2L;PELP1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.4199951703367694,1.3830574952319323,0.013948497854077254,0.606867575058245,1.0,87/366,16.87%,RPS6KA5;NANOS3;ENG;APBB2;SLC39A8;ESR1;SMARCA2;APP;MEF2C;ACVRL1;SOX7;NR5A2;INSR;AHR;IRF2;SOX13;STAT3;NR3C1;HIF1A;NOTCH1;RREB1;SOX17;CHD7;WWTR1;SOX18;SBNO2;TCF7L1;LIN54;SPIN1;EIF4E;MTF2;JMJD1C;PITX3;CCDC88A;TEAD2;ESRRG;CNBP;ASCC1;LYL1;FOXN2;TCF3;HNRNPD;CREM;KAT6B;WWC2;ZNF2;BACH1;MAFB;PRDM8;HINT1;MYBBP1A;SOX4;FOXN3;RBM3;BTG1;PRDM2;SP3;CYFIP1;RB1;RELA;UTP4;GLRX2;RPL6;RPL10;MTPN;ZSCAN21;DMTF1;ESRRB;NFKB2;ACVR2B;RYBP;ZNF423;ERC1;ATRX;YBX1;NR2C2;RPS6KA4;ORC5;HMG20A;DDIT3;GPBP1L1;ZFPL1;ORC3;HP1BP3;CHEK2;ACTR5;CASZ1
prerank,endocrine system development (GO:0035270),-0.5165862313560011,-1.3828592315630013,0.10309278350515463,0.470259706322279,1.0,7/21,5.87%,GLI2;WNT4;DKK3;TGFBR1;SALL1;SIX1;NF1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.5704056065002854,1.3827811243732495,0.11550632911392406,0.6063968614777008,1.0,7/27,7.32%,TEK;FLT1;PRKD1;PDGFB;PTK2B;TGFB1;PTK2
prerank,regulation of ruffle assembly (GO:1900027),0.601821864172946,1.3827485769814947,0.10197368421052631,0.6050258672312898,1.0,4/23,4.16%,ABI3;CAV1;EPS8;EVL
prerank,regulation of cellular localization (GO:0060341),-0.44029370957885977,-1.3826208024475042,0.038834951456310676,0.4689102997230804,1.0,10/46,7.97%,ADCY5;GSN;PRKN;EFNA5;PARD6G;MAP2;BRSK1;HSP90AA1;STXBP4;LRRK2
prerank,positive regulation of inflammatory response (GO:0050729),0.47554674400337676,1.3823652586367756,0.0610079575596817,0.6049189454788926,1.0,16/86,11.77%,IL6ST;APP;IL15;OSMR;PDE2A;NFKBIZ;NFKBIA;RPS19;WNT5A;TNFRSF1A;LPL;TNIP1;IL23A;VAMP8;NMI;RIPK1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.5965653179749956,1.3821586825467256,0.11505922165820642,0.6042354588077901,1.0,6/20,10.72%,SEMA6A;SEMA5B;SEMA7A;SEMA6B;SEMA6D;SEMA4D
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.667970933083346,1.3814382734133674,0.12784588441331,0.6053599252465383,1.0,5/12,10.96%,SMCHD1;CDYL;PCGF5;RBM15;YTHDC1
prerank,establishment of vesicle localization (GO:0051650),0.6239587539828579,1.3813897592391013,0.11724137931034483,0.6041043042503345,1.0,6/18,12.46%,RAB27A;RAB11A;LIMK2;SYNJ1;IKBKG;CCDC186
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.579012093504019,-1.3812828269134192,0.1076923076923077,0.4705030834993996,1.0,7/14,14.55%,DMD;ATP1B1;WNK4;ANK3;WNK1;SLC9A1;WNK3
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.42490491243779505,1.380939206823882,0.027932960893854747,0.604157524511101,1.0,49/259,11.88%,FGD5;ABCC4;DNM3;PARVB;ABLIM1;FNBP1L;EXOC6;NTN1;EHD4;CD2AP;FGD6;RAB11A;SRGAP2;NOTCH1;S1PR1;CNGB1;RAP1B;SPATA13;MTSS1;PPP1R9B;SSX2IP;DISC1;SDCBP;CEP41;OPHN1;CCDC88A;PCNT;RAC1;RAPGEF2;BBIP1;INPP5K;STK26;TNIK;EHD2;RAP1A;DYNLL1;EXOC5;ARHGEF7;TEKT5;EXOC4;OCRL;ANO6;CEP83;FSCN1;ARL13B;P2RY12;ACTR2;CYFIP1;EHD3
prerank,ganglion development (GO:0061548),0.6900737163437203,1.380806839998104,0.13937282229965156,0.6031467860264547,1.0,1/11,0.07%,NRP2
prerank,substrate-dependent cell migration (GO:0006929),0.6602660401852709,1.3806506938695744,0.13846153846153847,0.6022300748521328,1.0,8/14,11.12%,NTN1;ANKS1A;CD2AP;VEGFC;SDCBP;OPHN1;P2RY12;ITGA2
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.6055684881942508,-1.3805398174163814,0.12780269058295965,0.4705717401246647,1.0,5/11,20.20%,WNT4;BMP5;FGFR4;DGKQ;NR1H4
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.5827802347741338,1.3803163131057203,0.11532125205930807,0.6019088683659121,1.0,8/25,11.68%,APP;ANKRD13A;RIN3;SDCBP;RAC1;PSEN1;ITGB3;PICALM
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.5329907874823065,-1.3799656361977173,0.08229426433915212,0.47023710399812574,1.0,5/18,8.83%,PRKN;IRS1;CCN3;ADRA2A;SFRP1
prerank,calcineurin-mediated signaling (GO:0097720),0.6694062153392351,1.3792014400744819,0.1386861313868613,0.6027703362866214,1.0,3/10,6.02%,NFATC1;PPP3CA;PPP3CB
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.6694062153392351,1.3792014400744819,0.1386861313868613,0.6027703362866214,1.0,3/10,6.02%,NFATC1;PPP3CA;PPP3CB
prerank,regulation of actin filament-based movement (GO:1903115),-0.6249334311084911,-1.3791473762633195,0.11328976034858387,0.4704879018622279,1.0,2/10,1.61%,ANK2;PDPN
prerank,receptor internalization (GO:0031623),0.5289501395348034,1.3791161309914524,0.08206686930091185,0.6016248145364121,1.0,11/44,13.28%,DNM3;CALCRL;CAV1;CEACAM1;RAMP2;ARRB1;NEDD4;SCYL2;PICALM;RAB31;RAB5A
prerank,blood circulation (GO:0008015),0.5155688651519814,1.3785396748859162,0.09117221418234443,0.6019966149097051,1.0,7/49,5.29%,TBC1D8;NOS3;MYOF;ACVRL1;NPR1;ELN;DLL4
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5546657473856884,1.3778519033842698,0.10849056603773585,0.6030267924197796,1.0,8/33,7.19%,MEF2C;ACVRL1;MMRN2;NOTCH1;CARD10;DLL4;ATP2B4;TGFB1
prerank,detection of visible light (GO:0009584),0.6355500244840887,1.3776558051438792,0.11265164644714037,0.6022959898667748,1.0,3/16,7.02%,GNAQ;CNGB1;GNAT1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.7025149713420221,1.377276091713862,0.11688311688311688,0.6022085864116231,1.0,2/10,2.15%,SEMA6A;DAB2IP
prerank,chromatin organization (GO:0006325),0.44887306172209146,1.3770416604380817,0.0451693851944793,0.6015728813051554,1.0,34/132,18.63%,MECOM;ESR1;SMARCA2;BAZ2B;SOX9;KDM6A;PADI4;TCF7L1;MTF2;CHD1;KDM4C;ARID1A;EZH1;SMARCA5;NPM3;SMARCE1;RB1;TOP1;PADI1;SETDB2;NPM1;KAT2B;ATRX;BAZ1A;HMG20A;JARID2;PIH1D1;HP1BP3;KDM5C;KDM4A;EHMT1;PHF19;PAK1;CHRAC1
prerank,regulation of cation channel activity (GO:2001257),-0.3808678824005138,-1.3731853169182398,0.04119850187265917,0.484805787502405,1.0,31/89,15.49%,ANK2;DMD;DLG2;NLGN2;ACTN2;DLG4;FGF14;JPH1;GRIA2;ANK3;DLG1;CACNB2;SLMAP;GRIA1;GRIA3;NLGN1;PRKACA;KCNAB1;DLG3;CACNB1;GRIA4;SHANK1;PRRT1;GRIN2A;AHNAK;JPH2;CAMK2B;CACNG4;SHISA7;LRRC7;NETO1
prerank,presynapse organization (GO:0099172),-0.6274899616440939,-1.3728988385410235,0.12173913043478261,0.4834861243693037,1.0,6/10,16.11%,NLGN2;LRRTM3;NLGN1;NLGN3;FZD1;DVL1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.6520216186817805,1.3726303312787442,0.15265866209262435,0.6150742588591719,1.0,5/13,11.62%,IL6ST;STAT3;IL27RA;JAK1;OASL
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.6194150121132355,1.3725497807220297,0.122040072859745,0.6139019687532911,1.0,6/17,11.02%,PIEZO1;PODXL;RET;SKAP1;SFRP2;P2RY12
prerank,cellular component maintenance (GO:0043954),0.6503262953444308,1.3720687594666203,0.14076782449725778,0.6139864658633478,1.0,5/12,14.39%,INSR;FYN;ITGA3;PICK1;IGF1R
prerank,positive regulation of interferon-gamma production (GO:0032729),0.5122609281724739,1.3720676133962029,0.10260115606936417,0.6125838681854637,1.0,5/48,10.08%,IL1R1;PDE4D;ZFPM1;IL23A;CYRIB
prerank,hydrogen peroxide metabolic process (GO:0042743),0.6053836932456907,1.3715344989244205,0.12585034013605442,0.6129014064978874,1.0,5/19,16.72%,MAOB;PXDN;CAT;PRDX2;PRDX1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.4384455738476586,-1.3710321799316174,0.06748466257668712,0.486699009746677,1.0,18/44,18.12%,ANK2;ACTN2;ATP1B1;WNK4;KCNMA1;AKAP6;KCNMB2;KCNJ2;WNK1;ATP1B2;GABBR1;KCNJ10;KCNN2;WNK3;GNG2;KCNJ15;KCNJ6;KCNN3
prerank,actin filament-based transport (GO:0099515),0.5963305059191374,1.37064860359518,0.1323024054982818,0.6144507772631589,1.0,5/21,10.90%,FNBP1L;MYO1D;ACTN4;MYO1E;MYO1C
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.5838419537061327,1.3703702595532588,0.13402061855670103,0.6139598331285057,1.0,8/24,18.23%,NOD1;CASP8;IKBKG;RIPK2;TRAF6;TAB3;IRAK2;AAMP
prerank,positive regulation of nervous system process (GO:0031646),0.6141721536695612,1.3696461475204413,0.12478031634446397,0.6149061969900683,1.0,3/18,3.04%,UNC13B;PARD3;TNFRSF1B
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.6788843564265298,1.3688196544116684,0.14962121212121213,0.6162478604393742,1.0,3/10,6.24%,PIEZO1;PODXL;SKAP1
prerank,glycoprotein metabolic process (GO:0009100),0.5089534894430539,1.3684396955778824,0.09985734664764621,0.6160504480137524,1.0,9/53,9.52%,ST6GALNAC3;MGAT4A;STT3B;HIF1A;MAN2A1;B4GALT5;ST8SIA4;B3GNT6;TNIP1
prerank,negative regulation of cell motility (GO:2000146),0.45474201474485687,1.3682019800999479,0.0685640362225097,0.6154229944857735,1.0,21/108,8.41%,FRMD5;LIMCH1;MCTP1;DACH1;ENG;ACVRL1;CLDN5;ADARB1;CCDC125;SRGAP3;SRGAP2;PTPRJ;SRGAP1;STK24;SMAD7;PTPRK;DUSP22;ADAM15;STK26;NF2;SFRP2
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.5493947804760425,1.3680586565553858,0.0853462157809984,0.614498332569702,1.0,15/37,19.72%,ENTPD1;ISG20;RNASEH2A;MTREX;HNRNPD;NUDT16;RNASEH2C;RNASEH2B;NUDT15;XRN2;PNPT1;ENTPD3;NUDT1;ADPRM;NUDT9
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.639633743265057,1.3670563778826168,0.13227513227513227,0.6164959458583574,1.0,8/16,20.84%,CAV1;BCL3;NF2;INPP5F;ADIPOR1;PPP2R1A;LEPROT;PIBF1
prerank,cellular response to growth factor stimulus (GO:0071363),0.4492760914472252,1.3669892436294913,0.036904761904761905,0.6153825202769408,1.0,32/151,7.67%,SEMA6A;FLT1;BMPR2;KDR;TBX1;PDE8A;MEF2C;ERN1;ACVRL1;PRKD1;PLCG1;PDGFB;PTPN12;IQGAP1;DAB2IP;PDE2A;PRKD2;NR3C1;NOTCH1;FLT4;SOX9;ACVR2A;SMAD7;DLL4;RAMP2;WNT5A;DUSP22;ACVR1;RAPGEF2;INPP5K;TGFB1;RAP1A
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.41760422799453295,1.3668549290889276,0.015300546448087432,0.6144312881179337,1.0,91/327,18.96%,RPS6KA5;ENG;APBB2;SLC39A8;ESR1;SMARCA2;MEF2C;ACVRL1;SOX7;NR5A2;INSR;AHR;IRF2;SOX13;STAT3;NR3C1;HIF1A;NOTCH1;RREB1;SOX17;ACTN4;CHD7;WWTR1;SOX18;SBNO2;TCF7L1;LIN54;SPIN1;MTF2;JMJD1C;PITX3;TEAD2;ESRRG;CNBP;ASCC1;LYL1;FOXN2;TCF3;HNRNPD;CREM;KAT6B;WWC2;ZNF2;BACH1;MAFB;PRDM8;HINT1;MYBBP1A;SOX4;COPS2;FOXN3;ZMIZ1;BTG1;PRDM2;SP3;RB1;RELA;UTP4;GLRX2;RPL6;ZSCAN21;DMTF1;ESRRB;NFKB2;ACVR2B;RYBP;ZNF423;ERC1;ATRX;YBX1;NR2C2;RPS6KA4;HMG20A;DDIT3;GPBP1L1;ZFPL1;HP1BP3;CHEK2;ACTR5;CASZ1;CXXC1;RFX3;PHF19;ZSCAN26;MLX;MLXIPL;PFDN5;NR1D2;RALY;FUS;HMGN5
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.45821502727257357,1.3667824485762052,0.06623376623376623,0.6119247555936073,1.0,32/104,21.16%,RPS6KA5;LYN;ICAM2;FYN;PLCG2;PAK2;IKBKB;NRAS;KRAS;NFKB1;PSMA2;MALT1;RELB;IKBKG;PSMA8;PSMA6;CUL1;RELA;MUC1;TRAF6;PSME1;TAB3;PSMA4;PSMF1;PAK1;CARD9;PRKACB;BCL10;PSMB1;PSMB7;PSMD2;MUC6
prerank,cellular response to lectin (GO:1990858),0.45821502727257357,1.3667824485762052,0.06623376623376623,0.6119247555936073,1.0,32/104,21.16%,RPS6KA5;LYN;ICAM2;FYN;PLCG2;PAK2;IKBKB;NRAS;KRAS;NFKB1;PSMA2;MALT1;RELB;IKBKG;PSMA8;PSMA6;CUL1;RELA;MUC1;TRAF6;PSME1;TAB3;PSMA4;PSMF1;PAK1;CARD9;PRKACB;BCL10;PSMB1;PSMB7;PSMD2;MUC6
prerank,positive regulation of GTPase activity (GO:0043547),0.4306336587571265,1.3662991854196467,0.038869257950530034,0.6121320384002613,1.0,33/188,8.91%,TBC1D8;DOCK9;PKP4;TGM2;NET1;ITGA6;RALGAPA2;F11R;TBC1D30;ARHGEF15;TBC1D4;CCDC125;BCR;SRGAP2;RALGAPA1;ARHGAP27;SGSM1;TBC1D22A;CAV2;ADRB1;TBC1D15;SIPA1L3;RAP1GDS1;CD40;RAPGEF2;TBC1D12;BCAR3;RAP1A;TBC1D2;AGRN;RSU1;ARHGEF7;ARHGEF26
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.5886566775203045,-1.3658164588342254,0.10284463894967177,0.4993388244326096,1.0,6/12,26.47%,INSIG2;KDELR3;GPAA1;INSIG1;RER1;HSPA5
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.6225276488351417,-1.3656358146234246,0.09956709956709957,0.49781308756449133,1.0,2/10,9.39%,ALDH7A1;HNMT
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4874771938185509,1.3654312180745667,0.08979591836734693,0.6135083026013305,1.0,16/72,7.08%,NET1;HEG1;F11R;EPS8;ARHGEF3;RASIP1;ARHGEF2;CCDC125;BCR;PRAG1;ADGRG1;KCTD10;OPHN1;RAC1;ARRB1;ITGA3
prerank,protein localization to phagophore assembly site (GO:0034497),-0.59419815188929,-1.365418740039242,0.1172566371681416,0.4964658259404052,1.0,6/11,27.29%,WIPI1;PACS2;ATG9A;STX17;WDR45;WIPI2
prerank,icosanoid secretion (GO:0032309),0.6636529390714919,1.3649304385005405,0.14513274336283186,0.6137343816412275,1.0,1/12,0.18%,ABCC4
prerank,potassium ion transmembrane transport (GO:0071805),-0.35565684547795073,-1.3647062018116207,0.009852216748768473,0.4964750995465787,1.0,23/135,9.97%,ATP1A2;SLC24A3;KCNK2;NALCN;SLC1A3;SLC12A2;KCNB2;SLC9A9;KCNK5;ATP1B1;KCNQ3;ABCC9;KCND2;KCND3;KCNC2;KCNJ2;KCNS3;KCNQ4;KCNJ13;KCNAB1;SLC24A2;ATP1B2;KCNQ5
prerank,response to exogenous dsRNA (GO:0043330),0.61967844269238,1.364607235646789,0.1256544502617801,0.6134592959812788,1.0,7/18,14.67%,CAV1;SLC3A2;RALB;RFTN1;CGAS;IFIH1;IRAK3
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.5836310363019446,-1.3645855148004797,0.10722610722610723,0.49480713530270876,1.0,8/14,20.71%,IRS1;PPARGC1A;IRS2;SLC45A3;PTPN2;DDB1;GPLD1;NNMT
prerank,modulation by symbiont of host process (GO:0044003),0.6836921657281722,1.3645256160584025,0.14100185528756956,0.6123721210691555,1.0,1/10,1.56%,B2M
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.45675534863773315,1.3629876922265933,0.06371911573472042,0.6160942513732528,1.0,32/105,21.16%,RPS6KA5;LYN;ICAM2;FYN;PLCG2;PAK2;IKBKB;NRAS;KRAS;NFKB1;PSMA2;MALT1;RELB;IKBKG;PSMA8;PSMA6;CUL1;RELA;MUC1;TRAF6;PSME1;TAB3;PSMA4;PSMF1;PAK1;CARD9;PRKACB;BCL10;PSMB1;PSMB7;PSMD2;MUC6
prerank,negative regulation of cytokine production (GO:0001818),0.43925749649072726,1.3613430946698528,0.0471584038694075,0.6203360843594468,1.0,24/163,7.94%,LEF1;RPS6KA5;HDAC9;RNF125;CD200;NLRC5;HDAC7;SIGIRR;CD34;HOMER2;TMSB4X;UBA7;DLL1;JAK3;CEACAM1;N4BP1;CUEDC2;RAC1;BCL3;BTN2A2;TIGIT;ARRB1;SRGN;TRIM25
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.5449690123594145,1.360759447991032,0.11162790697674418,0.6207628478593946,1.0,11/33,14.03%,DGKZ;PRKD2;NECTIN2;PTPRJ;TESPA1;CEACAM1;LCK;IKBKG;RC3H1;RELA;SLA2
prerank,negative regulation of endothelial cell migration (GO:0010596),0.5419962500558524,1.3605316604693,0.11353032659409021,0.6201937304888498,1.0,8/36,7.19%,MEF2C;ACVRL1;PTPRM;DAB2IP;NOTCH1;DLL4;ATP2B4;TGFB1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.5332079369940834,1.3604566298732026,0.10651828298887123,0.6191265865470159,1.0,6/33,5.29%,PTPRG;ACVRL1;PTPRM;DAB2IP;EVL;DLL4
prerank,regulation of cellular component size (GO:0032535),0.5466850636393379,1.359198758167624,0.11987381703470032,0.6218997643062582,1.0,10/30,16.40%,EPS8;RIN3;MSN;RAC1;RPTOR;LARS1;PICALM;MTPN;RDX;HP1BP3
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.5443575825695106,-1.3585443213010264,0.12183908045977011,0.5094120935855868,1.0,3/17,2.05%,ANK2;SNTA1;CACNA2D1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.4442842636074981,1.358224682630168,0.052503052503052504,0.6237302577962917,1.0,38/153,13.42%,PRKCH;RPS6KA5;ERN1;PRKD1;PDGFB;PRKD2;PKN3;PKN2;PAK2;RPS6KA3;PKN1;STK4;LMTK2;MARK3;IKBKB;RPS6KA1;HIPK1;MAST2;MAPK8;PLK2;ULK1;AURKA;DYRK1A;NEK6;SGK3;AKT2;RICTOR;CDK2;MAPKAPK3;AKT3;GAS6;STK38;MAP3K13;RIPK1;MKNK2;TOP1;TGFBR2;UHMK1
prerank,cellular response to peptide (GO:1901653),0.4984666746921162,1.3575132436897088,0.08203677510608204,0.6246922926578246,1.0,19/56,14.46%,NOD1;CAV1;APP;ICAM1;VCAM1;ARHGEF2;CASP4;FYN;XBP1;CACNA1A;ATP1A3;PSEN1;RPL23;EPHA4;GRIN1;LGMN;RIPK2;IGF1R;ZFP36L1
prerank,calcium ion import (GO:0070509),-0.46806462991674735,-1.3568782658178002,0.11748633879781421,0.5121342003658056,1.0,9/28,10.92%,CACNA1C;CACNA1D;SLC8A1;MCU;CACNB2;CACNA1G;ATP2A2;TRPC4;MICU1
prerank,regulation of DNA repair (GO:0006282),-0.43917002232732916,-1.356323848929514,0.0943952802359882,0.5116867522386385,1.0,4/44,1.86%,EYA2;EGFR;EYA1;EYA4
prerank,lipid oxidation (GO:0034440),0.6615849605135113,1.355674894811237,0.15467625899280577,0.6291665332627802,1.0,1/12,0.59%,ADIPOR2
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5716938573532755,1.3555180849366262,0.1342062193126023,0.6283176494924217,1.0,9/24,9.08%,EPN2;MMRN2;DAB2IP;HHEX;PRKD2;HIF1A;NEDD4;ITGA5;PTPN1
prerank,modulation by host of symbiont process (GO:0051851),0.5572328860326171,1.3552548617460545,0.1008,0.6278311077550984,1.0,11/31,20.17%,LEF1;CX3CR1;INPP5K;CHD1;TFAP4;SNW1;RRP1B;CTDP1;CARD9;SAP30BP;SP1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.5496644219201284,1.355077807174215,0.11812297734627832,0.6270832667672345,1.0,12/29,17.44%,RPS19;RPS14;RPS16;RRS1;RPS8;HELB;UTP4;NOL10;RPS21;UTP6;NOP14;HEATR1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.543081696904346,1.354834397438613,0.10939907550077041,0.6265093424667731,1.0,7/33,7.19%,PDGFB;GATA2;STAT3;NR3C1;HIF1A;FOSL1;TGFB1
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.5606224270173273,-1.3547448107390052,0.12796208530805686,0.5140575907380809,1.0,6/15,24.10%,ALDH4A1;GGT5;PRODH;HOGA1;GGT1;GOT2
prerank,secondary palate development (GO:0062009),0.6283813516029757,1.354544994882612,0.16074450084602368,0.6261059808437142,1.0,3/14,5.81%,LEF1;CHD7;WNT5A
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.5750009460554145,1.354432858043352,0.1314935064935065,0.6251540908988588,1.0,8/24,14.80%,CTSC;EFNA1;PTK2B;UCHL5;EPHA4;UBE3A;NUDT15;PSME1
prerank,ribosomal small subunit assembly (GO:0000028),0.6321658925810407,1.3543350033260626,0.14726027397260275,0.6241325863450126,1.0,5/16,11.28%,RPS15;RPS19;RPS14;RPSA;RPS27
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.5476379543747499,-1.3537756789737838,0.11255411255411256,0.5147548433508434,1.0,8/16,20.51%,PYGB;PHKB;PYGM;GAA;AGL;AOAH;PHKG1;PHKA2
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5922098304603206,-1.3536364495602493,0.12415349887133183,0.5131295311345976,1.0,4/11,9.62%,CACNA2D1;CACNB2;CACNB1;BIN1
prerank,cellular response to alcohol (GO:0097306),-0.4310168668764974,-1.3535353398955774,0.07142857142857142,0.5114741750955206,1.0,13/42,9.67%,ADCY5;ADCY1;ADCY2;GRAMD1B;CDH1;ADCY7;GRAMD1C;ADCY6;LRP6;GNAI1;SFRP1;PTGFR;SMO
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.5386263513480002,-1.3534020753074743,0.11576354679802955,0.5098175094496437,1.0,5/17,3.81%,ATP1A2;BMP7;TFPI;BMP4;AR
prerank,phasic smooth muscle contraction (GO:0014821),0.6716370525766828,1.3530737253748808,0.16353383458646617,0.6269307570557608,1.0,2/10,13.83%,EDN1;HTR1D
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.6634465439896844,1.3530532335419725,0.2024866785079929,0.6256608865666371,1.0,2/10,1.14%,ACER2;NEXMIF
prerank,membrane protein proteolysis (GO:0033619),0.5315469466211534,1.3530341581290948,0.11526946107784432,0.624411899422185,1.0,15/37,14.87%,MYH9;ADAM10;SPPL2A;RET;TGFB1;NFKB1;ERAP1;PSEN1;RHBDD1;MBTPS2;APH1A;RELA;ADAM17;TRAF6;SPPL3
prerank,positive regulation of fat cell differentiation (GO:0045600),0.5039439665317087,1.3529100053531102,0.11127167630057803,0.623528926418058,1.0,13/47,12.96%,PTGS2;PPARD;ZBTB16;SOX13;LRP5;RREB1;XBP1;LPL;SFRP2;CREB1;CCDC71L;PIM1;ZFP36
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.5393007194517255,-1.352097049124836,0.11961722488038277,0.5114746168689007,1.0,10/16,8.46%,IGF1;BMPR1A;FGFR2;TGFBR3;ERBB4;FGF2;ZFPM2;AKAP6;RBPJ;GLI1
prerank,prostaglandin biosynthetic process (GO:0001516),0.6067841194709388,1.3516990803856603,0.14136125654450263,0.6263468141645544,1.0,5/18,7.28%,PTGS2;PLA2G4A;EDN1;PTGS1;CBR1
prerank,regulation of viral entry into host cell (GO:0046596),0.549481071380144,1.351630252252417,0.13771517996870108,0.6252541123797252,1.0,8/30,7.94%,LY6E;TRIM14;NECTIN2;TRIM68;PTX3;MID2;SNX3;TRIM25
prerank,positive regulation of monooxygenase activity (GO:0032770),0.5610684722905624,1.3512163630208127,0.13344316309719934,0.6253272297897888,1.0,7/26,11.79%,GCH1;SCARB1;HIF1A;FGF23;NOS1AP;CYP27B1;NUS1
prerank,retinal metabolic process (GO:0042574),-0.5724253261763608,-1.350770095773071,0.13333333333333333,0.5131154075503394,1.0,4/12,16.33%,ABCA4;CYP1B1;RDH13;RDH10
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.6175428900358235,1.350530377666601,0.15177065767284992,0.6262625748657977,1.0,7/18,13.08%,HEG1;RASIP1;CCDC125;KCTD10;ITGA3;ABL2;MET
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.5426677219043543,-1.3497550573771482,0.10550458715596331,0.5139615155450531,1.0,7/15,9.44%,UST;DSE;DCN;BGN;CSPG4;VCAN;DSEL
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.5522750807437852,1.3490772489123035,0.1322314049586777,0.6298353652485311,1.0,10/27,20.74%,CTPS1;GSR;AK4;DCTD;DUT;RRM2B;CMPK1;TXNRD1;GLRX;DTYMK
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.4388464514055226,1.3490133152904251,0.044794188861985475,0.6287138990713177,1.0,16/152,7.02%,ADGRG6;ADGRL4;CALCRL;GNAQ;ADGRL2;ADCY4;WASF2;PDE2A;S1PR1;ADGRG3;ADGRE5;ADGRG1;GNAI2;RAMP2;MCHR1;GNAT1
prerank,cellular response to interleukin-12 (GO:0071349),0.505516167637817,1.3485356349487236,0.10526315789473684,0.6289842532504707,1.0,9/48,6.74%,LCP1;MSN;RAP1B;PLCB1;PAK2;HNRNPF;CA1;MTAP;JAK1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.4796364186019574,1.348442479233919,0.09491978609625669,0.6280302587312804,1.0,11/70,6.19%,TEK;PARVB;MEF2C;PEAK1;EFNA1;SRGAP2;PXN;ACTN1;SIPA1L3;OPHN1;RAC1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.498032641567092,1.3484066706208435,0.10245310245310245,0.6268543113272252,1.0,18/55,16.27%,TNFSF10;CAV1;DAB2IP;FAS;TPD52L1;PAK2;BOK;BCL2L11;LCK;CRADD;BCL2L1;SIAH1;RIPK1;BID;RACK1;S100A9;DDIT3;BMF
prerank,positive regulation of B cell activation (GO:0050871),0.51481692468295,1.3483305829474466,0.0944527736131934,0.6258111009373157,1.0,11/50,10.91%,CD38;MEF2C;BST1;TIRAP;XBP1;SHLD1;CD40;TNFRSF13C;MAD2L2;IL7;CD320
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.54318837151288,-1.3480852615789924,0.12189616252821671,0.5168099393691241,1.0,4/16,5.44%,SOX5;PTN;SOX6;HOXB4
prerank,regulation of dopamine secretion (GO:0014059),-0.49358885010527875,-1.3480827207382713,0.09367088607594937,0.5148373823486312,1.0,12/25,26.25%,PRKN;SYT1;SYT9;SYT11;SYT12;DTNBP1;SNCA;SYT3;SYT2;SYT6;KCNA2;SYT5
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5371528014680946,1.3477083120875435,0.11890243902439024,0.6264464453351828,1.0,14/36,14.04%,NLRC5;EDN1;CASP4;HIF1A;WNT5A;AGPAT1;CASP1;CSF1;CXCR4;IL7;GAS6;RIPK1;ADAM17;UBE2K
prerank,regulation of sensory perception of pain (GO:0051930),-0.5927228423913973,-1.3472793213882372,0.1301518438177874,0.5151403079183983,1.0,3/11,6.57%,CCN3;TMEM100;MGLL
prerank,replicative senescence (GO:0090399),-0.5845550149040618,-1.3468128268028974,0.14512471655328799,0.5143875098921312,1.0,8/12,25.57%,PLA2R1;SERPINE1;WNT16;TP53;ATR;CHEK1;TERT;ATM
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.6459332754821904,1.3467966168202417,0.1690909090909091,0.6281628414506376,1.0,2/12,7.19%,ESR1;TGFB1
prerank,neuronal action potential (GO:0019228),-0.49045558653649646,-1.3465924124502195,0.10688836104513064,0.5129831946095356,1.0,12/22,27.56%,SCN7A;ANK3;CACNA1G;KCNMB2;GPER1;SCN1A;SCN8A;SCN2A;SCN5A;KCNA2;SCN9A;CACNA1H
prerank,regulation of lymphocyte proliferation (GO:0050670),0.6166808594921901,1.3457432416998985,0.1543859649122807,0.6304430830050097,1.0,4/16,10.58%,AHR;TNFRSF1B;TNFSF8;LST1
prerank,prostanoid biosynthetic process (GO:0046457),0.6284589240193715,1.3455849004249116,0.14612676056338028,0.6296998973128002,1.0,4/15,5.15%,PTGS2;PLA2G4A;EDN1;PTGS1
prerank,response to interferon-gamma (GO:0034341),0.48163245160818574,1.3455831528531899,0.0965034965034965,0.6284190864228884,1.0,12/67,10.48%,GCH1;DAPK1;GBP5;GBP4;GBP7;WNT5A;CD40;CASP1;CITED1;CYP27B1;RPL13A;CCL14
prerank,positive regulation of protein modification process (GO:0031401),0.4246637759141125,1.3449052889532571,0.04171494785631518,0.6293038636703324,1.0,34/203,7.56%,TEK;LIMCH1;PECAM1;KDR;ENG;TBX1;APP;PDE8A;PPP1R16B;INSR;VEGFC;PPP2R5A;LYN;FAS;EFNA1;FLT4;FGF23;SOX9;STK4;RALB;ACVR2A;VEGFD;ALG10B;LIMK2;CD40;RAC1;DYRK1A;KRAS;ARRB1;TNIK;TGFB1;NOS1AP;PTK2;NIBAN1
prerank,B cell receptor signaling pathway (GO:0050853),0.5470572261878179,1.3435385504416695,0.11556982343499198,0.632334614001685,1.0,7/32,8.32%,CD38;MEF2C;PLCG2;SH2B2;BMX;LCK;RFTN1
prerank,regulation of monooxygenase activity (GO:0032768),0.5794725535624914,1.3433768348367903,0.1335559265442404,0.6316895801148154,1.0,5/23,7.46%,NOS3;CAV1;NOSTRIN;NOS1AP;NOSIP
prerank,negative regulation of inflammatory response (GO:0050728),0.425696599247633,1.3426927991495328,0.05041031652989449,0.6325495951978822,1.0,21/182,5.78%,TEK;CALCRL;CYSLTR1;PPARD;ADCY4;CD200;PLCG1;MYH9;LYN;MFHAS1;YES1;GNB1;TNFRSF1B;LPCAT3;FYN;PRKAR2B;PLCG2;ADRB1;RPS19;PLK2;RAMP2
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.6081833009518312,-1.3423991040622245,0.14137214137214138,0.5229083496928137,1.0,6/10,23.23%,GABRG2;GABRA2;GABRG3;GABRA1;GABRA5;GABRA3
prerank,positive regulation of DNA replication (GO:0045740),-0.5455112890571204,-1.3419042209272318,0.12614678899082568,0.5222646884532471,1.0,3/16,8.46%,EGFR;GLI2;GLI1
prerank,T cell homeostasis (GO:0043029),0.6664077940832209,1.3413714085363,0.18386491557223264,0.6355214395240433,1.0,2/10,4.70%,FAS;JAK3
prerank,positive regulation of exocytosis (GO:0045921),0.5184813073346585,1.341101899290061,0.1309148264984227,0.6351557778139147,1.0,4/35,4.77%,RAB27A;CADPS2;EXPH5;SDCBP
prerank,contractile actin filament bundle assembly (GO:0030038),0.6117951971609306,1.3407830439626824,0.152753108348135,0.6335591257822533,1.0,4/15,6.87%,FAM171A1;PDLIM1;SORBS1;ARRB1
prerank,stress fiber assembly (GO:0043149),0.6117951971609306,1.3407830439626824,0.152753108348135,0.6335591257822533,1.0,4/15,6.87%,FAM171A1;PDLIM1;SORBS1;ARRB1
prerank,smooth muscle contraction (GO:0006939),-0.5432421878866229,-1.3406964525570657,0.140625,0.5237454725205455,1.0,7/14,16.50%,ROCK2;EDNRA;SLC8A1;BDKRB2;ACTA2;ADRA1A;MYH11
prerank,positive regulation of cellular process (GO:0048522),0.39900927350392895,1.3401671504473651,0.004153686396677051,0.6343014381549329,1.0,84/565,9.43%,FRMD5;LEF1;TJP1;TBC1D8;RAB27A;FLT1;ACER2;TGM2;IL6ST;KDR;CAV1;TBX1;LIFR;IL15;STX3;CLDN5;INSR;KITLG;PDGFB;VEGFC;PARD3;GATA2;IL6R;EDN1;OSMR;LRP5;LYN;PRKD2;TAL1;ADAM10;FASN;PTK2B;PDGFD;TNFRSF11A;PPP3CA;NOTCH1;CNOT6;PTPRJ;ACACB;TNFRSF1B;BST1;AQP11;ACTN4;WWTR1;CNOT6L;FLT4;ADGRG1;FGF23;SOX9;RPS6KA3;DLL1;RPS19;SDCBP;XBP1;RPS6KA1;SLC6A6;GNAI2;VEGFD;GREM1;MAPK8;H3-3A;WNT5A;CNBP;CHP2;RAC1;CDKN1B;FOSL1;KRAS;TGFB1;PDGFC;PTK2;AGPAT1;TGFA;KDM4C;RPTOR;NEUROD1;SFRP2;AKT2;IL7R;DICER1;RPL23;CDK2;CSF1;SOX4
prerank,negative regulation of anoikis (GO:2000811),0.614642701011892,1.3401404444460747,0.1619718309859155,0.633142168463936,1.0,4/14,7.81%,CAV1;NOTCH1;PTK2;ITGA5
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5878466698648122,1.3393669458812203,0.15245901639344261,0.634249563556126,1.0,6/21,8.63%,PLA2G4A;LPCAT3;PLA2G2D;OSBPL10;MBOAT1;PLAAT3
prerank,determination of left/right symmetry (GO:0007368),0.5329279565280732,1.339233169427202,0.1278538812785388,0.6334007667449503,1.0,6/36,8.52%,TBX1;ZIC3;NOTCH1;DLL1;PKD2;CFAP53
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5865299175378013,1.3387016106033405,0.14453781512605043,0.6338386178447496,1.0,5/20,10.32%,RPS6KA5;DIP2B;ARRB1;SOX4;GLYR1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5913147636573771,1.338575429012726,0.15912897822445563,0.6329835752720534,1.0,4/19,2.96%,TJP1;NEXMIF;NOTCH1;PPM1F
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.39332065804146593,1.3383870329747463,0.0,0.6323754830332633,1.0,142/834,11.51%,ERG;LEF1;MRTFB;ELK3;RPS6KA5;FOXO1;EPAS1;PBX1;BMPR2;LDB2;ENG;ITGA6;TBX1;ESR1;SMARCA2;APP;PPARD;MEF2C;LMO2;ACVRL1;CRTC1;MAML2;PRKD1;NR5A2;AHR;SMAD1;ZIC3;NFATC1;PDGFB;NLRC5;IRF2;GATA2;DAB2IP;EDN1;ARHGEF2;LRP5;HHEX;PRKD2;STAT3;TAL1;NR3C1;PPP3CA;HIF1A;PLXND1;NOTCH1;KLF7;RREB1;NFKBIA;CCNK;SOX17;NCK1;WWTR1;TCF12;SOX18;PPP1R12A;MAFF;FOSL2;SOX9;MRTFA;RPS6KA3;NCOA1;DLL1;FOXF1;KLF2;ELK4;SS18;IKBKB;XBP1;RPS6KA1;SBNO2;TET3;ACVR2A;EPC1;SMAD7;TCF7L2;TCF4;GREM1;FOXF2;LPIN3;HOXA10;MTF2;WNT5A;PPP3CB;KLF10;CD40;CNBP;ACVR1;ATMIN;CHP2;SKAP1;JUNB;TOX3;NR1I3;BTBD18;FOXA3;FOSL1;IRF2BPL;HNF1B;ARRB1;TNFRSF1A;TGFB1;RBM14;TCF3;HOXD8;NFKB1;PKD2;AGRN;NEUROD1;SFRP2;KAT6B;CITED1;NRL;CREB1;SUB1;SMARCA5;BRD4;NRIP1;ZFPM1;IER2;SOX4;TCF15;TNIP1;IKBKG;PCGF5;RNF4;CREB3L4;SMAD5;NFIB;POU2F1;GLYR1;ZMIZ1;USF2;GABPB1;MC1R;CSRNP1;ASXL1;ACTR2;ATF6;GLMP;PRDM2;SP3;GRIN1
prerank,response to muscle stretch (GO:0035994),-0.5417905381239942,-1.33789500851312,0.13114754098360656,0.5298353623179181,1.0,5/15,12.38%,DMD;GSN;SLC8A1;RYR2;SLC9A1
prerank,positive regulation of JNK cascade (GO:0046330),0.4820476784590871,1.3377454530720094,0.10027472527472528,0.6331763496277542,1.0,14/70,6.15%,APP;TNFRSF19;DAB2IP;MFHAS1;PTK2B;TPD52L1;TAOK2;PLCB1;TRAF1;FLT4;TIRAP;EDAR;SDCBP;DUSP22
prerank,sphingoid metabolic process (GO:0046519),0.6494243854842315,1.3375470625853865,0.17491166077738515,0.6325785700766049,1.0,5/12,5.59%,DEGS2;PLPP1;SGPP2;SPTLC3;ASAH2
prerank,regulation of interleukin-12 production (GO:0032655),0.5041919963477681,1.3371053272415054,0.12143928035982009,0.6327674655591528,1.0,12/47,14.67%,FOXP1;PLCB1;PLCG2;TIRAP;JAK3;MAST2;CD40;TIGIT;MAPK11;IL23A;RIPK2;IRAK3
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.5703817240158171,1.3369814158135847,0.13290113452188007,0.6318960766544033,1.0,11/25,18.12%,EFNA1;OPHN1;RPS7;RPL23;EPHA4;HSP90AB1;PRKCG;RPL11;CSNK2A1;CSNK2A2;PSMF1
prerank,negative regulation of hydrolase activity (GO:0051346),0.5081181828157971,1.3355944061575746,0.10845070422535211,0.6351487127559309,1.0,9/49,8.15%,LRCH1;F11R;SH3BP4;DAB2IP;PLIN5;PTX3;EGLN1;GNAT1;RASA4
prerank,spinal cord development (GO:0021510),-0.5759577978212053,-1.335464313913761,0.11946902654867257,0.5348568768660487,1.0,5/12,5.87%,GLI2;VIT;PKD1;LOXL3;NF1
prerank,cartilage development (GO:0051216),-0.4129165853216935,-1.3351367376939274,0.06230529595015576,0.5338623485182896,1.0,13/49,7.56%,SOX5;SULF1;OSR1;SULF2;BMP4;PKD1;SOX6;RUNX2;FGF2;SLC39A14;ITGB8;CCN3;CD44
prerank,amino acid import across plasma membrane (GO:0089718),-0.4836484864898244,-1.3349434563067468,0.13114754098360656,0.5323991090686239,1.0,7/24,3.64%,SLC7A2;SLC6A13;SLC1A3;SLC47A1;SLC1A5;SLC6A9;SLC22A4
prerank,calcium ion transport (GO:0006816),-0.3666578376982505,-1.3345076873851485,0.03980099502487562,0.5316279495135099,1.0,23/113,8.91%,SLC24A3;TRPM3;ANK2;CACNA1C;NALCN;SLC8A3;CACNA2D1;CACNA1D;PKD1;GRIN3A;SLC8A1;P2RX4;RAMP1;CACNB2;CACNA1G;ITGAV;TRPC3;STIM1;TRPC6;TRPC1;ATP2A2;RYR2;SLC24A2
prerank,regulation of bone mineralization (GO:0030500),-0.40385442513987957,-1.3341448211659355,0.06968641114982578,0.5306594223798102,1.0,17/55,7.67%,BMP6;BMPR1A;PTN;WNT4;BMP7;ADGRV1;ENPP1;OSR1;BMP4;GPM6B;SLC8A1;FBN2;BMP2K;CCN1;BCOR;NOTUM;ECM1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.6196332252652831,1.3339625418721808,0.16819012797074953,0.6390736994972317,1.0,6/15,16.61%,DTX3L;SMAD7;RPS7;RPL23;MAD2L2;RPL11
prerank,positive regulation of autophagy (GO:0010508),0.4657738152599931,1.3338676621772358,0.08032128514056225,0.6381601937215838,1.0,12/81,6.34%,FOXO1;KDR;PRKD1;DAPK1;SH3BP4;TRIM14;PIK3C2A;TRIM68;PLK2;ULK1;MID2;SH3GLB1
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5865953118573314,1.3336258530624066,0.15033783783783783,0.637674450327124,1.0,8/21,7.27%,NOS3;PTK2B;NOTCH1;FGF23;SOX9;GREM1;TGFB1;SRGN
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.61161406306403,1.3335755987457534,0.16666666666666666,0.6365995072931584,1.0,6/14,12.24%,PRKD2;NECTIN2;TESPA1;LCK;IKBKG;RELA
prerank,electron transport chain (GO:0022900),0.6263951790330405,1.3330850218775843,0.16579406631762653,0.6369515399558738,1.0,1/15,0.24%,PDIA5
prerank,rRNA transcription (GO:0009303),0.6027389671444839,1.332947389904208,0.15025906735751296,0.6362081428461732,1.0,10/17,24.39%,CAVIN1;SPIN1;TAF1B;ANG;NIFK;POLR1G;GTF3C1;SIRT7;TCOF1;BRF1
prerank,positive regulation of ERAD pathway (GO:1904294),0.6337573208871341,1.3328939984099153,0.17017543859649123,0.6351321064532962,1.0,2/13,6.89%,CAV1;ATXN3
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.6190173172532389,-1.331671975974743,0.1425233644859813,0.5355435358510817,1.0,3/10,16.15%,PRKN;SNCA;MT3
prerank,regulation of mast cell activation (GO:0033003),0.6611995913526275,1.3316501015773214,0.18470149253731344,0.637928450272335,1.0,2/10,2.80%,LYN;NECTIN2
prerank,regulation of interleukin-2 production (GO:0032663),0.5089292795704016,1.3315283922939978,0.11879699248120301,0.6370740349850701,1.0,7/43,4.02%,SPTBN1;PRKD2;HDAC7;PDE4D;PLCG2;CD34;HOMER2
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.588192749858274,1.3311364084011006,0.14383561643835616,0.6372135357329962,1.0,5/18,4.52%,MTUS1;IL6R;LYN;PTK2B;F7
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.53429114551634,1.3310136889625468,0.12559618441971382,0.6364000931835777,1.0,6/33,5.78%,TEK;KDR;ICAM1;GATA2;TCF7L2;RAMP2
prerank,cellular response to cAMP (GO:0071320),0.5352589362636297,1.3293751008035404,0.1276595744680851,0.6404756040606931,1.0,8/30,7.67%,AHR;PDE2A;KCNQ1;RAP1B;RAPGEF2;INPP5K;RAP1A;PKD2
prerank,endoderm formation (GO:0001706),-0.4367975050369604,-1.3292614699072787,0.09577464788732394,0.5403625239265182,1.0,10/35,10.16%,COL8A1;COL12A1;VTN;COL11A1;ITGB5;COL6A1;MMP14;ITGAV;INHBA;MMP2
prerank,sensory perception of sound (GO:0007605),-0.37371693461754707,-1.3282552084317838,0.04878048780487805,0.5412492623276834,1.0,18/88,8.37%,EYA1;ROR1;COL1A1;COL4A3;CEMIP;ADGRV1;EML2;COL11A1;DCDC2;KIT;CACNA1D;GRM7;GSDME;ATP6V0A4;PCDH15;WHRN;ALDH7A1;RIPOR2
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.47655421602734377,1.3281776589673497,0.10263522884882108,0.6431887649521091,1.0,15/67,9.40%,UTRN;CDK6;LIMS2;PDGFB;DOCK1;NEDD9;PTK2B;PPM1F;RREB1;RAC1;SKAP1;RSU1;ARHGEF7;CRK;CSF1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.6663891250730355,1.3281263711533615,0.18490566037735848,0.6421498939866144,1.0,5/10,16.63%,NFKBIZ;SMAD7;MALT1;RC3H1;NFKBID
prerank,organic acid transport (GO:0015849),0.454562617976506,1.3280421899682755,0.0922266139657444,0.6412351269822848,1.0,14/94,6.75%,ABCC4;SLCO2B1;ABCG2;ATP8B1;PPARD;SLC7A7;SLC38A5;SLC3A2;STARD5;NCOA1;SLC6A6;CEACAM1;SLC43A2;SLC26A1
prerank,regulation of cell cycle (GO:0051726),0.4112509336079519,1.3278322367774817,0.041758241758241756,0.6406755974770774,1.0,54/271,13.42%,MECOM;NANOS3;DCUN1D3;APBB2;ERN1;PPP1R13B;CDK6;NEK7;ADARB1;IQGAP1;DAB2IP;STAT3;PIM3;ADAM10;NOTCH1;SIK1;AFAP1L2;TTC28;JMY;SOX9;PPP1R9B;SDCBP;LIN54;UHRF2;PTPRK;TCF7L2;ASAH2;XIAP;LIN9;JUNB;CDKN1B;TGFB1;NEK6;PKD2;RNF167;NF2;CTBP1;AKT2;PUM1;RPL23;MYBBP1A;DDIAS;RAD23A;TFAP4;CDC26;RB1;BIRC3;RNF112;RPRD1B;NOP53;RHOB;RACK1;HSP90AB1;UHMK1
prerank,regulation of postsynapse organization (GO:0099175),0.5441562663543752,1.327098546762128,0.15235008103727715,0.6416123265096118,1.0,4/28,5.81%,SHANK3;ABI3;PPFIA2;WNT5A
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5767030419176257,1.3266214417563384,0.15692821368948248,0.6418964211807893,1.0,4/18,5.73%,ELOVL7;ACSL4;ELOVL5;ACSL5
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5440394527420452,1.3263958953123047,0.13551401869158877,0.6413984336664277,1.0,8/35,7.47%,HEG1;RASIP1;DAB2IP;CCDC125;KCTD10;FBP1;ITGA3;SYNGAP1
prerank,membrane organization (GO:0061024),0.4081151133334661,1.3261427575964084,0.04282407407407408,0.6410114205097441,1.0,43/227,11.77%,DNM3;MYOF;FNBP1L;CERT1;SPTBN1;EPN2;HIP1;HIP1R;FZD4;REEP1;LPCAT3;PIK3C2A;FCHO2;ARPC3;GLTP;AP2B1;VAMP4;WNT5A;CHMP2B;CCDC88A;SH3GLB1;DCSTAMP;ARRB1;ATP2C1;SNX3;AP2A1;TGFA;CHMP4A;CHMP4B;IL7R;SYNJ1;PLEKHA8;SNAP23;GAPVD1;A4GALT;OCRL;CBL;SCARB2;VAMP8;PICK1;ACTR2;PICALM;CORO1C
prerank,histone H3 acetylation (GO:0043966),0.5172560223523577,1.3260107090472781,0.12074303405572756,0.6402457409608483,1.0,10/40,15.53%,LEF1;JADE2;JADE1;KAT6B;JADE3;YEATS2;KAT2B;MBIP;KAT6A;TRIM16
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.6465046300881732,1.3249198733902559,0.17196261682242991,0.6425340250374133,1.0,3/13,2.79%,NRP2;PLXNA4;PLXND1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.5041204210509421,1.3246591557293208,0.1244309559939302,0.642147059625756,1.0,10/45,12.60%,ICAM1;VCAM1;B2M;IRF2;TRIM68;JAK1;TRIM25;FCGR1A;OASL;MID1
prerank,oogenesis (GO:0048477),0.6119352242486864,1.324639477701524,0.17657342657342656,0.6410173785838282,1.0,4/15,8.20%,NANOS3;NANOS2;MARF1;TRIP13
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.4684743033750071,1.3244301991509317,0.09549795361527967,0.6404912488570909,1.0,27/72,18.10%,LIFR;CASP8;TRAF1;SIGIRR;SPPL2A;IKBKB;HIPK1;IFNAR2;JAK1;TNFRSF1A;AGPAT1;PTPN1;IKBKG;IL7;GAS6;CBFB;RIPK1;BIRC3;RACK1;HSP90AB1;IRAK3;OTULIN;STAT1;BIRC2;IRAK2;IFNGR1;CDC37
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.6296528946228316,1.3241049403232636,0.16869565217391305,0.6404005394255843,1.0,4/13,8.41%,KDR;ENG;DLL4;SFRP2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.587870322750859,1.3239614110237925,0.1780821917808219,0.6396621717650119,1.0,4/19,3.96%,KDR;VCAM1;PTPRJ;SELP
prerank,positive regulation of defense response (GO:0031349),0.4460428157580571,1.3238742907127985,0.0888030888030888,0.638754592282983,1.0,14/89,11.77%,APP;MEF2C;IL15;PDE2A;GBP5;NFKBIZ;NFKBIA;WNT5A;TNFRSF1A;LPL;TNIP1;IL23A;NMI;RIPK1
prerank,positive regulation of cartilage development (GO:0061036),0.6091885196833097,1.3237671473327484,0.16666666666666666,0.6379420505532369,1.0,4/17,4.24%,BMPR2;ZBTB16;ACVRL1;SOX9
prerank,regulation of protein kinase A signaling (GO:0010738),-0.5153818713355008,-1.3231903272719407,0.1162227602905569,0.5541341613826604,1.0,9/20,17.12%,ADGRV1;AKAP12;AKAP7;AKAP6;LRRK2;PRKAR1B;PRKAR1A;TCIM;PJA2
prerank,positive regulation of histone deacetylation (GO:0031065),0.6327482028239382,1.3229758831724734,0.18739054290718038,0.6392856967087471,1.0,4/12,10.68%,PRKD1;PRKD2;CTBP1;APLNR
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.4854789373411883,-1.3229482236775656,0.14039408866995073,0.55283106558414,1.0,5/25,7.78%,ANK2;CEMIP;CACNB2;AKAP6;TRPC1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.6354281516427243,1.3227954687294916,0.1660839160839161,0.6387297386043301,1.0,4/12,3.22%,PRKG1;MEF2C;PDGFB;DOCK4
prerank,positive regulation of cell population proliferation (GO:0008284),0.40005109169329206,1.3227340969255266,0.020342612419700215,0.6377704488854387,1.0,65/423,9.43%,PRKCH;LEF1;TJP1;TBC1D8;FLT1;ACER2;IL6ST;KDR;TBX1;LIFR;MEF2C;IL15;STX3;CLDN5;CDK6;INSR;KITLG;PDGFB;VEGFC;FOXP1;IL6R;EDN1;OSMR;LRP5;LYN;ADAM10;PTK2B;PDGFD;TNFRSF11A;NOTCH1;CNOT6;BST1;AQP11;WWTR1;CNOT6L;FLT4;FGF23;SOX9;TOX;DLL1;SDCBP;XBP1;GNAI2;VEGFD;TCF7L2;GREM1;DLL4;WNT5A;CNBP;CHP2;FOSL1;KRAS;TGFB1;PDGFC;PTK2;TGFA;MAP3K3;KDM4C;SFRP2;AKT2;IL7R;RPL23;CDK2;CSF1;SOX4
prerank,vesicle organization (GO:0016050),0.5028234090062834,1.3221536281295199,0.1329394387001477,0.6385590826016754,1.0,7/46,7.27%,FNBP1L;CAV1;CD34;CAV2;ALS2CL;CHMP2B;SRGN
prerank,regulation of JNK cascade (GO:0046328),0.4470090646132019,1.3221246949237735,0.10745891276864729,0.6374625608048348,1.0,14/101,4.77%,MECOM;APP;TNFRSF19;DAB2IP;MFHAS1;PTK2B;TPD52L1;TAOK2;PLCB1;TRAF1;FLT4;TIRAP;EDAR;SDCBP
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.5294571535420367,1.3219892827158204,0.14678899082568808,0.6367211328022905,1.0,10/36,8.49%,SGMS1;DAB2IP;FAS;TPD52L1;TRAF1;TMBIM6;CX3CR1;ASAH2;PTPMT1;CRADD
prerank,protein polymerization (GO:0051258),-0.41096225684240073,-1.321148517191277,0.08116883116883117,0.5562754864453121,1.0,6/55,3.76%,ARHGAP6;GAS7;GSN;PRKN;SPIRE1;COBL
prerank,neutrophil activation (GO:0042119),0.6367879150345882,1.3210758776528846,0.1806083650190114,0.6384893206123355,1.0,3/12,5.07%,IL15;PREX1;KMT2E
prerank,adipose tissue development (GO:0060612),0.651180350444579,1.3210284983916785,0.17657657657657658,0.6374469877425153,1.0,3/11,4.85%,SPTLC2;LRP5;XBP1
prerank,phosphatidylserine metabolic process (GO:0006658),0.5367554791405995,1.320535440411323,0.14637904468412943,0.6379143993229274,1.0,7/32,8.63%,PLA2G4A;SERINC5;LPCAT3;PLA2G2D;OSBPL10;MBOAT1;PLAAT3
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.5369836765756433,1.3204761528611069,0.16228748068006182,0.6369401026056634,1.0,4/31,3.51%,SHANK3;ABI3;EFNA1;PPFIA2
prerank,defense response to Gram-positive bacterium (GO:0050830),0.5126995536871238,1.320429085631538,0.13282442748091602,0.6359387660763745,1.0,9/40,9.58%,GBP4;TIRAP;GBP7;RPL39;DROSHA;PGLYRP2;LYG2;ANG;DEFA6
prerank,cellular response to nutrient levels (GO:0031669),0.4862013936310103,1.3197860870147362,0.1130690161527166,0.6368719098893806,1.0,11/62,8.25%,FOXO1;BMPR2;STK24;KCNB1;RALB;XBP1;ULK1;KLF10;STK26;LPL;RPTOR
prerank,sodium-independent organic anion transport (GO:0043252),0.6453288681513616,1.3193560158889115,0.17037037037037037,0.6370684425983835,1.0,3/10,3.98%,SLCO2B1;SLCO2A1;SLC16A2
prerank,phosphatidylcholine catabolic process (GO:0034638),0.6668546740404854,1.3193546074026958,0.18243243243243243,0.6359202221981259,1.0,2/10,5.52%,PLA2G4A;ENPP2
prerank,inorganic anion transport (GO:0015698),-0.4180349667927338,-1.318724058665047,0.0932475884244373,0.56113937767087,1.0,9/53,8.50%,SLC4A10;SLC13A4;ENPP1;SLC26A7;ANO1;CLCN2;ANO4;SLC5A5;ENPP3
prerank,gliogenesis (GO:0042063),0.6098778400867377,1.3185353386580825,0.17123287671232876,0.6374840485433029,1.0,7/15,17.94%,CDK6;CDH2;NFIB;NDUFS2;CD9;METTL14;MMP24
prerank,positive regulation of programmed cell death (GO:0043068),0.4037083077926882,1.3179150808508069,0.037199124726477024,0.6382144743711269,1.0,55/272,12.85%,FOXO1;TNFSF10;UNC13B;TGM2;NET1;DCUN1D3;ITGA6;MCF2L;DAPK1;ARHGEF3;RASGRF2;HIP1R;DAB2IP;ARHGEF2;FAS;STK3;CASP8;JMY;PLEKHG5;KALRN;STK4;PREX1;FOXL2;MAPK8;BOK;CTNNBL1;BCL2L11;DNAJA1;SPDEF;STPG1;NEUROD1;SFRP2;PSEN1;CRADD;ARHGEF7;ARHGEF26;MAP3K11;SOX4;TNFRSF8;SIAH1;ANO6;TFAP4;BNIP3;APH1A;RNPS1;ATF6;RIPK1;TRIO;BID;TNFAIP8;OMA1;RHOB;ARHGEF9;RACK1;GNA13
prerank,response to retinoic acid (GO:0032526),0.47787121108098174,1.3177245753435962,0.12177650429799428,0.6376811141728034,1.0,15/59,11.33%,ACER2;TBX1;FZD4;LYN;PTK2B;SOX9;RET;WNT5A;WNT9B;BRINP2;CREB1;OVCA2;TWF2;ABL2;ASXL1
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.40323380863280345,1.3176477301765985,0.03934426229508197,0.6368099374706285,1.0,107/306,20.52%,ALAS1;RPS15;IGF2BP3;RPS19;RPLP1;RPS14;RPSA;RPS16;EPC1;RPL38;RPS20;RPL39;RPL34;RPS7;RNASEH2A;BCL3;PWP1;B4GALT5;RPS24;TAF1B;RPA1;MCM10;RPL37A;SRBD1;RPS18;RPL36;RSL24D1;POLA1;RPL15;RPL14;BRIP1;B3GNT6;RPS8;MRPS18A;RPL23;RPL17;DUT;CDK2;TNIP1;RPL9;HELB;RPL4;DHPS;RPL13A;RPS11;RPL32;RPL22;MMS19;HUS1;RPL31;RPS27;RNPS1;RPS23;RMI1;MCM9;MRPL13;RPL13;EEF2K;MRPS12;RPS12;MRPL35;HBS1L;RPL6;WARS1;GRWD1;MRRF;TOP1;RPL10;MRPL41;PTMA;MRPL52;RPS29;RPS6;MEF2A;RPS25;TOPORS;RPL35A;RPL29;RPS13;RPL18;RPL27A;MRPS16;RPS21;RPL27;MRPS5;MRPL23;ORC5;EEFSEC;RPS10;MRPL37;ORC3;RPL11;RPLP2;EEF2;RFC3;MRPL11;RPL8;RPL18A;POLR3A;DBF4;NR4A2;RPS3;POLR2L;RPL21;RPL3;MRPL43;RAD17
prerank,positive regulation of signal transduction (GO:0009967),0.4048106037500647,1.3176241041663024,0.04524886877828054,0.6357346415647318,1.0,50/238,11.65%,VWF;SHANK3;TEK;NOS3;IL6ST;ERN1;MAML2;EPN2;LIMS2;DAB2IP;HHEX;PRKD2;STAT3;JCAD;FAS;PTK2B;HIF1A;NOTCH1;TSPAN5;TPD52L1;CAV2;DLL1;SORBS1;KLF2;F7;DISC1;XBP1;SPIN1;DLL4;TSPAN14;UCHL5;SASH1;AGPAT1;PKD2;ITGA5;CRADD;DEPDC1B;IL7R;ZRANB1;IHH;CYP27B1;MGAT5;ZMIZ1;IL7;MYO1C;JAG2;GAS6;ASXL1;GRIN1;ITGB3
prerank,negative regulation of response to stimulus (GO:0048585),0.4845514802528369,1.3174552780508477,0.11624649859943978,0.6350712928647207,1.0,13/60,9.08%,MCTP1;CDK6;LYN;PIM3;KLF7;LPCAT3;AQP11;KIF26A;SRMS;CD34;ACVR1;MAP3K3;PTPN1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.4680628861761739,1.3173625152094683,0.10803324099722991,0.6342282164441435,1.0,9/68,7.31%,APP;IL6R;ARHGEF2;STAT3;PLCG2;TIRAP;XBP1;WNT5A;LPL
prerank,regulation of chromatin binding (GO:0035561),0.6587491777507175,1.3171224232116785,0.1882998171846435,0.633886613820165,1.0,7/10,27.71%,HMBOX1;DTX3L;CDT1;PARP9;MED25;GMNN;DDX11
prerank,regulation of protein binding (GO:0043393),0.4361854278570092,1.3166827303057524,0.07187894073139975,0.634178491725573,1.0,25/114,9.32%,CAV1;APP;EPB41;CLDN5;B2M;PDGFB;HIP1R;BTBD1;STK3;FKBP1A;STK4;TMBIM6;DISC1;MARK3;RALB;DTX3L;TCF7L2;MAPK8;AURKA;RAPGEF2;TRIB3;CTNNBIP1;PSEN1;CRK;ZFPM1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.544705686996017,1.316534107884275,0.15746753246753248,0.6334778052095174,1.0,11/26,15.51%,LYN;STAT3;EFNA1;AIM2;FYN;APH1A;EPHA4;GRIN1;PICALM;PSME1;VSIR
prerank,neural crest cell migration (GO:0001755),0.5138026851043231,1.3157506287278804,0.16030534351145037,0.6346864475152456,1.0,4/36,1.70%,SEMA6A;TBX1;SEMA5B;SEMA7A
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.6497815490608717,1.3157108524401213,0.172147001934236,0.6336784704381153,1.0,2/11,2.40%,CAV1;NEDD4L
prerank,negative regulation of growth (GO:0045926),0.43974000018366466,1.3156066204504797,0.09445843828715365,0.6329266596499665,1.0,18/121,7.19%,BMPR2;DCUN1D3;APBB2;SMARCA2;ACVRL1;SH3BP4;NPR1;NOTCH1;PTPRJ;SOX17;PPP1R9B;VGLL4;ADAM15;FBP1;DCSTAMP;CDKN1B;JADE1;TGFB1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.4418398834331333,1.3153333159859475,0.0685640362225097,0.6327337338882363,1.0,32/114,18.55%,AIM2;PTK2B;TNFRSF11A;TNFRSF1B;NFKBIA;ACTN4;TRAF1;TMSB4X;TNFRSF25;EDAR;IKBKB;CD40;TNFSF8;TNFRSF1A;PSMA2;TNFRSF13C;TNFRSF9;TNFRSF8;PSMA8;PSMA6;RIPK1;BIRC3;RELA;ADAM17;TRAF6;PSME1;BAG4;STAT1;BIRC2;PSMA4;PSMF1;TNFRSF12A
prerank,negative regulation of DNA binding (GO:0043392),0.5362555581353288,1.3152490020579595,0.15275590551181104,0.6318955421271186,1.0,2/28,3.12%,LEF1;NFKBIA
prerank,neutrophil mediated immunity (GO:0002446),0.39356099154528296,1.3151035996562102,0.02109704641350211,0.6312302751486006,1.0,82/432,15.60%,PTPRB;CTSC;RAB27A;PECAM1;LRG1;ATP8A1;CD93;B2M;PRCP;OSTF1;IQGAP1;ADAM10;STK10;PTPRJ;ATP11B;STOM;TNFRSF1B;ADGRG3;RAP1B;BST1;ADGRE5;FUCA2;CAT;LCN2;ENPP4;SDCBP;MCEMP1;KMT2E;QSOX1;CEACAM1;TSPAN14;SCAMP1;PTX3;RAC1;NRAS;PPBP;NFKB1;RAP1A;ATP6V0A1;PSMA2;ATP11A;ARMC8;DYNLL1;DYNC1LI1;PSEN1;GDI2;SNAP23;ANO6;VAMP8;SPTAN1;CPPED1;ACTR2;PGM2;IRAK4;DEGS1;GMFG;CYFIP1;DBNL;APEH;STXBP3;GSTP1;PA2G4;RAB7A;IMPDH1;ERP44;RAB31;ACTR10;HSP90AB1;PFKL;AOC1;ADAM17;RAB5B;ASAH1;S100A9;GGH;HMOX2;RAB18;SVIP;RAB6A;DGAT1;APAF1;CEP290
prerank,myofibril assembly (GO:0030239),0.5079920554058089,1.3149706683026643,0.1375579598145286,0.6305230779926875,1.0,3/42,4.00%,PGM5;FLII;TMOD3
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.6450709521738214,1.3145933991056558,0.1695205479452055,0.6305363954413903,1.0,4/13,3.07%,ESR1;PLPP1;NR3C1;ABHD2
prerank,regulation of cell-matrix adhesion (GO:0001952),0.483358239396054,1.3139769622955515,0.10518731988472622,0.6312682864751533,1.0,15/64,9.40%,LIMCH1;ACER2;UTRN;NEXMIF;CDK6;PEAK1;PTK2B;BST1;SKAP1;ADAM15;PTK2;RASA1;NF2;SLK;CSF1
prerank,negative regulation of endocytosis (GO:0045806),0.5564461970528451,1.313757060907169,0.16129032258064516,0.6308344258505816,1.0,3/24,1.42%,MCTP1;CAV1;PRKD1
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.5399467993216908,1.313512103471749,0.16411042944785276,0.6304808314076363,1.0,2/28,1.05%,SHANK3;APP
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.38391690513756555,1.3124612776103806,0.0,0.632525386690268,1.0,178/1082,11.51%,MECOM;ERG;LEF1;MRTFB;ELK3;FLI1;RPS6KA5;FOXO1;EPAS1;CD38;PBX1;BMPR2;LDB2;ENG;ITGA6;TBX1;ESR1;SMARCA2;APP;PPARD;MEF2C;ZBTB16;LMO2;ACVRL1;CRTC1;MAML2;PRKD1;NR5A2;AHR;SMAD1;ZIC3;NFATC1;PDGFB;NLRC5;IRF2;GATA2;DAB2IP;ELF2;MLLT3;EDN1;FZD4;ARHGEF2;LRP5;HHEX;PRKD2;STAT3;TAL1;NR3C1;PPP3CA;HIF1A;NOTCH1;KLF7;RREB1;AFAP1L2;NFKBIA;CCNK;KDM3A;SOX17;NCK1;WWTR1;PLCB1;TCF12;SOX18;PPP1R12A;MAFF;FOSL2;SOX9;MRTFA;RPS6KA3;NCOA1;DLL1;FOXF1;KLF2;ELK4;SS18;IKBKB;DTX3L;XBP1;RPS6KA1;SBNO2;FOXL2;TET3;ACVR2A;KMT2E;EPC1;SMAD7;TCF7L2;TCF4;SPIN1;GREM1;ARID1B;FOXF2;LPIN3;HOXA10;MTF2;RET;WNT5A;PITX3;TEAD2;ESRRG;PPP3CB;KLF10;CD40;ATF7IP;CNBP;ACVR1;ATMIN;CHP2;SKAP1;JUNB;BCL3;TOX3;NR1I3;FOXA3;FOSL1;DYRK1A;IRF2BPL;SOST;HNF1B;ETS2;INPP5K;LYL1;ARRB1;TNFRSF1A;TGFB1;RBM14;TCF3;HOXD8;NFKB1;PKD2;HNRNPD;PCBD2;AGRN;ARID1A;RPTOR;NEUROD1;SFRP2;KAT6B;PSEN1;CITED1;NRL;CREB1;FOXK1;SMARCA5;BRD4;MAFB;NRIP1;ZFPM1;IER2;SOX4;TCF15;TNIP1;MAP2K3;EDRF1;IKBKG;PCGF5;RNF4;CREB3L4;SMAD5;NFIB;POU2F1;MAD2L2;GLYR1;ZMIZ1;USF2;GABPB1;TFAP4;MC1R;MMS19;CSRNP1;ASXL1;ACTR2;ENY2;ATF6;GLMP;PRDM2;SP3;GRIN1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.6474297953074585,1.3123977109399922,0.17477477477477477,0.6316061160563352,1.0,4/11,13.06%,CAV1;BCL3;NF2;ADIPOR1
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.4797477434941501,-1.312194275517748,0.11691542288557213,0.5784432503392845,1.0,5/25,7.11%,ERRFI1;CBLB;SLC6A9;PPARA;SNX6
prerank,keratan sulfate biosynthetic process (GO:0018146),0.5458728085719349,1.3121756774430018,0.15723270440251572,0.6312275149657832,1.0,8/26,9.90%,ST3GAL6;ST3GAL1;B3GNT3;B4GALT4;B3GNT4;B4GALT5;B4GAT1;SLC35D2
prerank,positive regulation of cell communication (GO:0010647),-0.47420175197922276,-1.312062751968706,0.10824742268041238,0.5768020287199044,1.0,6/28,6.89%,WLS;CLSTN2;DLG4;SYT1;ANK3;PTPN23
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.5886781029573136,1.311857105093539,0.17744610281923714,0.6310921275875262,1.0,2/18,2.55%,SHANK3;PTK2B
prerank,sprouting angiogenesis (GO:0002040),0.4894934902783225,1.3118135132153683,0.1299093655589124,0.6301256249193347,1.0,13/51,5.78%,TEK;KDR;ENG;EPHB4;ACVRL1;VEGFC;PTK2B;ADGRA2;FLT4;DLL1;VEGFD;GREM1;RAMP2
prerank,cardiac atrium morphogenesis (GO:0003209),0.6054324247595015,1.3106698191318,0.17077175697865354,0.6324522383635125,1.0,5/16,9.32%,BMPR2;ENG;NOTCH1;DLL4;ZFPM1
prerank,cellular response to hormone stimulus (GO:0032870),0.47375052077663915,1.3102835806061919,0.11533052039381153,0.6326302834603169,1.0,16/69,6.76%,CAV1;MEF2C;LMO2;SOCS2;STAT3;NR3C1;NCOA1;XBP1;GHR;SERPINB9;ATP1A3;ATP1A1;RAMP2;NCOA4;SOST;INPP5K
prerank,magnesium ion transport (GO:0015693),-0.5704645679727574,-1.3098111429538601,0.19495412844036697,0.5812822028443259,1.0,6/12,19.14%,SLC41A1;TUSC3;MAGT1;MRS2;CNNM4;NIPA1
prerank,cell-cell junction organization (GO:0045216),0.46251594970393,1.3092503727149993,0.10377358490566038,0.6348434439825053,1.0,16/79,9.77%,TJP1;PKP4;CADM1;CLDN5;OCLN;LIMS2;TJP2;NECTIN2;PVR;CDH2;CTNNA1;TGFB1;TRPV4;CDH15;ANG;TJP3
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.5156385855077557,-1.3090526176911328,0.163855421686747,0.5815077696468297,1.0,6/16,16.97%,DPYSL3;DPYD;UPB1;NT5E;NT5C1A;DPYSL2
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.5635039016237153,-1.3083318267717605,0.14186046511627906,0.5815819144715098,1.0,7/13,11.81%,BMP6;BMPR1A;TGFBR1;BMP4;DAB2;TGFB3;NUP93
prerank,glycoprotein biosynthetic process (GO:0009101),0.4593391353391726,1.308139353803938,0.11141304347826086,0.6372347444423275,1.0,12/79,9.52%,ST3GAL6;CSGALNACT1;BMPR2;GALNTL5;B3GNT3;ALG10B;B3GNT4;B4GALT5;ST8SIA4;ST6GALNAC2;B3GNT6;TNIP1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.543920577634581,1.3079352752532805,0.1532258064516129,0.63673043406611,1.0,7/24,10.72%,SEMA6A;SEMA5B;SEMA7A;SEMA6B;SEMA6D;DSCAM;SEMA4D
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.5551261715290716,1.3070361097284935,0.16404886561954624,0.6383663503020017,1.0,6/22,14.13%,B2M;STX7;MALT1;IL23A;CYRIB;TRAF6
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5924034935595617,-1.3068919984170937,0.16142557651991615,0.5837937134527514,1.0,6/11,11.57%,PDK1;MAP3K5;PRKCD;CYP1B1;PRODH;DIABLO
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.52744622734373,-1.3067192570480914,0.14655172413793102,0.5803246893680101,1.0,4/16,4.87%,ARHGAP6;PHLDB2;THBS1;APOD
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.52744622734373,-1.3067192570480914,0.14655172413793102,0.5803246893680101,1.0,4/16,4.87%,ARHGAP6;PHLDB2;THBS1;APOD
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.4229519715207764,1.306424325372011,0.08333333333333333,0.6391499179220363,1.0,22/140,6.19%,CHN2;ARHGAP31;TGM2;NET1;MCF2L;ARHGEF3;ARAP3;CD2AP;RASGRF2;ARHGEF2;BCR;SRGAP3;SRGAP2;SRGAP1;RHOJ;PLEKHG5;KALRN;ARHGAP8;PREX1;ARHGAP17;OPHN1;RAC1
prerank,retinol metabolic process (GO:0042572),-0.5425520643803983,-1.3061686028511468,0.15081206496519722,0.5799491251721834,1.0,3/14,5.06%,RBP4;DHRS3;CYP1B1
prerank,aortic valve morphogenesis (GO:0003180),0.5276746359539137,1.3061438563143017,0.16899224806201552,0.6388508801691067,1.0,9/30,7.19%,NOS3;TIE1;NFATC1;EFNA1;NOTCH1;ELN;SOX9;DLL4;TGFB1
prerank,regulation of protein transport (GO:0051223),0.5481666610042079,1.3060888006741922,0.15833333333333333,0.6379199457039159,1.0,11/27,16.62%,LCP1;PPM1F;DNAJA1;SNX3;LLGL1;PTPN1;GAPVD1;RHBDF2;NDEL1;CHP1;NDFIP2
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.4346936958552562,1.305967669195128,0.09090909090909091,0.637204570260225,1.0,20/117,10.93%,CALCRL;CYSLTR1;ADCY4;PLCG1;MYH9;LYN;YES1;GNB1;FYN;PRKAR2B;PLCG2;ADRB1;PLK2;RAMP2;PLA2G2D;CREB1;FCGR1A;INSL3;MC1R;MC4R
prerank,negative regulation of vascular permeability (GO:0043116),0.6173744659631389,1.3052105941950745,0.1879432624113475,0.6384730165271009,1.0,5/12,5.78%,CLDN5;PDE2A;PTPRJ;CEACAM1;RAMP2
prerank,neutrophil degranulation (GO:0043312),0.39071696968110614,1.3051093445621234,0.026427061310782242,0.637705761660777,1.0,79/425,15.60%,PTPRB;CTSC;RAB27A;PECAM1;LRG1;ATP8A1;CD93;B2M;PRCP;OSTF1;IQGAP1;ADAM10;STK10;PTPRJ;ATP11B;STOM;TNFRSF1B;ADGRG3;RAP1B;BST1;ADGRE5;FUCA2;CAT;LCN2;ENPP4;SDCBP;MCEMP1;QSOX1;CEACAM1;TSPAN14;SCAMP1;PTX3;RAC1;NRAS;PPBP;NFKB1;RAP1A;ATP6V0A1;PSMA2;ATP11A;ARMC8;DYNLL1;DYNC1LI1;PSEN1;GDI2;SNAP23;ANO6;VAMP8;SPTAN1;CPPED1;ACTR2;PGM2;DEGS1;GMFG;CYFIP1;DBNL;APEH;STXBP3;GSTP1;PA2G4;RAB7A;IMPDH1;ERP44;RAB31;ACTR10;HSP90AB1;PFKL;AOC1;RAB5B;ASAH1;S100A9;GGH;HMOX2;RAB18;SVIP;RAB6A;DGAT1;APAF1;CEP290
prerank,regulation of lamellipodium assembly (GO:0010591),0.5166796943112746,1.3050420254704291,0.15031645569620253,0.6368363259712776,1.0,11/34,15.49%,ABI3;OCLN;WASF2;NCKAP1;RAC1;TWF2;FSCN1;ACTR2;CYFIP1;ACTR3;ARPC2
prerank,regulation of T cell cytokine production (GO:0002724),0.6087297771246182,1.3049393154684417,0.1860036832412523,0.6360797372806241,1.0,4/15,8.38%,B2M;TNFRSF1B;SMAD7;MALT1
prerank,positive regulation of myelination (GO:0031643),0.6345761622527147,1.3045960359302258,0.18773234200743494,0.6361079620831721,1.0,3/11,9.21%,PARD3;TNFRSF1B;DICER1
prerank,regulation of interleukin-10 production (GO:0032653),0.5010710753391641,1.30436809365743,0.11659192825112108,0.6357438494924036,1.0,7/44,9.76%,STAT3;PLCG2;CD34;DLL1;JAK3;TIGIT;IL23A
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3898712631035958,1.3039472277910904,0.034957627118644065,0.6359506964117504,1.0,75/390,9.89%,NRP2;TEK;FOXO1;PTPRG;FLT1;KDR;TIE1;EPHB4;ANKS1A;PRKD1;INSR;PDGFB;VEGFC;DOCK1;NEDD9;ELMO1;WASF2;SOCS2;LYN;PRKD2;STAT3;EFNA1;PTK2B;PDGFD;DDIT4;YES1;PTPRJ;MPZL1;MTSS1;FYN;NCK1;PIK3C2A;PLCB1;PXN;SRMS;FLT4;SH2B2;CAV2;PAK2;FGF23;KALRN;SORBS1;LMTK2;ARPC3;SDCBP;GRB14;GHR;AP2B1;NCKAP1;VEGFD;ARPC1B;RET;HNRNPF;GTF2F2;RAC1;RAPGEF2;BCAR3;PDGFC;LCK;PTK2;RASA1;AP2A1;ATP6V0A1;GRB7;GAB1;PSEN1;SHOC2;AKT2;ARHGEF7;ATP6V1G2;CRK;CSF1;CEP57;MAPK11;MAPKAPK3
prerank,positive regulation of dendrite extension (GO:1903861),0.5834878114185186,1.3036996603488622,0.19680851063829788,0.6356426561665786,1.0,3/17,2.97%,SMURF1;NEDD4L;ITSN2
prerank,plasma membrane repair (GO:0001778),0.6199836695146127,1.3028342192016356,0.18231046931407943,0.637181540235622,1.0,2/13,1.98%,MYOF;MYH9
prerank,sympathetic nervous system development (GO:0048485),0.6173286091125654,1.302436861397728,0.16440677966101694,0.6373586251500916,1.0,1/15,0.07%,NRP2
prerank,regulation of macrophage cytokine production (GO:0010935),0.6239149575249376,1.3021675696427444,0.19889502762430938,0.637091829783369,1.0,5/13,7.19%,SEMA7A;PLCG2;WNT5A;CUEDC2;TGFB1
prerank,neutrophil activation involved in immune response (GO:0002283),0.3893586442842055,1.301325181675729,0.02748414376321353,0.6385856365838863,1.0,79/428,15.60%,PTPRB;CTSC;RAB27A;PECAM1;LRG1;ATP8A1;CD93;B2M;PRCP;OSTF1;IQGAP1;ADAM10;STK10;PTPRJ;ATP11B;STOM;TNFRSF1B;ADGRG3;RAP1B;BST1;ADGRE5;FUCA2;CAT;LCN2;ENPP4;SDCBP;MCEMP1;QSOX1;CEACAM1;TSPAN14;SCAMP1;PTX3;RAC1;NRAS;PPBP;NFKB1;RAP1A;ATP6V0A1;PSMA2;ATP11A;ARMC8;DYNLL1;DYNC1LI1;PSEN1;GDI2;SNAP23;ANO6;VAMP8;SPTAN1;CPPED1;ACTR2;PGM2;DEGS1;GMFG;CYFIP1;DBNL;APEH;STXBP3;GSTP1;PA2G4;RAB7A;IMPDH1;ERP44;RAB31;ACTR10;HSP90AB1;PFKL;AOC1;RAB5B;ASAH1;S100A9;GGH;HMOX2;RAB18;SVIP;RAB6A;DGAT1;APAF1;CEP290
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.588952342623794,-1.299714065389729,0.15670103092783505,0.5969602617018137,1.0,4/10,12.94%,ATP1A2;ADRA2A;BIN1;VDAC1
prerank,positive regulation of signaling (GO:0023056),-0.43292648822660185,-1.2994561913394989,0.11917098445595854,0.595702790615925,1.0,13/37,21.06%,WLS;CLSTN2;DLG4;SYT1;ANXA2;PTPN23;RAB29;GRIK2;SNCA;RIMS1;CD80;CLSTN3;KCTD13
prerank,mesoderm formation (GO:0001707),0.591279795359322,1.2992524835235968,0.1821247892074199,0.643867473135959,1.0,4/17,11.65%,BMPR2;ITGA3;ITGA2;ITGB3
prerank,regulation of dendrite extension (GO:1903859),0.5790881499264929,1.2992204193405328,0.1929203539823009,0.6428816401614658,1.0,3/18,2.97%,SMURF1;NEDD4L;ITSN2
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.533893194940679,-1.2991959538564137,0.15473441108545036,0.594593943604137,1.0,5/14,26.78%,MOXD1;DAGLA;SLC22A2;DAGLB;SLC5A7
prerank,negative regulation of programmed cell death (GO:0043069),0.39283385229888124,1.2988790417542366,0.032397408207343416,0.6428685472130491,1.0,78/355,14.65%,MECOM;LEF1;TEK;TJP1;FOXO1;CD38;IL6ST;KDR;RNF144B;SOCS2;PIM3;ADAM10;FAS;PTK2B;NFKBIA;FLT4;BABAM2;PAK2;AMIGO2;CAT;SOX9;RPS6KA3;TMBIM6;IKBKB;XBP1;RPS6KA1;GREM1;MAPK8;PLK2;XIAP;SERPINB9;WNT5A;BCL3;DNAJA1;HNRNPK;AVEN;TIGAR;PTK2;RASA1;NFKB1;BNIP2;MALT1;PSEN1;AKT2;RHBDD1;EGR3;BCL2L1;HIGD2A;CBL;IL7;SEMA4D;GAS6;BNIP3;RIPK1;BIRC3;PIM1;TMBIM4;THOC6;TMIGD1;BID;RELA;TNFAIP8;RIPK2;GSTP1;PA2G4;PHIP;PRDX2;RAB7A;MET;RPL10;PTMA;NPM1;TRAF6;HIGD1A;IGF1R;TOPORS;PROC;ERC1
prerank,negative regulation of neuron projection development (GO:0010977),-0.39168436153223224,-1.2986406570111035,0.07777777777777778,0.5942462871241104,1.0,17/56,16.80%,LPAR1;DPYSL3;PTPN9;PTPRS;EFNB2;ADCY6;NLGN1;DCC;SEMA3A;RAB29;APOE;NGEF;RTN4;CBFA2T2;STX1B;MT3;TSKU
prerank,regulation of fibrinolysis (GO:0051917),-0.5541296050886642,-1.2985787124693957,0.1746031746031746,0.5923833478205217,1.0,3/13,10.28%,THBS1;FAP;SERPINE1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.5955304068422412,1.2985483248255976,0.18214936247723132,0.6427564512730629,1.0,5/15,7.81%,TJP1;SMAD1;DLL1;JAK1;ITGA5
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.5404892588269099,-1.2985255988110527,0.167816091954023,0.5905607202092138,1.0,8/13,8.46%,BMPR1A;FGFR2;TGFBR3;ERBB4;FGF2;ZFPM2;RBPJ;GLI1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.5027842985301019,1.297969376594805,0.16296296296296298,0.6434184400723051,1.0,6/35,5.29%,FLT1;CAV1;MEF2C;PTPRM;CAV2;DLL4
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.46350905788919833,-1.297805579799788,0.10846560846560846,0.5907060210779512,1.0,3/27,6.06%,LPAR1;GRM1;AGTR1
prerank,regulation of fat cell differentiation (GO:0045598),0.45321093659263395,1.2973860784801348,0.11756756756756757,0.6442237296872874,1.0,18/74,12.96%,FOXO1;PPARD;ZBTB16;GATA2;LRP5;WWTR1;XBP1;WNT5A;TRIB3;TGFB1;LPL;SFRP2;CREB1;ZFPM1;CCDC71L;ASXL1;TRIO;ZFP36
prerank,regulation of synapse assembly (GO:0051963),-0.4189543430563432,-1.2970423232174835,0.12140575079872204,0.5909849779518757,1.0,15/46,12.11%,GPC6;NLGN2;CLSTN2;CUX2;PTPRD;IL1RAPL1;LRFN5;ROBO2;NRXN1;NLGN1;NLGN3;GPC4;MDGA1;SRPX2;GRID2
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.52474834336755,1.296718604826655,0.1637239165329053,0.645304752200098,1.0,10/33,12.26%,ACER2;NEXMIF;LYN;EFNA1;RET;PTK2;PIK3CG;SFRP2;P2RY12;MUC1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),-0.3402446861458677,-1.2965939916859492,0.03773584905660377,0.5903228025424201,1.0,29/142,12.89%,ATP1A2;CACNA1C;LPAR1;PLCE1;ADCY5;PDGFRA;EDNRA;DLG4;ADRA1B;CCR9;SLC8A1;SLC35G1;CD55;SMAD3;TRPC3;AGTR1;PRKACA;TRPC6;TRPC1;BDKRB2;PTGDR;RYR2;PTGFR;TRPC4;TBXA2R;ADRA1A;S1PR3;TRPC5;GPER1
prerank,dendritic spine organization (GO:0097061),0.5379274684830869,1.2964320555336573,0.1653290529695024,0.6451427836850979,1.0,6/26,12.00%,SHANK3;INSR;FYN;ITGA3;PICK1;LGMN
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.593913094027835,-1.2962244655797424,0.1858974358974359,0.5894765987826971,1.0,3/10,4.72%,ACTN2;SEMA5A;CARMIL1
prerank,glucan catabolic process (GO:0009251),-0.5341656115344209,-1.2962035509287766,0.14666666666666667,0.5875575857081156,1.0,7/15,20.51%,PYGB;PHKB;PYGM;GAA;AGL;PHKG1;PHKA2
prerank,ureteric bud morphogenesis (GO:0060675),-0.5305525430453608,-1.2956046946760464,0.1566265060240964,0.5873088618617908,1.0,7/16,16.01%,BMP4;FGF2;SALL1;SIX1;NPNT;WNT11;PAX8
prerank,respiratory system development (GO:0060541),-0.44604272551845253,-1.2951042179248664,0.1402116402116402,0.586827053750418,1.0,12/32,12.67%,FGFR2;GLI2;FGF1;PDPN;BMP4;RBP4;LOXL3;FGF2;VEGFA;STRA6;CCDC39;FGF7
prerank,regulation of interleukin-6 production (GO:0032675),0.4395841333512328,1.2946403034122864,0.10546875,0.6495518318299538,1.0,12/96,7.31%,APP;CD200;IL6R;ARHGEF2;STAT3;AFAP1L2;PLCG2;TIRAP;XBP1;WNT5A;ARRB1;LPL
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.5386285988947694,1.2944432519024895,0.14925373134328357,0.6491064274332689,1.0,9/26,20.27%,OCLN;RAC1;TRPV4;MET;PAK1;CDK5RAP2;NUMA1;CLIP1;RPS3
prerank,regulation of dendritic spine development (GO:0060998),0.5539162831595661,1.294269053738172,0.19152542372881357,0.6486160985788016,1.0,3/19,3.51%,SHANK3;MEF2C;PPFIA2
prerank,T cell activation (GO:0042110),0.45435042957785776,1.2942087033231189,0.13685636856368563,0.6477586495329588,1.0,16/69,11.03%,LFNG;LCP1;CTPS1;PPP3CA;MSN;NCK1;CHD7;CASP8;FKBP1A;DLL4;PPP3CB;LCK;PIK3CG;SOX4;ICOSLG;JAG2
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5281762061543204,1.2932152344045547,0.15495207667731628,0.6497153986781319,1.0,9/33,14.46%,LEF1;CASP8;DCSTAMP;CTNNBIP1;CSF1;IL23A;RIPK1;TRAF6;ZFP36L1
prerank,vascular transport (GO:0010232),-0.3668743319712834,-1.2926347508575209,0.07079646017699115,0.591960309178577,1.0,26/81,10.00%,ATP1A2;SLC24A3;SLC7A2;LRP1;SLC6A13;SLCO3A1;SLC1A3;SLC13A3;SLC16A12;LEPR;SLC2A13;SLC22A8;SLC12A2;SLC6A1;SLC1A5;SLC6A9;ABCC9;SLCO1C1;SLC5A3;SLC1A2;SLC5A5;LRP3;SLC4A3;ATP1B2;SLC2A10;SLC27A1
prerank,vitamin D metabolic process (GO:0042359),0.6055890129024012,1.292445859203742,0.18374558303886926,0.651023050238879,1.0,4/13,12.00%,FGF23;CYP27B1;CYP2R1;LGMN
prerank,positive regulation of cell differentiation (GO:0045597),0.40589261827535944,1.2921048523972325,0.06792873051224944,0.6509901692755137,1.0,47/237,9.92%,PRKCH;LEF1;ZHX3;BMPR2;IL6ST;KDR;PPARD;MEF2C;ZBTB16;ACVRL1;PRKD1;KITLG;IL6R;ARHGEF2;LRP5;WWTR1;PLCB1;CD34;CDH2;SOX9;RPS6KA3;SDCBP;XBP1;RPS6KA1;SLC6A6;ACVR2A;CEACAM1;TCF4;CTNNA1;ACVR1;RAPGEF2;TGFB1;LPL;TCF3;NFKB1;RAP1A;BNIP2;CTNNBIP1;BRINP2;CDH15;NEUROD1;SFRP2;CREB1;CSF1;TCF15;MAPK11;SPAG9
prerank,nucleosome assembly (GO:0006334),0.526700869598219,1.2920521805229879,0.16071428571428573,0.6500884271154576,1.0,11/31,16.74%,SOX9;PADI4;H3-3A;KAT6B;SMARCA5;HAT1;NAP1L4;GRWD1;NPM1;ATRX;ANP32B
prerank,positive regulation of lamellipodium organization (GO:1902745),0.5160036214671399,1.2917023526299243,0.15689381933438987,0.650079279215546,1.0,14/32,15.49%,OCLN;WASF2;RREB1;NCKAP1;ENPP2;RAC1;ARHGEF7;TWF2;FSCN1;ACTR2;CYFIP1;CORO1C;ACTR3;ARPC2
prerank,phosphate-containing compound metabolic process (GO:0006796),0.40695216681141694,1.2916431953155363,0.0676779463243874,0.6492345711004791,1.0,33/198,10.42%,PTPRB;INPP5D;PLCB4;PLA2G4A;PLPP1;PLCG1;GPD2;STAT3;PPP3CA;PFKFB3;PLCB1;PLCG2;PAK2;LIMK2;PPP3CB;ITPKB;PLA2G2D;FBP1;INPP5K;TGFB1;TIGAR;LPL;AGPAT1;PIK3CG;CERKL;DUSP23;DUSP16;PLAAT3;PANK2;SYNJ1;PDXP;INPP1;OCRL
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.48800534859840905,-1.2910494142929483,0.13972602739726028,0.5948087542331167,1.0,9/21,11.81%,BMP6;BMPR1A;TGFBR1;BMP4;CCN3;DAB2;SLC2A10;TGFB3;NUP93
prerank,transport across blood-brain barrier (GO:0150104),-0.3646691000453321,-1.2907964081146701,0.06167400881057269,0.5936784214742095,1.0,26/83,10.00%,ATP1A2;SLC24A3;SLC7A2;LRP1;SLC6A13;SLCO3A1;SLC1A3;SLC13A3;SLC16A12;LEPR;SLC2A13;SLC22A8;SLC12A2;SLC6A1;SLC1A5;SLC6A9;ABCC9;SLCO1C1;SLC5A3;SLC1A2;SLC5A5;LRP3;SLC4A3;ATP1B2;SLC2A10;SLC27A1
prerank,protein glycosylation (GO:0006486),0.4290724429534262,1.290759815931577,0.10579345088161209,0.650749491193741,1.0,26/125,14.54%,ST3GAL6;SLC39A8;ST3GAL1;MGAT4A;STT3B;GALNT18;GALNTL5;EOGT;AQP11;B3GNT3;TET3;ALG10B;B3GNT4;B4GALT5;ST8SIA4;ST6GALNAC2;B3GNT6;B4GAT1;MGAT5;NUS1;TET2;DPAGT1;PMM2;OGA;FUT2;ALG6
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.557315504697698,1.2907584255203046,0.1760797342192691,0.6497100498281151,1.0,3/21,3.73%,PPP1R16B;MFHAS1;FKBP1A
prerank,positive regulation of histone acetylation (GO:0035066),0.5549339416428751,1.2904556939424308,0.16071428571428573,0.6495545250057758,1.0,6/23,16.37%,RPS6KA5;ARRB1;GLYR1;MUC1;RPS6KA4;PIH1D1
prerank,regulation of aerobic respiration (GO:1903715),0.5869092288136668,1.2901800942788435,0.1915966386554622,0.6493235642627052,1.0,4/15,12.56%,CBFA2T3;AK4;ABCD1;NOP53
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.5572808737863184,-1.2898021860465674,0.17155756207674944,0.5947117439976852,1.0,5/14,13.49%,SEC24D;SEC31A;MIA3;SEC23A;TBC1D20
prerank,regulation of apoptotic process (GO:0042981),0.38011441473169955,1.2893614247159981,0.01116751269035533,0.6507410239934802,1.0,144/676,14.65%,LEF1;TEK;TJP1;FOXO1;CD38;ACER2;TNFSF10;UNC13B;TGM2;NET1;IL6ST;KDR;DCUN1D3;ITGA6;MEF2C;PPP1R13B;MCF2L;DAPK1;ARHGEF3;RASGRF2;RNF144B;HIP1;HIP1R;DAB2IP;ARHGEF2;SOCS2;PIM3;ADAM10;FAS;ANP32A;PTK2B;NFKBIA;GLS2;ACTN4;STK3;CASP8;JMY;FLT4;BABAM2;PAK2;ACTN1;CAT;TNFRSF25;PLEKHG5;SOX9;KALRN;RPS6KA3;STK4;TMBIM6;JAK3;PREX1;IKBKB;XBP1;RPS6KA1;FOXL2;GREM1;MAPK8;PLK2;XIAP;SERPINB9;WNT5A;BOK;BCL3;TOX3;CTNNBL1;BCL2L11;DNAJA1;STK26;HNRNPK;AVEN;SPDEF;PTK2;RASA1;NFKB1;CASP1;BNIP2;NF2;STPG1;NEUROD1;MALT1;SFRP2;PSEN1;CITED1;RBM25;CRADD;AKT2;TRIM24;ARHGEF7;ARHGEF26;SLK;RHBDD1;MAP3K11;EGR3;SOX4;TNFRSF8;BCL2L1;HIGD2A;SIAH1;CBL;ANO6;IL7;SEMA4D;TFAP4;GAS6;BNIP3;APH1A;RNPS1;ATF6;RIPK1;BIRC3;PIM1;TMBIM4;TRIO;THOC6;TMIGD1;BID;RELA;TNFAIP8;NOP53;OMA1;RHOB;RIPK2;GSTP1;ARHGEF9;PA2G4;PHIP;RACK1;GNA13;PRDX2;RPL10;SIGMAR1;PTMA;RPS6;NPM1;TRAF6;MAP3K20;HIGD1A;BCL2L14;IGF1R;TOPORS;RYBP;PROC;APC;ERC1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.3146258172466483,-1.289285797638317,0.0,0.5943054962316714,1.0,42/248,8.86%,RNF220;BICC1;RBMS3;EGFR;ZEB2;WLS;LGR4;FGFR2;GLI3;COL1A1;IGFBP2;PRKN;GPC3;PTK7;CTNND2;DKK3;SEMA5A;IGFBP6;DAAM2;DACT1;CAPRIN2;INVS;LYPD6;LRRK1;PLEKHA4;LZTS2;PSME4;SFRP4;TMEM64;LRP6;NOTUM;AMFR;AXIN2;SIAH2;DAB2;GPC5;LRRK2;BTRC;TLE2;GLI1;SFRP1;MCC
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.42191981455839456,1.2892269264215674,0.09284818067754078,0.650079981430179,1.0,21/124,10.26%,LEF1;SMURF1;NFATC1;CELSR1;FZD6;FZD4;PPP3CA;GNB1;PLCB1;AP2B1;TCF7L2;WNT5A;TNRC6C;PPP3CB;RAC1;WNT9B;AP2A1;PSMA2;SFRP2;PSMA8;PSMA6
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.5991565992135435,1.2892234819449577,0.21651376146788992,0.6490532705403481,1.0,4/14,11.69%,USP15;PUM1;OASL;PUM2
prerank,protein dephosphorylation (GO:0006470),0.423368866153361,1.2889907328682066,0.1,0.6487340417646222,1.0,25/135,9.08%,PTPRB;PTPRG;PTPN14;CTTNBP2NL;PTPRM;PPP2R5A;PTPN12;PPP3CA;PTPRJ;PPM1F;MTM1;NCK1;SSH2;PPP1R12A;PTPRK;PPP2R2C;PPM1L;PPP3CB;MTMR6;DUSP22;PPM1D;PPP2R5E;DUSP16;PPP2R5B;PTPN1
prerank,negative regulation of cell growth (GO:0030308),0.4295158442339201,1.2884734855813733,0.11097410604192355,0.6492344223593554,1.0,19/121,7.19%,BMPR2;DCUN1D3;APBB2;SMARCA2;ACVRL1;SH3BP4;NPR1;PTPRJ;SOX17;DIP2B;PPP1R9B;VGLL4;ULK1;ADAM15;FBP1;DCSTAMP;CDKN1B;JADE1;TGFB1
prerank,protein-containing complex subunit organization (GO:0043933),0.4358298531013298,1.2883606603764897,0.1010498687664042,0.6485448803981195,1.0,26/109,14.61%,SLC2A1;OCLN;CD2AP;MAGI1;PARD3;FAS;PTK2B;TRAF1;CARD10;SOX9;TEAD2;CD40;SKAP2;LLGL1;NIFK;IKBKG;TFAP4;PICALM;NUP98;CAPZA1;NUP205;NUP133;IL1RAP;PEX14;NUP54;APC
prerank,cellular response to purine-containing compound (GO:0071415),-0.5712996612376564,-1.2882516499803853,0.18318965517241378,0.5954805958207584,1.0,4/10,18.02%,SLC8A1;RYR2;GSTM2;CASQ2
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.5995321350737366,1.2880651098743254,0.20864661654135339,0.6483998547670831,1.0,5/13,16.20%,PRR5L;CNOT1;RC3H1;CNOT7;PNPT1
prerank,error-prone translesion synthesis (GO:0042276),0.5595211628201008,1.2875729811085992,0.19381107491856678,0.6488783933296088,1.0,4/21,10.28%,POLK;RPA1;PRIMPOL;MAD2L2
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.5083540227737878,1.287471815818673,0.15552099533437014,0.6481394584487798,1.0,8/33,10.53%,HIP1;HIP1R;FBXW7;AFAP1L2;CCDC88A;BCAR3;TGFA;CBL
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.4287090935805458,1.28712328591923,0.1028858218318695,0.6481767868261094,1.0,14/116,5.78%,CALCRL;CYSLTR1;ADCY4;PLCG1;MYH9;LYN;YES1;GNB1;FYN;PRKAR2B;PLCG2;ADRB1;PLK2;RAMP2
prerank,regulation of membrane repolarization (GO:0060306),0.6080447710217088,1.2871025383090668,0.21082089552238806,0.6472108037890844,1.0,4/13,7.12%,CAV1;NEDD4L;KCNQ1;KCNE2
prerank,regulation of cell population proliferation (GO:0042127),0.38084207695690203,1.2870474773616132,0.006122448979591836,0.6463687191015379,1.0,112/691,11.03%,LEF1;TJP1;TBC1D8;NOS3;FLT1;ACER2;PTPN14;BMPR2;IL6ST;KDR;ENG;TBX1;LIFR;SMARCA2;APP;CBFA2T3;IL15;STX3;ACVRL1;SOX7;CLDN5;CD200;CDK6;INSR;KITLG;PLPP1;PDGFB;VEGFC;ADARB1;SH3BP4;IL6R;DAB2IP;EDN1;OSMR;ARHGEF2;LRP5;HHEX;LYN;STAT3;ADAM10;PTK2B;PDGFD;TNFRSF11A;NOTCH1;CNOT6;PTPRJ;BST1;AQP11;WWTR1;CNOT6L;FLT4;ELN;ADGRG1;FGF23;SOX9;TES;PPP1R9B;DLL1;SDCBP;XBP1;BTG3;GNAI2;VEGFD;PTPRK;TCF7L2;GREM1;DLL4;XIAP;BOK;CCDC88A;KLF10;CNBP;DUSP22;CHP2;RAPGEF2;JUNB;CDKN1B;FOSL1;KRAS;PPM1D;TGFB1;PDGFC;PTK2;PKD2;TGFA;NF2;KDM4C;RNF139;CTBP1;PINX1;SFRP2;SGK3;AKT2;IL7R;RPL23;CDK2;CSF1;SOX4;CYP27B1;SST;TNFRSF9;TNFRSF8;NUAK1;BTG2;DHPS;CCL14;IL7;TFAP4;BTG1;NMI;MCTS1;JAG2
prerank,chromatin remodeling (GO:0006338),0.43394507186062237,1.2867423509395328,0.11594202898550725,0.6463127840791671,1.0,32/100,19.93%,ESR1;SMARCA2;BAZ2B;SOX9;KDM6A;PADI4;ARID1B;CECR2;KDM4C;ARID1A;EZH1;SMARCA5;NPM3;SRCAP;SMARCE1;RB1;HNRNPC;TOP1;NPM1;KAT2B;ATRX;BAZ1A;JARID2;PIH1D1;ACTR5;KDM5C;KDM4A;PAK1;BAHD1;CHRAC1;GATAD2B;CHD1L
prerank,positive regulation of cellular catabolic process (GO:0031331),0.42686060245005925,1.286641009349777,0.08758169934640522,0.6456150338381916,1.0,29/132,11.44%,FOXO1;APP;PRKD1;INSR;DAPK1;SH3BP4;MSN;TRIM14;HIF1A;PFKFB3;TNFRSF1B;PIK3C2A;PLIN5;DTX3L;VGLL4;TRIM68;PLK2;ULK1;PRR5L;MID2;SH3GLB1;PSEN1;AKT2;PTPN1;NPRL2;CNOT1;RC3H1;BNIP3;ATF6
prerank,barbed-end actin filament capping (GO:0051016),0.5792570507825423,1.2862228416539,0.185,0.6447360959479921,1.0,2/18,1.52%,FLII;EPS8
prerank,actin filament capping (GO:0051693),0.5792570507825423,1.2862228416539,0.185,0.6447360959479921,1.0,2/18,1.52%,FLII;EPS8
prerank,sodium ion homeostasis (GO:0055078),-0.4796168499707258,-1.2859587468919844,0.14285714285714285,0.6002042131222811,1.0,4/21,3.34%,ATP1A2;SLC12A2;ATP1B1;SLC8A1
prerank,response to nitric oxide (GO:0071731),0.606740058362442,1.285792784669998,0.19039451114922812,0.6449968030556101,1.0,3/13,9.40%,FOXO1;EGLN1;CDK2
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.601487045582526,1.2854940019822245,0.1894353369763206,0.6448860424001309,1.0,6/15,22.31%,ERN1;TSEN34;RTCB;TSEN2;CPSF1;RTRAF
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5924874965707898,1.285389226386561,0.1954225352112676,0.6441582859885009,1.0,6/15,13.14%,TENT4A;TNRC6C;BTG2;CNOT1;ZFP36;CNOT7
prerank,positive regulation of ossification (GO:0045778),-0.42321792255851026,-1.2853189679765828,0.11419753086419752,0.6000129115111724,1.0,12/39,6.81%,BMP6;BMPR1A;PTN;WNT4;BMP7;ADGRV1;OSR1;BMP4;GPM6B;SLC8A1;FBN2;CCN1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.570762131633035,1.2851026492950102,0.19661016949152543,0.6440017600144614,1.0,3/20,2.78%,EPAS1;DCUN1D3;HIF1A
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.3987068127342351,-1.28460588602063,0.10461538461538461,0.6001560012861413,1.0,10/46,7.33%,PLCL1;ALDH1A1;DOCK7;LGR4;NPR3;ADAMTS5;FOXC2;ACOT11;NOVA1;RBPJ
prerank,regulation of cholesterol efflux (GO:0010874),0.5202652923315513,1.2844104331444344,0.15822784810126583,0.6450129028307559,1.0,5/30,5.80%,CAV1;PLTP;NFKBIA;EEPD1;ABCA3
prerank,positive chemotaxis (GO:0050918),-0.5028307921661281,-1.2841394674153324,0.18295739348370926,0.5995844516285953,1.0,8/17,17.85%,ANGPT1;NRP1;SEMA5A;TSC2;VEGFA;FGF7;FGF10;SCG2
prerank,response to hydroxyurea (GO:0072710),0.6308781367912835,1.2839609293216268,0.2182468694096601,0.6453689533418774,1.0,9/11,29.33%,FMR1;DDI1;ATRX;DDI2;SPIDR;RTF2;TIMELESS;DDX11;KAT7
prerank,positive regulation of organelle assembly (GO:1902117),0.48879451731389456,1.2837916139018468,0.1467065868263473,0.6448760420755758,1.0,11/44,11.10%,LCP1;CNOT6;CNOT6L;RALB;SDCBP;CCDC88A;SH3GLB1;G3BP1;CNOT1;FSCN1;CNOT2
prerank,negative regulation of viral transcription (GO:0032897),0.616683361256154,1.2834213987720715,0.19888475836431227,0.6450427204180479,1.0,5/13,18.74%,TRIM14;MID2;ZFP36;IFITM3;TRIM62
prerank,negative regulation of binding (GO:0051100),0.4483852265099057,1.2831654770237186,0.125,0.6448146540856877,1.0,18/81,15.04%,LEF1;CAV1;PDGFB;NFKBIA;TMBIM6;DISC1;RALB;MAPK8;AURKA;CTNNBIP1;ZFPM1;ARHGAP28;TFAP4;CARD16;RACK1;ILRUN;PEX14;STYX
prerank,axon guidance (GO:0007411),0.4039140083358748,1.2825922392210776,0.08247422680412371,0.6454863055980272,1.0,27/201,6.19%,NRP2;SHANK3;SEMA6A;RPS6KA5;PLXNA4;NTN1;SEMA5B;EPHB4;SPTBN1;PTPRM;SEMA7A;PLCG1;EFNA1;PLXND1;NOTCH1;KLF7;BSG;FYN;LAMA3;ROBO4;EVL;LAMA1;SEMA6B;RET;OPHN1;WNT5A;RAC1
prerank,maturation of SSU-rRNA (GO:0030490),0.5125623287834777,1.2825317409902661,0.18902439024390244,0.6446921843851768,1.0,18/34,26.40%,RPS19;RPS14;RPS16;RPS8;HELB;UTP4;NOL10;SRFBP1;RIOK1;UTP6;NOP14;HEATR1;RIOK2;RPS28;NGDN;RIOK3;MRPS11;WDR46
prerank,cellular response to hydroxyurea (GO:0072711),0.6438115176576286,1.282381799469413,0.22163120567375885,0.644142733428282,1.0,8/10,27.71%,FMR1;DDI1;ATRX;DDI2;SPIDR;RTF2;TIMELESS;DDX11
prerank,eye development (GO:0001654),-0.3887209935292875,-1.2820290019121472,0.08058608058608059,0.6040373615974692,1.0,14/54,12.20%,CACNA1C;FBN1;SMOC1;COL5A1;EFEMP1;MEIS1;RBP4;SH3PXD2B;FBN2;HIPK2;PBX4;PBX3;TGFB2;STRA6
prerank,defense response to symbiont (GO:0140546),0.4374157442801906,1.2818687671185394,0.12037037037037036,0.64468494597821,1.0,28/92,19.14%,SERINC3;NLRC5;IRF2;SERINC5;SAMHD1;DDIT4;ISG20;CD40;IFNAR2;RNASE1;MLKL;CGAS;G3BP1;BCL2L1;NT5C3A;BNIP3;ZMYND11;OASL;RELA;CNOT7;IFIH1;IFITM3;STAT1;PLSCR1;ATG7;EIF2AK2;BST2;IFITM1
prerank,B cell proliferation (GO:0042100),0.5778029371520935,1.2818136210010869,0.17850953206239167,0.6438425727937425,1.0,3/17,6.03%,MEF2C;CTPS1;CD40
prerank,negative regulation of ossification (GO:0030279),0.5505256582906689,1.2816681891459922,0.1751592356687898,0.6433162309071813,1.0,8/23,7.27%,MEF2C;PTK2B;NOTCH1;FGF23;SOX9;GREM1;SOST;SRGN
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.5057557484435727,1.2815629617750541,0.1689497716894977,0.642687170612914,1.0,17/36,20.47%,AQP11;SDCBP;N4BP1;EIF3H;OPHN1;UCHL5;NOP53;HSP90AB1;GIPC1;RYBP;UBXN1;PRKCG;RPL11;USP7;PSMF1;USP25;TAF9
prerank,negative regulation of developmental process (GO:0051093),0.4644440122204212,1.2814218629356449,0.14804469273743018,0.6421529767775083,1.0,17/69,12.61%,NOS3;TBX1;CDK6;ARHGEF15;NOTCH1;KLF7;SOX9;DLL1;GREM1;WNT9B;TGFB1;NFIB;RC3H1;GAS6;BNIP3;SINHCAF;OMA1
prerank,ribosomal large subunit assembly (GO:0000027),0.5396669725893483,1.281287013573066,0.17627118644067796,0.641553203948639,1.0,10/24,23.72%,RSL24D1;RRS1;RPL6;NOP53;RPL10;FASTKD2;RPL11;RPL3;TRAF7;DDX28
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.5622256119124456,1.2811078361716477,0.17943925233644858,0.6411006440115731,1.0,4/16,5.29%,PPP1R16B;GATA2;JCAD;DLL4
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.41634450353040464,-1.280181911653759,0.12464589235127478,0.607367814814371,1.0,15/41,18.69%,ANK2;ACTN2;KCNMA1;ANK3;AKAP6;KCNMB2;KCNJ2;GABBR1;KCNJ10;KCNN2;GNG2;KCNJ15;KCNJ6;KCNN3;ACE2
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.4300821859412896,1.2800104700944037,0.09567496723460026,0.6434236260046787,1.0,19/108,8.49%,ACER2;NOD1;TNFSF10;SOX7;DAPK1;HIP1;HIP1R;FAS;CASP4;PPM1F;CASP8;FOXL2;CYCS;BOK;LCK;GRAMD4;CASP1;MALT1;CRADD
prerank,cellular response to interferon-beta (GO:0035458),0.6041437789134876,1.2798893609009667,0.19304347826086957,0.6428119113943478,1.0,6/14,17.66%,AIM2;UBE2K;IRGM;PNPT1;STAT1;CDC34
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.4782796675566786,-1.2797963771865648,0.15425531914893617,0.6066634487808341,1.0,9/23,17.93%,GJA1;BMP4;FGF2;SIX1;VEGFA;SMO;PIK3CD;PAX8;MDK
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.6211976113662007,1.2797418506744236,0.2210144927536232,0.6422911122823363,1.0,3/11,3.88%,PTGS2;CD200;CD34
prerank,receptor-mediated endocytosis (GO:0006898),0.4176979138497075,1.2795855693167106,0.09328358208955224,0.6418084114371955,1.0,15/132,5.78%,DNM3;CALCRL;FNBP1L;CAV1;INSR;HIP1R;SCARB1;STAB1;ARHGAP27;CAV2;FCHO2;DLL1;AP2B1;SCARF1;RAMP2
prerank,sulfate transport (GO:0008272),-0.5357413856332551,-1.2792600670825964,0.17539863325740318,0.6063604705310683,1.0,3/14,2.95%,SLC13A4;SLC26A7;SLC26A2
prerank,production of siRNA involved in RNA interference (GO:0030422),0.628868063137598,1.2790999168648156,0.2111111111111111,0.6422944083066491,1.0,5/10,21.73%,DROSHA;DICER1;HENMT1;MRPL44;PRKRA
prerank,cellular response to light stimulus (GO:0071482),0.46341588765826713,1.2788018811499524,0.12952646239554316,0.6421424732390564,1.0,20/66,19.07%,POLK;GNB1;CNGB1;PTPRK;N4BP1;OPN4;GNAT1;NEDD4;RHBDD1;OPN5;ERCC4;FMR1;EIF2AK4;PDE6B;NPM1;YY1;BMF;KDM1A;DHX36;BAK1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.5270886022498931,1.2784524035406224,0.17445482866043613,0.6422676479158799,1.0,9/27,14.64%,ERN1;RNASE1;RNASE4;KHNYN;DICER1;NUDT16;RPP30;ZC3H12C;TRIR
prerank,regulation of transmembrane transport (GO:0034762),0.5267554467443852,1.278400896777191,0.1747269890795632,0.641457975023431,1.0,6/31,7.73%,SLC2A1;CTTNBP2NL;OCLN;NEDD4L;TRIB3;NEDD4
prerank,regulation of B cell apoptotic process (GO:0002902),0.6052797718494596,1.278366508170726,0.20502901353965183,0.6405829562221075,1.0,2/12,2.30%,FOXP1;LYN
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.598091588675512,1.2783022776722073,0.20210896309314588,0.6398333115623818,1.0,2/15,2.62%,NLRC5;SAMHD1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.46857685889165845,1.2780476172980104,0.1514705882352941,0.6396359053318381,1.0,16/54,16.73%,DCUN1D3;CAV1;SMAD7;N4BP1;DNAJA1;ARRB1;PINX1;SOX4;SPOPL;VPS28;NXN;UBXN1;PRKCG;CHP1;RPL11;CTNNB1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.543060499983161,1.277969679252193,0.2003454231433506,0.6389103099084913,1.0,7/23,8.44%,APP;INSR;PDGFB;HIF1A;PFKFB3;NFKB1;PSEN1
prerank,microvillus assembly (GO:0030033),0.5763773672304798,1.2779445637426314,0.20214669051878353,0.6380380371843779,1.0,5/14,7.67%,RAP1B;RAPGEF2;STK26;TNIK;RAP1A
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.5775278031969828,1.2777688536371872,0.1811965811965812,0.6375891856423822,1.0,7/18,14.34%,TEK;PTK2B;RAP1B;LLGL1;CYRIB;RACK1;CDH5
prerank,regulation of cell differentiation (GO:0045595),-0.336454670188539,-1.2776500099836794,0.030303030303030304,0.6091246048933513,1.0,30/148,12.06%,PHLDB2;SMOC1;FGFR2;EPHA3;ZFHX3;DDX5;PRKCB;TRPS1;CCN2;PHLDB1;TGFBR1;DAG1;RUNX2;AR;IGF2;YWHAG;NGF;SIX1;NF1;NLGN1;DDX17;ST7;PRKACA;BCL6;BIN1;ALK;RUNX1;CAMK1;NREP;FLOT2
prerank,positive regulation of chemokine production (GO:0032722),0.4857887006224192,1.2774503496864955,0.1606060606060606,0.6375603057369251,1.0,6/44,7.31%,APP;IL6R;HIF1A;TIRAP;WNT5A;LPL
prerank,ceramide catabolic process (GO:0046514),0.6051635518251526,1.2772024914425226,0.20462633451957296,0.637277270071001,1.0,2/14,5.59%,ACER2;ASAH2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.6209276892142669,1.2768589905771242,0.2087912087912088,0.6373579595275335,1.0,6/12,20.66%,INSR;BNIP3;IGF1R;FYCO1;IRGM;SETX
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.41715426496888974,-1.2766877597440591,0.13529411764705881,0.6100677773417258,1.0,14/43,10.16%,IGF1;BMPR1A;PDGFRB;IGFBP5;GJA1;IL18;BMP4;CDH13;THBS1;FGF2;ADAMTS1;RBPMS2;CCN4;MMP2
prerank,carboxylic acid transport (GO:0046942),-0.3894702946151524,-1.2765314402507038,0.09507042253521127,0.6085915807210395,1.0,13/55,11.40%,SLC6A13;SLC13A3;SLC16A12;SLC1A5;SLC6A12;SLC6A9;SLC16A6;SLC16A11;PSAP;SLC6A15;SLC66A1;SLC7A6;SLC6A7
prerank,negative regulation of establishment of protein localization (GO:1904950),0.6278224801834995,1.2763048105115928,0.21401515151515152,0.6381024588202305,1.0,5/10,16.62%,PPM1F;DNAJA1;SNX3;TERF1;NDFIP2
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.5749185346959511,1.2758305255958888,0.1825938566552901,0.6385171069887097,1.0,5/17,7.15%,CLDN5;F11R;PPP1R12A;IKBKB;TNFRSF1A
prerank,positive regulation of protein ubiquitination (GO:0031398),0.44789908219363117,1.2757769605891955,0.13237221494102228,0.6377257457998132,1.0,25/80,20.64%,DCUN1D3;CAV1;FBXW7;FKBP1A;SMAD7;MYCBP2;XIAP;TRIB3;MALT1;UBE3A;BIRC3;PRICKLE1;RIPK2;TRAF6;TOPORS;NDFIP2;BIRC2;CUL3;KDM1A;PTTG1IP;PLK1;UBE2L3;BCL10;PDCD6;PEF1
prerank,spliceosomal complex assembly (GO:0000245),-0.42018446359038264,-1.2756887828448473,0.13649851632047477,0.6090220767001716,1.0,8/46,12.93%,CELF2;SRSF5;CELF4;DDX39B;LUC7L3;SRPK2;SF1;CELF1
prerank,chromatin assembly (GO:0031497),0.4982069353331499,1.275636088759584,0.16873065015479877,0.637213857298386,1.0,14/38,20.22%,SOX9;PADI4;LIN54;H3-3A;KAT6B;EZH1;SMARCA5;NAP1L4;GRWD1;NPM1;ATRX;ANP32B;BAHD1;SART3
prerank,negative regulation of dephosphorylation (GO:0035305),0.5637902902444354,1.275623117515419,0.20672268907563024,0.6363185201214122,1.0,4/18,10.38%,PPP1R16B;MFHAS1;INPP5K;GPATCH2
prerank,keratan sulfate metabolic process (GO:0042339),0.5175693222961536,1.275035837441187,0.16718266253869968,0.6371270036880814,1.0,8/31,9.90%,ST3GAL6;ST3GAL1;B3GNT3;B4GALT4;B3GNT4;B4GALT5;B4GAT1;SLC35D2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.4547708368072906,1.2750270427677703,0.12552301255230125,0.6362159218783044,1.0,13/73,8.49%,ACER2;NOD1;TNFSF10;HIP1;HIP1R;FAS;CASP4;CASP8;CYCS;BOK;LCK;CASP1;CRADD
prerank,melanosome localization (GO:0032400),0.5541912112496978,1.2749348793558133,0.19895287958115182,0.6355553208075159,1.0,3/21,3.63%,RAB27A;RAB11A;SHROOM2
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.6023305523103439,1.2745456229749677,0.2261682242990654,0.635757348908989,1.0,6/13,22.75%,IRAK4;TRAF6;IRAK2;PIK3R4;TNIP2;PIK3AP1
prerank,vasculature development (GO:0001944),0.5773448768109415,1.2744203194814165,0.22473867595818817,0.6351822207272858,1.0,6/16,4.48%,BMPR2;ACVRL1;FBXW7;SOX18;FLT4;FOXF1
prerank,intestinal lipid absorption (GO:0098856),0.6199087119131511,1.2743598028885472,0.2196969696969697,0.6344355991715277,1.0,3/11,12.61%,UGCG;SOAT2;LIMA1
prerank,actin filament organization (GO:0007015),0.41147532863149217,1.2734485287438622,0.10596833130328867,0.6361716837891542,1.0,24/151,8.46%,FLII;SHROOM4;LCP1;EPS8;MYO1D;CD2AP;NEDD9;ELMO1;HIP1;HIP1R;ARHGEF2;SHROOM2;SHROOM1;TMOD3;EVL;ACTN1;PPP1R9B;PLS3;ARHGAP17;RAC1;TPM3;TRPV4;RHOBTB1;MYO1E
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.6184830116514528,1.2731977732155833,0.19499105545617174,0.6360186678492644,1.0,3/14,5.81%,ADAM10;PTK2B;WNT5A
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.5156592440844857,1.272387244716907,0.1784037558685446,0.6374926057284432,1.0,10/32,17.41%,CDK17;POLA1;CDT1;BACH1;BRD4;CDK18;RB1;ESRRB;E2F7;KLF11
prerank,endochondral bone morphogenesis (GO:0060350),0.6321388683755023,1.2723861741367115,0.22122302158273383,0.6365717505915266,1.0,2/11,1.15%,BMPR2;MEF2C
prerank,regulation of cholesterol storage (GO:0010885),0.5761991433460997,1.2723790524407472,0.20774647887323944,0.6356718174196029,1.0,6/15,15.84%,PPARD;SCARB1;LPL;ABCG1;TTC39B;ABCA1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.5602899348921212,1.2720509775062678,0.21607142857142858,0.6356935961642828,1.0,4/18,6.76%,SLC2A1;OCLN;TRIB3;INPP5K
prerank,response to UV-A (GO:0070141),-0.5197719482997658,-1.2718964062761975,0.19047619047619047,0.6180697151284904,1.0,3/14,13.54%,EGFR;MMP2;CERS1
prerank,regulation of stress fiber assembly (GO:0051492),-0.36990712919731067,-1.2718636669686512,0.072992700729927,0.6162691055158868,1.0,25/74,11.30%,ARHGAP6;PHLDB2;LPAR1;CGNL1;ROCK2;PPM1E;TMEFF2;ARHGEF10L;NRP1;CCN2;TGFBR1;ARAP1;ARHGEF10;TPM1;RHPN2;CARMIL1;ALMS1;SFRP1;FHOD1;RGCC;ASAP3;TGFB3;S100A10;ARHGEF18;PFN2
prerank,pancreas development (GO:0031016),0.6162037974867489,1.2717451354498785,0.20707964601769913,0.6356455300801345,1.0,3/12,5.25%,ZIC3;FOXF1;TCF7L2
prerank,peptidyl-serine modification (GO:0018209),0.4119902150046868,1.2717316148631561,0.09036860879904875,0.6347644550431951,1.0,38/166,13.42%,PRKCH;RPS6KA5;PRKD1;PDGFB;PRKD2;PKN3;PKN2;PAK2;RPS6KA3;PKN1;STK4;LMTK2;MARK3;IKBKB;RPS6KA1;HIPK1;MAST2;MAPK8;PLK2;ULK1;AURKA;DYRK1A;NEK6;SGK3;AKT2;RICTOR;CDK2;MAPKAPK3;PARP2;AKT3;GAS6;STK38;MAP3K13;MKNK2;NAA11;TOP1;TGFBR2;UHMK1
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.44512492208156956,-1.2715476974549442,0.14905149051490515,0.6152479037712854,1.0,13/30,11.52%,DSE;DCN;BGN;CSPG4;NDNF;CHST15;VCAN;CHSY3;ARSB;CHSY1;CHST3;DSEL;HEXA
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.5741749140237015,1.2708728489325027,0.21621621621621623,0.6362425992415265,1.0,5/16,11.79%,GCH1;SCARB1;HIF1A;NOS1AP;NUS1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.6089622888229032,1.2705278343468933,0.21311475409836064,0.6363193197770625,1.0,4/12,13.74%,CAV1;RALB;CGAS;IFIH1
prerank,positive regulation of apoptotic process (GO:0043065),0.38615502077174496,1.270422604891623,0.05723542116630669,0.6357020051189747,1.0,59/293,12.85%,FOXO1;TNFSF10;UNC13B;TGM2;NET1;DCUN1D3;ITGA6;MCF2L;DAPK1;ARHGEF3;RASGRF2;HIP1R;DAB2IP;ARHGEF2;FAS;SIK1;TPD52L1;STK3;CASP8;JMY;PLEKHG5;KALRN;STK4;PREX1;FOXL2;MAPK8;BOK;CTNNBL1;BCL2L11;DNAJA1;SPDEF;STPG1;NEUROD1;SFRP2;PSEN1;CRADD;ARHGEF7;ARHGEF26;MAP3K11;MYBBP1A;SOX4;TNFRSF8;SIAH1;ANO6;TFAP4;BTG1;BNIP3;APH1A;RNPS1;ATF6;RIPK1;TRIO;BID;TNFAIP8;OMA1;RHOB;ARHGEF9;RACK1;GNA13
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.43185564982351227,1.2695275969010977,0.11413748378728923,0.6374420508212358,1.0,24/100,10.72%,TEK;FLT1;KDR;PPP1R16B;INSR;PIP5K1B;PDGFB;DAB2IP;LYN;PDGFD;SELP;SOX9;PIK3IP1;IER3;CEACAM1;PDGFC;PTK2;PIK3CG;NEDD4;GAB1;PPP2R5B;FBXL2;CBL;SEMA4D
prerank,neuron projection fasciculation (GO:0106030),-0.5716447293307142,-1.2695208253381491,0.18478260869565216,0.6193111237732728,1.0,7/10,24.01%,SEMA5A;NRCAM;CNTN4;RTN4;ARHGAP35;EPHB3;EPHB2
prerank,negative regulation of MAPK cascade (GO:0043409),0.4376973663856663,1.2692028422797468,0.12301587301587301,0.6374986783943647,1.0,7/87,2.87%,SEMA6A;FOXO1;CAV1;CNKSR3;DAB2IP;LYN;PTPRJ
prerank,glycogen catabolic process (GO:0005980),-0.5245790008336784,-1.2692001646962965,0.17763157894736842,0.6184994273192266,1.0,7/15,20.51%,PYGB;PHKB;PYGM;GAA;AGL;PHKG1;PHKA2
prerank,skeletal muscle organ development (GO:0060538),0.5280082475326681,1.2688417656969941,0.18341307814992025,0.6376302356478568,1.0,3/26,5.01%,CAV1;MEF2C;FOXL2
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.5248626027959851,1.2686075025778556,0.19504132231404958,0.6374389848421063,1.0,6/26,9.79%,HTR2A;PLCG2;LCK;PKD2;ITPR3;ERO1A
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.5972060090389074,1.268553924013719,0.21061946902654868,0.6366657316678594,1.0,7/14,11.79%,KDR;VEGFC;FLT4;VEGFD;GAB1;MYO1C;NUS1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.48545882624146813,1.2685109050551735,0.16124260355029585,0.6358901920988252,1.0,9/43,7.19%,PPARD;PDGFB;GATA2;STAT3;NR3C1;HIF1A;SOX9;FOSL1;TGFB1
prerank,cellular response to metal ion (GO:0071248),-0.33665053749403545,-1.2681571705823655,0.02727272727272727,0.6196222966461071,1.0,20/123,6.52%,BMP6;EGFR;PRKN;ADCY1;SLC41A1;ADGRV1;DLG2;SLC12A2;DLG4;SYT1;P2RX4;CDH1;ADCY7;ANK3;PRKAA2;RASGRP2;NLGN1;SYT9;SYT11;SYT12
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.47553689225380713,1.2678741460612495,0.1606060606060606,0.6367699348228947,1.0,9/49,7.15%,IL6ST;IL15;IL6R;LYN;STAT3;GHR;CD40;STAP2;TNFRSF1A
prerank,primary alcohol metabolic process (GO:0034308),-0.45972171065729384,-1.2675627815562116,0.15025906735751296,0.6194762265367789,1.0,5/25,5.06%,IGF1;RBP4;DHRS3;NAAA;CYP1B1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.49954011042934654,1.2675097357284968,0.18478260869565216,0.6368568573791723,1.0,4/37,1.90%,PRKG1;MEF2C;ERN1;PDGFB
prerank,neuron remodeling (GO:0016322),0.6354730309776149,1.2674430673945023,0.20727272727272728,0.6361200801728407,1.0,3/10,5.38%,APP;ANKS1A;SCARF1
prerank,heterocycle biosynthetic process (GO:0018130),0.5905954070979171,1.2672020126366708,0.22321428571428573,0.6359504319524446,1.0,3/14,9.99%,GCH1;GPHN;MOCOS
prerank,positive regulation of cellular component movement (GO:0051272),0.5351863843473449,1.2661930320410806,0.18635607321131448,0.6378660059046002,1.0,6/24,8.71%,NTN1;LYN;ACTN4;RPS19;CAVIN1;AKT2
prerank,regulation of cellular respiration (GO:0043457),0.5645262755665832,1.2660330715113857,0.2138047138047138,0.637406717245382,1.0,4/17,16.20%,CBFA2T3;IFNAR1;NOP53;PNPT1
prerank,ncRNA transcription (GO:0098781),0.60358990465499,1.2652577022439513,0.24113475177304963,0.638648539485141,1.0,7/13,16.66%,CAVIN1;SPIN1;ANG;NIFK;SNAPC3;POLR1G;GTF3C1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.5102023771919949,1.2652103552478209,0.18524332810047095,0.6378745015572475,1.0,10/32,17.21%,MCTP1;MEF2C;KCNMB4;SNCAIP;MCTP2;PNKD;FMR1;RAB5A;RIMS4;CPLX2
prerank,negative regulation of heart contraction (GO:0045822),-0.563486331887013,-1.2648766809044136,0.21487603305785125,0.6255558112486596,1.0,1/11,0.03%,ATP1A2
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4175964363887297,1.2648433165852024,0.13022113022113022,0.6380033137121373,1.0,41/136,20.15%,ESR1;CD200;NLRC5;DAB2IP;FZD6;AIM2;SIK1;ADGRG3;NFKBIA;SIGIRR;TMSB4X;ID1;SMAD7;TCF7L2;EGLN1;ARRB1;PKD2;CTNNBIP1;TAF3;MAD2L2;NFKBIE;GAS6;RB1;PIM1;TRIB1;EIF2AK4;LRRC14;PEX14;IRAK3;DDIT3;OTULIN;CHP1;ERBIN;IRAK2;MAP2K5;USP7;KDM1A;NLRP3;TAX1BP1;HES1;HAVCR2
prerank,response to cAMP (GO:0051591),0.4934291531687696,1.2645193221129298,0.16485225505443235,0.6380373999420587,1.0,9/37,8.44%,AHR;PDE2A;KCNQ1;RAP1B;RAPGEF2;INPP5K;RAP1A;PKD2;CITED1
prerank,regulation of amyloid-beta formation (GO:1902003),-0.43487659305072046,-1.2640957956858252,0.16292134831460675,0.6260585511618088,1.0,8/34,10.31%,IGF1;ROCK2;SLC2A13;LRRTM3;NTRK2;RTN1;BIN1;APOE
prerank,cAMP biosynthetic process (GO:0006171),-0.5677494703493591,-1.2638600346339461,0.20758928571428573,0.6248503121057204,1.0,5/10,5.03%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6
prerank,nucleoside phosphate catabolic process (GO:1901292),0.5963173975600106,1.2628726358480775,0.21920289855072464,0.6417965167271692,1.0,1/13,0.26%,ENTPD1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.6126289136001227,1.2625678974700825,0.21920289855072464,0.6417546269492316,1.0,5/11,7.76%,TBX1;LRP5;SOX9;WNT5A;CTNNBIP1
prerank,dendritic spine morphogenesis (GO:0060997),0.5783724451509171,1.2616518501428065,0.20469798657718122,0.6435320395143945,1.0,1/15,0.09%,SHANK3
prerank,prostaglandin metabolic process (GO:0006693),0.5306214840202337,1.2608796038239918,0.18668831168831168,0.6448822224477622,1.0,4/26,5.15%,PTGS2;PLA2G4A;EDN1;PTGS1
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.4917654510001131,1.2606582892574854,0.17787742899850523,0.6446444025881308,1.0,11/43,7.76%,ZHX3;BMPR2;IL6ST;MEF2C;PRKD1;IL6R;LRP5;WWTR1;ACVR2A;ACVR1;CTNNBIP1
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.5385050152870887,1.260599329282598,0.2026359143327842,0.6439378964393869,1.0,8/24,11.76%,PDE2A;RASD2;PDE4D;PRKAR2B;RAPGEF2;CGAS;APLNR;PDE3A
prerank,microvillus organization (GO:0032528),0.5870346553997785,1.2597117212202062,0.21794871794871795,0.6454235207827435,1.0,5/13,7.67%,RAP1B;RAPGEF2;STK26;TNIK;RAP1A
prerank,regulation of cellular component organization (GO:0051128),0.4177187215541879,1.259648722465935,0.10353227771010962,0.6447120614739313,1.0,36/135,17.23%,TJP1;NET1;HIP1;HIP1R;DAB2IP;MLLT3;SOCS2;RAP1B;TAOK2;CEACAM1;OPHN1;WNT5A;AURKA;RAPGEF2;CISH;SNCAIP;RAP1A;NEDD4;CAMSAP2;RPTOR;SGK3;PTPN1;MAD2L2;SEMA4D;ABL2;PICALM;IL17RB;RAB5A;RAB5B;KLK8;IRAK3;PAK4;IRGM;PACSIN2;NUBP1;TMC8
prerank,acylglycerol metabolic process (GO:0006639),0.49005380070172877,1.2594023839249153,0.16415662650602408,0.6445384057519963,1.0,10/37,15.38%,CAV1;DGKZ;ABHD2;DGKH;LPL;PLAAT3;GK5;DGKE;PNPLA2;DGAT1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.6070758671263525,1.2592561420166428,0.21414538310412573,0.6440671494528855,1.0,4/12,11.15%,ELF2;LYN;RC3H1;CBFB
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.5007224259874313,1.2592131402978382,0.17220543806646527,0.6433024298182941,1.0,8/39,15.26%,MYRIP;ACSL4;TCF7L2;SOX4;UCN;DOC2B;AIMP1;LRRC8A
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.5095945673041373,-1.2589497370820828,0.18867924528301888,0.6372854587463951,1.0,3/17,4.64%,MAGI2;PDGFRB;ITGA1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5131013624320118,-1.2588397944160432,0.19036144578313252,0.6357112252720765,1.0,5/15,7.44%,GRM7;GRM5;GRM1;GRM3;DAGLA
prerank,regulation of actin filament polymerization (GO:0030833),0.4580030577913724,1.258794098679763,0.16381766381766383,0.6436099509323105,1.0,15/69,13.24%,KANK3;ESAM;HIP1R;PTK2B;NCK1;SSH2;EVL;NCKAP1;CDC42EP3;RASA1;ARHGAP28;CYRIB;TWF2;DBNL;MTPN
prerank,positive regulation of MAPK cascade (GO:0043410),0.3930709018703321,1.2587923799755056,0.08126410835214447,0.6427321241180347,1.0,39/245,7.67%,TEK;FLT1;KDR;TBX1;APP;PDE8A;ICAM1;INSR;SEMA7A;PDGFB;HTR2A;IQGAP1;DAB2IP;EDN1;PRKD2;JCAD;MFHAS1;PTK2B;PDGFD;FBXW7;NOTCH1;PTPRJ;TPD52L1;TAOK2;PLCG2;FLT4;CAV2;PIK3R6;TIRAP;ARHGAP8;RET;CD40;RAPGEF2;ARRB1;BCAR3;TGFB1;PDGFC;PIK3CG;RAP1A
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5696543386276306,1.2585078138281254,0.224283305227656,0.6426520414564877,1.0,3/18,1.86%,FLT1;MEF2C;PLCG1
prerank,clathrin-dependent endocytosis (GO:0072583),0.5312108370808467,1.2582717503156051,0.1779935275080906,0.6424147755214107,1.0,8/26,11.68%,FNBP1L;ITSN2;FCHO2;DLL1;AP2B1;AP2A1;INPP5F;PICALM
prerank,regulation of calcium ion transport (GO:0051924),-0.38818020050768687,-1.2578948073279905,0.11827956989247312,0.6367235390702901,1.0,11/54,9.01%,ANK2;BCL2;CACNA2D1;CACNA1D;P2RX4;IL16;CACNB2;STIM1;TRPC6;ADRA2A;EFHB
prerank,regulation of nervous system process (GO:0031644),0.5558160358955595,1.2573019055208783,0.20341880341880342,0.6443427314718108,1.0,2/18,1.05%,NOS3;APP
prerank,positive regulation of interleukin-10 production (GO:0032733),0.5159516952908405,1.256875685474873,0.20483870967741935,0.6446380805433728,1.0,5/30,9.76%,STAT3;PLCG2;CD34;TIGIT;IL23A
prerank,positive regulation of interleukin-8 production (GO:0032757),0.47889910696892524,1.2558841678859698,0.19013062409288825,0.6465001945757933,1.0,5/49,4.33%,NOD1;PRKD2;STAT3;AFAP1L2;TIRAP
prerank,positive regulation of response to stimulus (GO:0048584),0.4836022620590765,1.2558755509902502,0.18063583815028902,0.645635667873045,1.0,13/40,20.47%,ABI3;IL15;B2M;WNT5A;CGAS;FMR1;IFIH1;NSMCE4A;YPEL3;NSMCE1;IER5;HOMER1;TAF9
prerank,ion transport (GO:0006811),-0.3465365637587272,-1.2558754138985273,0.09375,0.6406122499549848,1.0,21/111,10.43%,SLC24A3;TRPM3;SLC1A3;PIEZO2;SLC8A3;SLC26A7;SLC12A2;SLC9A9;SLC26A2;SLC8A1;WNK4;ANO1;GLRB;SLC1A2;TRPC6;SLC5A5;SLC24A2;SLC20A1;WNK1;SLC4A2;GABRB1
prerank,signal transduction by p53 class mediator (GO:0072331),0.5169046742520628,1.2557669211862712,0.1867283950617284,0.6450416985111472,1.0,8/30,9.33%,ACER2;PPP1R13B;JMY;GREM1;BOK;BCL3;HINT1;MYBBP1A
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5774191036600046,-1.2556181215589495,0.22587719298245615,0.6394030998238821,1.0,2/10,2.91%,GLI3;BMP4
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.6244764446185214,1.2556167488214935,0.23792486583184258,0.6437327409042314,1.0,2/10,7.02%,CNGB1;GNAT1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.6244764446185214,1.2556167488214935,0.23792486583184258,0.6437327409042314,1.0,2/10,7.02%,CNGB1;GNAT1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.5569231907451407,1.2553853121786467,0.22279792746113988,0.6434037415278665,1.0,6/20,14.06%,ENTPD1;APP;CASP1;ANO6;HSP90AB1;TXNIP
prerank,exit from mitosis (GO:0010458),0.5876117604880099,1.2553541648754007,0.21915285451197053,0.6426034858569041,1.0,6/12,23.21%,EPS8;CHMP4B;PPP2R2D;CTDP1;SIRT7;CLASP2
prerank,positive regulation of vascular permeability (GO:0043117),0.6117388103943782,1.25535056559156,0.2522202486678508,0.641749843420155,1.0,8/12,11.76%,TJP1;OCLN;TJP2;PDE2A;TGFB1;TRPV4;TJP3;PDE3A
prerank,regulation of cytoplasmic transport (GO:1903649),-0.5551925453554158,-1.2553496219059983,0.18475750577367206,0.6383309991662846,1.0,5/11,17.10%,ATP9A;LRRK2;SRC;MAP2K2;MAP2K1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.5568947713172805,1.2552620372230654,0.23172905525846701,0.6411190098903276,1.0,4/16,10.08%,CEACAM1;STX7;IL23A;CYRIB
prerank,negative regulation of axon extension (GO:0030517),0.5070322193996198,1.2551805868763741,0.1889400921658986,0.640475674821013,1.0,5/30,5.69%,SEMA6A;SEMA5B;SEMA7A;DIP2B;SEMA6B
prerank,positive regulation of cell junction assembly (GO:1901890),0.45917076220683967,1.2551531159565013,0.16885007278020378,0.6397007153132446,1.0,6/56,2.96%,TEK;KDR;CAV1;CLDN5;PTPRJ;PPM1F
prerank,actin polymerization or depolymerization (GO:0008154),-0.39139703462454856,-1.255112563603794,0.1291390728476821,0.6370817991710462,1.0,9/50,6.70%,ARHGAP6;GAS7;MICAL3;GSN;MICAL2;SPIRE1;COBL;ABI2;VILL
prerank,muscle contraction (GO:0006936),-0.33336492520871225,-1.2549591202814943,0.107981220657277,0.6356436184125941,1.0,28/126,14.64%,CALD1;DMD;ROCK2;SNTA1;ITGB5;ACTN2;EDNRA;SLC8A1;ASPH;GNAO1;SNTB1;DTNA;TPM1;ITGA1;TMOD2;BDKRB2;MYL9;SSPN;TPM2;MYOM1;ACTA2;DES;ADRA1A;LMOD1;TLN1;ARHGEF11;TPM4;FXYD1
prerank,response to chemokine (GO:1990868),0.6048819526679892,1.2548186538004282,0.20757825370675453,0.6397581013136018,1.0,1/13,0.16%,LRCH1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.42299021543274784,1.2540498484694318,0.13480392156862744,0.6410208390273691,1.0,23/112,7.32%,ENG;MEF2C;ACVRL1;CLDN5;F11R;SMAD1;SMURF1;PARD3;NRROS;PDE2A;NR3C1;PXN;FKBP1A;SOX9;ID1;SMAD7;PTPRK;USP15;WNT5A;DUSP22;ACVR1;TGFB1;PTK2
prerank,cellular response to glucose stimulus (GO:0071333),0.5025257872659008,1.254008008879791,0.18867924528301888,0.6402694667826883,1.0,10/30,14.39%,UNC13B;ERN1;KCNB1;XBP1;RAB11FIP5;SOX4;GAS6;RAB11B;RACK1;IGF1R
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.6001837026939,1.2533438979091311,0.2366412213740458,0.6412374385229433,1.0,6/11,11.82%,ARHGEF2;CASP8;PELI1;YBX3;RIPK1;BIRC3
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.4410872672413486,-1.2528254013434885,0.1503957783641161,0.639920819616543,1.0,11/28,22.78%,ZIC1;PRKCD;CDH1;SMAD3;MAVS;PIK3R2;TRIM28;UBR5;HDAC3;JUP;BAG3
prerank,defense response to virus (GO:0051607),0.42299327542576776,1.2528156481175285,0.14398943196829592,0.6418096418467168,1.0,29/100,19.14%,SERINC3;NLRC5;IRF2;SERINC5;SAMHD1;DDIT4;ISG20;CD40;IFNAR2;RNASE1;MLKL;CGAS;G3BP1;BCL2L1;NT5C3A;BNIP3;ZMYND11;OASL;RELA;CNOT7;IFIH1;IFITM3;STAT1;PLSCR1;ZDHHC1;ATG7;EIF2AK2;BST2;IFITM1
prerank,response to progesterone (GO:0032570),0.5599815536174627,1.2526143664645562,0.20862068965517241,0.6415190230138778,1.0,5/18,11.72%,CAV1;ABHD2;TGFB1;CATSPERD;UBE3A
prerank,negative regulation of cartilage development (GO:0061037),-0.538720379748146,-1.2522735059973267,0.20616113744075829,0.6397234656617815,1.0,4/13,4.07%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,positive regulation of lipid transport (GO:0032370),-0.5525944866751143,-1.252212876917252,0.21541950113378686,0.6380128976785198,1.0,3/12,10.31%,LRP1;SPP1;APOE
prerank,regulation of cell development (GO:0060284),0.5021252821178118,1.251838068861741,0.2073170731707317,0.642725991221809,1.0,6/36,5.49%,FOXO1;HDAC9;ADGRA2;DLL1;RPS19;CX3CR1
prerank,glucose homeostasis (GO:0042593),0.4351317912743111,1.25170389459074,0.14945652173913043,0.6422342131880157,1.0,13/83,9.43%,FOXO1;ADIPOR2;INSR;STAT3;HIF1A;KLF7;KCNB1;TCF7L2;FOXA3;INPP5K;NEUROD1;FOXK1;SOX4
prerank,establishment of melanosome localization (GO:0032401),0.5592580548568783,1.2513782006466017,0.2185792349726776,0.6422189254061728,1.0,3/19,3.63%,RAB27A;RAB11A;SHROOM2
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.5453282762545097,-1.2511738007440112,0.20905172413793102,0.6392365087566224,1.0,4/12,8.88%,ANK2;ANXA6;UBASH3B;RYR2
prerank,supramolecular fiber organization (GO:0097435),-0.29798771330587276,-1.2508824631008064,0.031578947368421054,0.6382079134993792,1.0,90/333,14.09%,COL1A2;COL3A1;CGNL1;COL4A5;COL1A1;ADAMTS2;COL8A1;TNXB;GSN;COL4A6;COL5A1;COL12A1;COL22A1;PRKN;COL25A1;COL4A3;COL4A4;LOXL1;COL6A2;CLIP4;FAT1;COL6A3;COL11A1;HSPG2;COL6A1;PLOD2;COL8A2;TGFBR1;COL26A1;MYO5A;SERPINH1;COL13A1;FBLN5;COL18A1;PPP1R9A;COL23A1;RHOBTB2;LOXL3;COL27A1;RND3;TPM1;CARMIL1;DLG1;CYP1B1;COL5A3;TMOD2;NF1;CLIP3;TGFBI;COL16A1;P4HB;LUM;LOX;SIAH2;COL14A1;SHROOM3;EFEMP2;COL9A2;MPRIP;KIF24;RHOBTB3;APH1B;TUBGCP5;GGA2;MDM2;KATNAL1;COL20A1;DDR2;TPM2;DPT;ADAMTS14;CST3;P4HA1;DES;TGFB2;MAP7D3;MYO1B;LMOD1;MFAP4;WDR73;TSPAN15;B4GALT7;COL19A1;DBN1;PCM1;COL15A1;LAMC2;GGA1;P3H4;TPM4
prerank,negative regulation of complement activation (GO:0045916),-0.5785980499289016,-1.2505712912660054,0.20750551876379691,0.6372302113866982,1.0,2/10,4.95%,SERPING1;CD55
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.3327594915225578,-1.2505383222419852,0.05063291139240506,0.6354622944959282,1.0,21/140,9.21%,CACNA1C;LPAR1;PLCE1;ADCY5;PDGFRA;CACNA2D1;EDNRA;DLG4;ADRA1B;CCR9;JPH1;SLC8A1;P2RX4;CD55;TRPC3;GRM1;AGTR1;BDKRB2;PTGDR;RYR2;PTGFR
prerank,protein O-linked glycosylation (GO:0006493),0.4254692602577762,1.2502885545730191,0.14437086092715232,0.644323037686075,1.0,19/96,12.26%,ST6GAL1;TMTC2;ST3GAL1;GALNT18;GALNT14;GALNT15;EOGT;B3GNT3;TET3;B3GNT4;B4GALT5;ST6GALNAC2;B3GNT6;B4GAT1;RXYLT1;ST6GALNAC4;C1GALT1;TET2;MUC1
prerank,negative regulation of cellular process (GO:0048523),0.3699966268371396,1.2502576982687645,0.04316546762589928,0.6435487059299134,1.0,86/521,11.08%,NOS3;PTPN14;BMPR2;JAM2;PLXNA4;DCUN1D3;TBX1;APBB2;SMARCA2;APP;PDE8A;CBFA2T3;ACVRL1;SOX7;CTTNBP2NL;PRKD1;PPP1R13B;PODXL;CD200;CDK6;PLPP1;MYH9;ADARB1;SH3BP4;DAB2IP;LYN;ADAM10;PTK2B;SRGAP2;NPR1;PLXND1;NOTCH1;PTPRJ;TNFRSF1B;LPCAT3;AQP11;SOX17;NCK1;CD34;ADGRG1;ACTN1;TES;PPP1R9B;DLL1;TMBIM6;VGLL4;BTG3;PTPRK;DLL4;TMEM98;KLF10;RAPGEF2;CBLL1;ADAM15;BTN2A2;FBP1;BTBD18;DCSTAMP;CDKN1B;JADE1;ADAMDEC1;PPM1D;TGFB1;RASA1;SNX3;PKD2;RNF167;NF2;RNF139;CTBP1;PINX1;SFRP2;CHMP4B;DSCAM;SOX4;CYP27B1;SST;TNFRSF8;BTG2;RAD18;VAMP8;SEMA4D;TFAP4;BTG1;NMI;BNIP3
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.5069121486695494,1.2502305310832107,0.2128,0.6427540928636113,1.0,12/29,16.45%,IL15;SOCS2;STAT3;JAK3;GHR;IFNAR1;IFNAR2;PKD2;NMI;SOCS6;STAT6;STAT1
prerank,regulation of coagulation (GO:0050818),0.6153048446071799,1.2500123724575523,0.225130890052356,0.6424802564813308,1.0,3/11,14.60%,CAV1;PROCR;PROC
prerank,neural crest cell differentiation (GO:0014033),0.564202780404085,1.2499231954908074,0.22564935064935066,0.6418646090239166,1.0,3/18,6.67%,MEF2C;CDH2;CYP26C1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.487862682174776,-1.2498782971097628,0.20595533498759305,0.6356228059076972,1.0,6/17,7.33%,NOTCH2;BMPR1A;BMP4;JAG1;HEYL;RBPJ
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.4574725519605832,-1.2494660198755996,0.17447916666666666,0.6349596604707738,1.0,7/24,4.07%,SOX5;ADAMTS12;TRPS1;EFEMP1;TGFBR1;SOX6;WNT9A
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.5900185826594492,1.248804143389683,0.23268206039076378,0.6441360496591417,1.0,9/14,23.27%,TIRAP;HNRNPA0;YBX3;ANGEL2;HNRNPC;ZFP36;DAZL;ELAVL1;MAPK14
prerank,positive regulation of binding (GO:0051099),0.4332916144768583,1.2487724033923289,0.14986737400530503,0.6433712456291251,1.0,18/84,8.51%,CAV1;APP;EPB41;CLDN5;B2M;HIP1R;STK3;FKBP1A;HMBOX1;STK4;MARK3;RALB;DTX3L;TCF7L2;RAPGEF2;TRIB3;PSEN1;CDT1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.34776618018018435,-1.2480280133610613,0.08139534883720931,0.6375347951723709,1.0,17/107,8.91%,SLC24A3;ANK2;ATP13A5;ATP13A3;SLC8A3;SLC41A1;SLC30A10;ATP1B1;SLC8A1;DMPK;SLC39A14;SLC39A13;STIM1;ATP2A2;SLC39A10;RYR2;SLC24A2
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.5164715961436174,1.2478312485530867,0.19699499165275458,0.6450050465242549,1.0,5/30,7.19%,FLT1;KDR;MLLT3;FLT4;TGFB1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.561463245216914,1.2477994007460411,0.2332155477031802,0.6442383426917864,1.0,11/16,27.16%,CHMP4A;CHMP4B;VPS28;TMEM50B;STAM;VTA1;LEPROT;VPS36;VPS25;TMEM50A;CHMP4C
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.4040686115714725,1.247759307512555,0.11616766467065869,0.6435165376844931,1.0,23/151,7.67%,TEK;KDR;APP;PDE8A;ICAM1;SEMA7A;PDGFB;HTR2A;PRKD2;MFHAS1;PTK2B;PDGFD;TNFRSF11A;FBXW7;NOTCH1;FLT4;TIRAP;ARHGAP8;RAPGEF2;ARRB1;TGFB1;PDGFC;RAP1A
prerank,acylglycerol biosynthetic process (GO:0046463),-0.46309946503172467,-1.2477053705117864,0.168,0.6365781938294137,1.0,6/23,6.93%,AGMO;PLCE1;MOGAT3;LPGAT1;GK;LPIN1
prerank,negative regulation of cell projection organization (GO:0031345),-0.39316878589677223,-1.2469906404215203,0.1396103896103896,0.6369493124671194,1.0,14/48,16.80%,LPAR1;DPYSL3;PTPN9;PTPRS;EFNB2;ADCY6;DCC;SEMA3A;RAB29;APOE;CBFA2T2;STX1B;MT3;TSKU
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.45718178725921604,1.24684472747815,0.15239477503628446,0.6452404081580986,1.0,25/57,23.62%,RPS15;RPS19;RPS16;RPL38;TGS1;RPS7;RPS24;XPO1;RRS1;RPL14;NOP16;RPS6;NPM1;RPS25;RIOK1;RPL35A;EMG1;RPL11;NOP14;NOM1;RIOK2;RPS28;RPL7;RPL26;CUL4B
prerank,morphogenesis of an epithelium (GO:0002009),-0.4467877335101182,-1.2465049829850159,0.2077922077922078,0.636528250947186,1.0,5/25,6.53%,FGFR2;DAG1;TBX18;LRP6;AHI1
prerank,outflow tract septum morphogenesis (GO:0003148),0.5373825413716189,1.246397011789717,0.19906687402799378,0.6456973895036513,1.0,4/24,0.88%,NRP2;BMPR2;ENG;TBX1
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.33365671855440887,-1.2462592382016435,0.0787037037037037,0.6354250640875471,1.0,32/108,11.97%,TRABD2B;SULF1;WLS;LRP1;FGFR2;PRKN;GPC3;PTK7;CTNND2;RNF43;SULF2;DCDC2;GRB10;WWOX;DAAM2;RSPO3;RSPO2;DACT1;SALL1;SFRP4;CXXC4;NOTUM;LRRK2;FOXL1;BTRC;SFRP1;TSC2;APCDD1;SMARCA4;RUNX1;FZD7;DACT3
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.4863612101988236,-1.2461396492817518,0.18888888888888888,0.6340241698365511,1.0,6/18,11.24%,PDPN;SMAD3;EFEMP2;RGCC;DDR2;RUNX1
prerank,regulation of glucose metabolic process (GO:0010906),-0.4204799154433144,-1.245783391774848,0.16172506738544473,0.6332835689197442,1.0,10/34,16.92%,PRKN;IRS1;PDK1;OGT;SELENOS;RORA;IRS2;SLC45A3;DGKQ;GPLD1
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.48693458354105906,1.245492870871921,0.196875,0.647332591366747,1.0,9/39,13.69%,FNBP1L;MYO1D;ACTN4;PPFIA2;BICDL1;MYO1E;MYO1C;CCDC186;NDEL1
prerank,negative regulation of apoptotic process (GO:0043066),0.3749212233233891,1.2453883617718673,0.04756871035940803,0.6467660058389294,1.0,114/444,18.07%,PRKCH;LEF1;TEK;TJP1;FOXO1;CD38;IL6ST;KDR;CAV1;TBX1;MEF2C;RNF144B;SOCS2;PIM3;ADAM10;FAS;PTK2B;NOTCH1;NFKBIA;FLT4;BABAM2;PAK2;CAT;SOX9;RPS6KA3;DLL1;TMBIM6;FOXQ1;IKBKB;XBP1;RPS6KA1;GREM1;CX3CR1;MAPK8;PLK2;ASAH2;XIAP;SERPINB9;WNT5A;BCL3;TOX3;DNAJA1;HNRNPK;AVEN;PTK2;RASA1;NFKB1;BNIP2;ITGA5;MALT1;PSEN1;CITED1;AKT2;RHBDD1;EGR3;BCL2L1;HIGD2A;CBL;IL7;SEMA4D;SFN;GAS6;BNIP3;RB1;RIPK1;BIRC3;PIM1;TMBIM4;LGMN;THOC6;CARD16;TMIGD1;BID;RELA;TNFAIP8;RIPK2;GSTP1;PA2G4;PHIP;PRDX2;RPL10;PTMA;SOD2;NPM1;TRAF6;HIGD1A;IGF1R;TOPORS;PROC;ERC1;PRKCG;TPT1;NAA16;BAG4;AREL1;MERTK;NIBAN2;ANGPTL4;MAEA;PROK2;CTNNB1;BCL2L10;BIRC2;ARL6IP1;BAG1;MAP2K5;APIP;MGMT;PRKAA1;ARHGDIA;CSNK2A1;CSNK2A2;CFL1;CIB1
prerank,regulation of hemopoiesis (GO:1903706),-0.5444826317127008,-1.2450955013587042,0.2345415778251599,0.6334563876458279,1.0,4/10,13.93%,PTN;PRKCB;RUNX1;IL17D
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.46314053231005087,1.2450118697236336,0.17991004497751126,0.6470199385141828,1.0,4/46,2.30%,SEMA6A;CNKSR3;DAB2IP;LYN
prerank,mesenchymal to epithelial transition (GO:0060231),-0.5678371901392963,-1.244709263343223,0.23129251700680273,0.632887543873819,1.0,4/10,16.01%,BMP4;SALL1;FZD7;PAX8
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.4986794268551936,-1.2446574818849607,0.19956616052060738,0.6312623326740611,1.0,6/16,15.53%,APPL2;PPARA;ADCY7;APOD;CHID1;SIRPA
prerank,carbohydrate derivative catabolic process (GO:1901136),0.5512532841882835,1.2443625083793763,0.21052631578947367,0.6480005955595337,1.0,2/18,2.62%,STT3B;SAMHD1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.5701770436308604,1.2441846032239692,0.22800718132854578,0.6476765877930204,1.0,8/16,24.44%,RAD21L1;HASPIN;RB1;PDS5A;PDS5B;RAD21;NIPBL;NAA50
prerank,regulation of presynapse organization (GO:0099174),-0.48191973018168377,-1.2439873661536012,0.1853546910755149,0.6296929377596909,1.0,6/18,11.48%,GPC6;PTPRD;IL1RAPL1;LRFN5;GPC4;MDGA1
prerank,regulation of presynapse assembly (GO:1905606),-0.48191973018168377,-1.2439873661536012,0.1853546910755149,0.6296929377596909,1.0,6/18,11.48%,GPC6;PTPRD;IL1RAPL1;LRFN5;GPC4;MDGA1
prerank,protein modification process (GO:0036211),0.43731577572381464,1.2439352582887928,0.15256588072122051,0.6474889404401867,1.0,15/76,11.67%,ST3GAL6;ST3GAL1;YES1;CPE;UBA7;PADI4;ST8SIA4;AKT2;FBXL2;FBXW2;ERO1A;UBE2D3;ICMT;ABL2;STK38
prerank,erythrocyte differentiation (GO:0030218),0.4690037088818105,1.2437103185273393,0.19850746268656716,0.6472976798920624,1.0,8/44,5.07%,LYN;TAL1;MFHAS1;ALAS1;RPS19;JAK3;RPS14;KMT2E
prerank,Rap protein signal transduction (GO:0032486),0.6220712824192365,1.2432673153714695,0.22495274102079396,0.6476735154240945,1.0,4/10,7.67%,RAP1B;PLK2;RAPGEF2;RAP1A
prerank,regulation of necroptotic process (GO:0060544),0.5199383077728915,1.2430882411981337,0.20666666666666667,0.6473366140444725,1.0,8/23,11.82%,ARHGEF2;CASP8;SDCBP;PELI1;MLKL;YBX3;RIPK1;BIRC3
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.591709254707923,1.2429373373750365,0.260707635009311,0.6468943679935741,1.0,2/12,6.38%,CEACAM1;TRIB3
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.5785287399122657,1.242872762501017,0.24214417744916822,0.6462370260464897,1.0,1/14,1.32%,ERN1
prerank,Golgi ribbon formation (GO:0090161),0.5826191551309831,1.2424221524802241,0.2577854671280277,0.6466421709913559,1.0,5/13,8.30%,STX6;VAMP4;VTI1A;GCC2;TMED5
prerank,cellular sodium ion homeostasis (GO:0006883),-0.5051345277147478,-1.2423834013290997,0.19318181818181818,0.6325506761792747,1.0,4/15,3.34%,ATP1A2;SLC12A2;ATP1B1;SLC8A1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.5117249083377086,1.2422211328896642,0.21003134796238246,0.6463313995738339,1.0,8/29,14.04%,NLRC5;SAMHD1;WNT5A;IFNAR2;PTPN1;CNOT7;HSP90AB1;UBE2K
prerank,regulation of axonogenesis (GO:0050770),-0.3876292121998206,-1.2422091729519305,0.13846153846153847,0.6313322551231219,1.0,13/51,10.49%,ROBO1;PLXNA2;KIF13B;TIAM2;BRSK1;NTRK2;LRRC4C;ROBO2;NGF;MAP6;PLXNB1;SIPA1L1;SLIT2
prerank,gene expression (GO:0010467),0.3744084581102718,1.242022191132714,0.06673842841765339,0.6460187196274189,1.0,125/348,20.44%,RBPMS;ADARB1;HHEX;TSPAN5;DDX54;RPS15;IGF2BP3;RPS19;RPLP1;RPS14;RPSA;RPS16;EPC1;RPL38;EIF4E;TSPAN14;RPS20;RPL39;RPL34;DROSHA;HNRNPF;RPS7;BCL3;NXF2;PWP1;RPS24;TAF1B;HNRNPK;RPL37A;SRBD1;HNRNPD;RPS18;RPL36;RSL24D1;WDR33;RPL15;RPL14;THOC2;RPS8;MRPS18A;RPL23;RPL17;SMG7;TNIP1;RPL9;RPL4;RNGTT;DHPS;RPL13A;RPS11;RBM3;RPL32;RPL22;MMS19;YTHDC1;NUP214;RPL31;RPS27;RNPS1;RPS23;ADAR;MRPL13;RPL13;MRPS12;RPS12;NUP98;THOC6;MRPL35;HBS1L;RPL6;WARS1;MRRF;RPL10;FASTKD2;MRPL41;PTMA;UPF2;NUP205;NUP133;MRPL52;RPS29;RPS6;MEF2A;NUP153;NUP54;RPS25;TOPORS;RPL35A;RPL29;RPS13;XRN2;RPL18;NUP43;RPL27A;MRPS16;RPS21;RPL27;MRPS5;MRPL23;TSPAN33;DDX20;AGFG1;HNRNPUL1;RPS10;MRPL37;RPL11;THOC3;ALYREF;RPLP2;CDC40;MRPL11;RPL8;THOC1;CPSF1;PRPF4;RPL18A;GLE1;THOC5;POLR3A;NR4A2;RPS3;POLR2L;RPL21;RPL3;MRPL43
prerank,nucleotide catabolic process (GO:0009166),0.5748891397879488,1.2418150795575036,0.24035087719298245,0.6457704354974894,1.0,5/16,14.57%,GDA;SAMHD1;NT5C2;XDH;NUDT15
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.5688940698008716,1.2416592577505596,0.23036649214659685,0.6454065812316359,1.0,5/15,7.21%,KDR;PTK2B;SRMS;DYRK1A;BMX
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.5690409249700938,1.2410215686142605,0.2594594594594595,0.6462987201526639,1.0,4/15,4.05%,KDR;PRKD1;PRKD2;TMSB4X
prerank,cellular response to oxygen-containing compound (GO:1901701),0.3783712080368573,1.2395795445944442,0.0990990990990991,0.6494609550493106,1.0,51/291,11.17%,FOXO1;TGM2;TBX1;ESR1;MEF2C;PRKD1;AHR;DAPK1;PDGFB;SH3BP4;DAB2IP;FZD4;PDE2A;LYN;KCNQ1;PTK2B;GNB1;TNFRSF1B;RAP1B;PXN;SOX9;TIRAP;XBP1;SBNO2;PTPRK;CX3CR1;MAPK8;ATP2B4;RET;WNT5A;RAPGEF2;WNT9B;IL36G;INPP5K;PPBP;LPL;NFKB1;RAP1A;PKD2;CASP1;BRINP2;RPTOR;CREB1;NRIP1;CDK2;DEFA6;PDXP;LARS1;TWF2;P2RY12;ABL2
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.36020700046160153,1.2392589839399262,0.0,0.6494531737295829,1.0,258/1668,11.51%,MECOM;DACH2;ERG;LEF1;MRTFB;ELK3;FLI1;RPS6KA5;FOXO1;LHX6;EPAS1;TEAD4;HDAC9;DACH1;ZHX3;PBX1;BMPR2;LDB2;ENG;CAV1;ITGA6;TBX1;ESR1;SMARCA2;APP;PPARD;TSHZ2;MEF2C;ZBTB16;TOX4;LMO2;ACVRL1;CRTC1;MAML2;PRKD1;NR5A2;AHR;ETV6;SMAD1;ZIC3;LRRFIP1;NFATC1;NLRC5;IRF2;FOXP1;GATA2;MED13L;DAB2IP;ELF2;SOX13;EDN1;ARHGEF2;LRP5;HHEX;PDE2A;PRKD2;STAT3;TAL1;NEDD4L;EFNA1;NR3C1;PPP3CA;FNIP2;HIF1A;NOTCH1;EBF1;KLF7;RREB1;KLF8;NFKBIA;PKNOX2;CCNK;KDM3A;SOX17;TGIF1;PITX1;NCK1;WWTR1;BAZ2B;ARID3B;ZFP57;TCF12;JMY;SOX18;TSHZ1;PPP1R12A;HMBOX1;MAFF;FOSL2;RIPPLY3;SOX9;TOX;ZNF292;ZBTB46;MRTFA;RPS6KA3;NCOA1;PKN1;DLL1;FOXF1;KLF2;ELK4;FOXQ1;SS18;RPS14;SDCBP;IKBKB;MCPH1;XBP1;RPS6KA1;SP6;SBNO2;ZFP92;FOXL2;TET3;TCF7L1;ID1;ACVR2A;EPC1;SMAD7;TCF7L2;TCF4;GREM1;ARID1B;DLL4;PHF20;FOXF2;ATP2B4;LPIN3;HOXA10;MTF2;JMJD1C;LIN9;WNT5A;TNRC6C;RCOR1;PITX3;TEAD2;ESRRG;PPP3CB;KLF10;CD40;CNBP;DUSP22;ACVR1;ATMIN;CHP2;SKAP1;JUNB;TOX3;TRIB3;NR1I3;FBP1;FOXA3;ELF5;FOSL1;IRF2BPL;HNF1B;ETS2;ASCL4;LYL1;KLF13;ARRB1;HNRNPK;CHD1;PPM1D;SPDEF;TNFRSF1A;TGFB1;RBM14;TCF3;HOXD1;HOXD8;NFKB1;PKD2;GMEB2;GATAD2A;TGFA;AGRN;MAMSTR;BACH2;KDM4C;ARID1A;CTBP1;NEUROD1;CREM;SFRP2;KAT6B;PSEN1;CITED1;WWC2;NRL;ZNF2;PHF6;TAF3;EZH1;CREB1;SUB1;FOXK1;SMARCA5;BRIP1;BACH1;BRD4;MAFB;CHD2;RELB;NRIP1;DICER1;CRK;RPL23;ZFPM1;IER2;EGR3;SOX4;TCF15;TNIP1;AEBP2;YEATS2;MED27;IKBKG;PCGF5;RNF4;CREB3L4;ZBTB10;MAMLD1;SMAD5;NFIB;SRCAP;POU2F1;SKIL;MAD2L2;GLYR1;CNOT1;UBE2D3;ZMIZ1;SP2;USF2;SMARCE1;GABPB1;SEMA4D;PHF20L1;SPEN;TFAP4;MC1R;KLF12;CEBPD;CNOT2;CSRNP1;CBFB;EID1;ASXL1;ACTR2;ENY2;ATF6;GLMP;PRDM2;SP3;GRIN1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.42045794540178194,1.2392248096063643,0.1566579634464752,0.6487275301429526,1.0,19/93,8.41%,CAV1;APP;PRKD1;CNKSR3;PRKD2;FNIP2;DDIT4;PDE4D;PPM1F;NCK1;STK4;SH2D3C;SMAD7;ATP2B4;INPP5K;BCAR3;TGFB1;RPTOR;SFRP2
prerank,cellular response to dsRNA (GO:0071359),0.5741124153690323,1.2390514715096457,0.2357142857142857,0.6483837048256713,1.0,5/15,14.08%,CAV1;RALB;CGAS;IFIH1;NPM1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3920752229191401,1.2387190395915058,0.11175785797438882,0.6484483960409785,1.0,32/199,8.68%,RPS6KA5;NOS3;PTPRG;HDAC9;BMPR2;NOVA2;MEF2C;IL15;DAB2IP;PAEP;EFNA1;NOTCH1;KLF7;RAB11FIP1;LAMA4;EVL;SOX9;RPS19;ID1;SMAD7;RAB11FIP5;N4BP1;ATP2B4;PGAM5;BTN2A2;WNT9B;SOST;TGFB1;SRGN;SFRP2;WWC2;PROCR
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.6120504356164506,1.2382141188341256,0.25636363636363635,0.6489843247067683,1.0,3/11,7.48%,NOVA2;IGF2BP3;RASA1
prerank,cellular component assembly (GO:0022607),0.3815963722624933,1.2378157656847224,0.09977324263038549,0.6492768008903681,1.0,43/253,11.68%,PARVB;SLC2A1;LCP1;SPTBN1;OCLN;EPS8;LIMS2;CD2AP;MAGI1;PARD3;NEDD9;FAS;PTK2B;SHROOM2;TRAF1;SHROOM1;CARD10;RHOJ;SOX9;PLS3;RAD21L1;NCKAP1;QSOX1;STX7;OPHN1;ABCA3;WNT5A;TEAD2;CD40;RAC1;RP1L1;TGFB1;TRIP13;SKAP2;LLGL1;NIFK;IKBKG;FSCN1;TFAP4;GAS6;ACD;CYFIP1;PICALM
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.5154433125622954,1.2377018669598792,0.22044728434504793,0.6487710566326856,1.0,7/29,9.32%,ENG;NOTCH1;S1PR1;FKBP1A;SMAD7;TGFB1;ZFPM1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.5162444481493729,1.237411036604126,0.233278955954323,0.648714857780494,1.0,10/24,15.49%,OCLN;WASF2;NCKAP1;RAC1;TWF2;FSCN1;ACTR2;CYFIP1;ACTR3;ARPC2
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.45407445715540956,1.2370104096914567,0.1816860465116279,0.6489825798285694,1.0,12/57,10.43%,IL6ST;IL15;IL6R;LYN;STAT3;GHR;CD40;STAP2;TNFRSF1A;NF2;IL23A;INPP5F
prerank,regulation of keratinocyte migration (GO:0051547),-0.5455046501113425,-1.2363572325128347,0.23076923076923078,0.6464931213219915,1.0,6/12,25.33%,IQSEC1;ADAM9;FGF7;FGF10;PTEN;MTOR
prerank,cellular response to retinoic acid (GO:0071300),0.4730992116856953,1.2361879518442704,0.19375,0.6504446241043116,1.0,12/42,11.17%,TBX1;FZD4;LYN;PTK2B;SOX9;RET;WNT5A;WNT9B;BRINP2;CREB1;TWF2;ABL2
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.45977695406763414,1.236156532229529,0.18556701030927836,0.6497259834783703,1.0,8/52,7.08%,PRKCH;EPB41;STX3;SPTBN1;NKD2;SORBS1;ATP2B4;ITGA3
prerank,natural killer cell activation (GO:0030101),0.5249703630922611,1.236147122201577,0.24675324675324675,0.6489281877551352,1.0,3/23,4.27%,PBX1;CASP8;TOX
prerank,muscle organ development (GO:0007517),-0.38014846139869457,-1.2360446265078686,0.16393442622950818,0.6456238515733884,1.0,14/54,7.27%,LAMA2;IGF1;DMD;SGCD;COL6A3;FHL1;VAMP5;LARGE1;SGCE;ITGA11;SOX6;EVC;SPEG;MKX
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.482351275496989,1.2360330212470065,0.19619326500732065,0.6484320124775201,1.0,9/39,8.44%,KDR;ENG;TIE1;RASIP1;LRP5;DLL4;PKD2;SFRP2;CITED1
prerank,positive regulation of protein import (GO:1904591),-0.4279041631271719,-1.235800881689992,0.16893732970027248,0.6446319399245629,1.0,11/30,22.78%,ZIC1;PRKCD;CDH1;SMAD3;MAVS;PIK3R2;TRIM28;UBR5;HDAC3;JUP;BAG3
prerank,sensory perception (GO:0007600),-0.3941632433050529,-1.2347414048978615,0.1423948220064725,0.645932473135594,1.0,9/45,10.22%,ADGRV1;P2RX4;GNAS;PCDH15;WHRN;PTGES;ADORA2A;RETREG1;TTC8
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6000346592299456,1.2343250925224332,0.2339688041594454,0.6523805351069027,1.0,3/12,7.31%,FOXP1;TIRAP;LPL
prerank,carbohydrate derivative transport (GO:1901264),0.5545698460141726,1.2340633534587728,0.2453151618398637,0.6523202908628759,1.0,5/18,12.83%,PLTP;SCARB1;SLC10A7;SLC15A2;ABCG1
prerank,negative regulation of protein catabolic process (GO:0042177),-0.4088775533247823,-1.2339779738315837,0.182370820668693,0.6463588201452114,1.0,15/40,22.41%,EGFR;TIMP3;SNRNP70;TIMP2;SIRT2;MDM4;CST3;RGP1;AZIN1;SNCA;CDK5RAP3;PTPN3;AGAP2;CYP51A1;BANP
prerank,C4-dicarboxylate transport (GO:0015740),-0.5148901265494038,-1.2336594299371648,0.2154566744730679,0.6455216638816059,1.0,10/14,31.38%,SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18;SLC25A14;SLC13A5;LRRC8D;SLC25A10;LRRC8E
prerank,regulation of response to cytokine stimulus (GO:0060759),0.5511504928656069,1.2329196022887405,0.24273504273504273,0.6547312357438422,1.0,8/19,20.47%,LIFR;WNT5A;CBFB;IFIH1;IRAK2;MAP2K5;PARP9;TAF9
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.5230405009816221,1.2326947440628038,0.21256038647342995,0.6545573932753467,1.0,5/25,12.23%,TNFSF10;BIK;BCL2L11;BNIP3;BID
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4367711403977308,1.2324060066470237,0.15984147952443858,0.6545012345923521,1.0,23/76,19.72%,DCUN1D3;CAV1;RASD2;FBXW7;FKBP1A;SMAD7;MYCBP2;XIAP;MALT1;TNIP1;UBE3A;BIRC3;SAE1;PRICKLE1;RIPK2;TRAF6;NDFIP2;BIRC2;CUL3;WDR48;PTTG1IP;UBE2L3;BCL10
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.43313645768845,1.2323313415697206,0.1865771812080537,0.6538978663675726,1.0,19/73,21.15%,LMO2;KITLG;GATA2;TAL1;TCF12;TCF3;PSMA2;PSMA8;PSMA6;CBFB;PSME1;PSMA4;METTL14;PSMF1;EIF2AK2;DHX36;PSMB1;PSMB7;PSMD2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.43169787388319053,1.2319446383575177,0.17670682730923695,0.6542106207097238,1.0,18/76,13.02%,CBFA2T3;SMURF1;RNF144B;FBXW7;NKD2;SMAD7;RNF144A;TRIB3;PTK2;RNF139;RAD23A;SUMO2;COP1;HECTD1;NOP53;PRICKLE1;RACK1;TRIB1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.46479998797695626,1.2318775833806055,0.18591549295774648,0.6535973096942828,1.0,6/46,3.60%,TEK;PARVB;PEAK1;EFNA1;SRGAP2;PXN
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5534753924737199,1.2317331145064183,0.2195540308747856,0.6531742867492463,1.0,3/17,7.65%,RAB27A;KCNB1;STX1A
prerank,positive regulation of interleukin-2 production (GO:0032743),0.518896345593314,1.2316932891677532,0.23294509151414308,0.65246036774673,1.0,5/25,8.38%,SPTBN1;PRKD2;PDE4D;PLCG2;MALT1
prerank,regulation of transforming growth factor beta production (GO:0071634),0.5683156643461016,1.231444152935864,0.23440134907251264,0.6523483960654347,1.0,4/18,3.88%,PTGS2;CD200;HIF1A;CD34
prerank,negative regulation of gene expression (GO:0010629),0.3786254900752947,1.2311704350939272,0.09409190371991247,0.6522797985507068,1.0,61/302,13.14%,RPS6KA5;NANOS3;HDAC9;KDR;ENG;ESR1;APP;MEF2C;ERN1;ACVRL1;CLDN5;OCLN;DAPK1;PDGFB;FOXP1;GATA2;ADAM10;FBXW7;HIF1A;NOTCH1;CD34;IGF2BP3;TMBIM6;PTBP3;EPC1;DLL4;NANOS2;N4BP1;ATP2B4;H3-3A;MTF2;TNRC6C;AURKA;BTN2A2;TASOR;PPM1D;TGFB1;SRGN;NFKB1;GRB7;RNF139;SFRP2;PSEN1;DICER1;NUDT16;AEBP2;BTG2;CNOT1;RPL13A;APLNR;PPHLN1;DCP2;MRPL13;PICALM;RB1;LGMN;XDH;RACK1;ZFP36;FMR1;CNOT7
prerank,positive regulation of phosphorylation (GO:0042327),0.38283556193865276,1.2310101838101848,0.10626398210290827,0.6519074650666281,1.0,42/240,8.99%,TEK;LIMCH1;PECAM1;FLT1;KDR;ENG;ITGA6;TBX1;TIE1;APP;PDE8A;EPHB4;INSR;VEGFC;LYN;FAS;EFNA1;HIF1A;PFKFB3;FLT4;FGF23;SOX9;STK4;LMTK2;RALB;SDCBP;ACVR2A;VEGFD;RET;LIMK2;CD40;RAC1;KRAS;ARRB1;TNIK;TGFB1;PTK2;NIBAN1;PSEN1;AKT2;ANG;DSCAM
prerank,regulation of ossification (GO:0030278),0.48903597495617596,1.2303858007335464,0.2237037037037037,0.6527996754191514,1.0,11/36,9.59%,BMPR2;MEF2C;ZBTB16;NOTCH1;S1PR1;SOX9;WNT5A;ACVR1;SOST;ANKH;CYP27B1
prerank,import into cell (GO:0098657),-0.4051859267415657,-1.2302921587316598,0.17275747508305647,0.6538047765570949,1.0,9/41,5.35%,ATP1A2;SLC6A13;SLC1A3;SLC47A1;GLUL;SLC22A4;SNAP25;SLC5A3;SLC39A14
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.47916967548241746,1.2301864779532325,0.22692889561270801,0.6526032672752721,1.0,8/39,7.94%,ACER2;NEXMIF;FZD4;NOTCH1;ACTN4;ADAM15;RASA1;NF2
prerank,superoxide anion generation (GO:0042554),-0.5192097930781074,-1.2300646837478035,0.21896162528216703,0.6526834039371748,1.0,6/13,24.16%,NOX4;ALOX12;CYBB;NOX1;NCF2;TAFA4
prerank,cellular calcium ion homeostasis (GO:0006874),-0.3265706419007404,-1.2299882310370736,0.06030150753768844,0.6511895850254715,1.0,23/133,10.92%,SLC24A3;ANK2;ATP13A5;ATP13A3;BCL2;SLC8A3;ATP1B1;SLC8A1;MCU;DMPK;SLC35G1;TRPC3;STIM1;PRKACA;TRPC6;ANXA6;TRPC1;ATP2A2;RYR2;SLC24A2;TRPC4;CXCL12;MICU1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.41089874485993594,1.2299079817737295,0.15452261306532664,0.6525827747074978,1.0,35/109,21.15%,NFATC1;PLCG1;LYN;PPP3CA;PLCG2;PAK2;IKBKB;MAPK8;PPP3CB;RAC1;NFKB1;PSMA2;MALT1;IKBKG;PSMA8;PSMA6;CUL1;RELA;TRAF6;PSME1;SOS1;LAT;CALM1;TAB3;MAP2K4;GRB2;PSMA4;PSMF1;PAK1;BCL10;PSMB1;MAP3K1;MAP2K7;PSMB7;PSMD2
prerank,canonical Wnt signaling pathway (GO:0060070),0.44296255263299045,1.229827475327543,0.1625,0.6520224157741475,1.0,10/68,6.47%,LEF1;CAV1;DIXDC1;FZD6;FZD4;LRP5;TCF7L1;TCF7L2;WNT5A;WNT9B
prerank,cell junction organization (GO:0034330),0.42774263633464366,1.2293389564722592,0.1715076071922545,0.6525289784118095,1.0,12/71,8.44%,TJP1;APBB2;APP;OCLN;PPFIBP1;LIMS2;TJP2;PPFIA2;OPHN1;TGFB1;AGRN;PSEN1
prerank,protein targeting to lysosome (GO:0006622),0.5274281652708049,1.2288435074345416,0.24310344827586206,0.6531119741928276,1.0,9/20,18.57%,NCOA4;GCC2;NEDD4;SCARB2;M6PR;GNPTAB;RAB7A;NAGPA;GGA3
prerank,synaptic vesicle transport (GO:0048489),0.6148338854965821,1.2278377130553004,0.23674242424242425,0.6550680884437257,1.0,1/11,0.41%,RAB27A
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5087517214085201,1.227421185777594,0.2317262830482115,0.6553649856025078,1.0,3/26,4.33%,CAV1;MFHAS1;TIRAP
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.46974616769725064,-1.2269646621079457,0.1957547169811321,0.657986164727549,1.0,7/21,10.16%,IGF1;BMPR1A;IGFBP5;GJA1;FGF2;ADAMTS1;MMP2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.4271458623482808,1.2265066188241005,0.16971279373368145,0.657103279016256,1.0,22/87,10.53%,ENG;ACVRL1;CLDN5;F11R;SMAD1;SMURF1;PARD3;NRROS;PXN;FKBP1A;ID1;SMAD7;PTPRK;USP15;DUSP22;ACVR1;TGFB1;PTK2;CITED1;SMAD5;ZMIZ1;CBL
prerank,positive regulation of filopodium assembly (GO:0051491),-0.4536420016614852,-1.2260169606047768,0.20572916666666666,0.6589502538467364,1.0,12/24,15.91%,DPYSL3;DOCK11;NRP1;RHOQ;TENM2;ARAP1;NLGN1;RIPOR2;TGFB3;PALM;PLPPR5;RALA
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.5693734053472653,1.2258028353037111,0.2617801047120419,0.6582665798993231,1.0,4/15,4.22%,SCARB1;FBXW7;SIK1;PLIN5
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.6101362254586865,1.2255098780263416,0.2504743833017078,0.658236782639581,1.0,2/10,6.11%,ESR1;ATF7IP
prerank,cell junction maintenance (GO:0034331),-0.5164444897769142,-1.2244998187018383,0.2243436754176611,0.6615304720897012,1.0,7/14,32.10%,NLGN2;CLDN1;MYADM;CHCHD10;DCTN1;PRTN3;PARD6A
prerank,regulation of MAPK cascade (GO:0043408),0.3955211454934486,1.2244519757406542,0.1354534746760895,0.6603340379884887,1.0,25/157,7.16%,TEK;FLT1;KDR;CAV1;TBX1;INSR;PDGFB;IQGAP1;DAB2IP;LYN;JCAD;FAS;PTPRJ;TAOK2;STK3;PLCG2;FLT4;CAV2;PAK2;STK4;CEACAM1;GREM1;RET;BCAR3;TNIK
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.4161838775771221,1.2242867918086233,0.17086092715231788,0.6599680492429684,1.0,15/88,10.60%,EXOC6;CLINT1;APP;EXOC6B;SCAMP1;DOP1B;ARRB1;AP2A1;EXOC5;AP1S2;LLGL1;PUM1;SNAP23;EXOC4;VAMP8
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.4224141530859474,1.2240631415990777,0.16205533596837945,0.6597709016434972,1.0,15/93,6.29%,APP;TNFRSF19;DAB2IP;MFHAS1;PTK2B;TPD52L1;TAOK2;PLCB1;TRAF1;FLT4;TIRAP;EDAR;SDCBP;DUSP22;SASH1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.5788516602374422,1.2237995350090338,0.2575187969924812,0.6597138074954901,1.0,3/13,12.89%,PTGS2;NAXE;SLC5A8
prerank,sphingolipid catabolic process (GO:0030149),0.5702739145095799,1.2231452216880891,0.24014336917562723,0.6607465007968267,1.0,3/15,5.59%,ACER2;ENPP2;ASAH2
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3553765257840041,1.2229190061132214,0.003,0.6605836151271258,1.0,240/1646,11.49%,MECOM;DACH2;ERG;LEF1;ELK3;FLI1;RPS6KA5;FOXO1;LHX6;EPAS1;CDK17;ATP8B1;CD38;TEAD4;HDAC9;DACH1;ZHX3;PBX1;ENG;TBX1;APBB2;SLC39A8;ESR1;SMARCA2;PPARD;TSHZ2;MEF2C;CBFA2T3;ZBTB16;TOX4;ACVRL1;SOX7;NR5A2;INSR;AHR;ETV6;SMAD1;ZIC3;LRRFIP1;NFATC1;PDGFB;IRF2;FOXP1;GATA2;MED13L;DAB2IP;ELF2;SOX13;MLLT3;FZD4;LRP5;HHEX;STAT3;TAL1;NR3C1;HIF1A;NOTCH1;EBF1;PPM1F;KLF7;RREB1;AFAP1L2;KLF8;PKNOX2;CCNK;KDM3A;SOX17;TGIF1;PITX1;CHD7;WWTR1;PLCB1;BAZ2B;ARID3B;ZFP57;TCF12;JMY;SOX18;TSHZ1;HMBOX1;MAFF;FOSL2;SOX9;TOX;ZNF292;ZBTB46;RPS6KA3;NCOA1;PKN1;FOXF1;KLF2;ELK4;FOXQ1;SCMH1;IKBKB;DTX3L;VGLL4;RPS6KA1;SP6;SBNO2;ZFP92;FOXL2;TCF7L1;ID1;LIN54;KMT2E;EPC1;SMAD7;PTPRK;TCF7L2;TCF4;SPIN1;ARID1B;PHF20;FOXF2;ATP2B4;HOXA10;MTF2;JMJD1C;LIN9;RET;WNT5A;RCOR1;PITX3;TEAD2;ESRRG;PPP3CB;KLF10;ATF7IP;CNBP;ACVR1;ATMIN;SKAP1;JUNB;BCL3;TOX3;TRIB3;FOXA3;ELF5;CDKN1B;FOSL1;DYRK1A;IRF2BPL;ASCC1;SOST;HNF1B;ETS2;INPP5K;ASCL4;LYL1;KLF13;ARRB1;HNRNPK;CHD1;SPDEF;TGFB1;FOXN2;TCF3;HOXD1;HOXD8;ZNF326;NFKB1;GMEB2;HNRNPD;GATAD2A;TGFA;PCBD2;MAMSTR;BACH2;KDM4C;ARID1A;POLA1;CTBP1;NEUROD1;CREM;SFRP2;KAT6B;PSEN1;CITED1;WWC2;NRL;CDT1;ZNF2;PHF6;CREB1;SUB1;FOXK1;SMARCA5;BRIP1;BACH1;BRD4;MAFB;PRDM8;CHD2;RELB;HINT1;CRK;MYBBP1A;EGR3;SOX4;TCF15;AEBP2;YEATS2;MED27;MAP2K3;EDRF1;PCGF5;RNF4;CREB3L4;ZBTB10;MAMLD1;SMAD5;NFIB;SRCAP;POU2F1;MAD2L2;FOXN3;ZMIZ1;SP2;CDK18;USF2;SMARCE1;PHF20L1;RBM15;SPEN;TFAP4;BTG1;MMS19;KLF12;GAS6;CEBPD;CNOT2;CSRNP1;CBFB;EID1;ENY2;ATF6;ZMYND11;PRDM2;SP3
prerank,mitochondrial fission (GO:0000266),0.5657208618628364,1.2226444296338168,0.2643884892086331,0.660564017323537,1.0,1/16,0.27%,DNM3
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.49134223809475897,1.2226152239072094,0.21428571428571427,0.6598372418800231,1.0,2/33,1.15%,PRKG1;MEF2C
prerank,positive regulation of T cell migration (GO:2000406),0.5474935550943684,1.2218773481630427,0.22483221476510068,0.6611078775449916,1.0,3/20,5.81%,APP;ADAM10;WNT5A
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.4364443633087583,-1.2216892649814826,0.17032967032967034,0.6677247580289835,1.0,6/27,9.63%,ANK2;CACNA1C;DLG1;ATP2A2;RYR2;CTNNA3
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.5126193284820487,-1.2215201548810737,0.2211764705882353,0.6664387551932692,1.0,4/14,4.07%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.3860242218304535,-1.2213319493074615,0.15868263473053892,0.6651910167315738,1.0,16/44,11.30%,LPAR1;ROCK2;PPM1E;ARHGEF10L;NRP1;CCN2;TGFBR1;ARHGEF10;TPM1;CARMIL1;SFRP1;FHOD1;RGCC;TGFB3;S100A10;PFN2
prerank,negative regulation of nuclear division (GO:0051784),-0.5433131062435059,-1.221106615922971,0.23529411764705882,0.6641307967782283,1.0,3/11,6.91%,BMP7;BMP4;TOM1L2
prerank,histone acetylation (GO:0016573),0.4324163020872463,1.2207992164321257,0.19478737997256515,0.6631495998255925,1.0,16/69,15.53%,LEF1;EPC1;PHF20;JADE2;JADE1;KAT6B;HAT1;JADE3;YEATS2;EP400;PHF20L1;KAT2B;MBIP;ZZZ3;KAT6A;TRIM16
prerank,nitrogen compound transport (GO:0071705),0.40020375673402037,1.2206381695019837,0.1316425120772947,0.662742289916,1.0,24/141,11.25%,CALCRL;ABCG2;CERT1;SLC6A2;MYH9;SEC14L1;SLC7A7;EDN1;SLC38A5;ATP11B;SLC3A2;SLC6A6;SCAMP1;RAMP2;CHMP2B;SLC43A2;SLC52A3;ARRDC1;SLC15A2;RAB38;SLC38A1;SCARB2;CD320;PICK1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.5167778666931006,1.2187715606056786,0.23076923076923078,0.6670686276825859,1.0,6/24,9.79%,HTR2A;PLCG2;LCK;PKD2;ITPR3;ERO1A
prerank,pyruvate metabolic process (GO:0006090),-0.3719030078046114,-1.2187097930663715,0.13564668769716087,0.6694468841572143,1.0,21/52,27.49%,ME1;ENO2;ME2;HK2;TPI1;LDHB;VDAC1;HOGA1;PDHA1;DLAT;ENO3;PFKFB1;PFKM;PCK2;NR4A3;HAGH;ALDOA;PKM;ENO1;ALDOC;LDHAL6B
prerank,positive regulation of phagocytosis (GO:0050766),0.46695733999597155,1.2186681280741056,0.19497784342688332,0.6665980471735304,1.0,4/47,2.87%,RAB27A;IL15;GATA2;PTPRJ
prerank,regulation of neuron apoptotic process (GO:0043523),-0.3379302784046853,-1.2183728249238093,0.1152073732718894,0.6685850044519694,1.0,23/96,12.11%,EPHA7;PRKN;BCL2;NUPR1;SLC30A10;NRBP2;PPARGC1A;NDNF;NTRK2;NGF;SIX1;TRIM2;NF1;EGLN3;SNX6;CPEB4;SRPK2;RETREG1;APOE;TGFB3;NFATC4;TGFB2;GRID2
prerank,neuron development (GO:0048666),0.4021474663018709,1.2181217101985469,0.16339066339066338,0.6673051226753863,1.0,19/141,7.73%,FRY;FRYL;PBX1;APP;UGCG;MEF2C;STX3;PTPRM;RAB11A;LYN;PPP1R9B;BICDL1;XBP1;OPHN1;ULK1;RAPGEF2;RP1L1;B4GALT5;NEDD4
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.46990264628629075,-1.2177806131705768,0.21323529411764705,0.6685987844127449,1.0,7/19,12.48%,RENBP;PGM3;NAGK;GFPT1;UGP2;GFPT2;GNPDA1
prerank,lipoprotein biosynthetic process (GO:0042158),0.594677219873307,1.21732650247503,0.27461139896373055,0.6685588828425697,1.0,1/11,1.07%,UGCG
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5642125959942874,1.2167402135634096,0.25396825396825395,0.6693944211046514,1.0,4/16,15.51%,DLL1;JAK3;IL23A;VSIR
prerank,endothelial cell migration (GO:0043542),0.47550313079539797,1.2165700632422038,0.2161339421613394,0.6690481011600891,1.0,8/37,5.04%,NOS3;MYH9;ADGRA2;PLXND1;PXN;SOX18;PLEKHG5;ID1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.42632929580405643,1.2162254552000116,0.18488529014844804,0.6691911099862534,1.0,16/83,12.27%,CDK17;CDK6;EIF4E;PLK2;ACVR1;CDKN1B;POLA1;CDT1;BACH1;BRD4;CDK2;CDK18;CUL1;EIF4EBP1;RB1;MAX
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.3719023026783993,-1.2161897757995523,0.13666666666666666,0.6715914233266952,1.0,11/57,8.20%,LPAR1;ADCY5;ADCY1;ADCY2;AKAP12;GRM7;ADCY7;ADCY6;PSAP;GNAI1;ADRA2A
prerank,metal ion homeostasis (GO:0055065),0.4712935609506599,1.2159860556466362,0.20474777448071216,0.669053351351056,1.0,7/40,11.51%,TMTC2;CAV1;SLC12A7;TRPV6;SLC12A9;CYP27B1;GRIN1
prerank,alpha-amino acid metabolic process (GO:1901605),-0.38886445670337655,-1.215830190767439,0.14414414414414414,0.670797355807159,1.0,13/45,13.71%,GLUL;ASPA;NOX4;NAALAD2;SLC25A12;GPT2;ASPG;GOT1;MTHFD1;RIMKLA;OAT;SLC25A13;CBS
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4413458255843684,1.2152340607387122,0.19775596072931276,0.6703151173716212,1.0,13/62,11.15%,MEF2C;ZBTB16;CDK6;LYN;PTK2B;KMT2E;H3-3A;TNRC6C;MAFB;ZFPM1;RBM15;EIF6;CBFB
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.5153655597243784,-1.2151079064510264,0.23318385650224216,0.6712279334617065,1.0,5/13,12.66%,IRS1;IGF2;PRKCZ;ECHDC3;SNX5
prerank,cellular response to superoxide (GO:0071451),0.6181648762941854,1.2149385955851673,0.27450980392156865,0.6703231240626315,1.0,1/10,0.33%,NOS3
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.5440549070009528,-1.2149061340165093,0.257847533632287,0.6701239426455414,1.0,2/10,6.91%,IL18;PRKCZ
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.5110793557225868,1.214727361000262,0.22596153846153846,0.6700880265161974,1.0,6/23,8.06%,PIEZO1;MEF2C;EDN1;GREM1;TGFB1;ATP11A
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.44709703309466375,1.2147130282767817,0.2,0.6693203392644783,1.0,2/53,1.96%,CALCRL;HTR2A
prerank,Notch signaling pathway (GO:0007219),0.4434171951096591,1.2145185551049578,0.20689655172413793,0.6690294915052055,1.0,17/59,15.00%,SORBS2;PBX1;MAML2;ADAM10;PLXND1;NOTCH1;DLL1;DTX3L;DLL4;PSEN1;JAG2;APH1A;ADAM17;ZNF423;SNW1;KAT2B;YBX1
prerank,protein neddylation (GO:0045116),0.5733199563252566,1.2144984737026348,0.26223776223776224,0.668291104494226,1.0,2/13,7.38%,DCUN1D3;RNF7
prerank,anterograde axonal transport (GO:0008089),-0.4114929862172249,-1.2144891686157677,0.17073170731707318,0.6696044180067328,1.0,17/37,28.76%,DLG2;KIF3A;KIF1A;KIF5C;RAB27B;AP3D1;DTNBP1;KIF1B;TRAK1;HSPB1;KIF5A;RAB21;SNAPIN;MAP1A;SPAST;BLOC1S4;AP3B2
prerank,regulation of fatty acid oxidation (GO:0046320),-0.49559943914375126,-1.213546054254917,0.22695035460992907,0.6705201020635101,1.0,4/16,5.85%,APPL2;PPARA;PPARGC1A;PRKAG2
prerank,response to interferon-beta (GO:0035456),0.5249953489952914,1.21335777260219,0.25,0.6707045699629318,1.0,11/22,19.14%,AIM2;IFNAR2;UBE2K;IFITM3;IRGM;PNPT1;STAT1;CDC34;PLSCR1;BST2;IFITM1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.45983482058452124,1.2127076644736992,0.22021116138763197,0.671696076894926,1.0,14/44,18.99%,NANOS3;NANOS2;TNRC6C;PRR5L;PUM1;BTG2;CNOT1;RC3H1;ZFP36;CNOT7;ZFP36L1;PNPT1;METTL14;DHX36
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.4016192841406453,1.212649630852859,0.18741976893453144,0.6710753469671467,1.0,30/121,11.65%,PECAM1;IL6ST;IL15;PDGFB;NEDD9;IL6R;ARHGEF2;LYN;STAT3;EFNA1;PTK2B;PTPRJ;PLCG2;PAK2;GHR;GREM1;ENPP2;CD40;ACVR1;STAP2;TNFRSF1A;TGFB1;ITGA5;PTPN1;IL23A;FCGR1A;SEMA4D;GAS6;EPHA4;ITGB3
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5529674736346653,1.212638267092223,0.24193548387096775,0.6703119372604152,1.0,4/14,5.29%,MMRN2;NOTCH1;CARD10;DLL4
prerank,fatty acid biosynthetic process (GO:0006633),0.43457136772849325,1.212441995068739,0.18907563025210083,0.670055490995258,1.0,10/63,12.13%,ELOVL7;PTGS2;ABHD2;ELOVL5;XBP1;ASAH2;LPL;LTC4S;DEGS1;ABCD1
prerank,positive regulation of T cell differentiation (GO:0045582),0.4748830715613347,1.2121373863595197,0.21996879875195008,0.6700798257613041,1.0,8/36,10.63%,LEF1;XBP1;TESPA1;IHH;SOX4;IL23A;ZMIZ1;IL7
prerank,negative regulation of phosphorylation (GO:0042326),-0.34490282816350426,-1.2119359425754954,0.14741035856573706,0.6735320127727145,1.0,13/85,4.33%,PID1;PTPN13;NTRK3;PLPP3;PRKN;BMP7;FBLN1;NUPR1;HDAC4;PPARA;BMP4;IGFBP3;IMPACT
prerank,membrane repolarization (GO:0086009),-0.49813464044794087,-1.211866937459994,0.23595505617977527,0.6720021529508146,1.0,5/15,9.89%,ATP1A2;ATP1B1;KCND3;KCNJ2;ATP1B2
prerank,positive regulation of response to external stimulus (GO:0032103),0.3968300369634211,1.2115201345378575,0.17039800995024876,0.6709882190654738,1.0,24/128,11.77%,APP;IL15;STX3;PDGFB;PDE2A;GBP5;NFKBIZ;PPM1F;NFKBIA;SCARF1;USP15;WNT5A;SASH1;TNFRSF1A;TGFB1;LPL;PUM1;TNIP1;IL23A;NMI;P2RY12;OASL;PUM2;RIPK1
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5267498387012803,-1.2111706570042982,0.23880597014925373,0.6722827370708563,1.0,5/12,11.10%,NBL1;BMP5;CCN3;SLIT2;MIA3
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.49382485264723935,1.210982466752481,0.23885350318471338,0.6716038268000076,1.0,5/29,5.73%,ELOVL7;ACSL4;FASN;ELOVL5;ACSL5
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.3652107642585412,-1.210614668558306,0.14285714285714285,0.6722050867472279,1.0,8/61,4.80%,EYA2;EGFR;EYA1;PDGFRB;EYA4;SMOC2;FGF2;PARP3
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3772019389382577,1.2088424194485228,0.13008130081300814,0.6764231102598955,1.0,27/214,7.67%,SEMA6A;TEK;KDR;APP;PDE8A;ICAM1;SEMA7A;CNKSR3;PDGFB;HTR2A;DAB2IP;LYN;PRKD2;MFHAS1;PTK2B;PDGFD;FBXW7;NOTCH1;FLT4;TIRAP;ARHGAP8;CEACAM1;RAPGEF2;ARRB1;TGFB1;PDGFC;RAP1A
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.4291661892255419,1.2078554932502215,0.2,0.6783449947105876,1.0,14/72,8.27%,TEK;FLT1;KDR;INSR;PDGFB;LYN;PDGFD;SELP;SOX9;PDGFC;PTK2;PIK3CG;NEDD4;GAB1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.45810326672679846,-1.2078242537222785,0.20963855421686747,0.6784570747358807,1.0,11/22,26.40%,TIMP3;TIMP2;ADRA2A;APOE;ADAM9;GPLD1;PTPN3;PACSIN3;SNX33;NRDC;TIMP1
prerank,acylglycerol catabolic process (GO:0046464),0.4957968140992263,1.2070387169944765,0.21746031746031746,0.6797656952668023,1.0,6/30,15.52%,ABHD2;LIPE;LPL;FABP12;PNPLA2;FAAH
prerank,icosanoid metabolic process (GO:0006690),0.47330602345627826,1.2067714736324138,0.23076923076923078,0.6797181694196865,1.0,7/40,8.78%,PTGS2;PLA2G4A;PTGS1;ALOX5AP;EPHX1;PON2;LTC4S
prerank,glycine transport (GO:0015816),0.6402054345366416,1.2065786974149229,0.28832116788321166,0.6794383663947934,1.0,2/10,2.69%,SLC6A5;SLC38A5
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.5256645799517635,1.2063453384305294,0.2504145936981758,0.6792672926938661,1.0,8/21,14.87%,MYH9;ADAM10;SPPL2A;ERAP1;PSEN1;APH1A;ADAM17;SPPL3
prerank,triglyceride catabolic process (GO:0019433),0.5271460901074604,1.2063450324263418,0.24493243243243243,0.6784759087824708,1.0,3/19,14.02%,LPL;FABP12;PNPLA2
prerank,negative regulation of receptor internalization (GO:0002091),0.5826535191760127,1.2063341919798372,0.28186714542190305,0.6777170013087478,1.0,3/12,4.77%,ANKRD13A;RIN3;SDCBP
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.4495040792392516,1.2063173932087383,0.22043795620437956,0.6769806661116531,1.0,8/52,7.19%,PRKCH;STX3;SPTBN1;NKD2;SORBS1;ATP2B4;ITGA3;ATP2C1
prerank,regulation of intracellular protein transport (GO:0033157),0.4949716518582637,1.2062139932862317,0.22906793048973143,0.6764770805762889,1.0,10/32,15.60%,PTPN14;LCP1;PRR5L;PCNT;TGFB1;GCC2;PTPN1;UHMK1;NDEL1;CEP290
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.5557204055564602,-1.206027506787574,0.2711864406779661,0.681962666602372,1.0,5/10,25.33%,IQSEC1;ADAM9;FGF7;FGF10;MTOR
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.41656586252151995,-1.2059187759834955,0.2,0.6805488511417873,1.0,9/32,5.68%,SDC2;HECW2;ADGRB3;OBSL1;CUX2;PTPRD;CAPRIN2;IL1RAPL1;CUX1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.5580917568624708,1.2058160312181603,0.25087719298245614,0.6767817455242987,1.0,7/16,22.68%,INSR;BNIP3;IGF1R;IRAK3;GLE1;TBC1D25;HDAC6
prerank,regulation of activated T cell proliferation (GO:0046006),-0.42003355121044217,-1.205787622767804,0.2131578947368421,0.6791929791661717,1.0,4/30,5.09%,IGF1;IGFBP2;IL18;IGF2
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.4085354141513456,-1.2057264423296767,0.19101123595505617,0.6776643540692153,1.0,9/34,12.38%,ANK2;ATP1B1;SLC8A1;P2RX4;PRKACA;ATP2A2;RYR2;ADRA1A;SLC9A1
prerank,negative regulation of myoblast differentiation (GO:0045662),0.572147473831124,1.2052299735593488,0.2722602739726027,0.6775784151635149,1.0,5/13,12.65%,NOTCH1;SOX9;DLL1;TGFB1;PRICKLE1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.47631287651482096,1.2050035676738504,0.2353846153846154,0.6774072297884899,1.0,11/35,13.39%,ESR1;PLPP1;NR3C1;KDM3A;DDX54;NCOA4;NEDD4;ARID1A;ZMIZ1;UBE3A;PMEPA1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.4470870357876813,1.205001067058761,0.20232896652110627,0.6766244104028875,1.0,24/59,22.62%,DAB2IP;NFKBIA;IKBKB;BCL3;TNFRSF1A;RELB;IKBKG;RIPK1;BIRC3;RELA;RIPK2;TRAF6;NKIRAS1;ERC1;TBKBP1;TAB3;BIRC2;TIFA;IRAK2;REL;BCL10;NLRC3;TANK;TRAF2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.43510561300068246,1.2048255614229626,0.21551724137931033,0.6763125273885949,1.0,12/60,12.24%,LEF1;SOX9;TCF7L2;TNRC6C;ATF7IP;HNF1B;PPM1D;NFKB1;SUB1;MED27;CBFB;RELA
prerank,protein acetylation (GO:0006473),0.4881137750919219,1.2038860122795607,0.2224025974025974,0.6781269909628402,1.0,6/30,15.39%,FOXO1;HAT1;NAA11;KAT2B;KAT6A;NAA16
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.5803427379451451,1.2036086085618893,0.26788990825688075,0.6780832803647954,1.0,3/13,3.02%,PTGS2;SOX13;RREB1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.5045512625607274,1.2034065013913218,0.24328859060402686,0.6778434637292603,1.0,2/24,2.95%,ABCG2;ALAS1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5645389969755432,1.2032821385012828,0.2746858168761221,0.6773779740854781,1.0,5/13,12.24%,PPARD;PDGFB;SOX9;NFIB;RELA
prerank,regulation of interleukin-1 production (GO:0032652),0.5507916360202005,1.2031629974401037,0.2677966101694915,0.6769244298496726,1.0,3/15,11.07%,FOXP1;CEACAM1;GAS6
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.47657026095630695,1.2030058714436362,0.237741456166419,0.6765310691262024,1.0,7/35,8.27%,CAV1;NOTCH1;JAK3;GHR;BCL3;NF2;PIGU
prerank,cardiac ventricle development (GO:0003231),0.5221442393643972,1.2024737077677552,0.25375626043405675,0.6772031528017913,1.0,4/20,5.29%,ENG;PDE2A;NOTCH1;DLL4
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3527608444412477,1.2024639274290303,0.05141129032258065,0.6764479049413954,1.0,136/807,13.14%,MECOM;LEF1;ELK3;RPS6KA5;FOXO1;ATP8B1;CD38;HDAC9;DACH1;ZHX3;LDB2;CAV1;ESR1;SMARCA2;PPARD;MEF2C;CBFA2T3;ZBTB16;SOX7;AHR;ETV6;LRRFIP1;PDGFB;IRF2;FOXP1;DAB2IP;SOX13;EDN1;HHEX;PDE2A;STAT3;NEDD4L;EFNA1;NR3C1;FNIP2;NOTCH1;PPM1F;KLF7;RREB1;KLF8;TGIF1;PLCB1;ZFP57;SOX18;HMBOX1;RIPPLY3;SOX9;KLF2;ELK4;RPS14;SDCBP;SCMH1;MCPH1;VGLL4;SBNO2;FOXL2;ID1;EPC1;SMAD7;PTPRK;TCF7L2;DLL4;MTF2;WNT5A;RCOR1;KLF10;ATF7IP;CNBP;DUSP22;BCL3;TRIB3;NR1I3;FBP1;CDKN1B;IRF2BPL;ETS2;INPP5K;SPDEF;TGFB1;TCF3;NFKB1;GATAD2A;CTBP1;CREM;SFRP2;KAT6B;PSEN1;CITED1;WWC2;PHF6;TAF3;EZH1;CREB1;FOXK1;BACH1;NRIP1;DICER1;RPL23;ZFPM1;MYBBP1A;YEATS2;POU2F1;SKIL;MAD2L2;FOXN3;CNOT1;UBE2D3;SP2;SMARCE1;SEMA4D;RBM15;SPEN;TFAP4;KLF12;GAS6;CNOT2;CBFB;EID1;ZMYND11;PRDM2;SP3;RB1;DCAF1;SAMD1;MIER1;RELA;MUC1;MAX;SIRT6;NOP53;PRICKLE1;PA2G4;ZFP36;MIDEAS;RPL10;CNOT7
prerank,positive regulation of heart rate (GO:0010460),0.5485336282980504,1.2023663130734785,0.27241379310344827,0.6759602125895933,1.0,4/17,4.10%,EDN1;KCNQ1;PDE4D;ADRB1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.41917947265426914,1.2021580401613454,0.18518518518518517,0.6757307481681886,1.0,12/78,7.19%,PRKCH;ABI3;STX3;SPTBN1;PPP2R5A;NKD2;NUMB;SORBS1;STX7;ATP2B4;ITGA3;TGFB1
prerank,artery development (GO:0060840),0.5140608345837633,1.201995103979536,0.2525083612040134,0.675390199078334,1.0,7/23,7.67%,BMPR2;ENG;TBX1;ACVRL1;PDE2A;SMAD7;PKD2
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.5748801631319184,1.201986166874891,0.2943327239488117,0.6746356682335058,1.0,5/13,12.97%,NOTCH1;CPE;FOXF1;SFRP2;TGFBR2
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.4911946298504387,1.2018096091994028,0.2222222222222222,0.6743737730597184,1.0,4/29,5.25%,LEF1;TLE4;TCF7L1;TCF7L2
prerank,heme biosynthetic process (GO:0006783),0.512090967026448,1.2017042732888996,0.2354948805460751,0.6738828425159307,1.0,2/22,2.95%,ABCG2;ALAS1
prerank,carboxylic acid catabolic process (GO:0046395),-0.519523115672231,-1.2016131794755875,0.25877192982456143,0.6877214800123,1.0,4/12,12.86%,RENBP;NAGK;GNPDA1;PON3
prerank,lymphocyte migration (GO:0072676),0.4929398260930977,1.2014908087746614,0.23937007874015748,0.6736892977185452,1.0,4/32,10.48%,MSN;S1PR1;RET;CCL14
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.4218251721524402,1.2004810286284795,0.21282401091405184,0.6755963669902767,1.0,20/75,14.67%,HEG1;RASIP1;DAB2IP;LRP5;HHEX;LYN;PTPRJ;PRKAR2B;PKIG;CDKN1B;INPP5K;PTPN1;TFAP4;STK38;RB1;GSTP1;INCA1;DUSP7;APC;IRAK3
prerank,small GTPase mediated signal transduction (GO:0007264),0.40514005376607726,1.2002810548498077,0.1867704280155642,0.6753858232325242,1.0,22/103,10.43%,ARHGAP31;RAPGEF5;NTN1;PRKD1;BCR;GNB1;RREB1;GRAP;RASGRP3;RALB;PLK2;CCDC88A;RAC1;RAPGEF2;NRAS;KRAS;SHOC2;RAB38;CDK2;G3BP1;MAPK11;RGL2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.41962794667519615,1.1999260988148608,0.2143845089903181,0.6755174523261356,1.0,11/69,9.76%,APP;ARHGEF2;STAT3;PTPRJ;PLCG2;TIRAP;WNT5A;LPL;PSEN1;TNFRSF8;IL23A
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.5068798382041283,1.1997751987734064,0.246875,0.6751849833393045,1.0,4/29,8.63%,PLA2G4A;LPCAT3;PLA2G2D;PLAAT3
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.4993527330614468,1.1996764968795346,0.2688,0.6746441974569302,1.0,6/26,13.06%,ADIPOR2;ELOVL5;CEACAM1;TRIB3;EIF6;ADIPOR1
prerank,keratinocyte differentiation (GO:0030216),0.4915373238775423,1.1995431181291898,0.2520193861066236,0.6742517641362237,1.0,7/29,14.36%,UGCG;BCR;EXPH5;WNT5A;CLIC4;TXNIP;ASAH1
prerank,epithelial cell differentiation (GO:0030855),-0.33823828196540356,-1.198859040484524,0.14084507042253522,0.6941953368917841,1.0,18/88,12.94%,FSTL1;MAF;FGFR2;BMP4;ERBB4;SCUBE1;ANXA1;SIX1;JAG1;DAB2;BDH2;GLI1;VEGFA;TAGLN;ANXA4;RAB10;FZD7;VDAC1
prerank,organophosphate ester transport (GO:0015748),0.4995444126303657,1.1987137605129938,0.25127334465195245,0.6757446984200008,1.0,4/24,5.80%,PLTP;SCARB1;PRELID2;ABCA3
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.4968644112156388,1.1986971690206798,0.24875621890547264,0.6750204247725328,1.0,4/29,5.73%,TNFSF10;CAV1;PAK2;RET
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.5922813219574827,1.198484205439614,0.289048473967684,0.6747991787218826,1.0,3/12,5.58%,SEMA6A;DAB2IP;ATP2B4
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5867167873861815,1.1978831041479636,0.28832116788321166,0.6756509723367764,1.0,3/10,4.24%,TBX1;LRP5;SOX9
prerank,regulation of protein phosphorylation (GO:0001932),0.3723770321731028,1.1976938091406462,0.1401766004415011,0.6754106370094582,1.0,43/256,8.92%,TEK;LIMCH1;PECAM1;KDR;ENG;TBX1;APP;PDE8A;OCLN;INSR;VEGFC;PPP2R5A;DAB2IP;LYN;FAS;EFNA1;FNIP2;BST1;FYN;WWTR1;FLT4;FGF23;SOX9;STK4;RALB;ACVR2A;VEGFD;LIMK2;CCDC88A;CD40;PRR5L;RAC1;KRAS;INPP5K;ARRB1;TNIK;TGFB1;PTK2;NIBAN1;PPP2R5E;PPP2R5B;AKT2;BRD4
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3770985231721369,1.1974594785291595,0.14651162790697675,0.6752733757687898,1.0,40/208,12.71%,NOD1;TNFSF10;ESR1;TNFRSF19;PRKD1;DAB2IP;TRIM14;CASP8;FKBP1A;TRAF1;PLCG2;PLEKHG5;TIRAP;EDAR;IKBKB;TRIM68;PELI1;PLK2;WNT5A;CD40;MID2;TNFRSF1A;ATP2C1;NEK6;CASP1;MAP3K3;TRIM25;MALT1;BRD4;TNIP1;IKBKG;ZMYND11;IRAK4;RIPK1;BIRC3;CARD16;MIER1;RELA;RIPK2;GSTP1
prerank,protein N-linked glycosylation (GO:0006487),0.4274429295183854,1.1968616286802642,0.2111888111888112,0.6761594486694671,1.0,5/66,1.66%,ST6GAL1;SLC39A8;ST3GAL1;MGAT4A;STT3B
prerank,positive regulation of transferase activity (GO:0051347),0.39210607176071516,1.1968472760159612,0.1687192118226601,0.675434868276052,1.0,21/142,7.80%,TEK;FLT1;KDR;DCUN1D3;TIE1;EPHB4;CD200;INSR;NEK7;SERINC5;FBXW7;FLT4;HMBOX1;LMTK2;DTX3L;GREM1;RET;TRIB3;TGFB1;WRAP53;HNRNPD
prerank,blood vessel diameter maintenance (GO:0097746),0.4694775355276896,1.1966045456489707,0.2391304347826087,0.67532270697465,1.0,5/34,5.43%,NOS3;EDN1;NPR1;KLF2;KCNMB4
prerank,glycerophospholipid metabolic process (GO:0006650),0.421217783846206,1.1965628833125936,0.21052631578947367,0.674667556155206,1.0,19/75,17.73%,GPCPD1;PLA2G4A;PLCG1;SERINC5;PLCB1;DGKH;ENPP6;ABCA3;PLA2G2D;SYNJ1;PDXP;GDPD1;PIGQ;PIGG;PNPLA6;PIGF;SERINC1;PIGL;PIGC
prerank,chondrocyte differentiation (GO:0002062),-0.4085664332028229,-1.196522961548396,0.2222222222222222,0.6993044345650975,1.0,9/32,5.80%,SOX5;SULF1;OSR1;SULF2;BMP4;SOX6;RUNX2;SLC39A14;CCN3
prerank,inositol phosphate-mediated signaling (GO:0048016),0.5182426751623314,1.196004263699222,0.26812816188870153,0.6754730014154845,1.0,5/19,10.32%,NFATC1;EDN1;PPP3CA;PPP3CB;NMUR2
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.4924746608958663,1.1950301911565748,0.2176,0.6773384696591531,1.0,6/25,10.53%,HIP1;HIP1R;AFAP1L2;CCDC88A;BCAR3;CBL
prerank,axon development (GO:0061564),-0.3453769487280397,-1.1949698476473076,0.14339622641509434,0.7023386707237004,1.0,20/78,11.84%,DOCK7;FGFR2;SEMA5A;GRM7;BRSK1;PLP1;S100A6;ANK3;SHTN1;RYK;NTNG1;S100B;CTNNA2;DCC;NRCAM;CNTN4;GAP43;BAIAP2;NREP;RAB10
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.49590533439722073,-1.1949005779424189,0.24819277108433735,0.7007600165310959,1.0,7/16,28.57%,LRP1;APOE;MYOCD;ABCA7;CYP51A1;HMGCR;TREM2
prerank,regulation of response to biotic stimulus (GO:0002831),0.49740549804716877,1.1949001275783733,0.2681744749596123,0.6769510529371376,1.0,11/28,17.24%,FOXP1;SAMHD1;CASP8;TIRAP;N4BP1;XIAP;ERAP1;BIRC3;ZMPSTE24;BIRC2;ELMOD2
prerank,rRNA 3'-end processing (GO:0031125),-0.5428836099127149,-1.194721020492819,0.2472885032537961,0.699533984197605,1.0,4/10,19.09%,ERI3;EXOSC7;EXOSC3;EXOSC9
prerank,negative regulation of metabolic process (GO:0009892),-0.3685779720829437,-1.1944901879876841,0.16896551724137931,0.6984859925692166,1.0,10/54,7.33%,PLCL1;ALDH1A1;DOCK7;LGR4;NPR3;ADAMTS5;FOXC2;ACOT11;NOVA1;RBPJ
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.44030404431947845,1.194364923531976,0.22644163150492264,0.6776788546068613,1.0,19/54,16.88%,CASP4;CASP8;TRAF1;SPPL2A;IKBKB;HIPK1;TNFRSF1A;CASP1;IKBKG;GAS6;RIPK1;BIRC3;CARD16;GSTP1;RACK1;ADAM17;UBE2K;OTULIN;BIRC2
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.3409704747383279,-1.1941360178212488,0.1590909090909091,0.6978178478364356,1.0,23/80,17.63%,PLPP3;ATP9A;KIF3C;KIF3A;COPB1;COPZ2;COPG1;KDELR3;COPA;ERGIC1;TMED9;GBF1;ERGIC2;ARFGAP1;HTT;ARCN1;BICD2;KIFAP3;KLC1;GOLPH3L;ARFGAP2;KIF5A;SCFD1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5840561694430695,1.194037038796876,0.29924242424242425,0.6777901407446197,1.0,3/10,11.77%,PDE8A;STK26;RIPK1
prerank,cellular response to hexose stimulus (GO:0071331),0.5090489904438262,1.1938232733402112,0.26360544217687076,0.677598150235418,1.0,8/23,14.39%,UNC13B;ERN1;KCNB1;XBP1;SOX4;GAS6;RACK1;IGF1R
prerank,cellular response to osmotic stress (GO:0071470),0.526290383202727,1.193413349209078,0.2724252491694352,0.6779514347150613,1.0,6/21,14.46%,ARHGEF2;PKD2;TRPV4;YBX3;MYLK;ZFP36L1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.3733784500215023,-1.193366296660936,0.17275747508305647,0.6983957798222205,1.0,16/51,11.30%,LPAR1;ROCK2;PPM1E;ARHGEF10L;NRP1;CCN2;TGFBR1;ARHGEF10;TPM1;CARMIL1;SFRP1;FHOD1;RGCC;TGFB3;S100A10;PFN2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.3344431661879465,-1.1933396092409665,0.13636363636363635,0.6967654276804355,1.0,25/86,14.23%,BMP6;SULF1;ZEB2;BMPR1A;FOXD1;BMP5;BMP7;TGFBR1;BMP4;THBS1;TWSG1;CCN1;RBPJ;DAB2;TGFB1I1;HIPK2;INHBA;SLC2A10;TGFB3;TGFB2;NUP93;ACVR1B;GDF11;GDF1;CITED2
prerank,nuclear membrane disassembly (GO:0051081),-0.49606561020557416,-1.193237775012638,0.25740318906605925,0.69537832328118,1.0,5/14,13.32%,PRKCB;LPIN1;PRKCA;AKAP8L;CNEP1R1
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5529646196549037,1.1929488914185404,0.2804878048780488,0.678379527460038,1.0,2/13,2.89%,CAV1;PDE4D
prerank,sterol homeostasis (GO:0055092),0.4247743907417946,1.1928168686872256,0.20567375886524822,0.6779761043657694,1.0,13/65,12.83%,HDAC9;CAV1;SCARB1;LRP5;MALL;XBP1;CNBP;LPL;SOAT2;CYP39A1;ABCD1;LIMA1;ABCG1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.37505633279047923,-1.1925814936520602,0.17846153846153845,0.6956473403477322,1.0,10/46,4.87%,IGF1;PDGFRB;OGN;IGFBP5;IL18;BMP4;CDH13;THBS1;IGFBP3;APOD
prerank,regulation of cellular biosynthetic process (GO:0031326),0.49085544704254264,1.191767015061308,0.2360248447204969,0.6800195978388663,1.0,8/28,13.06%,ADIPOR2;TNFRSF1B;CX3CR1;RAC1;NOS1AP;SIRT5;EIF6;ADIPOR1
prerank,Fc receptor signaling pathway (GO:0038093),0.3966030262440025,1.191629917731091,0.18952618453865336,0.6796395966508798,1.0,35/110,21.15%,NFATC1;PLCG1;LYN;PPP3CA;PLCG2;PAK2;IKBKB;MAPK8;PPP3CB;RAC1;NFKB1;PSMA2;MALT1;IKBKG;PSMA8;PSMA6;CUL1;RELA;TRAF6;PSME1;SOS1;LAT;CALM1;TAB3;MAP2K4;GRB2;PSMA4;PSMF1;PAK1;BCL10;PSMB1;MAP3K1;MAP2K7;PSMB7;PSMD2
prerank,regulation of cytoplasmic translation (GO:2000765),-0.4993000896403793,-1.191546817358044,0.25617977528089886,0.6971389766970503,1.0,4/14,7.23%,CPEB1;CPEB2;CPEB3;CPEB4
prerank,positive regulation of insulin secretion (GO:0032024),0.47977634915061007,1.191170509281087,0.25223880597014925,0.6801415167848002,1.0,4/36,6.02%,MYRIP;ACSL4;TCF7L2;PPP3CB
prerank,regulation of myelination (GO:0031641),0.49630347215263754,1.1911598575739302,0.25955414012738853,0.6794245124505555,1.0,5/25,9.21%,JAM2;PARD3;TNFRSF1B;TMEM98;DICER1
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.4637260394373032,-1.191066324787445,0.23809523809523808,0.696946477080386,1.0,3/19,3.51%,CAMK1D;IL34;THBS1
prerank,sodium ion export across plasma membrane (GO:0036376),-0.49382964506191773,-1.1908664330562615,0.2565789473684211,0.695823127078149,1.0,4/13,12.38%,ATP1A2;ATP1B1;ATP1B2;SLC9A1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.4121678688025573,1.1900208089150874,0.19385026737967914,0.6817104323803085,1.0,20/85,13.02%,CBFA2T3;RNF144B;ECSCR;DAB2IP;FBXW7;NKD2;SMAD7;RNF144A;TRIB3;ATXN3;KCNE2;RAD23A;SUMO2;COP1;HECTD1;NOP53;PRICKLE1;RACK1;FMR1;TRIB1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.44903234985297996,-1.1898207129670288,0.23002421307506055,0.6971883912208817,1.0,9/21,19.99%,DCDC2;EVC;ARMC9;GLI1;SFRP1;SMO;KIF7;ULK3;GAS8
prerank,multivesicular body assembly (GO:0036258),0.47143209212555215,1.1897826548635713,0.25,0.6815587327670272,1.0,14/30,25.40%,RAB11A;CHMP2B;CHMP4A;CHMP4B;VPS28;VPS37C;STAM;VTA1;TSG101;VPS36;STAM2;PDCD6IP;CHMP3;VPS25
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3972539407819256,1.1896443054783752,0.21098626716604243,0.6811964180707423,1.0,21/118,7.73%,SHANK3;ABI3;TBX1;LFNG;MEF2C;NEDD4L;ADGRA2;PLXND1;LZTS1;PPFIA2;FLT4;PAK2;CDH2;DLL1;TSPAN12;CEACAM1;FMNL2;EGLN1;TNIK;TGFB1;NEDD4
prerank,regulation of cell growth (GO:0001558),0.3784958656604345,1.1891699109728755,0.1522491349480969,0.6816501289100801,1.0,31/204,8.66%,BMPR2;NET1;DCUN1D3;APBB2;SMARCA2;ACVRL1;SH3BP4;SOCS2;ADAM10;NPR1;PTPRJ;SOX17;KIF26A;TAOK2;RPS6KA3;PPP1R9B;SDCBP;VGLL4;RPS6KA1;CEACAM1;H3-3A;CISH;ADAM15;FBP1;DCSTAMP;CDKN1B;JADE1;TGFB1;RPTOR;SFRP2;SGK3
prerank,regulation of stem cell proliferation (GO:0072091),-0.4723081246958376,-1.188987968343169,0.245,0.6978780813539628,1.0,7/17,24.98%,FBLN1;GJA1;AGO3;HNRNPU;HMGB2;TERT;PTPRC
prerank,mesonephros development (GO:0001823),-0.5348225061794788,-1.188921816595527,0.2653061224489796,0.6963663801918967,1.0,4/11,2.91%,FGF1;BMP7;OSR1;BMP4
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5972601316246009,1.1888947578408127,0.27599243856332706,0.681594459597056,1.0,5/11,13.78%,ATF7IP;TASOR;PPHLN1;SIRT6;SETDB2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.5876877325831358,1.1884320214905477,0.31135531135531136,0.6821133822541201,1.0,3/10,4.24%,ZBTB16;ACVRL1;SOX9
prerank,regulation of filopodium assembly (GO:0051489),-0.3949488316274833,-1.1883423929254011,0.20612813370473537,0.6962703421303141,1.0,16/38,15.91%,DPYSL3;DOCK11;NRP1;RHOQ;PRKCD;TENM2;ARAP1;FXR2;NLGN1;RIPOR2;TGFB3;GAP43;PALM;PLPPR5;CAPZB;RALA
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.5067271575690975,1.1881146104539353,0.27403846153846156,0.6822225955783398,1.0,5/25,9.68%,STAT3;TAL1;HIF1A;ACVR2A;MAPK11
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.4820817790352665,-1.1881069964023556,0.24178403755868544,0.695313358672922,1.0,3/16,4.02%,PID1;PPARA;PPARGC1A
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3812179023767983,1.1877770333326996,0.17541766109785203,0.682411821135179,1.0,22/166,8.79%,TEAD4;HDAC9;ESR1;PPARD;MAML2;NR5A2;NR3C1;HDAC7;NOTCH1;WWTR1;CAVIN1;TEAD2;ESRRG;GTF2F2;NR1I3;TAF1B;POLR1A;RRN3;GTF2E2;TAF3;TAF4B;SMARCA5
prerank,nerve growth factor signaling pathway (GO:0038180),-0.5416603422293005,-1.1874005707002775,0.2600896860986547,0.6956663767982829,1.0,3/10,6.42%,MAGI2;NGF;KIDINS220
prerank,positive regulation of interleukin-12 production (GO:0032735),0.48532541318178185,1.1870304966779297,0.2621359223300971,0.6836278661606578,1.0,7/31,12.68%,PLCB1;PLCG2;TIRAP;CD40;MAPK11;IL23A;RIPK2
prerank,negative regulation of interleukin-2 production (GO:0032703),0.5306204523360525,1.1869248140278936,0.29747899159663865,0.6831608172442464,1.0,5/18,12.96%,HDAC7;CD34;HOMER2;HOMER3;ZFP36
prerank,melanosome transport (GO:0032402),0.5329895837962181,1.1862588050216343,0.27090909090909093,0.6834454123129745,1.0,2/18,2.18%,RAB27A;RAB11A
prerank,pigment granule transport (GO:0051904),0.5329895837962181,1.1862588050216343,0.27090909090909093,0.6834454123129745,1.0,2/18,2.18%,RAB27A;RAB11A
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3890887386817371,1.1862090269441274,0.18192918192918192,0.6828409744204021,1.0,17/138,8.69%,TEAD4;HDAC9;ESR1;PPARD;MAML2;NR5A2;NR3C1;HDAC7;NOTCH1;WWTR1;TEAD2;ESRRG;GTF2F2;NR1I3;GTF2E2;TAF3;TAF4B
prerank,positive regulation of protein metabolic process (GO:0051247),0.3996655984816524,1.1861119169756784,0.2075,0.6823289648333832,1.0,22/110,13.24%,FOXO1;APP;SMURF1;DAB2IP;PAEP;NEDD4L;NFKBIA;KLF2;MAPK8;PLK2;WNT5A;CDKN1B;TGFB1;NEDD4;PSEN1;CSF1;IL23A;VPS28;RILP;RAB7A;ASB11;MTPN
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.49859153306148785,1.1850647054149226,0.2676282051282051,0.6843711735888189,1.0,4/25,5.84%,ABI3;TBC1D30;EVL;LIMK2
prerank,negative regulation of cell migration (GO:0030336),0.3855946493139518,1.1850523516819287,0.19269521410579346,0.6836574528113654,1.0,23/137,6.84%,PTPRG;LIMCH1;MCTP1;DACH1;ENG;NEXMIF;ACVRL1;CLDN5;ADARB1;DAB2IP;SRGAP3;SRGAP2;PTPRJ;SRGAP1;STK24;ADGRG1;EVL;SMAD7;PTPRK;DUSP22;RAC1;ADAM15;STK26
prerank,negative regulation of calcium ion transport (GO:0051926),-0.4900006552818544,-1.1844804143431447,0.26905829596412556,0.7024048104131148,1.0,1/15,0.03%,ATP1A2
prerank,intracellular lipid transport (GO:0032365),0.5097760298636397,1.1843266236340066,0.2787682333873582,0.6848559704124164,1.0,6/21,12.13%,CERT1;ACACB;ABCD4;PLEKHA8;CPT1A;ABCD1
prerank,positive regulation of JUN kinase activity (GO:0043507),0.49866716533588024,1.1842341591609298,0.2673611111111111,0.6843587393480731,1.0,5/23,9.15%,DAB2IP;EDN1;TNFRSF11A;SASH1;MAP3K11
prerank,response to glucose (GO:0009749),0.4493405228408903,1.1838341061547673,0.24311926605504589,0.6847518636232949,1.0,14/46,14.39%,UNC13B;ERN1;KCNB1;XBP1;TCF7L2;LPL;EIF2B5;NEUROD1;SOX4;GAS6;RACK1;PFKL;EIF2B2;IGF1R
prerank,nitric oxide mediated signal transduction (GO:0007263),0.5299650861695363,1.1833393085648165,0.2571428571428571,0.6853467026281864,1.0,1/16,0.33%,NOS3
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5144049807553404,1.1832093094806466,0.27380952380952384,0.6849330677432215,1.0,4/22,4.33%,DAB2IP;LYN;MFHAS1;TIRAP
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.5364429838823224,1.1829636716531404,0.275,0.6848410128455011,1.0,5/16,10.28%,SMCHD1;SHLD1;CGAS;HELB;MAD2L2
prerank,axonogenesis (GO:0007409),0.36855049716343286,1.182891329493553,0.16518847006651885,0.684296834104394,1.0,36/237,8.99%,NRP2;SHANK3;SEMA6A;RPS6KA5;APP;SEMA5B;EPHB4;SPTBN1;SEMA7A;PLCG1;PARD3;EFNA1;NOTCH1;KLF7;BSG;FYN;TAOK2;LAMA3;ROBO4;EVL;LMTK2;LAMA1;SEMA6B;RET;OPHN1;ULK1;WNT5A;PPP3CB;B4GALT5;PTK2;GRB7;GAB1;FEZ2;LLGL1;SEMA6D;DSCAM
prerank,osteoclast differentiation (GO:0030316),0.5064899088456059,1.1819326434187964,0.27495908346972175,0.686007370919023,1.0,5/22,9.40%,FOXP1;TNFRSF11A;SBNO2;DCSTAMP;CSF1
prerank,negative regulation of response to wounding (GO:1903035),-0.4558116163926569,-1.1815993642449638,0.2459016393442623,0.7090762607550762,1.0,8/19,17.93%,PTPRS;FGF2;CD109;CASK;AJAP1;SERPINE1;CERS2;MDK
prerank,I-kappaB phosphorylation (GO:0007252),0.5842190291309471,1.1814116412125688,0.29981718464351004,0.686680973375898,1.0,1/10,2.15%,DAB2IP
prerank,positive regulation of cell development (GO:0010720),0.47517861951718193,1.1812949611339554,0.25,0.6862490092214154,1.0,9/31,17.66%,TGM2;NUMB;CX3CR1;SPEN;PDE3A;SNW1;NIBAN2;RFX3;RASSF10
prerank,negative regulation of cellular metabolic process (GO:0031324),0.4620256476480982,1.180964231739197,0.2518628912071535,0.6862998050217674,1.0,9/37,7.58%,ANKRD13A;RIN3;EDN1;PLIN5;SDCBP;PTX3;BTN2A2;SIRT5;NFKB1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.5592718651511197,1.1802008845578988,0.2771929824561403,0.6876082144746255,1.0,4/14,5.60%,PPP3CA;PPM1F;NCK1;PPP2R2C
prerank,microtubule anchoring at centrosome (GO:0034454),-0.5309279989426638,-1.1801854300128887,0.2733333333333333,0.7114781490940609,1.0,7/10,32.19%,NINL;KIF3A;PCM1;CCDC68;CEP19;DCTN1;NIN
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.5960789716063706,1.179734749605964,0.2948717948717949,0.6881192094454318,1.0,2/10,0.87%,ENG;CAV1
prerank,regulation of interleukin-8 production (GO:0032677),0.4212773488725329,1.1796136828732973,0.22941970310391363,0.6876774775538845,1.0,8/69,6.87%,NOD1;PRKD2;STAT3;AFAP1L2;TMSB4X;TIRAP;BCL3;ARRB1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.4413599884202552,-1.1789049561456733,0.2433734939759036,0.7135242578666523,1.0,6/22,12.06%,BMP7;CD44;MBP;GCNT2;WNK1;FLOT2
prerank,regulation of synapse maturation (GO:0090128),0.5848580467144102,1.1785316503020298,0.3018867924528302,0.6898950834459142,1.0,2/10,2.15%,ARHGEF15;DAB2IP
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.40950094761839845,1.17852570019207,0.21467391304347827,0.6891719872102141,1.0,20/86,8.41%,PECAM1;APP;IL15;PDGFB;IL6R;ARHGEF2;EFNA1;PTK2B;PTPRJ;BST1;FYN;PLCG2;PAK2;GHR;ENPP2;ACVR1;TGFB1;ITGA5;SAMSN1;SFRP2
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.5812263262397426,1.178043803364974,0.3132075471698113,0.6897159805972682,1.0,4/10,11.76%,PDE2A;PDE4D;APLNR;PDE3A
prerank,negative regulation of JNK cascade (GO:0046329),0.4842045344476002,1.1778617172538348,0.2814569536423841,0.6895074277170343,1.0,1/31,0.03%,MECOM
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.5495340717359579,1.1778559121361174,0.30642201834862387,0.6887870401089148,1.0,3/14,9.08%,DAB2IP;BCL2L11;PTPN1
prerank,positive regulation of histone modification (GO:0031058),0.4622285645271411,1.1777466186221341,0.25263157894736843,0.6883273817722686,1.0,12/33,22.09%,RPS6KA5;ARRB1;CTBP1;GLYR1;APLNR;FMR1;RPS6KA4;KDM1A;SAP30BP;SART3;TADA2B;NIPBL
prerank,cellular response to interleukin-7 (GO:0098761),0.5408130320899626,1.177721862105566,0.3076923076923077,0.686934737285464,1.0,7/17,10.63%,SOCS2;STAT3;JAK3;CISH;JAK1;IL7R;IL7
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.5408130320899626,1.177721862105566,0.3076923076923077,0.686934737285464,1.0,7/17,10.63%,SOCS2;STAT3;JAK3;CISH;JAK1;IL7R;IL7
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.45277511982950475,-1.1773217597018821,0.2826086956521739,0.7146299646684118,1.0,7/20,17.13%,ACADSB;MCCC2;IVD;BCKDHB;ACAT1;ACAD8;ALDH6A1
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.45277511982950475,-1.1773217597018821,0.2826086956521739,0.7146299646684118,1.0,7/20,17.13%,ACADSB;MCCC2;IVD;BCKDHB;ACAT1;ACAD8;ALDH6A1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.4087360839580666,1.1767898184646153,0.2396694214876033,0.6886409317995063,1.0,11/73,9.76%,APP;ARHGEF2;STAT3;PTPRJ;PLCG2;TIRAP;WNT5A;LPL;PSEN1;TNFRSF8;IL23A
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5253067409961477,1.1763158492005321,0.2927689594356261,0.6892158132805221,1.0,2/17,7.31%,HDAC9;LPL
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.49714257600396317,1.1762186306925142,0.272,0.6887636559140357,1.0,3/26,2.55%,SHANK3;APP;PTK2B
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.35347156988453865,-1.1760098085104784,0.16887417218543047,0.716783193897357,1.0,10/61,5.63%,ROBO1;NOTCH2;IGF1;LPAR1;COL3A1;AKAP13;RASGRF1;ALS2;AUTS2;NGF
prerank,regulation of osteoblast differentiation (GO:0045667),0.41348177494586624,1.1759396428956288,0.22563417890520696,0.6888143226483372,1.0,19/82,8.44%,ZHX3;BMPR2;IL6ST;MEF2C;PRKD1;CDK6;IL6R;LRP5;HDAC7;NOTCH1;WWTR1;FGF23;SOX9;ACVR2A;GREM1;ACVR1;PTK2;CTNNBIP1;CITED1
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.33244316542519686,-1.1757847800610337,0.17898832684824903,0.7157102466019307,1.0,15/75,9.89%,ATP1A2;SLC8A3;CACNA2D1;SLC12A2;SLC6A1;SLC9A9;ATP1B1;SLC8A1;ABCC9;SLC39A14;KCNJ2;KCNJ13;SLC39A10;SLC24A2;ATP1B2
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.5549056540090053,1.1754505288722532,0.2903225806451613,0.689378376103811,1.0,2/14,1.15%,PRKG1;MEF2C
prerank,cellular macromolecule catabolic process (GO:0044265),0.43803730625232196,1.1750488112238362,0.2555391432791728,0.6896886295900035,1.0,16/49,16.71%,STT3B;DAB2IP;ISG20;RNASEH2A;MTREX;UBE2G1;HNRNPD;RAB12;RIPK1;RNASEH2C;RNASEH2B;OGA;XRN2;RNF5;PNPT1;CHEK2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.30744060750989,-1.174869847424208,0.12666666666666668,0.7167634959466938,1.0,30/166,10.53%,SAMD4A;IGF1;EGFR;ZEB2;PLD1;PDGFRB;GLI2;IRS1;SLC6A9;LPGAT1;THBS1;P2RX4;CPEB3;SMOC2;FGF2;PPARGC1A;HSP90AA1;FXR2;IGF2;SMAD3;LDLR;SREBF1;GLI1;PRR16;LARP6;RGCC;CIRBP;SLC27A1;ARNT;FGFR4
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.495635958313174,1.1746744070083672,0.2647058823529412,0.6899927227930591,1.0,5/23,9.46%,ELOVL7;ACSL4;ELOVL5;ACSL5;FAR2
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.5336248100515253,-1.1741429121336475,0.2753303964757709,0.7173099905866501,1.0,6/10,29.59%,DLGAP4;DLGAP1;NPTXR;DLGAP2;NPTX2;BEGAIN
prerank,peptide catabolic process (GO:0043171),-0.4358938881591923,-1.1741350993953452,0.24867724867724866,0.7156681194032771,1.0,4/23,7.50%,CPQ;GGT5;NPEPPS;ENPEP
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.5269514011926723,-1.173957029784311,0.29894736842105263,0.7145142554933812,1.0,4/11,10.56%,IGF1;IRS1;TSC2;EIF2AK3
prerank,cellular senescence (GO:0090398),-0.41415281719408964,-1.1737347261561084,0.23655913978494625,0.7135756891025716,1.0,13/27,28.74%,PRKCD;ECRG4;TBX2;CDKN1A;TBX3;MAP2K1;ULK3;SMC6;TERF2;ID2;CALR;CDKN2B;SMC5
prerank,cholesterol homeostasis (GO:0042632),0.4192615228657183,1.1736766606138056,0.24074074074074073,0.6919077758421885,1.0,9/64,8.05%,HDAC9;CAV1;SCARB1;LRP5;MALL;XBP1;CNBP;LPL;SOAT2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.5031254627472688,1.1730278272559007,0.27411167512690354,0.6928346214978377,1.0,3/22,8.76%,ESR1;HNF1B;SUB1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.4765011791248582,1.1726521183500314,0.2640625,0.6931311785322403,1.0,6/34,9.08%,PTPRB;PTPN12;PTPRJ;DUSP22;DUSP16;PTPN1
prerank,modification-dependent protein catabolic process (GO:0019941),0.3694902922204776,1.1725692992520709,0.1928406466512702,0.6926589573268979,1.0,51/193,18.12%,RNF125;KLHL3;SMURF1;RNF144B;NEDD4L;ZNRF3;DTX3L;XBP1;KCTD10;FBXL4;RNF144A;KCTD6;AURKA;UBL7;UBE3B;ARRB1;ATXN3;UBE2G1;RNF7;FBXL7;ARRDC1;RNF167;NEDD4;TRIM25;ANAPC7;UBE2H;RNF146;ANAPC1;SIAH1;CBL;RC3H1;CDC26;MYLIP;LONP1;ANAPC16;RNF215;UBE2K;KLHL8;TOPORS;BUB3;ARIH2;ELOC;AREL1;RNF5;NDFIP2;NEDD8;CUL3;UBE2I;CDC34;RNF40;PSMF1
prerank,purine nucleotide catabolic process (GO:0006195),0.5656641506846046,1.1724311494055468,0.30824372759856633,0.6923094020153195,1.0,5/13,14.57%,GDA;NT5C2;HINT1;XDH;NUDT15
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.42214361801460454,-1.1723612137606763,0.24050632911392406,0.7159756513821273,1.0,8/24,12.18%,IGF1;IRS1;ENPP1;SELENOS;IGF2;PPP1R3C;IRS2;PPP1R3F
prerank,regulation of mitotic cell cycle (GO:0007346),0.37492137239112955,1.1722564381785636,0.19327731092436976,0.6920624177548121,1.0,33/171,12.00%,APP;NEK7;IQGAP1;TAL1;PIM3;SIK1;AFAP1L2;TTC28;CAV2;PKN2;SDCBP;BTG3;EIF4E;ASAH2;CDKN1B;TGFB1;NEK6;BRINP2;PSMA2;ANAPC7;PDXP;PSMA8;ANAPC1;BTG2;ANGEL2;PSMA6;TFAP4;BTG1;CUL1;EIF4EBP1;CDC26;RB1;LGMN
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.4663660451745954,1.1710601878133449,0.27370030581039756,0.6945825330538863,1.0,13/37,16.27%,CAV1;NCK1;BOK;RPS7;BCL2L11;LCK;BCL2L1;SIAH1;BID;RACK1;S100A9;DDIT3;BMF
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.5268757634180445,1.1709788677443749,0.29508196721311475,0.6940692399841317,1.0,3/17,5.16%,DGKZ;PTPRJ;CEACAM1
prerank,regulation of cytokinesis (GO:0032465),0.4119192394137406,1.1707410127208837,0.23015873015873015,0.6939860402403867,1.0,22/78,21.86%,PKP4;RAB11A;PKN2;PLK2;AURKA;SH3GLB1;AURKC;PDXP;BCL2L1;KIF23;GIPC1;E2F7;RHOA;CALM1;CUL3;PRPF40A;CETN2;PLK1;PRKCE;GIT1;PIK3R4;RACGAP1
prerank,nucleoside salvage (GO:0043174),0.5809012523165649,1.170511273826731,0.3383742911153119,0.6938757496084542,1.0,3/10,9.67%,UCK2;UPP1;HPRT1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.5229165345071026,1.1703136930945741,0.2920353982300885,0.6936741771200565,1.0,3/18,4.89%,CTSC;MSN;VGLL4
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.43647133618400585,1.1702304248654425,0.25872093023255816,0.6931693912256154,1.0,20/48,24.61%,ARID1B;TAF1B;POLR1A;ARID1A;SMARCA5;MYBBP1A;ZMIZ1;MYO1C;POLR1G;CDCA4;POLR1B;KAT2B;SERTAD2;TAF1A;ATAD2;POLR2L;DEK;PHF2;ERCC6;SMARCD1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.4500497768327478,1.1699750834467662,0.25903614457831325,0.6931211680560192,1.0,7/38,12.71%,ESR1;DAB2IP;CASP8;TNIP1;ZMYND11;RIPK1;GSTP1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.39694739238263393,-1.1699047114195302,0.23433242506811988,0.7213785752395393,1.0,10/33,9.58%,EGFR;ANXA1;CCND2;STXBP4;ADAMTS1;GLI1;PAF1;UBE2E2;RGCC;TFDP1
prerank,ephrin receptor signaling pathway (GO:0048013),0.4036663956250964,1.1697807832792275,0.22872340425531915,0.692909053431371,1.0,23/82,11.51%,EPHB4;ANKS1A;LYN;EFNA1;YES1;FYN;KALRN;ARPC3;SDCBP;AP2B1;ARPC1B;RAC1;PTK2;RASA1;AP2A1;PSEN1;ARHGEF7;CRK;ANKS1B;APH1A;EPHA4;ACTR2;GRIN1
prerank,cellular response to chemokine (GO:1990869),0.4426772756156898,1.169415537959149,0.26600284495021337,0.6931465305603298,1.0,3/46,6.89%,LRCH1;PTK2B;PPBP
prerank,ribosomal subunit export from nucleus (GO:0000054),0.5494555707018092,1.1692344918314812,0.30204778156996587,0.6929033970991174,1.0,5/13,14.08%,RPS15;XPO1;RRS1;EIF6;NPM1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.5436119281601546,1.1687525072309337,0.2936936936936937,0.6935139149270854,1.0,8/14,27.15%,WRAP53;MMS19;ACTR2;WDR48;FUS;ERCC6;ARID2;TIMELESS
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.5362372011900794,-1.1687350420013864,0.3036529680365297,0.723343008373163,1.0,5/10,26.22%,GALNT13;POGLUT2;GALNT1;GALNT3;GALNT16
prerank,negative regulation of cilium assembly (GO:1902018),0.5624247576029642,1.1686459901827564,0.3090909090909091,0.6930513461933111,1.0,2/12,5.84%,TBC1D30;LIMK2
prerank,mammary gland epithelium development (GO:0061180),-0.47777055064497287,-1.1675759614391705,0.2863741339491917,0.7250525755245966,1.0,2/14,3.27%,WNT4;ERBB4
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.5056583620282099,1.167047699130475,0.2976190476190476,0.696618736965514,1.0,8/20,18.07%,ZBTB16;CDK6;PTK2B;MAFB;ZFP36;ZFP36L1;CDC73;CIB1
prerank,sterol transport (GO:0015918),0.5152814812810965,1.1667325281875063,0.2777777777777778,0.6967076336091503,1.0,1/19,0.87%,CAV1
prerank,negative regulation of actin filament polymerization (GO:0030837),0.5085983386165541,1.166542397760868,0.3055091819699499,0.6964858157767312,1.0,7/22,12.08%,KANK3;HIP1R;SSH2;TMSB4X;CYRIB;TWF2;PFN4
prerank,negative regulation of defense response to virus (GO:0050687),-0.5249271705296183,-1.1664515179859167,0.29004329004329005,0.7266494756711458,1.0,7/10,31.08%,PCBP2;ITCH;TRAF3IP1;PPM1B;C1QBP;RNF26;MUL1
prerank,regulation of lipid storage (GO:0010883),0.4959864811300604,1.1661864813435416,0.2879045996592845,0.6967060765233579,1.0,6/22,11.65%,FBXW7;NFKBIA;PLIN5;LPL;NFKB1;ITGB3
prerank,nucleotide-sugar metabolic process (GO:0009225),0.5544520657478443,1.1661148916481239,0.2916666666666667,0.6961834261596267,1.0,1/12,0.48%,CSGALNACT1
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.4373947870874393,-1.1660730707056481,0.2639225181598063,0.7261414457316856,1.0,2/22,1.35%,ALDH1A2;RBP1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.4081719607506739,1.1657323585953803,0.23544973544973544,0.6964755659146383,1.0,16/78,13.02%,CAV1;CBFA2T3;RNF144B;NKD2;SMAD7;RNF144A;TRIB3;RAD23A;SUMO2;COP1;HECTD1;SIRT6;NOP53;PRICKLE1;RACK1;TRIB1
prerank,cellular protein catabolic process (GO:0044257),0.4228859221941986,1.165057540683386,0.260806916426513,0.697585368140573,1.0,17/59,12.95%,CTSC;DAB2IP;CASP8;AP2B1;UBE2G1;AP2A1;CTSK;CTSO;MALT1;RAB12;PSMA6;BNIP3;MYLIP;RIPK1;LONP1;LGMN;RAB7A
prerank,plasma membrane organization (GO:0007009),0.42610167641547425,1.1645031879562588,0.24964336661911554,0.6982766841541406,1.0,6/61,1.98%,MYOF;FNBP1L;UGCG;SPTBN1;CAVIN2;MYH9
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.39897966398724904,1.164366285261976,0.23712737127371275,0.6979206683379786,1.0,12/86,9.80%,APP;OCLN;EDN1;PTK2B;NCK1;EVL;NCKAP1;RAC1;CDC42EP3;TRPV4;PSEN1;PDXP
prerank,actin-myosin filament sliding (GO:0033275),-0.38522565365206163,-1.1641461659469952,0.22946175637393768,0.7284340504791281,1.0,6/38,14.09%,DMD;ACTN2;TPM1;TPM2;DES;TPM4
prerank,muscle filament sliding (GO:0030049),-0.38522565365206163,-1.1641461659469952,0.22946175637393768,0.7284340504791281,1.0,6/38,14.09%,DMD;ACTN2;TPM1;TPM2;DES;TPM4
prerank,heart development (GO:0007507),0.3767494903147248,1.1632309225301494,0.20534629404617255,0.7002556711061558,1.0,27/150,7.67%,TEK;HDAC9;BMPR2;TBX1;MEF2C;EPHB4;HEG1;ACVRL1;INSR;PDGFB;NOTCH1;SOX17;CHD7;CASP8;FKBP1A;SOX18;PDLIM1;SOX9;KDM6A;FOXF1;RBM20;RAMP2;ACVR1;CDKN1B;TGFB1;PTK2;PKD2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5647444477493426,1.1632135504408514,0.31204379562043794,0.6996021255959161,1.0,5/12,13.42%,PTPN14;TGFB1;NEDD4;NUP214;UHMK1
prerank,negative regulation of developmental growth (GO:0048640),-0.4037552411275056,-1.1630606655154385,0.2661290322580645,0.7300211598420733,1.0,16/30,22.32%,PTPRS;MAP2;DCC;DUSP10;WWC1;CDKN1A;CDKL3;RTN4;SEMA3G;BBS2;ULK2;MT3;NKD1;PTEN;PTCH1;RNF6
prerank,regulation of extracellular matrix organization (GO:1903053),-0.4784330166613626,-1.16296858048868,0.2921108742004264,0.7286480008319514,1.0,9/15,11.24%,LRP1;AEBP1;DDR1;FAP;EFEMP2;SLC2A10;DDR2;FGFR4;RUNX1
prerank,positive regulation of macrophage migration (GO:1905523),-0.45149471519165946,-1.1628969138229215,0.2731829573934837,0.7272087026133145,1.0,3/19,3.66%,IL34;THBS1;P2RX4
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.4898015093145168,-1.1627534825851706,0.28159645232815966,0.7260255330088545,1.0,3/13,7.11%,ERRFI1;CBLB;SNX6
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.5020659152254617,-1.1624128418205493,0.28635346756152125,0.725399325408761,1.0,5/12,23.21%,IDH2;IDH1;IDH3A;ACO2;IDH3G
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.4805606020608332,1.162364425477413,0.27751196172248804,0.7011475550275836,1.0,5/27,3.98%,SHANK3;TJP1;F11R;WASF2;PAK2
prerank,regulation of cell projection organization (GO:0031344),-0.49364787791689824,-1.1621211933754703,0.31390134529147984,0.7245726272902275,1.0,9/13,32.12%,NTNG1;MOV10;MFSD2A;MACF1;MYO9A;CCL19;TREM2;SPRY2;ERMN
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.45441973603358776,-1.1619819422137736,0.2716627634660422,0.723350082983451,1.0,5/17,6.53%,BMP4;FGF2;SFRP4;TMEM100;AHI1
prerank,chromatin assembly or disassembly (GO:0006333),-0.5155172354603367,-1.1618356483286632,0.2771618625277162,0.7221555097785453,1.0,5/11,27.59%,HDAC8;MTA2;TP53;RBBP4;HIRIP3
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.4919666550925679,-1.161458209138062,0.27045454545454545,0.7216210785170988,1.0,5/13,19.61%,BMP5;DKK3;APOE;PLEK;REST
prerank,actin crosslink formation (GO:0051764),0.566843545402578,1.1614573711811984,0.3333333333333333,0.7028275269385911,1.0,2/12,1.52%,LCP1;EPS8
prerank,regulation of muscle cell differentiation (GO:0051147),0.47961377029757535,1.1612357423900648,0.2751572327044025,0.7026638169958797,1.0,9/31,9.92%,HDAC9;MEF2C;CDH2;CTNNA1;TCF3;BNIP2;CDH15;MAPK11;SPAG9
prerank,regulation of interleukin-17 production (GO:0032660),0.4628493727967623,1.16104133001923,0.25462962962962965,0.7024759408580731,1.0,8/31,18.29%,IL15;TGFB1;RFTN1;IL23A;VSIR;SLC7A5;DDIT3;CARD9
prerank,nucleocytoplasmic transport (GO:0006913),0.4408628768308458,1.1610380247198904,0.27102803738317754,0.7017713171160791,1.0,10/40,15.76%,ANP32A;RSRC1;BACH2;XPO1;MALT1;CITED1;NUP98;NUP205;NPM1;DDX20
prerank,cellular response to glucagon stimulus (GO:0071377),-0.4551334863711343,-1.1609316161428547,0.2559241706161137,0.7215022016631966,1.0,9/17,14.41%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6;PRKACA;PRKAR1B;PRKAR1A;ADCY3
prerank,RNA catabolic process (GO:0006401),0.4385478692031574,1.1606796797295527,0.2728658536585366,0.7020184164569212,1.0,13/46,16.20%,ERN1;ISG20;NANOS2;RNASEH2A;MTREX;HNRNPD;NUDT16;DCP2;RNASEH2C;RNASEH2B;ZFP36;XRN2;PNPT1
prerank,regulation of biomineral tissue development (GO:0070167),0.4946727577350223,1.1598820495857796,0.2884927066450567,0.7033683303167738,1.0,8/26,11.07%,NOS3;NOTCH1;S1PR1;SOX9;TGFB1;ANKH;CYP27B1;GAS6
prerank,leukotriene biosynthetic process (GO:0019370),0.5581300360112093,1.1597080308160501,0.30236486486486486,0.7031136694278731,1.0,3/14,8.78%,PLA2G4A;ALOX5AP;LTC4S
prerank,regulation of acrosome reaction (GO:0060046),0.5650506406597734,1.159703293747143,0.3181818181818182,0.7024154830738936,1.0,1/10,3.58%,PLCB1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.5364182036050499,1.1596944845858153,0.2979094076655052,0.701735641999628,1.0,3/16,3.02%,PTGS2;SOX13;RREB1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.42952024966898733,-1.1591279515454904,0.26,0.7236489232502675,1.0,10/23,19.03%,ZEB2;THBS1;DAB2;TGFB1I1;HIPK2;SLC2A10;CITED2;CDKN1C;MEN1;FLCN
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.42952024966898733,-1.1591279515454904,0.26,0.7236489232502675,1.0,10/23,19.03%,ZEB2;THBS1;DAB2;TGFB1I1;HIPK2;SLC2A10;CITED2;CDKN1C;MEN1;FLCN
prerank,neutrophil migration (GO:1990266),0.4192474568267562,1.1589138202159077,0.2361111111111111,0.7030782928391204,1.0,7/58,11.53%,PECAM1;EDN1;BSG;PPBP;PIK3CG;CCL14;IRAK4
prerank,N-glycan processing (GO:0006491),0.5323981540460474,1.1588921566887833,0.29635761589403975,0.7024308490424666,1.0,5/18,15.07%,MGAT4A;MAN2A1;ST8SIA4;GNPTAB;MAN1A2
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5752626378372676,1.1585932958371106,0.3134057971014493,0.7025267236886684,1.0,2/10,5.49%,CEACAM1;CX3CR1
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.4839187140404062,-1.1581378574758017,0.3054892601431981,0.7249112562888007,1.0,5/13,23.72%,GAB2;STX4;SYK;ITGB2;SPHK2
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5188125476729414,1.158099821588465,0.2937181663837012,0.7031506824325036,1.0,5/19,4.73%,SEMA6A;DAB2IP;JCAD;DLL1;TSPAN12
prerank,dendritic cell migration (GO:0036336),0.5315357835952531,1.1578534910070146,0.3048780487804878,0.7030886889461844,1.0,3/16,10.12%,EPS8;PIK3CG;CXCR4
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.4386220950891137,1.1575473725449583,0.25,0.7031930881787823,1.0,11/45,8.27%,RPS6KA5;PLCG1;IQGAP1;PTK2B;PIK3C2A;SOX9;TGFB1;PTK2;GRB7;TGFA;GAB1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.33033523199129294,-1.1575337839672957,0.205761316872428,0.7251169897262693,1.0,13/80,9.93%,SAMD4A;PLD1;ROCK2;SLC2A13;PRKCD;THBS1;CPEB3;LRRTM3;FXR2;PRR16;LARP6;SMPD3;CIRBP
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.5705658280396313,1.1572123355210933,0.32,0.702719661346302,1.0,3/10,11.58%,AP2B1;AP2A1;MYLIP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.5705658280396313,1.1572123355210933,0.32,0.702719661346302,1.0,3/10,11.58%,AP2B1;AP2A1;MYLIP
prerank,epithelial to mesenchymal transition (GO:0001837),0.44208566204407806,1.1571924999917391,0.26822157434402333,0.7020729017967114,1.0,9/47,7.19%,LEF1;ENG;HIF1A;NOTCH1;SOX9;FOXF2;WNT5A;TASOR;TGFB1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.41052151795763187,1.1571187012723188,0.24273255813953487,0.7015553045160303,1.0,12/65,8.88%,HIP1;PTPN12;HIP1R;DAB2IP;MVB12B;PTPRJ;AFAP1L2;CEACAM1;CCDC88A;BCAR3;TGFA;ARHGEF7
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5100359526616971,1.1569243283073987,0.28668941979522183,0.7013581014446166,1.0,5/22,7.26%,PDGFB;PDGFD;TAOK2;GREM1;PDGFC
prerank,inhibitory synapse assembly (GO:1904862),-0.5068361720783805,-1.1567685135956676,0.2980561555075594,0.7258954765990796,1.0,5/11,13.10%,GABRG2;GABRA2;PLXNB1;LGI2;GABRB3
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.5410269578442375,1.155862542698848,0.3083941605839416,0.7033820557656485,1.0,2/13,3.90%,ELOVL7;ELOVL5
prerank,lipoprotein catabolic process (GO:0042159),-0.5111867821342124,-1.1556359797182003,0.3008474576271186,0.7276727329305173,1.0,6/11,19.06%,NOTUM;APOE;CTSD;ABHD10;ABHD17C;PPT1
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.49283930393265957,-1.1556078998551689,0.31072210065645517,0.7261556162219094,1.0,6/13,25.57%,RNF152;CASTOR2;SZT2;SESN2;ITFG2;ATM
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.32002010010291676,-1.1555028514408223,0.19369369369369369,0.72484311451068,1.0,18/101,10.53%,SAMD4A;PLD1;CYFIP2;OGT;THBS1;CPEB3;ASPH;HSP90AA1;DACT1;FXR2;AGTR1;EZR;BTRC;PRR16;LARP6;INHBA;CIRBP;FGFR4
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.48711316634896235,1.1554862696688601,0.3079416531604538,0.7036484585931987,1.0,7/26,12.00%,APP;TAL1;PKN2;EIF4E;PPP1R10;EIF4EBP1;LGMN
prerank,positive regulation of secretion (GO:0051047),0.5633983552358318,1.1550205191543355,0.3179190751445087,0.7041492262029206,1.0,2/11,4.85%,NPR1;XBP1
prerank,protein localization to cell surface (GO:0034394),-0.4156245918222409,-1.1547766328147218,0.2647058823529412,0.7253699734539116,1.0,11/26,17.33%,ANK2;ANGPT1;FBLN5;GGA2;PRRT1;FGF7;JAM3;GGA1;WNT11;FGF10;UNC50
prerank,cGMP metabolic process (GO:0046068),0.5568236931451356,1.1547250059527159,0.3238434163701068,0.704164034460218,1.0,2/12,2.59%,PDE2A;NPR1
prerank,amino acid transport (GO:0006865),-0.3616615463947588,-1.153545238032831,0.2113564668769716,0.727208508491821,1.0,11/49,11.16%,SLC7A11;SLC7A2;PDPN;SLC1A5;SLC6A12;SLC38A11;SLC25A47;SLC6A15;SLC7A14;SLC7A6;SLC43A1
prerank,regulation of small molecule metabolic process (GO:0062012),-0.41544838807752305,-1.1532117402948583,0.26558265582655827,0.7265280503397236,1.0,6/28,10.31%,PRKN;PDK1;PPARA;RORA;EPHX2;APOE
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.31114935536035376,-1.1529681320086407,0.16267942583732056,0.7256047556756826,1.0,23/122,11.64%,SAMD4A;IGF1;EGFR;PLD1;PDGFRB;GLI2;IRS1;SLC6A9;THBS1;CPEB3;AR;SMOC2;FGF2;FXR2;IGF2;GLI1;PRR16;LARP6;RGCC;CIRBP;FGFR4;IRS2;TGFB2
prerank,regulation of cell-substrate adhesion (GO:0010810),0.44076181013124316,1.1528972793538124,0.26785714285714285,0.7081515913974825,1.0,9/42,8.12%,PDGFB;FZD4;NOTCH1;PPM1F;BST1;RAC1;ATXN3;PTK2;RSU1
prerank,cellular protein metabolic process (GO:0044267),0.34724599017636637,1.152758483221388,0.16790648246546228,0.7078210016075559,1.0,115/396,16.71%,ST3GAL6;APP;ST3GAL1;MGAT4A;MSRB3;DAB2IP;ADAM10;YES1;FUCA2;RPS15;FGF23;CPE;CDH2;UBA7;IGF2BP3;RPS19;RPLP1;RPS14;PADI4;RPSA;RPS16;QSOX1;RPL38;CSF2RB;SPARCL1;ABCA3;RPS20;RPL39;RPL34;RPS7;VWA1;RPS24;ST8SIA4;UBE2G1;GOLM1;RPL37A;SRBD1;RPS18;RPL36;RSL24D1;RPL15;PSEN1;AKT2;RPL14;RPS8;MRPS18A;RPL23;RPL17;CSF1;TNIP1;APLP2;FBXL2;FBXW2;ERO1A;RPL9;RAB12;RPL4;UBE2D3;DHPS;RPL13A;RPS11;RPL32;RPL22;ICMT;GAS6;APH1A;RPL31;ABL2;RPS27;RPS23;MRPL13;RPL13;STK38;RIPK1;MRPS12;RPS12;LGMN;MRPL35;HBS1L;RPL6;WARS1;OMA1;LAMB1;MRRF;RPL10;MRPL41;ADAM17;SPCS1;MRPL52;RPS29;RPS6;PNPLA2;RPS25;CP;PROC;RPL35A;RPL29;SPPL3;MSRB2;RPS13;EVA1A;RPL18;RPL27A;MRPS16;RPS21;RPL27;MRPS5;MRPL23;TMEM132A;RNF5;NAGPA;RPS10;MRPL37;RPL11;CHEK2
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5787380870633181,1.1527524198759993,0.3083941605839416,0.7071260811342942,1.0,3/10,5.28%,LYN;FAS;GREM1
prerank,basement membrane organization (GO:0071711),-0.4828468324611299,-1.1515923129330503,0.3038277511961722,0.728059794952663,1.0,5/14,8.81%,NID1;NID2;NTN4;NTNG1;FLRT2
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.33130794299881833,-1.151528949327632,0.18411552346570398,0.7266694298209584,1.0,21/74,11.74%,PHLDB2;EPHA3;COL1A1;BMP5;PDPN;PHLDB1;TGFBR1;SPRED1;DAG1;SMAD3;AXIN2;DAB2;TGFB1I1;VASN;SFRP1;GCNT2;RGCC;TGFB3;SPRED3;TGFB2;SPRED2
prerank,Rac protein signal transduction (GO:0016601),0.5077551935999429,1.1508521388215858,0.30701754385964913,0.7113575552246107,1.0,6/18,12.14%,EPS8;ELMO1;NCKAP1;RAC1;CYFIP1;DBNL
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4023136613299547,1.150819144397071,0.2496626180836707,0.7107300474753433,1.0,13/80,8.38%,NOD1;TNFSF10;SOX7;DAPK1;PPM1F;RPS6KA3;RPS6KA1;FOXL2;XIAP;CYCS;GRAMD4;CASP1;MALT1
prerank,limb development (GO:0060173),-0.41033179073739734,-1.150293272958083,0.26683291770573564,0.7287393529399129,1.0,5/28,5.52%,SMOC1;GLI3;PCSK5;RSPO2;SALL1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.40916321356437757,1.150272015029645,0.2524271844660194,0.7114691981112705,1.0,18/79,10.35%,BMPR2;EPN2;SMAD1;SMURF1;MMRN2;DAB2IP;HHEX;NOTCH1;ACVR2A;SMAD7;GREM1;ATP2B4;SOST;NEDD4;PTPN1;SMAD5;SKIL;UBE2D3
prerank,positive regulation of glycolytic process (GO:0045821),0.5011882574599136,1.1500401897106975,0.31095406360424027,0.7106274197086159,1.0,4/20,2.85%,APP;INSR;HIF1A;PFKFB3
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.5011882574599136,1.1500401897106975,0.31095406360424027,0.7106274197086159,1.0,4/20,2.85%,APP;INSR;HIF1A;PFKFB3
prerank,dopamine metabolic process (GO:0042417),0.5287849816241011,1.1492255201347021,0.3026086956521739,0.7120942884362186,1.0,4/18,7.34%,MAOA;GCH1;MAOB;SNCAIP
prerank,negative regulation of viral entry into host cell (GO:0046597),0.5576681318877305,1.1490777401746957,0.3179297597042514,0.7118026986126701,1.0,4/12,7.58%,LY6E;PTX3;MID2;SNX3
prerank,B cell homeostasis (GO:0001782),0.5648743490507193,1.1490422227841899,0.32456140350877194,0.7111908290092748,1.0,2/10,2.30%,MEF2C;LYN
prerank,negative regulation of chemotaxis (GO:0050922),0.4626176492387433,1.1488929342872634,0.28662420382165604,0.7108955433386028,1.0,5/31,5.69%,SEMA6A;SEMA5B;SEMA7A;NOTCH1;SEMA6B
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.4187649653889817,-1.1486837834222443,0.25,0.7318949313101557,1.0,10/26,17.09%,EGFR;ANXA1;CCND2;ADAMTS1;UBE2E2;RGCC;TFDP1;CDK10;HYAL1;FGF10
prerank,positive regulation of microtubule polymerization (GO:0031116),0.47437197628363753,1.1478536718965122,0.2961165048543689,0.7129165365158597,1.0,9/28,21.10%,OCLN;RAC1;MET;PAK1;CDK5RAP2;NUMA1;CLIP1;RPS3;GIT1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.3397667349064657,-1.1471902250846118,0.2376237623762376,0.7346231866033045,1.0,18/72,17.35%,FGFR2;FGF1;HNRNPH1;SPRED1;FGF2;RBFOX2;TIA1;FLRT1;FLRT2;FGFBP1;FGFR4;SPRED2;FGF7;POLR2B;HNRNPA1;POLR2K;FGF10;GTF2F1
prerank,regulation of neutrophil migration (GO:1902622),0.5773910282111288,1.1468991773552712,0.3425742574257426,0.7147021283940396,1.0,2/10,6.19%,BST1;RAC1
prerank,cell-cell junction assembly (GO:0007043),0.42360329602814273,1.146839244194567,0.2637517630465444,0.7141555862675013,1.0,9/63,5.78%,TJP1;PKP4;CLDN5;PKN2;PAK2;CDH2;SMAD7;CTNNA1;RAMP2
prerank,inflammatory response (GO:0006954),0.3587483746581006,1.1463881726788345,0.2116279069767442,0.7145741277288091,1.0,28/195,10.48%,HDAC9;NOD1;F11R;NRROS;STAT3;MFHAS1;AFAP1L2;SELE;ADGRE5;ACKR1;IKBKB;PTX3;CD40;RAC1;PLA2G2D;IL36G;PPBP;HNRNPA0;TNFRSF1A;TGFB1;PIK3CG;NFKB1;LY75;PXK;RELB;IKBKG;CXCR4;CCL14
prerank,histone H4 acetylation (GO:0043967),0.43485069317147285,1.1462769229662655,0.28939393939393937,0.714162110057451,1.0,8/47,10.04%,LEF1;EPC1;PHF20;JADE2;JADE1;HAT1;JADE3;EP400
prerank,superoxide metabolic process (GO:0006801),0.47121311184852166,1.1462672220050836,0.3127962085308057,0.71349473554237,1.0,3/29,4.80%,NOS3;NRROS;PREX1
prerank,synaptic vesicle localization (GO:0097479),0.5602236396359787,1.14598012703561,0.32509505703422054,0.7135452102859422,1.0,1/13,0.41%,RAB27A
prerank,endothelial tube morphogenesis (GO:0061154),0.5715593519672024,1.1457616279129548,0.31390977443609025,0.7134411672043038,1.0,7/10,19.35%,ACVRL1;PRKD2;CCM2;RHOB;RHOA;CTNNB1;STARD13
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.40858355016789816,1.1456810406369677,0.2770083102493075,0.7129756612886983,1.0,10/70,11.15%,LMO2;GATA2;TAL1;TCF12;TCF3;PSMA2;TCF15;PSMA8;PSMA6;CBFB
prerank,positive regulation of catabolic process (GO:0009896),0.41895716141978406,1.1455970101367934,0.27932960893854747,0.7124896253911929,1.0,15/65,15.74%,FOXO1;SMURF1;DAB2IP;NEDD4L;PLK2;WNT5A;CDKN1B;NEDD4;VPS28;RILP;RAB7A;ASB11;APC;VSIR;AREL1
prerank,regulation of intracellular pH (GO:0051453),-0.3871378249054108,-1.145137468336784,0.2647887323943662,0.739153589679997,1.0,15/34,27.66%,SLC4A10;SLC9A9;LRRK2;SLC4A3;SLC4A2;SLC9A1;SLC26A6;CFTR;SLC4A8;NOX1;SLC9A8;CLN3;TMEM165;SLC9A4;SLC9A2
prerank,positive regulation of calcium ion transport (GO:0051928),-0.3825133275529948,-1.1451282519234223,0.2691131498470948,0.7376001072692188,1.0,7/36,7.50%,ANK2;PDGFRB;CACNA1D;P2RX4;CACNB2;TRPC3;TRPC6
prerank,central nervous system myelination (GO:0022010),-0.5214352235205919,-1.14431066222035,0.3082039911308204,0.738332814313256,1.0,8/11,22.35%,PLP1;B4GALT6;CNTNAP1;MYRF;TENM4;PTEN;ABCA2;SOX10
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.4368802879292673,1.1442255729637765,0.27696793002915454,0.7153561903628078,1.0,17/42,24.18%,SMCHD1;SHLD1;WRAP53;CGAS;HELB;MAD2L2;MMS19;ACTR2;SIRT6;SPIDR;WDR48;KDM1A;FUS;RMI2;RIF1;ERCC6;ARID2
prerank,neurotransmitter transport (GO:0006836),-0.33528628812742434,-1.1439944683858865,0.18823529411764706,0.7376023178889078,1.0,26/73,17.14%,ATP1A2;SLC1A3;GLUL;SYT1;APBA1;BRSK1;SNAP25;NAAA;NRXN1;SLC6A15;SLC1A2;LIN7A;GABRA2;SNPH;CASK;PTPRN2;NRXN2;SLC29A1;GAD2;SLC1A1;RIMS1;SLC22A2;SYN1;DVL1;PDZD11;PPFIA1
prerank,mRNA methylation (GO:0080009),0.527040106739489,1.1439272459783953,0.3260135135135135,0.7154779619830064,1.0,9/15,27.24%,CBLL1;WTAP;VIRMA;TRMT6;METTL14;TRMT61B;METTL16;TRMT10C;NSUN2
prerank,circulatory system development (GO:0072359),0.380400463471023,1.1439147233347384,0.24648786717752236,0.7148179068214511,1.0,23/118,7.67%,TEK;HDAC9;TBX1;MEF2C;HEG1;ACVRL1;PDGFB;FBXW7;NOTCH1;SOX17;CASP8;SOX18;FLT4;PDLIM1;SOX9;KDM6A;FOXF1;RBM20;RAMP2;ACVR1;CDKN1B;TGFB1;PKD2
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.397263917551795,-1.1437192156361908,0.2569832402234637,0.7369079106926621,1.0,2/33,1.14%,IGF1;PRKN
prerank,regulation of phosphorylation (GO:0042325),0.37950083505384113,1.1434208624824882,0.23645320197044334,0.7154483196933962,1.0,29/120,14.34%,LDB2;ITGA6;APP;NLRC5;LYN;FNIP2;HIF1A;SDCBP;IKBKB;CCDC88A;CDKN1B;PTK2;DYNLL1;PSEN1;ANG;DSCAM;BTBD10;NUP214;EIF6;CORO1C;NUP98;NOP53;PHIP;SLC2A6;NUP205;NUP133;NUP153;NUP54;CDH5
prerank,response to cholesterol (GO:0070723),-0.4536940285525099,-1.1433420131335206,0.3175355450236967,0.7364352115715118,1.0,5/17,9.67%,TGFBR1;GRAMD1B;GRAMD1C;LRP6;SMO
prerank,protein localization to lysosome (GO:0061462),0.4702107349541096,1.1432916384156622,0.3106312292358804,0.7150861618226539,1.0,13/28,23.45%,SH3BP4;NCOA4;GCC2;NEDD4;SCARB2;GLMP;M6PR;RAB7A;NAGPA;GGA3;KPTN;MFSD1;LMBRD1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.4870030665639641,1.1432795031225147,0.30505709624796085,0.7144233224550224,1.0,7/24,15.53%,PRKCH;CTSK;CYP27B1;CBFB;ZFP36;ZFP36L1;TRIM16
prerank,vascular process in circulatory system (GO:0003018),0.5382445165767913,1.1430450426768812,0.31433823529411764,0.7136747168138432,1.0,2/13,2.59%,NOS3;NPR1
prerank,regulation of tube diameter (GO:0035296),0.5382445165767913,1.1430450426768812,0.31433823529411764,0.7136747168138432,1.0,2/13,2.59%,NOS3;NPR1
prerank,cellular response to organic substance (GO:0071310),0.3856071279811747,1.1428140871279395,0.24720496894409938,0.7135595087657312,1.0,19/116,7.68%,LEF1;PTPN14;BMPR2;ACVRL1;PDGFB;PTPN12;SOCS2;STAT3;SIGIRR;NCOA1;GHR;ACVR2A;MAPK8;ASAH2;RAMP2;ACVR1;INPP5K;TGFB1;CASP1
prerank,oligosaccharide metabolic process (GO:0009311),0.4348304678803496,1.1420101539892398,0.30576070901033975,0.7149981937381457,1.0,2/46,0.45%,ST3GAL6;ST6GALNAC3
prerank,second-messenger-mediated signaling (GO:0019932),0.39731983857434894,1.141924653556315,0.2706359945872801,0.7145204001706719,1.0,12/82,11.02%,NOS3;MCTP1;PLCG1;EDN1;SELE;PLCG2;PPP1R9B;CX3CR1;NEUROD1;CXCR4;NMUR2;P2RY12
prerank,regulation of neuroblast proliferation (GO:1902692),-0.46749896221020687,-1.141555433393989,0.30855855855855857,0.7401333885343336,1.0,7/15,14.60%,PTN;NF1;LRRK2;SMARCD3;VEGFA;FZD3;TAFA1
prerank,activation of protein kinase A activity (GO:0034199),-0.46139585093327834,-1.1413953375459065,0.2796208530805687,0.7390409204038747,1.0,10/16,16.77%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6;PRKACA;PRKAR1B;PRKAR1A;ADCY3;PRRC1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.5222131471825375,1.1409724500835559,0.31703204047217537,0.7162943941926654,1.0,3/17,8.63%,PLA2G4A;PLA2G2D;PLAAT3
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3698885439039312,1.140970201922181,0.22655298416565164,0.7156146862062833,1.0,32/158,12.68%,NOD1;TNFSF10;TNFRSF19;PRKD1;TRIM14;CASP8;FKBP1A;PLEKHG5;TIRAP;EDAR;IKBKB;TRIM68;PELI1;PLK2;CD40;MID2;TNFRSF1A;ATP2C1;NEK6;CASP1;MAP3K3;TRIM25;MALT1;BRD4;IKBKG;IRAK4;RIPK1;BIRC3;CARD16;MIER1;RELA;RIPK2
prerank,cellular response to tumor necrosis factor (GO:0071356),0.36394426827977183,1.1407688391385802,0.22235434007134364,0.7154276835479102,1.0,45/175,18.55%,DAB2IP;ARHGEF2;AIM2;PTK2B;TNFRSF11A;TNFRSF1B;NFKBIA;ACTN4;TRAF1;TMSB4X;TNFRSF25;EDAR;IKBKB;CD40;TNFSF8;DCSTAMP;INPP5K;TNFRSF1A;PSMA2;TNFRSF13C;YBX3;TNFRSF9;TNFRSF8;PSMA8;PSMA6;CCL14;RIPK1;BIRC3;RELA;ZFP36;GBP3;ADAM17;HAS2;TRAF6;ASAH1;ZFP36L1;PSME1;BAG4;STAT1;BIRC2;ERBIN;PSMA4;CIB1;PSMF1;TNFRSF12A
prerank,long-chain fatty acid metabolic process (GO:0001676),0.41377486769425553,1.1406460962902647,0.2652777777777778,0.7150498968569965,1.0,13/64,15.52%,PTGS2;PLA2G4A;ACSL4;ELOVL5;ASAH2;EPHX1;ACSL5;LTC4S;CPT1A;ABCD1;GSTP1;PNPLA8;FAAH
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5752340053041437,1.140592731275109,0.33030852994555354,0.7144919237992949,1.0,4/10,16.13%,DAB2IP;EFNA1;EPHA4;RIC1
prerank,regulation of monocyte differentiation (GO:0045655),0.5312780522058964,1.1403229098232446,0.3165217391304348,0.7145404819400704,1.0,5/14,9.40%,CDK6;FOXP1;DCSTAMP;CTNNBIP1;CSF1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.5413554631762476,1.1403002992512348,0.31314878892733566,0.7139028062393951,1.0,4/15,7.19%,JAK3;SMAD7;CUEDC2;TGFB1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.5237473948000737,-1.1398477448437623,0.326271186440678,0.7418504201548581,1.0,6/10,21.75%,IRS1;IRS2;SLC45A3;SNCA;GPLD1;PTH1R
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.507404464820376,1.138477825619116,0.3350694444444444,0.7178502906377842,1.0,6/20,12.24%,SMAD1;HIF1A;NOTCH1;XBP1;SMAD5;RELA
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.5280806388156793,1.1380302174405457,0.3231597845601436,0.7183210299458389,1.0,7/12,15.53%,CYP26A1;KLF2;CYP26C1;CNOT1;ASXL1;SNW1;TRIM16
prerank,positive regulation of T cell proliferation (GO:0042102),0.4208602637094866,1.1378899445635655,0.2855072463768116,0.7180136659935894,1.0,9/55,9.77%,IL6ST;VCAM1;IL15;NCK1;JAK3;IL27RA;TNFRSF13C;IL23A;ICOSLG
prerank,detection of calcium ion (GO:0005513),-0.4759195417252478,-1.1377751639349876,0.2942583732057416,0.7462740099220536,1.0,4/13,8.88%,SYT1;KCNMB2;STIM1;RYR2
prerank,peptide metabolic process (GO:0006518),-0.32315714952886815,-1.1375426647275486,0.18705035971223022,0.7453881569837548,1.0,12/75,10.21%,AEBP1;DMD;CPQ;MGAT3;PCSK5;GSTT1;NPEPPS;CPXM2;ENPEP;GSTM1;CPXM1;SPCS3
prerank,negative regulation of cell communication (GO:0010648),0.4889043577802499,1.13747901205699,0.3252818035426731,0.718436387199469,1.0,5/21,9.08%,KIF26A;SRMS;FGF23;ACVR1;PTPN1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.55861846794659,1.1364893062375914,0.34766355140186916,0.719596602772966,1.0,3/11,6.74%,PTK2B;JAK3;JAK1
prerank,cellular response to interleukin-2 (GO:0071352),0.55861846794659,1.1364893062375914,0.34766355140186916,0.719596602772966,1.0,3/11,6.74%,PTK2B;JAK3;JAK1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.5323519801122762,1.1358220665115017,0.3262786596119929,0.7207281043276627,1.0,6/13,19.88%,BCL2L11;BNIP3;BMF;RHOT1;RHOT2;BNIP3L
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.5579705773441633,1.135346673120904,0.340036563071298,0.721220323112439,1.0,3/11,7.19%,MEF2C;GREM1;TGFB1
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.459216306771954,1.1352279474501552,0.3098159509202454,0.7208612369071323,1.0,9/31,10.72%,CDK6;LRP5;HDAC7;NOTCH1;FGF23;SOX9;GREM1;CITED1;SEMA4D
prerank,pulmonary valve development (GO:0003177),0.505029874946485,1.1352107330293673,0.3373083475298126,0.7202236141384416,1.0,5/18,3.04%,NOS3;BMPR2;NFATC1;NOTCH1;TNFRSF1B
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.36281143916633274,1.1350256598775588,0.24719101123595505,0.72006468941282,1.0,26/150,9.18%,TEK;ENG;ESR1;INSR;KITLG;PDGFB;HIP1;MFHAS1;RASD2;PTPRJ;FYN;FGF23;F7;TCF7L2;CX3CR1;RET;RAC1;TRIB3;TGFB1;LCK;PTK2;PIK3CG;TGFA;GAB1;AKT2;RICTOR
prerank,fatty acid elongation (GO:0030497),0.5323014620934647,1.134625491479726,0.32169117647058826,0.7204406308267726,1.0,2/13,3.90%,ELOVL7;ELOVL5
prerank,regulation of autophagy (GO:0010506),0.35731781549509445,1.134534785987878,0.21882086167800455,0.7199617600030508,1.0,35/216,11.44%,FOXO1;ACER2;ERN1;PRKD1;DAPK1;RASIP1;SH3BP4;STAT3;TRIM14;FBXW7;PIK3C2A;EIF4E;MAPK8;TRIM68;PLK2;ULK1;BOK;DRAM2;MID2;SH3GLB1;TRIB3;ATP6V0A1;NEDD4;RPTOR;FOXK1;ATG101;ATP6V1G2;FBXL2;EXOC4;NPRL2;DEPP1;PRKAB1;BNIP3;ABL2;ATF6
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.5041549263023455,-1.1344363605930925,0.32265446224256294,0.7527353394958561,1.0,5/11,21.92%,STX4;TICAM1;MAVS;ITGB2;CAMK4
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.5051626945709465,1.1343327307690925,0.3216168717047452,0.719807490410032,1.0,9/17,25.56%,NUS1;DPAGT1;ALG6;ALG8;MPDU1;DOLK;ALG12;ALG14;DOLPP1
prerank,regulation of secretion by cell (GO:1903530),0.4180519297020529,1.1342657727529104,0.2936857562408223,0.7192885792247746,1.0,14/54,17.21%,MCTP1;MEF2C;KCNMB4;SNCAIP;LLGL1;RAB12;VAMP8;RAB26;MCTP2;FMR1;RHBDF2;RIC1;RAB8B;CPLX2
prerank,homocysteine metabolic process (GO:0050667),-0.49162684610887714,-1.1342296545772488,0.33189655172413796,0.7517576499577163,1.0,6/11,25.00%,NOX4;CBS;BLMH;CTH;MMUT;MTRR
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4089887068139891,1.1340368937344274,0.2845303867403315,0.7192132879114338,1.0,15/63,12.77%,TNFSF10;CAV1;ITGA6;FAS;CASP8;TRAF1;PAK2;TCF7L2;ACVR1;ZMYND11;RIPK1;BID;RELA;GSTP1;PHIP
prerank,regulation of focal adhesion assembly (GO:0051893),0.42310401369701844,1.1339857264141628,0.28489208633093527,0.7186603728973134,1.0,10/54,7.32%,TEK;LIMCH1;KDR;ACVRL1;PEAK1;PTPRJ;PPM1F;DUSP22;RAC1;PTK2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.39786390491003537,1.1338530021587996,0.2609289617486339,0.7183027750630674,1.0,22/76,21.62%,CD200;NLRC5;DAB2IP;AIM2;NFKBIA;TMSB4X;ARRB1;LRRC14;IRAK3;DDIT3;G3BP2;OTULIN;CHP1;ERBIN;IRAK2;MAP2K5;USP7;NLRP3;TAX1BP1;HAVCR2;DAP;NLRC3
prerank,glycogen metabolic process (GO:0005977),-0.4044973707825726,-1.1334542524808116,0.30971128608923887,0.7524934676624936,1.0,12/27,20.51%,PYGB;PHKB;PYGM;PRKAG2;PER2;GAA;PPP1R3C;UGP2;AGL;GYS1;PHKG1;PHKA2
prerank,regulation of nervous system development (GO:0051960),-0.3746944558004495,-1.1334516325189103,0.22674418604651161,0.7509333714403338,1.0,12/37,19.07%,DOCK7;PTN;SIRT2;PER2;HEYL;LGI4;BHLHE41;HEY2;NPHP3;HMGB2;HEY1;TENM4
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.5074617717385825,-1.1333917245845442,0.32489451476793246,0.7495522686397543,1.0,1/10,0.41%,ZEB2
prerank,positive regulation of vasoconstriction (GO:0045907),0.5364164942506483,1.1331659805179863,0.35315985130111527,0.7193183254110954,1.0,1/13,0.87%,CAV1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.3629262757214799,-1.1330915720723322,0.23809523809523808,0.7489373773509779,1.0,12/48,14.80%,ANK2;DMD;CEMIP;JPH1;AKAP6;PRKACA;TRPC1;UBASH3B;GSTM2;GPER1;JPH2;SNCA
prerank,cAMP metabolic process (GO:0046058),-0.4774688315642859,-1.133078386037527,0.3242009132420091,0.7474094362862289,1.0,5/13,5.03%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6
prerank,regulation of JUN kinase activity (GO:0043506),0.4482040437787063,1.132989334040636,0.29853181076672103,0.7190867773554448,1.0,13/33,20.27%,DAB2IP;EDN1;TNFRSF11A;SASH1;DNAJA1;MAP3K11;AIDA;GSTP1;TRAF6;PAK1;HIPK3;DUSP19;RPS3
prerank,positive regulation of immune response (GO:0050778),0.40892933246274565,1.1328257490242286,0.275,0.718832060320411,1.0,13/64,19.89%,IL6ST;IL15;GBP5;XBP1;SKAP1;IL23A;NMI;EIF2AK4;KARS1;PLSCR1;POLR3B;NLRP3;SLC15A4
prerank,neuron maturation (GO:0042551),0.5072042539726225,1.1324648858415276,0.32608695652173914,0.7190936346533912,1.0,4/18,6.84%,APP;ANKS1A;SCARF1;B4GALT5
prerank,protein autoubiquitination (GO:0051865),-0.3391767747630232,-1.132394487754693,0.2669039145907473,0.74798085097981,1.0,13/61,13.01%,RNF220;PRKN;SH3RF1;SH3RF3;RNF13;SH3RF2;AMFR;RNF181;MDM2;LRSAM1;DDB2;ITCH;UBE2B
prerank,negative regulation of blood coagulation (GO:0030195),0.43710695146393125,1.1312968328026722,0.3046757164404223,0.721318877882713,1.0,5/38,4.52%,NOS3;PDGFB;EDN1;CD34;F7
prerank,regulation of response to oxidative stress (GO:1902882),0.5547953614377751,1.1310424939954047,0.359106529209622,0.7212726553485856,1.0,1/11,0.55%,MCTP1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.4738870396939521,1.1307379780747684,0.3113964686998395,0.7213881790853716,1.0,6/26,12.13%,RAB27A;PLCG2;ABCB7;COA8;GRIN1;ABCD1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.508397969388709,1.1306449482251022,0.34219269102990035,0.7209700166119725,1.0,1/17,0.21%,TEK
prerank,long-chain fatty acid import into cell (GO:0044539),0.5602950126832175,1.130589228532754,0.34896810506566606,0.7204362577945856,1.0,1/10,0.53%,SLC2A1
prerank,anterior/posterior pattern specification (GO:0009952),-0.34282359347343555,-1.13054025928315,0.2508250825082508,0.7520505470921538,1.0,12/53,7.01%,WLS;HOXC4;HOXC6;TGFBR1;HOXA3;HOXA5;PCSK5;HOXA7;HOXC5;HOXB4;HOXB3;HEYL
prerank,regulation of vasoconstriction (GO:0019229),0.47077736414027527,1.130442008729507,0.30097087378640774,0.7201076896546051,1.0,3/27,5.43%,BMPR2;CAV1;KCNMB4
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.4668740276065997,1.130106315892559,0.32247557003257327,0.7203068361621687,1.0,12/25,28.42%,CHMP2B;CHMP4A;CHMP4B;RILP;TMEM50B;VTA1;LEPROT;CHMP3;TMEM50A;LYST;CHMP4C;SORT1
prerank,regulation of protein autophosphorylation (GO:0031952),0.44732856257384834,1.1299120163880423,0.31268882175226587,0.7201282054006649,1.0,8/36,8.58%,ENG;PDGFB;PPP2R5A;PDGFD;TAOK2;PDGFC;PPP2R5E;PPP2R5B
prerank,negative regulation of protein modification process (GO:0031400),-0.32926919797477194,-1.1294022768296226,0.23357664233576642,0.7538952394307283,1.0,12/79,6.30%,PID1;PTPN13;NTRK3;DMD;PLPP3;PRKN;SNTA1;FBLN1;IGFBP3;IMPACT;PRKAA2;LRP6
prerank,phosphatidylinositol metabolic process (GO:0046488),0.38097863533817616,1.1288577434147358,0.2729624838292367,0.7221703585249417,1.0,21/109,10.43%,INPP5D;PLA2G4A;PLCG1;PIP5K1B;PITPNM2;MTM1;PGAP1;PIK3C2A;PLCB1;PLCG2;PIK3R6;MTMR6;PLA2G2D;INPP5K;BMX;PIK3CG;PLAAT3;SYNJ1;PLEKHA8;OCRL;INPP5F
prerank,protein localization to cell junction (GO:1902414),0.4797570908986396,1.1287990517814044,0.3366174055829228,0.7216545073213052,1.0,5/22,6.74%,TJP1;HEG1;TJP2;PAK2;JAK1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.45083662881381564,1.1287695696022504,0.28680981595092025,0.7210647274350143,1.0,5/38,2.48%,CAV1;APP;PDGFB;NEDD9;EFNA1
prerank,MAPK cascade (GO:0000165),0.3446947781007288,1.1286631233649165,0.22404371584699453,0.7206878484144152,1.0,49/295,11.51%,SHANK3;TEK;RASAL2;KDR;MEF2C;SPTBN1;KITLG;RASGRF2;PDGFB;DAB2IP;FYN;TAOK2;RASGRP3;FGF23;SOX9;MARK3;JAK3;IKBKB;CSF2RB;MAPK8;RET;RAPGEF2;NRAS;KRAS;JAK1;TNIK;TGFB1;PTK2;SYNGAP1;RASA1;NFKB1;PSMA2;TGFA;MAP3K3;RASA4;SHOC2;ZDHHC9;MAPK11;IKBKG;PSMA8;BCL2L1;PSMA6;RGL2;CCM2;RASA2;SPTAN1;ICMT;CUL1;GRIN1
prerank,cellular response to ketone (GO:1901655),-0.3813837294226718,-1.1283604521351367,0.2852760736196319,0.7552418079667077,1.0,11/35,9.21%,ADCY5;ROCK2;ADCY1;ADCY2;AR;ADCY6;SPP1;GNAI1;SFRP1;SRC;PTGFR
prerank,negative regulation of viral life cycle (GO:1903901),0.5220661706169929,1.128084655747291,0.3285968028419183,0.7214910799395903,1.0,4/15,7.58%,LY6E;PTX3;MID2;SNX3
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.40320593327874804,-1.1280194898374138,0.27296587926509186,0.7546172124722681,1.0,3/26,8.20%,ATP1A2;GNB5;ADRA2A
prerank,histone deubiquitination (GO:0016578),0.5103199575395193,1.1279361917472213,0.3150684931506849,0.7211920882398192,1.0,8/18,21.44%,USP3;USP15;BRCC3;ENY2;USP7;USP21;TRRAP;ATXN7
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3579501639824835,1.127633245286803,0.24468085106382978,0.7212579624382334,1.0,42/190,13.51%,CAV1;ESR1;CD2AP;SH3BP4;DAB2IP;PDE2A;LYN;DDIT4;HDAC7;PTPRJ;PDE4D;ADGRG3;CASP8;TMSB4X;MARK3;PIK3IP1;TNFAIP8L1;VGLL4;ATP2B4;TRIB3;INPP5K;WWC2;UBR1;PPP2R5B;TNIP1;MAP2K3;BCL2L1;NPRL2;CYRIB;APLNR;NMI;ZMYND11;PDE3A;RIPK1;PEBP1;RELA;XDH;NOP53;GSTP1;RACK1;ADIPOR1;THEM4
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.3056338468278568,-1.127108932796038,0.15,0.755585729185866,1.0,38/117,19.92%,IGF1;ALDH1A2;ABAT;ACADSB;PPARA;ME1;CYP26B1;ACOT11;ALDH4A1;GGT5;CPT1C;NAAA;MCCC2;CKB;PER2;ME2;PCCB;ACSL3;ECHDC3;MECR;AASDH;SLC5A6;LDHB;VDAC1;GPAM;SCPEP1;HOGA1;PDHA1;SCP2;ALOX12;DLAT;PDZD11;ACSF2;ANGPTL3;AOAH;CYP2S1;SLC27A4;HAGH
prerank,monocarboxylic acid catabolic process (GO:0072329),0.4936878287089856,1.127094291525809,0.33665008291873966,0.721992624081913,1.0,4/21,6.67%,PPARD;CYP26A1;LPIN3;CYP26C1
prerank,negative regulation of hormone secretion (GO:0046888),0.5678381113537715,1.1265700295999836,0.3663003663003663,0.7226243843555571,1.0,3/10,5.33%,RAB11FIP1;FGF23;RAB11FIP5
prerank,protein targeting to membrane (GO:0006612),0.3912119281335294,1.1264746357400977,0.28415300546448086,0.7222066014288907,1.0,26/83,19.50%,PARD3;AQP11;TAOK2;SDCBP;SEC63;TRAM1;ZDHHC18;CHMP4A;CHMP4B;PEX26;ZDHHC9;ICMT;MYO1C;ABCD1;ALDH3A2;PEX14;VPS37C;RAB8B;ARL6IP1;ZDHHC24;SEC62;SIL1;ZDHHC1;NACA;ZDHHC6;SSR1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.5665057868015146,1.1263567697011894,0.3359683794466403,0.7218513690311922,1.0,3/10,12.34%,CAV1;KCNE2;KCNRG
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4590114984113643,1.1263258296462446,0.3099510603588907,0.7212595269365257,1.0,9/34,11.98%,FOXO1;GATA2;WWTR1;WNT5A;TRIB3;TGFB1;ZFPM1;ASXL1;TRIO
prerank,regulation of innate immune response (GO:0045088),0.41456492009128776,1.125789364408231,0.3052486187845304,0.7219975653828443,1.0,18/57,18.35%,GBP5;SAMHD1;CASP8;TIRAP;N4BP1;XIAP;IFNAR2;ERAP1;PTPN1;NMI;BIRC3;HSP90AB1;IRAK3;BIRC2;PLSCR1;CDC37;POLR3B;PARP9
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.4546027477879817,-1.125724413119024,0.2982005141388175,0.7582585601075915,1.0,4/17,2.89%,PID1;NUPR1;HDAC4;PPARA
prerank,regulation of protein dephosphorylation (GO:0035304),0.448531646915842,1.1257180421079318,0.31587057010785824,0.7215270122683417,1.0,4/37,2.50%,PPP1R16B;PPP2R5A;PPP1R2;MFHAS1
prerank,cardiac muscle cell development (GO:0055013),-0.4272038108149434,-1.1256291711691815,0.2817551963048499,0.756976091871441,1.0,7/20,11.06%,PDGFRB;PDGFRA;CXADR;SLC8A1;OBSL1;VEGFA;FHOD3
prerank,glutamate receptor signaling pathway (GO:0007215),0.4497178090894841,1.125564805609827,0.3082942097026604,0.7212660373812015,1.0,6/37,4.05%,GNAQ;APP;PTK2B;PLCB1;HOMER2;KCNB1
prerank,gene silencing by miRNA (GO:0035195),0.4668563306772788,1.1254600606508816,0.30495356037151705,0.7208681235726435,1.0,10/32,13.14%,CNOT6;TNRC6C;DICER1;PUM1;CNOT1;EIF6;ADAR;PUM2;ZFP36;CNOT7
prerank,base conversion or substitution editing (GO:0016553),0.5526419733153409,1.1253907005336412,0.34111310592459604,0.7203970108775651,1.0,3/11,11.59%,ADARB1;NUDT16;ADAR
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.41863085564953556,-1.1253435818255193,0.3145780051150895,0.7562900374529246,1.0,6/21,6.96%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6;GUCY1A1
prerank,cytoskeleton organization (GO:0007010),0.3702901011136455,1.1251769653346757,0.2610340479192938,0.7202922121830907,1.0,18/114,9.05%,SEMA6A;FGD5;ARAP3;NEDD9;FGD6;NECTIN2;DST;FMNL3;SIPA1L3;CDC42BPB;MAST2;FMNL2;RAC1;CECR2;TNIK;RHOBTB1;ANK1;ZRANB1
prerank,ventricular septum morphogenesis (GO:0060412),-0.40619604084407956,-1.124972781873325,0.30833333333333335,0.7558564533051102,1.0,8/27,7.01%,ROBO1;BMPR1A;TGFBR3;TGFBR1;BMP4;ZFPM2;ROBO2;HEYL
prerank,response to interleukin-6 (GO:0070741),0.5733318133633174,1.124567296460137,0.35135135135135137,0.7211890523707123,1.0,4/10,8.44%,ST3GAL6;SBNO2;NFKB1;CITED1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.32272195387994174,-1.1241675472868375,0.23134328358208955,0.7566114675240673,1.0,20/75,11.84%,DOCK7;SDC2;FGFR2;DCDC2;MAP2;BRSK1;S100A6;ANK3;FARP1;SHTN1;RYK;NTNG1;MAP6;S100B;CTNNA2;DCC;NRCAM;CNTN4;BAIAP2;RAB10
prerank,myotube cell development (GO:0014904),-0.5190471148868621,-1.123991076187597,0.35550935550935553,0.7556318937238538,1.0,2/10,5.73%,IGF1;SIX1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.4706634750969002,-1.1239582726631954,0.291196388261851,0.7541966829951948,1.0,8/16,33.42%,SLC39A14;PRKCA;GPER1;MRAP2;ACP3;C3;PDE6G;GRP
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.503649720346018,1.1239517893399675,0.34539473684210525,0.7220497907523378,1.0,2/18,2.55%,SHANK3;PTK2B
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.5349949687392475,1.1239320138795765,0.3565217391304348,0.7214425266958356,1.0,4/14,10.53%,PLCG1;ECSCR;CD40;ANO6
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.48716016865381623,1.1233707221822453,0.34098360655737703,0.7222087658301837,1.0,8/24,9.92%,MEF2C;CDH2;CTNNA1;TCF3;BNIP2;CDH15;MAPK11;SPAG9
prerank,mitochondrion transport along microtubule (GO:0047497),0.5271361668442519,1.1233613941469263,0.34615384615384615,0.7215757249303127,1.0,6/13,23.77%,HIF1A;RHOT1;RHOT2;OPA1;UXT;NEFL
prerank,carbohydrate catabolic process (GO:0016052),-0.3636496074113388,-1.1232360963188317,0.24096385542168675,0.7547890303028572,1.0,20/38,38.61%,ENO2;HK2;TPI1;ENO3;PFKFB1;PFKM;NEU1;ALDOA;NAGA;PKM;ENO1;ALDOC;MAN2C1;NEU2;HKDC1;GAPDH;ALDOB;NEU3;ENO4;HK3
prerank,positive regulation of chemotaxis (GO:0050921),0.42802472871577724,1.1231456393589248,0.30338733431516934,0.7214227284560866,1.0,9/43,4.52%,KDR;STX3;PRKD1;PDGFB;IL6R;PRKD2;PPM1F;TMSB4X;F7
prerank,regulation of microglial cell activation (GO:1903978),-0.4566201688732764,-1.123098573109408,0.32608695652173914,0.7536633850906451,1.0,7/15,31.85%,LDLR;SYT11;SPHK1;TTBK1;PTPRC;TREM2;GRN
prerank,mitochondrion morphogenesis (GO:0070584),-0.4904003306463756,-1.1229202366092415,0.34521158129175944,0.7526263070572317,1.0,1/11,0.15%,PID1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.41522070347948165,1.1228282264932963,0.29831932773109243,0.7215283022838906,1.0,11/56,7.19%,BMPR2;ENG;RBPMS;ACVRL1;SDCBP;ACVR2A;SMAD7;GREM1;ACVR1;SNX25;TGFB1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.45895000570678646,-1.12252766075644,0.32084309133489464,0.7521970023457136,1.0,3/16,6.04%,PRKN;PDK1;RORA
prerank,muscle cell development (GO:0055001),-0.38474887883070585,-1.1223152168363526,0.30310880829015546,0.7512325112744631,1.0,9/30,9.62%,ANK2;IGF1;DMD;CXADR;SLC8A1;SGCZ;EFEMP2;VEGFA;BIN1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.31648117125473707,-1.1222917100395742,0.21722846441947566,0.7498086871688515,1.0,19/84,14.68%,CELF2;SON;DDX5;RBFOX1;CELF4;FXR2;DAZAP1;DDX17;NOVA1;RBFOX2;SRPK2;TIA1;U2AF2;CIRBP;RBM4;SF1;CELF1;HNRNPU;HNRNPA1
prerank,regulation of tumor necrosis factor production (GO:0032680),0.37228733322538793,1.1222082201883106,0.283289817232376,0.7224697576730505,1.0,24/112,15.51%,APP;FOXP1;ARHGEF2;STAT3;PTPRJ;PLCG2;CD34;TIRAP;CX3CR1;WNT5A;LPL;PSEN1;DICER1;TNFRSF8;IL23A;MC1R;GAS6;RIPK1;GSTP1;ZFP36;IFIH1;ILRUN;IRAK3;VSIR
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.35924566696031396,1.122100661657246,0.2708089097303634,0.7220680559615116,1.0,29/182,9.21%,KDR;ENG;ESR1;APP;MEF2C;ACVRL1;CLDN5;OCLN;ANKRD13A;PDGFB;RIN3;FOXP1;GATA2;ADAM10;FBXW7;HIF1A;NOTCH1;CD34;SDCBP;DLL4;ATP2B4;TNRC6C;AURKA;TGFB1;NFKB1;SFRP2;PSEN1;SUB1;DICER1
prerank,positive regulation of cell killing (GO:0031343),0.5310036799387104,1.121844819914392,0.31868131868131866,0.7220301811969193,1.0,3/13,6.19%,MAPK8;WNT5A;RAC1
prerank,cellular amino acid catabolic process (GO:0009063),-0.31978901032907375,-1.1217231692219065,0.24814814814814815,0.7498860546333639,1.0,24/87,17.13%,DDO;GLUL;ABAT;ACADSB;ASPA;ALDH4A1;MCCC2;IVD;PRODH;HMGCLL1;ALDH7A1;FAH;HNMT;BCKDHB;PHYKPL;ACAT1;GOT1;CBS;HOGA1;ACAD8;CARNS1;GSTZ1;BLMH;ALDH6A1
prerank,mitochondrion localization (GO:0051646),0.4911418066984724,1.1217046469436425,0.3385416666666667,0.7217464112804521,1.0,7/19,18.61%,NECTIN2;MTM1;MEF2A;MSTO1;MFN1;ZBED3;TRAK2
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.4619853247343878,-1.1216438573285237,0.3105022831050228,0.7486369955445076,1.0,4/15,9.10%,PRKN;BCL2;CD44;MDM2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.34783546817557487,-1.1210635301289376,0.25501432664756446,0.7487669331553083,1.0,8/52,6.56%,CELF2;DDX5;RBFOX1;CELF4;FXR2;DDX17;NOVA1;RBFOX2
prerank,activation of GTPase activity (GO:0090630),0.3812889268660591,1.1204335020523044,0.2769640479360852,0.7244044622003237,1.0,13/89,6.30%,TBC1D8;RALGAPA2;TBC1D30;ARHGEF15;TBC1D4;CCDC125;BCR;RALGAPA1;SGSM1;TBC1D22A;TBC1D15;SIPA1L3;TBC1D12
prerank,regulation of developmental growth (GO:0048638),0.46456387113618924,1.1204293344768483,0.3102918586789555,0.723762632538769,1.0,5/29,4.92%,APP;INSR;PLCB1;DLL1;GHR
prerank,positive regulation of heart contraction (GO:0045823),-0.43865017861404176,-1.1199334199732827,0.3256997455470738,0.7505055577498586,1.0,5/19,12.18%,ATP1A2;ATP2A2;RYR2;TGFB2;ADRA1A
prerank,hyaluronan catabolic process (GO:0030214),-0.4332861354617988,-1.1195776763884193,0.31971153846153844,0.7501187355766126,1.0,6/18,16.16%,CEMIP;FGF2;CD44;HEXA;SLC9A1;HYAL1
prerank,positive regulation of protein catabolic process (GO:0045732),0.3885886036565165,1.1194161485454621,0.28761651131824234,0.7256734458242247,1.0,11/84,7.73%,FOXO1;SMURF1;DAB2IP;NEDD4L;MSN;TNFRSF1B;VGLL4;PLK2;WNT5A;CDKN1B;NEDD4
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.41844681172599696,1.119277848658203,0.29806259314456035,0.7253401059560366,1.0,8/50,14.13%,NOD1;APP;ACTN4;SASH1;IL23A;NMI;RELA;TRAF6
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.4536467049288836,-1.1191557841993862,0.3150984682713348,0.7498160027264819,1.0,12/15,51.86%,FAH;GSTZ1;KYAT1;HGD;HAAO;KYNU;AADAT;TDO2;KMO;QDPR;IDO1;ACMSD
prerank,regulation of B cell activation (GO:0050864),0.4592759608979456,1.11898180409961,0.32608695652173914,0.7253997050629929,1.0,9/25,29.19%,AHR;SAMSN1;ZFP36L1;TNIP2;IKZF3;SH3KBP1;NOD2;THEMIS2;TNFAIP3
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.46642261047042255,-1.1187616796786963,0.3392461197339246,0.7494481777667482,1.0,5/14,16.72%,IL18;CD55;PTPN22;CD81;SYK
prerank,positive regulation of secretion by cell (GO:1903532),0.3986606205589944,1.1184816326937126,0.29714285714285715,0.7259664187243313,1.0,10/70,8.96%,RAB27A;UNC13B;CADPS2;CD2AP;EDN1;KCNB1;EXPH5;TGFB1;STX1A;ANG
prerank,cell chemotaxis (GO:0060326),-0.3447262180546741,-1.117894257908552,0.2576271186440678,0.7503851618596863,1.0,11/60,6.06%,LPAR1;PDGFRB;PDGFRA;NRP1;KIT;SEMA5A;CCR9;PRKCD;PARVA;CCN3;AGTR1
prerank,protein localization to cell periphery (GO:1990778),0.3658237083267821,1.1176291033596188,0.2656826568265683,0.7274276852480204,1.0,24/133,7.67%,CAV1;EHD4;SPTBN1;F11R;SMURF1;RAB11A;TSPAN5;DENND4C;BSG;NKD2;PACS1;FCHO2;KCNB1;IKBKB;TSPAN14;RAMP2;RAPGEF2;TMEM88;INPP5K;ATP1B3;TNFRSF1A;TNIK;EHD2;RAP1A
prerank,amino acid transmembrane transport (GO:0003333),-0.36012486315629166,-1.1174883269330824,0.27491408934707906,0.7500676254674018,1.0,6/45,3.64%,SLC7A11;SLC6A13;SLC47A1;SFXN2;SLC38A11;SLC22A4
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.4553311780197582,1.1174166716992435,0.3222748815165877,0.7273164811181816,1.0,7/30,6.87%,NET1;F11R;ARHGEF3;PRAG1;ADGRG1;RAC1;ARRB1
prerank,regulation of neuron differentiation (GO:0045664),-0.33200367056512853,-1.1173535476185106,0.2529182879377432,0.7490015709986023,1.0,29/76,20.46%,ZFHX3;NBL1;BMP7;IMPACT;VWC2;YWHAG;NGF;SIX1;NLGN1;HEYL;DTX1;LRRK2;NRCAM;BIN1;ALK;CNTN4;BRINP3;GPRC5B;NREP;MMD2;DISP3;HEY1;REST;SOX2;CDK5RAP3;NTF3;TIAM1;ID2;KCTD11
prerank,organelle assembly (GO:0070925),0.3375677442540305,1.1168273436571654,0.22570194384449244,0.7281936423889178,1.0,55/384,13.01%,PGM5;ABCC4;FLII;ABLIM1;FNBP1L;EXOC6;EHD4;NEK7;RAB11A;NOTCH1;STARD9;CNGB1;CD34;TMOD3;SSX2IP;DISC1;CEP41;STX7;EDC3;ULK1;ABCA3;CHMP2B;PCNT;BBIP1;CDS2;RBM14;EHD2;NEK6;GRB7;DYNLL1;EXOC5;RAB38;CHMP4A;CHMP4B;ATG101;TEKT5;G3BP1;EXOC4;VPS28;OCRL;CEP83;ARL13B;RC3H1;RPS23;ACTR2;LSM3;EMC6;EHD3;DBNL;GABARAPL1;RAB43;RILP;WDR11;RAB7A;MYH6
prerank,negative regulation of immune response (GO:0050777),0.3599730840462043,1.1165292685831765,0.2703349282296651,0.7283238308933828,1.0,22/154,11.05%,CALCRL;CYSLTR1;ADCY4;PLCG1;MYH9;LYN;YES1;GNB1;FYN;PRKAR2B;PLCG2;ADRB1;PLK2;RAMP2;SAMSN1;CREB1;FCGR1A;INSL3;MC1R;NMI;MC4R;RC3H1
prerank,positive regulation of cytokinesis (GO:0032467),0.44856407179558977,1.1164719321041459,0.3293051359516616,0.7278181284483453,1.0,7/32,17.22%,PKP4;PKN2;AURKC;KIF23;GIPC1;RHOA;CUL3
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.4088376474893296,-1.1164661020143132,0.33251833740831294,0.7501490149463518,1.0,3/23,4.34%,FGFR2;TGFBR3;TPM1
prerank,cell projection assembly (GO:0030031),0.4769831014888486,1.1161507180148427,0.34024179620034545,0.7279991518865404,1.0,4/22,6.19%,PARVB;RHOJ;NCKAP1;RAC1
prerank,regulation of T cell mediated immunity (GO:0002709),0.5485462194577396,1.116121400293644,0.3690248565965583,0.7274261214040495,1.0,1/10,3.04%,TNFRSF1B
prerank,cellular response to topologically incorrect protein (GO:0035967),0.4479159585698596,1.1151265049629855,0.3343558282208589,0.729251145646053,1.0,6/31,9.12%,ERN1;DAB2IP;TMBIM6;ATXN3;PTPN1;RHBDD1
prerank,positive regulation of nuclear division (GO:0051785),0.46016832022377174,1.1150973969457405,0.3443708609271523,0.7286808316600769,1.0,6/25,7.88%,INSR;PDGFB;EDN1;LRP5;AURKA;TGFA
prerank,regulation of cell-cell adhesion (GO:0022407),0.43177278283716025,1.1147906064385822,0.32272727272727275,0.7288061462172488,1.0,8/39,7.94%,PTPRG;PODXL;MAGI1;CEACAM1;SMAD7;TGFB1;PTK2;NF2
prerank,ganglioside metabolic process (GO:0001573),0.4858814803597762,1.1147213879507702,0.3441033925686591,0.7283176789940925,1.0,4/20,11.40%,ST6GALNAC3;ST8SIA4;ST6GALNAC4;CLN6
prerank,regulation of peptidase activity (GO:0052547),0.48646923740780046,1.114474206807279,0.33843537414965985,0.7283066607084753,1.0,1/19,0.87%,CAV1
prerank,positive regulation of lipid storage (GO:0010884),0.47769035285987144,1.1144012856878553,0.32608695652173914,0.7278344429613433,1.0,4/21,7.58%,SCARB1;PLIN5;LPL;NFKB1
prerank,regulation of cilium assembly (GO:1902017),0.4100299799227623,1.1140417715136952,0.30952380952380953,0.7281111795169248,1.0,7/62,7.83%,TBC1D8;TBC1D30;TBC1D22A;TBC1D15;LIMK2;CCDC88A;TBC1D2
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.48872259288672365,-1.1137834238097244,0.3419354838709677,0.7549092692405427,1.0,4/12,16.61%,IGF1;AKAP6;SLC9A1;CAMTA1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.48872259288672365,-1.1137834238097244,0.3419354838709677,0.7549092692405427,1.0,4/12,16.61%,IGF1;AKAP6;SLC9A1;CAMTA1
prerank,potassium ion homeostasis (GO:0055075),-0.4040944657150831,-1.113697710810884,0.33663366336633666,0.7536759889384037,1.0,6/23,9.89%,ATP1A2;SLC12A2;ATP1B1;KCNMA1;KCNJ2;ATP1B2
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3957972825555196,1.1133614667081926,0.3255172413793103,0.7292541727311392,1.0,20/72,16.71%,ACER2;CNOT6;CNOT6L;PLK2;AURKA;BCL3;CDKN1B;CRADD;SOX4;BTG2;CNOT1;TFAP4;SFN;CNOT2;MUC1;CNOT7;CDC25C;ATRX;E2F7;CHEK2
prerank,regulation of protein secretion (GO:0050708),-0.2969648759786825,-1.1132298670237144,0.1853448275862069,0.7535779955704639,1.0,23/119,12.02%,BMP6;CACNA1C;IGF1;RAPGEF4;SLC12A2;CACNA1D;DPP4;FRMD4A;SNAP25;KCNC2;PER2;PRKCA;KCNS3;EZR;ERP29;ADRA2A;RHBDF1;STXBP5L;APOE;TGFB3;MYOM1;TGFB2;ADAM9
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.3800221392215039,1.112974914600164,0.29624664879356566,0.7295692014604351,1.0,23/95,16.53%,MEF2C;DAB2IP;TNFRSF1B;TIRAP;XBP1;SBNO2;CX3CR1;MAPK8;WNT5A;IL36G;PPBP;NFKB1;CASP1;DEFA6;CYRIB;CARD16;RELA;GSTP1;ZFP36;TRAF6;IRGM;RHOA;CDC73
prerank,glycerolipid metabolic process (GO:0046486),0.5501053001003541,1.1125476204383802,0.3813084112149533,0.7300204321320839,1.0,2/11,9.80%,DGKZ;PDXP
prerank,reverse cholesterol transport (GO:0043691),0.5201246734099215,1.112457769106785,0.35714285714285715,0.7296119936953115,1.0,3/13,15.84%,SCARB1;ABCG1;ABCA1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.47899140549199004,-1.112424551537001,0.3413566739606127,0.7544326870393361,1.0,4/12,12.66%,IRS1;IGF2;PRKCZ;SNX5
prerank,polyol metabolic process (GO:0019751),0.4218575090382691,1.1121327588001257,0.29646017699115046,0.7298042126459666,1.0,9/46,10.42%,INPP5D;PLCB4;PLCG1;PLCB1;PLCG2;ITPKB;SYNJ1;INPP1;OCRL
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.4810864429037444,-1.1120243619698695,0.36486486486486486,0.754126301568073,1.0,4/12,13.32%,PRKCB;LPIN1;PRKCA;CNEP1R1
prerank,blood vessel endothelial cell migration (GO:0043534),0.47534996475979857,1.1117205904339467,0.3339011925042589,0.730206719561897,1.0,6/22,5.28%,KDR;EPHB4;MYH9;SOX18;ID1;GREM1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.5106183760848135,1.111708192226255,0.3421516754850088,0.7295785582313098,1.0,5/16,16.40%,SELE;SELP;RELA;TRAF6;RHOA
prerank,protein localization to organelle (GO:0033365),-0.29646363349010596,-1.1115394663429936,0.20786516853932585,0.754141985092715,1.0,38/133,18.32%,ANK2;COL1A1;BMP7;BICD1;BMP4;TULP3;WDR35;MICALL1;OBSL1;SIX1;LMNA;ARL3;LAMP2;LRRK2;OPTN;IFT20;TIA1;PAF1;MDM2;GBF1;GET4;EHD1;CNEP1R1;BICD2;BBS9;MTCH2;BBS2;SYS1;ARFRP1;DVL1;ABCA7;SCG3;GET1;IFT140;DDRGK1;TULP1;FAM83H;RAB35
prerank,metal ion transport (GO:0030001),0.3785506999325422,1.111443071750176,0.29697766097240474,0.7295970919847615,1.0,17/86,11.28%,CALCRL;CAV1;SLC39A8;SLC3A2;CACNA1E;FYN;CACNA1A;RAMP2;TRPV6;ATP2C1;PKD2;TRPV4;PSEN1;CYP27B1;CDH23;NMUR2;NIPA2
prerank,cardiac ventricle morphogenesis (GO:0003208),0.4424147939138904,1.1112160807035365,0.3158682634730539,0.7295434101074988,1.0,11/41,9.43%,ENG;MEF2C;NOTCH1;FKBP1A;CPE;FOXF1;SMAD7;DLL4;TGFB1;SFRP2;SOX4
prerank,epithelial cell migration (GO:0010631),0.4358051794446955,1.1110718882702242,0.33035714285714285,0.7292669918471263,1.0,8/37,4.40%,NOS3;ADGRA2;PLXND1;PXN;PKN3;PKN2;PLEKHG5;PKN1
prerank,positive regulation of dendritic spine development (GO:0060999),0.48714260123935177,1.1110249028166792,0.3468013468013468,0.7287287011246851,1.0,1/20,0.09%,SHANK3
prerank,sensory perception of light stimulus (GO:0050953),-0.31209163715773536,-1.1105305424724867,0.23348017621145375,0.7555192133245724,1.0,11/87,5.98%,COL1A1;SLC4A10;ADGRV1;EYA4;EML2;COL11A1;EFEMP1;COL18A1;DHRS3;PCDH15;WHRN
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.5698460564006284,1.1101139680656968,0.37662337662337664,0.7303225294114797,1.0,3/10,13.49%,ADAM10;WNT5A;ADAM17
prerank,regulation of histone acetylation (GO:0035065),0.4469933691967841,1.1097422036410127,0.3344,0.7306280481789591,1.0,9/33,20.69%,RPS6KA5;ARRB1;CTBP1;GLYR1;RPS6KA4;RAPGEF3;TAF7;SETD5;TADA2B
prerank,protein-containing complex assembly (GO:0065003),0.3435643943594516,1.1094289343528563,0.26,0.7307257236696313,1.0,42/259,14.61%,LEF1;CTSC;SLC2A1;OCLN;CD2AP;MAGI1;PARD3;ADAM10;FAS;AIM2;PTK2B;TLE4;CASP8;TRAF1;CARD10;SOX9;TCF7L1;TCF7L2;BOK;TEAD2;CD40;TNFRSF1A;FBXL7;TGFA;SKAP2;LLGL1;NIFK;IKBKG;ANO6;TFAP4;CUL1;PICALM;RIPK1;DBNL;TRAPPC3;CAPZA1;PREB;IL1RAP;PEX14;ASH2L;BCL9L;APC
prerank,positive regulation of DNA binding (GO:0043388),-0.38809544818404695,-1.1089440604350436,0.3026706231454006,0.7587113117685839,1.0,4/31,5.63%,IGF1;PRKN;SIRT2;NGF
prerank,negative regulation of hippo signaling (GO:0035331),0.528161689378147,1.1088314063981295,0.35036496350364965,0.7315716441687016,1.0,4/12,9.65%,MARK3;VGLL4;WWC2;MAP2K3
prerank,regulation of chemotaxis (GO:0050920),0.4512501378709193,1.1088178180597286,0.35139318885448917,0.7309536731196232,1.0,10/30,11.02%,STX3;PDGFB;ADGRA2;PPM1F;ZSWIM6;MYCBP2;TGFB1;CYRIB;CXCR4;P2RY12
prerank,negative regulation of cell population proliferation (GO:0008285),0.33625941041286234,1.1087969030589722,0.24248927038626608,0.7303625130842534,1.0,51/351,10.01%,NOS3;PTPN14;BMPR2;SMARCA2;APP;CBFA2T3;ACVRL1;SOX7;CD200;CDK6;B2M;PLPP1;ADARB1;SH3BP4;GATA2;DAB2IP;LYN;PTK2B;NOTCH1;PTPRJ;MTSS1;AQP11;ADGRG1;SLC16A2;SOX9;TES;DLL1;VGLL4;BTG3;PTPRK;GREM1;DLL4;WNT5A;KLF10;RAPGEF2;CDKN1B;PPM1D;TGFB1;PKD2;CTNNBIP1;NF2;RNF139;CTBP1;PINX1;SFRP2;ANG;SOX4;CYP27B1;SST;TNFRSF8;BTG2
prerank,digestive tract morphogenesis (GO:0048546),-0.46897448140847664,-1.1086256716242104,0.31690140845070425,0.758144546105573,1.0,5/14,12.20%,FGFR2;PDGFRA;RBPMS2;GLI1;STRA6
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.47214988730090257,-1.1078693587112372,0.3558951965065502,0.7588937304901507,1.0,8/13,35.59%,SEC16B;CD81;SEC16A;EDEM2;TMEM30B;SORL1;TM9SF4;SAR1A
prerank,regulation of protein export from nucleus (GO:0046825),0.4792090298347378,1.107707000419869,0.34824281150159747,0.7324038007344267,1.0,6/23,17.53%,PTPN14;TCF7L2;GAS6;UHMK1;ANP32B;RAPGEF3
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.4518434170800908,1.1071627157308022,0.3488372093023256,0.7331278838168771,1.0,8/31,14.38%,PPP1R13B;HIP1R;CASP8;MAPK8;BOK;SFN;BID;YWHAQ
prerank,positive regulation of innate immune response (GO:0045089),0.45278947589412544,1.1071436313830658,0.3282208588957055,0.732550122629658,1.0,10/30,19.89%,NLRC5;GBP5;RPS19;WNT5A;NMI;UBE2K;PLSCR1;POLR3B;TRIM62;SLC15A4
prerank,inositol phosphate metabolic process (GO:0043647),0.41936869546593203,1.106832154017956,0.30389221556886226,0.7327013889874235,1.0,9/46,10.42%,INPP5D;PLCB4;PLCG1;PLCB1;PLCG2;ITPKB;SYNJ1;INPP1;OCRL
prerank,positive regulation of multicellular organismal process (GO:0051240),0.33932519670430933,1.1066641124348255,0.26673866090712745,0.7324717717298996,1.0,33/308,7.54%,PRKCH;LEF1;EPAS1;ADIPOR2;BMPR2;CAV1;CADM1;ZBTB16;IL15;PDGFB;NPR1;RREB1;KDM3A;WWTR1;PLCB1;ADRB1;SOX9;RPS19;LCN2;SDCBP;XBP1;GHR;WNT5A;SHLD1;GATM;ESRRG;ACVR1;INPP5K;B4GALT5;TGFB1;PDGFC;AGPAT1;PIK3CG
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.30776200723017694,-1.1065928974570531,0.24347826086956523,0.7611493404634434,1.0,34/94,23.48%,NINL;HSP90AA1;YWHAG;ALMS1;AHI1;CC2D2A;IQCB1;PRKACA;KIF24;SDCCAG8;NPHP1;CEP63;RPGRIP1L;CEP89;CEP192;ODF2;MKS1;RAB3IP;CEP152;CEP43;PCM1;TTBK2;TCTN1;DCTN3;TCTN2;DYNC1H1;C2CD3;TMEM67;CKAP5;HAUS6;B9D2;HAUS2;SFI1;CSNK1E
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.47741464102955705,1.106359735318562,0.3390625,0.7326164440474808,1.0,5/25,5.06%,BMPR2;ENG;ACVRL1;NOTCH1;ACVR2A
prerank,protein localization to chromosome (GO:0034502),0.4504775297903547,1.106261016442003,0.3370253164556962,0.7322594287808636,1.0,12/34,21.38%,ESR1;RPA1;PINX1;HASPIN;ACD;MCM9;RB1;ATRX;RAD21;PLK1;MSH2;XRCC4
prerank,positive regulation of histone methylation (GO:0031062),-0.40214283351012314,-1.1058064038316542,0.29873417721518986,0.7619003646929102,1.0,5/24,8.59%,OGT;AUTS2;TET1;CTR9;PAF1
prerank,cellular response to amyloid-beta (GO:1904646),0.43994000021105245,1.1057568827925817,0.3373860182370821,0.7328913466311455,1.0,11/35,12.00%,APP;ICAM1;VCAM1;CASP4;FYN;CACNA1A;ATP1A3;PSEN1;EPHA4;GRIN1;LGMN
prerank,protein K48-linked ubiquitination (GO:0070936),0.4100996887972825,1.105682540596118,0.31098430813124106,0.7324216516854964,1.0,17/54,17.66%,KLHL3;NEDD4L;ZNRF1;DTX3L;PELI1;UBE2G1;UBE2H;RNF146;RNF4;UBE2D3;UBE3A;UBE2K;TOPORS;ARIH2;RNF5;CUL3;CDC34
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.44417471090766725,1.1056665597913335,0.31825037707390647,0.7318261433798804,1.0,8/32,9.33%,PPP1R13B;DDIT4;JMY;HIPK1;BOK;BCL3;HINT1;MYBBP1A
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.49165955652165033,-1.1056531945200563,0.3554083885209713,0.7608698836622692,1.0,3/11,10.27%,AXL;SELENOS;CXCL12
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.4317141548040682,1.1054604546434028,0.3409090909090909,0.7317240842832378,1.0,15/37,17.98%,SDCBP;N4BP1;EIF3H;UCHL5;RPS7;RPL23;NOP53;HSP90AB1;GIPC1;RYBP;UBXN1;RPL11;USP7;CSNK2A1;CSNK2A2
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.43956013393638266,1.1053194090757643,0.350076103500761,0.7314585075439928,1.0,7/37,4.00%,CADM1;ICAM1;VCAM1;PVR;SELE;SELP;AMIGO2
prerank,response to ATP (GO:0033198),-0.42742430128408426,-1.1051564670787302,0.32839506172839505,0.7608639229604461,1.0,4/18,8.14%,P2RX4;ABCC9;TRPC3;TAF1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.4587565920217405,1.1050712755679022,0.3419354838709677,0.7314886934301424,1.0,5/24,7.19%,IL6ST;PTGS2;HIF1A;FLT4;TGFB1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.39175598938148576,-1.1049870735015146,0.324468085106383,0.7599065201789446,1.0,10/27,9.78%,DCN;BGN;CSPG4;CHST15;PXYLP1;VCAN;CHSY3;CHSY1;CHST3;XYLT1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.37610175511694616,1.1047766674565724,0.31233243967828417,0.7316613583204589,1.0,23/101,16.53%,MEF2C;DAB2IP;LYN;TNFRSF1B;XBP1;SBNO2;CX3CR1;MAPK8;WNT5A;IL36G;PPBP;TGFB1;NFKB1;CASP1;DEFA6;CARD16;RELA;GSTP1;ZFP36;TRAF6;IRGM;RHOA;CDC73
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.4792108399972655,1.1047552105451177,0.33217391304347826,0.7310971938753789,1.0,8/23,18.35%,NLRC5;JAK1;HSP90AB1;IRGM;STAT1;IFNGR1;CDC37;PARP9
prerank,aorta development (GO:0035904),-0.46630747384495663,-1.1043807750977133,0.32751091703056767,0.760298095220268,1.0,6/14,7.83%,ROBO1;LRP1;PDGFRB;ROBO2;JAG1;EFEMP2
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.45762516367865413,-1.1043412996365887,0.33753148614609574,0.7589830400078715,1.0,5/15,16.01%,BMP4;SIX1;VEGFA;SMO;PAX8
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.44758009356390405,1.1040542811057492,0.3213166144200627,0.7322287390020821,1.0,13/30,17.84%,SDCBP;N4BP1;EIF3H;UCHL5;NOP53;HSP90AB1;GIPC1;RYBP;UBXN1;STYX;SVIP;RPL11;USP7
prerank,response to insulin (GO:0032868),0.3825266332298306,1.103552807364792,0.30949105914718017,0.7328385802780264,1.0,13/80,8.71%,FOXO1;HDAC9;INSR;TBC1D4;DENND4C;SORBS1;XBP1;CEACAM1;LPIN3;TRIB3;INPP5K;CITED1;AKT2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.4656048633147396,1.103530799029239,0.3409090909090909,0.7322694309685829,1.0,9/27,14.23%,TAOK2;IKBKB;MAPK8;NFKB1;MAPK11;IKBKG;CCM2;CUL1;MAP3K20
prerank,cellular response to decreased oxygen levels (GO:0036294),-0.3347765733438924,-1.1034418637888836,0.2962962962962963,0.7601153042989498,1.0,19/65,9.58%,CPEB1;BMP7;SLC8A3;CPEB2;SIRT2;NDNF;KCND2;RORA;EGLN3;LMNA;P4HB;NPEPPS;MDM4;CPEB4;SFRP1;MDM2;HIPK2;VEGFA;RGCC
prerank,regulation of type I interferon production (GO:0032479),0.38583711091271883,1.103234624332946,0.31895424836601305,0.732373790761339,1.0,23/84,20.46%,RNF125;LRRFIP1;NLRC5;UBA7;TIRAP;NFKB1;TRIM25;POLA1;CGAS;G3BP1;RELA;IFIH1;NFKB2;ILRUN;GPATCH3;STAT6;CTNNB1;POLR3B;DHX36;TAX1BP1;POLR3A;POLR2L;NLRP4
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.503064351037835,1.1030193202109122,0.33562822719449226,0.732263921835518,1.0,4/14,14.13%,CARD10;TIRAP;MALT1;TRAF6
prerank,lipid modification (GO:0030258),0.4351292821995692,1.102221390380321,0.33839150227617604,0.733589938932886,1.0,6/37,8.34%,PLPP1;DGKZ;SGPP2;LPCAT3;DGKH;MBOAT1
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.36809945196889315,1.1021874700174288,0.30884184308841844,0.733042834814718,1.0,15/124,7.73%,FRY;FRYL;APP;STX3;PTPRM;RAB11A;LYN;PPP1R9B;BICDL1;OPHN1;ULK1;RAC1;RAPGEF2;PKD2;NEDD4
prerank,cellular response to zinc ion (GO:0071294),-0.46649666844346,-1.1015462109878833,0.33031674208144796,0.7641652505213854,1.0,2/15,16.15%,P2RX4;MT3
prerank,covalent chromatin modification (GO:0016569),0.5080861767352429,1.101357171593492,0.3836363636363636,0.7344992363043494,1.0,6/14,23.01%,CHD1;AURKC;PARP2;SETD5;SIRT7;HLCS
prerank,regulation of histone modification (GO:0031056),-0.46494763675834794,-1.1008333981034406,0.348780487804878,0.764832782065656,1.0,6/13,20.71%,IGF2;AKAP8L;CDK9;MYOCD;FLCN;NNMT
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.3952498466595932,1.1005849599976385,0.3231622746185853,0.7358163334631276,1.0,12/66,5.24%,CAV1;CDK6;B2M;PTPRM;DAB2IP;FBXW7;MTSS1;AQP11;CAV2;SOX9;CEACAM1;PTPRK
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.4179341820744637,1.1002812857731674,0.3170731707317073,0.7359396059628547,1.0,14/49,16.87%,CAV1;SGMS1;BOK;BCL2L11;LCK;PTPMT1;BCL2L1;SIAH1;BID;RACK1;S100A9;DDIT3;BMF;BCL2L10
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.45880217828765246,-1.0995279850749147,0.3436123348017621,0.7671152339094984,1.0,2/13,2.47%,AXL;IL18
prerank,RNA polyadenylation (GO:0043631),0.4560648765953169,1.099321482193698,0.336322869955157,0.7370563495738987,1.0,13/26,29.09%,APP;WDR33;MTPAP;PNPT1;CDC73;CPSF1;TENT4B;CPSF3;PCF11;CPSF2;TUT1;PAPOLA;CSTF3
prerank,mRNA polyadenylation (GO:0006378),0.4560648765953169,1.099321482193698,0.336322869955157,0.7370563495738987,1.0,13/26,29.09%,APP;WDR33;MTPAP;PNPT1;CDC73;CPSF1;TENT4B;CPSF3;PCF11;CPSF2;TUT1;PAPOLA;CSTF3
prerank,response to growth factor (GO:0070848),0.4327859730654638,1.0992905792463847,0.34260614934114203,0.7365001186705666,1.0,14/41,19.04%,BMPR2;ACVRL1;PDGFB;ACVR2A;ACVR1;TWF2;RACK1;TGFBR2;ERBB2;ACVR2B;CTNNB1;MAP2K5;CIB1;CPNE3
prerank,response to alcohol (GO:0097305),-0.39051779192395025,-1.0988269757360065,0.3023255813953488,0.7676863107899418,1.0,5/27,10.93%,TGFBR3;TGFBR1;GRIN3A;SLIT2;GRIN2A
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.4546561034111644,1.0988018942442694,0.3634920634920635,0.7371484762968372,1.0,4/27,5.58%,UTRN;NEDD4L;FXYD6;ATP2B4
prerank,innate immune response in mucosa (GO:0002227),0.5438112839068119,1.0986766032706816,0.36259541984732824,0.7368187726961817,1.0,2/10,9.58%,RPL39;DEFA6
prerank,hyaluronan metabolic process (GO:0030212),-0.3996070591769248,-1.0983073983311529,0.3047858942065491,0.7677951056531496,1.0,7/23,16.16%,CEMIP;FGF2;CD44;HEXA;SLC9A1;ABCC5;HYAL1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3713839588598723,1.098137525802106,0.3096179183135705,0.7374917020406941,1.0,11/98,5.58%,PRKCH;STX3;SPTBN1;PPP1R13B;FYN;NKD2;CASP8;KCNB1;SORBS1;MAPK8;ATP2B4
prerank,regulation of TORC1 signaling (GO:1903432),-0.37245030329196493,-1.0979344535772173,0.32697547683923706,0.767439111780316,1.0,14/33,25.57%,RNF152;KLHL22;CASTOR2;SZT2;SMCR8;GPR137B;SESN2;DGKQ;GPR137C;FLCN;ITFG2;PIP4P1;RRAGD;ATM
prerank,fatty acid metabolic process (GO:0006631),0.3686528962097425,1.0979307751054335,0.29316770186335406,0.7373705567459772,1.0,14/115,8.78%,ADIPOR2;PTGS2;PPARD;ACSL4;FASN;CRAT;XBP1;ALOX5AP;LPIN3;ACSL5;CYP4B1;LPL;PON2;LTC4S
prerank,negative chemotaxis (GO:0050919),0.4374438939975733,1.097757934422747,0.360062893081761,0.7371728032580406,1.0,3/33,1.70%,SEMA6A;NTN1;SEMA7A
prerank,post-translational protein modification (GO:0043687),0.3328633944018754,1.0976748358057498,0.2513542795232936,0.7367335374244209,1.0,62/332,15.79%,EPAS1;DCUN1D3;KLHL3;APP;KLHL5;ZBTB16;MGAT4A;STT3B;RAB11A;SOCS2;KLHL2;ADAM10;NEURL2;FBXW7;HIF1A;BTBD1;FUCA2;FGF23;CDH2;PTP4A2;QSOX1;SPARCL1;FBXL4;KCTD6;CISH;VWA1;RNF7;GOLM1;FBXL7;PSMA2;RAB2A;RAB38;RHBDD1;CSF1;APLP2;FBXW2;PSMA8;COPS2;PSMA6;ASB10;FBXO30;ICMT;GAS6;COPS4;CUL1;COP1;RAB11B;LAMB1;ASB11;RAB5A;ASB4;PNPLA2;FBXL3;CP;PROC;SOCS6;PSME1;EVA1A;ELOC;DCAF10;TMEM132A;DCAF17
prerank,engulfment of apoptotic cell (GO:0043652),-0.45635663134637305,-1.0967541283310447,0.36486486486486486,0.7692193500992635,1.0,3/15,3.74%,THBS1;RHOBTB2;XKR4
prerank,positive regulation of interleukin-17 production (GO:0032740),0.47280982604598826,1.0962640059127629,0.3517915309446254,0.7397038766565762,1.0,4/22,9.76%,IL15;TGFB1;RFTN1;IL23A
prerank,camera-type eye morphogenesis (GO:0048593),-0.49786024272785334,-1.0961983522989909,0.38084632516703787,0.7693280786969414,1.0,8/10,26.54%,TENM3;NF1;LRP6;VEGFA;TBX2;SKI;KDM2B;IFT122
prerank,cellular response to insulin stimulus (GO:0032869),0.3604237506843077,1.095911594224226,0.3205619412515964,0.7399385245299905,1.0,21/124,9.13%,FOXO1;HDAC9;INSR;TBC1D4;DENND4C;PIK3C2A;SH2B2;CAV2;SORBS1;XBP1;GRB14;CEACAM1;LPIN3;TRIB3;INPP5K;BCAR3;ATP6V0A1;GRB7;GAB1;AKT2;ATP6V1G2
prerank,carbohydrate biosynthetic process (GO:0016051),0.47420538972160553,1.0957702391929216,0.3573825503355705,0.7396449093143646,1.0,1/21,0.14%,ST3GAL6
prerank,postsynaptic membrane organization (GO:0001941),0.49137433143825265,1.0956126209110228,0.3556701030927835,0.7394273906163461,1.0,2/17,4.37%,SHANK3;GPHN
prerank,cellular response to unfolded protein (GO:0034620),0.4548217187426583,1.0951416675082561,0.34894991922455576,0.7399567111109939,1.0,5/26,9.12%,ERN1;DAB2IP;TMBIM6;PTPN1;RHBDD1
prerank,neuromuscular process controlling balance (GO:0050885),-0.46934624823297444,-1.0950993394288604,0.36607142857142855,0.7708370017047941,1.0,5/12,23.03%,NRXN1;PCDH15;SHANK1;TPP1;CLN3
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.49512927072227403,-1.09497309797555,0.36796536796536794,0.7697731284813925,1.0,4/10,17.01%,CACNA2D1;CACNB2;PDE4B;CACNB3
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.515514011090239,1.0948263022761764,0.38461538461538464,0.7401317509207286,1.0,4/14,6.24%,PRKAR2B;PKIG;ATP2B4;RAPGEF2
prerank,neuron migration (GO:0001764),0.41657772976720625,1.0947641762494233,0.3521739130434783,0.7396677425179853,1.0,8/48,6.24%,MEF2C;CELSR1;NAV1;DDIT4;CEP85L;DISC1;RAC1;RAPGEF2
prerank,nucleoside catabolic process (GO:0009164),-0.4752272667787072,-1.0943650532506874,0.3389473684210526,0.7700750268499207,1.0,4/11,15.67%,DPYD;UPB1;NT5E;NT5C1A
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.4637718862897685,-1.093803948461057,0.33940774487471526,0.7702869798685807,1.0,2/12,2.46%,DPYSL3;DPYD
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.4010016704688893,1.093406094521166,0.3601694915254237,0.7423025147321893,1.0,4/52,5.02%,PDIA5;ERN1;XBP1;EXTL3
prerank,negative regulation of protein ubiquitination (GO:0031397),0.4005399785669639,1.0930427075655653,0.3367496339677892,0.7426088708450235,1.0,14/50,16.49%,CAV1;DTX3L;SMAD7;N4BP1;DNAJA1;ARRB1;PINX1;SOX4;SPOPL;VPS28;NXN;UBXN1;PRKCG;CHP1
prerank,oligosaccharide biosynthetic process (GO:0009312),0.47525280829361455,1.0930111780412173,0.3656462585034014,0.7420687311728382,1.0,1/20,0.14%,ST3GAL6
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.4713954834285887,1.0929346700513716,0.3614649681528662,0.7416329481977274,1.0,3/22,5.16%,DGKZ;PTPRJ;CEACAM1
prerank,regulation of T cell chemotaxis (GO:0010819),0.5443620788574777,1.0928552767147577,0.3981981981981982,0.7412111490674657,1.0,3/11,13.49%,ADAM10;WNT5A;ADAM17
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.40230717663299,-1.092708309596094,0.3241206030150754,0.7718784334478349,1.0,10/23,20.86%,CAMK1D;DPP4;MCU;RIPOR2;DAPK2;SLIT2;JAM3;MDK;CCL19;CD74
prerank,response to ethanol (GO:0045471),-0.45352985457141315,-1.0923943815175787,0.3476297968397291,0.7713531769331409,1.0,3/14,10.93%,GRIN3A;ADCY7;GRIN2A
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.33293674476568885,-1.0921958520458024,0.3154121863799283,0.770531457323615,1.0,22/57,15.49%,DLG2;NLGN2;ACTN2;DLG4;GRIA2;DLG1;GRIA1;GRIA3;NLGN1;DLGAP4;DLG3;GRIA4;SHANK1;PRRT1;GRIN2A;CAMK2B;CACNG4;SHISA7;DLGAP1;NPTXR;LRRC7;NETO1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.4611946268138532,-1.0916764040142437,0.3579676674364896,0.7706461877197107,1.0,2/14,3.51%,IL34;THBS1
prerank,organelle organization (GO:0006996),0.3266737511425109,1.091347660959057,0.2701271186440678,0.7443146288170559,1.0,60/388,13.27%,SEMA6A;FGD5;NOS3;FNBP1L;ATP8B1;CAV1;PRKD1;ARAP3;NEDD9;FGD6;NECTIN2;DST;ALAS1;VPS13D;FMNL3;CAV2;PLIN5;SIPA1L3;STX7;CDC42BPB;MAST2;DOP1B;CYCS;ABCA3;CHMP2B;FMNL2;CECR2;CYP26C1;SYNE1;TNIK;TMEM135;SIRT5;TMED7;PKD2;RAB2A;TMED5;RAB38;PLAAT3;ABCD4;CHMP4A;CHMP4B;ARHGEF7;ANK1;ZRANB1;MREG;GABPB1;HPS3;TFB2M;RNF112;LONP1;ABCD1;SNX11;RAB43;PHIP;BRWD3;RAB7A;RAB31;PLD2;ATL1;CSPG5
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.43074063291640075,1.0912514285300672,0.34802431610942247,0.7439362669600069,1.0,6/32,14.48%,RPS19;RPL39;PPBP;ANG;DEFA6;S100A9
prerank,regulation of signal transduction (GO:0009966),0.3421091958842926,1.0911421180748717,0.31002331002331,0.7435761635575048,1.0,33/190,10.11%,RGS3;LIFR;ESR1;LFNG;APP;UGCG;PRKD1;SOCS2;PRAG1;GIT2;MFNG;BST1;FYN;NCK1;KIF26A;WWTR1;PLCB1;PXN;SRMS;DLL1;TSPAN12;TCF7L1;ACVR1;ITGA3;VWA2;TGFB1;SNX3;LLGL1;PTPN1;CRK;ZFAND2B;CDC42SE2;RGS12
prerank,positive regulation of phospholipase activity (GO:0010518),-0.4069118402336802,-1.09100689411319,0.32558139534883723,0.7711441622295495,1.0,7/22,6.06%,NTRK3;FGFR2;PDGFRB;PDGFRA;KIT;FGF2;AGTR1
prerank,response to glucagon (GO:0033762),-0.4157281556766973,-1.0907830372855176,0.35853658536585364,0.7704218024893856,1.0,9/19,14.41%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6;PRKACA;PRKAR1B;PRKAR1A;ADCY3
prerank,tRNA aminoacylation (GO:0043039),0.419083936857539,1.090665559590493,0.3343465045592705,0.7441270688452599,1.0,9/37,15.56%,GARS1;FARS2;IARS1;LARS1;WARS1;RARS1;AIMP1;QRSL1;KARS1
prerank,microglial cell activation (GO:0001774),0.47181743865367426,1.090609362169693,0.3642611683848797,0.7436512837373372,1.0,2/21,5.49%,APP;CX3CR1
prerank,response to metal ion (GO:0010038),0.3924777086938242,1.0901679714090369,0.3441011235955056,0.7441194582314801,1.0,9/67,7.99%,CAV1;NEDD4L;PPP3CA;HIF1A;GPHN;PAM;TRPV6;NEDD4;ITPR3
prerank,regulation of lamellipodium organization (GO:1902743),-0.4519095371083318,-1.0901556391000966,0.329004329004329,0.7707644760053259,1.0,3/14,7.56%,PDPN;CARMIL1;CD44
prerank,acute-phase response (GO:0006953),0.5258239891972105,1.0900100542475428,0.3927272727272727,0.7438965358813422,1.0,5/12,17.88%,IL6R;SIGIRR;ITIH4;IL22;PLSCR1
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.5434259522155723,1.089306753111807,0.39264990328820115,0.7449841375899012,1.0,2/10,3.43%,TBX1;ACTN4
prerank,defense response to tumor cell (GO:0002357),0.5471830908405497,1.0891668232818303,0.4117647058823529,0.7447012436656493,1.0,2/10,1.63%,ABI3;DAPK1
prerank,embryonic heart tube development (GO:0035050),0.517780585310436,1.0887926619387085,0.38661710037174724,0.7449943973751064,1.0,3/14,6.15%,SOX17;SOX18;ACVR1
prerank,cellular response to organonitrogen compound (GO:0071417),0.3671261204861229,1.088619602662782,0.3297587131367292,0.7448100038325367,1.0,19/99,12.24%,MEF2C;AHR;SH3BP4;PDE2A;KCNQ1;RAP1B;SOX9;XBP1;CTNNA1;RAPGEF2;INPP5K;RAP1A;PKD2;RPTOR;PDXP;LARS1;P2RY12;PDE3A;RELA
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.5428452878847179,1.0885252030979338,0.3659491193737769,0.744423007695447,1.0,4/10,7.19%,NOTCH1;TNFRSF1B;TNFRSF1A;TGFB1
prerank,neuron projection extension (GO:1990138),0.4439146395178539,1.088227043452641,0.35949764521193095,0.7445478761964784,1.0,5/32,6.02%,NRP2;SEMA5B;IQGAP1;ULK1;PPP3CB
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.4203154051850064,1.0881935408163657,0.35745296671490595,0.744006318737233,1.0,8/45,7.19%,BMPR2;ENG;RBPMS;ACVRL1;SDCBP;ACVR2A;ACVR1;TGFB1
prerank,endosome organization (GO:0007032),0.41768946824260317,1.0880206651005149,0.34332833583208394,0.7438242297037388,1.0,9/41,13.30%,RAB27A;ALS2CL;CLCN3;CHMP2B;EEA1;SNX3;CORO1C;RILP;EXOC8
prerank,central nervous system neuron development (GO:0021954),0.5068105727649777,1.087842967128352,0.3870967741935484,0.7436110611308241,1.0,3/15,6.84%,LHX6;RAPGEF2;B4GALT5
prerank,postreplication repair (GO:0006301),0.41848221431510596,1.0872672936285592,0.3533834586466165,0.7443763635458139,1.0,16/45,27.02%,POLK;RPA1;TRIM25;WDR33;PRIMPOL;RAD18;USP43;RFC3;NSMCE1;MSH2;UBE2V2;RFC5;ZBTB1;POLN;RPA3;UBE2N
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3697214875319097,1.08723728967231,0.30279898218829515,0.7438437034272238,1.0,26/100,14.98%,CBFA2T3;RNF144B;NKD2;SDCBP;SMAD7;N4BP1;EIF3H;FOXF2;UCHL5;RNF144A;TRIB3;XPO1;GNA12;RAD23A;SUMO2;COP1;HECTD1;NOP53;PRICKLE1;RACK1;TRIB1;HSP90AB1;GIPC1;RYBP;UBXN1;ARIH2
prerank,motor neuron axon guidance (GO:0008045),0.4899038273044197,1.0861608873136916,0.3932980599647266,0.7458431717026568,1.0,3/15,11.35%,NTN1;RAC1;EPHA4
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5242740611339453,1.0855433799074448,0.37842778793418647,0.746746350749505,1.0,5/11,15.29%,ARID1B;ARID1A;ZMIZ1;CDCA4;SERTAD2
prerank,regulation of exosomal secretion (GO:1903541),-0.4200026457241531,-1.0851018141284412,0.3325635103926097,0.7835691033034954,1.0,7/19,18.15%,PRKN;ATP9A;SDC4;SMPD3;SDC1;SNF8;VPS4A
prerank,visual perception (GO:0007601),-0.3100275214673915,-1.0850381948544998,0.2723404255319149,0.782326940272535,1.0,9/84,4.60%,COL1A1;SLC4A10;ADGRV1;EYA4;EML2;COL11A1;EFEMP1;COL18A1;DHRS3
prerank,gland development (GO:0048732),-0.32109424929864844,-1.0847061805487357,0.28888888888888886,0.7818858698953252,1.0,12/59,5.87%,FGFR2;GLI2;TGFBR3;WNT4;DKK3;TGFBR1;IGSF3;COBL;ANXA1;SALL1;SIX1;NF1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.4350278436912821,1.0844873195848905,0.35714285714285715,0.7487453286037116,1.0,2/30,1.66%,ST6GAL1;STT3B
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.4810838095107885,1.0842926930909786,0.38986013986013984,0.7486132921541091,1.0,5/18,18.91%,LYN;SH2B2;SLA2;FPR3;BCAR1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.5196616076934532,1.0838339381302773,0.387719298245614,0.7491228152573726,1.0,4/12,8.46%,PODXL;IQGAP1;PROM1;MYO1E
prerank,ketone body metabolic process (GO:1902224),-0.4909382431147725,-1.083800700466214,0.38461538461538464,0.7831155950519803,1.0,6/10,14.68%,OXCT1;HMGCLL1;BDH2;ACAT1;BDH1;AACS
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.49854717729172565,1.0837788563078805,0.38380281690140844,0.7486339081055505,1.0,1/16,1.44%,CLDN5
prerank,T cell mediated immunity (GO:0002456),0.5093463495848062,1.0830009450326956,0.38294010889292196,0.7499100536408196,1.0,1/13,0.92%,CADM1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.48191960290957947,-1.082986842515237,0.39166666666666666,0.7840227436257896,1.0,4/10,15.67%,DPYD;UPB1;NT5E;NT5C1A
prerank,nervous system development (GO:0007399),0.32680635919413176,1.0829369332760976,0.2889125799573561,0.749432542232488,1.0,40/429,7.26%,ADGRG6;SHANK3;SEMA6A;MPZ;DNM3;SLC2A1;RAPGEF5;LDB2;MEF2C;ZBTB16;ZIC3;CELSR1;NAV1;GDA;STAT3;ADGRA2;SNTG2;PLXND1;HAPLN3;BTBD1;CHD7;WWTR1;PCDHB4;EVL;CDH2;KALRN;MAL;RPS6KA3;IGF2BP3;MBNL1;NCKAP1;SEMA6B;OPHN1;DYRK1A;IRF2BPL;CYP26C1;ATXN3;ST8SIA4;TGFB1;PDGFC
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.38834509796554606,-1.0824311348565478,0.3233082706766917,0.784225990284154,1.0,2/26,1.37%,LGR4;APPL2
prerank,macrophage activation involved in immune response (GO:0002281),0.49657405946023914,1.0819502235081722,0.387037037037037,0.7512734703868245,1.0,4/13,10.91%,PLCG2;SBNO2;CX3CR1;NMI
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.4313573745663435,1.0818874562965863,0.36619718309859156,0.7508189279300749,1.0,7/34,9.25%,LIMS2;DOCK1;NEDD9;RREB1;RAC1;ARHGEF7;CRK
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.5167818009096274,1.0818102329589872,0.3844765342960289,0.7504073894402539,1.0,7/13,22.76%,UBA7;SAE1;DESI2;DESI1;ATG7;UBA3;SENP6
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.4207839238825031,1.0815694975972578,0.3505917159763314,0.7503980803353774,1.0,6/42,11.99%,POLK;RPA1;TRIM25;POLA1;PRIMPOL;USP43
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.39721906210504576,-1.0812354389641932,0.3673469387755102,0.7860854721516779,1.0,9/23,25.18%,ZWINT;PLK5;CHFR;ZFYVE19;VPS4A;SETMAR;CDK5RAP3;CHEK1;BUB1B
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.33683949949512676,-1.0808423306929704,0.3431372549019608,0.7858389940303462,1.0,15/52,17.90%,ME1;ADHFE1;ME2;IDH2;ALDH1L1;GCLC;FPGS;GPT2;IDH1;GOT1;MTHFD1;SLC19A1;HOGA1;MTHFD2L;MDH1
prerank,protein prenylation (GO:0018342),0.5301706812736405,1.080655029398051,0.4025735294117647,0.7520944268752979,1.0,6/10,26.25%,PGGT1B;PTAR1;FNTA;FNTB;RABGGTB;CHML
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.36167626288670507,1.0805004893703722,0.3425196850393701,0.7518583551323167,1.0,15/102,7.58%,FOXO1;HDAC9;CAV1;ADCY4;INSR;TBC1D4;DENND4C;PRKAR2B;SORBS1;XBP1;CEACAM1;LPIN3;TRIB3;INPP5K;NFKB1
prerank,cholesterol transport (GO:0030301),0.40538252148081516,1.0803360761165237,0.3719512195121951,0.7516699469854325,1.0,9/45,16.11%,CAV1;SCARB1;STARD5;SOAT2;LIMA1;ABCG1;ABCA1;STX12;STAR
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.3983327709959646,-1.080019187453061,0.376657824933687,0.7867706212690986,1.0,5/24,11.64%,EPHA7;NUPR1;NF1;SRPK2;TGFB2
prerank,negative regulation of kinase activity (GO:0033673),0.38866779824610576,1.0799500374824555,0.34277620396600567,0.7520564437049145,1.0,16/62,13.02%,GNAQ;PPP2R5A;PPM1F;WWTR1;PAK2;CEACAM1;TRIB3;CDKN1B;INPP5K;NPRL2;SFN;RB1;GSKIP;WARS1;GSTP1;TRIB1
prerank,detection of mechanical stimulus (GO:0050982),0.4743126736486045,1.079837421852781,0.40237691001697795,0.7517343040884399,1.0,5/19,8.36%,PIEZO1;CDH2;PTK2;PKD2;PKDREJ
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.37983838458530256,1.0796320243270634,0.35138888888888886,0.7516107697772695,1.0,5/72,3.63%,SHANK3;KANK3;HIP1R;ARHGEF2;SSH2
prerank,nucleosome organization (GO:0034728),0.39004082747242497,1.0793790595016897,0.35581061692969873,0.751598819451644,1.0,21/55,24.62%,SOX9;PADI4;LIN54;H3-3A;ARID1A;KAT6B;SMARCA5;NAP1L4;SRCAP;SMARCE1;GRWD1;NPM1;ATRX;ANP32B;VPS72;SART3;PRDM9;SMARCC1;ARID2;SMARCD1;SET
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.4068626238935941,1.0792123627177896,0.3601756954612006,0.7514071093285994,1.0,5/47,5.28%,FOXO1;DAB2IP;FAS;TAOK2;GREM1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.43271019947678746,-1.079152704328053,0.35121951219512193,0.7877704425128521,1.0,8/17,23.37%,CAMK1D;MCU;RIPOR2;DAPK2;MDK;CCL19;CD74;DNM1L
prerank,mesenchymal cell differentiation (GO:0048762),0.4050324344872616,1.0787660590218835,0.36554621848739494,0.7518940395296052,1.0,9/51,7.19%,LEF1;ENG;MEF2C;HIF1A;NOTCH1;SOX9;FOXF2;WNT5A;TGFB1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.4405324459372121,1.0786995931330834,0.38301282051282054,0.751445136505046,1.0,5/26,7.19%,IL6ST;PTGS2;HIF1A;FLT4;TGFB1
prerank,cellular response to heat (GO:0034605),-0.3629622016757507,-1.078274031194414,0.3261455525606469,0.7887829302336109,1.0,6/35,8.80%,FGF1;THBS1;ANO1;HSP90AA1;PRKACA;RBBP7
prerank,positive regulation of cellular component organization (GO:0051130),0.3611018278826191,1.0781387217622276,0.34581772784019976,0.7522087964514007,1.0,15/107,7.19%,SHANK3;INSR;DAB2IP;TAL1;NEDD4L;ATP10A;FNIP2;BIK;ABCB7;TIRAP;DLL1;CBLL1;SH3GLB1;BCL2L11;TGFB1
prerank,atrioventricular valve development (GO:0003171),0.5098331009693042,1.0781132246525051,0.3793706293706294,0.7516545559684439,1.0,6/14,12.97%,BMPR2;NOTCH1;ACVR1;ZFPM1;APLNR;TGFBR2
prerank,DNA double-strand break processing (GO:0000729),-0.415010762308742,-1.077976881457067,0.3738738738738739,0.7881592904340664,1.0,13/18,40.76%,RAD50;SETMAR;KAT5;DNA2;SLX4;BARD1;RAD52;ATM;BLM;EXD2;RNF138;NBN;BRCA1
prerank,regulation of interferon-gamma production (GO:0032649),0.38211728654939364,1.0776021432968559,0.34829931972789113,0.7522923248271706,1.0,6/71,11.07%,IL1R1;PDE4D;ZFPM1;IL23A;CYRIB;GAS6
prerank,positive regulation of RNA splicing (GO:0033120),0.4380154210157638,1.0775341913484549,0.3824884792626728,0.7518198482115162,1.0,8/29,14.78%,ERN1;RBM20;SF3B4;DYRK1A;HNRNPLL;RBM3;NUP98;SNW1
prerank,positive regulation of leukocyte migration (GO:0002687),0.4480341385211318,1.0772845559285813,0.3983333333333333,0.7518180208751272,1.0,4/27,9.40%,ICAM1;IL6R;F7;CSF1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.5056491389440952,1.0772804979954427,0.40145985401459855,0.7512199604759854,1.0,3/13,13.08%,PDE8A;RACK1;MET
prerank,leukotriene metabolic process (GO:0006691),0.48250316920875685,1.0769715333139624,0.37152209492635024,0.7513613980449432,1.0,3/19,8.78%,PLA2G4A;ALOX5AP;LTC4S
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.4207386098171385,-1.0766941547181796,0.371007371007371,0.7903541580216028,1.0,8/19,23.37%,CAMK1D;MCU;RIPOR2;DAPK2;MDK;CCL19;CD74;DNM1L
prerank,regulation of kinase activity (GO:0043549),0.3717605235175432,1.0763855967394869,0.34838709677419355,0.7521369420387679,1.0,12/89,6.60%,TEK;FLT1;LDB2;KDR;TIE1;EPHB4;INSR;NLRC5;FLT4;LMTK2;RET;CDKN1B
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.4130800383110972,1.075612600482597,0.3943217665615142,0.7534381471964398,1.0,8/42,12.75%,SMARCA2;ARID1B;CECR2;ARID1A;SMARCA5;SRCAP;SMARCE1;HNRNPC
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.4317287567217667,-1.075380080441953,0.3744292237442922,0.7927591247231993,1.0,3/16,6.34%,DDX5;CELF4;DDX17
prerank,glutamine family amino acid metabolic process (GO:0009064),0.4168199387211631,1.0749608829819404,0.37598736176935227,0.7543811747137248,1.0,4/33,3.41%,SLC39A8;DGLUCY;GLS2;GLS
prerank,atrioventricular valve morphogenesis (GO:0003181),0.4879298715921755,1.0748170015907885,0.400990099009901,0.7541138367908772,1.0,6/19,9.43%,BMPR2;EFNA1;NOTCH1;ACVR1;ZFPM1;SOX4
prerank,negative regulation of protein localization to membrane (GO:1905476),0.45090139516906985,1.0748068366379389,0.36318407960199006,0.7535295137153261,1.0,7/24,11.68%,ABI3;PPP2R5A;NUMB;INPP5K;TGFB1;BCL2L1;PICALM
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.37033260174307675,1.0747024113449197,0.36164736164736166,0.753182098074502,1.0,19/87,11.17%,ABI3;ESAM;F11R;EPS8;HIP1R;IQGAP1;CELSR1;PTK2B;BST1;TAOK2;ARHGAP17;CCDC88A;RAC1;RHOBTB1;RICTOR;CRK;TWF2;FSCN1;ABL2
prerank,calcium ion import across plasma membrane (GO:0098703),-0.4481910350131747,-1.0743472508932115,0.38657407407407407,0.7944773665813974,1.0,4/14,8.91%,SLC8A3;CACNA2D1;SLC8A1;SLC24A2
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5178553721367145,1.0742665835300733,0.40512820512820513,0.7536338424214197,1.0,4/12,4.45%,LFNG;PTK2B;MFNG;DLL1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.37714921138048796,1.074265197339418,0.3716216216216216,0.7530318916423762,1.0,14/73,11.07%,CAV1;APP;PRKD1;PRKD2;FNIP2;STK4;SH2D3C;ATP2B4;BCAR3;TGFB1;RPTOR;SFRP2;MAD2L2;GAS6
prerank,positive regulation of cell cycle process (GO:0090068),0.3671483474898423,1.0741663254466336,0.36617842876165113,0.7526342446618143,1.0,24/91,18.87%,PKP4;INSR;PDGFB;EDN1;LRP5;PKN2;AURKA;TGFA;DYNC1LI1;AURKC;NUDT16;KIF23;PHIP;MAP3K20;GIPC1;ATRX;E2F7;RHOA;CEP295;CUL3;RAD21;PLSCR1;BTC;NUMA1
prerank,amyloid fibril formation (GO:1990000),0.3933154412336672,1.0740480795255718,0.35693215339233036,0.7523088945115187,1.0,11/51,11.77%,APP;B2M;ADAM10;TSPAN5;FKBP1A;TSPAN14;H3-3A;SNCAIP;SIAH1;APH1A;RIPK1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.4246198755372905,1.0739116496833532,0.4069591527987897,0.752045558933455,1.0,9/35,11.68%,B2M;HIP1;HIP1R;RAC1;SMAP1;HNRNPK;CBL;MKLN1;PICALM
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.539481724966576,1.0739066662459789,0.40409683426443205,0.7514560662597053,1.0,3/10,17.24%,SIGIRR;IRAK3;MAP2K5
prerank,positive regulation of dephosphorylation (GO:0035306),0.4467676251004165,1.0736493628740313,0.39072847682119205,0.7515050133470589,1.0,9/27,18.67%,PPP1R16B;PPP2R5A;CHP2;TGFB1;CDH5;SPPL3;PPP1R7;CALM1;MTMR9
prerank,positive regulation of neutrophil migration (GO:1902624),-0.42101639089496745,-1.0733531645635432,0.34146341463414637,0.7960528549907182,1.0,8/18,23.37%,CAMK1D;MCU;RIPOR2;DAPK2;MDK;CCL19;CD74;DNM1L
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.38964524370749953,-1.0727262226553096,0.3602015113350126,0.796341752658039,1.0,6/24,4.41%,ARHGAP6;PHLDB2;CGNL1;TMEFF2;ARAP1;RHPN2
prerank,apoptotic DNA fragmentation (GO:0006309),0.48852076743864636,1.072427628719376,0.3848797250859107,0.7539169526260902,1.0,6/16,22.84%,FOXL2;CECR2;DICER1;ENDOG;KPNB1;HMGB1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.48935677397295635,-1.0723218355306559,0.37336244541484714,0.7931926007634635,1.0,8/10,31.73%,SMARCAL1;DNA2;SLX4;XRCC3;EXO1;ERCC1;BLM;WRN
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.48935677397295635,-1.0723218355306559,0.37336244541484714,0.7931926007634635,1.0,8/10,31.73%,SMARCAL1;DNA2;SLX4;XRCC3;EXO1;ERCC1;BLM;WRN
prerank,t-circle formation (GO:0090656),-0.48935677397295635,-1.0723218355306559,0.37336244541484714,0.7931926007634635,1.0,8/10,31.73%,SMARCAL1;DNA2;SLX4;XRCC3;EXO1;ERCC1;BLM;WRN
prerank,atrial septum development (GO:0003283),-0.4581654051228428,-1.0719630085216434,0.40503432494279173,0.7929010411750181,1.0,2/13,0.29%,ANK2;NOTCH2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.3219631244336669,-1.0717818376719663,0.3125,0.7920439931186585,1.0,10/59,14.85%,ALDH1A2;CYP7B1;CYP27A1;ABCD3;PER2;ACACA;OSBPL3;OSBPL6;HOGA1;SCP2
prerank,sulfur amino acid metabolic process (GO:0000096),-0.3810596036575612,-1.071412820860631,0.36548223350253806,0.791749096327767,1.0,10/24,27.97%,NOX4;SMS;GCLC;MTHFD1;CBS;CTH;MMUT;ADI1;MTRR;CDO1
prerank,organelle fission (GO:0048285),0.45777020525088163,1.0711642448948053,0.38841567291311757,0.7563107643897585,1.0,1/24,0.27%,DNM3
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.36574148436706017,-1.0709327207173949,0.34210526315789475,0.7917152922597235,1.0,7/32,5.24%,PID1;IGF1;NUPR1;ZBTB20;PPARA;PPARGC1A;PRKAA2
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.37821811293896734,1.0709297562951638,0.35497237569060774,0.7562860819228289,1.0,13/70,12.23%,IL6R;DAB2IP;FAS;TNFRSF1B;CASP8;HIPK1;BOK;TNFRSF1A;TGFB1;CRADD;BCL2L1;RIPK1;BID
prerank,cellular response to cadmium ion (GO:0071276),-0.39740598291510665,-1.070734471015966,0.3770053475935829,0.7909217553532181,1.0,1/24,0.38%,EGFR
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.5024326378125192,-1.0706226381711563,0.386411889596603,0.7884800025456876,1.0,3/10,18.12%,MBP;WNK1;MYADM
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.5024326378125192,-1.0706226381711563,0.386411889596603,0.7884800025456876,1.0,3/10,18.12%,MBP;WNK1;MYADM
prerank,ERBB signaling pathway (GO:0038127),0.38550601266607537,1.0702863148595634,0.36149584487534625,0.7573328396532917,1.0,25/64,19.29%,RPS6KA5;PLCG1;PTPN12;IQGAP1;PTK2B;PIK3C2A;SOX9;TGFB1;PTK2;GRB7;TGFA;GAB1;CBL;KIF16B;ADAM17;ERBB2;SOS1;ERBIN;GRB2;CDC37;AAMP;BTC;BCAR1;CPNE3;PTPRR
prerank,negative regulation of B cell proliferation (GO:0030889),0.5261537184891559,1.0700581671837388,0.39811320754716983,0.7572696867970472,1.0,2/11,11.05%,LYN;RC3H1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.4624221395161685,-1.0700497474392443,0.3802197802197802,0.7887465692859483,1.0,5/12,9.63%,CACNA1C;DLG1;RYR2;BIN1;CTNNA3
prerank,regulation of actin filament-based process (GO:0032970),-0.3184465118775009,-1.0699542802545148,0.29296875,0.7876696401081429,1.0,14/70,8.44%,LRP1;EPHA3;PDGFRB;ROCK2;EFNA5;RHOQ;PRKCD;GPM6B;RHOBTB2;RND3;ARHGAP18;EZR;CNN2;RHOBTB3
prerank,epithelium development (GO:0060429),-0.29147347003344093,-1.069807838643867,0.27555555555555555,0.7866905819694799,1.0,23/107,12.94%,ALDH1A2;FGFR2;WNT4;ERRFI1;OSR1;MEOX2;DAG1;PKD1;LOXL3;DACT1;KANK2;SALL1;SIX1;RCN3;AHI1;BDH2;VEGFA;SMO;TAGLN;ANXA4;MTHFD1;TBX2;VDAC1
prerank,neural tube development (GO:0021915),-0.4356915583964475,-1.069663407382516,0.3629807692307692,0.785744655619734,1.0,3/15,4.68%,ALDH1A2;PKD1;DACT1
prerank,regulation of cell cycle process (GO:0010564),0.3638760221899025,1.069552763554968,0.35678391959798994,0.7579406895271698,1.0,30/104,22.95%,DCUN1D3;RAB11A;CAV2;SOX9;PLK2;AURKA;SH3GLB1;AURKC;NUDT16;PDXP;BCL2L1;MAD1L1;RPRD1B;CDC25C;APC;CALM1;CTNNB1;PRPF40A;CSNK2A1;CSNK2A2;CETN2;NUMA1;PLK1;DBF4;RMI2;GIT1;PIK3R4;RACGAP1;TIPIN;SND1
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.41919361288725693,1.0691849642842575,0.37738853503184716,0.7582150353420106,1.0,9/34,12.77%,INSR;PDGFB;EDN1;LRP5;AURKA;TGFA;ANAPC7;RB1;PHIP
prerank,protein localization to plasma membrane (GO:0072659),0.3533937324949907,1.0691757346837256,0.33863080684596575,0.7576307055633734,1.0,24/129,7.67%,EHD4;SPTBN1;F11R;SMURF1;RAB11A;TSPAN5;DENND4C;BSG;NKD2;PACS1;FCHO2;KCNB1;IKBKB;TSPAN14;RAMP2;CCDC88A;RAPGEF2;TMEM88;INPP5K;ATP1B3;TNFRSF1A;TNIK;EHD2;RAP1A
prerank,ether lipid biosynthetic process (GO:0008611),0.5353389533895496,1.0691400453332691,0.4015151515151515,0.7571132700096526,1.0,1/10,1.64%,PLA2G4A
prerank,negative regulation of organelle assembly (GO:1902116),0.42397961516034277,1.0688551674911506,0.3962558502340094,0.7572090684655086,1.0,8/35,10.31%,TBC1D30;MTM1;LIMK2;RBM14;FEZ2;CHMP4A;CHMP4B;NBDY
prerank,peptidyl-asparagine modification (GO:0018196),0.4295147473504629,1.0688396361628534,0.3620414673046252,0.7566427666711256,1.0,2/31,1.66%,ST6GAL1;STT3B
prerank,Wnt signaling pathway (GO:0016055),0.3669553585015621,1.0687527139490867,0.3403141361256545,0.756242301776849,1.0,14/92,9.05%,LEF1;DIXDC1;FZD6;FZD4;LRP5;PLCG2;CPE;TCF7L1;TCF7L2;WNT5A;WNT9B;SNX3;SFRP2;ZRANB1
prerank,calcium ion import into cytosol (GO:1902656),-0.4372083638892087,-1.0686883134773273,0.3976190476190476,0.7872434004072072,1.0,4/15,8.91%,SLC8A3;CACNA2D1;SLC8A1;SLC24A2
prerank,mitotic metaphase plate congression (GO:0007080),0.3928721739800268,1.0685146399602943,0.36714285714285716,0.7562345163010852,1.0,8/51,8.75%,RAB11A;CHMP2B;PINX1;KIF22;CDT1;RRS1;CHMP4A;CHMP4B
prerank,response to prostaglandin E (GO:0034695),-0.476308858319363,-1.0678924368234308,0.39325842696629215,0.7880328499460018,1.0,5/10,18.89%,TGFBR3;ADCY6;SFRP1;GNG2;CCL19
prerank,negative regulation of cell development (GO:0010721),-0.3870144276921102,-1.0678236245279578,0.350253807106599,0.7868619146281067,1.0,3/25,1.37%,IGF1;FBN1;APPL2
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.48367859887568887,1.0678099267619656,0.38144329896907214,0.757352877614306,1.0,4/16,10.41%,ST6GALNAC3;ST8SIA4;ST6GALNAC4;A4GALT
prerank,tyrosine metabolic process (GO:0006570),-0.4786533322634948,-1.067562765149604,0.38852097130242824,0.7862862584366318,1.0,6/11,45.06%,FAH;GSTZ1;HGD;THAP4;DCT;IYD
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5108215433806935,1.0674907439027408,0.40869565217391307,0.7575445100250752,1.0,4/11,17.10%,LPCAT3;ATL1;MOSPD3;ARL6IP1
prerank,nucleotide biosynthetic process (GO:0009165),-0.425430659417131,-1.066958483863635,0.3808411214953271,0.7866663244765636,1.0,8/18,20.89%,NMNAT2;ME1;PRPS2;MTHFD1;NMNAT1;PRPSAP2;NMNAT3;PRPSAP1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.4709249230061025,1.0669452857850803,0.3798977853492334,0.7583262508574034,1.0,6/20,13.14%,CNOT6;TNRC6C;HELZ;CNOT1;EIF6;CNOT7
prerank,axon extension (GO:0048675),0.4569853264161255,1.0669042005184988,0.3774193548387097,0.7578123632277265,1.0,4/23,6.02%,NRP2;SEMA5B;ULK1;PPP3CB
prerank,amyloid precursor protein catabolic process (GO:0042987),0.49721584926440243,1.0666953149560834,0.4340659340659341,0.7577088544667377,1.0,6/14,13.49%,ADAM10;DYRK1A;PSEN1;APH1A;ABCG1;ADAM17
prerank,negative regulation of double-strand break repair (GO:2000780),0.4400833382070538,1.0665212005878826,0.390282131661442,0.7575367489566527,1.0,7/30,12.39%,RNF169;SMCHD1;SHLD1;CGAS;HELB;MAD2L2;CYREN
prerank,regulation of organelle organization (GO:0033043),0.3736453313677222,1.0662199957899336,0.3815261044176707,0.7576695375269835,1.0,24/80,20.33%,TJP1;F11R;PDE2A;MSN;MTM1;PAK2;PTK2;CAMSAP2;CDT1;SCARB2;PJVK;EHD3;CLIC4;PREB;S100A9;RDX;ARL6IP1;ARMH3;RHOT1;DIAPH1;RHOT2;VPS35;TAOK1;SURF4
prerank,regulation of actin filament depolymerization (GO:0030834),-0.4721385270680703,-1.0659259636741827,0.4116331096196868,0.7882515538284488,1.0,2/12,2.74%,PLEKHH2;SEMA5A
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.330769734816762,-1.0656769184040484,0.3300653594771242,0.7876346721402849,1.0,7/55,6.06%,PID1;PDGFRB;PRKN;THBS1;SIRT2;CYP1B1;AGTR1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.47785428027908144,-1.0654848773426668,0.39373601789709173,0.7868096992800887,1.0,2/11,7.56%,BCL2;CD44
prerank,renal absorption (GO:0070293),0.5067389975943573,1.0654265520090145,0.4018348623853211,0.7589667144113167,1.0,3/10,8.42%,KLHL3;KCNQ1;SLC15A2
prerank,cardiolipin metabolic process (GO:0032048),0.5087425955852386,1.0652417285220956,0.40421792618629176,0.7588179938028026,1.0,3/13,7.86%,PLA2G4A;HADHA;PTPMT1
prerank,fatty acid transmembrane transport (GO:1902001),0.4727509789614035,1.0652403788767677,0.3974151857835218,0.7582243848853486,1.0,5/19,12.13%,SLC2A1;ACACB;ABCD4;CPT1A;ABCD1
prerank,positive regulation of ruffle assembly (GO:1900029),0.5159441193778427,1.0642714914946827,0.4311594202898551,0.7599347880955323,1.0,3/13,13.69%,EPS8;P2RY12;NDEL1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.382170784791362,1.0633394581326254,0.3805436337625179,0.7615567568023959,1.0,13/66,7.54%,FLT1;PDGFB;DAB2IP;EDN1;PDGFD;TNFRSF11A;TPD52L1;PIK3R6;CD40;SASH1;TGFB1;PDGFC;PIK3CG
prerank,phagosome-lysosome fusion (GO:0090385),0.5389492520633283,1.0632886214696107,0.4288354898336414,0.7610810369712948,1.0,4/10,15.55%,ARL8B;RAB7A;RAB7B;SYT7
prerank,membrane lipid metabolic process (GO:0006643),0.4553247493077626,1.0629726936926793,0.39080459770114945,0.7612144383804141,1.0,4/22,10.36%,ST3GAL6;B4GALT4;CERKL;ST6GALNAC4
prerank,response to amyloid-beta (GO:1904645),0.40946622996743787,1.0629488093650363,0.37031484257871067,0.7606813264002485,1.0,11/44,12.00%,APP;ICAM1;VCAM1;CASP4;FYN;CACNA1A;ATP1A3;PSEN1;EPHA4;GRIN1;LGMN
prerank,calcium ion homeostasis (GO:0055074),-0.29563103414449604,-1.062796805637715,0.3269230769230769,0.7929565403692146,1.0,13/95,8.91%,SLC24A3;ANK2;ATP13A5;ATP13A3;SLC8A3;ATP1B1;SLC8A1;DMPK;FAM20A;STIM1;ATP2A2;RYR2;SLC24A2
prerank,iron ion transmembrane transport (GO:0034755),0.5238620111379262,1.0627387658884522,0.42,0.7605633134509485,1.0,2/10,4.14%,SLC39A8;ABCB7
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.46857557877291434,-1.062571327277324,0.40486725663716816,0.7909141205457026,1.0,2/12,1.83%,EFNA5;FBLN1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.46857557877291434,-1.062571327277324,0.40486725663716816,0.7909141205457026,1.0,2/12,1.83%,EFNA5;FBLN1
prerank,monocyte differentiation (GO:0030224),0.5179770945533765,1.0624666559618512,0.4148550724637681,0.7606302803197743,1.0,2/10,1.98%,PIR;MYH9
prerank,cardiac cell development (GO:0055006),-0.46824806179538,-1.06240423653965,0.37445887445887444,0.7900538759298452,1.0,4/11,9.33%,CXADR;SLC8A1;JAG1;VEGFA
prerank,Notch signaling involved in heart development (GO:0061314),-0.47899523946058375,-1.0623079767899128,0.38009049773755654,0.7890095614281832,1.0,7/11,18.10%,NOTCH2;JAG1;HEYL;RBPJ;SNAI1;HEY2;HEY1
prerank,Golgi to plasma membrane transport (GO:0006893),0.40802409059846356,1.062230112527664,0.38772455089820357,0.7605863519360483,1.0,11/47,13.30%,EXOC6;SPTBN1;EXOC6B;VAMP4;GCC2;EXOC5;LLGL1;EXOC4;RAB26;RAB31;EXOC8
prerank,regulation of protein localization to nucleus (GO:1900180),0.4120538363339231,1.0621046869189565,0.3748148148148148,0.7602907423541694,1.0,7/43,7.19%,MFHAS1;WWTR1;CARD10;DTX3L;CTNNA1;LIMK2;TGFB1
prerank,regulation of sodium ion transport (GO:0002028),-0.3571717752321832,-1.0617399281691824,0.3554913294797688,0.7893349518224981,1.0,8/34,5.09%,SNTA1;WNK4;P2RX4;NKAIN4;ANK3;DLG1;SLMAP;NKAIN2
prerank,mitotic recombination (GO:0006312),-0.43064808365388907,-1.0615400883813895,0.39408866995073893,0.7885488780506174,1.0,10/15,30.03%,TEP1;RAD50;DMC1;SMC6;TPRKB;GEN1;RAD52;XRCC3;SMC5;ERCC1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3199800714373867,1.0615290472775623,0.34824281150159747,0.7609960718728082,1.0,93/341,21.42%,RNF125;KLHL3;SMURF1;RNF144B;NEDD4L;MVB12B;FBXW7;ZNRF1;ZNRF3;DTX3L;XBP1;KCTD10;PELI1;FBXL4;RNF144A;KCTD6;AURKA;UBL7;UBE3B;ARRB1;ATXN3;UBE2G1;RNF7;FBXL7;ARRDC1;RNF167;NEDD4;PSMA2;TRIM25;ARMC8;ANAPC7;UBE2H;ZRANB1;RNF146;SPOPL;RNF4;PSMA8;ANAPC1;RAD23A;ZFAND2B;VPS28;SIAH1;PSMA6;UBE2D3;CBL;RC3H1;CDC26;MYLIP;COP1;ANAPC16;RNF215;UBE2K;KLHL8;TOPORS;BUB3;UBXN1;PSME1;ARIH2;ELOC;VPS37C;AREL1;RNF5;DDIT3;UBE3D;MAEA;CRBN;NDFIP2;CTNNB1;BIRC2;NHLRC1;NEDD8;CUL3;UBE2I;PSMA4;CDC34;RNF40;PSMF1;ZFAND2A;APPBP2;PLK1;TSG101;UBE2L3;PSMB1;FBXO8;KCTD2;ARIH1;TRIM71;PSMB7;RNF111;KCTD5;PSMD2;HACE1;UBXN2A
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.44729555925993203,1.0614320972145825,0.39158576051779936,0.7606318282772802,1.0,5/25,8.89%,CSGALNACT1;B3GNT3;B3GNT4;B3GNT6;B4GAT1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.4893105411633778,1.0608889714791958,0.4044526901669759,0.7613096148192208,1.0,5/14,16.06%,NFKBIA;TMSB4X;PKD2;NFKBIE;G3BP2
prerank,phospholipid dephosphorylation (GO:0046839),0.41361578358275874,1.0607111268660343,0.4003067484662577,0.7611729536178073,1.0,15/37,19.81%,PLPP1;SGPP2;MTM1;MTMR6;INPP5K;SYNJ1;OCRL;INPP5F;MTMR12;PLPP6;PLPP5;MTMR9;SACM1L;MTMR2;PLPPR2
prerank,positive regulation of telomere capping (GO:1904355),0.47134141742334734,1.060535301705924,0.40407470288624786,0.7610054646452504,1.0,2/17,7.80%,NEK7;HNRNPD
prerank,positive regulation of macroautophagy (GO:0016239),0.39742641691422126,1.0603331850309292,0.3883211678832117,0.7609092461638287,1.0,13/48,17.38%,KDR;SPTLC2;VPS13D;RALB;SH3GLB1;IKBKG;BNIP3;GNAI3;FYCO1;RAB3GAP2;IRGM;EPM2A;HSPB8
prerank,histone H4 deacetylation (GO:0070933),0.5281216754074917,1.0600440178131503,0.42778793418647165,0.7610097313816414,1.0,2/10,5.91%,HDAC9;RCOR1
prerank,positive regulation of protein secretion (GO:0050714),0.37821144906238996,1.059983045415166,0.3651452282157676,0.7605746411397345,1.0,9/69,9.43%,MYRIP;UNC13B;CD2AP;ACSL4;EXPH5;TCF7L2;TGFB1;ANG;SOX4
prerank,regulation of cytoskeleton organization (GO:0051493),-0.29063114567331144,-1.0598422250857193,0.32142857142857145,0.7919570618581528,1.0,19/108,8.57%,PHLDB2;LRP1;EPHA3;PDGFRB;ROCK2;EFNA5;RHOQ;PHLDB1;BICD1;PRKCD;GPM6B;RHOBTB2;RND3;ARHGAP18;PRKAA2;MAP6;EZR;RHOBTB3;PLXNB1
prerank,epidermal cell differentiation (GO:0009913),0.4164768352650763,1.0597422005516537,0.39908256880733944,0.7605775120734475,1.0,8/41,16.73%,UGCG;BCR;WNT5A;USH2A;CLIC4;TXNIP;ASAH1;CTNNB1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.4296871555307116,-1.0594834712064445,0.375,0.7915863282995809,1.0,8/15,26.34%,NLGN2;NLGN1;CNTNAP4;ADRA1A;CLN3;BAIAP3;ZDHHC12;ZDHHC3
prerank,L-amino acid transport (GO:0015807),-0.3658426050551055,-1.0593619801435683,0.35693215339233036,0.7905998321460147,1.0,9/28,18.27%,SLC7A2;SLC1A3;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18;PRAF2;SLC36A1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.42649041241094365,-1.0592154947631924,0.38497652582159625,0.7896803400574691,1.0,3/17,7.25%,BMP6;CD55;PRKCA
prerank,methylguanosine-cap decapping (GO:0110156),0.535534777624643,1.0591744992944097,0.4355716878402904,0.7613249000603813,1.0,7/10,28.77%,EDC3;DCP2;PNRC2;LSM1;DCP1B;PATL2;DCPS
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.3647853605139884,-1.0589778382060298,0.3463687150837989,0.7890213935300061,1.0,8/31,8.88%,BMPR1A;FGFR2;TGFBR3;TGFBR1;TPM1;ZFPM2;RBPJ;RYR2
prerank,chloride transport (GO:0006821),-0.30595164300106703,-1.0588061769539336,0.3309608540925267,0.7881907364943581,1.0,18/74,14.64%,SLC4A10;SLC1A3;SLC26A7;SLC12A2;SLC6A1;ANO1;GLRB;CLCN2;GABRG2;ANO4;GABRA2;GABRB1;ANO3;GABRG3;GABRB3;SLC26A6;SLC1A1;FXYD1
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.3439530304342053,-1.0582879447036326,0.3582089552238806,0.7883456031358829,1.0,2/40,1.60%,PID1;BCL2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.47536281768282423,1.058256457311484,0.4094903339191564,0.7628825612807105,1.0,8/17,20.08%,LYN;TAOK2;MID1;KLHDC10;ARL6IP5;CARD9;EIF2AK2;TAOK1
prerank,regulation of cartilage development (GO:0061035),0.47064874623610164,1.0582009317187875,0.4194078947368421,0.7624229958550544,1.0,3/18,4.24%,BMPR2;ZBTB16;SOX9
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.4352713420853103,-1.058176652890757,0.38072289156626504,0.7873439807361335,1.0,4/15,6.30%,GLI2;EDA;WNT6;LRP6
prerank,regulation of epithelial cell proliferation (GO:0050678),0.36557130077885414,1.0581745634329958,0.37917222963951935,0.7618975726065057,1.0,15/85,8.41%,TBX1;TIE1;ACVRL1;PRKD1;CDK6;B2M;DAB2IP;SGPP2;MTSS1;AQP11;SOX9;TCF7L2;TGFB1;TGFA;SFRP2
prerank,regulation of receptor internalization (GO:0002090),0.4209624857084795,1.0576910207483163,0.3856,0.7624729112237586,1.0,12/35,12.99%,ANKRD13A;INSR;RIN3;SELE;SDCBP;GREM1;ARRB1;SCYL2;MKLN1;PICK1;TBC1D5;FMR1
prerank,plasma membrane invagination (GO:0099024),0.4287377338255782,1.05733341092036,0.39712918660287083,0.7627223329489015,1.0,3/29,1.98%,DOCK1;ELMO1;MYH9
prerank,DNA dealkylation (GO:0035510),0.5330666033144902,1.0569060650027908,0.423828125,0.7625499239816793,1.0,4/10,17.68%,ASCC1;ASCC3;MPG;MGMT
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.5330666033144902,1.0569060650027908,0.423828125,0.7625499239816793,1.0,4/10,17.68%,ASCC1;ASCC3;MPG;MGMT
prerank,insulin receptor signaling pathway (GO:0008286),0.379603586533164,1.056482391105863,0.3807531380753138,0.7629644897459057,1.0,13/69,9.13%,FOXO1;INSR;PIK3C2A;SH2B2;CAV2;SORBS1;GRB14;BCAR3;ATP6V0A1;GRB7;GAB1;AKT2;ATP6V1G2
prerank,regulation of macrophage chemotaxis (GO:0010758),0.46009005882530296,1.0564805340696959,0.4,0.7623812773191312,1.0,4/21,9.40%,MTUS1;PTK2B;PTK2;CSF1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.5259207127570007,1.0563696133533114,0.41320754716981134,0.762071066425761,1.0,4/11,20.81%,WRAP53;TERF1;CCT7;CCT2
prerank,metal ion export (GO:0070839),-0.3657571160228792,-1.0558816757306841,0.3520408163265306,0.7925884730043041,1.0,4/31,4.77%,ATP1A2;KCNK5;ATP1B1;KCND3
prerank,positive regulation of protein kinase activity (GO:0045860),0.3439630522829479,1.0558128371203133,0.3910411622276029,0.7627892146589231,1.0,38/148,16.72%,INSR;PDGFB;NEDD9;IQGAP1;IL6R;DAB2IP;EFNA1;PTK2B;TAOK2;STK3;PAK2;STK4;RALB;CCDC88A;RAPGEF2;TNIK;PTK2;RAP1A;RPTOR;PTPN1;CSF1;MAP2K3;IL23A;FCGR1A;GAS6;EPHA4;ITGB3;TGFBR2;HSP90AB1;TRAF6;PAK4;MMD;ACE;IRGM;PIH1D1;LAT;RHOA;CALM1
prerank,cell cycle G1/S phase transition (GO:0044843),0.386072202563354,1.055604731708811,0.3751783166904422,0.7626855530947075,1.0,26/61,26.70%,CDK6;EIF4E;PLK2;ACVR1;CDKN1B;MAP3K11;CDK2;CUL1;EIF4EBP1;RB1;MAX;CUL3;CDC34;E2F3;CUL2;DBF4;CCNH;TRIM71;LATS1;CRLF3;CCNA2;CUL4B;PLK3;HINFP;USP37;CACUL1
prerank,regulation of gene expression (GO:0010468),0.31014855360323895,1.0553174254907354,0.31959798994974875,0.7627568610472786,1.0,116/903,9.80%,LEF1;RPS6KA5;NOS3;RAB27A;NOVA2;KDR;ENG;APBB2;SLC39A8;ESR1;SMARCA2;APP;MEF2C;ACVRL1;SOX7;CLDN5;NR5A2;OCLN;CDK6;INSR;AHR;SMAD1;PDGFB;IRF2;FOXP1;GATA2;SOX13;PDE2A;LYN;STAT3;ADAM10;NR3C1;MSN;TRIM14;FBXW7;HIF1A;NOTCH1;NFKBIZ;PPM1F;RREB1;SOX17;CHD7;WWTR1;CASP8;SOX18;PLCG2;CD34;FGF23;SOX9;KDM6A;IGF2BP3;PTBP3;RBM20;MBNL1;MBNL2;SBNO2;TCF7L1;LIN54;SPIN1;DLL4;MAPK8;TRIM68;ATP2B4;MTF2;SERPINB9;JMJD1C;RAMP2;WNT5A;TNRC6C;PITX3;TEAD2;AFF1;ESRRG;AURKA;HNRNPF;CNBP;RPS7;UBAP2;BTN2A2;IL36G;ASCC1;KRAS;MBNL3;LYL1;HNRNPK;TGFB1;FOXN2;NOS1AP;TCF3;ZNF326;NFKB1;HNRNPD;MARF1;CREM;SFRP2;KAT6B;PSEN1;CITED1;WWC2;ZNF2;BACH1;MAFB;PRDM8;YBX3;HINT1;DICER1;PUM1;IHH;RPL23;MYBBP1A;CDK2;CSF1;SOX4;MAPK11;ICOSLG;HNRNPLL
prerank,long-term synaptic potentiation (GO:0060291),-0.39910719507618786,-1.0549566077397607,0.3665893271461717,0.7938259082944931,1.0,8/21,13.39%,SLC8A3;TSHZ3;PRKCZ;SLC24A2;STX4;GRIN2A;NFATC4;GRIN2D
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.5182156052605391,1.054930386167852,0.41229656419529837,0.7630284953861203,1.0,3/11,7.19%,MEF2C;GREM1;TGFB1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3226332191281877,1.0545972192014772,0.36666666666666664,0.7631911273122158,1.0,85/336,21.05%,FOXO1;ACER2;POLK;FOXP1;LYN;SAMHD1;FNIP2;TNFRSF1B;CCNK;TAOK2;USP3;BABAM2;UBA7;RNF169;DTX3L;HERC2;XIAP;BOK;BCL3;BCL2L11;MTREX;RPA1;MCM10;TIGAR;POLA1;PSEN1;BACH1;CGAS;RAD51D;IKBKG;BCL2L1;PARP2;BTG2;RAD18;HELB;RECQL;XRCC2;FAN1;MMS19;SFN;HUS1;MCM9;UNG;BID;WDR76;NOP53;ERCC4;FMR1;SUSD6;NSMCE4A;NPM1;ASH2L;YY1;TOPORS;OARD1;APC;ENDOV;DDIT3;PDS5A;PDS5B;CHEK2;GTF2H4;BCL2L10;SPIDR;GRB2;WDR48;MGMT;KMT5B;RFC3;CIB1;PAK1;RBBP5;BAK1;NUDT1;GTF2H1;CHD1L;TAOK1;RPS3;TAF9;RAD17;HIC1;SETX;MSH2;RMI2;TRRAP
prerank,DNA replication initiation (GO:0006270),0.41993762717548333,1.0538152708839712,0.40061633281972264,0.7644859680617165,1.0,16/37,26.95%,RPA1;MCM10;POLA1;CDT1;CDK2;PRIM2;ORC5;ORC3;CDC34;DBF4;PURA;ORC6;GMNN;PRIM1;MCM6;RPA3
prerank,toll-like receptor signaling pathway (GO:0002224),0.36243141359877873,1.0538143927386276,0.39473684210526316,0.7639043545199459,1.0,23/84,17.16%,CASP8;PLCG2;TIRAP;RPS6KA3;IKBKB;CTSK;RFTN1;TNIP1;IKBKG;MAPKAPK3;UBE2D3;NMI;IRAK4;RIPK1;BIRC3;LGMN;RIPK2;TRAF6;S100A9;IRAK3;TAB3;BIRC2;IRAK2
prerank,cellular transition metal ion homeostasis (GO:0046916),0.3613319239814466,1.0531785099368562,0.3715046604527297,0.764901352384092,1.0,10/91,11.19%,ABCG2;SLC39A8;APP;SLC31A1;ABCB7;LCN2;LCK;GLRX3;ATP7B;CUL1
prerank,protein deacetylation (GO:0006476),0.4111206515821603,1.0529815515775065,0.40536512667660207,0.7648094634997182,1.0,8/41,12.97%,HDAC9;HDAC7;RCOR1;RBM14;SIRT5;MIER1;SIRT6;MIDEAS
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.3487664233406455,1.0529661092989586,0.37926829268292683,0.7642697986296059,1.0,20/128,7.32%,BMPR2;ENG;ACVRL1;CLDN5;F11R;SMAD1;SMURF1;PARD3;NRROS;PXN;FKBP1A;ID1;ACVR2A;SMAD7;PTPRK;USP15;DUSP22;ACVR1;TGFB1;PTK2
prerank,regulation of neuroinflammatory response (GO:0150077),0.46649094094932453,1.052609655586192,0.4058219178082192,0.7645412345403667,1.0,3/19,3.04%,PTGS2;CD200;TNFRSF1B
prerank,neuropeptide signaling pathway (GO:0007218),0.38219849827582675,1.0525797396990693,0.38202247191011235,0.7640361977867508,1.0,13/58,19.92%,CYSLTR1;NXPH2;CPE;RAPGEF2;HCRTR1;MCHR1;NMUR2;LTB4R;AGRP;HCRTR2;OPRL1;GLRA3;PPY
prerank,regulation of dephosphorylation (GO:0035303),0.48467559125505905,1.052075566764389,0.41207815275310833,0.7646431687490592,1.0,3/15,9.37%,PPP1R16B;INPP5K;SMG7
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.37042265107726446,1.0519774887945097,0.40193370165745856,0.7642961946269148,1.0,9/74,6.15%,NOS3;TNFSF10;ITGA6;ICAM1;ARHGEF2;FAS;CASP8;TCF7L2;ACVR1
prerank,axonal transport of mitochondrion (GO:0019896),0.506422243916032,1.0514148509431054,0.43357933579335795,0.7649746861650655,1.0,6/11,27.45%,HIF1A;ACTR10;TRAK2;OPA1;NEFL;HAP1
prerank,pinocytosis (GO:0006907),-0.47565265314867133,-1.051205069649144,0.41885964912280704,0.8029327210118491,1.0,7/10,29.02%,CARMIL1;SNX5;PPT1;PYCARD;DOCK2;SNX33;AHSG
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.40774506171635433,1.0507616340439236,0.3980169971671388,0.7658850570357676,1.0,6/46,5.74%,SHANK3;MEF2C;DGKZ;PTK2B;CDH2;OPHN1
prerank,necroptotic process (GO:0070266),0.47524753920403906,1.0505571253710635,0.4404332129963899,0.7657730539669534,1.0,5/16,17.68%,PGAM5;MLKL;RIPK1;TRPM7;IPMK
prerank,regulation of protein metabolic process (GO:0051246),0.4057690377749815,1.0504270022026911,0.3819548872180451,0.7654979535325297,1.0,13/44,17.24%,APP;NEDD4L;FKBP1A;KLF2;MAPK8;PM20D2;SPOPL;MTPN;HSP90AB1;ACE;CHEK2;NEDD8;MAP2K5
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.35877609603611366,1.0501523137088207,0.39731543624161075,0.7655646771634241,1.0,19/94,11.19%,ERN1;PPP1R13B;DAB2IP;FNIP2;CASP4;PPM1F;TNFRSF1B;STK24;JMY;BOK;TRIB3;BCL2L11;HINT1;MYBBP1A;ERO1A;BCL2L1;SFN;BNIP3;CUL1
prerank,negative regulation of innate immune response (GO:0045824),0.4203176447786545,1.050067014281431,0.41576506955177744,0.7651820006414535,1.0,7/34,14.67%,NLRC5;SAMHD1;RPS19;USP15;NMI;CNOT7;IRAK3
prerank,negative regulation of lipid storage (GO:0010888),0.4631125314352173,1.049728183301823,0.41578947368421054,0.7654181160179228,1.0,7/19,15.84%,PPARD;NFKBIA;ITGB3;ABCG1;PNPLA2;TTC39B;ABCA1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.3468221172912337,1.0494968920974135,0.3700887198986058,0.7653759682142133,1.0,28/119,14.97%,INPP5D;PIP5K1B;SOCS2;PITPNM2;MTM1;PIK3C2A;PLCG2;PIK3R6;MTMR6;CISH;ITPKB;INPP5K;BMX;PIK3CG;PIGU;SYNJ1;PLEKHA8;OCRL;INPP5F;MTMR12;RAB5A;PIGQ;PGAP4;SLA2;PIGG;SOCS4;SOCS6;PIGF
prerank,protein localization to membrane (GO:0072657),0.33109150477332594,1.0494902043310526,0.3622508792497069,0.7648046733287867,1.0,32/187,9.04%,SHANK3;CAV1;EHD4;SPTBN1;F11R;SMURF1;RAB11A;TSPAN5;DENND4C;BSG;NKD2;PACS1;FCHO2;KCNB1;CPE;IKBKB;TSPAN14;RAMP2;RAPGEF2;SH3GLB1;TMEM88;INPP5K;ATP1B3;TNFRSF1A;TNIK;EHD2;RAP1A;AGRN;RFTN1;RAB38;ARL5A;ANK1
prerank,response to cadmium ion (GO:0046686),-0.38443623087356793,-1.0492863342486731,0.40599455040871935,0.8068501310541328,1.0,1/26,0.38%,EGFR
prerank,negative regulation of signal transduction (GO:0009968),0.3230599888492732,1.0491077636269732,0.36525612472160357,0.7651150642408638,1.0,41/249,8.44%,SEMA6A;EGFL7;NTN1;EPN2;NFATC1;MMRN2;PTPN12;GATA2;DAB2IP;HHEX;LYN;DDIT4;FBXW7;PTPRJ;NCK1;KIF26A;NKD2;SRMS;SIGIRR;CYP26A1;PLIN5;DLL1;TMBIM6;GRB14;VGLL4;DLL4;CX3CR1;ASAH2;KCTD6;ACVR1;CYP26C1;SOST;INPP5K;ARRB1;ARRDC1;GRB7;NEDD4;CTNNBIP1;MOSMO;SFRP2;CITED1
prerank,heart process (GO:0003015),-0.4404638547933678,-1.0490668222875918,0.4,0.806164205313458,1.0,3/14,7.62%,SGCD;NOX4;SGCZ
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.37966111092839944,1.048913678039721,0.3905579399141631,0.7649956021897114,1.0,10/59,12.24%,LEF1;SOX9;TCF7L2;TNRC6C;FOSL1;PPM1D;NFKB1;MED27;CBFB;RELA
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.4685385351450694,1.0488506899290053,0.40347826086956523,0.7645802515611695,1.0,5/18,13.80%,HHEX;NXF2;THOC2;ENY2;NUP133
prerank,erythrocyte development (GO:0048821),0.520008787890954,1.0482477036120765,0.41100917431192663,0.7654754738605745,1.0,1/10,2.95%,ALAS1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.43191894063794,1.0479435103157488,0.4,0.7656034169320541,1.0,7/25,10.06%,ITGA6;APP;SDCBP;PSEN1;ANG;DSCAM;BTBD10
prerank,dorsal/ventral pattern formation (GO:0009953),-0.39918211742925847,-1.0474877082176015,0.40759493670886077,0.8093486722997354,1.0,3/20,1.09%,BMPR1A;GLI2;NBL1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.4378557820614978,1.0472000508530594,0.3974358974358974,0.7667792890097144,1.0,10/25,24.44%,SF3B4;SCAF11;PRPF4;SRSF10;LSM1;PRPF3;TRA2B;DBR1;SRSF4;SLU7
prerank,in utero embryonic development (GO:0001701),-0.38102182185149325,-1.0470466868035102,0.38242894056847543,0.8092270684670377,1.0,7/25,10.39%,FGFR2;ARNT2;TGFBR1;PKD1;IGF2;VEGFA;TGFB3
prerank,cyclooxygenase pathway (GO:0019371),0.5226882166722701,1.047007340467604,0.43151969981238275,0.7666763894655462,1.0,3/10,7.28%,PTGS2;PTGS1;CBR1
prerank,organophosphate catabolic process (GO:0046434),0.5082007380446831,1.0470055963048877,0.4121996303142329,0.7661036043585834,1.0,3/11,14.57%,ENPP2;PDXP;NUDT15
prerank,mitochondrial translation (GO:0032543),0.35147857921819703,1.0469924242261068,0.39644218551461247,0.7655639887238562,1.0,46/104,26.40%,MRPS18A;NDUFA7;MRPL13;MRPS12;MRPL35;MRRF;FASTKD2;MRPL41;MRPL52;MTRF1L;MRPL4;MTIF3;QRSL1;MRPS16;MRPS5;MRPL23;MRPL37;MRPL11;PTCD3;MRPS26;MRPL54;GADD45GIP1;MRPS9;MRPL43;MRPL12;MRPL44;MRPS30;NOA1;MRPL1;MRPL17;RARS2;AURKAIP1;MRPL50;MTIF2;MRPL15;MRPL19;DAP3;MRPL14;MRPL32;MRPL39;MRPS11;MRPL9;MRPL46;GFM1;MRPL24;MRPL42
prerank,glycolytic process (GO:0006096),-0.35353171231333635,-1.0468810127251578,0.3671875,0.8083799751115405,1.0,15/28,38.61%,ENO2;HK2;TPI1;ENO3;PFKFB1;PFKM;ALDOA;PKM;ENO1;ALDOC;HKDC1;GAPDH;ALDOB;ENO4;HK3
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.4200870370303393,-1.046734396412365,0.3747072599531616,0.8074480231104099,1.0,4/17,13.37%,CPEB1;CPEB3;CTR9;CDK9
prerank,glycosphingolipid metabolic process (GO:0006687),0.4091995200708181,1.046430198529961,0.4114977307110439,0.766305617682697,1.0,4/42,4.87%,ST6GALNAC3;UGCG;ESYT2;GLTP
prerank,intracellular protein transport (GO:0006886),0.31573433931402034,1.0462061688957327,0.38127090301003347,0.7662380037800979,1.0,81/304,19.18%,TBC1D8;RASSF9;STX3;TBC1D30;SMURF1;TBC1D4;ARHGEF2;STAT3;IPO11;SGSM1;TBC1D22A;TBC1D15;STX6;HERC2;STX7;PPP1R10;TBC1D12;ARL4A;TGFB1;TMED7;AP2A1;STX1A;TBC1D2;XPO1;TMED5;RAB38;AKT2;ARL5A;AP3B1;VPS28;IPO8;MYO1C;NUP214;ACD;PICK1;HOMER3;STX8;TBC1D5;RAB43;STXBP3;TBC1D8B;PRICKLE1;WDR11;RABGAP1L;RAB7A;RAB31;RAB5A;PREB;EVI5;NUP133;RAB5B;NPM1;NUP153;RAB32;SNX13;GIPC1;STX11;TNPO3;RAB18;RAB6A;AP1S3;RAB3GAP2;STX12;RIC1;CHP1;RPL11;TLK1;SNX1;DESI1;RAB1A;CDC37;SIL1;COG7;GGA3;TRAK2;VPS26B;STAM;ARL5B;E2F3;PTTG1IP;MYO6
prerank,response to calcium ion (GO:0051592),0.3574902035088381,1.0444739559694987,0.3952569169960474,0.7696176221145969,1.0,16/102,8.15%,CAV1;MEF2C;CPNE8;IQGAP1;PPP3CA;PLCG2;ALOX5AP;KCNMB4;WNT5A;CHP2;ITPKB;TRPV6;PKD2;NEDD4;ITPR3;RASA4
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.49077289130105406,1.0444405021604355,0.4021543985637343,0.7691052789368139,1.0,5/13,15.29%,ARID1B;ARID1A;ZMIZ1;CDCA4;SERTAD2
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.3792742828846204,-1.0441151261505317,0.41404358353510895,0.8134904495641937,1.0,4/21,4.27%,PRKN;SLC30A10;PPARA;SIRT2
prerank,cortical actin cytoskeleton organization (GO:0030866),0.4641669059723674,1.0438813606114694,0.42759795570698467,0.7699064278399779,1.0,6/20,8.56%,LCP1;FMNL3;IKBKB;NCKAP1;FMNL2;LLGL1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.4615343370723082,1.04329079114501,0.4219554030874786,0.7707095191496384,1.0,3/20,8.44%,TGM2;RAP1GDS1;PSEN1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.3609165753957469,1.0424812092660198,0.3955026455026455,0.7721048649356481,1.0,29/86,25.54%,EPAS1;HIF1A;KLF2;EGLN1;PSMA2;BACH1;PSMA8;PSMA6;MUC1;HIGD1A;PSME1;ELOC;DDIT3;DNAJB1;PSMA4;PSMF1;CUL2;PSMB1;PSMB7;PSMD2;EGLN2;ANKRD2;GCN1;PSMA5;PSMC3;VHL;PSMD3;CREBBP;PSMA3
prerank,cellular response to alkaloid (GO:0071312),0.4638710215673114,1.0421220133991351,0.43838028169014087,0.7723920147914626,1.0,2/17,7.40%,TGM2;CASP7
prerank,cell part morphogenesis (GO:0032990),-0.43345262219772307,-1.0418288404270144,0.42298850574712643,0.818699132521308,1.0,1/13,0.15%,PID1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.46537589832218107,-1.0415628372065344,0.43544857768052514,0.818106710373704,1.0,2/11,4.27%,NRP1;SIRT2
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.38194394657445974,1.0413119115050902,0.3968481375358166,0.7737002718102267,1.0,12/56,17.16%,NOD1;PLCG2;RPS6KA3;CTSK;MAPKAPK3;IRAK4;LGMN;TRAF6;S100A9;TAB3;TIFA;IRAK2
prerank,positive regulation of endocytosis (GO:0045807),-0.3317381159059122,-1.0412363149020933,0.37971014492753624,0.8176785035537751,1.0,12/45,11.53%,LRP1;GPC3;VTN;APPL2;AXL;BICD1;NLGN1;CLIP3;DAB2;SERPINE1;APOE;SGIP1
prerank,regulation of viral life cycle (GO:1903900),0.44988374380108925,1.0411209973338311,0.42758620689655175,0.7735665465743751,1.0,4/21,7.94%,TRIM14;NECTIN2;TRIM68;TRIM25
prerank,response to iron ion (GO:0010039),-0.4476286464463156,-1.0404109883808814,0.40898876404494383,0.8186687579621708,1.0,2/12,1.60%,BMP6;BCL2
prerank,renal filtration (GO:0097205),-0.4667989131485095,-1.04021229301527,0.40461215932914046,0.8179174768029437,1.0,2/10,2.01%,SULF1;SULF2
prerank,long-chain fatty acid transport (GO:0015909),-0.3595607600712441,-1.0398100188302564,0.40607734806629836,0.8177603439942204,1.0,15/30,26.40%,ACSL1;ABCD3;PRKAA2;PRKAG2;ACACA;ACSL3;SLC27A1;APOE;MFSD2A;PRKAB2;SLC27A4;CPT2;PPARG;RPS6KB1;ABCD2
prerank,cell proliferation in forebrain (GO:0021846),-0.4715717441318896,-1.038740962584649,0.445916114790287,0.8194493461830413,1.0,1/10,0.41%,DOCK7
prerank,synapse assembly (GO:0007416),0.3668860100337952,1.0387374104694396,0.3963585434173669,0.7785080871884411,1.0,6/67,5.81%,SHANK3;DNM3;PLXND1;PCDHB4;CDH2;WNT5A
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.46912006225633074,1.038678026993312,0.4293286219081272,0.7780546672874702,1.0,3/16,6.38%,SOX9;CEACAM1;TRIB3
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.44611559831335335,1.038654125166491,0.4153605015673981,0.7775550929708508,1.0,4/24,7.10%,PLA2G4A;ABCA3;PLA2G2D;CDS2
prerank,artery morphogenesis (GO:0048844),0.4250582597533424,1.0384667227204543,0.4162754303599374,0.7774181250044017,1.0,6/30,5.19%,BMPR2;ENG;TBX1;NOTCH1;FOXF1;SMAD7
prerank,regulation of amyloid fibril formation (GO:1905906),0.4636597422258625,1.0381550556897865,0.4265232974910394,0.7775665852409063,1.0,7/15,23.33%,APP;PSEN1;PFDN1;PFDN5;IAPP;PFDN2;CLU
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.43916651809949675,1.0378716452010481,0.40793650793650793,0.7776688806792438,1.0,2/24,7.06%,POLK;RPA1
prerank,thyroid hormone generation (GO:0006590),-0.46900103210183086,-1.0371865753557585,0.44036697247706424,0.8226960466535602,1.0,2/10,7.79%,CPQ;SLC5A5
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.3670284146802057,1.0369332129346083,0.413986013986014,0.7793234338984865,1.0,9/76,6.29%,NOD1;APP;HDAC7;ADGRG3;NFKBIA;ACTN4;TMSB4X;BCL3;SASH1
prerank,myotube differentiation (GO:0014902),0.4648514453046662,1.0365462599272721,0.44039735099337746,0.7796342236637682,1.0,2/17,1.15%,JAM2;MEF2C
prerank,phosphatidylcholine metabolic process (GO:0046470),0.3771205213304682,1.0362848382197638,0.42,0.7796578411221272,1.0,15/70,17.98%,PLA2G4A;LPCAT3;CEPT1;ENPP2;LPIN3;ABCA3;PLA2G2D;MBOAT1;PLAAT3;PEMT;CHKA;PNPLA8;TMEM86B;CSNK2A1;CSNK2A2
prerank,regulation of translation (GO:0006417),0.33068068373168175,1.0361054170938633,0.3875598086124402,0.7795129392812287,1.0,39/173,15.59%,NANOS3;APP;DAPK1;RPS6KA3;IGF2BP3;RPS6KA1;EIF4E;NANOS2;EIF3H;BCL3;NIBAN1;EIF1;GRB7;HNRNPD;RNF139;SOX4;BTG2;CNOT1;RPL13A;RBM3;EIF6;CYFIP1;MRPL13;EIF5B;RACK1;FMR1;EIF2AK4;RPL10;CNOT7;MTPN;PAIP1;NPM1;EIF2B2;ERBB2;LARP4B;YBX1;LSM14A;CTIF;EIF5
prerank,negative regulation of immune system process (GO:0002683),0.48530513992324553,1.0359253105826116,0.4504201680672269,0.7793123899115219,1.0,3/16,4.24%,CD200;LYN;SOX9
prerank,regulation of protein ubiquitination (GO:0031396),0.3468673798671153,1.035914463241287,0.41353383458646614,0.778764810584139,1.0,29/108,17.22%,CAV1;FBXW7;FKBP1A;SMAD7;N4BP1;FOXF2;MYCBP2;XIAP;SASH1;DNAJA1;ARRB1;PINX1;MALT1;SOX4;SPOPL;VPS28;UBE3A;BIRC3;NXN;PRICKLE1;RIPK2;HSP90AB1;TRAF6;UBXN1;PRKCG;CHP1;NDFIP2;BIRC2;CUL3
prerank,positive regulation of metabolic process (GO:0009893),0.35013197907029564,1.035365083822499,0.3911392405063291,0.7794660951111251,1.0,24/103,14.61%,EPAS1;ADIPOR2;CAV1;INSR;FASN;ACACB;KDM3A;ADRB1;LCN2;GATM;ESRRG;PDGFC;AGPAT1;CXCR4;PRKAB1;IL4R;UCP2;PEMT;SIRT6;OMA1;ADIPOR1;HADH;IGF1R;APC
prerank,regulation of cellular protein localization (GO:1903827),-0.331542205581768,-1.0346835528931217,0.35986159169550175,0.8284617654941955,1.0,9/45,10.82%,GPC6;GPC3;MAP2;HSP90AA1;PRKAA2;GPC5;GBF1;CCDC66;GPC4
prerank,positive regulation of neurogenesis (GO:0050769),0.36892675798944596,1.034605466347935,0.4101123595505618,0.7806470870762113,1.0,7/68,5.49%,SHANK3;TGM2;PLXNA4;PLXND1;NUMB;DISC1;CX3CR1
prerank,receptor signaling pathway via STAT (GO:0097696),0.4327111725704036,1.0344426634988986,0.4206219312602291,0.780442425599473,1.0,10/25,16.45%,SOCS2;STAT3;GHR;IFNAR1;IFNAR2;PKD2;NMI;SOCS6;STAT6;STAT1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.4510298859140842,1.0340144559772722,0.4663299663299663,0.7808417784561382,1.0,3/20,2.79%,ENG;ACVRL1;NOTCH1
prerank,positive regulation of DNA recombination (GO:0045911),0.43274620410195336,1.0337372815978927,0.42197452229299365,0.7809439303819667,1.0,12/27,24.18%,SHLD1;WRAP53;MAD2L2;MMS19;ACTR2;WDR48;KMT5B;FUS;RIF1;PRDM9;ERCC6;ARID2
prerank,response to hydrogen peroxide (GO:0042542),0.3920054526903241,1.0337308337092082,0.3956043956043956,0.7803844436866085,1.0,9/45,12.62%,NET1;FYN;STK24;CAT;STK26;RIPK1;RELA;GLRX2;RHOB
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5104519165352086,1.0336510129794636,0.45989304812834225,0.7799977776467433,1.0,3/10,2.96%,NEXMIF;NOTCH1;PPM1F
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4014810975792853,1.0335496830622468,0.4161490683229814,0.7796748787209372,1.0,6/40,3.26%,GNAQ;FLT1;ESR1;PLCG1;HTR2A;SELE
prerank,protein acylation (GO:0043543),0.40374014673785935,1.0334114324076533,0.4270986745213549,0.7794233084512692,1.0,10/38,21.13%,FOXO1;ZDHHC18;ZDHHC9;HHAT;KAT2B;KAT6A;ZDHHC1;ZDHHC6;ZDHHC8;SELENOK
prerank,protein localization to mitochondrion (GO:0070585),-0.4640474122867576,-1.0333014853611633,0.42543859649122806,0.8309469058851091,1.0,6/11,21.75%,LRRK2;HK2;MTCH2;RALA;COX18;MAIP1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.38113788873859983,1.0327271965877576,0.4124293785310734,0.7804411853969214,1.0,7/57,6.80%,TNFSF10;KDR;HIP1R;BIK;BOK;AURKA;BCL2L11
prerank,negative regulation of receptor binding (GO:1900121),0.5258178092317134,1.0324263153923852,0.46062992125984253,0.7805670223124884,1.0,2/10,6.31%,B2M;ADAM15
prerank,response to unfolded protein (GO:0006986),0.39318482339747496,1.032417210449571,0.42749244712990936,0.780024866143573,1.0,14/48,17.59%,ERN1;STT3B;DAB2IP;TMBIM6;DNAJA1;PTPN1;RHBDD1;DNAJB5;ERP44;HSP90AB1;DDIT3;HSPB8;DNAJB1;HSPE1
prerank,carbohydrate homeostasis (GO:0033500),0.3668384368590005,1.032248413334588,0.4157142857142857,0.7798313691688333,1.0,13/67,14.69%,ADIPOR2;INSR;STAT3;KLF7;KCNB1;TCF7L2;INPP5K;NEUROD1;SOX4;ADIPOR1;RPS6;IGF1R;MBD5
prerank,actin filament bundle organization (GO:0061572),0.40491858072532205,1.0320846504007677,0.4265625,0.7796550365501268,1.0,6/33,4.60%,LCP1;EPS8;NEDD9;SHROOM2;SHROOM1;PLS3
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.3799671296873572,-1.031983219225016,0.38403990024937656,0.8332682522692806,1.0,6/26,6.13%,IGF1;IRS1;RHOQ;C2CD5;OSBPL8;CLIP3
prerank,response to interferon-alpha (GO:0035455),0.48147364492790656,1.031795533107131,0.44655172413793104,0.7797849137314301,1.0,9/16,19.14%,IFNAR1;IFNAR2;GAS6;RO60;ADAR;IFITM3;EIF2AK2;BST2;IFITM1
prerank,sensory perception of pain (GO:0019233),-0.3961685690576371,-1.0315574384372168,0.42462311557788945,0.8331492190971704,1.0,12/21,35.10%,P2RX4;PTGES;RETREG1;TRPA1;CCR2;KCNA2;SCN9A;CCL2;CHRNB2;ALOXE3;P2RX7;MME
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.440033734343224,1.031349639595281,0.45634266886326197,0.7802800978407204,1.0,4/23,12.71%,PTGS2;ASAH2;LTC4S;GSTP1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.4410989014960756,1.031057634135183,0.446843853820598,0.7804009080864364,1.0,1/26,0.09%,SHANK3
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.40424510054831436,1.031022475606589,0.416793893129771,0.7799201548721035,1.0,8/39,10.28%,NEXMIF;PODXL;NOTCH1;PPM1F;TGFB1;PTK2;NF2;MAD2L2
prerank,cellular glucan metabolic process (GO:0006073),-0.45429652321555447,-1.0308763835089447,0.4155844155844156,0.8336636121960014,1.0,5/11,11.73%,PHKB;PYGM;PRKAG2;PPP1R3C;UGP2
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.42770962386717104,-1.0306439647562204,0.4528301886792453,0.8330021655588828,1.0,8/15,23.72%,PRKCD;SMPD3;SPHK1;NSMAF;ORMDL2;PLA2G6;SMPD2;SPHK2
prerank,negative regulation of nervous system development (GO:0051961),0.4649879856736776,1.0306270674491074,0.4233576642335766,0.780234486806084,1.0,2/17,2.79%,B2M;NOTCH1
prerank,peptide cross-linking (GO:0018149),-0.36754702725627664,-1.0305861017979565,0.40594059405940597,0.8318333572757456,1.0,4/25,5.33%,COL3A1;THBS1;NDNF;ANXA1
prerank,aorta morphogenesis (GO:0035909),0.4695698794981054,1.030172032810441,0.4435215946843854,0.780682827989092,1.0,4/17,5.29%,ENG;TBX1;ACVRL1;DLL4
prerank,ventricular septum development (GO:0003281),-0.3455901548337259,-1.0298766104598869,0.41025641025641024,0.832426867326445,1.0,14/37,15.00%,ROBO1;BMPR1A;TGFBR3;TGFBR1;ZFPM2;ROBO2;SALL1;HEYL;MDM4;SLIT2;TGFB2;STRA6;CITED2;HEY2
prerank,actin filament bundle assembly (GO:0051017),0.40559860796983876,1.0298448245327465,0.43929712460063897,0.7808999538982984,1.0,6/33,4.60%,LCP1;EPS8;NEDD9;SHROOM2;SHROOM1;PLS3
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.4686249870420132,1.0295519445943102,0.4358974358974359,0.7810435259670783,1.0,7/15,24.97%,REEP1;ATL1;RAB18;ZFYVE27;ARL6IP1;REEP3;LNPK
prerank,regulation of viral transcription (GO:0046782),0.3993001191814224,1.0288694780551542,0.4253731343283582,0.7820872251406749,1.0,13/39,22.65%,TRIM14;GTF2F2;MID2;NELFE;ZFP36;NELFCD;IFITM3;CTDP1;TRIM62;POLR2L;NELFB;NELFA;POLR2J
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.3995318870611947,-1.028405837931079,0.41705069124423966,0.8351552172184147,1.0,7/18,12.76%,UNC13C;GRIA2;GRIK4;GRIK2;GRIK5;GRID2;GRIK1
prerank,negative regulation of protein polymerization (GO:0032272),0.4264114493432726,1.0284030414978564,0.4220032840722496,0.7825854882514117,1.0,6/27,10.59%,KANK3;HIP1R;SSH2;DYRK1A;CYRIB;TWF2
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.3265021682447206,-1.0283604605203702,0.3885542168674699,0.8339626184274954,1.0,12/45,12.87%,BMP7;BMP4;GAS1;ZWINT;SMAD3;TOM1L2;TRIM35;BCL6;RGCC;FZD3;BRINP3;CHFR
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.43841756612546334,-1.0283350090575982,0.4406047516198704,0.832711939079092,1.0,4/13,9.96%,IGF1;RAMP1;SOAT1;SLC2A10
prerank,"phagocytosis, engulfment (GO:0006911)",0.4092894125477065,1.028121375912324,0.4120443740095087,0.7826552095524726,1.0,6/36,10.18%,DOCK1;ELMO1;MYH9;RAC1;RHOBTB1;FCGR1A
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3610165530424525,1.0281158539906678,0.41793103448275865,0.7821010599725128,1.0,7/76,6.66%,TEK;EDN1;PTK2B;NCK1;EVL;NCKAP1;CDC42EP3
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.409951557139653,1.0280902404403711,0.4301587301587302,0.7815895197444694,1.0,11/32,20.60%,CAVIN1;TAF1B;POLR1A;RRN3;POLR1G;POLR1B;GTF2H4;TAF1A;GTF2H1;POLR2L;CCNH
prerank,positive regulation of axon extension (GO:0045773),0.4443520958709596,1.0278130384091015,0.4411764705882353,0.7816757610583857,1.0,6/22,12.14%,NTN1;SEMA7A;DSCAM;TWF2;MAP3K13;DBNL
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.45371445628344015,-1.0275623990450706,0.4490238611713666,0.8337167487398084,1.0,9/12,31.85%,LRRK2;PPT1;ATP6AP2;CLN3;TMEM165;TMEM199;TMEM9;CCDC115;GRN
prerank,regulation of histone methylation (GO:0031060),-0.43892922091680187,-1.0275482941858987,0.42152466367713004,0.8324531847771082,1.0,5/13,22.58%,TET1;CTR9;PAF1;NNMT;AASS
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.305645421275363,-1.0274920971859542,0.4121863799283154,0.8313166909399636,1.0,17/65,11.74%,FBN1;LTBP1;TGFBR1;HTRA3;SPRED1;PPARA;SMAD6;FBN2;SMAD3;CD109;ASPN;SNX6;TGFB1I1;VASN;SLC2A10;SPRED3;SPRED2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.4860884048215269,1.0274318710383687,0.44537815126050423,0.7819660615826316,1.0,3/14,10.28%,NECTIN2;SHLD1;MAD2L2
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.43670349868822567,1.0269998226939883,0.43790849673202614,0.78237275216147,1.0,7/24,10.81%,EPC1;H3-3A;MTF2;TASOR;PPM1D;AEBP2;PPHLN1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.3524352281517349,1.0268323810349604,0.436241610738255,0.7821868951183666,1.0,20/88,16.21%,NANOS3;DAPK1;DAB2IP;EDN1;IGF2BP3;NANOS2;NFKB1;GRB7;RNF139;BTG2;CNOT1;RPL13A;MRPL13;RACK1;FMR1;CNOT7;YBX1;LSM14A;RIC1;PAIP2B
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.44168469322915266,-1.0266211497370634,0.4336842105263158,0.8325247653907804,1.0,7/12,31.00%,AKR1B1;FDX1;FDXR;TSPO;TSPOAP1;CACNA1H;FDX2
prerank,negative regulation of cell differentiation (GO:0045596),0.3274932877686879,1.0265919445473008,0.4211764705882353,0.7821474853917557,1.0,37/181,13.06%,FOXO1;CAV1;TBX1;ZBTB16;CDK6;GATA2;DAB2IP;LRP5;EFNA1;PTK2B;HDAC7;NOTCH1;NFKBIA;WWTR1;FGF23;SOX9;DLL1;SMAD7;GREM1;WNT5A;TRIB3;TGFB1;SFRP2;CITED1;USH2A;ZFPM1;MAD2L2;SEMA4D;ASXL1;ITGB3;RB1;SINHCAF;TRIO;XDH;ABCG1;EIF2AK4;ADIPOR1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.48890948099707354,1.026411572667244,0.42752293577981654,0.7820218501992418,1.0,4/12,14.57%,STX3;STX1A;SNAP23;STX11
prerank,striated muscle cell differentiation (GO:0051146),0.4629979418625979,1.026005223116278,0.4383561643835616,0.7823781697048767,1.0,2/16,3.06%,MEF2C;SIK1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.4305124829897266,1.0255912299871135,0.43456375838926176,0.7828269370021969,1.0,10/23,19.67%,MTM1;MTMR6;INPP5K;SYNJ1;OCRL;INPP5F;MTMR12;MTMR9;SACM1L;MTMR2
prerank,cellular response to chemical stress (GO:0062197),0.35136909802666444,1.025330813002854,0.4261437908496732,0.7828468439182841,1.0,10/96,8.02%,FOXO1;CAV1;PRKD1;FAS;CAT;CYCS;GSR;PRR5L;PKD2;TRPV4
prerank,central nervous system development (GO:0007417),0.31780930409321395,1.0251150442846917,0.42857142857142855,0.7827452174568107,1.0,36/250,10.49%,SLC2A1;PBX1;ADGRL2;SHROOM4;ZBTB16;LSR;ZIC3;CELSR1;STAT3;ADGRA2;DDIT4;SNTG2;HAPLN3;CHD7;SHROOM2;ADGRG1;AMIGO2;CDH2;SOX9;MAL;RPS6KA3;DLL1;NCKAP1;CX3CR1;SEMA6B;CYP26C1;PDGFC;PKD2;DNAJC30;EIF2B5;SYNJ1;SOX4;CXCR4;NFIB;NMUR2;SCYL2
prerank,positive regulation of telomerase activity (GO:0051973),0.4110328926289866,1.0249502035124762,0.42586750788643535,0.7825374021032094,1.0,9/33,20.81%,NEK7;HMBOX1;GREM1;WRAP53;ACD;HSP90AB1;CTNNB1;MAP2K7;CCT2
prerank,protein insertion into ER membrane (GO:0045048),0.39873100392789085,1.0248287889985186,0.4177978883861237,0.7822605529237517,1.0,7/37,13.99%,APP;STX1A;TRAM1;TRAM1L1;EMC6;ALDH3A2;EMC3
prerank,extracellular matrix disassembly (GO:0022617),0.382175716012177,1.0247195116091432,0.4483240223463687,0.7819472001250867,1.0,7/53,8.22%,TLL1;LCP1;ADAM10;BSG;ADAM15;TLL2;CTSK
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.40429216139836577,-1.0245622053360492,0.42431761786600497,0.8370823882824844,1.0,3/19,2.89%,IRS1;PRKCD;PPARA
prerank,cellular component disassembly (GO:0022411),0.38165712422474163,1.0243480529571243,0.44537815126050423,0.7822363177688018,1.0,7/53,8.22%,TLL1;LCP1;ADAM10;BSG;ADAM15;TLL2;CTSK
prerank,proteoglycan biosynthetic process (GO:0030166),0.41213585283614446,1.0243384362369063,0.4385432473444613,0.7816955779246897,1.0,3/31,5.02%,CSGALNACT1;BMPR2;EXTL3
prerank,response to laminar fluid shear stress (GO:0034616),0.5179727225078932,1.024062590549471,0.46296296296296297,0.7818146340708942,1.0,4/10,17.24%,KLF2;SMAD7;ABCA1;MAP2K5
prerank,Ras protein signal transduction (GO:0007265),0.3340409616494197,1.0239878535090776,0.42351453855878635,0.7814281545207109,1.0,33/137,12.85%,NTN1;PRKD1;EPS8;ARHGEF3;ELMO1;CELSR1;GNB1;RREB1;GRAP;RAP1B;RASGRP3;ADGRG1;PLEKHG5;RALB;NCKAP1;PLK2;RAC1;RAPGEF2;CDC42EP3;NRAS;KRAS;RAP1A;GNA12;SHOC2;CDK2;G3BP1;MAPK11;RGL2;CYFIP1;RB1;DBNL;RHOB;GNA13
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.290845087520694,-1.0236418476715918,0.35019455252918286,0.8383218448922158,1.0,10/77,7.18%,IGF1;PRKN;BCL2;TGFBR1;SH3RF1;BMP4;THBS1;AR;ITGAV;SIAH2
prerank,regulation of macromolecule metabolic process (GO:0060255),0.3262579809076872,1.023503957280211,0.42023809523809524,0.7819734467181797,1.0,27/170,11.47%,NOVA2;APP;CDK6;AHR;FOXP1;TRIM14;HIF1A;NFKBIZ;KDM6A;IGF2BP3;TRIM68;AFF1;UBAP2;HNRNPK;RASA1;HNRNPD;MARF1;PSEN1;YBX3;IHH;CDK2;ATXN7L3B;SCARB2;APLNR;MKLN1;RO60;PRDM2
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.44004000284114125,1.0234869215684392,0.41983471074380163,0.7814524333829831,1.0,5/21,10.08%,CD2AP;DAB2IP;FBP1;SYNGAP1;CYRIB
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.4602979819869719,-1.0234241805590867,0.45661157024793386,0.8376299514852662,1.0,2/10,10.58%,CD55;CD81
prerank,fatty acid oxidation (GO:0019395),0.37681656759113813,1.0229973547445526,0.4373219373219373,0.7820149143700562,1.0,9/57,13.90%,ADIPOR2;PPARD;HADHA;ECI1;ABCD4;ABCD1;ADIPOR1;HADH;ALDH3A2
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.4199198442157764,1.0224531394688194,0.42476489028213166,0.782685166531693,1.0,7/29,11.82%,CASP8;IKBKB;CD40;IKBKG;UBE2D3;RIPK1;BIRC3
prerank,T cell differentiation in thymus (GO:0033077),-0.42580985590322207,-1.0223966939556284,0.4406779661016949,0.8391941990966664,1.0,1/14,0.70%,GLI3
prerank,atrial septum morphogenesis (GO:0060413),0.5140042679865626,1.022273385709748,0.46236559139784944,0.7825373838533938,1.0,4/10,9.43%,BMPR2;ACVR1;ZFPM1;SOX4
prerank,translesion synthesis (GO:0019985),0.3952830928092006,1.021861740534819,0.4076809453471196,0.7829244242294217,1.0,6/42,11.99%,POLK;RPA1;TRIM25;PRIMPOL;MAD2L2;USP43
prerank,establishment of protein localization to membrane (GO:0090150),0.3656955324056018,1.0208344911764848,0.4185022026431718,0.7846849763283761,1.0,14/66,12.45%,PARD3;RAB11A;REEP1;AQP11;TAOK2;SDCBP;SEC63;RFTN1;ZDHHC18;ZDHHC9;ICMT;MYO1C;BID;RAB11B
prerank,response to tumor necrosis factor (GO:0034612),0.35014825165180957,1.020629405220461,0.4477211796246649,0.7845988066550421,1.0,21/91,14.46%,GCH1;DAB2IP;ARHGEF2;ADAM10;TNFRSF11A;MAP4K3;SELE;CASP8;IKBKB;CD40;DCSTAMP;INPP5K;YBX3;CCL14;RIPK1;RELA;ZFP36;GBP3;HAS2;ASAH1;ZFP36L1
prerank,peptidyl-lysine modification (GO:0018205),-0.28209037532510656,-1.0204410979987242,0.3953488372093023,0.8434748612910853,1.0,18/99,12.23%,EYA1;LOXL1;HDAC4;PLOD2;LOXL3;SIRT2;NNAT;P3H3;SENP3;LOX;SENP7;POM121;RAE1;PIAS3;PIAS1;NUP93;NDC1;SENP5
prerank,cellular response to reactive oxygen species (GO:0034614),-0.31663486726652124,-1.0204187931623754,0.42517006802721086,0.8422429905656397,1.0,8/59,5.33%,EGFR;PDGFRA;MAP3K5;PRKCD;IMPACT;TPM1;CYP1B1;ANXA1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.4222716919948053,-1.0202302631485305,0.435665914221219,0.8414489377629495,1.0,4/15,16.72%,GLI3;CD55;HSPH1;SYK
prerank,neuron projection development (GO:0031175),0.33071568451154343,1.020190390740754,0.4306049822064057,0.7850290731307,1.0,20/168,7.85%,SHANK3;FRY;FRYL;APP;STX3;PTPRM;DAB2IP;RAB11A;LYN;SRGAP2;TAOK2;PPP1R9B;BICDL1;NCKAP1;OPHN1;ULK1;RAPGEF2;TNIK;NEDD4;CAMSAP2
prerank,lipid phosphorylation (GO:0046834),0.5130358841261632,1.0201262253627454,0.44155844155844154,0.7846259062769692,1.0,3/10,11.33%,DGKZ;DGKH;DGKE
prerank,regulation of chromosome segregation (GO:0051983),0.47341301747077164,1.0200900187597386,0.47017543859649125,0.7841577455454511,1.0,7/16,20.97%,PUM1;RAD18;PUM2;CSNK2A1;CSNK2A2;NUMA1;RMI2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.36075780953386677,1.0200504940265904,0.4344262295081967,0.7836887588650714,1.0,24/74,25.54%,EPAS1;HIF1A;NOTCH1;EGLN1;PSMA2;BACH1;PSMA8;PSMA6;HIGD1A;PSME1;ELOC;PSMA4;PSMF1;CUL2;PSMB1;PSMB7;PSMD2;EGLN2;PSMA5;PSMC3;VHL;PSMD3;CREBBP;PSMA3
prerank,negative regulation of ATPase activity (GO:0032780),-0.41434033831281064,-1.0198711178059283,0.43529411764705883,0.841145717644985,1.0,8/16,27.18%,IFIT1;TSC1;VCPKMT;TP53;ATP5IF1;PPIF;PAM16;PLN
prerank,renal water homeostasis (GO:0003091),-0.37514408446215325,-1.0198635797005982,0.4416243654822335,0.839862558642562,1.0,8/23,11.81%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6;PRKACA;PRKAR1B;PRKAR1A
prerank,oxoacid metabolic process (GO:0043436),-0.3615378253900523,-1.0197814062455486,0.4046997389033943,0.8388225721117426,1.0,4/27,8.02%,DDO;ENPP1;TPST1;ABHD14B
prerank,negative regulation of transport (GO:0051051),0.3757455212899935,1.019661902848368,0.4434907010014306,0.7840306586512614,1.0,9/51,12.95%,MCTP1;CTTNBP2NL;PRKD1;PPM1F;SNX3;PXK;ITGB3;RACK1;RAB7A
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3454249281207116,1.019322516560647,0.43924050632911393,0.784256835455193,1.0,19/101,9.00%,FLT1;PDGFB;DAB2IP;EDN1;PDGFD;TPD52L1;PIK3R6;RALB;ATP2B4;WNT5A;CD40;RAPGEF2;TGFB1;PDGFC;PIK3CG;PKD2;CCNYL1;RPTOR;CCNY
prerank,BMP signaling pathway (GO:0030509),0.3692304646886505,1.0186603999828738,0.4343163538873995,0.7852397632176644,1.0,10/62,7.19%,BMPR2;ENG;ACVRL1;SMAD1;SMURF1;ACVR2A;SMAD7;USP15;ACVR1;TGFB1
prerank,negative regulation of cellular component organization (GO:0051129),-0.29664640886018,-1.0186284646465533,0.3964285714285714,0.8407825741480162,1.0,16/74,13.17%,BMP6;EPHA3;TMEFF2;AR;IMPACT;FAP;CARMIL1;SYT11;PRKCZ;RTEL1;SRC;VEGFA;SCAMP5;LRSAM1;RUBCN;TRAF3IP1
prerank,protein transport (GO:0015031),0.30842082076322835,1.0184774394578728,0.4370290635091496,0.7851128549397802,1.0,88/332,20.25%,TBC1D8;CALCRL;STX3;SPTBN1;TBC1D30;MYH9;TBC1D4;ARHGEF2;SGSM1;TBC1D22A;TBC1D15;STX6;LMTK2;HERC2;SCAMP1;STX7;SLC10A7;RAMP2;VAMP4;CHMP2B;TBC1D12;ARL4A;ARRDC1;TMED7;AP2A1;STX1A;GCC2;ATP6V0A1;TBC1D2;TMED5;RAB38;ARL5A;NEURL1B;ATP6V1G2;AP3B1;AFM;RAB12;ACD;PICK1;STX8;TBC1D5;RAB26;RAB43;RAB11B;STXBP3;TBC1D8B;RILP;WDR11;ABCG1;RABGAP1L;RAB7A;RAB31;RAB5A;PREB;EVI5;RAB5B;TXNIP;NPM1;RAB32;SNX13;STX11;RAB18;RAB6A;CEP290;RAB3GAP2;ABCA1;STX12;RIC1;RAB8B;COPG2;SNX4;TLK1;ARL6IP5;SNX1;RAB1A;SIL1;COG7;GGA3;VPS26B;ARL5B;ATP6V1F;MYO6;TVP23B;VPS35;PPY;ATP6V1D;MIA2;PDCD6
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.4470673521109942,-1.0181110318494455,0.4512471655328798,0.8408890572892113,1.0,2/12,7.56%,BCL2;CD44
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.47365727258806634,1.0181095839851846,0.4347048300536673,0.7853607882523694,1.0,2/13,4.05%,NOS3;TMSB4X
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.41106668934647067,-1.0180772184892166,0.4452380952380952,0.8396898116358097,1.0,2/17,1.69%,ANK2;SNTA1
prerank,protein homotetramerization (GO:0051289),0.3752050437922742,1.0178334129588624,0.4298245614035088,0.7854356297081521,1.0,5/49,3.41%,B2M;GBP5;SAMHD1;ACACB;GLS
prerank,defense response to Gram-negative bacterium (GO:0050829),0.38233135312738054,1.0176806433020646,0.41437308868501527,0.7852288388020214,1.0,6/42,9.76%,IL6R;SELP;RPS19;DROSHA;DEFA6;IL23A
prerank,regulation of gluconeogenesis (GO:0006111),-0.36223507926646215,-1.0176504263405968,0.4438356164383562,0.8395389221524477,1.0,10/27,20.71%,OGT;PPARGC1A;SELENOS;C1QTNF3;PTPN2;DGKQ;DDB1;CRY1;PDK2;NNMT
prerank,positive regulation of developmental process (GO:0051094),0.32961320630623314,1.0175095390969795,0.4204946996466431,0.7850549140433869,1.0,21/164,6.84%,SHANK3;BMPR2;KDR;ZBTB16;INSR;PDGFB;DAB2IP;FZD4;RREB1;PLCB1;SOX9;RPS6KA3;XBP1;RPS6KA1;SLC6A6;ENPP2;WNT5A;SHLD1;AURKA;ACVR1;B4GALT5
prerank,calcium-mediated signaling (GO:0019722),0.3463895197507036,1.0169613055261135,0.442159383033419,0.7857268454475479,1.0,13/93,6.02%,MCTP1;KDR;VCAM1;PLCG1;EDN1;PPP3CA;PTPRJ;SELE;PLCG2;SELP;PPP1R9B;CX3CR1;PPP3CB
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.3895965040237943,-1.0168357207911067,0.4733009708737864,0.8405335064657866,1.0,14/19,46.02%,APOE;CHRFAM7A;CHRNA7;SLC5A7;CHRNB2;ACHE;COLQ;RAPSN;CHRNA5;CHRNA3;RIC3;CHRNE;CHRNB4;CHRNB3
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.41060317153841164,1.016708789936089,0.44711538461538464,0.7857383786920795,1.0,3/31,6.38%,DCUN1D3;FBXW7;TRIB3
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.4235685486311991,1.0165879542398544,0.4565560821484992,0.785461772434564,1.0,14/29,26.49%,CNOT6;EDC3;EXOSC1;DCP2;LSM3;HBS1L;CNOT7;LSM7;LSM1;DCP1B;LSM2;EXOSC4;DDX6;DIS3
prerank,potassium ion import across plasma membrane (GO:1990573),-0.3257562012909565,-1.016214401953455,0.44,0.8409938511975821,1.0,7/41,9.89%,ATP1A2;SLC12A2;ATP1B1;ABCC9;KCNJ2;KCNJ13;ATP1B2
prerank,regulation of BMP signaling pathway (GO:0030510),0.3613098895874561,1.01587936506676,0.43142476697736354,0.7865454275038107,1.0,15/73,10.35%,BMPR2;ENG;ACVRL1;SMAD1;SMURF1;NOTCH1;ACVR2A;SMAD7;GREM1;XIAP;SOST;ITGA3;SMAD5;SKIL;UBE2D3
prerank,regulation of exocytosis (GO:0017157),0.3817126679289456,1.0158406367561705,0.4406528189910979,0.7860827324360813,1.0,10/46,17.21%,RAB27A;CADPS2;EXPH5;RAB12;RAB26;RAB5A;STXBP6;RAB8B;SYTL4;CPLX2
prerank,arachidonic acid metabolic process (GO:0019369),0.40556587878124095,1.0156688124789577,0.45813586097946285,0.7859266340378884,1.0,5/35,7.28%,PTGS2;PLA2G4A;PTGS1;EPHX1;CBR1
prerank,regulation of viral genome replication (GO:0045069),0.3757827240317071,1.0156573753418086,0.43120567375886526,0.7853994541822882,1.0,16/56,19.14%,NR5A2;ADARB1;PKN2;ISG20;N4BP1;TNIP1;RAD23A;ADAR;OASL;CNOT7;IFIH1;IFITM3;PLSCR1;EIF2AK2;BST2;IFITM1
prerank,positive regulation of viral life cycle (GO:1903902),-0.3828622661378452,-1.0155611741720498,0.4293193717277487,0.8414736716765271,1.0,8/22,20.86%,AXL;P4HB;LGALS1;KPNA2;DDB1;VPS4A;TYRO3;CD74
prerank,regulation of cell division (GO:0051302),0.36283044138493564,1.0141579642558478,0.4318488529014845,0.7882094299050154,1.0,22/72,21.24%,RAB11A;MLLT3;TAL1;DLL1;PLK2;AURKA;SH3GLB1;SFRP2;AURKC;PDXP;BCL2L1;SFN;RACK1;ESRRB;TXNIP;CALM1;PRPF40A;CIB1;CETN2;PLK1;GIT1;PIK3R4
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.44486104755351824,1.0140215065804339,0.46286701208981,0.7879513833974373,1.0,6/20,11.68%,ABI3;PPP2R5A;NUMB;TGFB1;BCL2L1;PICALM
prerank,epithelial cell morphogenesis (GO:0003382),-0.39892967280392677,-1.0138577156689197,0.43914081145584727,0.8448459466264255,1.0,4/17,13.84%,COL22A1;COL18A1;DACT2;COL15A1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.4423217385221449,1.0138368414850265,0.4570446735395189,0.78781058843732,1.0,6/20,11.68%,ABI3;PPP2R5A;NUMB;TGFB1;BCL2L1;PICALM
prerank,actin nucleation (GO:0045010),0.44238951894193423,1.0137263790707174,0.45531197301854975,0.787498817379085,1.0,7/21,17.33%,JMY;ARPC3;ARPC1B;ACTR2;ACTR3;ARPC2;WHAMM
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.3793622213644429,1.0135031268564398,0.4301994301994302,0.7874598456610095,1.0,14/49,18.95%,MEF2C;KMT2E;H3-3A;TNRC6C;ZFPM1;RBM15;EIF6;CBFB;RAB7B;ASH2L;KAT2B;ITGA2B;CIB1;RBBP5
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.34789996112258487,1.01300996556209,0.43775100401606426,0.7880540443026047,1.0,21/87,18.30%,DCUN1D3;CDK6;AURKA;JADE1;AVEN;FBXL7;PKD2;PSMA2;PINX1;PSMA8;PSMA6;CUL1;RB1;ZFP36L1;APC;PSME1;E2F7;CDC73;PSMA4;PSMF1;RBL1
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.45827271831713745,-1.0128893772430758,0.4780793319415449,0.8463274133611445,1.0,5/10,17.68%,PFKP;HK2;GFPT1;GFPT2;PFKM
prerank,cellular response to organic cyclic compound (GO:0071407),0.3305853604417336,1.0128784519241116,0.4479804161566707,0.7877757456889793,1.0,21/141,7.67%,TGM2;ESR1;MEF2C;AHR;PDGFB;PDE2A;KCNQ1;NR3C1;MSN;GNB1;RAP1B;CTNNA1;ATP1A3;ATP1A1;RAPGEF2;NCOA4;INPP5K;TGFB1;CASP7;RAP1A;PKD2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.4372991004098967,-1.0127845419968269,0.4470842332613391,0.8453599228529673,1.0,3/12,9.11%,BMP7;CD44;GCNT2
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.3717772602236613,-1.0127342556167132,0.4469135802469136,0.8442404006487286,1.0,8/23,20.79%,MAP6;KIF1A;KIF5C;DYNC1I1;KIF1B;HOOK2;KIF5A;TUBA1C
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.4130502393785145,1.0126498313007757,0.4317111459968603,0.7877308016655521,1.0,7/30,11.82%,CASP8;IKBKB;CD40;IKBKG;UBE2D3;RIPK1;BIRC3
prerank,microtubule anchoring (GO:0034453),-0.43653626881767493,-1.0125070134394816,0.4584269662921348,0.8435401162347873,1.0,4/12,13.83%,BICD1;DAG1;BICD2;PCM1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.39591941026591887,-1.0119711532311,0.4329411764705882,0.8437054899893146,1.0,3/18,2.91%,EGFR;DDX5;BMP4
prerank,mononuclear cell differentiation (GO:1903131),0.42793837629956677,1.0107291948507438,0.4727272727272727,0.7914774121410869,1.0,3/24,2.30%,PIR;MYH9;LYN
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.29930756144400966,1.0105721829896595,0.44672131147540983,0.79126827549609,1.0,91/572,12.56%,HDAC9;DACH1;LDB2;CAV1;ESR1;SMARCA2;PPARD;MEF2C;ZBTB16;ETV6;LRRFIP1;PDGFB;IRF2;FOXP1;DAB2IP;SOX13;EDN1;HHEX;PDE2A;STAT3;NEDD4L;EFNA1;NR3C1;FNIP2;NOTCH1;KLF7;RREB1;KLF8;TGIF1;ZFP57;SOX18;HMBOX1;RIPPLY3;SOX9;KLF2;ELK4;RPS14;SDCBP;MCPH1;ID1;EPC1;SMAD7;TCF7L2;DLL4;MTF2;KLF10;CNBP;DUSP22;TRIB3;NR1I3;FBP1;IRF2BPL;ETS2;SPDEF;TCF3;NFKB1;NEDD4;GATAD2A;CTBP1;CREM;PSEN1;WWC2;PHF6;TAF3;EZH1;BACH1;NRIP1;DICER1;RPL23;ZFPM1;YEATS2;NFIB;SKIL;MAD2L2;CNOT1;UBE2D3;SP2;SEMA4D;SPEN;KLF12;CNOT2;CBFB;EID1;PRDM2;RB1;DCAF1;MIER1;RELA;MAX;SIRT6;NOP53
prerank,regulation of blood coagulation (GO:0030193),0.41920976673685745,1.009969522419786,0.4707792207792208,0.7920917024950708,1.0,4/27,4.62%,CAV1;EDN1;CD34;ENPP4
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.46845307289719673,1.009936779865267,0.46691176470588236,0.7916179657080283,1.0,4/14,18.86%,CSF1;IL23A;TRAF6;CCR1
prerank,phosphate ion homeostasis (GO:0055062),-0.4545270374726479,-1.0098379634616128,0.44635193133047213,0.8483468230881223,1.0,3/10,10.53%,ENPP1;SFRP4;FGFR4
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.32530362030852195,1.0096122258638196,0.4462809917355372,0.7917917164973685,1.0,16/159,4.17%,MPZ;PECAM1;CADM1;ICAM1;VCAM1;CLDN5;PTPRM;NECTIN2;PVR;SELE;BSG;PCDHB4;SELP;ROBO4;AMIGO2;CDH2
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.40059360112587494,-1.0093831016753942,0.43846153846153846,0.8482005079572271,1.0,4/17,12.18%,AKAP13;ADRA1B;ADRA2A;ADRA1A
prerank,negative regulation of signaling (GO:0023057),0.4239896698364583,1.0092158879869506,0.47527910685805425,0.7921220792460724,1.0,5/25,9.08%,KIF26A;SRMS;FGF23;ACVR1;PTPN1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.4576323347731788,-1.0090841588595214,0.47098214285714285,0.8477140741616712,1.0,2/10,11.24%,SH3RF1;RUNX1
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.46762805838627086,-1.008865750094491,0.47098214285714285,0.847022058424565,1.0,3/10,6.30%,BMP5;BMP7;LRP6
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.4018703093371015,1.0087353227322202,0.43829113924050633,0.7927137103858709,1.0,7/32,7.94%,ACER2;NEXMIF;ACVRL1;DUSP22;ADAM15;RASA1;NF2
prerank,actin cytoskeleton reorganization (GO:0031532),0.36115108476912317,1.0085661757705349,0.4534075104311544,0.7925672408618955,1.0,13/63,9.18%,PARVB;THSD7A;NEDD9;MYH9;S1PR1;CDC42BPB;TNIK;ATP2C1;PLEK2;TRPV4;GAB1;PTPN1;RICTOR
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.41779966918541245,1.00851811406578,0.43655589123867067,0.7921232084308508,1.0,2/29,1.05%,MCTP1;APP
prerank,androgen receptor signaling pathway (GO:0030521),0.4835032389779067,1.008356351747505,0.441340782122905,0.7919620721579584,1.0,5/11,13.39%,PLPP1;KDM3A;ARID1A;ZMIZ1;PMEPA1
prerank,regulation of cellular metabolic process (GO:0031323),-0.3209866621490075,-1.008317143874591,0.44694533762057875,0.8472056062836771,1.0,6/45,6.97%,PID1;PRKN;PPARA;TBC1D16;CYP1B1;ACACA
prerank,response to purine-containing compound (GO:0014074),-0.40627957300795337,-1.0079380934308741,0.4801980198019802,0.8469183396541344,1.0,4/17,8.88%,P2RX4;ABCC9;TRPC3;RYR2
prerank,defense response to fungus (GO:0050832),0.4528672543128652,1.0079318026855861,0.4880952380952381,0.7924024098490422,1.0,5/17,19.72%,PLCG2;CX3CR1;S100A9;CARD9;BCL10
prerank,endocytic recycling (GO:0032456),0.378044076278964,1.0078133717400632,0.47901591895803186,0.7921083493993715,1.0,9/50,12.95%,EHD4;DENND1B;STX6;LMTK2;EHD2;SNX3;EHD3;RAB11B;RAB7A
prerank,regulation of neurogenesis (GO:0050767),0.3704814344570412,1.0077267255528988,0.44573082489146165,0.7917464489924262,1.0,6/55,5.49%,TGM2;B2M;NOTCH1;NUMB;DLL1;CX3CR1
prerank,negative regulation of coagulation (GO:0050819),-0.42297742585297327,-1.0072014433559788,0.4672897196261682,0.847711648407977,1.0,6/14,10.33%,VTN;TFPI;SERPINE2;SERPINE1;APOE;HS3ST5
prerank,positive regulation of transporter activity (GO:0032411),-0.44088906380396,-1.007175238742812,0.466824644549763,0.8465222046205464,1.0,9/13,36.97%,TRPC6;WNK3;NR1H3;SGK2;SGK1;PDZK1;KCTD7;STK39;RXRA
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.41355053018688026,1.007167677487444,0.4509151414309484,0.7924755068910105,1.0,5/28,9.79%,ERN1;DAB2IP;CASP4;TRIB3;ERO1A
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.3670289926662481,1.0068186645212371,0.44105409153952846,0.7926895192164529,1.0,10/59,5.16%,PECAM1;CADM1;PTPRM;NECTIN2;PVR;BSG;ROBO4;AMIGO2;CDH2;CEACAM1
prerank,early endosome to late endosome transport (GO:0045022),0.4435212416599027,1.0067676787847457,0.4583333333333333,0.7922649331560043,1.0,7/20,13.28%,LMTK2;EEA1;STX8;KIF16B;RILP;RAB7A;RAB5A
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.40187858657321446,-1.0066714607322462,0.4515366430260047,0.8466849888356601,1.0,5/17,9.58%,EGFR;PKD1;CCND2;SPDYA;RGCC
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.37850747645051486,-1.0063053460246087,0.43908629441624364,0.8464029283528821,1.0,8/21,9.35%,DCN;BGN;CSPG4;CHST15;VCAN;CHSY3;CHSY1;CHST3
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.4428896927561166,1.006232731251388,0.4562607204116638,0.7929045209348584,1.0,4/21,14.08%,RAB11A;BRD4;CDC25C;NPM1
prerank,retina homeostasis (GO:0001895),0.4279776598441757,1.0062139391199605,0.46321070234113715,0.7924044012917955,1.0,2/23,3.16%,B2M;CNGB1
prerank,negative regulation of viral process (GO:0048525),0.36724845989027055,1.006186633408133,0.4742857142857143,0.7919237682619477,1.0,16/57,19.14%,TRIM14;ISG20;N4BP1;PTX3;MID2;TNIP1;OASL;ZFP36;IFIH1;IFITM3;STAT1;PLSCR1;EIF2AK2;TRIM62;BST2;IFITM1
prerank,transcription by RNA polymerase II (GO:0006366),0.30597400559982973,1.006023512144101,0.45652173913043476,0.7917328077525558,1.0,52/305,15.39%,TEAD4;HDAC9;ESR1;PPARD;MAML2;NR5A2;PIR;MLLT3;NR3C1;HDAC7;NOTCH1;RREB1;CCNK;WWTR1;GTF2I;XBP1;TEAD2;ESRRG;GTF2F2;NR1I3;KLF13;NFKB1;GMEB2;GTF2E2;WDR33;TRIP13;NELFE;TAF3;TAF4B;TRIM24;MED27;COPS2;RNGTT;EAF1;POU2F1;INTS11;CEBPD;CBFB;SNAPC3;RPRD1B;GTF2A2;BTF3;RNMT;INTS12;ESRRB;RPRD2;NRBP1;SNW1;KAT2B;ELOC;NR2C2;NELFCD
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3802985753075654,1.005816542552769,0.45170876671619614,0.7916338077931474,1.0,14/48,16.87%,FNIP2;DDIT4;TNFRSF1B;HIPK1;BOK;BCL3;BCL2L11;BCL2L1;SFN;TOPORS;SNW1;CHEK2;TMEM109;BCL2L10
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.3427044053217089,-1.0057670627193573,0.4599406528189911,0.8467038068745346,1.0,12/33,12.76%,NLGN2;LRRC4C;NGF;NLGN1;NRG3;GRIK4;NLGN3;IQSEC2;GRIK2;GRIK5;GRID2;GRIK1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.4387860398960042,1.0057071838593157,0.47417840375586856,0.7913242546810555,1.0,4/23,5.58%,TGM2;KCNQ1;GNB1;ATP2B4
prerank,regulation of protein-containing complex assembly (GO:0043254),0.33402710722887985,1.0053095862384755,0.4341772151898734,0.7916683911129971,1.0,29/110,17.23%,DAB2IP;TAL1;FNIP2;BIK;SELP;TIRAP;RALB;ULK1;ATF7IP;SH3GLB1;SOST;BCL2L11;TGFB1;CDT1;AIDA;RB1;BID;NOP53;WARS1;RACK1;PREB;CDH5;SVIP;ABCA1;IRGM;BMF;PIH1D1;SPIDR;TMC8
prerank,positive regulation of behavior (GO:0048520),0.48860812173870094,1.0052086925584836,0.4810126582278481,0.7913484304021967,1.0,1/10,1.15%,MEF2C
prerank,regulation of protein processing (GO:0070613),-0.38396570639268923,-1.0051890611443532,0.4648241206030151,0.8470363078762928,1.0,5/21,11.24%,CCBE1;GAS1;SERPINE2;LRRK2;RUNX1
prerank,regulation of receptor recycling (GO:0001919),-0.3987835487901469,-1.0050286266740684,0.43400447427293065,0.8462706616525697,1.0,5/16,14.80%,TBC1D16;ANXA2;OPTN;RAB29;SNCA
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.34811926273997773,-1.0045316904631518,0.4297520661157025,0.8464299110252828,1.0,7/30,7.46%,FSTL1;TGFBR3;DKK3;TWSG1;SMAD3;SFRP4;BCL9
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.4160975644040147,-1.0043589536038022,0.4768211920529801,0.8456215662817068,1.0,3/14,7.92%,DPYD;UPB1;NT5E
prerank,inorganic anion transmembrane transport (GO:0098661),-0.2978108507423805,-1.004193264739286,0.4360655737704918,0.8448263843912162,1.0,25/63,21.94%,SLC1A3;SLC12A2;SLC6A1;SLC26A2;ANO1;GLRB;GABRG2;ANO4;SLC5A5;GABRA2;SLC20A1;GABRB1;ANO3;SLC5A6;GABRG3;GABRB3;SLC1A1;CFTR;SLC4A8;SLC25A3;SLC25A14;CLCN1;GABRA1;GABRA5;SLC12A8
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.48118360461956483,1.0041829116812686,0.4781021897810219,0.7931156280348168,1.0,1/13,1.31%,STX3
prerank,cellular response to starvation (GO:0009267),0.32683922715629815,1.0041177937852963,0.4585365853658537,0.7927066085747038,1.0,24/147,13.47%,FOXO1;BMPR2;PRKD1;FAS;SIK1;STK24;RALB;XBP1;MAPK8;KLF10;SH3GLB1;STK26;RPTOR;ATP6V1G2;MYBBP1A;NPRL2;NUAK1;LARS1;PICK1;SIK2;GABARAPL1;XPR1;EIF2AK4;AOC1
prerank,ear morphogenesis (GO:0042471),-0.3824598380243508,-1.0030166466192507,0.43640897755610975,0.846809354968378,1.0,4/20,5.73%,ZIC1;FGFR2;OSR1;SIX1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.4919687560913204,1.0025885453509975,0.45787545787545786,0.7955677608344821,1.0,4/10,18.76%,FBXW7;TGFA;ADAM17;BTC
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.34440731576033023,-1.0025673190449864,0.46582278481012657,0.8469077858107671,1.0,12/30,22.31%,INSIG2;HMGCS1;NSDHL;ACAT2;INSIG1;FDFT1;FDPS;MVK;LSS;DHCR24;CYP51A1;DHCR7
prerank,regulation of tissue remodeling (GO:0034103),0.45550181794674277,1.0025502867787532,0.47038327526132406,0.7951188211776554,1.0,5/18,9.76%,IL15;FLT4;CEACAM1;TGFB1;IL23A
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.379747924847276,1.0024055232519113,0.4541420118343195,0.7949146446989963,1.0,9/42,15.56%,GARS1;FARS2;TARS3;IARS1;LARS1;WARS1;RARS1;AIMP1;KARS1
prerank,cellular response to type I interferon (GO:0071357),0.39365079410937526,1.0023789767619062,0.46017699115044247,0.7938904143329355,1.0,12/41,19.14%,IRF2;SAMHD1;ISG20;IFNAR1;IFNAR2;JAK1;ADAR;OASL;IFITM3;STAT1;BST2;IFITM1
prerank,type I interferon signaling pathway (GO:0060337),0.39365079410937526,1.0023789767619062,0.46017699115044247,0.7938904143329355,1.0,12/41,19.14%,IRF2;SAMHD1;ISG20;IFNAR1;IFNAR2;JAK1;ADAR;OASL;IFITM3;STAT1;BST2;IFITM1
prerank,response to ketone (GO:1901654),0.4230762460637944,1.002261123863714,0.44208809135399674,0.7936151141956886,1.0,5/24,11.72%,CAV1;ABHD2;TGFB1;CATSPERD;UBE3A
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.46304220369550797,1.0022097713162077,0.46511627906976744,0.7931890854397524,1.0,2/17,6.41%,PLA2G4A;PLA2G2D
prerank,extracellular transport (GO:0006858),0.48015681916342773,1.0021340045557026,0.4606946983546618,0.7928208882071335,1.0,4/12,19.68%,ARRDC1;SPA17;CABYR;TSG101
prerank,negative regulation of protein binding (GO:0032091),0.35666847743640956,1.00178632934499,0.46185286103542234,0.7931025543790711,1.0,11/71,9.32%,CAV1;B2M;PDGFB;TMBIM6;DISC1;RALB;MAPK8;AURKA;ADAM15;CTNNBIP1;ZFPM1
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.36430918482991936,-1.001460928707822,0.4765625,0.8474693117318935,1.0,10/24,26.52%,PFKP;ENO2;HK2;TPI1;ENO3;PFKM;ALDOA;PKM;ENO1;ALDOC
prerank,canonical glycolysis (GO:0061621),-0.36430918482991936,-1.001460928707822,0.4765625,0.8474693117318935,1.0,10/24,26.52%,PFKP;ENO2;HK2;TPI1;ENO3;PFKM;ALDOA;PKM;ENO1;ALDOC
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.3737927241421303,1.0009806120756735,0.44971264367816094,0.7943557897704167,1.0,15/53,15.12%,ECSCR;DAB2IP;FBXW7;FOXF2;OPHN1;UCHL5;KCNE2;XPO1;GNA12;RAD23A;FMR1;HSP90AB1;NUDT15;PSME1;PRKCG
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.39801406342444046,-1.0006968195593837,0.47804878048780486,0.8482455276783583,1.0,5/18,11.10%,PPARA;WNK1;PAG1;PTPN22;MIA3
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.35555280774789233,1.0006743642129676,0.4653333333333333,0.7945053346184188,1.0,18/71,17.07%,CTSC;CASP8;ATXN3;CTSK;CTSO;MALT1;CHMP4B;ZRANB1;RHBDD1;PSMA8;PSMA6;LONP1;LGMN;OMA1;DDI1;SOCS6;DDI2;NEDD8
prerank,positive regulation of lyase activity (GO:0051349),0.4671405112471684,1.0005833322435826,0.4558303886925795,0.7941729286764667,1.0,2/14,3.46%,NOS3;ORAI1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.43253199863988806,1.00022701961168,0.4756944444444444,0.7944586189595757,1.0,9/22,23.29%,CCNK;BTBD18;BRD4;CDC73;ALYREF;THOC1;THOC5;EAPP;ERCC6
prerank,mitochondrial protein processing (GO:0034982),0.5007792014380008,1.0001668996926047,0.4690265486725664,0.7940532839483746,1.0,2/11,12.61%,IMMP2L;OMA1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.32359219484521357,1.000160908454014,0.4630541871921182,0.7935288402139462,1.0,36/150,13.39%,GNAQ;ENG;CAV1;OCLN;CNKSR3;PARD3;DAB2IP;LYN;DDIT4;PDE4D;PPM1F;NCK1;WWTR1;PAK2;CEACAM1;SMAD7;GREM1;PRR5L;TRIB3;INPP5K;SNX25;TGFB1;NIBAN1;SAMSN1;SFRP2;SEMA4D;SFN;RB1;CORO1C;XDH;GSKIP;WARS1;GSTP1;RACK1;TRIB1;PMEPA1
prerank,regulation of phospholipase C activity (GO:1900274),0.46203204207449,1.0001528952604186,0.4767857142857143,0.7930058183942754,1.0,3/15,1.86%,FLT1;ESR1;PLCG1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.3537858125020581,1.0000355203473186,0.46164383561643835,0.7927288979685849,1.0,27/72,25.54%,CARD10;TIRAP;PSMA2;MALT1;RELB;DICER1;PSMA8;PSMA6;CUL1;BIRC3;RELA;NFKB2;TRAF6;PSME1;BIRC2;PSMA4;PSMF1;REL;PSMB1;PSMB7;PSMD2;PSMA5;TRAF2;PSMC3;COPS8;PSMD3;PSMA3
prerank,regulation of NMDA receptor activity (GO:2000310),0.4055179045077178,0.9996800669388696,0.4624624624624625,0.7929783477292219,1.0,4/32,2.55%,APP;MEF2C;DAPK1;PTK2B
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3762757264653052,-0.9995828008923022,0.4682926829268293,0.8501756000086915,1.0,8/20,22.19%,SLC8A3;MCU;MICU1;YME1L1;SLC25A23;SLC8B1;MAIP1;SMDT1
prerank,regulation of neuron projection arborization (GO:0150011),-0.4045339360028481,-0.999580326516054,0.47586206896551725,0.8489486500716573,1.0,8/15,16.33%,GRIP1;DLG4;NTNG1;MOV10;MFSD2A;MACF1;DVL1;MYO9A
prerank,cellular response to lipid (GO:0071396),0.3139283419767289,0.9993278715374239,0.46705882352941175,0.7932310120193312,1.0,32/191,9.58%,TBX1;ESR1;MEF2C;AHR;DAB2IP;FZD4;LYN;NR3C1;PTK2B;MSN;TNFRSF1B;SOX9;XBP1;SBNO2;CX3CR1;MAPK8;RET;ATP1A3;ATP1A1;WNT5A;ADAM15;NCOA4;WNT9B;IL36G;PPBP;LPL;NFKB1;CASP1;BRINP2;CREB1;NRIP1;DEFA6
prerank,regulation of vasculature development (GO:1901342),0.42086267159064933,0.998333142740392,0.4651539708265802,0.7948391392877784,1.0,8/26,16.73%,ADGRA2;PLXND1;TSPAN12;EGLN1;WARS1;ERBB2;PROK2;CTNNB1
prerank,regulation of T cell activation (GO:0050863),0.38593655912522723,0.9980247069302985,0.4633431085043988,0.7950008268712291,1.0,6/42,10.08%,TNFRSF1B;JAK3;TNFSF8;TIGIT;LCK;CYRIB
prerank,vasoconstriction (GO:0042310),0.48048851276528454,0.9978038852328015,0.4798464491362764,0.7949467945045234,1.0,2/11,3.42%,EDN1;PIK3C2A
prerank,termination of RNA polymerase I transcription (GO:0006363),0.4013245115404444,0.9977090789146391,0.4810126582278481,0.7946038036260288,1.0,10/30,20.60%,CAVIN1;TAF1B;POLR1A;POLR1G;POLR1B;GTF2H4;TAF1A;GTF2H1;POLR2L;CCNH
prerank,negative regulation of transferase activity (GO:0051348),0.41299225782558163,0.9976746953289435,0.45737704918032784,0.7941451736625266,1.0,8/28,12.96%,DTX3L;SMAD7;CDKN1B;INPP5K;PINX1;NPRL2;ERCC4;ZFP36
prerank,histone H3 deacetylation (GO:0070932),0.4692896968801124,0.9973778784020535,0.4740608228980322,0.794259493421761,1.0,2/15,4.55%,HDAC9;ELK4
prerank,DNA methylation (GO:0006306),0.4298044007855376,0.9973281917914296,0.44878048780487806,0.7938271631709283,1.0,10/23,17.85%,ZFP57;KMT2E;ATF7IP;PPM1D;GATAD2A;PICK1;SPOCD1;ATRX;EHMT1;TEX15
prerank,activation of protein kinase B activity (GO:0032148),-0.3501621677646556,-0.9971304271167193,0.47229551451187335,0.8544514543764533,1.0,6/29,8.20%,IGF1;NTRK3;FGF1;IL18;OSBPL8;ADRA2A
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.41498609565918526,0.9971047839308547,0.44745222929936307,0.7938115459243963,1.0,10/25,24.66%,CCNK;ZNF326;EAF1;ZMYND11;ALYREF;THOC1;THOC5;SETD5;ERCC6;TCEA2
prerank,cellular protein localization (GO:0034613),0.3039609512451066,0.9970925552043548,0.4693422519509476,0.793315848360501,1.0,55/285,14.79%,TBC1D8;ESAM;STX3;OCLN;TBC1D30;SMURF1;TBC1D4;CELSR1;ARHGEF2;HHEX;REEP1;SGSM1;TBC1D22A;CPE;TBC1D15;STX6;ID1;MESD;PTPRK;HERC2;STX7;WNT5A;TBC1D12;ARL4A;TMED7;AP2A1;STX1A;TBC1D2;PIGU;TMED5;RAB38;ARL5A;AP3B1;TM9SF1;PIGK;ACD;PICK1;STX8;TBC1D5;RAB43;STXBP3;TBC1D8B;CEP68;WDR11;RABGAP1L;RAB31;RAB5A;EVI5;RAB5B;AMOT;NPM1;RAB32;SNX13;STX11;RAB18
prerank,mammary gland development (GO:0030879),-0.37427781672759275,-0.9968643673232372,0.47549019607843135,0.8539077074974776,1.0,8/21,17.80%,GLI2;WNT4;ERBB4;VEGFA;TGFB3;PRLR;TBX3;ARHGAP35
prerank,bone morphogenesis (GO:0060349),0.4737737806882589,0.996463786858067,0.49730700179533216,0.7942171143925517,1.0,2/14,2.27%,BMPR2;LRP5
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.3850001231633503,-0.9964349966334182,0.46958637469586373,0.8538579530623102,1.0,5/19,8.02%,ENPP1;SLC26A2;TPST1;PAPSS2;ABHD14B
prerank,histone H3-K36 demethylation (GO:0070544),-0.4424270895230073,-0.9964014743094635,0.46120689655172414,0.8527229060673287,1.0,3/10,12.32%,KDM7A;KDM2A;KDM8
prerank,establishment of mitotic spindle localization (GO:0040001),-0.3537463734158464,-0.9963802467984801,0.45591939546599497,0.8515421881645123,1.0,16/28,33.41%,GJA1;GPSM2;HTT;UBXN2B;NUSAP1;NDC80;MISP;SPDL1;CENPA;CLASP1;DCTN1;FBXW11;INSC;ZW10;ESPL1;PKHD1
prerank,macrophage differentiation (GO:0030225),0.4664507751185383,0.9963723619614783,0.46210720887245843,0.7939001960543749,1.0,3/13,9.40%,IL15;CASP8;CSF1
prerank,negative regulation of catabolic process (GO:0009895),-0.3215727862531245,-0.9955969376039113,0.4370860927152318,0.8523960052906092,1.0,9/47,10.76%,EGFR;NUPR1;HDAC4;PPARA;SIRT2;MDM4;ADRA2A;ALK;CST3
prerank,negative regulation of hemostasis (GO:1900047),-0.4354639584451886,-0.9955418203812855,0.47845804988662133,0.8513062692597282,1.0,5/12,10.31%,VTN;TFPI;SERPINE2;SERPINE1;APOE
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.4518276798740824,0.9954475532346844,0.4863013698630137,0.7953720069860141,1.0,6/16,9.08%,PDGFB;PDGFD;PTPRJ;PIK3C2A;PDGFC;PTPN1
prerank,antibacterial humoral response (GO:0019731),0.45644474444744365,0.9950820544521158,0.46536412078152756,0.7956757908969917,1.0,3/16,9.58%,RPL39;ANG;DEFA6
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.2793939630206838,-0.9949740383710302,0.48148148148148145,0.8516493431281196,1.0,27/95,15.56%,ZEB2;TGFBR3;DKK3;TGFBR1;HTRA3;SPRED1;PPARA;THBS1;SMAD6;SMAD3;CD109;ASPN;SNX6;BCL9;DAB2;TGFB1I1;VASN;HIPK2;SLC2A10;SPRED3;SPRED2;NREP;LTBP4;CITED2;HTRA4;PPM1A;CDKN1C
prerank,membrane assembly (GO:0071709),-0.33818651844596703,-0.9949452286757436,0.47956403269754766,0.8504743579728322,1.0,14/34,12.33%,NLGN2;ANK3;PTPRD;IL1RAPL1;TLCD2;NRXN1;NLGN1;ANXA2;STX4;S100A10;NLGN3;STX2;FLOT2;NRXN2
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.4237046994106954,-0.9948689656682577,0.4976958525345622,0.8494735610072385,1.0,3/13,8.02%,ENPP1;TPST1;ABHD14B
prerank,mitotic sister chromatid segregation (GO:0000070),0.3377017040422678,0.9947124270719544,0.47127937336814624,0.7959432810463558,1.0,22/98,18.01%,TENT4A;RAB11A;RAD21L1;MCPH1;CHMP2B;PINX1;KIF22;HASPIN;RRS1;CHMP4A;CHMP4B;NCAPH;KIF23;RB1;PDS5A;PDS5B;CUL3;RAD21;CSNK2A1;CSNK2A2;SMC4;WRAP73
prerank,positive regulation of cyclase activity (GO:0031281),0.4799453073327854,0.9944431066078425,0.47668393782383417,0.7960198467606102,1.0,3/14,5.54%,NOS3;ORAI1;MAPK8
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.4572437514502252,0.9939670087976645,0.47183098591549294,0.796576273128275,1.0,3/14,5.81%,SEMA7A;PLCG2;WNT5A
prerank,positive regulation of protein polymerization (GO:0032273),0.35562599054522853,0.9937431434074265,0.4840499306518724,0.7965160756058264,1.0,7/65,6.66%,OCLN;PTK2B;NCK1;EVL;NCKAP1;RAC1;CDC42EP3
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.46038034125122695,0.9936545892417649,0.4694244604316547,0.79619629634952,1.0,2/14,4.45%,CAV1;DLL1
prerank,placenta development (GO:0001890),0.4668487315902368,0.9931811738388276,0.46096654275092935,0.7966939830639569,1.0,5/12,16.27%,PTK2;CITED1;ANG;PLAC1;E2F7
prerank,cellular lipid catabolic process (GO:0044242),0.4110241386825093,0.9930496792473549,0.47368421052631576,0.7964319815826848,1.0,3/27,5.61%,PPARD;ENPP2;LPIN3
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.41461898621587223,0.9928744767316865,0.465625,0.7962970992197552,1.0,12/28,23.29%,SMCHD1;DTX3L;SHLD1;WRAP53;MAD2L2;ACTR2;CYREN;KMT5B;PARP9;RIF1;SIRT7;ERCC6
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.35617257977218897,-0.9925776931406896,0.4404432132963989,0.8544870978674416,1.0,3/27,2.91%,EGFR;DDX5;BMP4
prerank,cellular response to BMP stimulus (GO:0071773),0.35836810624969,0.9920641665932624,0.478494623655914,0.7975027442651911,1.0,11/66,7.19%,BMPR2;ENG;ACVRL1;SMAD1;SMURF1;SOX9;ACVR2A;SMAD7;USP15;ACVR1;TGFB1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.4214481732606207,0.9919826941303035,0.4696969696969697,0.797153295787739,1.0,6/25,15.68%,B2M;PLCG2;WNT5A;MALT1;TRAF6;SLC7A5
prerank,regulation of MAP kinase activity (GO:0043405),0.3418307106140046,0.9918864242362253,0.4915032679738562,0.7968322715935814,1.0,15/92,7.54%,FLT1;PDGFB;DAB2IP;EDN1;LYN;PDGFD;PTPRJ;TPD52L1;PIK3R6;CD40;TRIB3;INPP5K;TGFB1;PDGFC;PIK3CG
prerank,embryonic appendage morphogenesis (GO:0035113),-0.42959473812401755,-0.991767177916537,0.4966887417218543,0.8554812933517102,1.0,5/12,21.10%,CYP26B1;LRP6;TGFB2;SKI;PTCH1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.4152340499462367,-0.9917481278365803,0.4788135593220339,0.8543088617267728,1.0,2/14,3.13%,NMNAT2;ME1
prerank,centromere complex assembly (GO:0034508),-0.3370091024294483,-0.9916537820894067,0.45722713864306785,0.8533148380926843,1.0,19/36,34.30%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;CENPK;CENPH;RBBP4;HELLS;KNL1;CENPF;CENPX;CENPA;CENPQ;NASP;DLGAP5;CENPC;CENPW
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.47118462535462047,0.9915369593401813,0.49645390070921985,0.7970628104983529,1.0,2/12,3.66%,CELSR1;LAMA3
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.3497078393140604,0.9912672711521292,0.48169014084507045,0.797103170512933,1.0,28/70,25.64%,B2M;IKBKB;MFSD6;TAP2;PSMA2;SNAP23;IKBKG;PSMA8;FCGR1A;PSMA6;VAMP8;PSME1;PSMA4;PSMF1;SEC22B;PSMB1;PSMB7;PSMD2;PSMA5;LNPEP;TAP1;CYBA;PSMC3;FCER1G;VAMP3;PSMD3;PSMA3;TAPBP
prerank,negative regulation of cellular protein localization (GO:1903828),0.39421185582028956,0.9909282996010662,0.45937961595273263,0.7973206669306222,1.0,8/34,13.79%,ANKRD13A;NEDD4L;MFHAS1;CTNNA1;DNAJA1;CDT1;PICALM;ILRUN
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.3861023483883884,0.9905575302845141,0.4865269461077844,0.7976173483607503,1.0,6/40,7.19%,LEF1;NOTCH1;WWTR1;SDCBP;TCF7L2;TGFB1
prerank,vitamin transport (GO:0051180),0.40403558088270664,0.9901683691528779,0.4766355140186916,0.7979449868918723,1.0,6/29,13.56%,ABCG2;SLC52A3;AFM;CD320;SLC2A6;TCN2
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.4995361074499332,0.9901069986547845,0.5095419847328244,0.797555092758152,1.0,2/10,6.03%,LYN;CD40
prerank,neuron apoptotic process (GO:0051402),0.43950165391832624,0.9898541181802674,0.4950980392156863,0.7975998636807818,1.0,5/19,12.23%,APP;FAS;SIAH1;BNIP3;BID
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.44120670486588703,0.9897401959419787,0.4663299663299663,0.797316397832072,1.0,5/17,11.57%,WASF2;NCKAP1;PICK1;GMFG;CYFIP1
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.42807866315241405,-0.9896161239507568,0.4807692307692308,0.8575376007422149,1.0,3/12,6.13%,EML2;MAP2;CLIP3
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.4772786931963292,0.9895452135271788,0.4635036496350365,0.7972097939868069,1.0,3/11,11.05%,JAK3;SMAD7;RC3H1
prerank,muscle tissue morphogenesis (GO:0060415),0.4517113726780186,0.9894916107492473,0.4824561403508772,0.7968123887046556,1.0,2/16,2.79%,TBX1;NOTCH1
prerank,presynaptic endocytosis (GO:0140238),-0.35606443004811733,-0.9893606134675956,0.5,0.8570159512246922,1.0,8/24,14.80%,NLGN2;SYT1;SYNJ2;NLGN1;STON2;NLGN3;AMPH;SNCA
prerank,cellular protein-containing complex assembly (GO:0034622),0.3164527846621555,0.9893528072796579,0.4897466827503016,0.7965758023239133,1.0,29/159,14.25%,SMAD1;HIP1;HIP1R;IMMP2L;NCK1;PIK3C2A;PXN;FKBP1A;FCHO2;TESPA1;RPL38;TCF4;VAMP4;TGFB1;CHMP4A;CHMP4B;TBCA;HIGD2A;VAMP8;POMP;PICALM;LONP1;NUP98;OMA1;HSP90AB1;RAB5IF;NUP205;HIGD1A;NUP153
prerank,urogenital system development (GO:0001655),-0.4403871188086625,-0.9888568197090214,0.5011441647597255,0.8571929878077198,1.0,6/11,24.61%,OSR1;ANXA1;PAX8;EPHB3;EPHB2;LHX1
prerank,regulation of catecholamine secretion (GO:0050433),-0.3490267646367651,-0.9887810907292055,0.4708860759493671,0.8561927263487263,1.0,8/29,17.01%,PRKN;SYT1;SYT9;SYT11;SYT12;DTNBP1;SNCA;SYT3
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.4038023616859227,0.9887600956047592,0.4611801242236025,0.7973457339933053,1.0,7/33,11.15%,ESR1;PKN1;TRIM68;H3-3A;KCTD6;KDM4C;CBFB
prerank,negative regulation of macrophage activation (GO:0043031),-0.39160495514496796,-0.9886501158152028,0.4767726161369193,0.8553613319107032,1.0,4/16,6.51%,IL31RA;LRFN5;LDLR;SYT11
prerank,response to UV (GO:0009411),0.33769453167348884,0.9881819037548554,0.4807692307692308,0.7980903955998636,1.0,18/95,14.31%,DCUN1D3;POLK;MAP4K3;CAT;PTPRK;N4BP1;MAPK8;BCL3;NEDD4;PRIMPOL;RHBDD1;MC1R;RELA;ERCC4;FMR1;EIF2AK4;NPM1;YY1
prerank,thymus development (GO:0048538),0.46379362192740586,0.9881717917934136,0.4724689165186501,0.7975874982778113,1.0,1/13,0.88%,TBX1
prerank,glycolipid biosynthetic process (GO:0009247),-0.32908401977670154,-0.9880754049874166,0.46788990825688076,0.8557588530575132,1.0,16/38,26.90%,LARGE1;ST6GALNAC5;PIGN;GBGT1;ST3GAL5;B4GALT6;PIGA;ST8SIA1;PIGH;PGAP3;SCCPDH;ST3GAL4;PIGW;DPM1;PIGV;DPM3
prerank,synapse organization (GO:0050808),0.32085595315870297,0.9878841703524001,0.4875,0.7977157546402625,1.0,11/125,4.37%,SHANK3;DNM3;UNC13B;APBB2;APP;PPFIBP1;PLXND1;PPFIA2;PCDHB4;CDH2;GPHN
prerank,RNA transport (GO:0050658),-0.28845513831952807,-0.9877859222847074,0.48226950354609927,0.8553055076074818,1.0,15/71,14.68%,RBFOX1;SRSF5;SIDT1;HNRNPA2B1;DDX39B;SIDT2;KIF5C;SRSF2;ATXN2;SRSF11;U2AF2;POM121;RAE1;NXF1;HNRNPA1
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.40321655398102446,0.9875596298964555,0.4803767660910518,0.7978708158920345,1.0,4/29,12.00%,JAM2;ANO6;GAS6;LGMN
prerank,cellular response to calcium ion (GO:0071277),0.35409788081710564,0.9872966034028191,0.4695035460992908,0.7979123201776674,1.0,14/67,14.03%,MEF2C;CPNE8;IQGAP1;PLCG2;ALOX5AP;WNT5A;CHP2;ITPKB;PKD2;RASA4;SYT15;LGMN;CLIC4;MEF2A
prerank,negative regulation of cell aging (GO:0090344),0.44955125168312327,0.9866447227936176,0.4571917808219178,0.7988164831333486,1.0,5/16,18.30%,CDK6;MAP3K3;AKT3;YBX1;RBL1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.4351233197989174,0.986495344578638,0.46153846153846156,0.7986067441203738,1.0,6/18,22.36%,EDN1;ABL2;PDP1;RFK;ATP7A;FXN
prerank,protein secretion (GO:0009306),-0.29796095654925636,-0.9860826431943087,0.46417445482866043,0.8588145692642414,1.0,9/56,11.84%,WLS;PCSK5;ANXA1;TANGO2;RCN3;COPG1;STEAP3;MIA3;RAB10
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.2996808858314673,-0.9859253705689287,0.4658385093167702,0.8580215716045397,1.0,25/56,26.96%,SON;ROCK2;SPIRE1;SNX18;ANK3;CIT;ARL3;JTB;RTKN;STAMBP;DCTN3;VPS4A;NUSAP1;RAB35;EFHC1;CKAP2;ALKBH4;CUL7;RHOC;SEPTIN9;SNX33;IST1;CENPA;CEP55;SPAST
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.33374907137621945,-0.9852819441871103,0.449438202247191,0.8585753625649515,1.0,14/33,21.04%,APPL2;PKD1;MN1;STXBP4;TAF1;GLI1;PAF1;PLK5;CDKN1A;TCIM;E2F1;DDRGK1;ID2;PTEN
prerank,cell projection organization (GO:0030030),0.3948411869333633,0.985269882478965,0.46771653543307085,0.8007792173689103,1.0,7/30,13.27%,PARVB;RHOJ;NCKAP1;RAC1;P2RY12;CYFIP1;CSPG5
prerank,positive regulation of kinase activity (GO:0033674),0.33311311780871095,0.9851948213302579,0.47275031685678076,0.8004016402128614,1.0,15/107,7.67%,TEK;FLT1;KDR;TIE1;EPHB4;INSR;IQGAP1;PTK2B;FLT4;LMTK2;RET;RAPGEF2;TIGAR;PTK2;RAP1A
prerank,actin filament network formation (GO:0051639),0.48321978566099594,0.9842322078748129,0.5101663585951941,0.8019225121292101,1.0,3/11,4.60%,LCP1;ACTN1;PLS3
prerank,protein kinase A signaling (GO:0010737),0.4757379771589235,0.9835872730999171,0.5018518518518519,0.8027845998523998,1.0,1/12,1.24%,LCP1
prerank,proton transmembrane transport (GO:1902600),-0.33838170035342585,-0.9835316704191784,0.46176470588235297,0.8619389299691601,1.0,5/36,12.38%,ATP1A2;ATP6V0A4;SLC25A27;ATP6V0D1;SLC9A1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.28092423692177204,-0.9834346196989158,0.4982078853046595,0.8609817822527072,1.0,23/87,17.35%,FGFR2;FGF1;HNRNPH1;SPRED1;FGF2;NDNF;RBFOX2;CD44;TIA1;FLRT1;FLRT2;SFRP1;FGFBP1;FGFR4;SPRED2;NR4A1;FGF7;POLR2B;HNRNPA1;POLR2K;HYAL1;FGF10;GTF2F1
prerank,stem cell development (GO:0048864),0.4544952031850065,0.9832344893181831,0.46921797004991683,0.8029891968068934,1.0,7/16,25.15%,CDH2;CYP26C1;KBTBD8;PDCD6;PEF1;TCOF1;NOLC1
prerank,regulation of cell size (GO:0008361),0.42128061515069826,0.9831737987416456,0.4855769230769231,0.8025864098578931,1.0,8/23,16.40%,EDN1;MSN;RAC1;RPTOR;LARS1;MTPN;RDX;RHOA
prerank,extracellular matrix assembly (GO:0085029),-0.36476531548812446,-0.9828432663802565,0.4792176039119804,0.8614085230195402,1.0,9/23,16.50%,TNXB;GPM6B;FBLN5;NTN4;NTNG1;EFEMP2;MFAP4;LAMB2;MYH11
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.4004450540662525,0.9827099365515114,0.47716535433070867,0.8030684619560478,1.0,4/33,5.06%,STAT3;TAL1;HIF1A;ACVR2A
prerank,catecholamine metabolic process (GO:0006584),-0.41703372743059597,-0.9826482792584887,0.47586206896551725,0.8606866058772413,1.0,1/14,1.14%,PRKN
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.3082909102183521,-0.9824980370958561,0.46534653465346537,0.8598669634253807,1.0,9/48,6.96%,ADCY5;AMPD3;ADCY1;ADCY2;SLC26A2;ADCY7;ADCY6;PAPSS2;GUCY1A1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.4747198465901994,0.9824636239252548,0.4731977818853974,0.8030554871721882,1.0,3/12,8.75%,SEC63;CHMP4A;CHMP4B
prerank,myelin assembly (GO:0032288),-0.46597844789617643,-0.9822318962437705,0.5115740740740741,0.8593586652129622,1.0,6/10,23.82%,EPB41L3;CNTNAP1;GPC1;TENM4;ABCA2;NCMAP
prerank,response to fatty acid (GO:0070542),0.4526461757249044,0.9821518912092102,0.49295774647887325,0.8032106518814295,1.0,3/17,7.31%,FOXO1;SOX9;LPL
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.366260251700131,-0.9820442772143004,0.48402948402948404,0.8586579473046644,1.0,13/23,33.41%,GJA1;GPSM2;HTT;UBXN2B;NDC80;MISP;SPDL1;CENPA;DCTN1;FBXW11;INSC;ZW10;PKHD1
prerank,regulation of spindle organization (GO:0090224),-0.39029370257324186,-0.9820338220895044,0.4742014742014742,0.8574803537251319,1.0,9/18,29.85%,PARP3;GNAI1;GPSM2;RAE1;DYNC1H1;TPX2;FSD1;DCTN1;MAP9
prerank,regulation of glycolytic process (GO:0006110),0.3518333787179449,0.9820067706951552,0.4830985915492958,0.8029788416372357,1.0,17/68,15.08%,APP;CBFA2T3;INSR;HIF1A;PFKFB3;FBP1;TIGAR;PSEN1;NUP214;EIF6;NUP98;SLC2A6;NUP205;NUP133;NUP153;NUP54;NUP43
prerank,neuromuscular junction development (GO:0007528),-0.36073990325341143,-0.9817771720951428,0.4648241206030151,0.8570792481554644,1.0,7/24,9.02%,PDZRN3;UNC13C;PPFIBP2;ANK3;CACNB2;LRRK2;CACNB1
prerank,mitotic spindle assembly (GO:0090307),0.37192837310266524,0.9813686581156053,0.48392036753445633,0.8038596077162153,1.0,18/42,23.21%,RAB11A;AURKC;STAG2;KIF23;STAG1;LSM14A;RHOA;CHEK2;ABRAXAS2;WRAP73;MZT1;BCCIP;KPNB1;PIBF1;KIF4A;RACGAP1;KIF2A;CLASP2
prerank,protein homotrimerization (GO:0070207),-0.4084157881628925,-0.9810847299255161,0.503562945368171,0.8564959745363137,1.0,4/14,11.97%,SLC1A5;SCARA5;SLC1A2;CLYBL
prerank,protein trimerization (GO:0070206),-0.4084157881628925,-0.9810847299255161,0.503562945368171,0.8564959745363137,1.0,4/14,11.97%,SLC1A5;SCARA5;SLC1A2;CLYBL
prerank,somite development (GO:0061053),-0.4269370983192421,-0.9810450836098693,0.49794238683127573,0.8554203743259569,1.0,4/11,11.22%,MEOX2;LOXL3;SMO;MTHFD1
prerank,RNA destabilization (GO:0050779),-0.3777015155393542,-0.9803096850696629,0.46731234866828086,0.8561992207949973,1.0,3/18,15.28%,ROCK2;CELF1;FTO
prerank,male gonad development (GO:0008584),0.3927483826268034,0.9800735738545419,0.4851190476190476,0.8061822544147774,1.0,8/34,13.52%,KITLG;BIK;SOX9;WNT5A;NCOA4;MAMLD1;ADAM21;SRD5A2
prerank,regulation of DNA binding (GO:0051101),0.3792665990713674,0.9800365827671687,0.4886039886039886,0.8057422651852582,1.0,6/44,8.51%,LEF1;NFKBIA;MAPK8;BCL3;TGFB1;CDT1
prerank,positive regulation of transport (GO:0051050),0.34262478354482284,0.9799201653529128,0.49466666666666664,0.8054765799622278,1.0,9/85,6.76%,RAB27A;IL15;HIP1R;GATA2;NEDD4L;DLL1;BOK;CBLL1;INPP5K
prerank,positive regulation of transmembrane transport (GO:0034764),-0.4190623402938189,-0.9797656515631471,0.4955357142857143,0.856535154573685,1.0,5/13,14.22%,ACSL1;C2CD5;CLIP3;AZIN1;SLC26A6
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.40328320594718675,0.9796469293982972,0.49128367670364503,0.805532502844276,1.0,14/31,26.49%,CNOT6;EDC3;EXOSC1;DCP2;LSM3;HBS1L;CNOT7;LSM7;LSM1;DCP1B;LSM2;EXOSC4;DDX6;DIS3
prerank,regulation of hormone secretion (GO:0046883),0.45403136327043153,0.9793721388606134,0.49040139616055844,0.8055972332652455,1.0,2/15,4.06%,EDN1;FGF23
prerank,brain development (GO:0007420),0.32063400577550133,0.9790745362595104,0.5056461731493099,0.8057219527994768,1.0,18/136,11.72%,SHANK3;PBX1;ADGRL2;SHROOM4;DDIT4;SHROOM2;ADGRG1;AMIGO2;CDH2;CX3CR1;RAPGEF2;DNAJC30;SYNJ1;CXCR4;NFIB;SCYL2;GRIN1;UBE3A
prerank,macrophage chemotaxis (GO:0048246),-0.4432586906512924,-0.978961696444132,0.4966292134831461,0.8575461420036772,1.0,4/10,35.44%,TAFA4;CCL2;CXCL17;CCL5
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.41618083966821134,0.9785662675273753,0.4742765273311897,0.8062919914842739,1.0,6/24,12.26%,HIF1A;NOTCH1;KLF2;MBTPS2;ATF6;MUC1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.3889601594039511,0.9781647741655434,0.4806800618238022,0.8066185827106136,1.0,8/34,14.67%,DAB2IP;LYN;MFHAS1;GRAMD4;OTUD4;RAB7B;LRRC14;IRAK3
prerank,regulation of complement activation (GO:0030449),0.3757582926722157,0.9778251397629385,0.4922360248447205,0.8068043981807494,1.0,4/40,7.56%,CFH;PROS1;CFB;CR1L
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.4238540574377929,-0.9777388285216819,0.48259860788863107,0.8597029279129665,1.0,5/12,17.93%,PPARA;WNK1;MIA3;FUT9;MDK
prerank,pentose-phosphate shunt (GO:0006098),-0.4404053848771862,-0.9777035151957247,0.513215859030837,0.8586127146875546,1.0,3/11,10.07%,H6PD;PGD;TKT
prerank,nucleotide metabolic process (GO:0009117),-0.3563556882252696,-0.9777010808090055,0.4872389791183295,0.8574363322999439,1.0,8/23,22.16%,NMNAT2;FHIT;ME1;ENPP3;NMNAT1;NMNAT3;CTPS2;GUK1
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.43860475497437706,-0.9775612995294409,0.5075921908893709,0.8566783340521628,1.0,4/11,7.60%,PRKN;PTPN23;DAB2;EZR
prerank,sensory organ development (GO:0007423),0.3686217128081488,0.9773189112234979,0.485273492286115,0.8073699046868238,1.0,7/51,4.99%,PBX1;CHD7;SHROOM2;FREM2;SMCHD1;SIPA1L3;HIPK1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.39701481789039916,0.9771504185238046,0.4884080370942813,0.8072093295343413,1.0,9/31,18.30%,DCUN1D3;CDK6;JADE1;PKD2;RB1;APC;E2F7;CDC73;RBL1
prerank,tryptophan catabolic process (GO:0006569),-0.428781634143655,-0.976945517351484,0.4666666666666667,0.8571235660549577,1.0,9/11,51.86%,KYAT1;HAAO;KYNU;AFMID;AADAT;TDO2;KMO;IDO1;ACMSD
prerank,cholesterol biosynthetic process (GO:0006695),-0.3354271992801498,-0.9765827843297229,0.4961038961038961,0.8568946557230899,1.0,12/31,22.31%,INSIG2;HMGCS1;NSDHL;ACAT2;INSIG1;FDFT1;FDPS;MVK;LSS;DHCR24;CYP51A1;DHCR7
prerank,positive regulation of cell growth (GO:0030307),0.3390163671428088,0.976160139928492,0.5006839945280438,0.8087761631434693,1.0,21/96,14.48%,NTN1;SEMA7A;SMURF1;EDN1;NEDD4L;ADAM10;ITSN2;RPS6KA3;SDCBP;RPS6KA1;H3-3A;RPTOR;SFRP2;TWF2;SEMA4D;MAP3K13;DBNL;MTPN;ADAM17;ERBB2;S100A9
prerank,acute inflammatory response (GO:0002526),0.41864540980379755,0.9760167023818807,0.47611202635914335,0.8085612012568144,1.0,7/23,17.88%,IL6R;SIGIRR;CTNNBIP1;ANO6;ITIH4;IL22;PLSCR1
prerank,protein-DNA complex assembly (GO:0065004),0.3252957284840337,0.9755732888099845,0.49937733499377335,0.8089638388628174,1.0,40/116,26.95%,SOX9;PADI4;TCF4;H3-3A;RPA1;PSMA2;KAT6B;CDT1;SMARCA5;NAP1L4;PSMA8;PSMA6;GRWD1;NPM1;PSME1;ATRX;ORC5;ORC3;ANP32B;GTF2H4;PSMA4;PSMF1;CETN2;GTF2H1;CHD1L;PSMB1;SART3;CCNH;PSMB7;PSMD2;PSMA5;PSMC3;CUL4B;ORC6;PSMD3;PSMA3;GTF2H5;GMNN;MCM6;RPA3
prerank,regulation of endocytosis (GO:0030100),0.3537617839974279,0.9754569948407169,0.4907539118065434,0.8086974534256945,1.0,8/61,6.25%,MCTP1;PRKD1;HIP1;HIP1R;NEDD4L;DLL1;OPHN1;CBLL1
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.31700560709450754,-0.975068826000025,0.446875,0.859771557690082,1.0,8/40,14.38%,SLC7A11;SLC13A3;SLC38A11;SLC27A1;SLC7A6;SLC5A6;ABCC5;SLC19A1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.42327985479998376,-0.9749686814592321,0.5034642032332564,0.8588748082779779,1.0,7/12,23.51%,ANO1;STX4;GPLD1;CFTR;PLA2G6;ADCY8;BAIAP3
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.42292431442049455,-0.9745684622899115,0.5124153498871332,0.8587540614315461,1.0,3/12,4.02%,IRS1;PPARA;PPARGC1A
prerank,regulation of insulin secretion (GO:0050796),0.3343952075575383,0.9745068263118496,0.5109114249037228,0.810270135442384,1.0,13/101,8.35%,MYRIP;SLC2A1;ACSL4;LRP5;CACNA1E;KCNB1;TCF7L2;CACNA1A;PPP3CB;STX1A;RAP1A;ITPR3;NEUROD1
prerank,development of primary male sexual characteristics (GO:0046546),0.3898466937163298,0.9743571825802886,0.49337260677466865,0.8100859438872161,1.0,8/34,13.52%,KITLG;BIK;SOX9;WNT5A;NCOA4;MAMLD1;ADAM21;SRD5A2
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.370251420423365,-0.9740327255054168,0.5023809523809524,0.8590541014068999,1.0,5/21,15.40%,HK2;H6PD;PGD;TKT;G6PC3
prerank,positive regulation of cellular metabolic process (GO:0031325),0.33048694426799413,0.9738473830042566,0.5212201591511937,0.810690450163307,1.0,22/98,12.99%,PPARD;INSR;PDGFB;FASN;ACACB;NFKBIA;SELE;GREM1;IFNAR1;ARRB1;TGFB1;CBR1;AGPAT1;CSF1;INPP5F;SCYL2;PICK1;RIPK1;TBC1D5;XDH;TGFBR2;FMR1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.477034146796749,0.9734742729850454,0.5161290322580645,0.8109387868693674,1.0,1/10,0.48%,CSGALNACT1
prerank,neuromuscular process (GO:0050905),0.44694685500091025,0.9726473462612609,0.5025466893039049,0.812168405118433,1.0,2/16,5.56%,GCH1;MYCBP2
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.289799790541897,-0.9723434378164555,0.5084745762711864,0.8622241911542927,1.0,13/63,12.25%,TIMP3;LEPR;BCL2;TIMP2;NUPR1;SIRT2;KLHL22;DAPL1;PTPN22;EIF4G3;CST3;RUBCN;RGP1
prerank,positive regulation of isotype switching (GO:0045830),0.4583698211325062,0.972261609481316,0.5083056478405316,0.8124986279266658,1.0,4/15,10.28%,SHLD1;CD40;TGFB1;MAD2L2
prerank,protein polyubiquitination (GO:0000209),0.2956646403260981,0.9720566565935354,0.5637362637362637,0.8124196699986761,1.0,60/297,18.12%,RNF125;KLHL3;SMURF1;RNF144B;NEDD4L;TRIM14;FBXW7;ZNRF1;TRAF1;DTX3L;TRIM68;PELI1;FBXL4;RNF144A;UBE3B;SASH1;UBE2G1;FBXL7;RNF167;NEDD4;PSMA2;ANAPC7;UBE2H;RNF146;FBXW2;RNF4;PSMA8;ANAPC1;SIAH1;PSMA6;UBE2D3;FBXO30;RC3H1;CBFB;CUL1;CDC26;MYLIP;UBE3A;HECTD1;DCAF15;UBE2K;TRAF6;FBXL3;TOPORS;PSME1;ARIH2;AREL1;RNF5;TPP2;UBE3D;CTNNB1;BIRC2;NHLRC1;CUL3;FBXW10;PSMA4;CDC34;HERC6;UBE2Q1;PSMF1
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.40796196516684197,-0.9715321081460794,0.5281385281385281,0.8631848804739098,1.0,2/14,8.50%,ENPP1;ENPP3
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3130198202510489,-0.9714787653992926,0.5194805194805194,0.8621347246653682,1.0,12/48,10.41%,DOCK5;NRP1;OBSL1;CUX2;PTPRD;CARMIL1;CAPRIN2;IL1RAPL1;CUX1;P4HB;FBXW8;S100A10
prerank,chromatin remodeling at centromere (GO:0031055),-0.3377414645083745,-0.9711688958407552,0.45879120879120877,0.861761695520837,1.0,14/31,27.03%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;CENPK;CENPH;RBBP4;HELLS;KNL1;CENPX;CENPA;CENPQ
prerank,regulation of mitochondrion organization (GO:0010821),-0.29991017996623764,-0.9707271369343293,0.5220125786163522,0.8617912241562941,1.0,15/47,23.37%,PID1;PRKN;PPARGC1A;SREBF1;LRRK2;SQSTM1;VDAC1;HAX1;MIEF2;PLSCR3;FLCN;HTRA2;STAT2;FZD5;DNM1L
prerank,regulation of neuron death (GO:1901214),0.34227129165267195,0.970194859884096,0.5089408528198074,0.8159193538460927,1.0,12/82,10.06%,MEF2C;CD200;DDIT4;TNFRSF1B;FYN;CD34;WNT5A;CHMP4A;CHMP4B;CSF1;IKBKG;BTBD10
prerank,divalent inorganic cation homeostasis (GO:0072507),0.4071457924765097,0.9701403329018391,0.5214521452145214,0.8155191388275304,1.0,5/25,11.51%,TMTC2;CAV1;TRPV6;CYP27B1;GRIN1
prerank,mitotic cytokinesis (GO:0000281),-0.30518349767300557,-0.9700635673934226,0.5219941348973607,0.8623783761999229,1.0,21/47,26.96%,SON;ROCK2;SNX18;ANK3;CIT;ARL3;JTB;RTKN;KLHDC8B;CNTROB;STAMBP;NUSAP1;RAB35;EFHC1;CKAP2;CUL7;RHOC;SNX33;CENPA;CEP55;SPAST
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.43826561428089006,0.9697940281104342,0.5234899328859061,0.8157141963836579,1.0,3/18,12.23%,HIP1R;BOK;BID
prerank,regulation of gene silencing by miRNA (GO:0060964),0.34817151574916316,0.9696170944886155,0.5070224719101124,0.8155295993829382,1.0,15/62,15.08%,STAT3;H3-3A;TGFB1;PUM1;IPO8;NUP214;PUM2;NUP98;ZFP36;FMR1;NUP205;NUP133;NUP153;NUP54;NUP43
prerank,regulation of myoblast differentiation (GO:0045661),0.3931149800745915,0.9696018765949652,0.4946889226100152,0.8150374648722896,1.0,6/32,7.19%,MEF2C;NOTCH1;PLCB1;SOX9;DLL1;TGFB1
prerank,positive regulation of positive chemotaxis (GO:0050927),0.44061890011587257,0.9694747420270884,0.5180722891566265,0.8147922912956185,1.0,4/15,5.18%,KDR;VEGFC;F7;VEGFD
prerank,protein catabolic process (GO:0030163),0.35288661979135033,0.9694550004671032,0.5159883720930233,0.8143140377248551,1.0,17/59,16.71%,STT3B;DAB2IP;CEACAM1;UBE2G1;CTRL;TRIM24;PSMA8;RAB12;SIAH1;CLN6;RIPK1;OGA;DDI1;SOCS6;RNF5;DDI2;CHEK2
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.32295193267584005,-0.9689599649726365,0.5305466237942122,0.8641567008167198,1.0,13/39,15.49%,DMD;OSR1;HECW2;FGF14;WNK4;ANK3;SLMAP;WNK1;GPD1L;SCN2B;WNK3;FXYD1;NETO1
prerank,integrin-mediated signaling pathway (GO:0007229),0.3442496221764311,0.9683025221495296,0.5,0.8161849727867054,1.0,13/73,7.81%,PRKD1;SEMA7A;DOCK1;NEDD9;MYH9;ADAM10;PTK2B;DST;LAMA3;CEACAM1;ADAM15;PTK2;ITGA5
prerank,negative regulation of bone mineralization (GO:0030502),0.4605153270799225,0.9681758114301195,0.5078534031413613,0.8159200553599408,1.0,5/13,12.01%,PTK2B;FGF23;GREM1;SRGN;RFLNB
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.4236741024942727,0.9678779324140427,0.5205479452054794,0.8160226860419723,1.0,4/20,6.38%,FBXW7;SIK1;CEACAM1;TRIB3
prerank,positive regulation of wound healing (GO:0090303),-0.3229049011089499,-0.9677770849635099,0.48633879781420764,0.8660877330496982,1.0,9/36,11.25%,PLPP3;VTN;THBS1;FOXC2;SMOC2;ANXA1;ADRA2A;SERPINE1;CLDN1
prerank,regulation of humoral immune response (GO:0002920),0.36747136110665046,0.9675290875748346,0.5250379362670713,0.8162137428768645,1.0,4/44,7.56%,CFH;PROS1;CFB;CR1L
prerank,T cell migration (GO:0072678),0.46672302172248703,0.9672120768880542,0.5208711433756806,0.8164038855572304,1.0,3/13,7.54%,MSN;S1PR1;PIK3CG
prerank,negative regulation of cellular senescence (GO:2000773),0.46180366509569526,0.9671116749685535,0.4782608695652174,0.8160885815334022,1.0,5/13,18.30%,CDK6;MAP3K3;AKT3;YBX1;RBL1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.3510022047236906,-0.9670208125978486,0.504,0.8668043539662336,1.0,10/25,26.52%,PFKP;ENO2;HK2;TPI1;ENO3;PFKM;ALDOA;PKM;ENO1;ALDOC
prerank,regulation of response to interferon-gamma (GO:0060330),0.4594442297666223,0.9669727676300909,0.49730700179533216,0.815877468022561,1.0,8/14,26.04%,JAK1;HSP90AB1;STAT1;IFNGR1;CDC37;PARP9;JAK2;SUMO1
prerank,anion transmembrane transport (GO:0098656),0.34963861130840784,0.9666218569741947,0.5217391304347826,0.8161377254787093,1.0,6/67,3.00%,LRRC8C;SLC6A5;SLC39A8;LRRC8B;SLC38A5;SLC3A2
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.4434952115797231,-0.9665803035067292,0.5320910973084886,0.8668219881432137,1.0,5/10,31.19%,MIA3;TICAM1;TREM2;TLR6;CD36
prerank,protein insertion into membrane (GO:0051205),0.38571956902287524,0.9658669107249792,0.5170278637770898,0.81719279982531,1.0,5/32,10.15%,APP;REEP1;STX1A;TRAM1;TRAM1L1
prerank,response to estradiol (GO:0032355),0.3944216071909437,0.9657834676926798,0.5226209048361935,0.8168223247968428,1.0,5/31,9.15%,ESR1;SOCS2;STAT3;TGFB1;NRIP1
prerank,regulation of cellular component movement (GO:0051270),0.36439862454083394,0.965739215700279,0.5007256894049347,0.8164008919168506,1.0,10/49,5.56%,CDK6;LYN;PRAG1;ACTN4;ZSWIM6;PKN2;ACTN1;PKN1;RPS19;MYCBP2
prerank,regulation of hippo signaling (GO:0035330),0.43183719360866185,0.9655157285589829,0.4982456140350877,0.8163698023717906,1.0,5/17,9.65%,MARK3;VGLL4;NF2;WWC2;MAP2K3
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.4426215028364896,0.965355267067804,0.49906191369606,0.8161839952337049,1.0,4/15,4.05%,PRKD1;PRKD2;NOTCH1;TMSB4X
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.3873337040828777,-0.9651650559572428,0.5316455696202531,0.8694157122539007,1.0,3/16,8.19%,AUTS2;BCOR;CTR9
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.45494636651097503,0.9649914602208922,0.5065666041275797,0.8159370026556569,1.0,4/11,10.42%,INPP5K;SYNJ1;INPP1;OCRL
prerank,inositol phosphate dephosphorylation (GO:0046855),0.45494636651097503,0.9649914602208922,0.5065666041275797,0.8159370026556569,1.0,4/11,10.42%,INPP5K;SYNJ1;INPP1;OCRL
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.41162664084765743,0.9649293157883746,0.5115511551155115,0.8150385752389143,1.0,6/23,14.38%,PPP1R13B;CASP8;MAPK8;SFN;BID;YWHAQ
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.41162664084765743,0.9649293157883746,0.5115511551155115,0.8150385752389143,1.0,6/23,14.38%,PPP1R13B;CASP8;MAPK8;SFN;BID;YWHAQ
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.4383474362085027,0.9645252131587934,0.5231316725978647,0.815395464301982,1.0,4/17,6.76%,PARD3;DDIT4;SMAD7;INPP5K
prerank,positive regulation of defense response to virus by host (GO:0002230),0.3978315373939015,0.9640068591556987,0.5049180327868853,0.8159200273351889,1.0,8/24,18.40%,AIM2;DTX3L;CGAS;IL23A;EIF2AK4;STAT1;PARP9;ZDHHC1
prerank,regulation of actin nucleation (GO:0051125),-0.4135439482620623,-0.963896921665023,0.5035971223021583,0.8714969944664266,1.0,4/12,23.89%,GSN;ARFIP2;ARPIN;CORO1B
prerank,negative regulation of type I interferon production (GO:0032480),0.3733116923447919,0.9638826859373962,0.5014792899408284,0.8156775486938602,1.0,9/40,14.77%,RNF125;NLRC5;UBA7;TRIM25;RELB;IFIH1;ILRUN;YY1;GPATCH3
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.4815093146416868,0.9638733740454773,0.5275310834813499,0.8151884845497936,1.0,4/10,21.37%,ATRX;JARID2;KDM1A;RIF1
prerank,activation of phospholipase C activity (GO:0007202),0.38791544057452615,0.963773370882226,0.49921996879875197,0.8148937119335927,1.0,4/29,3.26%,GNAQ;PLCG1;HTR2A;SELE
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.435561442270537,-0.9634468983988531,0.4989059080962801,0.8714117072717046,1.0,4/11,20.94%,PARP3;PARP11;PARP8;TIPARP
prerank,mRNA modification (GO:0016556),0.4130962353682442,0.9632122385232769,0.4944178628389155,0.8155896094330786,1.0,12/22,27.24%,CBLL1;WTAP;VIRMA;TRMT6;METTL14;TRUB1;PUS7;RPUSD2;TRMT61B;METTL16;TRMT10C;NSUN2
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.3391752972373838,0.9630603290954288,0.5472222222222223,0.8154082315287482,1.0,26/73,23.48%,ZFP57;EPC1;H3-3A;MTF2;TASOR;TAF1B;PPM1D;POLR1A;SMARCA5;MYBBP1A;AEBP2;PPHLN1;MYO1C;POLR1G;POLR1B;KAT2B;JARID2;PHF19;TAF1A;POLR2L;DEK;PHF1;PHF2;HDAC6;ERCC6;BMI1
prerank,neurotrophin signaling pathway (GO:0038179),-0.3600819192265586,-0.962826889025863,0.5230024213075061,0.8719381905225845,1.0,4/21,6.42%,MAGI2;NTRK2;NGF;KIDINS220
prerank,transcription by RNA polymerase I (GO:0006360),0.3798844405318804,0.9626816238186131,0.5162287480680062,0.8156997611333647,1.0,12/34,22.25%,CAVIN1;TAF1B;POLR1A;RRN3;POLR1G;POLR1B;GTF2H4;TAF1A;GTF2H1;POLR2L;CCNH;TCOF1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.39028579607404557,-0.962675498705031,0.5044444444444445,0.8711735523860143,1.0,4/15,5.73%,FGFR2;PDGFRA;TGFBR1;SIX1
prerank,programmed necrotic cell death (GO:0097300),0.42258836512259995,0.96256021638456,0.5250431778929189,0.8154451047233071,1.0,5/18,17.68%,PGAM5;MLKL;RIPK1;TRPM7;IPMK
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.41761033709019757,-0.9620703049188734,0.5153508771929824,0.871596687555243,1.0,2/11,3.66%,CDH13;P2RX4
prerank,protein K48-linked deubiquitination (GO:0071108),0.407309778122434,0.9620657546551362,0.5215231788079471,0.8159841879776722,1.0,7/23,18.88%,MINDY1;MINDY2;ATXN3;OTUD4;YOD1;USP8;USP25
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.4225236150394931,-0.9614705129641088,0.5341880341880342,0.871938454181454,1.0,6/11,20.67%,SIRT2;FAP;FZD3;PTGIS;TP53;DFFA
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.4485511103882123,0.9611247510184869,0.525305410122164,0.8175177089814237,1.0,8/16,21.37%,SMCHD1;DTX3L;SHLD1;WRAP53;MAD2L2;KMT5B;PARP9;RIF1
prerank,epidermis development (GO:0008544),-0.29398107454207684,-0.9609309872742705,0.5478547854785478,0.8721445409385342,1.0,11/56,14.02%,FGFR2;SVEP1;CCN2;CRABP2;ATP2A2;GLI1;SCEL;FLOT2;FGF7;EDA2R;LAMC2
prerank,response to histamine (GO:0034776),-0.4388308411733982,-0.9605753107333044,0.5273522975929978,0.8719172074761168,1.0,3/10,13.10%,GABRG2;GABRB1;GABRB3
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3112461110678375,0.9603853166957047,0.5464414957780458,0.8185665860272087,1.0,26/161,10.49%,CAV1;DAB2IP;SOX13;FZD6;MLLT3;FZD4;TLE4;SOX17;WWTR1;NKD2;STK3;ZNRF3;SOX9;STK4;TCF7L2;GREM1;WNT5A;TMEM88;SOST;JADE1;PSMA2;SFRP2;PSMA8;PSMA6;MAD2L2;SCYL2
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.37112592919129833,0.9603174409742448,0.5122324159021406,0.8181913207075948,1.0,10/41,11.51%,HTR2A;PLCG2;ATP2B4;TRPV6;LCK;PKD2;ITPR3;TRPV4;ERO1A;GRIN1
prerank,regulation of protein kinase B signaling (GO:0051896),0.30094856681967164,0.9602638874856421,0.5338882282996433,0.8177842095786124,1.0,28/193,9.18%,TEK;ENG;ESR1;INSR;KITLG;PDGFB;HIP1;MFHAS1;RASD2;PTPRJ;FYN;FGF23;F7;TCF7L2;CX3CR1;RET;RAC1;TRIB3;INPP5K;TGFB1;LCK;PTK2;PIK3CG;TGFA;GAB1;PPP2R5B;AKT2;RICTOR
prerank,neuron differentiation (GO:0030182),0.3101998796066927,0.9595510993857974,0.5473684210526316,0.8187538308468351,1.0,17/165,9.43%,LHX6;PBX1;UGCG;MEF2C;ACSL4;FZD4;DDIT4;XBP1;OPHN1;WNT5A;PITX3;WNT9B;NEUROD1;THOC2;USH2A;IER2;SOX4
prerank,positive regulation of immune system process (GO:0002684),0.43671473941964944,0.9595504238731674,0.5094991364421416,0.8182434619819637,1.0,1/16,1.28%,IL15
prerank,eye photoreceptor cell differentiation (GO:0001754),0.44659463453358234,0.9592434101515419,0.5141776937618148,0.8183801678286986,1.0,3/12,8.99%,STAT3;PROM1;DSCAM
prerank,retinoic acid metabolic process (GO:0042573),-0.39888264747159835,-0.9592151431141729,0.501187648456057,0.8742891050060501,1.0,2/14,3.66%,ALDH1A2;CYP26B1
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.3748910969732986,-0.9590206291459502,0.5364077669902912,0.8736689229495053,1.0,4/18,3.96%,DCN;PRKN;SPIRE1;MCU
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.2901778614515654,0.9590044790289848,0.5795698924731183,0.8184081535782403,1.0,39/348,7.25%,LEF1;NOS3;RAB27A;APP;MEF2C;CLDN5;OCLN;INSR;SMAD1;PDGFB;GATA2;PDE2A;STAT3;MSN;HIF1A;NOTCH1;PPM1F;SELE;PLCG2;CD34;FGF23;SOX9;KLF2;DTX3L;GREM1;DLL4;MAPK8;SERPINB9;RAMP2;WNT5A;TNRC6C;ATF7IP;RPS7;IL36G;KRAS;TASOR;ARRB1;TGFB1;NOS1AP
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.35554061277628224,0.95888057548579,0.5216095380029806,0.8181441915039322,1.0,10/47,12.97%,RAB27A;PDGFB;PLCG2;TGFB1;CBR1;GRIN1;RIPK1;XDH;GSTP1;TGFBR2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.33656422271248226,-0.9588597948747831,0.522911051212938,0.8729163280660047,1.0,9/29,12.28%,NOTCH2;IGF1;RASGRF1;NGF;ITGAV;SHC1;SRC;IRS2;MMD2
prerank,histone H3-K9 demethylation (GO:0033169),0.46427153431597523,0.9586528158020843,0.4991243432574431,0.818097386011744,1.0,5/11,18.41%,KDM3A;JMJD1C;KDM4C;KDM4A;KDM1A
prerank,genitalia development (GO:0048806),0.45691977391181016,0.957890042862837,0.5157894736842106,0.8191767765770334,1.0,3/12,5.81%,CHD7;FOXF2;WNT5A
prerank,sister chromatid segregation (GO:0000819),-0.3352664922146943,-0.9572291489825429,0.5242165242165242,0.8759999524748091,1.0,16/31,33.15%,TOP2B;ZWINT;KLHL22;NUSAP1;CENPK;KNSTRN;KIF18B;NDC80;KIFC1;TOP2A;CDCA8;SGO1;INO80;DSN1;ZW10;ESPL1
prerank,protein autoprocessing (GO:0016540),0.4402225699215902,0.9571554823509598,0.5422297297297297,0.820244976136985,1.0,5/17,22.36%,CASP4;CASP1;OMA1;TMPRSS2;FXN
prerank,ion homeostasis (GO:0050801),-0.33379498490842874,-0.9568197271259389,0.5273224043715847,0.8758762296578325,1.0,8/30,10.31%,SLC4A10;FHL1;WNK4;WNK1;SLC4A3;UNC80;SLC4A2;AP3D1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.4111820051811974,0.9565956802103788,0.5160744500846024,0.8209072015568232,1.0,9/20,18.10%,CASP8;SDCBP;PELI1;MLKL;RIPK1;BIRC3;ASAH1;BIRC2;CDC37
prerank,embryonic organ development (GO:0048568),0.34765981426878256,0.9563812595329999,0.5106685633001422,0.8208371616202408,1.0,11/61,9.32%,TEAD4;PBX1;KDR;KITLG;TAL1;SOX17;SOX18;TEAD2;TGFB1;NEUROD1;ZFPM1
prerank,regulation of cellular pH (GO:0030641),-0.3289344350070068,-0.9559225809413936,0.5502645502645502,0.8770700406488153,1.0,7/29,14.22%,SLC4A10;SLC9A9;SLC4A3;SLC4A2;SLC9A1;LACC1;SLC26A6
prerank,mitotic chromosome condensation (GO:0007076),0.40304118942268724,0.9557907266370267,0.5147058823529411,0.8215636932248004,1.0,8/26,19.68%,TENT4A;MCPH1;NCAPH;RB1;CSNK2A1;CSNK2A2;SMC4;PLK1
prerank,cilium organization (GO:0044782),0.30057612444081816,0.955584448858456,0.5533642691415314,0.8215142787977456,1.0,27/209,12.77%,ABCC4;ABLIM1;FNBP1L;EXOC6;EHD4;RAB11A;NOTCH1;CNGB1;SSX2IP;DISC1;CEP41;PCNT;BBIP1;EHD2;PKD2;DYNLL1;EXOC5;TEKT5;EXOC4;OCRL;CEP83;ARL13B;ACTR2;EHD3;RTTN;RILP;WDR11
prerank,regulation of immune effector process (GO:0002697),0.36891795929257254,0.9555203267410314,0.529320987654321,0.8211332523921303,1.0,4/41,7.56%,CFH;PROS1;CFB;CR1L
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.35404795877887774,0.9552785504504108,0.5206489675516224,0.821101165431503,1.0,16/54,16.71%,CNOT6;CNOT6L;PLK2;AURKA;CDKN1B;CRADD;SOX4;BTG2;CNOT1;SFN;CNOT2;MUC1;CNOT7;CDC25C;E2F7;CHEK2
prerank,regulation of cellular catabolic process (GO:0031329),0.34611871342075246,0.9549268252389053,0.5436893203883495,0.8213056401621502,1.0,11/62,12.13%,ACER2;DAPK1;BOK;DRAM2;TRIB3;RPTOR;FBXL2;DEPP1;SCARB2;ABL2;ABCD1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.390797144477278,0.9547643375978926,0.5031545741324921,0.8211461569677894,1.0,5/29,11.15%,ESR1;KCTD6;CNOT1;CNOT2;CBFB
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.37723637991219716,-0.9542811071902086,0.515970515970516,0.8801756485657266,1.0,4/18,5.87%,IL34;PTN;DAAM2;NF1
prerank,regulation of protein modification process (GO:0031399),0.35797591207048324,0.9535708085469212,0.5310245310245311,0.8231116201987474,1.0,12/50,14.87%,PPP1R16B;LYN;FNIP2;CCDC88A;PTK2;PARG;CORO1C;NOP53;WARS1;PHIP;CDH5;KAT2B
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.3735462174706259,0.953487236451214,0.5254730713245997,0.8227790445109359,1.0,10/41,11.35%,PDGFB;NEDD9;EFNA1;FBXW7;FYN;TGFA;PTPN1;FCGR1A;GAS6;EPHA4
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.30703355424249684,0.953463321916822,0.572928821470245,0.8223243512740295,1.0,29/172,13.28%,INPP5D;PLA2G4A;PIP5K1B;DGKZ;PITPNM2;MTM1;LPCAT3;PIK3C2A;PLCG2;PIK3R6;DGKH;CEPT1;LPIN3;MTMR6;PLA2G2D;INPP5K;CDS2;BMX;AGPAT1;PIK3CG;SYNJ1;PLEKHA8;OCRL;INPP5F;DGKE;MTMR12;PEMT;PLD2;RAB5A
prerank,protein modification by small protein conjugation (GO:0032446),0.2888576629537517,0.9532772068174564,0.615546218487395,0.8222056672749786,1.0,75/361,17.84%,EPAS1;DCUN1D3;KLHL3;SMURF1;NEDD4L;KLHL2;TRIM14;FBXW7;HIF1A;KLHL7;RNF38;ZNRF3;UBA7;DTX3L;UHRF2;KCTD10;HERC2;TRIM68;MYCBP2;RNF144A;CBLL1;ARRB1;UBE2G1;RNF7;TRIM47;FBXL7;ARRDC1;STX1A;NEDD4;RNF139;KLHL24;UBR1;TRIM24;ANAPC7;UBE2H;FBXL2;RAD18;UBE2D3;CBL;SUMO2;NUP214;CUL1;MYLIP;SAE1;NUP98;RACK1;RNF25;ASB11;ANAPC16;IFIH1;NUP205;NUP133;DCAF15;UBE2K;PEX14;KLHL8;FBXL3;NUP153;NUP54;TOPORS;MSL2;ARIH2;NUP43;ELOC;AREL1;OTULIN;CDC73;CRBN;NEDD8;CUL3;UBE2I;CDC34;RNF40;KLHL18;USP7
prerank,cGMP-mediated signaling (GO:0019934),-0.40986334645895317,-0.9524603378680891,0.5474137931034483,0.8837553887553409,1.0,4/13,13.60%,IRAG1;KCNC2;APOE;GUCY1B1
prerank,negative regulation of gluconeogenesis (GO:0045721),0.46034322825726565,0.9515649807529672,0.5150943396226415,0.8253002083829584,1.0,1/11,3.06%,SIK1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.3742344303165187,-0.9511442997496848,0.526829268292683,0.8859585896637795,1.0,1/19,0.34%,IGF1
prerank,mesenchymal cell development (GO:0014031),0.43139608580660926,0.9502205393495161,0.523728813559322,0.8276154700411833,1.0,3/18,6.67%,NOTCH1;CDH2;CYP26C1
prerank,peptide hormone secretion (GO:0030072),0.3949729783448579,0.9497550916794584,0.5292207792207793,0.8280847137008157,1.0,3/26,8.35%,EDN1;SNX19;NEUROD1
prerank,positive regulation of protein deacetylation (GO:0090312),0.4402971685030177,0.9497127731261269,0.5380622837370242,0.8276638821644874,1.0,6/14,22.09%,DYRK1A;CTBP1;APLNR;FNTA;SAP30BP;NIPBL
prerank,regulation of telomerase activity (GO:0051972),0.3615289392582171,0.9497025138324694,0.5369532428355958,0.8271825325824763,1.0,10/45,16.73%,NEK7;HMBOX1;GREM1;WRAP53;PINX1;ACD;ERCC4;HSP90AB1;TERF1;CTNNB1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.4506948803330608,0.9495892752203267,0.507168458781362,0.8269172248940844,1.0,5/13,13.14%,TNRC6C;BTG2;CNOT1;ZFP36;CNOT7
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.36483653474168004,-0.9492052335380526,0.5202863961813843,0.8900813606388733,1.0,5/20,9.58%,EGFR;PKD1;CCND2;SPDYA;RGCC
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.3613090252136666,-0.9486725275459824,0.5236907730673317,0.8903118147923946,1.0,4/20,8.20%,OSR1;ACTN2;HECW2;ADRA2A
prerank,zinc ion homeostasis (GO:0055069),-0.33863050671552397,-0.9486546204043093,0.5431472081218274,0.8891870635802566,1.0,5/28,8.47%,PRKN;SLC30A10;SLC39A14;SLC39A13;SLC39A10
prerank,positive regulation of ATPase activity (GO:0032781),-0.304808864428444,-0.9485325596410485,0.5309734513274337,0.888334627244431,1.0,11/41,20.08%,ATP1B1;TPM1;RYR2;ATP1B2;DNAJB11;PFN2;HNRNPU;FGF10;MSH6;SETMAR;DNAJB2
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.28445100736623974,-0.9484421053920968,0.5451388888888888,0.8873987102483029,1.0,20/66,17.41%,EGFR;APPL2;FHL1;PKD1;DACT1;DLG1;KANK2;ANXA1;CCND2;ADAMTS1;UBE2E2;RGCC;TFDP1;PLK5;CDKN1A;RBL2;HYAL1;E2F1;FGF10;CDK2AP2
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.4142142406553551,0.9482332454210888,0.5409836065573771,0.8293008750713119,1.0,4/22,5.29%,GATA2;SLC16A2;TOX;DLL4
prerank,regulation of macroautophagy (GO:0016241),0.3162389312122515,0.9481954441399015,0.5389527458492975,0.8288641280905163,1.0,16/105,11.08%,KDR;ERN1;LZTS1;QSOX1;MAPK8;ULK1;SH3GLB1;ATP6V0A1;NEDD4;RPTOR;ATG101;ATP6V1G2;IKBKG;EXOC4;PRKAB1;BNIP3
prerank,negative regulation of axonogenesis (GO:0050771),-0.3361361183765297,-0.9481441963659604,0.5306666666666666,0.8870667735438955,1.0,14/27,27.32%,PTPRS;MAP2;DCC;CDKL3;RTN4;SEMA3G;ULK2;MT3;PTEN;RNF6;GDI1;THY1;MAG;FGF13
prerank,iron-sulfur cluster assembly (GO:0016226),0.4061703516360337,0.9480147475059806,0.5024630541871922,0.8287284702689065,1.0,11/24,24.88%,ABCB7;GLRX3;MMS19;NUBP1;NUBP2;HSCB;LYRM4;FXN;NUBPL;CIAO2B;CIAPIN1
prerank,negative regulation of cell cycle (GO:0045786),0.33315275754526597,0.947880141731008,0.5497953615279673,0.8285081779358274,1.0,18/73,15.15%,PPP1R13B;CDK6;HHEX;BTG3;PTPRK;CDKN1B;TGFB1;RNF167;BRINP2;BTG2;ANGEL2;TFAP4;BTG1;RB1;RHOB;INCA1;APC;GMNC
prerank,regulation of transport (GO:0051049),0.3765786786025668,0.9478184730491991,0.5173501577287066,0.8281231865409167,1.0,3/36,2.18%,EPB41;ICA1;RAB11A
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3432588474197179,0.9476766445417654,0.5493562231759657,0.8279093563197971,1.0,17/63,16.71%,CNOT6;CNOT6L;PLK2;AURKA;CDKN1B;CRADD;CDK2;SOX4;BTG2;CNOT1;SFN;CNOT2;MUC1;CNOT7;CDC25C;E2F7;CHEK2
prerank,protein ubiquitination (GO:0016567),0.28175918817124407,0.9474454723442691,0.6233090530697191,0.827900617444419,1.0,121/471,21.82%,EPAS1;RNF125;KLHL3;SMURF1;RNF144B;RNF141;NEDD4L;KLHL2;TRIM14;FBXW7;HIF1A;KLHL7;RNF38;ZNRF1;ZNRF3;DTX3L;UHRF2;KCTD10;HERC2;TRIM68;PELI1;MYCBP2;FBXL4;RNF144A;UBE3B;CBLL1;SASH1;ARRB1;UBE2G1;RNF7;TRIM47;FBXL7;ARRDC1;RNF167;NEDD4;PSMA2;TRIM25;RNF139;KLHL24;UBR1;TRIM24;ANAPC7;UBE2H;RNF146;FBXL2;FBXW2;RNF4;PSMA8;RAD18;SIAH1;PSMA6;UBE2D3;CBL;FBXO30;RC3H1;CBFB;CUL1;MYLIP;UBE3A;RNF112;RACK1;RNF25;ASB11;ANAPC16;ASB4;DCAF15;UBE2K;PEX14;TRAF6;KLHL8;FBXL3;TOPORS;PSME1;MSL2;ARIH2;ELOC;AREL1;TPP2;UBE3D;OTULIN;CDC73;CRBN;CTNNB1;BIRC2;NHLRC1;NEDD8;CUL3;FBXW10;PSMA4;CDC34;RNF40;KLHL18;USP7;HERC6;UBE2Q1;PSMF1;ABCB11;PELI2;TRIM62;CUL2;KBTBD8;OBI1;PLK1;UBE2L3;BCL10;FBXO17;PSMB1;TRAF7;ARIH1;PHC1;TRIM71;PSMB7;THOP1;RNF111;PSMD2;HACE1;PEX10;VPS18;UBE2V2;FBXO25;RTF1
prerank,synaptic vesicle endocytosis (GO:0048488),0.3844934116932276,0.9470639828609495,0.5263975155279503,0.8281850597010232,1.0,6/33,9.20%,DNM3;ITSN2;FCHO2;OPHN1;STX1A;SYNJ1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3270575657636947,0.9470303000255003,0.54177545691906,0.8277553919152137,1.0,21/90,15.26%,EPAS1;ADIPOR2;CAV1;KDM3A;ADRB1;LCN2;GATM;ESRRG;PDGFC;CXCR4;PRKAB1;IL4R;UCP2;PEMT;SIRT6;OMA1;ADIPOR1;HADH;IGF1R;APC;STAT6
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.4245042811767771,-0.9469377789755279,0.5474137931034483,0.8878852711367198,1.0,6/10,23.72%,PRKCD;SMPD3;NSMAF;PLA2G6;SMPD2;SPHK2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.4245042811767771,-0.9469377789755279,0.5474137931034483,0.8878852711367198,1.0,6/10,23.72%,PRKCD;SMPD3;NSMAF;PLA2G6;SMPD2;SPHK2
prerank,negative regulation of autophagy (GO:0010507),-0.29994424548002013,-0.9468964878468688,0.5464285714285714,0.8868399339577576,1.0,16/54,17.29%,LEPR;SNRNP70;BCL2;NUPR1;NRBP2;SIRT2;KLHL22;LRRK2;DAPL1;PTPN22;EIF4G3;RUBCN;SNCA;SMCR8;MT3;TSC1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.45917663876986964,0.9467974572432692,0.5363128491620112,0.8277564379419525,1.0,1/12,1.30%,LMO2
prerank,positive regulation of nervous system development (GO:0051962),-0.297985511497741,-0.9467311214362095,0.5425219941348973,0.8861225361366142,1.0,12/42,12.89%,NLGN2;CLSTN2;CUX2;PTPRD;IL1RAPL1;NRXN1;NLGN1;SERPINF1;NLGN3;SRPX2;GRID2;GPER1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.4415862830235552,0.9467089036425778,0.5256637168141592,0.8274274669401235,1.0,6/13,23.35%,DPAGT1;ALG6;ALG8;MPDU1;ALG12;ALG14
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.3252146143955891,-0.9466388067019109,0.5389221556886228,0.8852310108250991,1.0,11/35,18.08%,MAGI2;PDGFRB;ITGA1;PPP4R4;PPP6R2;CRY2;HTT;PTPA;BOD1L1;TSC1;CSNK2B
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.3036675313483521,-0.9466004750068296,0.5504587155963303,0.8842155764362027,1.0,12/44,15.41%,GSN;SPIRE1;CARMIL1;NCK2;BIN1;PFN2;BAIAP2;CDC42EP4;LMOD1;CDC42EP5;CTTN;FCHSD2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.40897310100852274,0.9462074043604818,0.5253378378378378,0.8279343837547971,1.0,3/22,2.79%,IL6ST;EDN1;NOTCH1
prerank,female gamete generation (GO:0007292),0.3927257794787725,0.9459131298834255,0.5448818897637795,0.8280357467736057,1.0,4/29,8.20%,NANOS3;NANOS2;MARF1;TRIP13
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.4322452588174647,0.9456914030408952,0.5685920577617328,0.8279639168823946,1.0,3/18,13.64%,RAB11A;BRD4;CDC25C
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.47746995439676515,0.9455859811545306,0.5319926873857403,0.8276928494774827,1.0,7/10,30.22%,NF2;INPP5F;PPP2R1A;PIBF1;PPP2CA;PARP14;SOCS3
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.30341069701287793,-0.9451946262185733,0.535031847133758,0.886707501390562,1.0,10/44,15.19%,CYP7B1;CYP27A1;INSIG2;PRKAG2;PER2;OSBPL3;OSBPL6;INSIG1;SCP2;ALOX12
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.40992933072330945,0.9443713266822944,0.5218093699515347,0.8297097412232586,1.0,4/23,12.19%,SLC12A7;CLCN3;SLC12A9;SLC9A7
prerank,response to reactive oxygen species (GO:0000302),0.3511219828274647,0.9443122697902536,0.5342066957787481,0.8293210582020798,1.0,14/54,13.86%,HIF1A;FYN;STK24;PXN;CAT;PTPRK;MAPK8;STK26;PKD2;PJVK;COA8;GLRX2;GSTP1;SOD2
prerank,translational termination (GO:0006415),0.32313874909629436,0.9442354950396915,0.5694087403598972,0.8289745672485832,1.0,41/95,26.46%,MRPS18A;MRPL13;MRPS12;MRPL35;APEH;MRRF;MRPL41;MRPL52;MTRF1L;MRPL4;MRPS16;MRPS5;MRPL23;MRPL37;MRPL11;PTCD3;MRPS26;MRPL54;GADD45GIP1;MRPS9;MRPL43;MRPL12;MRPL44;MRPS30;MRPL1;MRPL17;N6AMT1;AURKAIP1;MRPL50;MRPL15;MRPL19;DAP3;MRPL14;MRPL32;MRPL39;MRPS11;MRPL9;MRPL46;MRPL24;MRPL42;GSPT2
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.39825496604760086,0.944226463144933,0.545,0.8284873876091468,1.0,8/27,20.54%,TIRAP;TNIP1;IRAK4;TRAF6;IRAK3;TAB3;IRAK2;MAP3K1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.4736949069309304,0.944038347711792,0.549165120593692,0.8283879810542204,1.0,3/10,20.81%,WRAP53;CCT7;CCT2
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.3295235909389624,-0.9437320156322032,0.5336927223719676,0.889394184298395,1.0,10/27,15.75%,SLC7A2;SLC1A3;SLC47A1;SLC6A9;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC22A2;SLC25A18
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.36067260563819886,-0.9434295213709514,0.5432692307692307,0.8890271000789617,1.0,5/18,11.91%,HDAC4;SOX6;CCN3;BHLHE41;FZD7
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.4241511337533151,0.9434283635099108,0.5238095238095238,0.8291253638431643,1.0,4/20,10.56%,ACSL4;FASN;FAR2;SLC25A1
prerank,coenzyme A biosynthetic process (GO:0015937),0.4521891341543061,0.9432447172058616,0.5388888888888889,0.8280113875781696,1.0,4/11,20.48%,SLC25A16;PANK2;PANK3;PPCDC
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.4521891341543061,0.9432447172058616,0.5388888888888889,0.8280113875781696,1.0,4/11,20.48%,SLC25A16;PANK2;PANK3;PPCDC
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.4521891341543061,0.9432447172058616,0.5388888888888889,0.8280113875781696,1.0,4/11,20.48%,SLC25A16;PANK2;PANK3;PPCDC
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.4052542243394281,0.9427049137953397,0.533003300330033,0.8286098048517931,1.0,4/23,7.24%,CBFA2T3;SIK1;FBP1;TIGAR
prerank,response to thyroid hormone (GO:0097066),0.44918828415407214,0.9424056769857238,0.5452898550724637,0.8287335884312912,1.0,1/13,1.30%,LMO2
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.4081621589092304,0.94227879661758,0.5366269165247018,0.82849019901245,1.0,1/21,0.87%,CAV1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.42076852473465437,0.9422417731375372,0.5404040404040404,0.8280678514154336,1.0,8/20,21.73%,DROSHA;DICER1;PUM1;PUM2;HENMT1;TRIM71;MRPL44;PRKRA
prerank,purine ribonucleotide catabolic process (GO:0009154),0.4049383039861107,0.9420504977368568,0.5380794701986755,0.8279737045085269,1.0,8/21,15.42%,PDE2A;PDE4D;NT5C2;HINT1;NUDT16;HPRT1;XDH;PDE9A
prerank,autophagosome assembly (GO:0000045),0.3581610607771156,0.9420218122392927,0.5525179856115108,0.8275337048215016,1.0,17/52,24.10%,SMURF1;ULK1;ATG101;EMC6;GABARAPL1;RAB43;RAB7A;ATG2A;ATG2B;IRGM;STX12;RAB1A;ATG7;VMP1;UBXN2A;RAB1B;RB1CC1
prerank,cardiocyte differentiation (GO:0035051),-0.42605818222256053,-0.9419450824612156,0.5708154506437768,0.8917813340452514,1.0,6/10,22.21%,AKAP13;TGFB2;MYOCD;KDM6B;EEF1AKMT4-ECE2;CBY1
prerank,positive regulation of phosphatase activity (GO:0010922),-0.35515229967543216,-0.9419184250915468,0.5200945626477541,0.8907065778776388,1.0,3/21,4.64%,MAGI2;PDGFRB;ITGA1
prerank,regulation of synapse organization (GO:0050807),0.39166799546350334,0.9413812869870795,0.550561797752809,0.8283862117326631,1.0,9/26,20.67%,MEF2C;WNT5A;NEDD4;EPHA4;ABHD17B;KLK8;PDLIM5;ABHD17A;SETD5
prerank,cholesterol efflux (GO:0033344),0.41316411594871233,0.9412895912185694,0.5354058721934369,0.8280928597675459,1.0,5/20,16.08%,SCARB1;SOAT2;ABCG1;ABCA1;STX12
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.2781672032389213,-0.9412860699170783,0.5894308943089431,0.8911971998289988,1.0,25/69,20.76%,PRKN;BCL2;SLC30A10;NRBP2;PPARGC1A;NDNF;NTRK2;NGF;SIX1;SNX6;CPEB4;RETREG1;APOE;TGFB3;NFATC4;PRKCI;MT3;NONO;MDK;CLCF1;PPT1;TYRO3;CRLF1;NTF3;AGAP2
prerank,mRNA metabolic process (GO:0016071),-0.2587627092634079,-0.9409839375033541,0.5491803278688525,0.8908086445284517,1.0,16/90,13.80%,SON;DDX5;SRSF5;PPARGC1A;HNRNPA2B1;PRKACA;PCBP2;SRSF2;AKAP8L;AGO3;SRSF11;U2AF2;CNOT10;CELF1;HNRNPR;LSM6
prerank,lymphocyte chemotaxis (GO:0048247),-0.3173334729444739,-0.9407962690681534,0.536986301369863,0.8901233708478913,1.0,3/34,3.99%,CYP7B1;SLC12A2;CXCL16
prerank,negative regulation of neuron differentiation (GO:0045665),0.41801148996809834,0.9398766802214491,0.5447019867549668,0.8304493697505347,1.0,3/22,4.45%,B2M;SOX9;DLL1
prerank,indolalkylamine catabolic process (GO:0046218),-0.4227096200894556,-0.9393553923812155,0.5271966527196653,0.8927886321083156,1.0,8/10,51.86%,KYAT1;HAAO;KYNU;AADAT;TDO2;KMO;IDO1;ACMSD
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.4057929299816151,-0.9392977738900861,0.5529157667386609,0.8918242594730843,1.0,3/13,5.09%,IGF1;IRS1;IGF2
prerank,negative regulation of MAP kinase activity (GO:0043407),0.35922613665785497,0.9392065254866433,0.5642540620384048,0.8313214491628726,1.0,11/44,14.67%,DAB2IP;LYN;PTPRJ;INPP5K;DNAJA1;PTPN1;AIDA;STK38;GSTP1;DUSP7;IRAK3
prerank,response to steroid hormone (GO:0048545),0.3775205570204684,0.9389078157831688,0.5366614664586583,0.8314029026057597,1.0,8/31,11.72%,CAV1;NR3C1;ABHD2;ATP1A3;ATP1A1;TGFB1;CATSPERD;UBE3A
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.4091002501368933,0.9386744513504075,0.5491803278688525,0.8313795105109008,1.0,6/21,9.92%,NCK1;TMBIM6;XBP1;BOK;BCL2L11;BCL2L1
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.4236616328092022,-0.9385177180378241,0.559652928416486,0.8926708680164638,1.0,5/11,18.16%,EGLN3;P4HB;P4HA1;P4HTM;P4HA2
prerank,anterograde trans-synaptic signaling (GO:0098916),0.2943018062630467,0.9384190531964692,0.580608793686584,0.8313942135408882,1.0,18/224,6.89%,MPZ;UNC13B;SLC6A5;SLC6A2;SLC12A7;HTR2A;PDE7B;CACNA1E;PRKAR2B;PCDHB4;RPS6KA3;SYPL1;SDCBP;RPS6KA1;CACNA1A;KCNMB4;HCRTR1;ATXN3
prerank,wound healing (GO:0042060),0.3403945763681804,0.938256698910405,0.5526695526695526,0.8312243857694215,1.0,6/62,2.91%,MYOF;PRCP;MYH9;SCARB1;PPP3CA;DST
prerank,mitochondrion organization (GO:0007005),0.3025215891826156,0.9382337709210756,0.5825242718446602,0.8307727736556273,1.0,25/165,14.26%,DNM3;NOS3;IMMP2L;ALAS1;BIK;MTM1;VPS13D;CAV2;CYCS;SIRT5;RAB38;BCL2L1;HIGD2A;GABPB1;AKT3;BNIP3;TFB2M;PITRM1;LONP1;BID;OMA1;RAB5IF;MEF2A;HIGD1A;RAB32
prerank,translational elongation (GO:0006414),0.319867151167772,0.9382329431189437,0.5759493670886076,0.830274208034078,1.0,42/101,26.40%,MRPS18A;MRPL13;EEF2K;MRPS12;MRPL35;RACK1;MRPL41;MRPL52;MRPL4;MRPS16;MRPS5;MRPL23;EEFSEC;MRPL37;EEF2;MRPL11;PTCD3;MRPS26;MRPL54;GADD45GIP1;MRPS9;MRPL43;MRPL12;MRPL44;MRPS30;MRPL1;MRPL17;AURKAIP1;MRPL50;MRPL15;MRPL19;DAP3;MRPL14;MRPL32;EEF1G;MRPL39;MRPS11;MRPL9;MRPL46;GFM1;MRPL24;MRPL42
prerank,tRNA metabolic process (GO:0006399),0.4232006399667487,0.938219175553322,0.5406871609403255,0.8297996607836785,1.0,5/17,15.56%,FARS2;DTD1;RPP30;ADAT1;KARS1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.4166148881117881,-0.9381433911423703,0.5146067415730337,0.8925384522888232,1.0,6/12,21.95%,ROCK2;APOE;FLOT2;ABCA7;CHRNA7;ABCA2
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.33468541088679704,0.9381423711504556,0.561046511627907,0.8294610480392326,1.0,9/75,7.90%,RGS3;EDN1;NMT2;GIT2;CNGB1;PLCB1;PPP1R9B;GNAT1;GUCA1B
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.4447723878370015,0.9379974938146289,0.5369369369369369,0.8292480100331117,1.0,7/13,22.80%,JAK3;PIGU;IL7R;MGAT5;CRLF2;HES1;JAK2
prerank,pharyngeal system development (GO:0060037),0.4441379455192065,0.9379779494491337,0.5540765391014975,0.8287863070682028,1.0,2/15,0.88%,BMPR2;TBX1
prerank,protein K63-linked deubiquitination (GO:0070536),0.3808584535026736,0.9375213660442961,0.5490506329113924,0.8292223777839736,1.0,10/31,18.88%,BABAM2;ATXN3;BRCC3;ZRANB1;OTUD4;ABRAXAS2;YOD1;USP8;USP7;USP25
prerank,regulation of leukocyte migration (GO:0002685),-0.3838497678009779,-0.9371943959588972,0.53125,0.8936604163686437,1.0,5/16,11.10%,HOXA7;ANXA1;VEGFA;CD81;MIA3
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.4087307367936274,0.9371050594649974,0.5695581014729951,0.8295840955736287,1.0,4/21,9.01%,TGM2;RAP1GDS1;MICU2;MCUB
prerank,cell-matrix adhesion (GO:0007160),0.32166101249772777,0.9366055032687528,0.5660621761658031,0.8301061931620621,1.0,15/95,7.13%,THSD1;VCAM1;PEAK1;BCR;TAOK2;PPFIA2;CD34;ACTN1;SORBS1;PTPRK;BCAM;RAC1;ADAM15;ITGA3;VWA2
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.3548695531745463,0.9354372196362919,0.5322338830584707,0.8319783208408119,1.0,9/47,9.25%,LIMS2;DOCK1;NEDD9;RREB1;ACTN4;RAC1;PTK2;ARHGEF7;CRK
prerank,protein complex oligomerization (GO:0051259),0.3221923362044384,0.9352814128676732,0.5498687664041995,0.8317991842066359,1.0,23/85,22.17%,LRRC8C;EHD4;AQP11;MAT2A;BOK;PKD2;RNF112;EHD3;ATL1;LRRC8A;G3BP2;PNPT1;TIFA;CARD9;FUS;GLRA3;BCL10;HOMER1;ELAVL1;CPSF6;JMJD6;OPA1;STOML2
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.3918778313640958,0.9350011730028039,0.5492307692307692,0.8318575871353509,1.0,10/25,21.98%,BTBD18;NELFE;BRD4;EAF1;ZMYND11;NELFCD;CDC73;NELFB;EAPP;NELFA
prerank,regulation of establishment of cell polarity (GO:2000114),-0.3746886210630281,-0.9347693006623108,0.5480769230769231,0.89863535870166,1.0,4/16,8.37%,GSN;ROCK2;SHTN1;RIPOR2
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.4481065244860234,0.9342291050732601,0.5483271375464684,0.8329174993123806,1.0,2/12,9.63%,UCK2;UPP1
prerank,selective autophagy (GO:0061912),0.3454860630221449,0.9341322166064487,0.5494505494505495,0.8326387788816769,1.0,11/56,15.34%,KLHL3;WDFY3;ULK1;PCNT;DYNLL1;DYNC1LI1;ARL13B;PJVK;RAB7A;ATG2A;ATG2B
prerank,negative regulation of transmembrane transport (GO:0034763),0.4683712437330242,0.9337940886932289,0.5251509054325956,0.8328693798792749,1.0,3/10,8.71%,CTTNBP2NL;INPP5K;AKT2
prerank,mitochondrial translational termination (GO:0070126),0.3236018161059456,0.9333590480957067,0.5891677675033025,0.8332623587028345,1.0,38/88,26.40%,MRPS18A;MRPL13;MRPS12;MRPL35;MRRF;MRPL41;MRPL52;MTRF1L;MRPL4;MRPS16;MRPS5;MRPL23;MRPL37;MRPL11;PTCD3;MRPS26;MRPL54;GADD45GIP1;MRPS9;MRPL43;MRPL12;MRPL44;MRPS30;MRPL1;MRPL17;AURKAIP1;MRPL50;MRPL15;MRPL19;DAP3;MRPL14;MRPL32;MRPL39;MRPS11;MRPL9;MRPL46;MRPL24;MRPL42
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.39184246898097097,0.9333158011830055,0.5418006430868167,0.8328590331717889,1.0,4/24,8.21%,B2M;MFSD6;TAP2;ERAP1
prerank,lipid biosynthetic process (GO:0008610),-0.2657321281460733,-0.9329049630237071,0.6138996138996139,0.9023768996955801,1.0,21/77,22.14%,ACSL1;ABCD3;AGPAT4;PRKAA2;SREBF1;ACACA;PCYT2;GPAM;SCD;PRLR;ACSS2;FDFT1;SCP2;MVK;AGPAT3;LPCAT1;FDXR;LSS;SCD5;CYP51A1;DHRS11
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.38859060484809677,-0.9328308828985493,0.5613636363636364,0.9014169535879476,1.0,1/13,0.70%,GLI3
prerank,RNA processing (GO:0006396),-0.23757974235169438,-0.9328042377323074,0.64375,0.9003382464237193,1.0,35/176,16.71%,CELF2;SON;HNRNPH1;ATXN1;BICD1;SRSF5;PPARGC1A;HNRNPA2B1;DDX39B;LUC7L3;DUSP11;DDX17;NOVA1;RBMS1;PRKACA;ADARB2;APOBEC1;SRSF2;SRPK2;AKAP8L;WBP4;SRSF11;U2AF2;ZCRB1;RBM4;RNASEL;CELF1;HNRNPR;LSM6;HNRNPU;ELAVL4;SNRNP48;RNPC3;NONO;TUT4
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.40990551757788135,-0.9324940127015959,0.5477707006369427,0.900021924800984,1.0,3/12,5.09%,IGF1;IRS1;IGF2
prerank,primary miRNA processing (GO:0031053),0.464632641525638,0.9317662219964751,0.5592592592592592,0.8354594894414431,1.0,2/10,6.04%,SMAD1;DROSHA
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.41615665697049803,-0.9315398995814588,0.55863539445629,0.9014402420033,1.0,5/11,21.95%,NECAB1;SOAT1;ABCA7;NECAB3;ABCA2
prerank,nuclear body organization (GO:0030575),-0.41196617850391787,-0.9309829175915265,0.5444191343963554,0.9016488037410414,1.0,8/12,30.49%,AFF2;SRPK2;HIPK2;USP50;HABP4;USPL1;ETS1;ZPR1
prerank,negative regulation of defense response (GO:0031348),0.32512817488965023,0.9305276632870737,0.5668874172185431,0.8374500228962779,1.0,4/77,3.30%,TEK;PPARD;MFHAS1;LPCAT3
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.4243095794640328,0.9304519711626341,0.5572390572390572,0.8371132122048345,1.0,2/15,3.90%,PPARD;ELOVL5
prerank,xenobiotic transport (GO:0042908),0.42417578452462584,0.930111502203311,0.5522388059701493,0.8373083913136077,1.0,3/17,8.42%,ABCG2;ABCA3;SLC15A2
prerank,membrane repolarization during action potential (GO:0086011),0.4388261351126957,0.9299034124045014,0.5334538878842676,0.8372305057128391,1.0,3/13,7.12%,KCNQ1;ATP1A1;KCNE2
prerank,regulation of autophagosome maturation (GO:1901096),-0.3943432677624584,-0.9296347506519103,0.5825892857142857,0.9039595389876768,1.0,6/13,26.51%,TMEM39A;RUBCN;SMCR8;ADRB2;CLN3;PHF23
prerank,phospholipid homeostasis (GO:0055091),-0.4179945331935846,-0.9292541368873337,0.5534188034188035,0.9038180301117023,1.0,4/11,18.06%,TLCD2;RCN3;TLCD1;ANGPTL3
prerank,protein destabilization (GO:0031648),-0.31581208987047393,-0.9292333338945261,0.5466666666666666,0.9027478739867087,1.0,7/32,14.80%,GSN;PRKN;BTRC;MDM2;KDM8;HTT;SNCA
prerank,positive regulation of lipid localization (GO:1905954),-0.4201561986208344,-0.9291608461152585,0.5665236051502146,0.9018085386659449,1.0,2/11,4.71%,LRP1;IKBKE
prerank,embryonic axis specification (GO:0000578),-0.3749405300729669,-0.9284695143014348,0.5591647331786543,0.9024026843154418,1.0,8/15,28.53%,COBL;SMAD6;CXXC4;TBX3;PTCH1;FZD5;STIL;RIPPLY2
prerank,positive regulation of neuron death (GO:1901216),-0.2983122801819318,-0.9282229509144998,0.5541795665634675,0.9018883769736452,1.0,9/46,14.80%,EPHA7;NUPR1;MAP3K5;EFNB2;NF1;SRPK2;TGFB2;C1QA;SNCA
prerank,regulation of protein kinase C signaling (GO:0090036),-0.37816421993596966,-0.9280763435574599,0.5458715596330275,0.9011097877505156,1.0,8/14,18.12%,ADGRV1;DGKD;ULK4;VEGFA;ADRA1A;GPD1L;WNT11;MYADM
prerank,inositol phosphate catabolic process (GO:0071545),0.4399058984903784,0.9279415889844506,0.5475285171102662,0.840704302716276,1.0,4/12,10.42%,INPP5K;SYNJ1;INPP1;OCRL
prerank,regulation of protein localization (GO:0032880),0.342972715466431,0.9276720462251641,0.5779685264663805,0.8407438692318863,1.0,15/58,15.71%,TRIM14;FBXW7;PPM1F;FKBP1A;STX6;MAPK8;TRIM68;TRIM25;ITGB3;PICALM;RACK1;RABGAP1L;HSP90AB1;CEP290;MMD
prerank,intermediate filament organization (GO:0045109),0.4230429142848635,0.9275499381286301,0.563922942206655,0.8405016730046182,1.0,4/17,19.29%,MTM1;KLHL24;BFSP2;DNAJB6
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3291140732851247,0.9264959726070644,0.5894308943089431,0.8421781642846716,1.0,18/80,14.61%,FNBP1L;OCLN;EPS8;WASF2;NCKAP1;CCDC88A;RAC1;CDC42EP3;AGRN;TWF2;FSCN1;P2RY12;ACTR2;CYFIP1;FMR1;NDEL1;ACTR3;APC
prerank,regulation of lipid biosynthetic process (GO:0046890),0.38084122932607717,0.9261859006472237,0.5595054095826894,0.842306628040233,1.0,8/32,16.11%,ADIPOR2;SORBS1;CEACAM1;CREB1;EIF6;ADIPOR1;ASAH1;STAR
prerank,zymogen activation (GO:0031638),-0.30552629310853224,-0.9247607812538231,0.5647382920110193,0.9083551117927576,1.0,6/39,10.93%,CYFIP2;ASPH;MMP14;KLK2;PLAT;GRIN2A
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.4601825686425164,0.9246184131908278,0.5614366729678639,0.8449739754196054,1.0,2/10,5.74%,MSN;OPHN1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.37870423026654143,0.9244720044320672,0.567043618739903,0.8447497872888506,1.0,8/29,22.47%,RAD21L1;TRIP13;MEIOB;TERB1;TERB2;RAD21;SIRT7;PRDM9
prerank,heterochromatin assembly (GO:0031507),0.4156090098163074,0.9244304721027821,0.5648464163822525,0.8443247014883176,1.0,4/20,8.64%,SMCHD1;H3-3A;ZNFX1;EZH1
prerank,glycine metabolic process (GO:0006544),0.43262914200813085,0.9243411845678478,0.5390199637023594,0.8440015747842716,1.0,1/12,4.22%,GLYAT
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.3534588443415635,-0.9242161549236385,0.5833333333333334,0.90864366566901,1.0,5/20,22.48%,AKR1B1;FDX1;FDXR;TSPO;TSPOAP1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.37632383681655446,-0.9234462555589229,0.5732323232323232,0.9094356704619571,1.0,5/15,7.47%,AAK1;SNAP91;BMP2K;DGKD;DAB2
prerank,regulation of neuron projection development (GO:0010975),0.29864835769405673,0.9233349523990727,0.5983510011778563,0.8455338120365178,1.0,24/163,8.44%,SHANK3;ABI3;ITGA6;PRKD1;DAB2IP;LYN;PRAG1;PTK2B;PPFIA2;PAK2;CDH2;TOX;DISC1;SCARF1;RET;WNT5A;CCDC88A;RAPGEF2;SNX3;RAP1A;CAMSAP2;TRPV4;MBOAT1;PSEN1
prerank,nuclear membrane organization (GO:0071763),-0.35785688049430897,-0.9232503840951147,0.5452436194895591,0.908797867154853,1.0,12/19,30.18%,AKAP8L;GPER1;UBXN2B;VPS4A;TARDBP;TMEM43;TOR1A;SPAST;TOR1B;DCTN1;TOR1AIP1;CHMP2A
prerank,membrane depolarization (GO:0051899),0.3672970370602251,0.9232422200029738,0.5576619273301737,0.8452377069117104,1.0,3/32,5.29%,CAV1;CACNA1E;CACNA1A
prerank,generation of neurons (GO:0048699),0.29416358143536453,0.9231226556652935,0.6185567010309279,0.844972396681124,1.0,17/190,6.47%,LHX6;MEF2C;CDK6;ACSL4;CELSR1;NAV1;FZD4;DDIT4;CEP85L;DLL1;DISC1;CX3CR1;OPHN1;WNT5A;RAC1;RAPGEF2;WNT9B
prerank,positive regulation of double-strand break repair (GO:2000781),0.35694617522687594,0.9229037557494858,0.5449010654490106,0.8448980337472064,1.0,13/39,18.84%,SMCHD1;DTX3L;SHLD1;WRAP53;MAD2L2;MMS19;ACTR2;SPIDR;WDR48;MGMT;KMT5B;PARP9;FUS
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.3725657495155266,0.9228534526535717,0.578538102643857,0.8445072573573166,1.0,9/33,18.30%,DCUN1D3;CDK6;JADE1;PKD2;RB1;APC;E2F7;CDC73;RBL1
prerank,lytic vacuole organization (GO:0080171),-0.3098126277399109,-0.9228472853492227,0.561046511627907,0.9086951482544526,1.0,13/32,25.33%,ARSB;GAA;LRRK2;CLVS2;HPS4;HPS1;HOOK2;TPP1;ACP3;SNAPIN;CLN3;LAMTOR1;MTOR
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.39627149546985374,-0.9228420599360521,0.5688073394495413,0.9075824416974791,1.0,4/13,17.98%,RHOQ;LRRK2;RAB23;ENTPD7
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.32737618084200365,-0.922741133039138,0.5699208443271768,0.9055447212321893,1.0,16/29,34.30%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;CENPK;CENPH;RBBP4;KNL1;CENPX;CENPA;CENPQ;NASP;CENPC;CENPW
prerank,CENP-A containing chromatin organization (GO:0061641),-0.32737618084200365,-0.922741133039138,0.5699208443271768,0.9055447212321893,1.0,16/29,34.30%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;CENPK;CENPH;RBBP4;KNL1;CENPX;CENPA;CENPQ;NASP;CENPC;CENPW
prerank,positive regulation of growth (GO:0045927),0.33479082852449743,0.9223299301013227,0.5687943262411348,0.8450565822678483,1.0,11/64,8.41%,INSR;ADAM10;PPM1F;PLCB1;RPS6KA3;SDCBP;RPS6KA1;H3-3A;RPTOR;RFTN1;SFRP2
prerank,connective tissue development (GO:0061448),0.3688094931899485,0.9219724452609023,0.5839874411302983,0.8452748746167348,1.0,6/35,6.06%,SPTLC2;ZBTB16;LRP5;SOX9;XBP1;SNORC
prerank,regulation of mononuclear cell migration (GO:0071675),0.39149592912155406,0.9219347683313432,0.5433715220949263,0.844847397372761,1.0,5/23,9.40%,LYN;STK10;MSN;PTK2;CSF1
prerank,regulation of ion transport (GO:0043269),-0.26568373521938776,-0.9218553129762608,0.6126482213438735,0.9066559048740409,1.0,32/76,26.46%,PRKN;SYT1;P2RX4;NKAIN4;ANK3;NKAIN2;SYT9;SYT11;SYT12;SNX6;KCNJ2;KCNJ13;WNK1;DTNBP1;KCNJ10;SNCA;KCNJ8;KCNJ15;SYT3;KCNJ6;NKAIN3;CLDN10;SYT2;VAMP2;SYT6;SPTBN4;STC1;KCNA2;WWP2;SYT5;CHRM1;TOR1A
prerank,positive regulation of gene expression (GO:0010628),0.27619608598692647,0.9218245422323894,0.670514165792235,0.8446129726787276,1.0,53/442,9.80%,LEF1;NOS3;RAB27A;CADM1;APP;TENT4A;MEF2C;IL15;ERN1;CLDN5;OCLN;SMAD1;PDGFB;GATA2;PDE2A;STAT3;MSN;HIF1A;NOTCH1;PPM1F;PLCG2;CD34;FGF23;SOX9;RBM20;DLL4;MAPK8;SERPINB9;RAMP2;WNT5A;TNRC6C;RPS7;BCL3;IL36G;DYRK1A;KRAS;TAF1B;POLR1A;TGFB1;NOS1AP;AGPAT1;PIK3CG;NIBAN1;HNRNPD;PSEN1;CITED1;SMARCA5;RPL23;MYBBP1A;CSF1;SOX4;MAPK11;HNRNPLL
prerank,chloride transmembrane transport (GO:1902476),-0.2877086806046163,-0.9214553131220579,0.616519174041298,0.9064765394533638,1.0,19/48,21.94%,SLC1A3;SLC12A2;SLC6A1;ANO1;GLRB;GABRG2;ANO4;GABRA2;GABRB1;ANO3;GABRG3;GABRB3;SLC1A1;CFTR;SLC4A8;CLCN1;GABRA1;GABRA5;SLC12A8
prerank,regulation of RNA metabolic process (GO:0051252),0.34064851015698344,0.9211143038074071,0.577304964539007,0.8455860331845974,1.0,14/59,11.62%,NOVA2;TNFRSF1B;IGF2BP3;PTBP3;RBM20;MBNL1;MBNL2;HNRNPF;MBNL3;RASA1;ZNF326;HNRNPLL;RC3H1;OASL
prerank,positive regulation of mRNA processing (GO:0050685),-0.3401221667551253,-0.921057919097691,0.5979381443298969,0.9064246640694544,1.0,5/21,9.93%,CELF4;DAZAP1;PAF1;LEO1;CIRBP
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.4168398432734045,-0.9208502869590297,0.5663716814159292,0.9058193113017324,1.0,2/10,5.09%,DNMT3A;IGF2
prerank,protein polyglutamylation (GO:0018095),0.4489205758945781,0.9207576251326098,0.5649819494584838,0.8458226708741639,1.0,5/11,21.08%,CEP41;TTLL7;TTLL5;TPGS1;TTLL9
prerank,positive regulation of neuron differentiation (GO:0045666),0.36030180117177685,0.9207389502561909,0.5550660792951542,0.8453581765781087,1.0,6/40,8.35%,MEF2C;ARHGEF2;TCF4;TCF3;BRINP2;NEUROD1
prerank,response to nutrient levels (GO:0031667),0.4105420749777682,0.9207270324390932,0.5570093457943925,0.8448855806720655,1.0,3/17,8.25%,KCNB1;ULK1;RPTOR
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.3523714089179072,-0.9206122211352191,0.5781637717121588,0.905310779477839,1.0,7/22,23.03%,NFATC2;DUSP10;BCL6;RUNX1;MDK;LAG3;FANCA
prerank,peptidyl-lysine methylation (GO:0018022),-0.3346987124215014,-0.9204976647281579,0.6005025125628141,0.9044831278385974,1.0,11/26,30.05%,KMT5A;EHMT2;SETD4;VCPKMT;EEF1AKMT1;METTL21A;ANTKMT;EEF2KMT;EEF1AKMT3;SETD7;METTL18
prerank,action potential (GO:0001508),0.33947272180932353,0.9201537958253171,0.562406015037594,0.8455419842844097,1.0,5/44,7.12%,GNAQ;KCNQ1;KCNB1;KCNMB4;KCNE2
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.3689887623021648,0.9201180318092533,0.5612903225806452,0.8451210419442293,1.0,2/32,1.86%,CAV1;PLCG1
prerank,cognition (GO:0050890),0.35448487976320875,0.9199091998361197,0.5682819383259912,0.8450403327481627,1.0,5/42,5.93%,APP;SHROOM4;CHD7;DOP1B;CHMP2B
prerank,midbody abscission (GO:0061952),0.41602844125795685,0.9192875294703639,0.5728987993138936,0.845807028172205,1.0,3/17,8.75%,CHMP2B;CHMP4A;CHMP4B
prerank,Rho protein signal transduction (GO:0007266),0.3375037468199448,0.9192290606579683,0.5640287769784172,0.845435323648513,1.0,7/53,4.23%,NTN1;EPS8;ARHGEF3;CELSR1;ADGRG1;RHOJ;PLEKHG5
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.41120470533573583,-0.918953127192835,0.5836909871244635,0.9072264724218277,1.0,4/10,30.05%,KMT5A;SETD4;SETD7;METTL18
prerank,transport along microtubule (GO:0010970),-0.39526577252411543,-0.9185444008592432,0.5782312925170068,0.9071561170377324,1.0,6/13,10.90%,ARHGAP21;APBA1;CLIP3;COPG1;DYNC1I1;SPG11
prerank,cytoplasmic translational initiation (GO:0002183),-0.3650976904785017,-0.9184081979956392,0.5775656324582339,0.9063950933207523,1.0,9/17,30.60%,EIF4A1;EIF2S2;RBM4;EIF3A;EIF2D;EIF4G1;EIF2B3;EIF4A2;EIF4B
prerank,modulation of chemical synaptic transmission (GO:0050804),0.31202122487527956,0.9182102459900353,0.6070528967254408,0.8470164326851807,1.0,15/107,8.39%,MCTP1;APP;MEF2C;DGKZ;BCR;BTBD9;CDH2;SYN3;CACNA1A;KCNMB4;CX3CR1;OPHN1;CLSTN1;SNCAIP;PXK
prerank,DNA conformation change (GO:0071103),0.41364871243888834,0.9180296253115124,0.5506003430531733,0.8468566800755893,1.0,4/17,15.37%,HHEX;HAT1;TOP1;KAT6A
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.3675845198706676,0.9180254007914816,0.5759493670886076,0.8463706640108785,1.0,6/31,16.11%,GCH1;GPHN;MOCOS;SRD5A2;SRD5A1;STAR
prerank,histone monoubiquitination (GO:0010390),-0.3336651179382484,-0.9179192998072777,0.5729442970822282,0.9064964745981534,1.0,10/24,23.33%,BCOR;CTR9;PAF1;LEO1;DDB2;RING1;ATXN7L3;DDB1;PCGF1;RNF20
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.3237056753339991,0.9175708267851718,0.613540197461213,0.8467546269764209,1.0,25/67,25.64%,B2M;IKBKB;TAP2;PSMA2;SNAP23;IKBKG;PSMA8;FCGR1A;PSMA6;VAMP8;PSME1;PSMA4;PSMF1;SEC22B;PSMB1;PSMB7;PSMD2;PSMA5;TAP1;CYBA;PSMC3;VAMP3;PSMD3;PSMA3;TAPBP
prerank,regulation of cholesterol esterification (GO:0010872),-0.4197465607736094,-0.9173613773312468,0.5695067264573991,0.9066755416574788,1.0,4/10,23.94%,AGTR1;APOE;ABCA2;LAMTOR1
prerank,histone H2A monoubiquitination (GO:0035518),-0.3580715989280053,-0.9172410715470808,0.5560975609756098,0.9058711852524022,1.0,7/17,21.52%,BCOR;PCGF2;DDB2;RING1;DDB1;PCGF6;PCGF1
prerank,neuromuscular synaptic transmission (GO:0007274),-0.35509594532820105,-0.9163470267501274,0.5915492957746479,0.9069735041854506,1.0,8/18,30.36%,DTNA;KIF1B;FCHSD2;TBC1D24;STAC3;TSPOAP1;SLC5A7;CHRNB2
prerank,positive regulation of cation channel activity (GO:2001259),0.35598492788358577,0.9161063777796855,0.573170731707317,0.8491768398012284,1.0,2/40,4.05%,SHANK3;TMSB4X
prerank,cellular response to radiation (GO:0071478),0.36093554417987095,0.91560818512913,0.5911764705882353,0.849645249040459,1.0,7/40,17.46%,NET1;OPN4;HUS1;OPN5;RHOB;SPIDR;GRB2
prerank,positive regulation of protein maturation (GO:1903319),0.4544727336611697,0.9155689923635589,0.5839285714285715,0.8492262086842518,1.0,3/11,9.43%,NKD2;RHBDD1;SOX4
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.3513285975183591,-0.915280335643379,0.5678391959798995,0.9085068657978193,1.0,1/20,0.34%,IGF1
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.4116240547321112,0.9144663358859699,0.5580985915492958,0.8508685348307159,1.0,3/18,6.07%,CAV1;NEDD4L;SLC43A2
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3436373086108362,0.914246074938296,0.56752655538695,0.8507960210656366,1.0,11/52,14.98%,PPP1R13B;FBXW7;CASP8;MAPK8;SH3GLB1;UBE2D3;SFN;SAE1;BID;YWHAQ;ARIH2
prerank,regulation of protein localization to cell periphery (GO:1904375),0.4101842938044703,0.9140696729177898,0.5866209262435678,0.8506556289533364,1.0,4/18,11.54%,SPTBN1;STX7;VAMP8;STX8
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.4617205337620496,0.9140459037785389,0.5754189944134078,0.8501990370153917,1.0,5/10,22.17%,CDT1;ATRX;E2F7;DBF4;STOML2
prerank,regulation of cellular protein catabolic process (GO:1903362),0.409530289727257,0.9132209003885957,0.5778894472361809,0.8512871785094429,1.0,3/18,4.89%,DAB2IP;MSN;VGLL4
prerank,positive regulation of viral genome replication (GO:0045070),0.37813989829951744,0.913009065248829,0.5801886792452831,0.851192586435511,1.0,6/29,13.14%,NR5A2;ADARB1;PKN2;RAD23A;ADAR;CNOT7
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.36277254688742133,0.9127474965329544,0.5859969558599696,0.8512184426287874,1.0,7/37,8.25%,APP;PARD3;DDIT4;SMAD7;INPP5K;TGFB1;RPTOR
prerank,negative regulation of viral genome replication (GO:0045071),0.35456409860540966,0.9127396394989165,0.5898203592814372,0.8507369434711564,1.0,12/40,19.14%,ISG20;N4BP1;INPP5K;TASOR;TNIP1;OASL;IFIH1;IFITM3;PLSCR1;EIF2AK2;BST2;IFITM1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.34278073260658803,0.9121560610017634,0.5911680911680912,0.8514140593049808,1.0,11/51,10.35%,BMPR2;SMAD1;SMURF1;NOTCH1;ACVR2A;SMAD7;GREM1;SOST;SMAD5;SKIL;UBE2D3
prerank,regulation of establishment of planar polarity (GO:0090175),0.3129330313058469,0.9117246110925605,0.6335149863760218,0.8517879330140024,1.0,13/88,12.83%,SMURF1;CELSR1;FZD6;FZD4;AP2B1;WNT5A;RAC1;AP2A1;PSMA2;PSMA8;PSMA6;PRICKLE1;VANGL2
prerank,regulation of protein catabolic process (GO:0042176),0.31311368396860473,0.9111648928034259,0.6164736164736164,0.8524057579023943,1.0,19/99,15.74%,FOXO1;SMURF1;DAB2IP;NEDD4L;PLK2;WNT5A;CDKN1B;SNX3;NEDD4;VPS28;MAD2L2;RAB26;RILP;RAB7A;ASB11;APC;IRAK3;PRKCG;AREL1
prerank,hexose metabolic process (GO:0019318),0.3526569158503157,0.9106469831625765,0.610248447204969,0.8529570857122217,1.0,7/39,14.35%,PPARD;FUCA2;FBP1;SORD;OMA1;PMM2;GALM
prerank,negative regulation of catalytic activity (GO:0043086),0.3926268384580993,0.9104680556944742,0.6061093247588425,0.8527870360355507,1.0,3/24,7.46%,NOTCH1;PPP1R12A;NOSIP
prerank,spindle assembly (GO:0051225),0.3194432348104395,0.9102724112971949,0.6110344827586207,0.852647602175288,1.0,20/67,23.21%,NEK7;RAB11A;STARD9;NEK6;STAG2;STAG1;LSM14A;RHOA;CHEK2;ABRAXAS2;WRAP73;MZT1;NUMA1;BCCIP;RPS3;KPNB1;PIBF1;SAC3D1;KIF2A;CLASP2
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.332675746817914,-0.9101342567933826,0.5738916256157636,0.9200255308230888,1.0,6/24,13.29%,DMD;JPH1;AKAP6;PRKACA;GSTM2;JPH2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.3954843704673498,0.9098878826326593,0.5811965811965812,0.8528889552096782,1.0,4/21,5.49%,TOX;DISC1;DLL4;CX3CR1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.33599067314610986,-0.9098683118188223,0.5879265091863517,0.9196094588467563,1.0,9/22,22.74%,DDX5;PLA2R1;SPRED1;SPRED3;SPRED2;CHD5;CDK5RAP3;ATR;MSX1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.30666523671530344,0.9096012071230436,0.6134020618556701,0.8529610951107416,1.0,22/104,14.60%,BMPR2;CAV1;SMAD1;SMURF1;NOTCH1;FKBP1A;ACVR2A;SMAD7;GREM1;ACVR1;SOST;SNX25;TGFB1;SMAD5;SKIL;UBE2D3;TGFBR2;PMEPA1;ADAM17;FAM89B;ACVR2B;BCL9L
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.43196932524804477,0.909085405407027,0.5795246800731262,0.8534892531931064,1.0,4/11,13.17%,DCTD;TPK1;NT5C3A;SLC19A3
prerank,protein localization to vacuole (GO:0072665),0.42743395448067484,0.9083113750950541,0.5658119658119658,0.8545133069091593,1.0,3/13,11.45%,SH3BP4;SH3GLB1;GLMP
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.38738896689894925,0.907763689741841,0.5901116427432217,0.8550872765097132,1.0,7/24,14.70%,LPCAT3;AQP11;TMBIM6;XBP1;BCL2L1;RACK1;UBXN1
prerank,anterior/posterior axis specification (GO:0009948),-0.37072231124586785,-0.9074600762932356,0.5870069605568445,0.9241370139379899,1.0,1/15,0.48%,WLS
prerank,positive regulation of lipid metabolic process (GO:0045834),0.3928842556756106,0.9072102207998347,0.5905383360522023,0.8557012045086961,1.0,3/22,8.69%,PPARD;SORBS1;CREB1
prerank,metallo-sulfur cluster assembly (GO:0031163),0.391803041074023,0.9070737018311592,0.5662847790507365,0.8554685529038175,1.0,10/22,24.88%,ABCB7;MMS19;NUBP1;NUBP2;HSCB;LYRM4;FXN;NUBPL;CIAO2B;CIAPIN1
prerank,lysine metabolic process (GO:0006553),-0.3934212904121464,-0.9063748909548347,0.5803571428571429,0.9245802272088619,1.0,8/12,40.80%,ALDH7A1;PHYKPL;GCDH;AASS;SLC25A21;HYKK;CRYM;AADAT
prerank,lysine catabolic process (GO:0006554),-0.3934212904121464,-0.9063748909548347,0.5803571428571429,0.9245802272088619,1.0,8/12,40.80%,ALDH7A1;PHYKPL;GCDH;AASS;SLC25A21;HYKK;CRYM;AADAT
prerank,regulation of protein kinase activity (GO:0045859),0.30500429120155514,0.9058856510526009,0.6181353767560664,0.8573835432402593,1.0,21/106,13.02%,GNAQ;IQGAP1;PTK2B;PPM1F;WWTR1;PAK2;CEACAM1;RAPGEF2;TRIB3;INPP5K;PTK2;RAP1A;CSF1;MAP2K3;SFN;GAS6;RB1;GSKIP;WARS1;GSTP1;TRIB1
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.34217446297664905,-0.9056771740564803,0.59846547314578,0.9252200497714335,1.0,7/22,17.93%,NOTCH2;FGFR2;STXBP4;CASK;FGF7;FGF10;MDK
prerank,hepaticobiliary system development (GO:0061008),-0.3371226076615682,-0.9052540611951101,0.6025316455696202,0.9252016861600382,1.0,4/20,5.87%,TGFBR3;WNT4;COBL;NF1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.4006345437214609,-0.9050862710089576,0.5726495726495726,0.9245253182036028,1.0,4/11,8.83%,RSPO3;PLEKHA4;DAB2;SFRP1
prerank,nucleus organization (GO:0006997),0.341781107773044,0.9049654826983506,0.5944767441860465,0.8586971531492963,1.0,11/47,14.28%,RPS19;CHMP2B;SYNE1;CHMP4A;CHMP4B;NUP98;PITPNB;NUP205;NUP133;SPAG4;NUP54
prerank,protein deubiquitination (GO:0016579),0.2813077879275646,0.9047332699961425,0.7047511312217195,0.8586809359703425,1.0,72/242,23.27%,ESR1;SMAD1;HIF1A;NFKBIA;MINDY1;USP3;BABAM2;MINDY2;SMAD7;USP15;UCHL5;ATXN3;SNX3;PSMA2;BRCC3;FOXK1;ZRANB1;TNIP1;IKBKG;PSMA8;RAD23A;PSMA6;OTUD4;ASXL1;ENY2;RIPK1;BIRC3;IFIH1;TRAF6;YY1;APC;MBD5;PSME1;KAT2B;USP12;OTULIN;RHOA;ACTR5;ABRAXAS2;BIRC2;NEDD8;RHOT1;YOD1;WDR48;NFRKB;WDR20;PSMA4;USP8;DESI2;USP7;PSMF1;SMAD2;STAM;USP25;USP21;NLRP3;PSMB1;TADA2B;PSMB7;TRRAP;PSMD2;ATXN7;TNIP2;PSMA5;EIF3F;TRAF2;CCNA2;BABAM1;JOSD1;STAM2;UCHL3;PSMC3
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.42496785261520764,0.9033595505312282,0.5692599620493358,0.8608374243758772,1.0,3/13,12.80%,NCK1;PTPN1;RACK1
prerank,glucose metabolic process (GO:0006006),-0.26971938344051233,-0.9031511968084812,0.6586206896551724,0.9280563627367444,1.0,20/58,21.06%,RBP4;PPARGC1A;APOD;SLC39A14;PER2;ENO2;GAA;SLC25A12;GOT1;TPI1;IRS2;SLC25A13;G6PC3;ENO3;PFKFB1;MDH1;CRY1;PCK2;BRAT1;ALDOA
prerank,regulation of microtubule polymerization (GO:0031113),0.3467123087664694,0.9030767030925304,0.610062893081761,0.8608689347222108,1.0,12/40,20.27%,OCLN;RAC1;DYRK1A;CAMSAP2;PRUNE1;MET;CDH5;PAK1;CDK5RAP2;NUMA1;CLIP1;RPS3
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.3555733838517723,-0.9029451497422314,0.5784313725490197,0.9274592889609732,1.0,3/18,4.53%,ROCK2;SLC2A13;LRRTM3
prerank,heterotypic cell-cell adhesion (GO:0034113),0.3853778895719387,0.9028555378881901,0.5971563981042654,0.8608170793319805,1.0,5/25,11.65%,VCAM1;CD200;ITGA5;IZUMO1;ITGB3
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.35830532091854855,0.9028482486354221,0.6038034865293186,0.8603392191124767,1.0,10/39,18.19%,SOCS2;PIK3C2A;CISH;ITPKB;PIK3CG;SLA2;SOCS4;SOCS6;EFR3B;PIK3C2B
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.3625026605647499,0.9026283789565517,0.5921875,0.8602949648662086,1.0,7/32,20.81%,NEK7;HMBOX1;ACD;CTNNB1;CCT7;MAP2K7;CCT2
prerank,regulation of establishment of protein localization (GO:0070201),0.4282457838992817,0.9021417613657932,0.5772058823529411,0.860796896834086,1.0,6/13,21.54%,DNAJA1;GAPVD1;CEP290;CEP295;SPIDR;CEP120
prerank,regulation of organelle assembly (GO:1902115),0.3219371490974238,0.9020730749615012,0.624484181568088,0.8604313235368389,1.0,13/72,14.08%,TBC1D8;MSN;TBC1D22A;TBC1D15;PLK2;TBC1D12;TBC1D2;RNF4;NPRL2;TBC1D5;RAB5A;EVI5;NPM1
prerank,smooth muscle tissue development (GO:0048745),0.442237980935211,0.902039456950129,0.5632582322357019,0.8600131834877761,1.0,1/10,0.85%,ENG
prerank,pulmonary valve morphogenesis (GO:0003184),0.4010744262538524,0.9018450139006712,0.5802047781569966,0.8599072355654491,1.0,3/17,2.79%,NOS3;NFATC1;NOTCH1
prerank,regulation of defense response to virus (GO:0050688),-0.3738611161119,-0.9018291921162104,0.5945945945945946,0.9290167705176924,1.0,8/14,28.37%,PCBP2;ITCH;TRAF3IP1;PPM1B;C1QBP;RNF26;IFNLR1;DHX9
prerank,endoplasmic reticulum organization (GO:0007029),0.3184107732746089,0.9014801614460702,0.6168091168091168,0.8601045241032831,1.0,13/72,16.00%,APP;REEP1;LPCAT3;CAV2;DOP1B;STX1A;TRAM1;TRAM1L1;RNF112;ATL1;ALDH3A2;RAB18;MOSPD3
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.3889304508508736,0.9008651637279459,0.5865546218487395,0.8608569805789131,1.0,5/20,14.61%,HHEX;CDKN1B;TFAP4;INCA1;APC
prerank,ERBB2 signaling pathway (GO:0038128),-0.3090775476154901,-0.9007853813454353,0.5994623655913979,0.9304644660696298,1.0,6/31,9.13%,EGFR;ERBB4;HSP90AA1;SHC1;PRKCA;SRC
prerank,maintenance of protein location in nucleus (GO:0051457),0.3984700649423376,0.9003256749198296,0.6058631921824105,0.8614397714720163,1.0,4/20,14.43%,BCL3;SYNE1;TAF3;TOPORS
prerank,release of cytochrome c from mitochondria (GO:0001836),0.4015800064184477,0.8996480746494728,0.5931623931623932,0.8622500444078709,1.0,6/17,13.86%,BOK;BCL2L1;GGCT;SFN;BID;SOD2
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.4460100961852228,0.8995557430760096,0.5927272727272728,0.8619361062241444,1.0,3/11,14.88%,H3-3A;HAT1;ATRX
prerank,TOR signaling (GO:0031929),0.380629006578741,0.8991490037016252,0.6062602965403624,0.8622126346772284,1.0,8/26,19.00%,CCDC88A;PRR5L;RPTOR;RICTOR;EIF4EBP1;RPS6;TIPRL;SYAP1
prerank,excitatory postsynaptic potential (GO:0060079),0.4071495101107271,0.8990898317808548,0.5902192242833052,0.8618193606682868,1.0,1/19,1.15%,MEF2C
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.3992711764444627,-0.8990319780867503,0.609375,0.9336100305657901,1.0,4/12,8.09%,CBLB;F3;APOD;IFT20
prerank,regulation of peptide hormone secretion (GO:0090276),0.31852931228502657,0.8987454134266254,0.5955983493810179,0.8620057874657858,1.0,10/67,8.35%,SLC2A1;CACNA1E;CHD7;KCNB1;CACNA1A;PPP3CB;STX1A;RAP1A;ITPR3;NEUROD1
prerank,melanocyte differentiation (GO:0030318),-0.3881748260768222,-0.898636544896584,0.5964912280701754,0.933436722540973,1.0,4/11,8.39%,ENPP1;MITF;KIT;USP13
prerank,carbohydrate transport (GO:0008643),0.44026795347678604,0.8983701883214412,0.5992578849721707,0.8622075675905817,1.0,1/11,3.32%,AQP11
prerank,negative regulation of ion transport (GO:0043271),-0.3337121909561696,-0.8982220333164201,0.6208651399491094,0.9333030467088456,1.0,8/24,14.80%,ACTN2;GPM6B;WNK4;SYT11;ADRA2A;WNK1;WNK3;SNCA
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.4282121064706044,0.8982067468996967,0.5846702317290553,0.8620333614919059,1.0,4/12,8.89%,B3GNT3;B3GNT4;B3GNT6;B4GAT1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.36166597616847307,-0.8978440798539046,0.6094527363184079,0.9330499999023222,1.0,6/16,20.98%,AMPD3;LHPP;ATIC;PAICS;PFAS;ADSS1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.4356113549864132,0.8977311956362505,0.5769911504424778,0.8624663216330636,1.0,6/11,30.59%,CYCS;UQCRQ;UQCRC1;UQCC3;UQCRC2;UQCR11
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.35947396777092055,-0.8976287636133585,0.58,0.9324563029564561,1.0,4/16,8.37%,RANBP3L;IGFBP3;BOC;RIPOR2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.4221794269642359,0.897623686465692,0.6007130124777184,0.862175025514527,1.0,5/14,22.31%,TSEN34;RTCB;TSEN2;CPSF1;RTRAF
prerank,cellular biogenic amine metabolic process (GO:0006576),0.44187409492353225,0.8972275821921821,0.5992647058823529,0.8624861575012582,1.0,1/12,1.04%,MAOA
prerank,iron ion homeostasis (GO:0055072),0.3305554746060351,0.8970408929913433,0.6090775988286969,0.8623784536082569,1.0,12/58,17.07%,ABCG2;B2M;ABCB7;LCN2;GLRX3;CUL1;PICALM;CP;HMOX2;FRRS1;NUBP1;NEDD8
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.34807850733675433,0.8969413031830674,0.5963020030816641,0.8620721906679566,1.0,14/39,20.04%,PTPN12;DAB2IP;PTPRJ;TGFA;ARHGEF7;CBL;LGMN;ERBB2;GRB2;SH3GL2;STAM;BTC;TSG101;EPS15
prerank,regulation of endocytic recycling (GO:2001135),-0.40345413020792853,-0.8960994265271093,0.6061269146608315,0.9350260819640364,1.0,4/11,13.78%,ACTN2;ATP9A;EHD1;ARHGAP1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.3968133033250826,0.8960844059996658,0.5947281713344317,0.8632826714388925,1.0,4/21,10.58%,JAK3;TIGIT;SAMSN1;LST1
prerank,T cell differentiation (GO:0030217),0.342422253864689,0.8954991969254681,0.5924242424242424,0.8639423009056523,1.0,9/40,14.46%,LFNG;SOX13;CHD7;DLL4;LCK;SOX4;JAG2;ADAM17;ZFP36L1
prerank,macrophage migration (GO:1905517),-0.3760693960331919,-0.8947981047918128,0.6087962962962963,0.9370574028218827,1.0,6/13,35.44%,P2RX4;TAFA4;CCR2;CCL2;CXCL17;CCL5
prerank,cellular defense response (GO:0006968),-0.2914705685763124,-0.8944187595991964,0.6288951841359773,0.936839001549906,1.0,7/40,14.14%,DCDC2;CCR9;LBP;LSP1;ADORA2A;RAB23;IL1RL2
prerank,protein homooligomerization (GO:0051260),0.2987930677828341,0.8937981016755294,0.6481958762886598,0.8667561592977411,1.0,27/114,19.72%,EHD4;B2M;GBP5;SAMHD1;ACACB;AQP11;GLS;ALOX5AP;MLKL;PKD2;HPRT1;RNF112;EHD3;SIGMAR1;ATL1;SOD2;G3BP2;PNPT1;TIFA;APIP;CBR4;CARD9;FUS;GLRA3;OSBPL2;ALDH1A3;BCL10
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.4423328889429624,0.8937526722206057,0.5722120658135283,0.8663498884539583,1.0,2/11,7.25%,ALG10B;NOS1AP
prerank,phosphate ion transmembrane transport (GO:0035435),0.43112915580500727,0.893565378477963,0.5657657657657658,0.8662391737693043,1.0,4/12,12.82%,SLC37A3;SLC25A30;SLC37A1;XPR1
prerank,mucosal immune response (GO:0002385),0.4097172251922191,0.8934883459711985,0.5884476534296029,0.865898468036194,1.0,2/15,9.58%,RPL39;DEFA6
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.3290340216543579,-0.8933148833018093,0.6403061224489796,0.9383160441028189,1.0,4/26,9.01%,IGF1;FHL2;AKAP6;EFHB
prerank,regulation of mitochondrial fission (GO:0090140),-0.32585852173072766,-0.8930990802252688,0.6088082901554405,0.9376818124786988,1.0,6/24,10.83%,DCN;PRKN;SPIRE1;MCU;LRRK2;DDHD1
prerank,signal transduction in response to DNA damage (GO:0042770),0.34577271542501936,0.8928438363074218,0.6223479490806223,0.866636170709345,1.0,14/49,20.52%,ACER2;BCL3;BRIP1;MAD2L2;HUS1;BID;MAP3K20;ATRX;E2F7;CHEK2;GRB2;TIPRL;MYO6;RAD17
prerank,positive regulation of proteolysis (GO:0045862),0.3337779905216568,0.8926165727080146,0.6285714285714286,0.8666110098508107,1.0,4/55,3.61%,CTSC;TNFRSF1B;NKD2;CASP8
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.37376194831587817,0.8925753069514618,0.6199376947040498,0.8662006254994129,1.0,6/29,11.69%,SMAD1;DROSHA;DICER1;PUM1;ADAR;PUM2
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.41648907647845324,-0.8925121529543149,0.6029723991507431,0.9379770884093535,1.0,1/10,1.37%,APPL2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.4399247863001214,0.8924856814342427,0.5927272727272728,0.8654008125590722,1.0,3/11,16.72%,FKBP1A;PKD2;CALM1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.4399247863001214,0.8924856814342427,0.5927272727272728,0.8654008125590722,1.0,3/11,16.72%,FKBP1A;PKD2;CALM1
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.41359035930181065,0.8922843823196467,0.6035087719298246,0.8653118108962152,1.0,2/15,2.22%,IL6ST;EDN1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.3337013409138974,0.8920275706526305,0.6354319180087847,0.865296943363965,1.0,15/51,24.52%,NEK7;HMBOX1;PINX1;DCP2;ACD;HNRNPC;TERF1;CTNNB1;CCT7;MAP2K7;CCT2;TEN1;SMG6;TENT4B;TNKS
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.38002383388039457,0.8919131080608849,0.5924092409240924,0.8650358466615637,1.0,3/23,4.92%,PTK2B;NOTCH1;GHR
prerank,proteasomal protein catabolic process (GO:0010498),0.2812163048510848,0.8919077823606845,0.7056778679026651,0.8645573334832467,1.0,56/201,21.42%,SMURF1;NEDD4L;FBXW7;ZNRF1;KCTD10;PELI1;ARRB1;ATXN3;UBE2G1;NEDD4;PSMA2;ARMC8;RNF139;RHBDD1;SPOPL;RNF4;PSMA8;RAD23A;ZFAND2B;SIAH1;PSMA6;UBE2D3;COP1;DDI1;UBE2K;TOPORS;UBXN1;SOCS6;PSME1;AREL1;RNF5;DDIT3;UBE3D;MAEA;CRBN;DDI2;CTNNB1;BIRC2;NHLRC1;CUL3;PSMA4;CDC34;PSMF1;DNAJB12;ZFAND2A;APPBP2;PSMB1;KCTD2;CCDC47;TRIM71;PSMB7;KCTD5;PSMD2;HACE1;SEL1L;UBXN2A
prerank,response to organophosphorus (GO:0046683),-0.3640397881313479,-0.8918087733200235,0.6062176165803109,0.9385820731839712,1.0,3/16,5.67%,P2RX4;ABCC9;TRPC3
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.40365769178322286,-0.89148944900363,0.6258205689277899,0.9382275184098536,1.0,3/10,2.53%,PRKCB;VTN;GRB10
prerank,positive regulation of protein processing (GO:0010954),0.38951879028238984,0.8902467010688797,0.5882352941176471,0.8672408869777785,1.0,4/19,9.12%,MYH9;LPCAT3;NKD2;RHBDD1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3170090352660137,0.8900886262596857,0.625,0.8670595055715566,1.0,22/64,25.66%,MLLT3;CCNK;GTF2F2;NELFE;EAF1;ELOC;NELFCD;CTDP1;CDC73;GTF2H4;GTF2H1;POLR2L;CCNH;NELFB;RTF1;NELFA;POLR2J;ADRM1;IWS1;TCEA2;PCID2;GTF2H5
prerank,acyl-CoA metabolic process (GO:0006637),0.3555469076284787,0.8898517426994589,0.6123076923076923,0.8670094427396218,1.0,3/35,4.22%,HMGCS2;ACACB;GLYAT
prerank,positive regulation of cell division (GO:0051781),0.34826513134725756,0.8892776934005225,0.6011994002998501,0.8676063780514051,1.0,3/38,3.97%,PKP4;TAL1;PKN2
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.27880220104586345,-0.8886520188102874,0.6749226006191951,0.9439124585292528,1.0,12/46,20.95%,ZIC1;PRKCD;CDH1;SMAD3;CAMK1;MAVS;PIK3R2;TRIM28;UBR5;TP53;HDAC3;JUP
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.3272097000841159,0.888636729270483,0.6346967559943583,0.8683749071189436,1.0,9/59,6.62%,PRKD1;PRKD2;LMTK2;HIPK1;CDC42BPB;MAPK8;ULK1;ACVR1;DYRK1A
prerank,phagolysosome assembly (GO:0001845),0.43969595017954033,0.8884071950165139,0.604355716878403,0.8683359830416406,1.0,4/12,15.55%,ARL8B;RAB7A;RAB7B;SYT7
prerank,proteoglycan metabolic process (GO:0006029),0.3746995087518707,0.8882686482037612,0.6038647342995169,0.8681244427222676,1.0,2/26,0.68%,CSGALNACT1;BMPR2
prerank,dendrite morphogenesis (GO:0048813),0.35462130127185176,0.8880171221263318,0.6202143950995406,0.8680974816282202,1.0,3/35,3.44%,SHANK3;KLF7;TAOK2
prerank,transepithelial transport (GO:0070633),0.41465991956783166,0.8877862604887334,0.5940766550522648,0.8680552465284952,1.0,2/15,4.50%,ABCG2;BEST1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.3340169037389883,0.8874215818088921,0.6212765957446809,0.8683030874331398,1.0,8/54,7.73%,CAV1;NEDD4L;KCNQ1;GNB1;KCNMB4;KCNE2;NOS1AP;NEDD4
prerank,regulation of proteolysis (GO:0030162),-0.27782853915650396,-0.8873907005236445,0.6366559485530546,0.9458110683293302,1.0,11/48,13.61%,CYFIP2;OGT;ASPH;SERPINE2;CAMK2N1;BTRC;PLAT;FGFR4;CST3;ITCH;LTBP4
prerank,potassium ion export across plasma membrane (GO:0097623),0.42186152112350606,0.8869515936344501,0.5852372583479789,0.8687411516273067,1.0,2/13,7.12%,KCNQ1;KCNE2
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.39234009096966727,0.8865597597493332,0.6012861736334405,0.8689906826021601,1.0,2/19,5.02%,CSGALNACT1;EXTL3
prerank,acetyl-CoA metabolic process (GO:0006084),0.40671144627920985,0.8846445524213844,0.6030405405405406,0.87223814013793,1.0,2/15,3.00%,HMGCS2;ACACB
prerank,nucleic acid metabolic process (GO:0090304),-0.26552496316856766,-0.8844830708426992,0.7016949152542373,0.9515659650509594,1.0,24/69,23.96%,HNRNPH1;ENPP1;HNRNPA2B1;DUSP11;RECQL5;RBFOX2;PCBP2;NT5E;ATXN2;RAD50;POLR2B;HNRNPR;HNRNPU;HNRNPA1;POLR2K;KPNA2;GTF2F1;SETMAR;PDE12;DNA2;POLR2I;POLG;DNASE2;DNASE1L2
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.3282881078386358,-0.8842655760707637,0.6253101736972705,0.9509824542905732,1.0,6/22,16.06%,BMP7;BMP4;INHBA;CDKN1A;CDKN1C;PLEK
prerank,regulation of lipid metabolic process (GO:0019216),0.3022153905399907,0.8841270656253627,0.6596026490066225,0.8727577985058245,1.0,7/88,5.72%,CAV1;PPARD;PLPP1;FASN;ACACB;NCOA1;TGS1
prerank,megakaryocyte differentiation (GO:0030219),0.43734505814253943,0.8840048351816515,0.6120527306967984,0.872504256034531,1.0,2/11,9.32%,TAL1;ZFPM1
prerank,lysosome organization (GO:0007040),-0.29054058486125917,-0.8826432646694136,0.6379821958456974,0.9537832520420654,1.0,14/36,25.33%,ARSB;GAA;LRRK2;CLVS2;HPS4;HPS1;HOOK2;TPP1;ACP3;SNAPIN;CLN3;LAMTOR1;TMEM165;MTOR
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.28102787028130644,0.8826333271854164,0.6943793911007026,0.8746355799319261,1.0,30/186,10.49%,CAV1;NFATC1;DAB2IP;SOX13;FZD6;MLLT3;FZD4;TLE4;SOX17;WWTR1;NKD2;STK3;ZNRF3;SOX9;STK4;VGLL4;TCF7L2;GREM1;WNT5A;TMEM88;SOST;JADE1;CTNNBIP1;PSMA2;SFRP2;CITED1;PSMA8;PSMA6;MAD2L2;SCYL2
prerank,cellular zinc ion homeostasis (GO:0006882),0.3675314675670974,0.8825483176615686,0.6218905472636815,0.8743068516544783,1.0,2/26,7.29%,SLC39A8;LCK
prerank,SNARE complex assembly (GO:0035493),0.43219267411454976,0.8821983892051882,0.6057866184448463,0.8745050084695853,1.0,3/10,15.84%,VAMP4;VAMP8;STXBP6
prerank,regulation of calcium ion import (GO:0090279),0.38554847728543973,0.8821211526685564,0.6286644951140065,0.8741626706670512,1.0,3/21,7.67%,PDGFB;FYN;PKD2
prerank,photoreceptor cell development (GO:0042461),-0.3686855187912438,-0.8821079837380774,0.6247139588100686,0.9538238498215923,1.0,5/14,17.77%,AHI1;ARL3;VEGFA;MFSD2A;TULP1
prerank,copper ion transport (GO:0006825),0.4276565087534443,0.8819563502662926,0.5869158878504673,0.8739774991883412,1.0,2/11,10.44%,SLC31A1;ATP7B
prerank,response to peptide hormone (GO:0043434),-0.28976246503448894,-0.8818430573925651,0.6728971962616822,0.9533337030308515,1.0,9/43,10.00%,TGFBR3;ROCK2;IRS1;IGFBP5;OGT;ANXA1;GNAI1;SRC;SLC27A1
prerank,cellular response to hypoxia (GO:0071456),-0.2345730979579819,-0.8816841590149135,0.7536231884057971,0.9525748893029208,1.0,20/126,10.26%,CPEB1;BMP7;SLC8A3;CPEB2;SIRT2;NDNF;KCND2;PSME4;RORA;EGLN3;LMNA;P4HB;NPEPPS;MDM4;SFRP1;MDM2;HIPK2;VEGFA;RGCC;ARNT
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.4027178399174133,0.88151134125644,0.6104553119730185,0.8743286984987537,1.0,5/18,16.49%,MFHAS1;CTNNA1;POLR1A;ILRUN;CHP1
prerank,negative regulation of JUN kinase activity (GO:0043508),0.4374225373002281,0.881355558357901,0.6,0.8741360437887826,1.0,7/10,26.60%,DNAJA1;AIDA;GSTP1;HIPK3;DUSP19;PDCD4;MAPK8IP1
prerank,"wound healing, spreading of cells (GO:0044319)",0.37766235853133945,0.8811881972866642,0.6314935064935064,0.8739687170657141,1.0,5/24,7.81%,LCP1;ACVRL1;MRTFA;CEACAM1;ITGA5
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.36900334522930694,0.8810897942015948,0.6252072968490879,0.873688334380187,1.0,2/26,3.35%,PDE8A;FYN
prerank,autonomic nervous system development (GO:0048483),-0.3522295428878614,-0.8809857353452976,0.6277372262773723,0.9531514921503593,1.0,3/17,8.20%,NRP1;NF1;SEMA3A
prerank,homotypic cell-cell adhesion (GO:0034109),-0.28887268475707395,-0.8806966556965397,0.673972602739726,0.9527181080563766,1.0,6/39,8.44%,PLPP3;PDGFRA;MEGF11;GNAS;UBASH3B;MYL9
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.4304841402614257,0.8796779185331569,0.6131386861313869,0.8759005330532776,1.0,5/11,14.94%,FYN;ABCB7;COA8;ABCD1;SLC18A2
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.35060279338274664,-0.8794932255616034,0.6004672897196262,0.9543963111389362,1.0,7/15,24.62%,RYR2;SPCS3;RAB10;SPCS2;RAB3GAP1;SRPRB;SEC61A1
prerank,inner ear morphogenesis (GO:0042472),0.3869519799266578,0.8794060110409825,0.6356209150326797,0.8759167571728911,1.0,4/22,6.35%,TBX1;CHD7;SOX9;TMIE
prerank,positive regulation of sodium ion transport (GO:0010765),0.43077779008738676,0.879332986664585,0.5957066189624329,0.8755774859314595,1.0,1/12,1.77%,CNKSR3
prerank,mRNA catabolic process (GO:0006402),0.3329321623514177,0.8789499362745529,0.6227272727272727,0.8757994677577602,1.0,18/44,27.12%,ERN1;NANOS2;NUDT16;NBDY;DCP2;RC3H1;ZFP36;XRN2;PNPT1;DHX34;RNH1;RIDA;NBAS;LSM2;EXOSC4;METTL16;HSPA1B;TUT7
prerank,negative regulation of biosynthetic process (GO:0009890),0.3987944242940587,0.8785991376540453,0.5933098591549296,0.8759711427747243,1.0,6/16,14.94%,ABCB7;CEACAM1;COA8;ABCD1;GSTP1;SLC18A2
prerank,RNA modification (GO:0009451),0.32731613894198847,0.878332122850441,0.6287339971550497,0.876007072503166,1.0,17/54,27.24%,ADARB1;CDKAL1;RBM15;NSUN4;ADAR;HENMT1;DTWD2;TRMT6;PUS7L;JMJD6;THUMPD1;TRUB1;PUS7;NSUN6;AARS2;LCMT2;NSUN2
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.2784083175639602,-0.8782526764577223,0.6607669616519174,0.9562128465942521,1.0,15/46,27.00%,HK2;TOMM40;AIFM1;TIMM22;RALA;TIMM17B;GRPEL2;TSPO;TIMM8B;TIMM21;TIMM9;DNAJC15;TIMM10;GDAP1;PAM16
prerank,negative regulation of synaptic transmission (GO:0050805),-0.32800412744406265,-0.877965040890142,0.639686684073107,0.955810282530255,1.0,5/23,10.66%,ATAD1;SYT11;LRRK2;SLC24A2;PRRT1
prerank,polyamine metabolic process (GO:0006595),-0.37742230606786575,-0.8777195916723586,0.6132723112128147,0.955269921340282,1.0,4/13,12.73%,OAZ2;SMS;ODC1;SAT1
prerank,protein tetramerization (GO:0051262),0.30945278260251863,0.8773116785398959,0.6541666666666667,0.8775076615471497,1.0,5/67,3.41%,B2M;GBP5;SAMHD1;ACACB;GLS
prerank,vesicle transport along microtubule (GO:0047496),-0.3302837946888021,-0.8770813358174797,0.647196261682243,0.9556500387178546,1.0,8/23,18.57%,KIF3A;KIF1A;DYNC1I1;HTT;KIFAP3;TRAK1;KIF5A;DYNC1H1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3138389900053194,0.8769826202299539,0.65,0.8776461449370375,1.0,21/62,25.66%,MLLT3;CCNK;GTF2F2;NELFE;EAF1;ELOC;NELFCD;CTDP1;CDC73;GTF2H4;GTF2H1;POLR2L;CCNH;NELFB;RTF1;NELFA;POLR2J;ADRM1;IWS1;PCID2;GTF2H5
prerank,positive regulation of axonogenesis (GO:0050772),0.34324809071854645,0.8768327723930358,0.6457055214723927,0.8774539898495126,1.0,4/43,2.79%,PLXNA4;NTN1;SEMA7A;PLXND1
prerank,regulation of ERBB signaling pathway (GO:1901184),0.4021192597902114,0.8766499139469057,0.6160409556313993,0.8773015207878738,1.0,6/15,14.37%,PTPN12;MVB12B;CEACAM1;LGMN;RHBDF2;ERBB2
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.37673164942413806,0.8763246162310926,0.6278688524590164,0.8774230635333784,1.0,2/22,5.81%,TNFRSF1B;WNT5A
prerank,aminoglycan metabolic process (GO:0006022),-0.38850505463508866,-0.8761558264339796,0.6475770925110133,0.9567371773434666,1.0,6/10,29.36%,XYLT1;B4GALT7;B3GAT2;CHST9;B3GALT6;GAL3ST3
prerank,"transcription, DNA-templated (GO:0006351)",0.27383383320465543,0.8759480077905677,0.7152777777777778,0.8776494263054573,1.0,56/207,20.95%,PIR;MLLT3;RREB1;CCNK;XBP1;EPC1;GTF2F2;BCL3;PWP1;KLF13;TAF1B;NFKB1;GMEB2;GTF2E2;TRIP13;NELFE;TAF3;TAF4B;TRIM24;SMARCA5;COPS2;RNGTT;EAF1;MMS19;CEBPD;CBFB;TFB2M;RO60;SNAPC3;RNPS1;GTF2A2;BTF3;RNMT;PTMA;MEF2A;TOPORS;ELOC;NELFCD;CTDP1;MNT;CDC73;GTF3C1;GTF2H4;TAF1A;HIPK3;GTF2H1;POLR3A;NR4A2;POLR2L;TAF9;TAF7;CCNH;SETX;MRPL12;DEK;NELFB
prerank,nuclear export (GO:0051168),-0.25270905764538115,-0.8758217971599219,0.7434944237918215,0.9563833607760512,1.0,17/80,18.99%,RANBP3L;ATXN1;SRSF5;PKD1;DDX39B;SRSF2;STRADA;SRSF11;U2AF2;POM121;RAE1;NXF1;HNRNPA1;CCHCR1;SRSF3;PHAX;RANBP17
prerank,sterol biosynthetic process (GO:0016126),-0.2985604701864312,-0.875663738509915,0.6587926509186351,0.9556034406586676,1.0,13/33,22.31%,INSIG2;PRKAG2;HMGCS1;NSDHL;ACAT2;INSIG1;FDFT1;FDPS;MVK;LSS;DHCR24;CYP51A1;DHCR7
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3603134856439015,0.8754544763886373,0.6336477987421384,0.8781125702524596,1.0,6/30,10.72%,CAV1;NF2;SAMSN1;SFRP2;INPP5F;SEMA4D
prerank,oligodendrocyte differentiation (GO:0048709),0.3876326152418708,0.8754001721053651,0.6191275167785235,0.8777405507433432,1.0,4/19,8.98%,SOX13;SOX9;EIF2B5;PRDM8
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.37625502255407933,0.8753815598332866,0.6204724409448819,0.8772896317810222,1.0,4/23,7.19%,ENG;SMAD7;ITGA3;TGFB1
prerank,negative regulation of macroautophagy (GO:0016242),0.3618144730124724,0.8753223295735021,0.631578947368421,0.8769196318309291,1.0,6/26,8.75%,LZTS1;MTM1;QSOX1;FEZ2;CHMP4A;CHMP4B
prerank,diacylglycerol metabolic process (GO:0046339),0.3804952510456463,0.8749118795031419,0.6260032102728732,0.8772052099619335,1.0,9/23,15.91%,DGKZ;LIPE;DGKH;ANG;DGKE;MOGAT1;PNPLA2;DGAT1;MOGAT2
prerank,photoperiodism (GO:0009648),0.36578135052331706,0.874719355336474,0.6414790996784566,0.8770986278829035,1.0,5/28,14.25%,CRTC1;SIK1;OPN5;PDE6B;FBXL3
prerank,lymphocyte mediated immunity (GO:0002449),-0.38048994934527475,-0.8745872247047034,0.6300211416490487,0.9570122162836119,1.0,3/12,15.07%,CD55;JAG1;GNL1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.4355906363008827,0.8742347041440426,0.6143667296786389,0.8774860337715146,1.0,2/10,2.87%,PTPN12;PTPRJ
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.33636055097114725,0.8740239659122939,0.6341085271317829,0.8773782599182354,1.0,12/40,12.99%,B2M;INSR;HIP1;SELE;GREM1;ARRB1;HNRNPK;SCYL2;CBL;PICK1;TBC1D5;FMR1
prerank,ribosomal large subunit biogenesis (GO:0042273),0.3189542044138651,0.87369507459752,0.6575539568345323,0.8775377519697177,1.0,20/54,25.00%,RPF1;RSL24D1;RRS1;RPL14;EIF6;RPL6;NOP53;NOP16;RPL10;NPM1;RPL35A;MAK16;RPL11;RPL3;TRAF7;RPL7;MRPL1;RPL26;LAS1L;WDR74
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.34767107920392637,0.873560301686841,0.6482334869431644,0.8772962791168831,1.0,7/35,10.56%,FASN;HMGCS2;ALOX5AP;PAM;LTC4S;FAR2;SLC25A1
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.33746298817236475,0.8734254104355326,0.6466165413533834,0.8770850417565714,1.0,11/41,15.08%,HIF1A;SCARB2;NUP214;EIF6;NUP98;SLC2A6;NUP205;NUP133;NUP153;NUP54;NUP43
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.4030427826239537,0.8731157283209128,0.6335740072202166,0.8771683944651002,1.0,6/15,18.91%,DDIT4;SOS1;ZFYVE27;GRB2;FRS2;BCAR1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.36690094466923145,0.8731042406534392,0.6340288924558587,0.8767110466177045,1.0,5/27,14.25%,CRTC1;SIK1;OPN5;PDE6B;FBXL3
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.4058564943153097,0.8724265591275426,0.6117850953206239,0.8775166568401216,1.0,3/15,7.12%,KCNQ1;ATP1A1;KCNE2
prerank,negative regulation of lyase activity (GO:0051350),-0.34965257155655954,-0.8721689171271704,0.6311881188118812,0.9613898344615469,1.0,6/16,25.00%,ADGRV1;GRM3;PALM;GABBR2;CCR2;MTRR
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.32966714923569107,0.8718549507553175,0.6497093023255814,0.8781304528453922,1.0,13/52,13.14%,CNOT6;PAN3;CNOT6L;EDC3;CNOT1;EXOSC1;DCP2;RC3H1;CNOT2;LSM3;HBS1L;ZFP36;CNOT7
prerank,regulation of primary metabolic process (GO:0080090),-0.23378432548717876,-0.8716639815172891,0.8097560975609757,0.9614178158702423,1.0,36/126,21.16%,CHD9;ROCK2;PPARA;LDLR;PSAP;PSME4;SREBF1;HMGCS1;ACACA;C1QTNF2;OAZ2;SMARCD3;TNFAIP8L3;APOE;FGFR4;ODC1;IRS2;PSMD12;GPAM;SCD;AZIN1;FDFT1;CERS2;FDPS;MVK;ABCA7;CARM1;PSMC4;PRKAB2;PSMB6;LSS;NCOR1;ZFP69;ID2;HDAC3;CYP51A1
prerank,establishment of spindle orientation (GO:0051294),-0.30800329527102394,-0.8710704640404711,0.6540404040404041,0.9617017560588611,1.0,15/28,33.41%,GJA1;GPSM2;HTT;UBXN2B;LLGL2;NDC80;MISP;SPDL1;CENPA;CLASP1;DCTN1;FBXW11;INSC;ZW10;PKHD1
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.40092753274443366,0.870896535135222,0.6112084063047285,0.8795022930480177,1.0,4/15,14.46%,NR3C1;BCL2L11;ZFP36;ZFP36L1
prerank,epithelial cell development (GO:0002064),0.3789953206919298,0.8703589982903692,0.6293823038397329,0.8800178221824009,1.0,3/20,9.47%,EXPH5;SIPA1L3;SLC4A7
prerank,organelle transport along microtubule (GO:0072384),-0.3023667934148667,-0.8703556417771312,0.6692913385826772,0.9621904650864276,1.0,8/31,17.04%,BICD1;ARHGAP21;COPG1;DYNC1I1;HTT;BICD2;TRAK1;MAP1S
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.39193166155880105,-0.870308968046336,0.6543478260869565,0.9611977834588183,1.0,2/10,2.48%,OSR1;HECW2
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.39515561997231513,0.8701612893913138,0.6142857142857143,0.8798897328778763,1.0,1/15,2.47%,GBP5
prerank,positive regulation of glucose import (GO:0046326),0.37756653002921614,0.8700872932732834,0.6236749116607774,0.8795500352910774,1.0,4/21,8.71%,OCLN;INSR;SORBS1;AKT2
prerank,apoptotic cell clearance (GO:0043277),0.3493217736251203,0.8699818973412253,0.6233974358974359,0.8792628995877062,1.0,6/30,11.65%,TGM2;SCARB1;RAC1;RHOBTB1;GAS6;ITGB3
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.3511944995576398,0.8699405029612958,0.6442622950819672,0.8788585674517636,1.0,4/31,11.05%,LYN;PLA2G2D;LST1;RC3H1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.39703282502500925,-0.8698005415070545,0.6353467561521253,0.9612185370963818,1.0,1/11,1.77%,GRK3
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.41219937943927226,0.8692163313822365,0.631484794275492,0.8796995985141521,1.0,4/13,8.89%,B3GNT3;B3GNT4;B3GNT6;B4GAT1
prerank,mesenchyme development (GO:0060485),0.3981953676298819,0.869124741500199,0.5918003565062389,0.8793973905160807,1.0,4/15,8.41%,BMPR2;FOXF1;PKD2;SFRP2
prerank,regulation of receptor binding (GO:1900120),0.4407842848485975,0.8690449333574349,0.6273408239700374,0.8790852104791916,1.0,2/10,6.31%,B2M;ADAM15
prerank,fibrinolysis (GO:0042730),-0.37450595135777415,-0.8688718786519739,0.65,0.9622544657419432,1.0,4/13,26.95%,PLAT;SERPINE1;PLAU;HRG
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.282373882641683,-0.8687788876281309,0.6795252225519288,0.9613569262502537,1.0,11/44,16.15%,SH3RF1;THBS1;NGF;FNIP1;SIAH2;CD44;SRC;VEGFA;SNCA;USP47;MT3
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.3700216714836867,-0.8687568979504078,0.6308411214953271,0.9603051262334418,1.0,3/13,13.18%,ADGRV1;GRM3;PALM
prerank,regulation of ERAD pathway (GO:1904292),0.42904516077853094,0.8687391146819153,0.6223776223776224,0.879204063452621,1.0,4/11,18.88%,AQP11;ATXN3;UBXN1;USP25
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.3706365945298058,-0.8686778346803669,0.638095238095238,0.9594004113943447,1.0,3/13,10.93%,CYFIP2;ASPH;GRIN2A
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.303261247382883,-0.8682523756940457,0.6666666666666666,0.9592910537791248,1.0,10/29,14.00%,ZBTB20;PPARA;LPGAT1;LDLR;SREBF1;SLC27A1;APOE;CNEP1R1;SLC45A3;MFSD2A
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.33564600150224005,-0.8682315731072099,0.6335697399527187,0.9582296227471363,1.0,8/19,23.37%,PRKN;SREBF1;VDAC1;HTT;HAX1;HTRA2;FZD5;DNM1L
prerank,regulation of smooth muscle contraction (GO:0006940),-0.3320289352258443,-0.8682025273300111,0.6513994910941476,0.9571975775953881,1.0,10/20,22.29%,PLCE1;KCNB2;SPHK1;CTTN;MYOCD;ZDHHC21;CHRM3;CHRM2;ADRB2;DAPK3
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.41762781181092457,0.8670888521880034,0.6388888888888888,0.8818100748309028,1.0,6/12,29.33%,CDT1;WDR18;TIPIN;GMNN;TICRR;KAT7
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.32917807203697586,-0.8668301768893703,0.6295399515738499,0.9591831018033414,1.0,4/20,19.24%,WNT4;C1QTNF3;CRY1;NCOR1
prerank,regulation of defense response to virus by host (GO:0050691),0.351157018352911,0.8666827284264337,0.6490384615384616,0.8820975794656628,1.0,8/30,18.40%,AIM2;DTX3L;CGAS;IL23A;EIF2AK4;STAT1;PARP9;ZDHHC1
prerank,negative regulation of response to external stimulus (GO:0032102),0.29067838086692044,0.8663899477252553,0.6984732824427481,0.8821820533387643,1.0,18/105,14.67%,TEK;PPARD;MFHAS1;LPCAT3;SIGIRR;TNFRSF1A;CRK;INPP5F;NMI;EPHA4;RB1;CARD16;TRIB1;ILRUN;KLK8;CDH5;PROC;IRAK3
prerank,amyloid precursor protein metabolic process (GO:0042982),0.3896541117322337,0.8663201532138503,0.6486486486486487,0.8818321116279019,1.0,5/18,13.49%,ADAM10;PSEN1;APH1A;ABCG1;ADAM17
prerank,sulfur compound biosynthetic process (GO:0044272),0.29261883903281316,0.8660069291616592,0.7062579821200511,0.881962841741351,1.0,23/104,14.08%,ST3GAL6;CSGALNACT1;ST3GAL1;B3GNT3;MAT2A;B4GALT4;SLC35B3;SLC10A7;B3GNT4;SLC26A1;B4GALT5;GSTO2;GSTA4;B4GAT1;SLC35D2;TPK1;GGCT;GCLM;MPST;GSTP1;CSPG5;NCAN;OPLAH
prerank,regulation of lipid kinase activity (GO:0043550),0.43476745003289985,0.8658840919527304,0.6263537906137184,0.8817393925000163,1.0,2/11,11.74%,PPP2R5A;RB1
prerank,bile acid biosynthetic process (GO:0006699),-0.3120080529084793,-0.8655804822746913,0.6484375,0.9608867430633476,1.0,5/24,14.85%,CYP7B1;CYP27A1;OSBPL3;OSBPL6;SCP2
prerank,phospholipid metabolic process (GO:0006644),0.3093846497573187,0.8648541466276874,0.6852861035422343,0.8832267244748163,1.0,9/71,9.80%,PLA2G4A;PLPP1;ENPP2;PLA2G2D;LPL;AGPAT1;MBOAT1;PLAAT3;PDXP
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.31777229937865914,0.8647322057715895,0.6690856313497823,0.8829885953851877,1.0,6/60,7.64%,NEK7;PDGFB;PRKD2;HMBOX1;GREM1;WRAP53
prerank,positive regulation of establishment of protein localization (GO:1904951),0.3875586806386849,0.8640660458437563,0.6125211505922166,0.8837815141978355,1.0,6/18,21.54%,WRAP53;CHP1;CEP295;CCT7;CCT2;CEP120
prerank,synaptic vesicle membrane organization (GO:0048499),0.38703890816789266,0.8637769727844107,0.6312056737588653,0.8838300555113308,1.0,3/17,9.52%,STX3;STX1A;SNAP23
prerank,membrane raft organization (GO:0031579),-0.3528547342947721,-0.8634466882363772,0.6577181208053692,0.9646127884277734,1.0,7/15,23.03%,ANXA2;S100A10;FLOT2;ABCA7;MYADM;PPT1;CLN3
prerank,mitochondrial translational elongation (GO:0070125),0.29894945749318036,0.8632384816670566,0.694300518134715,0.8843601206805844,1.0,37/88,26.40%,MRPS18A;MRPL13;MRPS12;MRPL35;MRPL41;MRPL52;MRPL4;MRPS16;MRPS5;MRPL23;MRPL37;MRPL11;PTCD3;MRPS26;MRPL54;GADD45GIP1;MRPS9;MRPL43;MRPL12;MRPL44;MRPS30;MRPL1;MRPL17;AURKAIP1;MRPL50;MRPL15;MRPL19;DAP3;MRPL14;MRPL32;MRPL39;MRPS11;MRPL9;MRPL46;GFM1;MRPL24;MRPL42
prerank,cortical cytoskeleton organization (GO:0030865),0.33253464687639983,0.8630299725177011,0.6597938144329897,0.8842844161205576,1.0,9/41,8.56%,LCP1;FMNL3;IKBKB;NCKAP1;FMNL2;RAC1;TRPV4;RHOBTB1;LLGL1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.3096843296820235,-0.8629691199464441,0.6675257731958762,0.9645437069846273,1.0,7/29,13.05%,GOLGA5;COPB1;COPZ2;COPG1;COPA;COG8;TRAPPC10
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.37772212185703546,0.8627092079819546,0.6567656765676567,0.8843780432927119,1.0,7/21,13.14%,CNOT6;PAN3;CNOT6L;CNOT1;CNOT2;ZFP36;CNOT7
prerank,protein targeting (GO:0006605),0.28347590639164966,0.8625451186801035,0.7022106631989596,0.8842274815208115,1.0,26/118,19.40%,RASSF9;PARD3;AQP11;TAOK2;SDCBP;SEC63;ZDHHC18;ZDHHC9;ZFAND2B;ICMT;MYO1C;HOMER3;PITRM1;SPCS1;GIPC1;AP1S3;VPS37C;RPL11;ZDHHC24;CDC37;ZDHHC1;TOMM22;TRAK2;ZFAND2A;NACA;ZDHHC6
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3528063740120705,0.8623402572268778,0.6253968253968254,0.8841542404661015,1.0,5/28,12.23%,DAB2IP;CASP8;TNFRSF1A;CRADD;BID
prerank,myoblast differentiation (GO:0045445),0.4122367219890598,0.8621978976273559,0.6224299065420561,0.8839347837048557,1.0,3/14,5.25%,EPAS1;MBNL1;TCF7L2
prerank,intracellular sterol transport (GO:0032366),0.39989367310280177,0.8612700842136705,0.6322033898305085,0.8851703545908465,1.0,7/13,25.23%,ABCG1;ABCA1;STAR;OSBPL2;STARD4;NPC1;RELCH
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.2961554953440716,-0.8612153584073264,0.6774193548387096,0.9672989490991878,1.0,13/31,22.93%,SYT1;CACNA1G;SYT9;SYT11;SYT12;ADRA2A;SCAMP5;SYT3;CBARP;REST;SYT2;RAB3GAP1;SYT6
prerank,cellular amide metabolic process (GO:0043603),0.2927812166198653,0.8612088617536701,0.6907630522088354,0.8847982191175658,1.0,8/102,5.61%,ST6GAL1;ST3GAL1;PLPP1;CPD;CPE;GLYAT;ASAH2;MTHFD1L
prerank,activation of protein kinase activity (GO:0032147),0.2907638182899903,0.8610076075887957,0.6973333333333334,0.8847112416555051,1.0,18/106,9.18%,ADCY4;INSR;PDGFB;PTK2B;TAOK2;STK3;PRKAR2B;PAK2;CARD10;TIRAP;STK4;GHR;WNT5A;CCDC88A;TNIK;MALT1;ANG;RICTOR
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.4246259304253285,0.860822420581517,0.6378986866791745,0.8845541970013295,1.0,3/12,9.40%,LYN;PTK2;CSF1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.3710980656789376,-0.8601895368477281,0.6690307328605201,0.9684839611193965,1.0,4/12,16.01%,SIX1;VEGFA;SMO;PAX8
prerank,ubiquinone metabolic process (GO:0006743),-0.3574995061382391,-0.8601422372490657,0.6359649122807017,0.9674762829254516,1.0,9/15,39.93%,COQ5;COQ8B;FDXR;AIFM2;COQ10A;COQ10B;COQ6;COQ8A;COQ9
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.39633487768048814,0.8600730992155592,0.6243291592128801,0.8854531260006252,1.0,2/14,3.04%,CD200;TNFRSF1B
prerank,regulation of multicellular organism growth (GO:0040014),0.3976650432552002,0.8596367185427092,0.6254237288135593,0.8857971878636584,1.0,2/15,4.92%,APP;GHR
prerank,positive regulation of bone resorption (GO:0045780),0.4224223506125866,0.8593043653656621,0.6399253731343284,0.8859256527127217,1.0,3/11,10.93%,TNFRSF11A;DCSTAMP;MC4R
prerank,skin development (GO:0043588),0.31039855433757263,0.8592696457693936,0.6795580110497238,0.885523822481549,1.0,8/65,7.08%,ITGA6;UGCG;LSR;BCR;DLL1;WNT5A;ASCL4;ITGA3
prerank,positive regulation of cellular protein localization (GO:1903829),0.30660435069957287,0.8589082290052212,0.6718972895863052,0.8856929253557871,1.0,10/69,10.07%,STX3;FYN;WWTR1;CARD10;DTX3L;LIMK2;CCDC88A;TGFB1;CDT1;VPS28
prerank,synaptic vesicle cycle (GO:0099504),-0.2986199845437848,-0.8589023471808843,0.6792452830188679,0.9692104495339806,1.0,4/30,5.90%,BRSK1;SNAP25;PCLO;NLGN1
prerank,double-strand break repair (GO:0006302),0.2813033599529089,0.857678892982529,0.7336504161712247,0.8874314358383959,1.0,37/158,18.35%,TENT4A;SAMHD1;BABAM2;DTX3L;HERC2;MAPK8;MMS22L;RPA1;TRIP13;POLA1;BRCC3;SMARCA5;BRIP1;RAD51D;SEM1;PARP2;MEIOB;RECQL;MAD2L2;XRCC2;FAN1;HUS1;RMI1;MCM9;CYREN;ERCC4;YY1;UBXN1;CHEK2;ACTR5;SPIDR;KDM4A;DCLRE1C;RAD21;CIB1;NSMCE1;PARP9
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.4160595084201597,0.8573061638996702,0.6126126126126126,0.8876365380168396,1.0,2/11,5.76%,KCNQ1;ATP1A1
prerank,negative regulation of cyclase activity (GO:0031280),-0.3633062362952524,-0.856954314324444,0.6707616707616708,0.9723741575217552,1.0,3/14,13.18%,ADGRV1;GRM3;PALM
prerank,pre-miRNA processing (GO:0031054),0.40780691219490134,0.8565048548940418,0.6462093862815884,0.8886453739851081,1.0,5/14,21.73%,DROSHA;DICER1;ADAR;MRPL44;PRKRA
prerank,mitochondrial transport (GO:0006839),-0.26537864737054817,-0.8564615022346654,0.7440476190476191,0.9723121969148424,1.0,18/53,24.97%,BCL2;HSP90AA1;TOMM40;TIMM22;SLC25A13;FLVCR1;MTX2;COX18;SLC25A4;TIMM17B;TSPO;MAIP1;TIMM8B;TIMM9;TMEM14A;PPIF;TIMM10;GDAP1
prerank,P-body assembly (GO:0033962),0.4117873882249494,0.8564048936888167,0.634011090573013,0.888357469515783,1.0,7/12,27.37%,EDC3;RC3H1;LSM3;LSM14A;EIF4ENIF1;DDX6;PATL2
prerank,cellular response to oxidative stress (GO:0034599),0.2853725803738385,0.8563685212008002,0.6948941469489415,0.8879545025626233,1.0,11/118,6.13%,FOXO1;PRKD1;DAPK1;HIF1A;PXN;CAT;PTPRK;MAPK8;CYCS;GSR;PRR5L
prerank,regulation of axon guidance (GO:1902667),-0.3783661509478424,-0.8563360552092033,0.6544622425629291,0.9715086251343936,1.0,3/10,9.33%,NRP1;ZSWIM8;VEGFA
prerank,glycerol metabolic process (GO:0006071),-0.3901296036005282,-0.8561768953892326,0.6589958158995816,0.9707979367954532,1.0,4/10,18.06%,GK;GOT1;TPI1;ANGPTL3
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.4027051771546996,0.8560863822817556,0.6265709156193896,0.8879794538605035,1.0,7/15,22.56%,KHNYN;DICER1;NUDT16;RPP30;ZC3H12C;RNASEH1;LACTB2
prerank,cellular response to acid chemical (GO:0071229),0.34779158781119707,0.8558739327674848,0.6408227848101266,0.8878964394989325,1.0,5/27,10.46%,SH3BP4;KLF2;XBP1;RPTOR;LARS1
prerank,negative regulation of RNA splicing (GO:0033119),0.38492040512485387,0.8555135333217049,0.657190635451505,0.8880787220294748,1.0,7/19,24.93%,TMBIM6;PTBP3;RNPS1;RPS13;SRSF10;SRSF4;RBMX
prerank,ERAD pathway (GO:0036503),-0.23928242415536546,-0.8553720588171614,0.807843137254902,0.971403416871823,1.0,19/83,20.42%,PRKN;UGGT2;SELENOS;RCN3;AMFR;USP13;UBXN4;JKAMP;UBE4B;NPLOC4;GET4;UBE2G2;UBE4A;RNF121;DNAJC18;USP19;FAM8A1;DNAJB2;TMEM67
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.3736925713603007,0.855219507445795,0.6578512396694215,0.8881327692244148,1.0,4/18,14.46%,NR3C1;BCL2L11;ZFP36;ZFP36L1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.26424241057215747,-0.8547463638664643,0.7366548042704626,0.9716695649604731,1.0,12/49,16.05%,SMAD6;IMPACT;DACT1;PRKCZ;SRC;THRA;JAM3;TRAF3IP1;ANKRD27;PYDC1;PPM1A;LCMT1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.38781836524712865,-0.8545158931832255,0.6547085201793722,0.9710671545095193,1.0,4/10,19.38%,OGT;SELENOS;DGKQ;PDK2
prerank,regulation of mitotic nuclear division (GO:0007088),0.3112787323836986,0.8544688338610029,0.687964338781575,0.8889843400061205,1.0,8/55,9.80%,INSR;PDGFB;EDN1;LRP5;CAV2;AURKA;TGFA;PDXP
prerank,sarcomere organization (GO:0045214),-0.30673611661030714,-0.8541176003536868,0.6753246753246753,0.9707951605543549,1.0,10/27,34.16%,ACTN2;TPM1;FHOD3;MYOM2;KRT19;TNNT3;MYPN;MYLK3;TCAP;OBSCN
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.41328227983177435,0.8535883692174654,0.6439393939393939,0.8901368103803052,1.0,11/11,58.70%,PKD1L3;RTP3;RTP4;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;LPO;PKD2L1
prerank,ether lipid metabolic process (GO:0046485),-0.3545181724830554,-0.8531708391299551,0.6838407494145199,0.9718019503380253,1.0,1/14,0.32%,AGMO
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.4185219309078127,0.8531390748610307,0.6238361266294227,0.890469454270414,1.0,2/11,6.74%,LYN;JAK1
prerank,gonad development (GO:0008406),0.3309172262312944,0.8526146396941102,0.6349206349206349,0.8910001195115544,1.0,7/41,10.69%,KITLG;BIK;SOX9;WNT5A;NCOA4;MAMLD1;ADAM21
prerank,regulation of protein localization to cell surface (GO:2000008),0.34660092071647575,0.8526062511571497,0.6585365853658537,0.8905394279272115,1.0,6/33,13.32%,STX3;NEDD4L;RAB11FIP5;PICALM;RAB11B;HSP90AB1
prerank,insulin secretion (GO:0030073),0.372035499323943,0.8521677796126538,0.6363636363636364,0.8908483747699477,1.0,4/19,12.45%,RAB11FIP5;SNX19;NEUROD1;RAB11B
prerank,liver development (GO:0001889),0.3362314445288875,0.8520531405992,0.6703125,0.8905795996851738,1.0,5/32,7.67%,LSR;ZIC3;XBP1;AURKA;PKD2
prerank,cellular response to amino acid stimulus (GO:0071230),0.33825389851275267,0.8518530028424197,0.6785714285714286,0.8904481125280763,1.0,6/33,10.46%,SH3BP4;FYN;XBP1;RPTOR;UBR1;LARS1
prerank,histone deacetylation (GO:0016575),0.3291516792846501,0.8516043418503954,0.6916167664670658,0.8904330152406974,1.0,7/43,12.97%,HDAC9;ELK4;RCOR1;RBM14;MIER1;SIRT6;MIDEAS
prerank,regulation of axon regeneration (GO:0048679),-0.3620089059209926,-0.8515156904600097,0.6494382022471911,0.9742835018307666,1.0,2/12,2.39%,PTN;PTPRS
prerank,positive regulation of cell cycle (GO:0045787),0.30795358874498513,0.8513974068127697,0.6823204419889503,0.890324089605321,1.0,13/62,12.00%,APP;PDGFB;TAL1;PKN2;EIF4E;CDKN1B;PKD2;CCNYL1;CCNY;NUDT16;RAD23A;EIF4EBP1;LGMN
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.29092932089455154,-0.8509732489611966,0.7220543806646526,0.9744363140699278,1.0,13/36,16.69%,VAMP5;ANK3;AFDN;OPTN;GGA2;RAB10;GGA1;BBS2;SYS1;ARFRP1;MACF1;GOLPH3L;GOLGA4
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.4247453226461113,0.8509331445884349,0.6454720616570327,0.890694860151958,1.0,3/10,11.07%,LYN;RAPGEF2;GAS6
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.4046889643480065,0.8505473947776989,0.6227758007117438,0.8909631222612174,1.0,6/13,25.07%,DDX20;AAR2;SRSF10;SART3;PRPF3;LSM2
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.3864289274109137,0.8502049760237849,0.643598615916955,0.891136289287729,1.0,4/16,8.19%,ESR1;DDX54;NCOA4;ARID1A
prerank,body fluid secretion (GO:0007589),-0.348976334042992,-0.850196004803224,0.6554809843400448,0.9749833337120656,1.0,5/15,14.92%,ERBB4;SLC22A4;VEGFA;PRLR;SLC22A2
prerank,mitotic cell cycle phase transition (GO:0044772),0.2677155023670525,0.850105627297156,0.7532163742690059,0.8908421607149165,1.0,47/203,20.69%,EPS8;CDK6;TPD52L1;PLCB1;PRKAR2B;PPP1R12A;EIF4E;CEP41;PLK2;AURKA;ACVR1;PCNT;CDKN1B;FBXL7;DYNLL1;CHMP4B;ANAPC7;CNTRL;CCNY;CDK2;CEP57;ANAPC1;CUL1;EIF4EBP1;PPP2R2D;RB1;MAX;CDC25C;FBXL3;CEP290;CCNJ;CTDP1;CHEK2;CEP72;CUL3;PPP2R2A;CDC34;CEP131;CETN2;CDK5RAP2;E2F3;CUL2;PLK1;DBF4;PPP2R1A;CCNH;TRIM71
prerank,GPI anchor metabolic process (GO:0006505),0.3484923054869665,0.8500421602926878,0.657331136738056,0.8904803755552083,1.0,8/26,17.73%,PGAP1;PIGU;PIGQ;PGAP4;PIGG;PIGF;PIGL;PIGC
prerank,regulation of protein targeting to membrane (GO:0090313),0.3493622753630355,0.8499904688127361,0.6584158415841584,0.8900983712149301,1.0,9/28,18.07%,FYN;KCNB1;INPP5K;AKT2;MYO1C;TCAF2;ERBB2;CHP1;CIB1
prerank,phosphate ion transport (GO:0006817),0.38981683279928075,0.8495889227847317,0.6523297491039427,0.8903272820983718,1.0,4/16,12.82%,SLC37A3;SLC25A30;SLC37A1;XPR1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2924650310647385,0.8494667943294063,0.7309782608695652,0.8900820401157652,1.0,13/85,12.83%,SMURF1;CELSR1;FZD6;FZD4;AP2B1;WNT5A;RAC1;AP2A1;PSMA2;PSMA8;PSMA6;PRICKLE1;VANGL2
prerank,protein stabilization (GO:0050821),0.2707230949038269,0.8493862116989805,0.7363420427553444,0.8897508869679677,1.0,50/168,22.22%,GNAQ;TSPAN1;HIP1;HIP1R;EFNA1;FBXW7;SOX17;STK3;STK4;SMAD7;ATF7IP;RPS7;TMEM88;ATP1B3;CREB1;RPL23;SOX4;AFM;EPHA4;COA8;GLMP;FKBPL;NOP53;HSP90AB1;NAA16;BAG4;IRGM;STX12;CHP1;RPL11;CHEK2;BAG1;USP7;CDC37;ZBED3;COG7;MTMR9;SWSAP1;NLK;CCT7;TAF9;CCNH;PPIB;CCT2;BAG2;SEL1L;PRKRA;TNIP2;CDC37L1;MFSD1
prerank,regulation of multicellular organismal development (GO:2000026),0.35372041022848644,0.8492839896930325,0.6463620981387479,0.8894562008112461,1.0,2/25,3.32%,INSR;SOX17
prerank,positive regulation of blood coagulation (GO:0030194),-0.34082932800154814,-0.8488091644575247,0.6807511737089202,0.9768776186009083,1.0,3/17,10.28%,F3;THBS1;SERPINE1
prerank,regulation of Golgi organization (GO:1903358),-0.333926885195176,-0.8483587313835308,0.6724137931034483,0.9767001639185189,1.0,7/17,24.44%,MYO5A;MAP2K2;RBSN;MAP2K1;PDE4DIP;RAB33B;CAMSAP3
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.332474438070408,0.8483528175376032,0.6743827160493827,0.890636839916177,1.0,9/41,15.52%,PLA2G4A;ELOVL5;PTGS1;EPHX1;DEGS1;ABCD1;GSTP1;PNPLA8;FAAH
prerank,DNA alkylation (GO:0006305),0.3751850258062233,0.8479851541839984,0.6412859560067682,0.8903731129534918,1.0,8/19,17.85%,KMT2E;ATF7IP;PPM1D;GATAD2A;SPOCD1;ATRX;EHMT1;TEX15
prerank,DNA methylation or demethylation (GO:0044728),0.3751850258062233,0.8479851541839984,0.6412859560067682,0.8903731129534918,1.0,8/19,17.85%,KMT2E;ATF7IP;PPM1D;GATAD2A;SPOCD1;ATRX;EHMT1;TEX15
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.3649568999984023,-0.847674646998641,0.6875,0.9770801015539368,1.0,2/13,2.91%,GLI2;BMP4
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.426382338125736,0.8473575551270723,0.6606822262118492,0.8905704661751646,1.0,3/10,7.24%,CBFA2T3;FBP1;TIGAR
prerank,negative regulation of glycolytic process (GO:0045820),0.426382338125736,0.8473575551270723,0.6606822262118492,0.8905704661751646,1.0,3/10,7.24%,CBFA2T3;FBP1;TIGAR
prerank,nucleotide-excision repair (GO:0006289),0.2881855390697758,0.8471769677861011,0.7227101631116688,0.8904114286016716,1.0,29/101,24.83%,POLK;ATXN3;RPA1;POLA1;BRIP1;COPS2;RAD23A;FAN1;MMS19;HUS1;COPS4;ERCC4;AQR;GTF2H4;USP7;RFC3;CETN2;GTF2H1;CHD1L;POLR2L;CCNH;RNF111;POLR2J;RFC5;ERCC6;CUL4B;COPS8;LIG4;POLL
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.3096283624307502,-0.8466183431126043,0.6979166666666666,0.9782872072236936,1.0,10/24,32.63%,KIF24;MAP7D3;NCKAP5L;TPPP3;CKAP5;KIF18B;FGF13;STMN4;STMN2;TPPP
prerank,negative regulation of neuron death (GO:1901215),0.2937455169269817,0.846439590234045,0.7427821522309711,0.891263426574199,1.0,14/93,10.06%,MEF2C;CD200;PTK2B;TNFRSF1B;CD34;FOXQ1;TOX3;RASA1;CITED1;CHMP4A;CHMP4B;CSF1;IKBKG;BTBD10
prerank,positive regulation of catalytic activity (GO:0043085),0.3393932441741774,0.8463572736351473,0.6909667194928685,0.8909476062096646,1.0,19/37,28.87%,CAV1;MAPK8;PSEN1;APH1A;ABL2;CIB1;ATP7A;MSH2;XRCC4;PHACTR4;FXN;MAPK14;B3GAT3;SOD1;NOD2;MSH3;BCAS3;MID1IP1;PSEN2
prerank,glutamate metabolic process (GO:0006536),0.3710353383873302,0.8461108447205767,0.6790123456790124,0.8909180266265138,1.0,3/19,3.41%,DGLUCY;GLS2;GLS
prerank,positive regulation of receptor internalization (GO:0002092),0.3577655358859439,0.8459404435178326,0.6633333333333333,0.8907624571253713,1.0,8/22,12.99%,INSR;SELE;GREM1;ARRB1;SCYL2;PICK1;TBC1D5;FMR1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.3144818957232993,0.845599000990505,0.6885714285714286,0.8909368538217716,1.0,11/51,14.97%,VEGFC;IL6R;F7;VEGFD;PTK2;CSF1;ANO6;GAS6;LGMN;ADAM17;PGF
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.37046749288500447,-0.8450701085370761,0.6409691629955947,0.9805113881898208,1.0,2/11,11.24%,TWSG1;RUNX1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.3026670256575375,-0.8450105166783742,0.6890080428954424,0.9795831107658446,1.0,5/25,18.10%,IGF1;PER2;DOT1L;HEY2;HEY1
prerank,response to gamma radiation (GO:0010332),0.3657700983387708,0.8437450422362051,0.660472972972973,0.8937884096420307,1.0,1/24,0.84%,DCUN1D3
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.275175557903336,-0.8436550576159867,0.7460815047021944,0.9813420220825129,1.0,4/43,6.51%,IGF1;LBP;SELENOS;SYT11
prerank,signal peptide processing (GO:0006465),-0.3732243712791428,-0.8435220813952649,0.6430205949656751,0.9805264656832553,1.0,3/11,13.77%,PCSK5;SPCS3;SPCS2
prerank,cell differentiation in spinal cord (GO:0021515),0.4155180343914757,0.8434982312650237,0.6187845303867403,0.8937640231730196,1.0,2/10,9.43%,SOX13;SOX4
prerank,primary neural tube formation (GO:0014020),-0.2981225156902877,-0.8430009781548601,0.7090395480225988,0.9805080378697877,1.0,7/30,11.64%,LMO4;COBL;LRP6;TSC2;FUZ;MTHFD1;TGFB2
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.32805901449522656,0.8429216277473698,0.677891654465593,0.8943028089464724,1.0,8/39,19.93%,POLK;RPA1;FAN1;ERCC4;GTF2H4;RFC3;GTF2H1;CHD1L
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.31576336591252213,0.8426599452758029,0.7004341534008683,0.8943344083178862,1.0,12/48,16.20%,HIF1A;TIGAR;NUP214;EIF6;NUP98;SLC2A6;NUP205;NUP133;NUP153;NUP54;NUP43;PNPT1
prerank,negative regulation of stem cell differentiation (GO:2000737),0.40343076051425575,0.8424512131228512,0.6169811320754717,0.8942353909662495,1.0,5/12,20.95%,NOTCH1;TCF15;ESRRB;HES1;NELFB
prerank,tube closure (GO:0060606),-0.29456390938841126,-0.8424252582318285,0.7106017191977078,0.9806040042970912,1.0,7/31,11.64%,LMO4;COBL;LRP6;TSC2;FUZ;MTHFD1;TGFB2
prerank,purine-containing compound catabolic process (GO:0072523),0.4051663478442396,0.8424199270270192,0.6386404293381037,0.8938352460772537,1.0,4/13,14.57%,GDA;NT5C2;XDH;NUDT15
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.37149653259078436,0.8424143919409935,0.6622296173044925,0.8933733240043902,1.0,5/21,11.77%,LIMCH1;PEAK1;PTK2;SLK;CORO1C
prerank,vacuolar acidification (GO:0007035),-0.31974746400373644,-0.8422308581334926,0.7012658227848101,0.9799592816009196,1.0,12/21,33.65%,ATP6V0A4;ATP6V0D1;PPT1;ATP6AP2;SLC11A1;CLN3;TMEM199;TMEM9;CCDC115;ATP6V0D2;GRN;DMXL2
prerank,DNA repair (GO:0006281),0.26074613207856395,0.8420837595682402,0.8268398268398268,0.8935005144988298,1.0,66/284,21.05%,TENT4A;POLK;USP3;BABAM2;DTX3L;HERC2;MAPK8;RNASEH2A;ASCC1;ATXN3;RPA1;ASCC3;WDR33;TRIP13;POLA1;PRIMPOL;BRCC3;SMARCA5;BRIP1;BACH1;RAD51D;RAD23A;PARP2;BTG2;RAD18;RECQL;MAD2L2;XRCC2;FAN1;MC1R;MMS19;HUS1;UNG;NOP53;MPG;ERCC4;NSMCE4A;NPM1;ENDOV;UBXN1;PDS5A;PDS5B;CHEK2;ACTR5;GTF2H4;KDM4A;DCLRE1C;WDR48;RAD21;MGMT;KMT5B;RFC3;CIB1;NSMCE1;PARP9;CETN2;NUDT1;PMS1;GTF2H1;CHD1L;FAAP100;RAD17;SETX;MSH2;RMI2;TRRAP
prerank,regulation of autophagosome assembly (GO:2000785),0.33528917800688124,0.8420124001924975,0.6697819314641744,0.8931635129268316,1.0,8/33,9.94%,MTM1;RALB;TBC1D12;SH3GLB1;FEZ2;CHMP4A;CHMP4B;NPRL2
prerank,positive regulation of cellular respiration (GO:1901857),-0.3703753894982915,-0.8418028371812195,0.6817204301075269,0.9798054146136289,1.0,1/11,1.96%,NUPR1
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.33078285106923844,-0.8417812332846307,0.6822429906542056,0.9787760577023638,1.0,6/18,29.32%,EHMT2;SETD4;KMT2D;SETMAR;SETD7;SETD1A
prerank,positive regulation of immune effector process (GO:0002699),0.34904395916684783,0.8416324271197935,0.6773648648648649,0.893400589231878,1.0,4/27,9.76%,PTPRJ;RPS19;XBP1;IL23A
prerank,positive regulation of embryonic development (GO:0040019),-0.332159884755435,-0.8415050264373656,0.6868932038834952,0.9783062346540937,1.0,2/19,1.98%,WNT4;OSR1
prerank,water transport (GO:0006833),-0.3591055078024872,-0.8411204581515993,0.6820175438596491,0.978042948388015,1.0,1/12,1.61%,PDPN
prerank,regulation of Ras protein signal transduction (GO:0046578),0.2869799653575377,0.8408562968333942,0.7335164835164835,0.894337173043442,1.0,12/85,8.50%,EPS8;DAB2IP;ARHGEF2;LYN;BCR;NOTCH1;DENND4C;ARHGAP17;OPHN1;FBP1;SYNGAP1;SHOC2
prerank,coenzyme A metabolic process (GO:0015936),0.38905144105473355,0.8402244892845498,0.6824817518248175,0.8950032336403968,1.0,5/14,20.83%,SLC25A16;PANK2;PANK3;PPCDC;CROT
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.2935905231125687,-0.8399025740450994,0.7025495750708215,0.9794573889679655,1.0,15/30,22.82%,VAMP5;ANK3;OPTN;GGA2;RAB10;GGA1;BBS2;SYS1;ARFRP1;MACF1;GOLPH3L;GOLGA4;SEC16A;VAMP2;PREPL
prerank,ubiquinone biosynthetic process (GO:0006744),-0.3508182752329126,-0.8398865088622899,0.6614349775784754,0.9784289252578628,1.0,9/15,39.93%,COQ5;COQ8B;FDXR;COQ10A;NDUFA9;COQ10B;COQ6;COQ8A;COQ9
prerank,negative regulation of insulin secretion (GO:0046676),0.37211265213082956,0.8391854076804242,0.642512077294686,0.8963637829818688,1.0,3/17,4.05%,PIM3;KLF7;KCNB1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.37821235553216825,0.8386114302716701,0.6695059625212947,0.8969282829082812,1.0,3/19,6.29%,DDIT4;HIPK1;BCL3
prerank,mitochondrial membrane organization (GO:0007006),-0.291855608730542,-0.8385037686377316,0.7205128205128205,0.9802743915674028,1.0,14/32,31.29%,BCL2;MICOS10;CHCHD3;CHCHD6;MTX2;SLC25A4;MAIP1;PPIF;SAMM50;DNAJC11;PMAIP1;APOO;TMEM11;IMMT
prerank,telomere maintenance (GO:0000723),-0.2616560282079805,-0.8376215053811271,0.7269736842105263,0.9810182758333886,1.0,23/50,31.73%,PARP3;RTEL1;TEP1;RAD50;XRCC5;XRCC6;SMC6;TERF2;DNA2;ATR;TPRKB;TERT;PRKDC;POLD1;LTO1;XRCC3;ATM;POLD2;SMC5;DCLRE1B;RPA2;BLM;WRN
prerank,zinc ion transport (GO:0006829),0.3607936013789444,0.8375444654159221,0.6478632478632479,0.8983549239757962,1.0,1/21,0.93%,SLC39A8
prerank,female gonad development (GO:0008585),-0.3150174840087564,-0.8372868714837799,0.6957605985037406,0.9806453225185606,1.0,7/19,19.55%,KIT;VEGFA;INHBA;CEBPB;NR2F2;INHBB;NUP107
prerank,catecholamine biosynthetic process (GO:0042423),0.4133616648765403,0.8372822804541357,0.6466302367941712,0.8983442227774703,1.0,1/11,1.56%,GCH1
prerank,monosaccharide transmembrane transport (GO:0015749),-0.34266338645047856,-0.8364689237781107,0.705607476635514,0.9813643909526103,1.0,4/16,13.98%,SLC5A3;SLC2A12;SLC2A10;SLC45A3
prerank,manganese ion transport (GO:0006828),-0.3579374296555599,-0.8363082839262449,0.68,0.9806077389754724,1.0,7/14,12.87%,SLC30A10;SLC39A14;TRPC3;TRPC6;TRPC1;TRPC4;TRPC5
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.2773181484822971,-0.8362806385332201,0.7584097859327217,0.9796153781506222,1.0,4/41,6.51%,IGF1;LBP;SELENOS;SYT11
prerank,alcohol catabolic process (GO:0046164),-0.37997363482747604,-0.8358224907077815,0.6659090909090909,0.9795063633608663,1.0,3/10,16.15%,CYP27A1;APOE;MT3
prerank,receptor recycling (GO:0001881),0.4169789696344393,0.8355747036494043,0.6383838383838384,0.9008582488594307,1.0,3/10,12.45%,LMTK2;EHD3;RAB11B
prerank,regulation of phosphate metabolic process (GO:0019220),0.3906315288637908,0.8355607839270225,0.6795096322241682,0.900416111692285,1.0,4/16,9.37%,IKBKB;TIGAR;PSEN1;SMG7
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.2524938773350432,-0.8354209534939007,0.7687687687687688,0.9792890345033304,1.0,9/56,9.58%,EGFR;ANXA1;CCND2;ANAPC5;ADAMTS1;RAD51B;UBE2E2;RGCC;TFDP1
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.35426132454317316,-0.8353689179732597,0.7027649769585254,0.9783289188180769,1.0,3/13,16.60%,CBLB;RGPD1;KPNA2
prerank,fatty acid transport (GO:0015908),0.3680085057634618,0.8351839763138293,0.660377358490566,0.9006379119216584,1.0,1/17,1.05%,PPARD
prerank,establishment of apical/basal cell polarity (GO:0035089),0.3898953873928188,0.8350021090453094,0.6702702702702703,0.9004860937062118,1.0,4/14,16.40%,MSN;OPHN1;FSCN1;RHOA
prerank,myoblast fusion (GO:0007520),0.39820660098235056,0.8348361930667532,0.6685393258426966,0.9003251444438601,1.0,2/12,7.78%,JAM2;PTGFRN
prerank,RNA stabilization (GO:0043489),-0.28269902790000595,-0.8347628762896872,0.7253731343283583,0.9784963741743771,1.0,9/33,22.77%,TENT5A;AXIN2;CIRBP;HNRNPU;TENT5C;E2F1;PHAX;SLC11A1;RBM24
prerank,peptidyl-proline modification (GO:0018208),-0.30634034314103264,-0.8344559975252747,0.7095238095238096,0.9780388664524132,1.0,5/25,14.31%,FKBP5;NKTR;FKBP10;PPIC;PPIH
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.295338749305526,0.8341970987960154,0.7053333333333334,0.9009857265908857,1.0,15/72,19.93%,POLK;ISG20;EDC3;RNASE1;RPA1;RNASE4;DICER1;FAN1;ERCC4;PNRC2;XRN2;GTF2H4;RFC3;GTF2H1;CHD1L
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.3375690140598521,0.8337083683539007,0.6651305683563749,0.9013546920509835,1.0,5/30,8.15%,FOXP1;PKN1;TRIM68;H3-3A;KDM4C
prerank,inner mitochondrial membrane organization (GO:0007007),-0.26469936843863606,-0.8329029253453947,0.7706422018348624,0.9801704207680584,1.0,19/47,31.29%,MICOS10;CHCHD3;CHCHD6;TIMM22;MTX2;ATP5PO;MAIP1;TIMM8B;TIMM9;TIMM10;ATP5ME;ATP5PF;SAMM50;ATP5MG;DNAJC11;APOO;TMEM11;DMAC2L;IMMT
prerank,regulation of axon extension (GO:0030516),0.3321115750068257,0.8328136759534085,0.693815987933635,0.9024444956321547,1.0,3/37,4.03%,NTN1;SEMA7A;DIP2B
prerank,negative regulation of interleukin-17 production (GO:0032700),0.40979646944395254,0.8327129410344734,0.6621359223300971,0.9021623598430049,1.0,2/10,15.98%,VSIR;DDIT3
prerank,epiboly involved in wound healing (GO:0090505),0.37320962711735955,0.8326395720967862,0.6616161616161617,0.9018020383934845,1.0,3/16,5.16%,LCP1;MRTFA;CEACAM1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.4003355126665398,0.8322810737935666,0.6690391459074733,0.9019628283031744,1.0,4/13,13.49%,PLCG1;AKT3;SIRT6;ADAM17
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.3931556822146588,0.8322383721279341,0.6550522648083623,0.9015626960861585,1.0,3/13,10.93%,LPCAT3;AQP11;MBTPS2
prerank,apoptotic mitochondrial changes (GO:0008637),0.3328035981453736,0.8319536847784186,0.6891025641025641,0.9015977468330212,1.0,9/32,13.86%,BIK;BOK;BCL2L1;GGCT;SFN;BNIP3;BID;THEM4;SOD2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.41325508789750887,0.8318948909822373,0.6617915904936015,0.90123683151745,1.0,2/11,4.22%,SCARB1;PLIN5
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.3423104746308313,-0.830630821639676,0.6944444444444444,0.9835870867180713,1.0,4/14,13.56%,PRKN;SELENOS;LRRK2;CREB3
prerank,organic cation transport (GO:0015695),-0.32260231764590425,-0.8304670854302051,0.7333333333333333,0.9828716439038548,1.0,5/20,15.06%,SLC47A1;SLC22A4;SLC25A42;SLC22A2;SLC22A18
prerank,regulation of stem cell differentiation (GO:2000736),0.2847404562475869,0.8304362766717688,0.737597911227154,0.9033229358178578,1.0,11/89,11.15%,LMO2;GATA2;TAL1;NOTCH1;TCF12;TCF3;PSMA2;TCF15;PSMA8;PSMA6;CBFB
prerank,regulation of macrophage differentiation (GO:0045649),-0.34039387361272155,-0.8293706558496341,0.6926503340757239,0.9840734420211321,1.0,4/15,14.70%,IL34;PRKCA;INHBA;PTPN2
prerank,regulation of urine volume (GO:0035809),0.4149374262847778,0.8293604729595115,0.6446428571428572,0.904763076421732,1.0,3/10,13.61%,NPR1;INPP5K;HAS2
prerank,synaptonemal complex assembly (GO:0007130),0.38211584892211437,0.8290838974766525,0.6707964601769911,0.9043124645924667,1.0,2/15,8.20%,RAD21L1;TRIP13
prerank,synaptonemal complex organization (GO:0070193),0.38211584892211437,0.8290838974766525,0.6707964601769911,0.9043124645924667,1.0,2/15,8.20%,RAD21L1;TRIP13
prerank,response to organonitrogen compound (GO:0010243),-0.2734666193735462,-0.8279890393988042,0.7311827956989247,0.9857530299985771,1.0,3/38,5.97%,PRKN;GLRB;RCN3
prerank,V(D)J recombination (GO:0033151),0.4045837461925186,0.8277512748260717,0.6672566371681415,0.9061621321967028,1.0,5/11,24.55%,TCF3;DCAF1;XRCC4;HMGB1;LIG4
prerank,GPI anchor biosynthetic process (GO:0006506),0.3305874061119113,0.827463240033989,0.696078431372549,0.9062109496416068,1.0,9/30,17.73%,PGAP1;PIGU;PIGK;PIGQ;PGAP4;PIGG;PIGF;PIGL;PIGC
prerank,response to endoplasmic reticulum stress (GO:0034976),0.27561187310825164,0.8274358434847109,0.7652933832709113,0.9057926013461837,1.0,14/107,11.44%,ERN1;RASGRF2;DAB2IP;CASP4;NCK1;TRIB3;BCL2L11;NIBAN1;EIF2B5;RNF139;RHBDD1;ERO1A;MBTPS2;ATF6
prerank,membrane lipid catabolic process (GO:0046466),-0.3789219668092626,-0.8274256910442505,0.6989010989010989,0.9858086553167201,1.0,6/10,28.64%,CYP1B1;PDXDC1;PPT1;SMPD2;NAGA;SGPL1
prerank,response to leucine (GO:0043201),0.404794264032023,0.8273955856714172,0.6487985212569316,0.9049290476477763,1.0,3/10,10.46%,RPTOR;UBR1;LARS1
prerank,cellular response to leucine (GO:0071233),0.404794264032023,0.8273955856714172,0.6487985212569316,0.9049290476477763,1.0,3/10,10.46%,RPTOR;UBR1;LARS1
prerank,steroid biosynthetic process (GO:0006694),-0.2525910818693543,-0.8272585961100221,0.8041958041958042,0.9850538715733219,1.0,15/56,22.31%,CYP7B1;CYP27A1;INSIG2;PRKAG2;OSBPL3;OSBPL6;INSIG1;PRLR;FDFT1;SCP2;FDXR;LSS;CYP51A1;DHRS11;DHCR7
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.3732486195269867,0.8271091411534033,0.6928702010968921,0.9049453945298704,1.0,3/17,5.28%,KDR;EPHB4;GREM1
prerank,nuclear pore organization (GO:0006999),0.3880739419283856,0.8267568100241948,0.6827956989247311,0.9050655547796672,1.0,5/14,14.28%,NUP98;NUP205;NUP133;NUP153;NUP54
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.3525922791044421,0.8263114275681477,0.6779359430604982,0.9053596338169804,1.0,7/22,22.58%,MVB12B;NEDD4;VPS28;VPS37C;STAM;TSG101;VPS36
prerank,negative regulation of interferon-beta production (GO:0032688),-0.3766520985268053,-0.8260483693999676,0.6807095343680709,0.9863700954787447,1.0,5/10,21.11%,PTPRS;SIRPA;CACTIN;PPM1B;PYCARD
prerank,synaptic vesicle recycling (GO:0036465),-0.2816228944026373,-0.8259481205590565,0.7777777777777778,0.9854935796573696,1.0,8/31,14.80%,NLGN2;SYT1;SYNJ2;NLGN1;STON2;NLGN3;AMPH;SNCA
prerank,kinetochore organization (GO:0051383),-0.35368231581600706,-0.8258282946171014,0.7080610021786492,0.9846529941888419,1.0,9/13,37.08%,CENPT;CENPH;NDC80;CENPF;CENPA;DLGAP5;CENPC;CENPW;MIS12
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.31416903853636274,-0.8256154305433835,0.7198067632850241,0.9840037585294213,1.0,5/22,13.40%,APOD;LRRK2;RAB23;SUFU;INSIG1
prerank,GTP metabolic process (GO:0046039),-0.3406737359261817,-0.8255907363803929,0.7159904534606205,0.9830111813154571,1.0,4/15,17.98%,RHOQ;LRRK2;RAB23;ENTPD7
prerank,chemical synaptic transmission (GO:0007268),0.25317034898242885,0.8250122582306111,0.8313253012048193,0.9071962972918688,1.0,17/284,5.43%,MPZ;UNC13B;SLC6A5;SLC6A2;SLC12A7;HTR2A;PDE7B;CACNA1E;PRKAR2B;PCDHB4;RPS6KA3;SYPL1;SDCBP;RPS6KA1;SYN3;CACNA1A;KCNMB4
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2823460020727545,0.8250066372211639,0.7371879106438897,0.9067454701528305,1.0,22/88,20.27%,DAB2IP;TAL1;FNIP2;BIK;TIRAP;SDCBP;SH3GLB1;BCL2L11;TGFB1;CDT1;BID;WARS1;RACK1;RAB7A;CDH5;BMF;PIH1D1;SPIDR;STAM;BAK1;TSG101;RPS3
prerank,histone modification (GO:0016570),0.27750562189023226,0.8246309600933344,0.7783505154639175,0.9069551244626289,1.0,16/109,13.20%,RPS6KA5;HDAC9;USP3;PADI4;PHF20;RCOR1;RBM14;KAT6B;AURKC;CDK2;PARP2;PHF20L1;ENY2;MIER1;MIDEAS;PADI1
prerank,regulation of cell death (GO:0010941),0.2819891502050553,0.8243260912677307,0.7466666666666667,0.9069914178744231,1.0,6/94,3.38%,ACER2;PDE8A;PRKD1;SRGAP2;TNFRSF1B;NCK1
prerank,monoacylglycerol metabolic process (GO:0046462),0.39065220169822334,0.82432400189883,0.6672794117647058,0.9065295287800095,1.0,4/13,15.91%,PLA2G4A;DGAT1;FAAH;MOGAT2
prerank,RNA 3'-end processing (GO:0031123),0.2931872669538838,0.8241169987945819,0.7375690607734806,0.9064242876985654,1.0,23/69,25.30%,TENT4A;WDR33;THOC2;RNPS1;THOC6;RPRD1B;MTPAP;RPRD2;PNPT1;THOC3;ALYREF;CDC40;THOC1;CPSF1;RPRD1A;THOC5;THOC7;SRSF4;TENT4B;SLU7;CPSF3;PCF11;CPSF2
prerank,response to amino acid (GO:0043200),0.32998584169529666,0.8240619428246612,0.7155963302752294,0.9060525643278271,1.0,6/31,11.51%,SH3BP4;TMBIM6;XBP1;RPTOR;LARS1;GRIN1
prerank,regulation of ion transmembrane transport (GO:0034765),0.337411177625051,0.8237680968258165,0.7064220183486238,0.9061204663739848,1.0,5/33,10.53%,NEDD4L;KCNQ1;KCNE2;NEDD4;ANO6
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.39597410030300706,0.8235549789026628,0.6935779816513762,0.906031736656149,1.0,4/12,15.38%,LPCAT3;SOAT2;APOC4;DGAT1
prerank,activin receptor signaling pathway (GO:0032924),-0.3319496206967625,-0.8235248495794012,0.6986301369863014,0.9860812261737014,1.0,4/15,12.53%,TGFBR1;SMAD3;INHBA;ACVR1B
prerank,secretion (GO:0046903),0.3879311705998086,0.8235150091467968,0.6598890942698706,0.9056344352651459,1.0,3/14,7.90%,NPR1;TPD52;GUCA1B
prerank,negative regulation of interleukin-6 production (GO:0032715),0.34422973301742965,0.8234585962307671,0.6936507936507936,0.9052730127720113,1.0,7/27,21.95%,CD200;ARRB1;GAS6;IRAK3;CD200R1;NLRC3;CX3CL1
prerank,regulation of stem cell population maintenance (GO:2000036),-0.3216457536998672,-0.8233472938258243,0.7364864864864865,0.9854267286157207,1.0,4/18,13.84%,PTN;CNOT3;TAF6L;WDR43
prerank,positive regulation of synaptic transmission (GO:0050806),0.292267252681626,0.8230171812452465,0.7409395973154362,0.9056017114701649,1.0,3/72,2.55%,SHANK3;APP;PTK2B
prerank,polarized epithelial cell differentiation (GO:0030859),0.38865286353984174,0.8229148674674568,0.6587591240875912,0.9053120846319366,1.0,2/13,5.74%,MSN;OPHN1
prerank,cGMP biosynthetic process (GO:0006182),0.4160231176428046,0.8228656462810295,0.6747211895910781,0.9049309877918129,1.0,1/10,2.59%,NPR1
prerank,positive regulation of translation (GO:0045727),-0.2275094923730509,-0.8226232791726009,0.8326693227091634,0.9857667497182716,1.0,9/94,9.93%,SAMD4A;PLD1;THBS1;CPEB3;FXR2;RMND1;PRR16;LARP6;CIRBP
prerank,regulation of RNA splicing (GO:0043484),0.29247109270305954,0.8224264094927867,0.74,0.9052202030425381,1.0,13/69,10.96%,ERN1;TMBIM6;PTBP3;RBM20;MBNL1;MBNL2;HNRNPF;DYRK1A;MBNL3;HNRNPK;ZNF326;HNRNPLL;YTHDC1
prerank,regulation of cholesterol transport (GO:0032374),-0.31371616186268764,-0.82232204939919,0.7263922518159807,0.9852677165212079,1.0,6/20,23.94%,LRP1;OSBPL6;TSPO;NR1H3;ABCA2;LAMTOR1
prerank,transition metal ion transport (GO:0000041),0.3287796023057534,0.8221743153551,0.7207488299531981,0.9051906834010969,1.0,4/35,10.44%,SLC39A8;SLC31A1;ATP2C1;ATP7B
prerank,positive regulation of macrophage activation (GO:0043032),-0.325451629733032,-0.8216525309629041,0.7053364269141531,0.9855308786932832,1.0,2/17,3.51%,LBP;THBS1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.3533106913673758,-0.8214491891868766,0.7025171624713958,0.9848642956470582,1.0,3/13,13.05%,APOD;RAB23;SUFU
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.3204088752459883,0.8212574691996409,0.7047184170471842,0.9062564117937711,1.0,6/40,12.23%,TNFSF10;BIK;BCL2L11;BCL2L1;BNIP3;BID
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.3887043973547724,0.8210932389587823,0.6509090909090909,0.9060791186718554,1.0,1/12,1.99%,FOXP1
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.3691771203660606,-0.8207747224025637,0.6652360515021459,0.9851099782545607,1.0,3/10,16.60%,PRKACA;APOE;ABCA7
prerank,regulation of macrophage activation (GO:0043030),0.32914001977016416,0.8199765659855479,0.6784,0.9075586830499063,1.0,3/30,5.81%,CD200;MFHAS1;WNT5A
prerank,protein maturation (GO:0051604),-0.2314497195142609,-0.8197181036763629,0.8634361233480177,0.9860840204913222,1.0,27/95,21.83%,AEBP1;F3;OGT;PCSK5;NNAT;MMP14;MMP16;TASP1;ADAM19;NAA40;CPXM2;APH1B;CPXM1;DNAJB11;CCS;TSPAN15;PCSK6;LMF1;NCSTN;CPM;CIAO1;NFU1;BACE1;NAA60;PTCH1;CTSS;EEF1AKMT4-ECE2
prerank,motile cilium assembly (GO:0044458),-0.36269963680700334,-0.8196142095745776,0.7035398230088495,0.985233329109494,1.0,4/12,15.43%,BBOF1;BBS5;CCDC39;RSPH9
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3374107286963966,0.8195536692411531,0.6963696369636964,0.907799814888153,1.0,4/28,12.14%,ESAM;RASA1;ARHGAP28;DBNL
prerank,cellular response to gamma radiation (GO:0071480),-0.32752251746165345,-0.8187198227156687,0.6963470319634704,0.9859246285114733,1.0,11/17,35.71%,MDM2;XRCC5;XRCC6;TSPYL5;TP53;ATR;CRYAB;ATM;WRN;HRAS;HSF1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.40226280688770033,0.8181972823858472,0.6880733944954128,0.9096491714798979,1.0,5/11,12.97%,SMAD7;USP15;ACVR1;TGFB1;TGFBR2
prerank,protein modification by small protein removal (GO:0070646),0.2528672309729136,0.8178101059127907,0.8504464285714286,0.909831808260034,1.0,72/252,23.27%,ESR1;SMAD1;HIF1A;NFKBIA;USP3;BABAM2;SMAD7;USP15;UCHL5;ATXN3;SNX3;PSMA2;BRCC3;FOXK1;ZRANB1;TNIP1;IKBKG;PSMA8;COPS2;RAD23A;PSMA6;OTUD4;COPS4;ASXL1;RIPK1;BIRC3;IFIH1;TRAF6;YY1;APC;MBD5;PSME1;KAT2B;USP12;RHOA;ACTR5;ABRAXAS2;BIRC2;NEDD8;RHOT1;YOD1;WDR48;NFRKB;WDR20;PSMA4;USP8;DESI2;DESI1;USP7;PSMF1;SMAD2;STAM;USP25;USP21;NLRP3;PSMB1;TADA2B;PSMB7;TRRAP;PSMD2;ATXN7;TNIP2;PSMA5;EIF3F;TRAF2;CCNA2;BABAM1;JOSD1;SENP6;STAM2;UCHL3;PSMC3
prerank,mRNA transport (GO:0051028),0.2764732464264353,0.8177300095089818,0.7644736842105263,0.9095206703583404,1.0,28/101,19.93%,HHEX;EIF4E;NXF2;WDR33;THOC2;SMG7;YTHDC1;NUP214;RNPS1;NUP98;THOC6;ZFP36;FMR1;UPF2;NUP205;NUP133;NUP153;NUP54;ZFP36L1;NUP43;AGFG1;THOC3;ALYREF;CDC40;THOC1;CPSF1;GLE1;THOC5
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.35316917701461376,0.8175866217782025,0.697986577181208,0.909301682047211,1.0,6/22,12.83%,LYN;EFNA1;EPHA4;PICALM;RELA;ABCG1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.3714403571597512,-0.8170319755908864,0.6967592592592593,0.9881146568208297,1.0,4/10,23.72%,CAMK1;SMARCB1;CHEK1;SPHK2
prerank,zinc ion transmembrane transport (GO:0071577),0.3492491799797837,0.8167847818278003,0.6785109983079526,0.9101977004409213,1.0,1/22,0.93%,SLC39A8
prerank,positive regulation of biosynthetic process (GO:0009891),0.3242274573260401,0.8165561803062936,0.7033639143730887,0.9101050005394207,1.0,7/40,13.24%,RAB27A;PLCG2;SORBS1;TGFB1;CREB1;GRIN1;MTPN
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.2874217956332668,-0.8164514336266958,0.7431693989071039,0.9881571579695582,1.0,4/32,4.64%,MAGI2;PDGFRB;PRKCD;ITGA1
prerank,bile acid metabolic process (GO:0008206),-0.28818659896711807,-0.8164135939657192,0.7184986595174263,0.9871948435181811,1.0,5/27,14.85%,CYP7B1;CYP27A1;OSBPL3;OSBPL6;SCP2
prerank,entry into host (GO:0044409),0.37563747295925465,0.8162251883730097,0.6684027777777778,0.9102000471799393,1.0,6/13,17.46%,CBLL1;CXCR4;CBL;MET;CTNNB1;GRB2
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.3950129576938342,0.8158766717177013,0.6955684007707129,0.910290201971024,1.0,3/11,22.80%,XBP1;TAF7;JAK2
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.2652841118950029,-0.8158233745167787,0.7818181818181819,0.9872975415891598,1.0,4/40,5.88%,PRKCD;KMT5A;FXR2;NEK4
prerank,regulation of fibroblast migration (GO:0010762),0.35804943922618265,0.8154636693193047,0.6878306878306878,0.9105213947848244,1.0,7/20,11.77%,PRR5L;RAC1;TGFB1;PTK2;GNA12;ARHGEF7;CORO1C
prerank,regulation of protein localization to centrosome (GO:1904779),-0.37345804361360324,-0.8153943563988868,0.6916666666666667,0.9870798359053705,1.0,1/10,2.18%,BICD1
prerank,negative regulation by host of viral process (GO:0044793),0.3955478675273184,0.8150395941701006,0.6421845574387948,0.9108284715197272,1.0,6/10,24.16%,CCNK;PTX3;EIF2AK4;VAPA;PSMC3;CRP
prerank,modulation by host of viral genome replication (GO:0044827),-0.35512112655832323,-0.8147958462604763,0.6995412844036697,0.9872053541832868,1.0,4/13,13.49%,PRKN;IFI27;NUCKS1;TBC1D20
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.35225698642768777,0.813351605221748,0.6996644295302014,0.9131611871604964,1.0,7/21,23.21%,ARHGEF2;CAMSAP2;APC;CIB1;TAOK1;ATXN7;CLASP2
prerank,regulation of TOR signaling (GO:0032006),0.29003283977466765,0.8131155149961065,0.7531734837799718,0.9131028972310574,1.0,10/67,11.07%,SH3BP4;DDIT4;TNFAIP8L1;RPTOR;GNA12;UBR1;RICTOR;NPRL2;LARS1;GAS6
prerank,regulation of DNA replication (GO:0006275),-0.2587275016185065,-0.8125800082405853,0.814935064935065,0.9903855892444814,1.0,6/49,9.21%,EGFR;GLI2;EHMT2;NUCKS1;GLI1;ZBTB38
prerank,steroid catabolic process (GO:0006706),0.4102623587334303,0.8120840698569983,0.6842105263157895,0.9144477910416611,1.0,2/10,9.59%,FGF23;CYP27B1
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.4018920455743591,0.8116661498678067,0.6897196261682244,0.914710296845382,1.0,2/10,11.05%,BTN2A2;RC3H1
prerank,cardiac muscle cell differentiation (GO:0055007),0.3515654635169744,0.8116180410185074,0.7037643207855974,0.9143210620722466,1.0,3/21,6.15%,MEF2C;SIK1;ACVR1
prerank,regulation of protein polymerization (GO:0032271),0.32237530547660365,0.8113456686756878,0.7329192546583851,0.9143137804748231,1.0,6/35,12.14%,ESAM;RASA1;CAMSAP2;ARHGAP28;PRUNE1;DBNL
prerank,negative regulation of myotube differentiation (GO:0010832),0.3876831221942964,0.8113447988614164,0.6837294332723949,0.9138530022206119,1.0,2/12,4.85%,NOTCH1;XBP1
prerank,response to X-ray (GO:0010165),-0.3407598324609743,-0.8111609345042887,0.7354260089686099,0.9919756406731558,1.0,5/14,19.16%,ANXA1;NUCKS1;IKBIP;XRCC5;XRCC6
prerank,peptidyl-threonine modification (GO:0018210),0.29203614952444307,0.8111450157586594,0.7462068965517241,0.9137378141052522,1.0,9/66,6.62%,PRKD1;PRKD2;LMTK2;HIPK1;CDC42BPB;MAPK8;ULK1;ACVR1;DYRK1A
prerank,negative regulation of translation (GO:0017148),0.2837607258900793,0.8108857889273635,0.7762803234501348,0.9137112319581931,1.0,16/87,13.14%,NANOS3;DAPK1;IGF2BP3;NANOS2;GRB7;RNF139;PUM1;BTG2;CNOT1;RPL13A;EIF4EBP1;MRPL13;RACK1;FMR1;EIF2AK4;CNOT7
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.3519079557852415,-0.8106017331493909,0.7087155963302753,0.9919804881675328,1.0,2/11,3.16%,ACTN2;GPM6B
prerank,synaptic vesicle exocytosis (GO:0016079),0.30892280748412854,0.8100585629329645,0.7407952871870398,0.9146046133452131,1.0,2/40,1.31%,UNC13B;STX3
prerank,histone lysine demethylation (GO:0070076),0.33740770772240136,0.8100184484355675,0.7111853088480802,0.9142213718338056,1.0,4/25,8.15%,KDM3A;KDM6A;JMJD1C;KDM4C
prerank,negative regulation of interleukin-8 production (GO:0032717),0.3642186512529091,0.8099338199525862,0.7020905923344948,0.913904650987483,1.0,3/17,6.87%,TMSB4X;BCL3;ARRB1
prerank,mitochondrion distribution (GO:0048311),0.389560652076276,0.8094200748987221,0.6833333333333333,0.9143238279254933,1.0,4/12,18.61%,MTM1;MEF2A;MSTO1;TRAK2
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.24031593405653723,-0.8091227466636067,0.8666666666666667,0.9935931337418342,1.0,8/68,10.34%,AMPD3;RHOQ;ENPP1;ACOT11;TPST1;LRRK2;ABHD14B;ACAT1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.26278202088148755,-0.8087814830722622,0.7950138504155124,0.9931916660098573,1.0,6/43,9.81%,EGFR;ERRFI1;CBLB;ITGA1;SNX6;MVP
prerank,negative regulation of lipid metabolic process (GO:0045833),0.34989206372358894,0.8083258345040766,0.7203791469194313,0.9157225101075732,1.0,2/22,5.16%,PPP2R5A;CEACAM1
prerank,DNA recombination (GO:0006310),-0.2686111711966703,-0.8082437310686224,0.7899686520376176,0.9930965552581477,1.0,19/37,31.73%,RECQL5;RAD51B;RTEL1;RAD50;RHNO1;DMC1;IGHMBP2;RAD51C;FBH1;GEN1;RAD52;XRCC3;RAD54L;RPAIN;EXO1;SUPV3L1;ERCC1;BLM;WRN
prerank,cellular response to glucose starvation (GO:0042149),-0.265074294245434,-0.8081173621616897,0.7904191616766467,0.99229834636842,1.0,12/41,16.39%,BRSK1;IMPACT;PRKAA2;PRKAG2;CPEB4;EIF2AK3;PRKAG3;SZT2;NUAK2;HNRNPA1;SESN2;PRKAG1
prerank,positive regulation of response to wounding (GO:1903036),-0.29420359175157274,-0.807919572853563,0.7806788511749347,0.9916457170184202,1.0,6/24,13.66%,PTN;VTN;ANXA1;ADRA2A;CLDN1;HBEGF
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.28029642550748257,-0.8078472441981898,0.771505376344086,0.9907617572489352,1.0,8/32,14.80%,CEMIP;AKAP6;TRPC1;GSTM2;GPER1;HTT;JPH2;SNCA
prerank,protein lipidation (GO:0006497),0.28851015799164875,0.8072520974971178,0.7684931506849315,0.9170717129421593,1.0,16/59,21.13%,UGCG;PIGU;ZDHHC18;ZDHHC9;HHAT;PIGQ;PGAP4;PIGG;PIGF;PIGL;PIGC;ZDHHC1;ATG7;ZDHHC6;ZDHHC8;SELENOK
prerank,positive regulation of tissue remodeling (GO:0034105),0.40919871122713636,0.8069272558030015,0.6823104693140795,0.9171560172591677,1.0,2/10,9.76%,IL15;IL23A
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.3137804459123881,0.806816657912491,0.7543581616481775,0.9168808382848567,1.0,4/37,5.95%,STAT3;GBP5;HIF1A;CUEDC2
prerank,UV protection (GO:0009650),-0.36830795914135506,-0.8060771544236817,0.7158119658119658,0.9929864326325136,1.0,3/10,12.52%,SCARA3;ERCC5;MFAP4
prerank,non-motile cilium assembly (GO:1905515),-0.27937739502224357,-0.8060592029027193,0.7857142857142857,0.9919783185463362,1.0,9/30,20.23%,IFT88;RPGRIP1L;TTC8;CEP89;FUZ;PCM1;TMEM17;C2CD3;IFT57
prerank,NAD biosynthetic process (GO:0009435),0.34751871814402263,0.8056912165573183,0.697754749568221,0.9182991671750012,1.0,1/20,0.99%,PTGS2
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.3440291161761586,0.8054044599481814,0.7213114754098361,0.9183099724479531,1.0,1/25,1.15%,MEF2C
prerank,spliceosomal snRNP assembly (GO:0000387),0.3142254009603891,0.805221686176773,0.7083333333333334,0.9181637334914847,1.0,19/38,31.88%,TGS1;WDR77;DDX20;AAR2;STRAP;SRSF10;SART3;SART1;PRPF3;SNRPD3;LSM2;SNUPN;PRMT5;COIL;SNRPD2;SNRPD1;SNRPB;CLNS1A;GEMIN8
prerank,histone mRNA catabolic process (GO:0071044),0.3762021787188312,0.8049640863818409,0.6964285714285714,0.9181050722214708,1.0,8/15,30.04%,DCP2;MTPAP;LSM1;TENT4B;EXOSC4;TUT7;TUT1;ERI1
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.322907608554841,0.8038908755480376,0.7317829457364341,0.9194315069228307,1.0,4/30,12.13%,ELOVL7;ELOVL5;ABCD4;ABCD1
prerank,fluid transport (GO:0042044),-0.3433554459812105,-0.8038625728964232,0.7136363636363636,0.99495054147162,1.0,1/12,1.61%,PDPN
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.36860259556977815,0.803575549293177,0.7017241379310345,0.9194864479778351,1.0,2/16,2.22%,IL6ST;EDN1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.38085296440077876,0.803553544127649,0.7078260869565217,0.9190632879958356,1.0,4/12,13.78%,ATF7IP;TASOR;PPHLN1;SETDB2
prerank,regulation of epidermal cell differentiation (GO:0045604),0.35029024191292546,0.802836089894982,0.7081260364842454,0.9198053701096527,1.0,8/21,14.46%,KLF7;MAFF;DLL1;CTSK;SFN;CBFB;ZFP36;ZFP36L1
prerank,positive regulation of type 2 immune response (GO:0002830),-0.3317964551327157,-0.8022415462317799,0.6941964285714286,0.9967570668953281,1.0,3/14,10.58%,IL18;PRKCZ;CD81
prerank,positive regulation of cell death (GO:0010942),0.2957063273918652,0.802147812731446,0.7651296829971181,0.9204684292460582,1.0,10/59,12.68%,ACER2;DDIT4;FYN;SLC6A6;WNT5A;CDKN1B;BNIP3;PICALM;RIPK1;RIPK2
prerank,regulation of translational initiation (GO:0006446),0.2861321475101663,0.8020242419551799,0.7836676217765043,0.9202034725446324,1.0,16/63,17.32%,NCK1;EIF3H;EIF1;EIF2B5;EIF4EBP1;EIF5B;FMR1;EIF2AK4;UHMK1;PAIP1;NPM1;EIF2B2;CTIF;EIF5;PAIP2B;CSDE1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.3651296280950484,0.8014736615664695,0.7041742286751361,0.920684071711992,1.0,4/15,6.15%,FKBP1A;ACVR2A;SMAD7;ACVR1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.3989769795890156,0.8012028014838988,0.6890130353817505,0.9206647804820459,1.0,1/12,0.70%,UNC13B
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.35311156081941575,-0.8008961825649186,0.7552742616033755,0.9981740573799373,1.0,2/11,6.79%,PRKN;P4HB
prerank,cilium assembly (GO:0060271),0.2447399900633459,0.8008857120175982,0.8835164835164835,0.9207508987227682,1.0,27/296,10.83%,ABCC4;ABLIM1;FNBP1L;EXOC6;EHD4;RAB11A;NOTCH1;CNGB1;PRKAR2B;SSX2IP;DISC1;CEP41;PCNT;SPATA6;RP1L1;BBIP1;EHD2;DYNLL1;EXOC5;CNTRL;TEKT5;CEP57;EXOC4;OCRL;CEP83;DYNLRB1;ARL13B
prerank,dendritic cell differentiation (GO:0097028),0.3421042696392903,0.7998319513855757,0.7,0.9221004593152603,1.0,4/22,12.97%,LYN;DCSTAMP;GAS6;TGFBR2
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.3365991745089678,-0.7997012384279388,0.7392241379310345,0.9993221003248133,1.0,6/13,24.63%,CDH13;LDLR;CD81;SYK;ITGB2;PPARG
prerank,pore complex assembly (GO:0046931),0.36305437940031215,0.799454265836063,0.7301038062283737,0.9222732521696163,1.0,6/19,15.58%,ADAM10;ANO6;NUP98;NUP205;NUP153;TSPAN33
prerank,positive regulation of protein export from nucleus (GO:0046827),0.3765226266567248,0.7994357203392533,0.6980802792321117,0.9218417006861077,1.0,7/15,27.39%,TCF7L2;GAS6;ANP32B;RAPGEF3;YWHAE;GSK3B;EMD
prerank,regulation of telomere capping (GO:1904353),0.3400382320442171,0.7992572005391642,0.7268445839874411,0.9216570463050182,1.0,2/23,7.80%,NEK7;HNRNPD
prerank,regulation of intracellular transport (GO:0032386),0.3157444422800071,0.7991771896011945,0.7438650306748467,0.921334497009982,1.0,8/38,13.69%,LCP1;DNAJC30;RNF139;PTPN1;INPP5F;NUP214;RAB11B;NDEL1
prerank,positive regulation of telomere maintenance (GO:0032206),0.32571125888558744,0.7989698886330164,0.7209302325581395,0.9212171924214453,1.0,5/31,14.88%,NEK7;PPP1R10;HNRNPD;SIRT6;ATRX
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.3946320573722385,0.7985664716885646,0.681214421252372,0.9214192551653594,1.0,2/11,5.28%,RIN3;GREM1
prerank,polyol biosynthetic process (GO:0046173),-0.3243934761086355,-0.7980459539301432,0.7589285714285714,1.0,1.0,3/16,8.27%,CYP27A1;FGF2;ISYNA1
prerank,DNA geometric change (GO:0032392),-0.29976412882678066,-0.7979755195748148,0.7777777777777778,1.0,1.0,5/24,11.03%,HNRNPA2B1;ANXA1;RECQL5;RTEL1;RAD50
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2609910224621748,0.7975012138770643,0.8374384236453202,0.9226995545567409,1.0,46/148,24.63%,PPP1R13B;JMY;RPS15;HIPK1;PHF20;RPS20;AURKA;RPA1;TAF3;RRS1;TAF4B;BRIP1;RICTOR;RPL23;CDK2;MAPK11;NUAK1;PRKAB1;HUS1;RMI1;NOP53;KAT6A;RPL11;CHEK2;EHMT1;PRKAA1;USP7;RFC3;CSNK2A1;CSNK2A2;TTC5;TAF9;TAF7;RAD17;RMI2;TAF15;MAP2K6;MAPKAP1;RFC5;MAPK14;PIP4K2B;PDPK1;RFFL;MBD3;PLK3;BRPF1
prerank,microtubule bundle formation (GO:0001578),0.30805064083468836,0.7970360183564783,0.7441176470588236,0.9229654069283859,1.0,12/42,23.78%,NAV1;RP1L1;CFAP46;SPAG16;CHP1;CDK5RAP2;NUMA1;CLIP1;PLK1;GAS2L1;CFAP206;RSPH4A
prerank,RNA biosynthetic process (GO:0032774),0.3179943481944143,0.7969539689541043,0.7411575562700965,0.9226414435112494,1.0,13/31,29.43%,POLA1;SMARCA5;HELB;PRIM2;TAF7;SETX;TTF2;BRF1;TCEA2;PRIM1;PRMT5;POLA2;RSF1
prerank,protein import into mitochondrial matrix (GO:0030150),-0.3024699238936034,-0.7968989291060536,0.7552447552447552,1.0,1.0,9/18,35.49%,TOMM40;TIMM17B;GRPEL2;TIMM21;DNAJC15;PAM16;TOMM70;TIMM23;DNAJC19
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.34128793971781557,-0.7966392965460047,0.7274725274725274,1.0,1.0,4/14,14.00%,IRS1;PPARA;IRS2;MFSD2A
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.3564755785637124,-0.7964569053047124,0.7121212121212122,0.999803897181962,1.0,4/10,9.13%,DCN;BCL2;LRRK2;SRC
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.38100696228923614,0.7964317423966772,0.6748582230623819,0.9230358637010594,1.0,3/11,12.26%,MAD2L2;TFAP4;MUC1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.33635137148826416,0.7963863089166077,0.7281879194630873,0.922662671632659,1.0,8/24,18.07%,FYN;KCNB1;AKT2;MYO1C;TCAF2;ERBB2;CHP1;CIB1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.3501443735846363,-0.7963845656321048,0.726027397260274,0.9988832088123746,1.0,7/12,36.36%,CDC14B;BTRC;PTEN;GORASP1;GOLGA2;UBE2C;UBE2S
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.30096707393862926,0.795842645618966,0.7481804949053857,0.9231087855758385,1.0,9/48,14.67%,NLRC5;SAMHD1;SIGIRR;OTUD4;GAS6;CARD16;GSTP1;CNOT7;IRAK3
prerank,estrogen metabolic process (GO:0008210),-0.3204298782435784,-0.7957282938558765,0.7125890736342043,0.9989910195818051,1.0,9/15,48.52%,CYP1B1;HSD17B14;HSD17B1;HSD17B2;HSD17B8;CYP1A1;SULT1A1;CYP19A1;HSD17B10
prerank,visual system development (GO:0150063),0.31335227467433857,0.7951656123032466,0.7334315169366715,0.9237387831814398,1.0,4/37,4.99%,PBX1;FREM2;SIPA1L3;HIPK1
prerank,regulation of microtubule depolymerization (GO:0031114),0.33966763511828624,0.7943313793976788,0.739202657807309,0.9246278545683109,1.0,8/25,23.21%,ARHGEF2;CAMSAP2;TRPV4;APC;CIB1;TAOK1;ATXN7;CLASP2
prerank,negative regulation of interleukin-12 production (GO:0032695),0.3687624903798078,0.7943138249497399,0.718978102189781,0.9242015552032009,1.0,3/14,14.67%,JAK3;TIGIT;IRAK3
prerank,ERK1 and ERK2 cascade (GO:0070371),0.34924882866356705,0.7936887866915137,0.7266666666666667,0.9247510496347656,1.0,2/21,4.24%,KDR;SOX9
prerank,positive regulation of reproductive process (GO:2000243),-0.2728042833408907,-0.7933622541311671,0.7642276422764228,1.0,1.0,11/31,27.95%,SIRT2;VEGFA;INHBA;ACVR1B;SYDE1;INHBB;CFAP69;C1QBP;CACNA1H;SMURF2;HYAL3
prerank,negative regulation of leukocyte migration (GO:0002686),0.3936791256730729,0.7932541601848049,0.6910112359550562,0.9250323737686098,1.0,1/10,1.50%,CD200
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.3876471830349932,0.7926176214980752,0.7106227106227107,0.9256125985909256,1.0,4/11,11.77%,RREB1;ENPP2;ARHGEF7;CORO1C
prerank,regulation of wound healing (GO:0061041),0.3044054181863051,0.7924685336474637,0.7566765578635015,0.9254124856587151,1.0,5/42,10.51%,CAV1;OCLN;PTK2;CRK;INSL3
prerank,triglyceride metabolic process (GO:0006641),0.2966480544988009,0.7912274518673125,0.784992784992785,0.9269669531949972,1.0,10/48,15.91%,CAV1;LPIN3;LPL;PLAAT3;FABP12;GK5;MOGAT1;PNPLA2;DGAT1;MOGAT2
prerank,positive regulation of coagulation (GO:0050820),-0.36178391041308167,-0.7908820809515664,0.7468879668049793,1.0,1.0,4/10,23.64%,THBS1;SERPINE1;ST3GAL4;HPSE
prerank,positive regulation of hemostasis (GO:1900048),-0.36178391041308167,-0.7908820809515664,0.7468879668049793,1.0,1.0,4/10,23.64%,THBS1;SERPINE1;ST3GAL4;HPSE
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.3341471547997679,0.7907504580582225,0.7346938775510204,0.9272580390326999,1.0,7/22,22.29%,PSMA2;PSMA8;PSMA6;PSMA4;PSMB1;PSMB7;PSMA5
prerank,cellular response to UV (GO:0034644),0.27905164484250855,0.7907389561433612,0.796221322537112,0.926822583286814,1.0,18/76,19.07%,POLK;PTPRK;N4BP1;NEDD4;RHBDD1;MC1R;CARD16;OPN5;ERCC4;FMR1;EIF2AK4;NPM1;YY1;BMF;ACTR5;KDM1A;DHX36;BAK1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.24011844118353873,0.7902929780281588,0.89587852494577,0.9270704487726724,1.0,71/314,21.42%,STT3B;SMURF1;NEDD4L;FBXW7;ZNRF1;KCTD10;PELI1;FBXL4;AURKA;ARRB1;ATXN3;UBE2G1;FBXL7;NEDD4;PSMA2;TRIM25;ARMC8;UBR1;ANAPC7;CDK2;FBXL2;SPOPL;RNF4;PSMA8;ANAPC1;RAD23A;ZFAND2B;SIAH1;PSMA6;UBE2D3;CUL1;CDC26;RB1;COP1;ANAPC16;UBE2K;FBXL3;TOPORS;BUB3;UBXN1;PSME1;AREL1;RNF5;DDIT3;UBE3D;MAEA;CRBN;CTNNB1;BIRC2;NHLRC1;CUL3;YOD1;PSMA4;CDC34;PSMF1;DNAJB12;ZFAND2A;APPBP2;DNAJC10;CUL2;PLK1;FBXO17;PSMB1;KCTD2;TRIM71;PSMB7;KCTD5;PSMD2;HACE1;SEL1L;UBXN2A
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.2908032901884259,-0.7897397551371281,0.7740384615384616,1.0,1.0,6/22,22.59%,ERI3;FTSJ3;EXOSC7;EXOSC3;EXOSC9;KRI1
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.2884643617441192,-0.7892559376426279,0.7700534759358288,1.0,1.0,7/26,18.82%,OGT;KMT5C;CTR9;SETD4;VCPKMT;KMT2D;BEND3
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.30798300616627894,-0.7889745510850004,0.7572815533980582,1.0,1.0,1/18,0.55%,FBN1
prerank,bicarbonate transport (GO:0015701),-0.2859458683372036,-0.7888806966933799,0.7602040816326531,1.0,1.0,8/25,17.53%,SLC4A10;SLC26A7;CA4;SLC4A3;SLC4A2;SLC26A6;CFTR;SLC4A8
prerank,mRNA export from nucleus (GO:0006406),0.26639828929775844,0.7888162115917952,0.8068783068783069,0.9290353343725744,1.0,36/102,25.31%,HHEX;EIF4E;NXF2;WDR33;THOC2;SMG7;YTHDC1;NUP214;RNPS1;ENY2;NUP98;THOC6;UPF2;NUP205;NUP133;NUP153;NUP54;NUP43;AGFG1;THOC3;ALYREF;CDC40;THOC1;CPSF1;GLE1;THOC5;THOC7;SMG6;IWS1;SRSF4;NUP42;SLU7;CPSF3;NUP85;CPSF2;PCID2
prerank,neural tube closure (GO:0001843),-0.2698338100419782,-0.7887051193831468,0.797583081570997,1.0,1.0,7/34,11.64%,LMO4;COBL;LRP6;TSC2;FUZ;MTHFD1;TGFB2
prerank,neutral amino acid transport (GO:0015804),0.33408887029706286,0.7881237639107764,0.7484756097560976,0.929708382899015,1.0,7/28,15.68%,SLC38A5;SLC3A2;SLC6A6;SLC43A2;SLC38A1;SLC36A4;SLC7A5
prerank,acylglycerol homeostasis (GO:0055090),0.3454094686099924,0.7876702471270272,0.7244897959183674,0.9299849866530737,1.0,6/20,18.18%,SCARB1;LPL;APOC4;PNPLA8;ANGPTL4;MLXIPL
prerank,response to ionizing radiation (GO:0010212),0.2812690307730262,0.787627467825228,0.7976031957390146,0.9295973515808297,1.0,3/70,3.93%,NET1;DCUN1D3;BABAM2
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.3643477710500953,0.7875563601896718,0.7245080500894454,0.9292504122603702,1.0,2/16,4.22%,SCARB1;PLIN5
prerank,histone H4-K16 acetylation (GO:0043984),0.348107648976377,0.7874879550695979,0.7197231833910035,0.9289110463096566,1.0,6/19,17.80%,PHF20;JADE2;JADE1;JADE3;MSL2;KANSL1
prerank,regulation of cilium movement (GO:0003352),-0.357406574127038,-0.7874568258408216,0.7300613496932515,1.0,1.0,4/10,25.00%,CCDC39;DNAH11;CFAP43;DRC1
prerank,regulation of lymphocyte activation (GO:0051249),0.38233918626977964,0.7870660430402278,0.7368421052631579,0.92912966749556,1.0,3/12,16.39%,LCK;DCAF15;LAT
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3215452997767936,0.7869676609662021,0.7213375796178344,0.9288257883192061,1.0,6/29,13.06%,DAB2IP;EFNA1;SMAD7;SFRP2;MAD2L2;ADIPOR1
prerank,alanine transport (GO:0032328),0.39949505128179474,0.7866126339563074,0.7055555555555556,0.9289137294348112,1.0,2/10,13.46%,SLC6A6;SLC36A4
prerank,regulation of osteoclast differentiation (GO:0045670),-0.2707045517334891,-0.7863826063528639,0.8135135135135135,1.0,1.0,6/33,17.91%,FBN1;UBASH3B;PRXL2A;GPR137B;CEBPB;FSTL3
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.36912018616475595,0.7863556844313325,0.7244525547445255,0.9288639227279984,1.0,4/13,15.98%,TMSB4X;PSEN1;MAD2L2;DDIT3
prerank,regulation of viral release from host cell (GO:1902186),0.3315567859606261,0.7862365362839387,0.7254901960784313,0.9285910253846592,1.0,3/21,7.94%,CHMP2B;MID2;TRIM25
prerank,mRNA destabilization (GO:0061157),-0.2618541091674481,-0.7859796826608209,0.8114754098360656,1.0,1.0,12/38,27.27%,ROCK2;CPEB3;MOV10;CELF1;FTO;RC3H2;TUT4;PDE12;RBM24;TARDBP;POLR2D;ZFP36L2
prerank,aggrephagy (GO:0035973),-0.27819940434253276,-0.7857096873406921,0.8086253369272237,1.0,1.0,4/27,8.68%,PRKN;IFT88;DYNC1I1;SQSTM1
prerank,regulation of feeding behavior (GO:0060259),0.38577576142139136,0.7855070757419376,0.7156133828996283,0.9292785067210338,1.0,4/11,16.55%,STAT3;UCN;EIF2AK4;AGRP
prerank,negative regulation of T cell activation (GO:0050868),0.31170286713953804,0.7849274946408495,0.7662538699690402,0.9297583534956396,1.0,4/35,6.50%,JAK3;CEACAM1;PLA2G2D;TIGIT
prerank,macroautophagy (GO:0016236),0.26137363124996005,0.7846853898985918,0.8524173027989822,0.9296747833830246,1.0,37/118,24.40%,KLHL3;ULK1;CHMP2B;PGAM5;TECPR1;DYNLL1;CHMP4A;CHMP4B;ATG101;ARL8B;VPS28;PRKAB1;VAMP8;TBC1D5;GABARAPL1;ILRUN;VPS37C;MFN1;YOD1;PRKAA1;MTERF3;CSNK2A1;CSNK2A2;TOMM22;ATG7;STAM;VTA1;TSG101;PLEKHM1;VTI1B;PIK3R4;VPS36;STAM2;PIP4K2B;RB1CC1;ZFYVE1;MTMR14
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.32413908230148536,-0.7845417940844595,0.7584650112866818,1.0,1.0,6/15,38.15%,SELENOS;NPLOC4;DERL2;HSP90B1;VCP;DERL1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.3097755730985556,0.7845209482353361,0.7850746268656716,0.9294812294572152,1.0,9/37,23.62%,POLK;RPA1;ERCC4;GTF2H4;RFC3;GTF2H1;CHD1L;RFC5;CUL4B
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.3385952010003681,-0.783892897018188,0.7450110864745011,1.0,1.0,4/12,20.94%,PARP3;PARP11;PARP8;TIPARP
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.2959932135921584,-0.78361065182108,0.7575757575757576,1.0,1.0,1/23,0.34%,IGF1
prerank,arachidonate transport (GO:1903963),-0.3522766031503417,-0.783278430322108,0.7420091324200914,1.0,1.0,2/10,8.03%,ANXA1;BDKRB2
prerank,arachidonic acid secretion (GO:0050482),-0.3522766031503417,-0.783278430322108,0.7420091324200914,1.0,1.0,2/10,8.03%,ANXA1;BDKRB2
prerank,positive regulation of hormone secretion (GO:0046887),0.35744178924983444,0.7832508536469247,0.7344827586206897,0.9310763270779576,1.0,2/17,10.60%,EDN1;VAMP8
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.37666527476923783,0.7825102472472689,0.7236842105263158,0.9317984226750703,1.0,3/11,11.77%,CASP8;RFTN1;RIPK1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.2688571098775688,0.7823260288456865,0.8125802310654685,0.9316508499703818,1.0,21/95,20.25%,SAMHD1;RAD21L1;MMS22L;RPA1;RAD51D;SEM1;MEIOB;RECQL;XRCC2;FAN1;HUS1;RMI1;MCM9;ERCC4;YY1;SPIDR;RAD21;NSMCE1;SWSAP1;GINS2;NSMCE2
prerank,protein O-linked mannosylation (GO:0035269),0.33639043777541233,0.7816264782438802,0.6889279437609842,0.9322923951712893,1.0,3/18,8.93%,TMTC2;B4GAT1;RXYLT1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.34074479444335837,0.7814210688965431,0.7179930795847751,0.9321621698137291,1.0,6/22,15.07%,PPM1F;PPM1D;DUSP16;DUSP2;DUSP7;PDP1
prerank,histone H4-K8 acetylation (GO:0043982),0.36454618072170764,0.7810101547386964,0.7338262476894639,0.93185750648891,1.0,4/15,9.47%,PHF20;JADE2;JADE1;JADE3
prerank,histone H4-K5 acetylation (GO:0043981),0.36454618072170764,0.7810101547386964,0.7338262476894639,0.93185750648891,1.0,4/15,9.47%,PHF20;JADE2;JADE1;JADE3
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.32822174624107214,0.7809055975648945,0.7352941176470589,0.93156066713526,1.0,4/26,9.32%,CDK6;CEACAM1;MAFB;ZFPM1
prerank,mitotic nuclear division (GO:0140014),0.27314248856174894,0.7805945808970433,0.8070422535211268,0.9315631660989333,1.0,19/71,20.84%,EPS8;RAB11A;CHMP4B;STAG2;PPP2R2D;STAG1;NDEL1;LSM14A;CTDP1;RHOA;CHEK2;ABRAXAS2;SMC4;WRAP73;MZT1;BCCIP;PLK1;KPNB1;PIBF1
prerank,glycogen biosynthetic process (GO:0005978),0.3696604495115369,0.7796865311433453,0.7118353344768439,0.9320761478072201,1.0,4/12,20.14%,GBE1;PGM2;NHLRC1;PGM1
prerank,glucan biosynthetic process (GO:0009250),0.3696604495115369,0.7796865311433453,0.7118353344768439,0.9320761478072201,1.0,4/12,20.14%,GBE1;PGM2;NHLRC1;PGM1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.298681543610497,-0.7796588428879502,0.7535211267605634,1.0,1.0,4/20,14.31%,FKBP5;NKTR;PPIC;PPIH
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.28238312749729183,-0.7794494295698001,0.779746835443038,1.0,1.0,6/26,10.43%,KANK2;HEYL;DAB2;SFRP1;CRY2;SMARCA4
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.35065141711423087,-0.7792335823947609,0.753880266075388,1.0,1.0,5/10,19.03%,PRKAA2;KLF15;MYOCD;DIP2A;FLCN
prerank,regulation of centrosome cycle (GO:0046605),0.34395834188643865,0.7788992885203481,0.7274247491638796,0.932862250966018,1.0,5/21,17.88%,CHMP2B;AURKA;CHMP4B;NPM1;CEP131
prerank,response to peptide (GO:1901652),0.3147823884065762,0.7788234892628341,0.7601246105919003,0.932511981853666,1.0,8/33,16.91%,STAT3;FYN;CACNA1A;EIF2B5;EIF2B2;STAT6;STAT1;ERBIN
prerank,recombinational repair (GO:0000725),0.27570313639192556,0.7787054897191414,0.8159268929503917,0.9322320363488272,1.0,14/77,14.31%,SAMHD1;MMS22L;RPA1;RAD51D;SEM1;MEIOB;RECQL;XRCC2;FAN1;HUS1;RMI1;MCM9;ERCC4;YY1
prerank,dendritic cell chemotaxis (GO:0002407),0.3658228937472399,0.7784342563002401,0.7290552584670231,0.9322076518954768,1.0,5/14,23.34%,PIK3CG;CXCR4;CCR1;HMGB1;TRPM2
prerank,quinone biosynthetic process (GO:1901663),-0.32920007642558274,-0.7778248970010461,0.7668845315904139,1.0,1.0,8/14,39.93%,COQ5;COQ8B;FDXR;COQ10A;COQ10B;COQ6;COQ8A;COQ9
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.37250089346391707,0.7772149660758516,0.7109090909090909,0.9336668215948114,1.0,4/12,12.71%,EDN1;TGFB1;AP2A1;GSTP1
prerank,mitochondrial fusion (GO:0008053),-0.30291879097578855,-0.7770661764273382,0.7878787878787878,1.0,1.0,5/18,24.97%,MIGA2;CHCHD3;MIEF2;BAX;GDAP1
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.3005148225829888,0.7768715993114147,0.7796852646638054,0.933730008966937,1.0,5/46,7.43%,PLA2G4A;DGKZ;DGKH;PLA2G2D;AGPAT1
prerank,positive regulation of organelle organization (GO:0010638),-0.26268008598500014,-0.7761638552253542,0.8134110787172012,1.0,1.0,5/32,9.73%,C2CD5;PPARGC1A;ANXA1;ANXA2;TMED9
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.34587833030156867,0.7756564393510098,0.7407407407407407,0.935153885777188,1.0,3/20,6.03%,PLCG1;ECSCR;CD40
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.2638030288847542,0.775520441682673,0.8185430463576159,0.9349395846277742,1.0,25/96,19.93%,HHEX;EIF4E;NXF2;WDR33;THOC2;SMG7;YTHDC1;NUP214;RNPS1;NUP98;THOC6;UPF2;NUP205;NUP133;NUP153;NUP54;NUP43;AGFG1;THOC3;ALYREF;CDC40;THOC1;CPSF1;GLE1;THOC5
prerank,protein targeting to peroxisome (GO:0006625),-0.2753478202750058,-0.7755002827269368,0.7946666666666666,1.0,1.0,11/29,26.75%,ABCD3;ATAD1;PEX1;PXMP2;PEX7;PEX11B;ZFAND6;GDAP1;PEX5;ABCD2;PEX16
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.22184826882764178,-0.7753090424428317,0.9338235294117647,1.0,1.0,15/80,15.32%,DENND2A;SGSM2;SNX32;SNX6;STX16;RHOBTB3;RAB29;TMED9;GBF1;RGP1;SNX5;TRAPPC10;GGA1;ARFRP1;RBSN
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.30521435272181663,-0.7749486587872338,0.7559241706161137,1.0,1.0,3/16,17.36%,WBP4;PSIP1;CACTIN
prerank,phagosome maturation (GO:0090382),0.3068799464667212,0.7744335260800368,0.77947932618683,0.936157249780509,1.0,8/35,14.26%,ATP6V0A1;RAB38;ATP6V1G2;MREG;RAB43;RAB7A;RAB31;RAB32
prerank,regulation of mRNA stability (GO:0043488),-0.20405724134776218,-0.7743048134283684,0.9759036144578314,1.0,1.0,29/145,20.38%,SAMD4A;ROCK2;PRKCD;FXR2;TENT5A;PSME4;AXIN2;PRKCA;CIRBP;EXOSC7;PSMD12;CELF1;IGF2BP2;CSDC2;HNRNPU;EXOSC3;TENT5C;FTO;RC3H2;HSPB1;PCBP4;SAMD4B;E2F1;TBRG4;PSMC4;PSMB6;EXOSC9;FASTKD3;PDE12
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.3102875067669918,0.7742858086540797,0.7723823975720789,0.9359406339171888,1.0,7/35,14.34%,PCDHB4;SELP;ATP2C1;CDH23;PCDHB5;PCDHB11;CDH5
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.330596070450887,0.7741560620515524,0.7451612903225806,0.9356942056989191,1.0,3/23,9.21%,FOXL2;CECR2;DICER1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.2982781259500291,0.7739533263851801,0.8,0.9355614341988318,1.0,10/41,15.08%,HIF1A;NUP214;EIF6;NUP98;SLC2A6;NUP205;NUP133;NUP153;NUP54;NUP43
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.26912561248189754,0.7737630697758284,0.8274932614555256,0.9353891393206085,1.0,27/84,25.54%,AURKA;PSMA2;ANAPC7;CDK2;PSMA8;ANAPC1;PSMA6;CDC26;RB1;ANAPC16;BUB3;PSME1;CUL3;PSMA4;PSMF1;PLK1;PSMB1;PSMB7;PSMD2;PSMA5;PSMC3;FZR1;UBE2D1;UBE2E1;PSMD3;FBXO5;PSMA3
prerank,negative regulation of autophagosome assembly (GO:1902902),0.36539880794050894,0.7731040287950953,0.7262969588550984,0.9359791767438698,1.0,4/13,8.75%,MTM1;FEZ2;CHMP4A;CHMP4B
prerank,fatty acid beta-oxidation (GO:0006635),0.28900814637941286,0.7728589800068215,0.8028985507246377,0.935912482453974,1.0,13/51,20.83%,PPARD;CRAT;HADHA;ECI1;ABCD4;ABCD1;HADH;AUH;ACAD10;ETFDH;ETFB;ETFA;CROT
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.32062258596499,0.7727099750830115,0.7419871794871795,0.9357011809258342,1.0,6/26,14.75%,APP;FBXW7;TGFA;CBL;ADAM17;SOCS4
prerank,cobalamin metabolic process (GO:0009235),0.3447539789529123,0.7724168443994095,0.756896551724138,0.9356960775338086,1.0,6/17,23.45%,ABCD4;CD320;TCN2;MTR;MMAA;LMBRD1
prerank,cellular response to estrogen stimulus (GO:0071391),0.36666326421867607,0.7723425391265889,0.7370304114490162,0.9353512019208554,1.0,4/14,14.22%,SERPINB9;NCOA4;TRIM24;PELP1
prerank,triglyceride homeostasis (GO:0070328),0.3213402498145025,0.7723374260645899,0.744,0.9349073093108609,1.0,7/26,18.18%,SCARB1;XBP1;LPL;APOC4;PNPLA8;ANGPTL4;MLXIPL
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.32680535058219085,0.772002156282169,0.7617602427921093,0.9349649127617444,1.0,4/26,6.02%,LRP5;PIM3;KLF7;PPP3CB
prerank,stress granule assembly (GO:0034063),-0.2920143868728977,-0.7719635995976122,0.7624703087885986,1.0,1.0,6/20,19.42%,BICD1;ATXN2;CIRBP;UBAP2L;DYNC1H1;ATXN2L
prerank,DNA damage checkpoint signaling (GO:0000077),-0.26540142276293344,-0.7717518707678289,0.7988826815642458,1.0,1.0,12/28,26.80%,CEP63;CLSPN;DOT1L;RHNO1;E2F1;DONSON;USP28;INTS7;ATR;CHEK1;ATM;RAD1
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.3936721847980398,0.7717116982438095,0.7306201550387597,0.934941943560048,1.0,5/10,21.95%,DISC1;CX3CR1;CTNNB1;KDM1A;CX3CL1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.2746061856188109,-0.7706659197307284,0.8228882833787466,1.0,1.0,8/26,19.83%,LARGE1;GK;GBGT1;TKT;TPI1;GAL3ST2;SCCPDH;ST3GAL4
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.377810361513661,0.7699311078116209,0.7427007299270073,0.9367719851296441,1.0,5/12,16.49%,HOMER2;ATP2B4;HOMER3;RCAN1;CHP1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.377810361513661,0.7699311078116209,0.7427007299270073,0.9367719851296441,1.0,5/12,16.49%,HOMER2;ATP2B4;HOMER3;RCAN1;CHP1
prerank,regulation of centriole replication (GO:0046599),0.34601665318403596,0.7691827308459107,0.7402135231316725,0.9374682489484015,1.0,6/17,18.81%,PLK2;RBM14;NPM1;KAT2B;CEP295;CDK5RAP2
prerank,chromosome condensation (GO:0030261),0.30929281977432765,0.7689912899074025,0.7703125,0.9373157428530062,1.0,8/36,19.68%,TENT4A;MCPH1;NCAPH;RB1;CSNK2A1;CSNK2A2;SMC4;PLK1
prerank,central nervous system neuron differentiation (GO:0021953),-0.257485499175205,-0.7689486268768553,0.8376811594202899,1.0,1.0,15/33,28.14%,MAP2;NTRK2;RYK;LRP6;MDGA1;GRID2;CHD5;MDGA2;FAIM2;SPOCK1;NPY;LHX1;KNDC1;CEND1;LMX1A
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.2797079015407273,-0.7689050708038248,0.8282352941176471,1.0,1.0,6/24,13.56%,NBL1;CCN3;CXCL12;SERPINE1;SLIT2;CREB3
prerank,carnitine shuttle (GO:0006853),-0.3351065795450591,-0.7686231230531897,0.74,1.0,1.0,3/11,6.97%,PRKAA2;PRKAG2;ACACA
prerank,purine nucleotide metabolic process (GO:0006163),0.32660945375391187,0.7684613165279155,0.7488,0.9376811933438195,1.0,8/24,19.92%,GDA;NT5C2;ADSL;HPRT1;XDH;NUDT15;GART;PNP
prerank,neutrophil chemotaxis (GO:0030593),0.281791032824303,0.767946395854008,0.8156028368794326,0.9380574014104422,1.0,5/53,10.48%,EDN1;BSG;PPBP;PIK3CG;CCL14
prerank,sensory perception of chemical stimulus (GO:0007606),-0.30655725665830846,-0.7679157849343119,0.7744186046511627,1.0,1.0,7/15,40.79%,GNAS;ADCY3;GNAL;CD36;BBS4;UBR3;C5AR1
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.2538294111130442,-0.7676339583310002,0.8533724340175953,1.0,1.0,13/36,21.44%,CEP63;CLSPN;DOT1L;RAD9B;RHNO1;E2F1;SETMAR;DONSON;USP28;INTS7;DNA2;ATR;CHEK1
prerank,endomembrane system organization (GO:0010256),0.24320192061142334,0.7674038049610291,0.8807556080283353,0.9384317341731678,1.0,14/178,8.88%,MYOF;ATP8B1;SPTBN1;PRKD1;CAV2;ALS2CL;DOP1B;CHMP2B;SYNE1;SRGN;TMED7;RAB2A;TMED5;ARHGEF7
prerank,cellular iron ion homeostasis (GO:0006879),0.28449743322014853,0.7670679876634767,0.8,0.938480335328124,1.0,10/55,17.07%,ABCG2;ABCB7;LCN2;GLRX3;CUL1;CP;HMOX2;FRRS1;NUBP1;NEDD8
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3239527521341546,0.766386298309061,0.7603305785123967,0.9390759591588982,1.0,5/22,14.61%,HHEX;CDKN1B;TFAP4;INCA1;APC
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.274560818325323,-0.7663353212316657,0.8407960199004975,1.0,1.0,5/27,7.94%,BRSK1;IL1RAPL1;NTNG1;CTNNA2;ULK4
prerank,regulation of mast cell degranulation (GO:0043304),0.3575322655575755,0.7655007370760774,0.7419928825622776,0.9399330761243336,1.0,1/14,2.30%,LYN
prerank,cellular response to hydrogen peroxide (GO:0070301),0.3084132566572695,0.7654876478473845,0.785483870967742,0.9395048649463309,1.0,6/33,13.15%,NET1;RIPK1;RNF112;RELA;RHOB;SIGMAR1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.2847440449145196,-0.7652471416210789,0.7406483790523691,1.0,1.0,5/22,17.00%,ROCK2;PPP4R4;CRY2;PTPA;BOD1L1
prerank,mRNA 3'-end processing (GO:0031124),0.26572742586878134,0.7641333477348052,0.8232189973614775,0.9411166893269601,1.0,24/78,25.30%,APP;WDR33;THOC2;RNPS1;THOC6;RPRD1B;MTPAP;RPRD2;CDC73;THOC3;ALYREF;CDC40;THOC1;CPSF1;RPRD1A;THOC5;CPSF6;THOC7;SRSF4;TENT4B;SLU7;CPSF3;PCF11;CPSF2
prerank,response to sterol (GO:0036314),-0.33745346039861013,-0.7638538552715592,0.7873684210526316,1.0,1.0,3/11,13.40%,TGFBR1;RORA;INSIG1
prerank,regulation of cell aging (GO:0090342),-0.3343422319072171,-0.7637098820356462,0.772093023255814,1.0,1.0,2/11,6.34%,NEK4;LMNA
prerank,protein kinase B signaling (GO:0043491),0.3292312421626155,0.7634682095375517,0.7587939698492462,0.9416414692062116,1.0,5/23,14.46%,KDR;TGFB1;GAS6;THEM4;ZFP36L1
prerank,regulation of microtubule nucleation (GO:0010968),-0.34815000347195546,-0.7633485818315141,0.7688888888888888,1.0,1.0,1/10,2.06%,EML2
prerank,regulation of gene silencing by RNA (GO:0060966),0.28514009334733575,0.762910087791408,0.8072992700729927,0.9415784135332569,1.0,12/50,15.08%,H3-3A;PUM1;IPO8;NUP214;PUM2;NUP98;FMR1;NUP205;NUP133;NUP153;NUP54;NUP43
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.28514009334733575,0.762910087791408,0.8072992700729927,0.9415784135332569,1.0,12/50,15.08%,H3-3A;PUM1;IPO8;NUP214;PUM2;NUP98;FMR1;NUP205;NUP133;NUP153;NUP54;NUP43
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.333136280978648,0.762720894770838,0.7663398692810458,0.9414147670439799,1.0,7/23,16.72%,APP;TGFB1;RPTOR;RIPK2;UBE2K;IRGM;CALM1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.3158175955792923,0.7626901215327679,0.7682119205298014,0.9410111851284199,1.0,7/27,16.40%,SKAP1;LCK;CYRIB;RELA;HAS2;TRAF6;RHOA
prerank,positive regulation of actin nucleation (GO:0051127),-0.33150273393528273,-0.762616007741782,0.7734204793028322,1.0,1.0,5/11,15.41%,GSN;ABI2;WASF3;WASF1;FCHSD2
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.3560177629202791,0.7626012840834078,0.7477797513321492,0.9406988586844457,1.0,2/14,12.13%,CRAT;ABCD1
prerank,gastrulation (GO:0007369),0.3494835807304729,0.7624658963086574,0.7526315789473684,0.9404610974843063,1.0,2/15,6.85%,LRP5;TASOR
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.2577116839972075,-0.7619213891884656,0.8601190476190477,1.0,1.0,8/38,16.22%,MAGI2;PPARA;DAG1;TSC2;PHLPP2;GPER1;PHLDA3;OTUD3
prerank,negative regulation of centrosome duplication (GO:0010826),0.3727246922478423,0.7617783857016224,0.7458866544789763,0.9410401112769149,1.0,4/11,18.81%,RBM14;NPM1;KAT2B;CDK5RAP2
prerank,lipid catabolic process (GO:0016042),0.3473779417014814,0.7616019428844176,0.75,0.9408670851606196,1.0,3/18,8.63%,LIPE;LPL;PLAAT3
prerank,mRNA stabilization (GO:0048255),0.2950158344043266,0.7612889752934452,0.7886297376093294,0.9408901490242023,1.0,16/40,24.36%,TIRAP;HNRNPA0;YBX3;ANGEL2;HNRNPC;ZFP36;PAIP1;YBX1;FUS;DAZL;ELAVL1;TAF15;NOCT;EIF4ENIF1;MAPK14;SYNCRIP
prerank,transition metal ion homeostasis (GO:0055076),0.31627454632596363,0.7604314625190736,0.759170653907496,0.9417335804632747,1.0,7/28,17.23%,B2M;ABCB7;XIAP;PICALM;CP;HMOX2;TMC8
prerank,fat cell differentiation (GO:0045444),0.27974203464928926,0.76022530875831,0.8137254901960784,0.9416070280172495,1.0,6/57,8.94%,FOXO1;TCF7L2;ERAP1;CTBP1;AKT2;MAFB
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.3640709949896565,0.7601412790903266,0.7486818980667839,0.9412829492774728,1.0,5/13,13.74%,WNT5A;AGPAT1;IL7;GAS6;IFIH1
prerank,regulation of regulated secretory pathway (GO:1903305),0.30581727218945987,0.7598820750555325,0.7808641975308642,0.9412282507162637,1.0,1/34,0.41%,RAB27A
prerank,DNA metabolic process (GO:0006259),0.2354450468995513,0.7596260752303432,0.9314917127071823,0.9411476095989278,1.0,64/270,21.82%,POLK;SAMHD1;USP3;UHRF2;TCF7L2;CNBP;RNASEH2A;RPA1;MCM10;POLA1;PRIMPOL;CDT1;BACH1;CDK2;RAD51D;PARP2;BTG2;RAD18;HELB;RECQL;XRCC2;FAN1;MMS19;HUS1;ACD;UNG;PARG;LONP1;GLRX2;NOP53;MPG;ERCC4;TOP1;NSMCE4A;NPM1;NUDT15;PRIM2;ENDOV;ORC5;ORC3;PDS5A;TERF1;PDS5B;GTF2H4;RAD21;CDC34;MGMT;KMT5B;USP7;RFC3;NUDT1;GTF2H1;CHD1L;DBF4;RAD17;ENDOG;MSH2;RMI2;TRRAP;PURA;RNASEH1;RIF1;UBE2V2;SIRT7
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.3293231219448394,-0.7595714637065257,0.7732181425485961,1.0,1.0,2/12,7.11%,HDAC8;AXIN2
prerank,regulation of ATP metabolic process (GO:1903578),0.2802038079375848,0.7592872169067936,0.8040345821325648,0.9411939582923093,1.0,12/54,15.08%,HIF1A;AK4;NUP214;EIF6;NUP98;ABCD1;SLC2A6;NUP205;NUP133;NUP153;NUP54;NUP43
prerank,phosphatidic acid metabolic process (GO:0046473),0.2914276646330163,0.7588132164537444,0.8229461756373938,0.9414620057512253,1.0,5/48,7.43%,PLA2G4A;DGKZ;DGKH;PLA2G2D;AGPAT1
prerank,protein monoubiquitination (GO:0006513),-0.2532095309949013,-0.7580751992872022,0.8284883720930233,1.0,1.0,7/36,14.30%,PRKN;KLHL22;CTR9;PAF1;LEO1;UBE2B;ATXN7L3
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.2772140160860622,0.7578099475576954,0.8207681365576103,0.9424945479049146,1.0,9/62,9.92%,ARHGEF2;ARMC10;TMBIM6;XBP1;DNAJA1;SFRP2;YBX3;DDIAS;BCL2L1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.313210675378071,-0.7574806056697219,0.7697516930022573,1.0,1.0,3/14,6.91%,IL18;ANXA1;PRKCZ
prerank,cytoplasmic microtubule organization (GO:0031122),0.2770741825895505,0.757026792636591,0.8149253731343283,0.9431728557116945,1.0,7/54,9.08%,RAB11A;DST;LIMK2;CCDC88A;CAMSAP2;TRPV4;SLK
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.32001087666200556,0.7568133634139154,0.7524271844660194,0.9430196691437694,1.0,4/27,7.26%,CDK6;PDGFB;WNT5A;PDGFC
prerank,protein localization to nucleus (GO:0034504),-0.20974465905039333,-0.7564988924097963,0.9469026548672567,1.0,1.0,25/102,20.11%,COL1A1;APPL2;BMP7;BMP4;SIX1;LMNA;PAF1;MDM2;TSC2;FAM53C;IPO13;POM121;NUP93;INTS13;CNEP1R1;HNRNPU;TNPO2;DVL1;ABCA7;SYK;CHCHD10;RANBP17;NOL8;NUP107;SEC13
prerank,regulation of fibroblast proliferation (GO:0048145),0.2936065614046977,0.7559401367598093,0.8053491827637445,0.9438127305630889,1.0,5/45,7.26%,CDK6;PDGFB;DAB2IP;WNT5A;PDGFC
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.31612636809544076,-0.7557353422069018,0.7911547911547911,1.0,1.0,4/14,10.00%,LPIN1;ETNK2;PCYT2;SLC27A1
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.2592666475633,-0.7556593937422422,0.8346883468834688,1.0,1.0,8/29,22.77%,TENT5A;AXIN2;CIRBP;HNRNPU;TENT5C;E2F1;SLC11A1;RBM24
prerank,regulation of B cell differentiation (GO:0045577),-0.3086535081451521,-0.7554707339485626,0.8203991130820399,1.0,1.0,7/17,28.75%,MMP14;SFRP1;INHBA;SYK;ID2;ZFP36L2;PPP2R3C
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.30052397958960253,0.7550647877256141,0.779874213836478,0.944669811109803,1.0,8/35,20.81%,NEK7;HMBOX1;ACD;CTNNB1;DHX36;CCT7;MAP2K7;CCT2
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.29647784465102445,0.7543768233374143,0.7653721682847896,0.9452133348609302,1.0,7/31,16.91%,PARD3;MSN;OPHN1;ANK1;PARD3B;RHOA;ERBIN
prerank,response to organic cyclic compound (GO:0014070),0.28157329487079563,0.7539672709317606,0.8081805359661495,0.9453641047378275,1.0,3/52,2.35%,ESR1;SOCS2;STAT3
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.21642492902328006,-0.7536167091450133,0.9205020920502092,1.0,1.0,23/82,24.45%,NINL;HSP90AA1;YWHAG;ALMS1;ATF5;PRKACA;SDCCAG8;CEP63;CEP192;ODF2;CEP152;CEP43;PCM1;DCTN3;DYNC1H1;TP53;CKAP5;HAUS6;HAUS2;TPX2;SFI1;CSNK1E;CENPF
prerank,cytosolic transport (GO:0016482),0.2539319464947366,0.7535319833997175,0.8789473684210526,0.9455664750148947,1.0,21/108,16.13%,MYO1D;STX6;LMTK2;DOP1B;EEA1;VTI1A;AP2A1;GCC2;SPAG9;ANKFY1;STX8;TBC1D5;EHD3;KIF16B;RILP;RAB7A;RAB5A;EVI5;ERC1;RAB6A;RIC1
prerank,histone ubiquitination (GO:0016574),-0.2809918392726806,-0.753465585091443,0.8226600985221675,1.0,1.0,5/21,14.30%,CTR9;PAF1;LEO1;UBE2B;ATXN7L3
prerank,regulation of transposition (GO:0010528),0.34839023419361465,0.7534156581764179,0.763668430335097,0.9452872727335571,1.0,5/13,25.38%,BTBD18;SPOCD1;TEX15;SIRT7;SMYD5
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.2677013244605774,0.753259016585269,0.8355978260869565,0.9450719580763085,1.0,3/76,1.96%,TGM2;ESR1;HTR2A
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.29374938966495684,-0.7528114274682823,0.8004587155963303,1.0,1.0,3/17,8.24%,ANK3;AKAP6;KCNAB1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.29043645826945663,-0.7523653620871915,0.8095238095238095,1.0,1.0,4/20,11.99%,IL18;LBP;PTPN22;TICAM1
prerank,negative regulation of protein secretion (GO:0050709),0.2969384653462145,0.7508422294760375,0.8057663125948407,0.9480911743820362,1.0,4/38,5.33%,CD200;RAB11FIP1;KCNB1;RAB11FIP5
prerank,positive regulation of protein transport (GO:0051222),0.27011189427363624,0.7506636902423905,0.8316400580551524,0.9478926159034717,1.0,11/67,12.83%,UNC13B;CD2AP;EXPH5;PRR5L;PCNT;ATP2C1;TGFB1;ANG;VPS28;RACK1;ABCG1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.3689227955848629,0.7506621777586985,0.7549194991055456,0.9474460672468866,1.0,2/12,9.76%,PAEP;IL23A
prerank,negative regulation of bone remodeling (GO:0046851),-0.33981577182507416,-0.7503868856200915,0.7732181425485961,1.0,1.0,4/11,19.83%,UBASH3B;SFRP1;GPR137B;TMEM119
prerank,sulfur compound transport (GO:0072348),0.3135555167499858,0.7503466193170565,0.788961038961039,0.9474677822663402,1.0,4/27,9.91%,ABCG2;SLC6A6;SLC26A1;SLC25A30
prerank,water-soluble vitamin metabolic process (GO:0006767),0.26552011351567567,0.7500678089211353,0.8499298737727911,0.9474339374459939,1.0,12/68,16.25%,SLC2A1;MTHFD1L;SLC52A3;GSTO2;ABCD4;PANK2;TPK1;CD320;SLC19A3;TCN2;RFK;MTR
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.3197914300112654,-0.749973014498266,0.795774647887324,1.0,1.0,5/12,24.01%,GLI2;SZT2;TSKU;SPTBN4;EPHB2
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.3226471796237528,0.7497170078478774,0.7816091954022989,0.9474977682377921,1.0,6/23,13.06%,HDAC7;ADGRG3;TMSB4X;NMI;RELA;ADIPOR1
prerank,positive regulation of viral process (GO:0048524),0.2741185127376006,0.7495175210081911,0.8394366197183099,0.947335132060418,1.0,11/60,16.14%,NR5A2;ADARB1;PKN2;GTF2F2;NELFE;RAD23A;ADAR;RAB7A;CNOT7;NELFCD;CTDP1
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.2785133748036262,-0.7493826678086174,0.8321167883211679,1.0,1.0,9/23,35.16%,SELENOS;TMED9;NPLOC4;SEC16A;SEC13;DERL2;HSP90B1;VCP;TECPR2
prerank,hematopoietic stem cell differentiation (GO:0060218),0.3742617116581708,0.7489629880978742,0.7474747474747475,0.9476901188357639,1.0,1/10,2.20%,MLLT3
prerank,response to acidic pH (GO:0010447),0.356227441095041,0.7489274519872452,0.7690941385435168,0.9472929374154895,1.0,4/13,16.49%,RAB11FIP5;LGMN;RAB11B;CHP1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.24155516277734804,-0.7488211260418893,0.8756756756756757,1.0,1.0,12/38,23.20%,PRKN;SREBF1;NPEPPS;LRRK2;ABLIM3;HPS4;RHOU;HAX1;HTRA2;ATP5IF1;VPS11;FZD5
prerank,regulation of phosphatase activity (GO:0010921),0.31704680885701364,0.7485122944865629,0.8098360655737705,0.9474482376628385,1.0,6/24,18.67%,PPP1R2;CHP2;GPATCH2;CHP1;TIPRL;MTMR9
prerank,RNA export from nucleus (GO:0006405),0.25310957212396973,0.7483498862536191,0.8681462140992167,0.9472364820181468,1.0,25/100,19.93%,HHEX;EIF4E;NXF2;WDR33;THOC2;SMG7;YTHDC1;NUP214;RNPS1;NUP98;THOC6;UPF2;NUP205;NUP133;NUP153;NUP54;NUP43;AGFG1;THOC3;ALYREF;CDC40;THOC1;CPSF1;GLE1;THOC5
prerank,regulation of microtubule-based movement (GO:0060632),-0.3235198318355632,-0.7480791103131644,0.7601713062098501,1.0,1.0,5/11,31.85%,MAP2;TTC21B;DRC1;LAMP1;NEFH
prerank,meiosis I (GO:0007127),0.3188509573462372,0.7478928044593598,0.7899159663865546,0.9474252721280286,1.0,4/23,13.34%,BTBD18;BCL2L11;MEIOB;ZSCAN21
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.3092951426613336,-0.7476600436408937,0.7861635220125787,1.0,1.0,7/14,27.42%,RMND1;UQCC2;MPV17L2;FASTKD3;TRUB2;MRPS27;C1QBP
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.3573248812992754,0.7475806108215972,0.7490974729241877,0.9474394947370142,1.0,4/12,15.84%,NFKBIA;ITGB3;ABCG1;ABCA1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.2685854702432834,0.7474286746866898,0.8603042876901799,0.9472068085816863,1.0,16/69,20.81%,CCNK;GTF2F2;GTF2E2;POU2F1;INTS11;SNAPC3;RPRD1B;GTF2A2;INTS12;RPRD2;POU2F2;RPRD1A;SP1;POLR2L;TAF9;INTS8
prerank,negative regulation of leukocyte activation (GO:0002695),0.3456060113353173,0.7468898054332053,0.7689655172413793,0.9475434144152816,1.0,1/15,1.50%,CD200
prerank,cellular response to estradiol stimulus (GO:0071392),0.33476671935239244,0.746869408885937,0.7635135135135135,0.947127873421681,1.0,1/18,0.95%,ESR1
prerank,neuron fate commitment (GO:0048663),0.3536533172980549,0.7468205243638927,0.74822695035461,0.9467615387433527,1.0,2/14,5.29%,DLL1;DLL4
prerank,cellular response to UV-A (GO:0071492),-0.32399013514554387,-0.746330012020486,0.7897091722595079,1.0,1.0,6/11,36.78%,MMP2;CERS1;PPID;TIMP1;MME;MMP3
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.25544585824508154,-0.7451673216386985,0.8469945355191257,1.0,1.0,11/31,27.00%,PEX1;TOMM40;AIFM1;PEX7;TIMM17B;GRPEL2;TIMM21;DNAJC15;PEX5;PEX16;PAM16
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.2432479726584421,-0.744930614943782,0.8929577464788733,1.0,1.0,13/39,24.50%,TANGO2;RCN3;COPG1;STEAP3;MIA3;RAB10;SCG2;NECAB3;OLFM2;LTBP2;RAB8A;RAB3C;CANX
prerank,lipid droplet organization (GO:0034389),0.3238024766403675,0.7445271480245341,0.7867298578199052,0.9495070030682979,1.0,8/22,28.57%,PLIN5;CDS2;RAB18;HILPDA;PPIA;ZFYVE1;AUP1;FAF2
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.30235186780744466,-0.7443381659900431,0.8309859154929577,1.0,1.0,6/17,30.18%,P4HB;HSPB1;HTRA2;NME5;TREM2;VNN1
prerank,regulation of mitochondrial translation (GO:0070129),-0.2806594112522136,-0.7441097411380448,0.8344827586206897,1.0,1.0,9/21,27.79%,RMND1;UQCC2;MPV17L2;FASTKD3;TRUB2;MTG1;MRPS27;C1QBP;TSFM
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.3168935816765904,0.7429821657339611,0.7808441558441559,0.951199106330359,1.0,8/21,23.72%,FOSL1;HNF1B;SUB1;DHX36;SETX;MED12;MED17;JUN
prerank,apoptotic nuclear changes (GO:0030262),0.3131091948051111,0.7426162706486218,0.8050713153724247,0.9512449981151007,1.0,3/24,9.21%,FOXL2;CECR2;DICER1
prerank,histone exchange (GO:0043486),-0.25150057332015696,-0.7423243550116161,0.8323699421965318,1.0,1.0,14/37,27.03%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;CENPK;ZNHIT1;CENPH;RBBP4;KNL1;CENPX;CENPA;CENPQ
prerank,telomere maintenance via telomerase (GO:0007004),0.3106677874330791,0.7422605048332944,0.8015873015873016,0.95127854261554,1.0,7/28,16.46%,RPA1;WRAP53;PINX1;CDK2;ACD;HSP90AB1;TERF1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.25765169715325953,0.7418513745271894,0.8654891304347826,0.9514183152519874,1.0,18/78,20.60%,PDGFB;HHEX;CCNK;CDKN1B;PKD2;CCNYL1;CCNY;TFAP4;INCA1;ADAM17;CDC25C;APC;CCNJ;CDC37;BCCIP;GTF2H1;PLK1;CCNH
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.2880585196248433,-0.7418462623654404,0.826879271070615,1.0,1.0,6/19,15.47%,DLG2;DLG1;DLG3;PRKCI;PATJ;LRRC7
prerank,fatty acid catabolic process (GO:0009062),0.2647773804653691,0.7413550003961056,0.8616010854816825,0.9516602332697973,1.0,11/67,16.68%,PPARD;ABHD2;LPIN3;HADHA;ECI1;ABCD4;ABCD1;HADH;ALDH3A2;FAAH;AUH
prerank,organophosphate biosynthetic process (GO:0090407),-0.2523970138680628,-0.7408718446321962,0.8739255014326648,1.0,1.0,10/37,16.82%,FGF2;AGPAT4;GK;PCYT2;TKT;TPI1;GPAM;AGPAT3;LPCAT1;PPIP5K2
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.28830601684684426,0.740077072331551,0.8249619482496194,0.953038723637561,1.0,18/38,27.93%,GBP5;USP15;SASH1;PUM1;NMI;OASL;PUM2;PLSCR1;POLR3B;CD180;SLC15A4;ZCCHC3;CYBA;RIOK3;POLR3F;DDX60;ADAM8;DHX58
prerank,positive regulation of intracellular protein transport (GO:0090316),0.2402013399438039,0.7396670892261923,0.9103194103194103,0.953177477816564,1.0,31/144,18.07%,PPP1R13B;FBXW7;FYN;CASP8;KCNB1;TCF7L2;MAPK8;PRR5L;CHP2;PCNT;SH3GLB1;TGFB1;PSEN1;AKT2;UBE2D3;MYO1C;SFN;GAS6;SAE1;BID;TCAF2;ERBB2;YWHAQ;ARIH2;CEP290;CHP1;ANP32B;RAPGEF3;CEP131;CSNK2A2;CIB1
prerank,Golgi inheritance (GO:0048313),-0.3242071791652894,-0.7396611616455749,0.8325892857142857,1.0,1.0,2/11,12.19%,GBF1;PLK5
prerank,response to hexose (GO:0009746),0.3138391352478124,0.7388672852563622,0.7996661101836394,0.9538483715062649,1.0,6/25,14.16%,TCF7L2;LPL;EIF2B5;NEUROD1;PFKL;EIF2B2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.26911416862892285,0.7387979271925669,0.8444130127298444,0.9535017137260238,1.0,16/55,23.27%,AURKA;AVEN;FBXL7;PSMA2;PINX1;PSMA8;PSMA6;CUL1;PSME1;PSMA4;PSMF1;PSMB1;PSMB7;PSMD2;PSMA5;PSMC3
prerank,inorganic ion transmembrane transport (GO:0098660),-0.32393733356161264,-0.7382054460298089,0.8041002277904328,1.0,1.0,8/12,41.31%,ABCC9;KCNJ8;CACNA1H;P2RX3;TRPM4;KCNJ11;RHAG;PKD2L1
prerank,chemical homeostasis (GO:0048878),0.26736373612393355,0.7381155309974868,0.8789546079779917,0.9539913020986943,1.0,7/61,10.52%,KLHL3;NEDD4L;FBXW7;AQP11;TLCD3A;SLC4A7;USF2
prerank,myeloid cell activation involved in immune response (GO:0002275),0.319233708531356,0.7368159688935942,0.7903780068728522,0.9553238118815472,1.0,4/18,15.56%,PLCG2;SBNO2;NMI;KARS1
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.2992135959602773,-0.7361574733482733,0.8408551068883611,1.0,1.0,5/17,24.98%,GJA1;HNRNPU;LTBP3;TERT;PTPRC
prerank,Golgi organization (GO:0007030),0.2443350061018834,0.7358547464323423,0.8961538461538462,0.9562311362272004,1.0,11/112,8.88%,ATP8B1;PRKD1;STX6;VAMP4;SYNE1;VTI1A;TMED7;GCC2;RAB2A;TMED5;ARHGEF7
prerank,peptidyl-glutamic acid modification (GO:0018200),0.3069257517355611,0.7356448939447959,0.8130081300813008,0.9560731076122955,1.0,7/24,21.08%,CEP41;TTLL7;TTLL10;NAA11;TTLL5;TPGS1;TTLL9
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.3239959832031988,-0.7355979337651574,0.816933638443936,1.0,1.0,4/10,22.83%,LBP;PTPN22;NR1H3;IFI35
prerank,regulation of myoblast fusion (GO:1901739),-0.3231893992820917,-0.7353840793322214,0.7875288683602771,1.0,1.0,3/11,14.77%,RIPOR2;EHD1;CD53
prerank,eosinophil chemotaxis (GO:0048245),-0.29984087935681514,-0.7353480150008884,0.7899761336515513,1.0,1.0,9/14,45.79%,SCG2;CCL2;CCL5;CCL4;CCL8;CCL7;CCL1;CCL3;CCL11
prerank,eosinophil migration (GO:0072677),-0.29984087935681514,-0.7353480150008884,0.7899761336515513,1.0,1.0,9/14,45.79%,SCG2;CCL2;CCL5;CCL4;CCL8;CCL7;CCL1;CCL3;CCL11
prerank,sterol metabolic process (GO:0016125),0.262875514761097,0.7352186455958506,0.869942196531792,0.956213423645592,1.0,11/60,15.84%,PPARD;CH25H;LBR;CYP26A1;CYP26C1;SOAT2;CYP39A1;CLN6;ABCG1;PMVK;ABCA1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.2845704367715043,-0.7346025447386245,0.8350785340314136,1.0,1.0,4/20,10.00%,PLOD2;GCLC;FPGS;SLC27A1
prerank,RNA metabolic process (GO:0016070),0.24104742197208334,0.7335288751909335,0.908974358974359,0.9581003597577061,1.0,38/127,21.21%,RBPMS;ADARB1;DDX54;ISG20;DROSHA;HNRNPF;GTF2F2;RNASE1;RNASEH2A;MTREX;HNRNPK;HNRNPA0;HNRNPD;RNASE4;LSM8;DICER1;RNGTT;RBM3;ADAR;RNASEH2C;RNASEH2B;HNRNPC;FASTKD2;WTAP;XRN2;DDX20;HNRNPUL1;PNPT1;METTL14;HNRNPM;THOC1;PRPF4;DHX36;POLR2L;LSM1;SETX;MRPL44;RNASEH1
prerank,regulation of telomere maintenance (GO:0032204),0.3068430358509234,0.7333859873375869,0.816,0.9578502024247355,1.0,8/26,18.99%,PPP1R10;HNRNPD;SIRT6;ERCC4;ATRX;YLPM1;USP7;DHX36
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.31112274158530956,-0.733168416797816,0.8112798264642083,1.0,1.0,8/13,35.59%,SEC16B;CD81;INSIG1;SEC16A;TMEM30B;SORL1;TM9SF4;SAR1A
prerank,positive regulation of calcium ion import (GO:0090280),0.3545380390842637,0.7321738082147075,0.8006993006993007,0.9590383319018314,1.0,1/12,1.90%,PDGFB
prerank,purine-containing compound salvage (GO:0043101),0.35138403368536564,0.7320505913307892,0.7587412587412588,0.9587718426682552,1.0,4/12,19.92%,GMPR;HPRT1;ADA;PNP
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.29085565865179674,-0.7317517341317614,0.8235294117647058,1.0,1.0,3/16,9.93%,CELF4;DAZAP1;CIRBP
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.29561243180879176,0.7313331866816949,0.7947882736156352,0.9592945500855634,1.0,8/30,20.80%,FBXW7;SH3GLB1;UBE2D3;SAE1;ARIH2;CSNK2A2;UBE2L3;LEPROT
prerank,positive regulation of vacuole organization (GO:0044090),0.3648856739413642,0.7311614265837997,0.7775735294117647,0.9591058269365842,1.0,2/10,6.34%,RALB;SH3GLB1
prerank,regulation of mitotic spindle organization (GO:0060236),-0.24625941441036245,-0.731071629768619,0.8597014925373134,1.0,1.0,13/35,30.25%,PARP3;GNAI1;GPSM2;RAE1;HNRNPU;DYNC1H1;TPX2;CHMP1A;FSD1;DCTN1;MAP9;CHMP2A;EML3
prerank,snRNA transcription (GO:0009301),0.2622092301445245,0.7304498961345712,0.8793342579750347,0.9596288700837684,1.0,16/70,20.81%,CCNK;GTF2F2;GTF2E2;POU2F1;INTS11;SNAPC3;RPRD1B;GTF2A2;INTS12;RPRD2;POU2F2;RPRD1A;SP1;POLR2L;TAF9;INTS8
prerank,positive regulation of chromosome organization (GO:2001252),0.3429883835984902,0.7303678842484546,0.7923211169284468,0.9592957683085288,1.0,5/15,18.99%,PPP1R10;SIRT6;ATRX;RAD21;DHX36
prerank,stem cell differentiation (GO:0048863),0.28462852970906927,0.7300802226442126,0.8251192368839427,0.959237985864341,1.0,3/39,5.64%,MEF2C;MLLT3;MTF2
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.3392388109507452,0.7299086182191138,0.7911504424778761,0.9590189339148297,1.0,1/15,1.05%,PPARD
prerank,regulation of cell cycle phase transition (GO:1901987),0.24952858022675894,0.7297761262596247,0.8943196829590488,0.9587489336974585,1.0,29/91,25.54%,FBXW7;ATP2B4;CDKN1B;PSMA2;ANAPC7;PSMA8;ANAPC1;PSMA6;TFAP4;CUL1;CDC26;ANAPC16;BUB3;PSME1;PSMA4;PSMF1;PLK1;DBF4;PSMB1;PSMB7;PSMD2;PSMA5;PSMC3;FZR1;UBE2D1;UBE2E1;PSMD3;FBXO5;PSMA3
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.2802241329416593,-0.7295165254362975,0.8274231678486997,1.0,1.0,8/18,22.04%,PTPN23;DAB2;EZR;SRC;MAP2K2;MAP2K1;VPS11;RAB21
prerank,regulation of mRNA catabolic process (GO:0061013),0.2404551441788859,0.7295098296506978,0.9234629861982434,0.9586505827535906,1.0,30/121,21.48%,ANP32A;IGF2BP3;PRR5L;HNRNPD;PSMA2;XPO1;PUM1;PSMA8;SERBP1;PSMA6;CNOT1;EXOSC1;DCP2;NUP214;RC3H1;PUM2;ZFP36;FMR1;CNOT7;ZFP36L1;PSME1;PNPT1;PSMA4;PSMF1;DHX36;PSMB1;PSMB7;ELAVL1;PSMD2;ZC3H14
prerank,regulation of vacuole organization (GO:0044088),0.3204463517970307,0.7294103808393908,0.7879310344827586,0.9583464470857598,1.0,5/20,13.28%,MTM1;TBC1D12;NPRL2;SCARB2;RAB5A
prerank,endodermal cell fate commitment (GO:0001711),-0.32895405036516,-0.7291426529734906,0.7829977628635347,1.0,1.0,3/10,9.36%,CTR9;PAF1;LEO1
prerank,protein heterooligomerization (GO:0051291),0.3207898667222253,0.728994322932345,0.7681660899653979,0.9584560998515911,1.0,9/17,28.12%,MAT2A;PKD2;GRIN1;CBR4;KRT10;CPSF6;FARSB;TMEM120B;GRIN2B
prerank,cellular response to amino acid starvation (GO:0034198),0.25799694178659494,0.7285632225276686,0.8698060941828255,0.9585763487637149,1.0,19/71,22.27%,PRKD1;FAS;MAPK8;SH3GLB1;RPTOR;ATP6V1G2;NPRL2;LARS1;EIF2AK4;CASTOR1;RHEB;EIF2AK2;ATP6V1F;KPTN;ATP6V1D;WDR59;DAP;TFEB;GCN1
prerank,positive regulation of interferon-beta production (GO:0032728),-0.2460220874519836,-0.7283428935457664,0.8978494623655914,1.0,1.0,16/33,39.15%,HSP90AA1;OAS2;MAVS;RNF135;POLR3D;IRF3;PTPN11;DHX9;IRF7;TOMM70;TLR8;TRIM56;TLR2;POLR3C;IRF5;OAS3
prerank,positive regulation of RNA metabolic process (GO:0051254),0.27588917179397066,0.7283248762709172,0.8280542986425339,0.9584690249380982,1.0,11/45,17.44%,ERN1;RBM20;DYRK1A;TGFB1;NFKB1;HNRNPLL;RIPK1;RELA;RIOK1;PNPT1;HEATR1
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.3207016936013696,-0.7282909731774055,0.8109339407744874,1.0,1.0,1/11,6.06%,AGTR1
prerank,platelet aggregation (GO:0070527),0.29530361297151564,0.7278772057976022,0.844551282051282,0.9586333649381324,1.0,6/33,12.55%,MYH9;ACTN1;PIK3CG;P2RY12;ITGB3;STXBP3
prerank,iron ion transport (GO:0006826),-0.23093082317895675,-0.7278458598044316,0.9208211143695014,1.0,1.0,8/47,13.78%,SCARA5;ATP6V0A4;SLC39A14;ATP6V1B2;STEAP3;ATP6V0D1;ATP6V0B;ARHGAP1
prerank,protein-DNA complex disassembly (GO:0032986),0.32519091012264784,0.7274965656010037,0.773286467486819,0.9586848985706387,1.0,8/16,24.62%,ARID1A;RPL23;SMARCE1;GRWD1;SMARCC1;ARID2;SMARCD1;SET
prerank,response to amino acid starvation (GO:1990928),0.2577022042401425,0.7272583269831133,0.8730822873082287,0.9585519494211002,1.0,19/72,22.27%,PRKD1;FAS;MAPK8;SH3GLB1;RPTOR;ATP6V1G2;NPRL2;LARS1;EIF2AK4;CASTOR1;RHEB;EIF2AK2;ATP6V1F;KPTN;ATP6V1D;WDR59;DAP;TFEB;GCN1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.3450582766673259,0.7268660706550545,0.776595744680851,0.9586078392483013,1.0,2/14,9.76%,PAEP;IL23A
prerank,DNA catabolic process (GO:0006308),0.35497045569217733,0.7266249215231463,0.7616487455197133,0.9584857162664002,1.0,2/11,15.02%,ISG20;XRN2
prerank,calcium import into the mitochondrion (GO:0036444),-0.32712082884530286,-0.7265182238461724,0.8281938325991189,1.0,1.0,5/10,22.19%,MCU;MICU1;SLC25A23;MAIP1;SMDT1
prerank,telomere maintenance via recombination (GO:0000722),-0.3183449172880186,-0.725854745999728,0.8337028824833703,1.0,1.0,7/11,30.03%,TEP1;RAD50;SMC6;TPRKB;XRCC3;SMC5;ERCC1
prerank,autophagosome organization (GO:1905037),0.27714221967376124,0.7255077446196563,0.8571428571428571,0.9595303414253857,1.0,16/50,24.10%,ULK1;ATG101;EMC6;GABARAPL1;RAB43;RAB7A;ATG2A;ATG2B;IRGM;STX12;RAB1A;ATG7;VMP1;UBXN2A;RAB1B;RB1CC1
prerank,negative regulation of cholesterol transport (GO:0032375),0.36257703863934904,0.7252067918740953,0.7464285714285714,0.9594985001122516,1.0,1/10,7.58%,NFKB1
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.3219547439112203,-0.7250774721774579,0.7920560747663551,1.0,1.0,7/12,30.82%,ACSL1;FADS2;SCP2;ELOVL1;FADS1;ACOT8;ELOVL2
prerank,tRNA processing (GO:0008033),0.26102003082312075,0.7247103021443516,0.8646408839779005,0.9597344717286042,1.0,19/61,27.24%,CDKAL1;FARS2;RPP30;TSEN34;RTCB;ADAT1;DTWD2;KARS1;TRMT6;TSEN2;CPSF1;RTRAF;THUMPD1;TRUB1;NSUN6;AARS2;TRMT10C;LCMT2;NSUN2
prerank,negative regulation of cell cycle process (GO:0010948),-0.21801409139376243,-0.7246464918285376,0.9478527607361963,1.0,1.0,16/61,19.58%,BMP7;BMP4;TOM1L2;EHMT2;RBBP7;TFDP1;PCGF2;CBX5;GPER1;RING1;ZFYVE19;E2F1;PCGF6;VPS4A;TFDP2;TERF2
prerank,autophagy of peroxisome (GO:0030242),-0.3161514677042708,-0.7236042846246368,0.8153153153153153,1.0,1.0,4/12,25.57%,SQSTM1;NBR1;PEX5;ATM
prerank,protein localization to Golgi apparatus (GO:0034067),0.30348451637781737,0.723059759610455,0.8036303630363036,0.9614435677871432,1.0,4/27,8.71%,GBP5;VPS13D;GCC2;ARL5A
prerank,histone H3-K4 trimethylation (GO:0080182),-0.31935588428275263,-0.7230517514031211,0.8157349896480331,1.0,1.0,4/11,18.82%,OGT;CTR9;KMT2D;BEND3
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.31452613840132393,0.7229256418484629,0.7932203389830509,0.9611651235004928,1.0,4/22,10.31%,NOTCH1;GHR;IL7R;MGAT5
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.3075472514358506,-0.7226142232779412,0.8141592920353983,1.0,1.0,3/13,10.21%,SYT1;CACNA1G;SCAMP5
prerank,histone H2B ubiquitination (GO:0033523),-0.32945018136397336,-0.7220891929193312,0.7793103448275862,1.0,1.0,3/10,9.36%,CTR9;PAF1;LEO1
prerank,negative regulation of secretion by cell (GO:1903531),0.28045639458559385,0.7214636361994599,0.8449848024316109,0.9625823309021473,1.0,7/38,13.37%,NOTCH1;TNFRSF1B;FGF23;TNFRSF1A;VAMP8;PNKD;RHBDF2
prerank,mitotic nuclear membrane organization (GO:0101024),0.26864916095790475,0.7214048161059314,0.8691860465116279,0.9617700732883593,1.0,21/51,27.39%,LBR;CHMP2B;CHMP4A;CHMP4B;NUP98;NUP205;NUP133;NUP43;UBE2I;PPP2R2A;VRK1;PPP2R1A;KPNB1;REEP3;CHMP3;PPP2CA;NUP85;SUMO1;ANKLE2;CHMP4C;EMD
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.26864916095790475,0.7214048161059314,0.8691860465116279,0.9617700732883593,1.0,21/51,27.39%,LBR;CHMP2B;CHMP4A;CHMP4B;NUP98;NUP205;NUP133;NUP43;UBE2I;PPP2R2A;VRK1;PPP2R1A;KPNB1;REEP3;CHMP3;PPP2CA;NUP85;SUMO1;ANKLE2;CHMP4C;EMD
prerank,positive regulation of glial cell differentiation (GO:0045687),0.32916396509698576,0.7211215986717336,0.8080279232111692,0.961672596492072,1.0,5/17,10.12%,NOTCH1;TNFRSF1B;TGFB1;DICER1;CXCR4
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3107678133165486,0.7204774899686007,0.8178752107925801,0.962061269625077,1.0,9/24,24.52%,PINX1;DCP2;ACD;HNRNPC;ERCC4;TERF1;TEN1;TENT4B;TNKS
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.2960437894375252,-0.7199880493304284,0.8644859813084113,1.0,1.0,5/15,14.77%,RIPOR2;CAMK1;ADAM9;EHD1;CD53
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.32311816681046346,0.7198347407254619,0.8028169014084507,0.9624544106149034,1.0,7/19,24.28%,PINX1;DCP2;ACD;HNRNPC;TERF1;TEN1;TENT4B
prerank,amyloid-beta metabolic process (GO:0050435),-0.29039958023267964,-0.7187742742051566,0.8434579439252337,1.0,1.0,5/16,19.39%,MGAT3;APH1B;NCSTN;ABCA7;BACE1
prerank,intracellular cholesterol transport (GO:0032367),-0.29034241083550044,-0.7182953507240518,0.8400954653937948,1.0,1.0,4/15,18.15%,LDLR;LRP6;SERAC1;VPS4A
prerank,regulation of mitotic spindle assembly (GO:1901673),0.32020380015169086,0.7182150410796064,0.8127090301003345,0.9640884736480867,1.0,7/19,27.16%,CHMP2B;CHMP4B;PLK1;PDCD6IP;CHMP3;HSPA1B;CHMP4C
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.32393377696089487,-0.718088667068907,0.8088888888888889,1.0,1.0,3/10,23.75%,CHFR;TUT4;UBC
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.3313894579948728,-0.717755856230597,0.8194130925507901,1.0,1.0,3/10,14.80%,KLF15;THAP7;SNCA
prerank,AMP metabolic process (GO:0046033),-0.3008636152159768,-0.7177498985533519,0.8116279069767441,1.0,1.0,2/13,7.92%,AMPD3;NT5E
prerank,dendrite self-avoidance (GO:0070593),0.3264858399245067,0.7173187037591893,0.7972508591065293,0.9647478444694321,1.0,3/16,8.99%,BSG;ROBO4;DSCAM
prerank,negative regulation of histone methylation (GO:0031061),0.3533273178937587,0.7168368556038037,0.7858472998137802,0.964897833492051,1.0,4/10,21.92%,MTF2;JARID2;KDM1A;PHF1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.24933930375636548,0.7166858998938404,0.9128630705394191,0.9646474953594153,1.0,13/84,13.14%,NANOS3;DAPK1;IGF2BP3;NANOS2;GRB7;RNF139;BTG2;CNOT1;RPL13A;MRPL13;RACK1;FMR1;CNOT7
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.278192801635969,-0.7155069973721995,0.8532110091743119,1.0,1.0,3/17,10.31%,FGF1;SREBF1;APOE
prerank,regulation of pH (GO:0006885),0.3509572123398964,0.7154962000136625,0.786096256684492,0.9657394058839022,1.0,3/11,12.19%,CLCN3;ATP1A4;SLC9A7
prerank,nuclear pore complex assembly (GO:0051292),-0.3247326723609858,-0.7152793913798037,0.8296460176991151,1.0,1.0,4/10,19.55%,NUP93;NDC1;RTN4;NUP107
prerank,cholesterol metabolic process (GO:0008203),0.25375641316956327,0.7151707309617756,0.8627167630057804,0.9657073471604151,1.0,11/68,15.84%,PPARD;CH25H;LBR;SCARF1;SOAT2;CLN6;ABCG1;GGPS1;PMVK;PLPP6;ABCA1
prerank,positive regulation of leukocyte activation (GO:0002696),0.3173912788550349,0.7150260210682026,0.8140350877192982,0.9654415929804934,1.0,4/18,15.56%,NECTIN2;WNT5A;CRLF2;KARS1
prerank,tetrapyrrole metabolic process (GO:0033013),0.3162832233059071,0.7149189740726521,0.8281786941580757,0.9651212825668116,1.0,6/18,23.45%,ABCD4;CD320;TCN2;MTR;MMAA;LMBRD1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.2999596140567821,0.7146728612803777,0.8306451612903226,0.964981923769656,1.0,7/29,16.46%,RPA1;WRAP53;PINX1;CDK2;ACD;HSP90AB1;TERF1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.2557580423205234,0.7143324074590292,0.8896551724137931,0.9649867691323893,1.0,8/66,8.44%,WWTR1;CARD10;DTX3L;LIMK2;CHP2;TGFB1;PINX1;PSEN1
prerank,homologous chromosome segregation (GO:0045143),0.30887607548613416,0.7141427586122279,0.8037865748709122,0.9647895145704115,1.0,6/20,25.24%,MEIOB;TERB1;TERB2;SIRT7;PRDM9;FMN2
prerank,regulation of rRNA processing (GO:2000232),0.3267216378314829,0.714119823631317,0.8068965517241379,0.9643765220926508,1.0,6/16,21.82%,NUDT16;RIOK1;KAT2B;HEATR1;RIOK2;SIRT7
prerank,substantia nigra development (GO:0021762),-0.24025431628806382,-0.7140050407949672,0.9025787965616046,1.0,1.0,7/37,11.92%,NDRG2;PLP1;SIRT2;CKB;MBP;COX6B1;S100A1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.24999031455353027,0.7132521153328406,0.8965034965034965,0.9650012786948812,1.0,28/68,31.06%,CAVIN1;TAF1B;POLR1A;WDR33;POLR1G;POLR1B;GTF2H4;TAF1A;CPSF1;GTF2H1;POLR2L;CCNH;SETX;SNRPD3;TTF2;CPSF3;PCF11;CPSF2;GTF2H5;LSM11;PRMT5;PAPOLA;POLR1F;CSTF3;CSTF2T;GTF2H2;SNRPB;POLR1H
prerank,negative regulation of DNA recombination (GO:0045910),0.2735249648948607,0.7129608467398572,0.8771929824561403,0.9649322818537435,1.0,13/43,22.65%,SMCHD1;SHLD1;CGAS;HELB;MAD2L2;ACD;ATRX;TERF1;POLR2L;MSH2;RMI2;RIF1;POLR2J
prerank,negative regulation of neurogenesis (GO:0050768),0.28132606985480424,0.71249741607548,0.8502340093603744,0.9650679499268455,1.0,3/34,6.24%,B2M;NOTCH1;RAPGEF2
prerank,protein export from nucleus (GO:0006611),0.29211671704530046,0.7121905789258156,0.8338709677419355,0.9649726436952338,1.0,8/27,17.76%,SMURF1;TGFB1;XPO1;DUSP16;NUP214;STYX;CHP1;DESI1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.310941580048694,-0.7120258532457765,0.8165548098434005,1.0,1.0,1/11,0.86%,GSN
prerank,protein deneddylation (GO:0000338),0.35736335743529385,0.7119137413605013,0.7907869481765835,0.9648865200430371,1.0,2/10,11.12%,COPS2;COPS4
prerank,steroid metabolic process (GO:0008202),-0.20617873418114513,-0.711904308160072,0.955719557195572,1.0,1.0,15/72,22.14%,CYP7B1;CYP27A1;CYP26B1;CYP1B1;FDX1;PRLR;FDFT1;SCP2;CUBN;FDXR;LSS;DHCR24;CYP51A1;TSPO;DHRS11
prerank,negative regulation by host of viral transcription (GO:0043922),0.3436736674147941,0.7118317381323584,0.7899461400359067,0.9645521294820407,1.0,4/12,23.72%,INPP5K;TFAP4;PSMC3;JUN
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.3065140781273548,0.7115665578733197,0.827054794520548,0.9644351866854842,1.0,4/21,11.82%,AIM2;FYN;GRIN1;BIRC3
prerank,histone H2A ubiquitination (GO:0033522),-0.2817620656777292,-0.7113838021630928,0.8407960199004975,1.0,1.0,6/17,21.52%,BCOR;DDB2;UBE2B;RING1;DDB1;PCGF1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.251346649152701,0.7111551665648765,0.8913043478260869,0.9644971492279311,1.0,17/72,24.02%,POLK;RPA1;COPS2;COPS4;ERCC4;AQR;GTF2H4;USP7;RFC3;GTF2H1;POLR2L;CCNH;POLR2J;RFC5;ERCC6;CUL4B;COPS8
prerank,nucleic acid-templated transcription (GO:0097659),0.27439514613107524,0.7111146854930612,0.8549848942598187,0.9641127390287207,1.0,9/42,14.43%,EPC1;BCL3;PWP1;TAF1B;MMS19;RNPS1;PTMA;MEF2A;TOPORS
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.2800486725604622,-0.7108335203967074,0.8541176470588235,1.0,1.0,4/17,14.25%,PRKN;CD44;MDM2;SNAI1
prerank,cellular response to nitrogen compound (GO:1901699),0.31127796589936035,0.7106720816239138,0.834983498349835,0.9642058382196876,1.0,7/20,17.06%,ATP2B4;FMR1;AOC1;DDI1;ATRX;DDI2;SPIDR
prerank,snRNA processing (GO:0016180),0.32259073915973824,0.7106318077126728,0.8003629764065335,0.9638147481485364,1.0,6/16,27.52%,INTS11;INTS12;INTS8;TOE1;INTS6L;TUT1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.27962891516320754,0.7105369051524594,0.862015503875969,0.9635070466427127,1.0,3/39,2.90%,UTRN;NEDD4L;FXYD6
prerank,glycoprotein catabolic process (GO:0006516),0.3245529986472519,0.7102360278830195,0.8045375218150087,0.9634214235829125,1.0,1/17,1.66%,STT3B
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.24135275502996195,0.7096296215044884,0.940026075619296,0.9637344589590017,1.0,23/104,20.60%,DAB2IP;LRP5;CCNK;RALB;TRIB3;CDKN1B;RPTOR;RB1;TRIB1;CDC25C;CCNJ;IRGM;PIH1D1;RHOA;CALM1;CIB1;CDC37;SYAP1;BCCIP;GTF2H1;TSG101;DUSP19;CCNH
prerank,DNA strand elongation (GO:0022616),-0.27778955928162913,-0.7095974582873309,0.8589743589743589,1.0,1.0,9/18,32.07%,RAD50;GINS3;GINS1;TERT;POLD2;GINS4;DCLRE1B;MCMDC2;MCM3
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.31302100422214313,0.7089354528410384,0.8240270727580372,0.9641420450033692,1.0,4/18,17.65%,CFAP53;SPA17;CABYR;RFX3
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.25872283659262374,0.7088446890527463,0.8851540616246498,0.962949259860251,1.0,1/61,0.35%,CTSC
prerank,COPII vesicle coating (GO:0048208),0.25872283659262374,0.7088446890527463,0.8851540616246498,0.962949259860251,1.0,1/61,0.35%,CTSC
prerank,vesicle coating (GO:0006901),0.25872283659262374,0.7088446890527463,0.8851540616246498,0.962949259860251,1.0,1/61,0.35%,CTSC
prerank,regulation of chromatin organization (GO:1902275),0.32835986436140224,0.7078417655733812,0.8017543859649123,0.963660906744821,1.0,4/14,20.67%,MLLT3;PARG;TLK1;SETD5
prerank,establishment of protein localization to organelle (GO:0072594),0.250742788676743,0.7077884523604964,0.8762169680111266,0.963280213685619,1.0,11/72,14.62%,RAB11A;STAT3;IPO11;PPP1R10;NEURL1B;IPO8;NUP214;PRICKLE1;NUP133;NUP153;TNPO3
prerank,cranial nerve development (GO:0021545),0.35433363764180265,0.7071502930798661,0.8,0.9636241648683722,1.0,1/11,3.47%,CHD7
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.17984025266623377,-0.7069069851355929,1.0,1.0,1.0,45/184,25.18%,APPL2;NINL;HECW2;PKD1;HSP90AA1;SIRT2;CDC14B;YWHAG;PSME4;ANAPC5;ALMS1;PRKACA;BTRC;SDCCAG8;CEP63;RGCC;ANAPC15;CEP192;ODF2;PLK5;CEP152;PSMD12;CEP43;PCM1;XPC;DDB1;E2F1;DCTN3;PSMC4;DYNC1H1;NEK11;PSMB6;ID2;CDC16;CKAP5;HAUS6;HAUS2;TPX2;SFI1;CSNK1E;UBC;CENPF;PSMD4;PSMC5;BUB1B
prerank,regulation of p38MAPK cascade (GO:1900744),0.27316318601737644,0.7064710960416777,0.8552036199095022,0.9640167351213107,1.0,3/35,6.29%,DAB2IP;MFHAS1;SASH1
prerank,snRNA metabolic process (GO:0016073),0.3201848472785113,0.7061569432808761,0.7948717948717948,0.9639512115775429,1.0,5/17,23.19%,MTREX;INTS11;INTS12;INTS8;RBM7
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.28622849550763874,0.7059936312444052,0.8569206842923794,0.9637172575254881,1.0,7/33,16.46%,RPA1;WRAP53;PINX1;CDK2;ACD;HSP90AB1;TERF1
prerank,B cell mediated immunity (GO:0019724),0.3468878244455481,0.7043386171587318,0.7926605504587156,0.9652354908684445,1.0,4/10,23.60%,SLA2;CARD9;MSH2;FCER1G
prerank,mitotic cytokinetic process (GO:1902410),0.3073622450824183,0.7040978402293255,0.8277591973244147,0.9650685036535527,1.0,3/20,8.75%,CHMP2B;CHMP4A;CHMP4B
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.24110393341798636,0.7035991387498364,0.920844327176781,0.9652391385223278,1.0,23/88,25.74%,FBXW7;FBXL4;FBXL7;PSMA2;FBXL2;PSMA8;PSMA6;CUL1;FBXL3;PSME1;PSMA4;PSMF1;CUL2;FBXO17;PSMB1;PSMB7;PSMD2;PSMA5;PSMC3;CUL4B;PSMD3;PSMA3;FBXW4
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.2870562959907793,0.7035263679181325,0.85062893081761,0.9648903750864447,1.0,7/33,14.46%,HTR2A;EDN1;PIK3C2A;PIK3CG;ERBB2;IGF1R;ZFP36L1
prerank,regulation of embryonic development (GO:0045995),0.2797605788694832,0.7032563986946536,0.8532695374800638,0.9647853304657277,1.0,14/34,23.21%,INSR;SOX17;PLCB1;B4GALT5;NR2C2;NIBAN2;EHMT1;CFL1;ZBED3;DHX36;RACGAP1;NIPBL;CRB2;CLASP2
prerank,cellular response to ATP (GO:0071318),-0.29609707948184827,-0.7029788005345402,0.8445475638051044,1.0,1.0,2/14,8.14%,P2RX4;TAF1
prerank,phospholipid biosynthetic process (GO:0008654),0.2806701071283919,0.7029035475254951,0.8700305810397554,0.9647670010382423,1.0,7/36,19.12%,SGMS1;MBOAT1;NUS1;DPAGT1;DOLK;CPNE3;GNPAT
prerank,positive regulation of protein depolymerization (GO:1901881),-0.3116860849546266,-0.702611459236921,0.8337028824833703,1.0,1.0,3/11,16.06%,SEMA5A;NES;PLEK
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.2689993604960381,-0.7017659860459167,0.8762376237623762,1.0,1.0,8/19,29.57%,AR;ICE2;CEBPA;BRF2;MAF1;MTOR;ZC3H8;NAB2
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.2695810046863254,-0.7016768361282878,0.8651960784313726,1.0,1.0,7/19,23.91%,AXL;MMP14;SYK;MDK;XRCC6;RHOH;PRKDC
prerank,negative regulation of B cell activation (GO:0050869),0.30644420329769145,0.7016137720117218,0.8389830508474576,0.9658359261301185,1.0,3/21,11.05%,LYN;SAMSN1;RC3H1
prerank,protein alkylation (GO:0008213),-0.2625347837555681,-0.7012726714735398,0.89,1.0,1.0,7/22,26.01%,LCMT1;VCPKMT;EEF1AKMT1;PRMT8;METTL21A;PRMT2;EEF2KMT
prerank,mitochondrial gene expression (GO:0140053),0.2665222094988544,0.7009296419973181,0.8855421686746988,0.9662068190601099,1.0,12/42,23.13%,MRPS18A;NDUFA7;TFB2M;MRPS12;FASTKD2;QRSL1;MRPS16;MRPL23;PTCD3;MRPL12;NOA1;RARS2
prerank,positive regulation of intracellular transport (GO:0032388),0.27423054663313806,0.7006824187340511,0.8687022900763359,0.9660479565542959,1.0,18/38,28.70%,PGAP1;PRR5L;PCNT;EHD2;NEDD4;CEP290;CEP131;NUMA1;MLC1;RIPOR1;TENM1;STX18;RUFY3;PLK3;B3GAT3;KIF20B;ICE1;BCAS3
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.31599217118760137,0.7005603936271301,0.8225806451612904,0.9657607207425011,1.0,4/17,14.03%,STAT3;BACH2;BTN3A3;SLA2
prerank,positive regulation of macrophage differentiation (GO:0045651),0.35156330184414847,0.6999562804330636,0.7980769230769231,0.9660140237941686,1.0,4/11,11.77%,CASP8;TGFB1;CSF1;RIPK1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.22586238307091905,0.6997697681889581,0.9620563035495716,0.965793149766076,1.0,31/145,21.15%,RAB11A;PRKAR2B;CEP41;AURKA;PCNT;AVEN;FBXL7;PSMA2;DYNLL1;PINX1;BRD4;CNTRL;CDK2;CEP57;PSMA8;PSMA6;CUL1;CDC25C;PSME1;CEP290;CEP72;PSMA4;CEP131;PSMF1;CETN2;CDK5RAP2;PLK1;PSMB1;PPP2R1A;PSMB7;PSMD2
prerank,protein mannosylation (GO:0035268),0.2924190832837953,0.699749467800161,0.8170731707317073,0.9653865653163591,1.0,3/22,8.93%,TMTC2;B4GAT1;RXYLT1
prerank,regulation of spindle assembly (GO:0090169),0.2950252734726225,0.6995172026385572,0.8377952755905512,0.9652331435339874,1.0,10/25,27.16%,CHMP2B;CHMP4B;RNF4;NUMA1;PLK1;SENP6;PDCD6IP;CHMP3;HSPA1B;CHMP4C
prerank,RNA interference (GO:0016246),0.31743678805388514,0.6993018679572601,0.8365896980461812,0.9650435595252514,1.0,5/17,21.73%,DROSHA;DICER1;HENMT1;MRPL44;PRKRA
prerank,ribonucleoprotein complex assembly (GO:0022618),0.22861363221784253,0.698675930545332,0.9371069182389937,0.9653607015779806,1.0,36/132,21.57%,RPS15;RPS19;RPS14;RPSA;RPL38;SRPK3;TGS1;RSL24D1;RRS1;DICER1;MCTS1;YTHDC1;EIF6;RPS27;RPL6;NOP53;RPL10;HSP90AB1;SCAF11;WDR77;EIF5;DDX20;LUC7L2;CDC73;RPL11;STRAP;SRSF10;SART3;SART1;RPL3;TRAF7;SETX;RPS28;CPSF6;SF3A2;DENR
prerank,nuclear membrane reassembly (GO:0031468),0.2585730527481151,0.6978156716811801,0.8963503649635036,0.9659036413087289,1.0,22/54,27.39%,LBR;CHMP2B;CHMP4A;CHMP4B;NUP98;NUP205;NUP133;NUP43;UBE2I;PPP2R2A;VRK1;PPP2R1A;KPNB1;UBXN2A;REEP3;CHMP3;PPP2CA;NUP85;SUMO1;ANKLE2;CHMP4C;EMD
prerank,linoleic acid metabolic process (GO:0043651),-0.2723424463511704,-0.6972313701644428,0.8729411764705882,1.0,1.0,9/17,30.94%,ACSL1;FADS2;GSTM2;ALOX12;ELOVL1;FADS1;ELOVL2;ALOXE3;ALOX5
prerank,regulation of cellular response to stress (GO:0080135),-0.1874887570615079,-0.6970395293288023,0.995,1.0,1.0,27/115,23.38%,ROCK2;PRKN;NUPR1;HSP90AA1;NEK4;AMFR;DNAJC7;POM121;RAE1;NUP93;NDC1;HSPH1;CAMK2B;CEBPB;NPAS2;USP19;AIFM2;NUP107;SEC13;ATR;MLST8;EIF4G1;ADCY8;CRYAB;BAG3;CLN3;AKT1S1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.2684595614108811,0.6963435209205154,0.8753709198813057,0.9671037924850072,1.0,4/42,10.82%,PTK2B;PPBP;CCL14;RBM15
prerank,proteolysis (GO:0006508),0.21428776083722953,0.6963155978941499,0.974669603524229,0.9667005368391163,1.0,51/252,19.52%,CTSC;PRCP;ADAM10;CASP4;CASP8;CPD;CPE;SPPL2A;F7;RET;SRGN;CASP7;CASP1;PM20D2;CTRL;ERAP1;CTSK;CTSO;MALT1;PSEN1;FBXL2;FBXW2;LAP3;PSMA6;APH1A;UBE3A;PITRM1;LONP1;LGMN;APEH;CAPN5;ADAM17;SPCS1;PCSK7;PROC;SPPL3;ZMPSTE24;ACE;DDI2;NEDD8;DESI2;DESI1;MMP24;CAPN7;CAPN12;USP25;TMPRSS2;LACTB;CTSH;FOLH1;UBA3
prerank,negative regulation of TOR signaling (GO:0032007),0.2770724335988611,0.6957666232060149,0.8691019786910198,0.9669025399846849,1.0,5/36,9.94%,SH3BP4;DDIT4;TNFAIP8L1;UBR1;NPRL2
prerank,granulocyte chemotaxis (GO:0071621),0.2536902905813154,0.6952391063401435,0.8920056100981767,0.9670578164806722,1.0,5/55,10.48%,EDN1;BSG;PPBP;PIK3CG;CCL14
prerank,cytoplasmic sequestering of protein (GO:0051220),0.32830459047383964,0.6943393388820922,0.8269581056466302,0.9676424894634762,1.0,3/13,10.97%,NFKBIA;PKD2;NFKBIE
prerank,serine family amino acid metabolic process (GO:0009069),-0.27833445020252956,-0.6940711403621833,0.8646788990825688,1.0,1.0,9/16,34.47%,GCLC;MTHFD1;SARS1;CBS;CTH;SEPSECS;CDO1;THNSL2;PSPH
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.28721456270257417,-0.6924024989981539,0.8603603603603603,1.0,1.0,7/15,26.14%,ADRA2A;APOE;ADAM9;GPLD1;PACSIN3;SNX33;NRDC
prerank,organonitrogen compound catabolic process (GO:1901565),0.2542816637376292,0.6920432742112714,0.9197183098591549,0.9697810133185407,1.0,12/57,15.85%,PLA2G4A;ENPP2;CTRL;ERAP1;TRIM24;SIAH1;CLN6;GNPDA2;MPST;PNPLA8;ADO;ACE
prerank,adrenergic receptor signaling pathway (GO:0071875),0.3100164964395046,0.6919993448697975,0.835725677830941,0.9693938960734432,1.0,3/20,6.24%,PDE4D;ADRB1;RAPGEF2
prerank,glutathione metabolic process (GO:0006749),0.2660521921050268,0.6906279967491751,0.8649045521292217,0.9704953436077692,1.0,8/38,14.08%,GSR;GSTA4;GGCT;GCLM;ETHE1;GLRX2;GSTP1;OPLAH
prerank,tRNA transport (GO:0051031),0.27094273019342935,0.6889121435532142,0.8951367781155015,0.9719607775024358,1.0,9/35,16.60%,NUP214;NUP98;NUP205;NUP133;NUP153;NUP54;YBX1;NUP43;XPOT
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.22741782105492558,-0.6886004117432413,0.9397590361445783,1.0,1.0,18/40,32.98%,NUCKS1;RTEL1;SMARCAL1;CDK9;BOD1L1;SETMAR;DONSON;ATR;POLE;FBH1;GEN1;POLD1;CENPX;BLM;ZRANB3;WRN;EXD2;EME2
prerank,regulation of isotype switching (GO:0045191),-0.2833526687176205,-0.688526941809837,0.8555555555555555,1.0,1.0,2/14,5.28%,PARP3;KMT5C
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.32954717387345,0.6875281274716175,0.8134328358208955,0.9730572841535035,1.0,3/12,20.81%,WRAP53;CCT7;CCT2
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.24954487119975075,0.6875166570923543,0.939521800281294,0.972638462796367,1.0,6/61,10.26%,CAV1;SIRT5;PSMA2;PANK2;PSMA8;PSMA6
prerank,early endosome to Golgi transport (GO:0034498),-0.31282075963135564,-0.6863505011681715,0.843956043956044,1.0,1.0,4/11,18.56%,TMED9;TRAPPC10;RBSN;SNX2
prerank,regulation of mRNA processing (GO:0050684),-0.23267719347066476,-0.6855988082876008,0.9331476323119777,1.0,1.0,8/32,19.61%,SON;SRPK2;TIA1;SF1;KHDRBS3;PABPN1;SRSF3;SAFB2
prerank,protein heterotetramerization (GO:0051290),0.31491406474306427,0.6850691355036731,0.8207885304659498,0.9748187017272362,1.0,6/13,24.70%,PKD2;GRIN1;CBR4;KRT10;CPSF6;FARSB
prerank,regulation of cellular response to heat (GO:1900034),0.23906330066448747,0.6846725582140759,0.9434210526315789,0.9748237273518892,1.0,29/77,27.05%,CD34;RPA1;RPTOR;NUP214;NUP98;HSP90AB1;NUP205;NUP133;NUP153;NUP54;NUP43;BAG4;CHORDC1;BAG1;HSPB8;DNAJB1;DNAJB6;IER5;BAG2;HIKESHI;YWHAE;FKBP4;NUP42;DNAJC2;NUP85;CREBBP;GSK3B;RPA3;HSPA1B
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.20120087891879662,-0.684068137946002,0.975,1.0,1.0,25/78,22.96%,SEC24D;KIF3C;KIF3A;SEC31A;DYNC1I1;SEC23A;ACTR1B;AP2S1;DCTN5;CTSD;KIFAP3;KLC1;CAPZB;KIF5A;DCTN4;DCTN3;CTSL;DYNC1H1;SEC13;KLC2;CD74;LAG3;CTSS;AP1S1;DYNC1LI2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.20120087891879662,-0.684068137946002,0.975,1.0,1.0,25/78,22.96%,SEC24D;KIF3C;KIF3A;SEC31A;DYNC1I1;SEC23A;ACTR1B;AP2S1;DCTN5;CTSD;KIFAP3;KLC1;CAPZB;KIF5A;DCTN4;DCTN3;CTSL;DYNC1H1;SEC13;KLC2;CD74;LAG3;CTSS;AP1S1;DYNC1LI2
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.3212627844789742,0.6839859422216222,0.8132231404958677,0.9751362691481152,1.0,7/13,28.04%,NELFE;NELFCD;NELFB;EAPP;NELFA;RNF168;RNF8
prerank,secretory granule organization (GO:0033363),0.34151417821277397,0.6838416659998569,0.8190298507462687,0.9748590296026034,1.0,2/10,15.84%,SRGN;ABCA1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.2981630346857464,0.68376094684966,0.8464163822525598,0.9745109536797045,1.0,10/21,27.10%,RPS7;RPL23;MAD2L2;RPL11;RAB1A;PLK1;BAG2;FZR1;FBXO5;MAD2L1
prerank,secondary alcohol metabolic process (GO:1902652),0.2602261474723518,0.683149165198071,0.8839009287925697,0.9747376754640844,1.0,5/42,12.83%,PPARD;CH25H;SOAT2;CLN6;ABCG1
prerank,ruffle organization (GO:0031529),-0.27696337132354665,-0.6824228111415718,0.8767772511848341,1.0,1.0,5/16,16.06%,TPM1;CARMIL1;ARFIP2;AIF1L;PLEK
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.249378361112848,-0.6822404734792383,0.8856447688564477,1.0,1.0,2/23,9.45%,AXL;INHBA
prerank,integrated stress response signaling (GO:0140467),-0.2903540103950516,-0.6812473057047184,0.8627002288329519,1.0,1.0,5/14,27.14%,IMPACT;EIF2AK3;EIF2AK1;HSPA5;CCL2
prerank,regulation of vesicle-mediated transport (GO:0060627),0.2352523000882404,0.6806458748707469,0.9393139841688655,0.976941537770317,1.0,20/91,17.84%,HIP1;HIP1R;RAB11A;SCARB1;OPHN1;RNF139;PTPN1;RAB12;INPP5F;ABL2;PICALM;RAB26;RAB11B;RAB5A;RAB5B;SYT7;RAB8B;PACSIN2;CPLX2;USP7
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.28971314481226546,-0.6792527386863734,0.8612334801762115,1.0,1.0,6/13,27.76%,CD44;MDM2;SNAI1;CD74;TWIST1;SNAI2
prerank,regulation of membrane depolarization (GO:0003254),0.30302929382945787,0.6789761719931147,0.8780918727915195,0.9783401533396374,1.0,2/18,5.19%,NEDD4L;SMAD7
prerank,myelin maintenance (GO:0043217),-0.3112979882689247,-0.6778087009225381,0.8643326039387309,1.0,1.0,1/10,1.47%,EPB41L3
prerank,cell cycle checkpoint signaling (GO:0000075),-0.29461791599232245,-0.6777403809865373,0.8601398601398601,1.0,1.0,2/12,12.87%,ZWINT;CHFR
prerank,retrograde axonal transport (GO:0008090),-0.2797460749804376,-0.6774522779385025,0.841726618705036,1.0,1.0,6/16,23.99%,DLG2;KIF1A;KIF5A;DYNC1H1;MAP1A;TMEM108
prerank,microtubule depolymerization (GO:0007019),-0.2694992581677493,-0.6773927976243462,0.8852040816326531,1.0,1.0,6/17,30.87%,KIF24;NCKAP5L;CKAP5;KIF18B;STMN4;STMN2
prerank,COPII-coated vesicle budding (GO:0090114),0.2411316320657866,0.6768609715263937,0.9305177111716622,0.9801394595792854,1.0,1/68,0.35%,CTSC
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.32797906317974085,0.6767184728518657,0.8338983050847457,0.9798579379934158,1.0,7/12,28.04%,NELFE;NELFCD;NELFB;EAPP;NELFA;RNF168;RNF8
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.3130629020548352,-0.6765314984078176,0.851258581235698,1.0,1.0,2/10,4.33%,SIRT2;IMPACT
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.29164624306001063,-0.6756812874993848,0.8733905579399142,1.0,1.0,3/12,8.51%,CLCN2;SREBF1;H6PD
prerank,C-terminal protein amino acid modification (GO:0018410),-0.30320061059092007,-0.6756026682724645,0.8512035010940919,1.0,1.0,4/11,18.92%,AGBL4;LCMT1;GPLD1;AGBL1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.27576024360761353,0.6751669371831103,0.885670731707317,0.9809754197999924,1.0,7/32,17.98%,LPCAT3;CEPT1;LPIN3;PEMT;CHKA;CSNK2A1;CSNK2A2
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.3149517218797575,-0.6747759658881036,0.8704883227176221,1.0,1.0,7/10,48.21%,ASRGL1;KYAT1;KYNU;PCBD1;THAP4;IYD;QDPR
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.3060890162720953,0.6745663073812971,0.8266199649737302,0.9811548488234587,1.0,3/15,9.86%,NEK6;ANAPC7;ANAPC1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.312799394448768,-0.6745542050609661,0.864516129032258,1.0,1.0,3/10,11.02%,RYK;LRP6;FZD1
prerank,regulation of astrocyte differentiation (GO:0048710),0.325802912167953,0.6744266326123891,0.8253358925143954,0.9808625336742334,1.0,2/12,11.35%,NOTCH1;EPHA4
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.29087959484695586,0.6743688850844983,0.8578595317725752,0.9804880333053095,1.0,5/23,16.16%,CAV1;DUSP22;CBL;SOCS4;SH3BP5L
prerank,mRNA processing (GO:0006397),0.20533333770171147,0.6742187176760202,0.9880043620501636,0.980215361181578,1.0,85/287,25.72%,NOVA2;ERN1;RSRC1;HNRNPF;GTF2F2;SF3B4;CTNNBL1;MTREX;HNRNPK;HNRNPA0;RBM14;HNRNPD;WDR33;THOC2;LSM8;RNGTT;RBM15;SPEN;YTHDC1;RNPS1;LSM3;THOC6;RPRD1B;HNRNPC;RNMT;DHX15;SMU1;ZMAT2;SF3B6;RPRD2;SCAF11;SNRNP25;SNW1;CWC27;YBX1;HNRNPUL1;AQR;LSM7;GTF2H4;CWC22;THOC3;ALYREF;PRPF40A;PHF5A;CDC40;METTL14;CWF19L2;HNRNPM;THOC1;CPSF1;RALY;FUS;PRPF4;RPRD1A;SRSF10;GTF2H1;THOC5;SART3;POLR2L;SART1;CCNH;ELAVL1;CPSF6;SF3A2;PRPF3;THOC7;POLR2J;TRA2B;AURKAIP1;DBR1;SNRPD3;SRSF4;SYNCRIP;SLU7;PSPC1;RBMX;SYF2;LSM2;CPSF3;SNRNP200;PCF11;CPSF2;PUF60;GTF2H5;HNRNPA3
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.3225446995159066,0.6734677298796294,0.8232142857142857,0.980526975260768,1.0,5/12,27.23%,SOX9;STRAP;MUC6;MUC13;NOD2
prerank,negative regulation of DNA replication (GO:0008156),0.3241779987521989,0.6717574210955993,0.848987108655617,0.9818542414034159,1.0,6/13,26.68%,GMNC;PDS5A;TERF1;RAD17;GMNN;GTPBP4
prerank,regulation of lipase activity (GO:0060191),-0.2891607916333266,-0.6716471790815588,0.8693693693693694,1.0,1.0,5/13,18.06%,PCSK5;PCSK6;SNCA;LMF1;ANGPTL3
prerank,histone mRNA metabolic process (GO:0008334),0.2776778952642461,0.6715802697236944,0.882258064516129,0.9816003902942891,1.0,13/27,30.84%,DCP2;MTPAP;LSM1;SNRPD3;TENT4B;CPSF3;EXOSC4;CPSF2;LSM11;TUT7;TUT1;ERI1;SNRPB
prerank,regulation of sequestering of triglyceride (GO:0010889),0.305637602377627,0.6710978998146635,0.8606271777003485,0.9816423491682006,1.0,4/15,14.53%,PLIN5;LPL;PNPLA2;APOC4
prerank,protein localization to kinetochore (GO:0034501),-0.2804512292230348,-0.6697533506363851,0.8954545454545455,1.0,1.0,9/14,42.35%,IK;CENPT;KNL1;SPDL1;CDK1;ZW10;MIS12;TTK;ZWILCH
prerank,neurogenesis (GO:0022008),0.2544718028801,0.6692747446699694,0.9101620029455081,0.9830008106413308,1.0,11/43,18.81%,CDK6;BTBD1;BTBD3;NEUROD1;THOC2;CXCR4;NDUFS2;METTL14;TRAK2;BTBD6;CDK5RAP2
prerank,DNA-dependent DNA replication (GO:0006261),0.2197683410851184,0.6690847408352567,0.9767441860465116,0.9827542190172472,1.0,38/128,26.95%,RPA1;MCM10;PSMA2;POLA1;PRIMPOL;CDT1;CDK2;PSMA8;HELB;RECQL;PSMA6;PRIM2;PSME1;ORC5;BAZ1A;ORC3;PSMA4;CDC34;RFC3;PSMF1;GINS2;MCMBP;DBF4;PSMB1;PSMB7;PURA;PSMD2;SIRT7;PSMA5;RFC5;PSMC3;ORC6;PSMD3;PSMA3;GMNN;PRIM1;MCM6;RPA3
prerank,respiratory electron transport chain (GO:0022904),0.3215687671398005,0.669064364992633,0.8500851788756388,0.9823430748811568,1.0,1/14,2.35%,GPD2
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.26470957096606906,-0.6688218731719604,0.9088669950738916,1.0,1.0,5/19,17.89%,ALDH1L1;FPGS;MTHFD1;SLC19A1;MTHFD2L
prerank,regulation of protein sumoylation (GO:0033233),0.3040221503093047,0.6684572338928094,0.8701754385964913,0.9825173178413562,1.0,4/17,16.73%,RASD2;ZMIZ1;SAE1;CTNNB1
prerank,negative regulation of mRNA processing (GO:0050686),-0.27212400183936813,-0.667694786543222,0.891358024691358,1.0,1.0,6/15,31.71%,U2AF2;PCBP4;BARD1;SRSF6;C1QBP;SRSF9
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.2655015877363899,-0.6674816172533786,0.9009661835748792,1.0,1.0,5/18,21.31%,PRKN;HSPB1;NONO;HTRA2;NME5
prerank,regulation of inclusion body assembly (GO:0090083),0.32841960133388176,0.6663844781482834,0.8226691042047533,0.9841424247623505,1.0,3/11,19.29%,SNCAIP;DNAJB1;DNAJB6
prerank,response to UV-B (GO:0010224),-0.29392826629643676,-0.6660307818743322,0.8809523809523809,1.0,1.0,7/12,37.15%,MFAP4;CDKN1A;HYAL1;CRIP1;HYAL3;MME;IL12A
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.290402838111849,0.6648611563647261,0.8545751633986928,0.9852084748891042,1.0,3/20,9.92%,FAS;BOK;BCL2L1
prerank,negative regulation of protein metabolic process (GO:0051248),0.2475733628069104,0.6643664212563958,0.9265785609397944,0.985246397535668,1.0,11/48,15.12%,EDN1;PTX3;NFKB1;SNX3;MAD2L2;ITGB3;RILP;PFDN1;HSP90AB1;IRAK3;PRKCG
prerank,nuclear envelope organization (GO:0006998),-0.25402143092082297,-0.6641906985050652,0.9120603015075377,1.0,1.0,7/20,28.88%,DMPK;NUP93;VPS4A;TMEM43;TOR1A;TOR1B;TOR1AIP1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.28566052882951054,0.6640499649575315,0.8708609271523179,0.9851073752284021,1.0,3/22,12.41%,MFHAS1;SASH1;XDH
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.32754166917915,0.6639148606609989,0.8382352941176471,0.9847962708652115,1.0,4/11,21.82%,PWP1;NOP53;PIH1D1;SIRT7
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.30681144949238204,-0.6638311828120953,0.8583877995642701,1.0,1.0,3/10,27.14%,EIF2AK3;HSPA5;CCL2
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.2471718855232769,-0.6636317095008315,0.9315789473684211,1.0,1.0,7/23,23.75%,DDB2;COPS7B;XPC;DDB1;CUL4A;COPS6;UBC
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.23742627452310372,-0.6631192761612269,0.9287671232876712,1.0,1.0,4/27,6.52%,SYT1;SYT9;SYT11;SYT12
prerank,negative regulation of cation channel activity (GO:2001258),-0.23800379895880816,-0.6628888742477578,0.9302325581395349,1.0,1.0,9/26,26.39%,SLC6A9;GNB5;KCNAB1;GSTM2;CASQ2;CBARP;GPR35;EPHB2;EPO
prerank,regulation of DNA metabolic process (GO:0051052),0.2504805531545312,0.6625180717335977,0.9195230998509687,0.9857403140688734,1.0,12/44,21.82%,HNRNPD;CDT1;SUB1;IL7R;HELB;PARG;YLPM1;WDR18;ALYREF;THOC1;UBE2V2;SIRT7
prerank,protein K63-linked ubiquitination (GO:0070534),0.2531366388960475,0.6623632913347884,0.9059180576631259,0.9854532553997183,1.0,9/41,15.79%,TRAF1;PELI1;UBE2G1;NEDD4;RNF4;HECTD1;TRAF6;ARIH2;RNF5
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.27289846237434856,-0.6621952617129013,0.9004739336492891,1.0,1.0,6/14,22.85%,BRCA2;XRCC5;TPP1;TERF2;ATR;TERT
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.31032506520839953,0.6613131642760711,0.8546099290780141,0.986049913264189,1.0,6/16,23.33%,SFRP2;DDIAS;BCL2L1;TPT1;RPS3;CLU
prerank,establishment of spindle localization (GO:0051293),0.3092145726211798,0.6612241568120258,0.8705440900562852,0.9857015113838766,1.0,6/14,23.35%,LLGL1;CFL1;ZBED3;KPNB1;CLASP2;MAP4
prerank,cellular response to oxygen levels (GO:0071453),-0.30185579700528026,-0.6607211484236809,0.8779443254817987,1.0,1.0,6/10,34.37%,CPEB4;ATP6V0D1;TMEM199;CCDC115;ATP6V1G1;ATP6AP1
prerank,positive regulation of protein acetylation (GO:1901985),0.3192700296983907,0.6606565834858175,0.8342644320297952,0.9857774383349676,1.0,5/12,20.08%,DIP2B;CEP295;RAPGEF3;PRKAA1;TAOK1
prerank,response to glucocorticoid (GO:0051384),0.2733140804357238,0.6606007329452057,0.883248730964467,0.9853962200618019,1.0,4/26,14.46%,NR3C1;BCL2L11;ZFP36;ZFP36L1
prerank,import into nucleus (GO:0051170),0.23154109754011995,0.6593516718859722,0.9416909620991254,0.9861413789479386,1.0,18/73,23.15%,STAT3;IPO11;PPP1R10;BACH2;IPO8;NUP214;PRICKLE1;NUP133;NUP153;TNPO3;DDX20;E2F3;PTTG1IP;KPNB1;CSE1L;HIKESHI;EIF4ENIF1;APPL1
prerank,cilium-dependent cell motility (GO:0060285),-0.24837668595532408,-0.6590512362108638,0.9093198992443325,1.0,1.0,8/22,25.00%,CFAP44;DNAH8;CCDC39;RSPH9;EFHC1;GAS8;DNAH2;DRC1
prerank,cellular respiration (GO:0045333),-0.21301138924453072,-0.6587429867497896,0.9536231884057971,1.0,1.0,15/41,29.33%,PPARGC1A;SLC25A13;SDHAF4;NR4A3;SLC25A14;MTFR1L;COQ10A;SDHC;UQCRB;NDUFS7;UQCR10;COX4I2;MDH2;COQ10B;MTLN
prerank,dopaminergic neuron differentiation (GO:0071542),-0.25440777552196225,-0.6586898502006255,0.9213759213759214,1.0,1.0,3/19,9.33%,RYK;LRP6;VEGFA
prerank,rRNA pseudouridine synthesis (GO:0031118),0.33310318855134324,0.6583628467053826,0.8330097087378641,0.9866215645485896,1.0,10/10,66.71%,RPUSD2;RPUSD4;RPUSD1;TSR3;NOP10;DKC1;NAF1;GAR1;RPUSD3;NHP2
prerank,positive regulation of viral transcription (GO:0050434),0.2751990787381527,0.658348751862628,0.8752,0.9862063571360088,1.0,8/25,22.65%,GTF2F2;NELFE;NELFCD;CTDP1;POLR2L;NELFB;NELFA;POLR2J
prerank,pre-replicative complex assembly (GO:0036388),0.23757397650315398,0.6583450412993995,0.9479606188466948,0.985776765433524,1.0,19/64,26.77%,PSMA2;CDT1;PSMA8;PSMA6;PSME1;ORC5;ORC3;PSMA4;PSMF1;PSMB1;PSMB7;PSMD2;PSMA5;PSMC3;ORC6;PSMD3;PSMA3;GMNN;MCM6
prerank,cellular response to ionizing radiation (GO:0071479),0.25166928747624867,0.6574929481425731,0.9167842031029619,0.9861307128419163,1.0,12/47,23.27%,NET1;HUS1;RHOB;MAP3K20;TMEM109;SPIDR;GRB2;KDM1A;NIPBL;TANK;RPL26;MAPK14
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.2935517592268186,-0.6563559478655325,0.8861283643892339,1.0,1.0,1/11,1.14%,PRKN
prerank,peroxisomal membrane transport (GO:0015919),-0.23700245356288974,-0.6557669148195365,0.9253333333333333,1.0,1.0,10/27,26.75%,ABCD3;ATAD1;PEX1;PXMP2;PEX7;PEX11B;GDAP1;PEX5;ABCD2;PEX16
prerank,cellular response to virus (GO:0098586),0.26863689171629496,0.6556699164689052,0.9049844236760125,0.9873864346066179,1.0,13/30,26.67%,HIF1A;MAPK11;FMR1;IFIH1;RRP1B;IRGM;POU2F2;POU2AF1;MAPK14;RIOK3;EIF5A;CXCL10;LGALS9
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.20739586674783583,0.6556020752461401,0.9905771495877503,0.9870204092019889,1.0,23/173,14.60%,CTSC;SPTBN1;PGAP1;PROS1;F7;VAMP4;COG5;VTI1A;TMED7;TGFA;RAB2A;DYNLL1;DYNC1LI1;TMED5;ANK1;SPTAN1;GAS6;TRAPPC3;CAPZA1;ACTR10;PREB;NRBP1;PROC
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.32864452712629044,0.655553556189543,0.8455743879472694,0.9862005626758544,1.0,2/10,14.61%,CDC42EP3;APC
prerank,regulation of pseudopodium assembly (GO:0031272),0.32864452712629044,0.655553556189543,0.8455743879472694,0.9862005626758544,1.0,2/10,14.61%,CDC42EP3;APC
prerank,'de novo' posttranslational protein folding (GO:0051084),0.2663935004995017,0.6555391598978999,0.8974358974358975,0.9857840521456492,1.0,14/30,30.95%,DNAJB5;ERO1A;UGGT1;BAG1;DNAJB1;HSPE1;DNAJB12;CCT2;GAK;HSPA1B;HSPA13;HSPA14;HSPA8;ST13
prerank,intracellular protein transmembrane transport (GO:0065002),-0.21493712091303827,-0.654749481259898,0.9636363636363636,1.0,1.0,15/42,27.00%,C2CD5;PEX1;TOMM40;AIFM1;PEX7;SEC61A2;TIMM17B;GRPEL2;TIMM21;DNAJC15;SEC61A1;PEX5;HSPA5;PEX16;PAM16
prerank,glutathione biosynthetic process (GO:0006750),0.3142720788872826,0.6546106199657266,0.8392226148409894,0.9861830157654219,1.0,3/11,14.08%,GGCT;GCLM;OPLAH
prerank,RNA methylation (GO:0001510),0.238173993142838,0.6544610132592023,0.9371584699453552,0.9858950145681942,1.0,19/60,27.24%,TGS1;CBLL1;RBM15;TFB2M;NSUN4;FBLL1;HENMT1;WTAP;VIRMA;TRMT6;METTL14;NSUN6;TRMT61B;ALKBH8;METTL16;TRMT10C;LCMT2;TRMT12;NSUN2
prerank,regulation of interferon-alpha production (GO:0032647),-0.23981593544222352,-0.6542534240355828,0.9081364829396326,1.0,1.0,3/23,13.33%,PTPRS;CHUK;MAVS
prerank,toxin transport (GO:1901998),0.3283313889810836,0.6531343218934866,0.8633879781420765,0.986659004602916,1.0,1/10,2.43%,ADAM10
prerank,microtubule polymerization (GO:0046785),-0.23137681059642676,-0.6528836300686045,0.937984496124031,1.0,1.0,9/28,28.95%,TUBGCP5;MAP7D3;TPPP3;CKAP5;CCDC57;TPX2;CLASP1;FGF13;GOLGA2
prerank,positive regulation of protein sumoylation (GO:0033235),-0.30722551254497055,-0.6526532290492284,0.8948545861297539,1.0,1.0,3/10,11.72%,HDAC4;PIAS3;PIAS1
prerank,ncRNA metabolic process (GO:0034660),0.25684639867971765,0.6526391727761756,0.9190839694656489,0.9866766572301369,1.0,5/37,13.29%,DTD1;DROSHA;DICER1;NIFK;HENMT1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.28612335692899676,0.6519778359459721,0.8892508143322475,0.9868456568477542,1.0,7/20,18.81%,NT5C2;AK4;ADSL;HPRT1;IMPDH1;ADSS2;GART
prerank,chromosome organization (GO:0051276),0.22326691611729937,0.6519274140818175,0.9646017699115044,0.9864606726023659,1.0,25/99,24.55%,HHEX;PADI4;TCF7L1;TCF7L2;H3-3A;MTF2;CDT1;EZH1;COPS2;COPS4;PADI1;NUP133;HMG20A;EHMT1;PHF19;BAHD1;CETN2;MSH2;GATAD1;PHF1;LATS1;SUV39H1;CUL4B;COPS8;LIG4
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.25913932196647005,-0.6511032215589542,0.9204819277108434,1.0,1.0,2/18,7.10%,UGGT2;AMFR
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.29751512819125897,-0.6503685841438056,0.865909090909091,1.0,1.0,1/10,4.27%,SIRT2
prerank,outer dynein arm assembly (GO:0036158),-0.26932004585729574,-0.6502631883231174,0.9097222222222222,1.0,1.0,7/14,36.44%,DNAL1;DNAH8;ODAD4;DNAAF5;ODAD1;CCDC63;DNAAF4
prerank,negative regulation of phosphatase activity (GO:0010923),-0.23108510222613254,-0.6483117979392726,0.9373297002724795,1.0,1.0,7/25,19.46%,PPP4R4;SH3RF2;CRY2;TGFB2;PTPA;BOD1L1;SH2D4A
prerank,maturation of 5.8S rRNA (GO:0000460),-0.25415423520895697,-0.647668657658751,0.8933649289099526,1.0,1.0,3/17,14.94%,NSA2;FTSJ3;RRP15
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.18489674669890444,-0.6458554700531848,0.9819494584837545,1.0,1.0,14/69,20.42%,SELENOS;AMFR;UBXN4;JKAMP;UBE4B;NPLOC4;UBE2G2;UBE4A;RNF121;DNAJC18;USP19;FAM8A1;DNAJB2;TMEM67
prerank,regulation of lipid catabolic process (GO:0050994),-0.2543692667385787,-0.645849698367472,0.9174757281553398,1.0,1.0,4/19,18.06%,ADRA2A;ALK;RARRES2;ANGPTL3
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3000484456815535,0.6458425701971519,0.8642201834862385,0.991392919313674,1.0,3/13,17.29%,RRS1;RPS21;NOP14
prerank,telomere organization (GO:0032200),-0.20818043916189902,-0.6453791575941281,0.9712460063897763,1.0,1.0,19/43,31.73%,PARP3;RTEL1;RAD50;DOT1L;XRCC5;XRCC6;TERF2;DNA2;ATR;TERT;PRKDC;POLD1;LTO1;ATM;POLD2;DCLRE1B;RPA2;BLM;WRN
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.29136157104589405,-0.6450009100717338,0.9019189765458422,1.0,1.0,3/11,11.02%,RYK;LRP6;FZD1
prerank,protein-containing complex disassembly (GO:0032984),0.23816513497666575,0.6449190301599629,0.9495677233429395,0.9917932609179354,1.0,7/54,16.73%,CAV1;TECPR1;RPL23;VAMP8;GABARAPL1;APC;CTNNB1
prerank,peptidyl-arginine modification (GO:0018195),0.2972311451648395,0.6449054520732567,0.8593481989708405,0.9913736578325864,1.0,4/15,21.32%,PADI4;PADI1;ART4;KRTCAP2
prerank,protein import into peroxisome membrane (GO:0045046),-0.24311967681690744,-0.6445057482555983,0.9282051282051282,1.0,1.0,8/22,26.75%,ABCD3;ATAD1;PXMP2;PEX11B;GDAP1;PEX5;ABCD2;PEX16
prerank,regulation of superoxide anion generation (GO:0032928),-0.2603078937402652,-0.6442661309340773,0.90625,1.0,1.0,4/14,22.37%,PRKCD;SYK;ITGB2;AATF
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.23399810313143093,-0.6438450514637446,0.9293193717277487,1.0,1.0,4/24,14.25%,BCL2;CD44;CXCL12;SNAI1
prerank,reticulophagy (GO:0061709),0.31083689968523825,0.6434655896035567,0.8458844133099825,0.9921379689441044,1.0,5/12,25.30%,ULK1;ATG2A;ATG2B;RB1CC1;UFM1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.22623973799497354,0.6432116477053772,0.9478737997256516,0.9919326799719203,1.0,16/65,23.27%,AURKA;AVEN;FBXL7;PSMA2;PINX1;PSMA8;PSMA6;CUL1;PSME1;PSMA4;PSMF1;PSMB1;PSMB7;PSMD2;PSMA5;PSMC3
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.2883237956314534,-0.6428089865430374,0.9149425287356322,1.0,1.0,4/11,25.20%,PAF1;LEO1;BARD1;ZC3H3
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.24072745134407952,-0.6423606839366822,0.9509043927648578,1.0,1.0,10/23,29.73%,HSP90AA1;TIMM22;COX18;MAIP1;TIMM8B;TIMM9;BAX;TIMM10;SAMM50;PMAIP1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.29258973304696934,0.6422518462478495,0.8786231884057971,0.9923275174729388,1.0,7/16,25.42%,NAA11;KAT2B;NAA16;NAA30;NAA35;NAA50;CREBBP
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.22374068068530134,0.6414439807132083,0.967966573816156,0.9925816885270875,1.0,14/79,13.22%,KIF26A;AP2B1;MFSD6;AP2A1;DYNLL1;DYNC1LI1;KIF22;AP1S2;KIF23;LGMN;RILP;RAB7A;CAPZA1;ACTR10
prerank,lipid homeostasis (GO:0055088),-0.1986768565530832,-0.6410490684331952,0.9716088328075709,1.0,1.0,16/57,24.63%,RBP1;ZBTB20;TLCD2;PRKAA2;RCN3;APOE;IRS2;ORMDL2;TLCD1;ANGPTL3;DGAT2;NR1H3;ABCA2;CEBPA;POLD1;PPARG
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.2879862063195039,0.6404992982946146,0.8756302521008403,0.9929219889582832,1.0,1/18,2.15%,DAB2IP
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.28148033820499657,-0.6391359652381035,0.8687089715536105,1.0,1.0,5/11,31.71%,SMARCAL1;DONSON;FBH1;BLM;ZRANB3
prerank,regulation of store-operated calcium entry (GO:2001256),0.31421428056552037,0.6390661540733938,0.8607594936708861,0.9936757470993464,1.0,4/10,22.07%,HOMER2;HOMER3;HOMER1;CASQ1
prerank,protein import into nucleus (GO:0006606),0.2290440393724377,0.6386284178769018,0.9585121602288984,0.9936126588317408,1.0,19/66,23.15%,STAT3;IPO11;PPP1R10;RPL23;IPO8;NUP214;PRICKLE1;NUP133;NUP153;NUP54;TNPO3;E2F3;PTTG1IP;KPNB1;CSE1L;KPNA4;HIKESHI;EIF4ENIF1;APPL1
prerank,regulation of secretion (GO:0051046),0.30263876832761166,0.6375208756958703,0.8761220825852782,0.9940456071175997,1.0,1/13,2.45%,KCNQ1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.24158231986730314,0.6373250956285232,0.9319526627218935,0.9937721570048768,1.0,13/50,19.29%,PAK2;RPS6KA3;RPS6KA1;XIAP;SFN;GAS6;CARD16;PIH1D1;ARL6IP1;CAAP1;MAP2K5;CSNK2A1;DNAJB6
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.2473721671865474,-0.6372124288549329,0.9196217494089834,1.0,1.0,1/18,1.60%,BCL2
prerank,positive regulation of exosomal secretion (GO:1903543),-0.2656336710063653,-0.636446221027678,0.9229074889867841,1.0,1.0,5/15,18.15%,SDC4;SMPD3;SDC1;SNF8;VPS4A
prerank,negative regulation of translational initiation (GO:0045947),0.3123741316105941,0.6354038957113274,0.8775510204081632,0.9948862150670279,1.0,4/13,16.21%,EIF4EBP1;FMR1;EIF2AK4;PAIP2B
prerank,protein localization to condensed chromosome (GO:1903083),-0.27488509865012256,-0.6351919595312396,0.8997722095671982,1.0,1.0,8/12,42.35%,IK;KNL1;SPDL1;CDK1;ZW10;MIS12;TTK;ZWILCH
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.2184729978872068,-0.6346405023513988,0.9626666666666667,1.0,1.0,7/32,15.59%,EML2;MAP2;CLIP3;NAV3;TTBK2;SNCA;APC2
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.2529173927047862,0.63410007806751,0.9226100151745068,0.9950680880173157,1.0,8/32,16.60%,NUP214;NUP98;NUP205;NUP133;NUP153;NUP54;NUP43;XPOT
prerank,tRNA export from nucleus (GO:0006409),0.2529173927047862,0.63410007806751,0.9226100151745068,0.9950680880173157,1.0,8/32,16.60%,NUP214;NUP98;NUP205;NUP133;NUP153;NUP54;NUP43;XPOT
prerank,Golgi to lysosome transport (GO:0090160),0.3084710677884567,0.6337692074424388,0.8645276292335116,0.9949062165418444,1.0,4/11,23.13%,ANKFY1;EHD3;AP1G1;GAK
prerank,ESCRT III complex disassembly (GO:1904903),0.3110143866745189,0.6330060645438367,0.8813868613138686,0.9946697803104181,1.0,1/10,5.93%,CHMP2B
prerank,ESCRT complex disassembly (GO:1904896),0.3110143866745189,0.6330060645438367,0.8813868613138686,0.9946697803104181,1.0,1/10,5.93%,CHMP2B
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.2515702748943142,0.6329628786143892,0.9175738724727839,0.9942768457218308,1.0,1/34,1.15%,MEF2C
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.24720685604730305,-0.6325680212626102,0.9304556354916067,1.0,1.0,9/18,32.07%,GINS3;GINS1;POLE;POLD2;GINS4;LIG1;MCMDC2;POLE3;MCM3
prerank,gas transport (GO:0015669),0.3102560883755963,0.6324415972642539,0.8717948717948718,0.9942619483451128,1.0,10/10,68.99%,CA2;IPCEF1;AQP5;MB;CYGB;AQP6;RHAG;NGB;AQP1;MYC
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.2774969806772585,-0.6324096953453726,0.9008620689655172,1.0,1.0,1/11,3.80%,UGGT2
prerank,base-excision repair (GO:0006284),-0.20136844242529905,-0.6323715923628317,0.9744408945686901,1.0,1.0,21/48,33.23%,ERCC5;RFC1;USP47;APEX2;NEIL3;DNA2;POLE;MUTYH;TDG;POLG;NTHL1;POLD1;POLB;POLD2;ADPRS;NEIL1;LIG1;RPA2;WRN;FEN1;PRMT6
prerank,positive regulation of type I interferon production (GO:0032481),0.22499962120486197,0.6321343949437587,0.9696969696969697,0.9941035008890095,1.0,15/73,20.36%,LRRFIP1;NFKB1;CGAS;G3BP1;RELA;RIPK2;IFIH1;NFKB2;STAT6;STAT1;CTNNB1;POLR3B;DHX36;POLR3A;POLR2L
prerank,protein K11-linked ubiquitination (GO:0070979),0.262458130672733,0.6321033182471197,0.9032786885245901,0.9936976966089953,1.0,6/27,11.32%,ANAPC7;UBE2H;RNF4;ANAPC1;UBE2D3;CDC26
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.2501104064080062,-0.6320901759068785,0.9031476997578692,1.0,1.0,5/16,24.40%,NUPR1;UQCC2;SLC25A33;PDE12;PPIF
prerank,cristae formation (GO:0042407),-0.22619467661805384,-0.6319094635676514,0.9453125,1.0,1.0,11/27,31.29%,CHCHD3;CHCHD6;ATP5PO;ATP5ME;ATP5PF;SAMM50;ATP5MG;DNAJC11;APOO;DMAC2L;IMMT
prerank,myeloid dendritic cell activation (GO:0001773),0.30541954257150816,0.6317480026509633,0.8766114180478821,0.9935441688216866,1.0,2/12,12.97%,DCSTAMP;TGFBR2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.20755265145613372,0.6310187382757103,0.9950248756218906,0.9937097421725158,1.0,14/128,9.54%,TPD52L1;PLCB1;PRKAR2B;PPP1R12A;CEP41;AURKA;PCNT;FBXL7;DYNLL1;BACH1;CNTRL;CCNY;CDK2;CEP57
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.2831191623629474,-0.6306692471739865,0.9051918735891648,1.0,1.0,4/11,24.94%,TIMM22;TIMM8B;TIMM9;TIMM10
prerank,protein palmitoylation (GO:0018345),-0.21663736326066824,-0.6304317118719756,0.9410187667560321,1.0,1.0,3/30,8.29%,GLUL;CLIP3;ZDHHC20
prerank,nucleosome disassembly (GO:0006337),0.29127363465381956,0.629707463061331,0.8806509945750453,0.9938686470466103,1.0,7/14,24.62%,ARID1A;SMARCE1;GRWD1;SMARCC1;ARID2;SMARCD1;SET
prerank,chromatin disassembly (GO:0031498),0.29127363465381956,0.629707463061331,0.8806509945750453,0.9938686470466103,1.0,7/14,24.62%,ARID1A;SMARCE1;GRWD1;SMARCC1;ARID2;SMARCD1;SET
prerank,negative regulation of viral release from host cell (GO:1902187),-0.2650920581982529,-0.6291520646588288,0.8957345971563981,1.0,1.0,4/13,26.30%,TRIM35;TRIM28;TRIM8;TRIM5
prerank,sensory perception of taste (GO:0050909),0.3120135576198844,0.6287717661394855,0.8777372262773723,0.9941480572595002,1.0,10/10,68.82%,PKD1L3;ASIC1;ASIC2;TAS1R3;GNAT3;TAS1R2;PKD2L1;TAS1R1;ASIC3;CD36
prerank,oligodendrocyte development (GO:0014003),0.2920690260720685,0.6286637991115273,0.8870967741935484,0.9937949183223999,1.0,4/15,14.16%,B4GALT5;EIF2B5;PRDM8;EIF2B2
prerank,miRNA metabolic process (GO:0010586),0.2752943945202531,0.6275711757506173,0.9051580698835274,0.9942013417845446,1.0,9/20,31.01%,DROSHA;DICER1;TRIM71;PRKRA;SND1;TENT4B;TUT7;PARN;DIS3L2
prerank,positive regulation of peptidase activity (GO:0010952),-0.24149514403031302,-0.627421031376019,0.9363207547169812,1.0,1.0,4/20,17.73%,RCN3;APH1B;NCSTN;DDRGK1
prerank,regulation of protein localization to Cajal body (GO:1904869),0.3073253405310401,0.6271254414940566,0.8939670932358318,0.9936804919485539,1.0,11/11,69.29%,CCT7;CCT2;CCT8;CCT6A;DKC1;LARP7;CCT4;CCT3;CCT5;TCP1;MEPCE
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.3073253405310401,0.6271254414940566,0.8939670932358318,0.9936804919485539,1.0,11/11,69.29%,CCT7;CCT2;CCT8;CCT6A;DKC1;LARP7;CCT4;CCT3;CCT5;TCP1;MEPCE
prerank,Golgi to endosome transport (GO:0006895),0.2866361625203987,0.6259806141926116,0.8936936936936937,0.9941208046510065,1.0,5/16,20.04%,DOP1B;AP2A1;KIF16B;AP1AR;EPS15
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.30825931949584473,0.6256057163187928,0.8584392014519057,0.9935365434590203,1.0,3/11,12.96%,TNRC6C;EIF6;ZFP36
prerank,miRNA mediated inhibition of translation (GO:0035278),0.30825931949584473,0.6256057163187928,0.8584392014519057,0.9935365434590203,1.0,3/11,12.96%,TNRC6C;EIF6;ZFP36
prerank,transferrin transport (GO:0033572),-0.21022655870881612,-0.6250256637351203,0.9697802197802198,1.0,1.0,6/33,13.78%,ATP6V0A4;ATP6V1B2;STEAP3;ATP6V0D1;ATP6V0B;ARHGAP1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.26156659534498555,0.6248312732457556,0.9129129129129129,0.9936746944565208,1.0,6/27,15.41%,CEPT1;LPIN3;PLA2G2D;PLAAT3;CHKA;PNPLA8
prerank,protein processing (GO:0016485),0.21191496603531382,0.6236862936378003,0.9788639365918098,0.9940880729684444,1.0,18/102,15.69%,ADAM10;CASP4;CPD;CPE;F7;SRGN;CASP1;PSEN1;APH1A;PITRM1;LGMN;OMA1;ADAM17;SPCS1;PCSK7;SPPL3;VSIR;ZMPSTE24
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.28052123786899924,0.6236203762676497,0.9037800687285223,0.9937011307462538,1.0,11/18,35.92%,DCP2;CCT7;CCT2;RUVBL1;RUVBL2;PARN;CCT8;CCT6A;NOP10;EXOSC10;DKC1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.22331416981836477,-0.6235010723540511,0.9607329842931938,1.0,1.0,11/28,32.33%,MAP2;MAP1S;MAP1A;CAMSAP3;CLASP1;SKA3;STMN4;MAPRE1;STMN2;ARL2;GBA2
prerank,axonal transport (GO:0098930),0.2456804546944509,0.6233183736352603,0.9400921658986175,0.9935066464528394,1.0,2/36,2.91%,HIF1A;DST
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.2861605318459248,-0.6230334452747313,0.9166666666666666,1.0,1.0,3/10,23.05%,IVD;GCDH;ACADS
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.24528674686293941,-0.6223205983059887,0.9255813953488372,1.0,1.0,9/17,36.51%,GET4;EMC8;GET1;EMC4;EMC1;BAG6;GET3;CAMLG;EMC10
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.28635447519514856,-0.622115066869162,0.9056224899598394,1.0,1.0,1/10,4.26%,HSP90AA1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.29057027949264375,0.6218517638182939,0.8974820143884892,0.9941611974900978,1.0,2/13,11.57%,DUT;UNG
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.23982103553693646,-0.6217867598568901,0.9124423963133641,1.0,1.0,5/18,27.27%,XRCC6;PRDM1;PRKDC;CCR2;ZFP36L2
prerank,intracellular pH reduction (GO:0051452),0.2488597455911104,0.6208116706209522,0.9314194577352473,0.9944817336251695,1.0,5/33,12.95%,CLCN3;ATP6V0A1;RAB38;ATP6V1G2;RAB7A
prerank,protein localization to centrosome (GO:0071539),-0.24408258607395097,-0.620166586445681,0.9322429906542056,1.0,1.0,4/17,19.17%,GOLGB1;CEP192;PCM1;C2CD3
prerank,cellular response to leucine starvation (GO:1990253),-0.288552026234443,-0.6199223683664196,0.9336188436830836,1.0,1.0,4/10,25.44%,IMPACT;SESN2;MTOR;RRAGD
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.2833467835095622,0.6194995023462395,0.8964912280701754,0.9950060354210031,1.0,5/15,17.83%,PLCG2;NPM1;CDC73;CUL3;KLHL18
prerank,lysosome localization (GO:0032418),0.24618712537731097,0.6188997322455555,0.9361393323657474,0.9950125770261835,1.0,11/37,24.24%,MYH9;PIK3CG;SPAG9;ARL8B;NDEL1;SYTL4;PLEKHM1;TFEB;HDAC6;RAB3A;BORCS5
prerank,transcription preinitiation complex assembly (GO:0070897),0.29549167900034157,0.6185152429932764,0.9061913696060038,0.9948755520202572,1.0,3/12,20.49%,TAF1B;GTF2A2;TAF7
prerank,ncRNA export from nucleus (GO:0097064),0.24357427676612625,0.6175853277950795,0.9338461538461539,0.9951246086698056,1.0,9/36,16.60%,NUP214;NUP98;NUP205;NUP133;NPM1;NUP153;NUP54;NUP43;XPOT
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.24845344452665002,-0.6174756503565968,0.9284009546539379,1.0,1.0,4/17,16.92%,ADRA2A;ALK;MFSD2A;GPLD1
prerank,mitotic spindle organization (GO:0007052),0.19806683904832628,0.6174107655856383,0.9927710843373494,0.994834322468078,1.0,39/153,23.38%,RAB11A;PLK2;AURKA;PCNT;NEK6;XPO1;DYNLL1;DYNC1LI1;AURKC;STAG2;KIF23;RPS27;NUP98;MAD1L1;STAG1;NDEL1;NUP133;BUB3;NUP43;LSM14A;RHOA;CHEK2;ABRAXAS2;WRAP73;PPP1CC;MZT1;BCCIP;CLIP1;PLK1;TAOK1;KPNB1;PIBF1;KIF4A;SBDS;CENPN;KIF2A;CLASP2;MAP4;DCTN6
prerank,ovarian follicle development (GO:0001541),0.2942200179889086,0.6169652685310684,0.8902654867256637,0.9947186739132388,1.0,4/13,14.16%,FOXL2;EIF2B5;ANG;EIF2B2
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.2629635609872706,-0.6167718361658945,0.9329004329004329,1.0,1.0,2/12,10.31%,LDLR;APOE
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.2667981733349613,-0.6167121177713962,0.9321266968325792,1.0,1.0,5/12,20.98%,LHPP;ATIC;PAICS;PFAS;ADSS1
prerank,negative regulation of protein transport (GO:0051224),-0.2211006999692078,-0.6165246107438505,0.9464285714285714,1.0,1.0,10/25,26.56%,ERP29;RHBDF1;APOE;PKDCC;NDFIP1;SERGEF;CYP51A1;RSAD2;WWP2;HMGCR
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.2573030746037103,0.6163148449575224,0.9369951534733441,0.9947657582150015,1.0,11/27,29.33%,PHF20;KAT6B;PHF20L1;KAT2B;KAT6A;TRRAP;NAA50;CREBBP;RUVBL1;RUVBL2;KAT7
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.27753997674317726,0.6161698072672985,0.8888888888888888,0.9944477056867023,1.0,5/18,16.19%,RAP1B;RAP1A;FMR1;RAB5A;RIMS4
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.3080683764177319,0.6159990951102815,0.8903107861060329,0.9941460845024102,1.0,3/10,18.80%,EMC6;EMC3;EMC7
prerank,regulation of chromosome organization (GO:0033044),0.2672191454730807,0.6155959223445912,0.9180064308681672,0.9940080439373943,1.0,7/22,24.55%,HNRNPD;CDT1;RB1;YLPM1;RMI2;SMG6;LIG4
prerank,regulation of response to stress (GO:0080134),-0.28405684111481777,-0.6154686427583898,0.9190371991247265,1.0,1.0,5/10,34.98%,EIF4G1;ADCY8;SLC38A2;CORO2B;DYRK3
prerank,proteasome assembly (GO:0043248),0.30387396603943073,0.6146248384778914,0.8863636363636364,0.9942616603985656,1.0,5/11,31.06%,POMP;PSMG2;ADRM1;OTUD6B;PSMG1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.255870229252086,-0.6136356522447254,0.9348837209302325,1.0,1.0,2/14,8.19%,AUTS2;CTR9
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.24478690442219414,-0.6134863647355507,0.9312796208530806,1.0,1.0,3/17,16.72%,PRKCZ;CEBPB;SYK
prerank,histone H2A acetylation (GO:0043968),-0.24705609740281553,-0.613024747082113,0.9438202247191011,1.0,1.0,6/16,23.72%,NAA40;MORF4L2;BRD8;ACTL6A;MEAF6;SPHK2
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.2326237428544629,-0.6128589159355986,0.9508599508599509,1.0,1.0,8/20,25.84%,ZWINT;KLHL22;TEX14;IK;CENPF;BUB1B;ATM;KNTC1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.2326237428544629,-0.6128589159355986,0.9508599508599509,1.0,1.0,8/20,25.84%,ZWINT;KLHL22;TEX14;IK;CENPF;BUB1B;ATM;KNTC1
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.2326237428544629,-0.6128589159355986,0.9508599508599509,1.0,1.0,8/20,25.84%,ZWINT;KLHL22;TEX14;IK;CENPF;BUB1B;ATM;KNTC1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.23883871343304813,0.6121956617920041,0.942215088282504,0.9954937154004717,1.0,7/36,17.57%,DAB2IP;EPC1;MAX;RYBP;APAF1;PHC3;EHMT1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.30795897959570834,0.6115223161432073,0.9056603773584906,0.9955197355691627,1.0,5/10,27.78%,PIH1D1;TAF9;RUVBL1;NUFIP1;RUVBL2
prerank,histone lysine methylation (GO:0034968),0.2479167650244775,0.6108123976220361,0.9295558958652373,0.9955945574200507,1.0,9/33,22.88%,KDM6A;SMYD3;SETDB2;ASH2L;CXXC1;RBBP5;PRDM9;SUV39H1;N6AMT1
prerank,protein import into peroxisome matrix (GO:0016558),-0.2609277601740306,-0.6103209058091285,0.927437641723356,1.0,1.0,5/12,26.75%,PEX1;PEX7;PEX5L;PEX5;PEX16
prerank,protein sumoylation (GO:0016925),0.2291883081086022,0.6082832003957538,0.9574780058651027,0.9968889443420615,1.0,12/49,15.08%,STX1A;SUMO2;NUP214;SAE1;NUP98;IFIH1;NUP205;NUP133;NUP153;NUP54;TOPORS;NUP43
prerank,autophagosome maturation (GO:0097352),-0.2091131046378962,-0.6075511084160092,0.9861878453038674,1.0,1.0,11/32,29.12%,LAMP2;ATP2A2;LIX1;LIX1L;VPS16;VIPAS39;CLN3;STX17;GABARAP;WIPI2;EPG5
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.24209560225110843,-0.6072321434078011,0.931350114416476,1.0,1.0,2/17,11.72%,SELENOS;NPLOC4
prerank,regulation of exit from mitosis (GO:0007096),-0.1984177000362766,-0.6069608172814823,0.9805555555555555,1.0,1.0,5/38,10.73%,SIRT2;CDC14B;ANAPC5;RGCC;ANAPC15
prerank,immunoglobulin mediated immune response (GO:0016064),-0.27501174846525356,-0.6063554346512624,0.941304347826087,1.0,1.0,4/10,34.32%,CD81;CD74;FCGR2B;TLR8
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.2452524141945899,0.6040053390993448,0.9479674796747968,0.9993359973709969,1.0,10/30,20.27%,DYRK1A;SFRP2;DDIAS;BCL2L1;TPT1;THOC1;KDM1A;PTTG1IP;THOC5;RPS3
prerank,folic acid metabolic process (GO:0046655),-0.24071411359236494,-0.6039571447884754,0.9254807692307693,1.0,1.0,5/18,17.89%,ALDH1L1;FPGS;MTHFD1;SLC19A1;MTHFD2L
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.2492018681205816,-0.6039554138481399,0.9232505643340858,1.0,1.0,1/13,2.79%,PRKCD
prerank,response to light stimulus (GO:0009416),0.2257892550643897,0.6036111536962099,0.9631728045325779,0.999159476533466,1.0,7/55,12.88%,MAP4K3;MAPK8;OPN4;GNAT1;PRIMPOL;OPN5;ERCC4
prerank,regulation of phospholipid metabolic process (GO:1903725),0.3046851571623934,0.6035920192172122,0.89272030651341,0.9987474508685058,1.0,3/10,19.67%,ABCA3;MTMR9;MTMR2
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.18479674371875682,0.6024222147836303,1.0,0.9990750690003393,1.0,77/264,26.50%,NOVA2;RSRC1;SRPK3;TGS1;HNRNPF;GTF2F2;SF3B4;CTNNBL1;MTREX;HNRNPK;HNRNPA0;RBM14;HNRNPD;WDR33;LSM8;RBM15;SPEN;YTHDC1;RNPS1;LSM3;HNRNPC;DHX15;SMU1;ZMAT2;SF3B6;SCAF11;SNRNP25;WDR77;SNW1;CWC27;YBX1;DDX20;HNRNPUL1;AQR;LSM7;CWC22;ALYREF;PRPF40A;PHF5A;CDC40;METTL14;CWF19L2;HNRNPM;CPSF1;RALY;STRAP;FUS;PRPF4;SRSF10;SART3;POLR2L;SART1;ELAVL1;SF3A2;PRPF3;POLR2J;TRA2B;DBR1;SNRPD3;SRSF4;SYNCRIP;SLU7;PSPC1;RBMX;SYF2;LSM2;CPSF3;SNRNP200;PCF11;CPSF2;PUF60;HNRNPA3;SNUPN;PRPF40B;GCFC2;DHX8;ISY1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.23260322991192056,-0.6003704836351751,0.9538834951456311,1.0,1.0,6/18,22.51%,COX16;COX19;COX17;COX18;FASTKD3;TIMM21
prerank,regulation of immunoglobulin production (GO:0002637),-0.22184599749211276,-0.5991783433818401,0.9750623441396509,1.0,1.0,6/23,27.98%,RBP4;STX4;CLCF1;EPHB2;PTPRC;FCGR2B
prerank,regulation of calcium-mediated signaling (GO:0050848),0.24960628610436533,0.5989484668368635,0.9349206349206349,1.0,1.0,4/25,14.03%,BST1;PLCG2;TMBIM4;SLA2
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.26627047436161844,0.5987925763526127,0.9114139693356048,1.0,1.0,5/16,17.73%,PIGQ;PIGG;PIGF;PIGL;PIGC
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.24761509445369154,0.596576738206882,0.9270664505672609,1.0,1.0,6/26,14.67%,SIGIRR;NMI;CARD16;TRIB1;ILRUN;IRAK3
prerank,central nervous system neuron axonogenesis (GO:0021955),0.29105435667090923,0.5964662171817823,0.9112318840579711,1.0,1.0,3/12,13.32%,MYCBP2;B4GALT5;HSP90AB1
prerank,carnitine metabolic process (GO:0009437),0.2875470418895801,0.5958993081013695,0.9332161687170475,1.0,1.0,2/12,11.13%,CRAT;CPT1A
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.24995245213106215,0.5928661981957843,0.9368088467614534,1.0,1.0,12/25,30.95%,DNAJB5;ERO1A;BAG1;DNAJB1;HSPE1;DNAJB12;GAK;HSPA1B;HSPA13;HSPA14;HSPA8;ST13
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.2904303583536606,0.5925057040235527,0.8974358974358975,1.0,1.0,3/10,21.03%,ATP5PD;VPS9D1;ATP5MC2
prerank,negative regulation of protein depolymerization (GO:1901880),0.25180197892958106,0.5922654818497757,0.9284525790349417,1.0,1.0,8/24,23.21%,ARHGEF2;CAMSAP2;LIMA1;APC;CIB1;TAOK1;ATXN7;CLASP2
prerank,axonemal dynein complex assembly (GO:0070286),-0.21151174415641455,-0.592142812190405,0.9536784741144414,1.0,1.0,12/27,36.44%,DNAI4;DNAL1;DNAH8;CCDC39;SPAG1;DRC1;TTC12;ODAD4;DNAAF5;ODAD1;CCDC63;DNAAF4
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.28057885448261183,0.5919523024741483,0.9070631970260223,1.0,1.0,4/12,20.25%,ANAPC7;RB1;CUL3;NSMCE2
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.28057885448261183,0.5919523024741483,0.9070631970260223,1.0,1.0,4/12,20.25%,ANAPC7;RB1;CUL3;NSMCE2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.28057885448261183,0.5919523024741483,0.9070631970260223,1.0,1.0,4/12,20.25%,ANAPC7;RB1;CUL3;NSMCE2
prerank,histone H3-K4 methylation (GO:0051568),0.25162366784968027,0.5918770955474616,0.9433070866141732,1.0,1.0,6/26,18.95%,KDM6A;TET3;TET2;ASH2L;CXXC1;RBBP5
prerank,regulation of interferon-beta production (GO:0032648),-0.18524203230645925,-0.5908682359611247,0.9823529411764705,1.0,1.0,10/46,21.68%,PTPRS;HSP90AA1;OAS2;MAVS;RNF135;SIRPA;CACTIN;PPM1B;PYCARD;POLR3D
prerank,tetrahydrofolate metabolic process (GO:0046653),0.29268065423512035,0.589940247256467,0.9089147286821705,1.0,1.0,1/10,5.61%,MTHFD1L
prerank,regulation of double-strand break repair (GO:2000779),0.2283549863638618,0.5896629353293017,0.9634703196347032,1.0,1.0,9/39,21.82%,RNF169;WRAP53;ACTR2;SIRT6;SPIDR;MGMT;KDM1A;DEK;SIRT7
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.22123165354945806,-0.5887501382985199,0.9703703703703703,1.0,1.0,8/21,25.84%,ZWINT;KLHL22;TEX14;IK;CENPF;BUB1B;ATM;KNTC1
prerank,tRNA wobble base modification (GO:0002097),-0.24761426418884985,-0.5881809569689347,0.936542669584245,1.0,1.0,14/14,75.27%,GTPBP3;ELP4;MTO1;ADAT2;URM1;TRMT9B;CTU1;CTU2;ALKBH1;ELP3;MOCS3;KTI12;DPH3;ALKBH8
prerank,rRNA catabolic process (GO:0016075),-0.23872462855200802,-0.5879524950558008,0.9443099273607748,1.0,1.0,3/16,19.09%,EXOSC7;EXOSC3;EXOSC9
prerank,autophagy of nucleus (GO:0044804),0.27464338487098083,0.5858935116248445,0.9147424511545293,1.0,1.0,4/16,18.45%,ULK1;ATG2A;ATG2B;ATG7
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.1806202168369391,0.5853694852016468,0.9988776655443322,1.0,1.0,70/241,26.50%,NOVA2;RSRC1;HNRNPF;GTF2F2;SF3B4;CTNNBL1;MTREX;HNRNPK;HNRNPA0;RBM14;HNRNPD;WDR33;LSM8;RBM15;SPEN;YTHDC1;RNPS1;LSM3;HNRNPC;DHX15;SMU1;ZMAT2;SF3B6;SNRNP25;SNW1;CWC27;YBX1;HNRNPUL1;AQR;LSM7;CWC22;ALYREF;PRPF40A;PHF5A;CDC40;METTL14;CWF19L2;HNRNPM;CPSF1;RALY;FUS;PRPF4;SRSF10;SART3;POLR2L;SART1;ELAVL1;SF3A2;PRPF3;POLR2J;TRA2B;DBR1;SNRPD3;SRSF4;SYNCRIP;SLU7;PSPC1;RBMX;SYF2;LSM2;CPSF3;SNRNP200;PCF11;CPSF2;PUF60;HNRNPA3;PRPF40B;GCFC2;DHX8;ISY1
prerank,regulation of histone deacetylation (GO:0031063),0.2754397728390552,0.5848627149274456,0.9230769230769231,1.0,1.0,4/13,22.09%,CTBP1;APLNR;SAP30BP;NIPBL
prerank,protein ADP-ribosylation (GO:0006471),-0.20850131072082823,-0.5842000274456007,0.9783783783783784,1.0,1.0,3/28,7.95%,SIRT2;PARP3;PARP11
prerank,7-methylguanosine mRNA capping (GO:0006370),0.23552473235818905,0.5839643218014584,0.9601910828025477,1.0,1.0,8/31,22.65%,GTF2F2;RNGTT;RNMT;GTF2H4;GTF2H1;POLR2L;CCNH;POLR2J
prerank,7-methylguanosine RNA capping (GO:0009452),0.23552473235818905,0.5839643218014584,0.9601910828025477,1.0,1.0,8/31,22.65%,GTF2F2;RNGTT;RNMT;GTF2H4;GTF2H1;POLR2L;CCNH;POLR2J
prerank,cellular response to copper ion (GO:0071280),-0.24000128371312096,-0.5835950588076684,0.963718820861678,1.0,1.0,2/16,16.15%,SNCA;MT3
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.2768341038549774,0.5834778339141526,0.9284467713787086,1.0,1.0,5/14,18.81%,ADSL;IMPDH1;RFK;ADSS2;GART
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.22592350221572088,0.5829983194411407,0.9571639586410635,1.0,1.0,6/43,12.56%,TAOK2;BABAM2;BRCC3;FOXN3;HUS1;NOP53
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.2908677822810841,0.5826785341093915,0.896551724137931,1.0,1.0,3/10,18.18%,ELOVL5;ABCD1;MLXIPL
prerank,organelle fusion (GO:0048284),-0.21593893499465538,-0.5824891970855777,0.9679012345679012,1.0,1.0,7/22,24.97%,MIGA2;CHCHD3;STX4;MIEF2;VPS11;BAX;GDAP1
prerank,regulation of mRNA metabolic process (GO:1903311),0.28775102853514706,0.5821216084683041,0.8880733944954129,1.0,1.0,4/11,23.76%,SRPK3;SLTM;CDK11B;IWS1
prerank,skeletal muscle contraction (GO:0003009),-0.22840317439563157,-0.5815277222192388,0.9712918660287081,1.0,1.0,7/19,38.99%,STAC3;TNNT3;TNNI1;TNNC1;TCAP;STAC2;TNNI2
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.21751055954141382,-0.5812046326751454,0.9702233250620348,1.0,1.0,2/22,7.10%,UGGT2;AMFR
prerank,protein import (GO:0017038),0.19985223553576878,0.5810171363056629,0.988,1.0,1.0,24/84,23.33%,STAT3;IPO11;PPP1R10;PEX26;IPO8;NUP214;ABCD1;PRICKLE1;NUP133;ALDH3A2;PEX14;NUP153;TNPO3;RAB8B;TOMM22;E2F3;PTTG1IP;KPNB1;CSE1L;HIKESHI;EIF4ENIF1;APPL1;HSPA4;CLU
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.25997113418542317,0.5806928958335321,0.9351535836177475,1.0,1.0,7/19,26.02%,GMPR;HPRT1;ADA;PNP;TYMS;POLL;ADK
prerank,cell cycle G2/M phase transition (GO:0044839),0.19072706666279543,0.5804493919668489,0.9987593052109182,1.0,1.0,13/129,9.54%,TPD52L1;PLCB1;PRKAR2B;PPP1R12A;CEP41;AURKA;PCNT;FBXL7;DYNLL1;CNTRL;CCNY;CDK2;CEP57
prerank,DNA replication (GO:0006260),0.19739831003361688,0.5793036510893915,0.9974424552429667,1.0,1.0,32/105,27.37%,RNASEH2A;RPA1;MCM10;POLA1;BRIP1;DUT;CDK2;HELB;HUS1;RMI1;MCM9;GRWD1;TOP1;ORC5;BAZ1A;ORC3;RFC3;MCMBP;DBF4;RAD17;RMI2;TIPIN;RFC5;TBRG1;SET;POLL;ORC6;MCM6;RPA3;RBBP8;TIMELESS;TICRR
prerank,negative regulation of chemokine production (GO:0032682),0.2702462007532338,0.5791495743675587,0.9413919413919414,1.0,1.0,3/14,17.24%,SIGIRR;GSTP1;MAP2K5
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.2751918444381656,0.5787672352165082,0.9288256227758007,1.0,1.0,3/14,12.71%,GAS6;CARD16;GSTP1
prerank,tRNA wobble uridine modification (GO:0002098),-0.24761426418884985,-0.577885703885168,0.9493087557603687,1.0,1.0,14/14,75.27%,GTPBP3;ELP4;MTO1;URM1;ELP1;TRMT9B;CTU1;CTU2;TRMU;ELP3;MOCS3;KTI12;DPH3;ALKBH8
prerank,regulation of steroid metabolic process (GO:0019218),0.2510303606716711,0.5767054203020082,0.9270315091210614,1.0,1.0,8/23,21.93%,PANK2;ABCG1;ASAH1;TTC39B;STAR;ABCB11;FMO5;RORC
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.23579818815831377,0.5765575648445244,0.9404580152671755,1.0,1.0,5/32,12.56%,TAOK2;BABAM2;BRCC3;FOXN3;NOP53
prerank,protein deacylation (GO:0035601),0.24640150592759422,0.5756353123943553,0.9495798319327731,1.0,1.0,4/23,12.48%,HDAC7;SIRT5;ABHD17B;SIRT6
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.2319420356944398,-0.5749687402577044,0.9598108747044918,1.0,1.0,6/16,25.44%,KLHL22;GPR137B;GPR137C;FLCN;PIP4P1;RRAGD
prerank,respiratory chain complex IV assembly (GO:0008535),-0.2144593563576671,-0.5748720807527452,0.9689922480620154,1.0,1.0,6/21,22.51%,COX16;COX19;COX17;COX18;FASTKD3;TIMM21
prerank,maintenance of protein localization in organelle (GO:0072595),0.25806081584583185,0.5745438292277198,0.9458544839255499,1.0,1.0,3/19,14.43%,BCL3;TAF3;TOPORS
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.24969077329287806,-0.5737155958357496,0.9312796208530806,1.0,1.0,5/12,25.48%,BDH2;GCLC;HAGH;GGT1;CNDP2
prerank,steroid hormone biosynthetic process (GO:0120178),-0.19765087593997632,-0.5717183741195307,0.9738219895287958,1.0,1.0,6/29,22.48%,AKR1B1;FDX1;FDXR;TSPO;DHCR7;TSPOAP1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.27750891553084506,0.5708163454351908,0.9314814814814815,1.0,1.0,2/12,12.22%,CDT1;MAD1L1
prerank,lipid droplet formation (GO:0140042),0.2912922542910842,0.5702171375704757,0.9094269870609981,1.0,1.0,1/10,7.10%,CDS2
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.2125652025830891,0.5667842928388217,0.9742120343839542,1.0,1.0,16/57,24.27%,TAOK2;BABAM2;BRCC3;CDK2;FOXN3;HUS1;NOP53;CHEK2;PLK1;TAOK1;RAD17;RINT1;TIPIN;BABAM1;FZR1;SDE2
prerank,sulfur amino acid catabolic process (GO:0000098),-0.25757037180294007,-0.5660139018164972,0.934640522875817,1.0,1.0,4/10,25.00%,CBS;BLMH;CTH;MTRR
prerank,protein targeting to mitochondrion (GO:0006626),-0.17405539294626637,-0.565314799519063,0.9968652037617555,1.0,1.0,16/52,28.72%,HSP90AA1;TOMM40;AIFM1;TIMM22;TIMM17B;GRPEL2;TSPO;TIMM8B;TIMM21;TIMM9;DNAJC15;TIMM10;GDAP1;PAM16;SAMM50;PMPCB
prerank,organelle disassembly (GO:1903008),0.22396211397921253,0.5646904479416769,0.9638932496075353,1.0,1.0,12/33,25.30%,ULK1;MCTS1;MRRF;MTIF3;ATG2A;ATG2B;VRK1;DENR;RB1CC1;PLK3;MTIF2;UFM1
prerank,regulation of catabolic process (GO:0009894),0.25020847558195397,0.5639697595655397,0.9534482758620689,1.0,1.0,1/18,2.40%,NEDD4L
prerank,regulation of G0 to G1 transition (GO:0070316),0.21914384284185648,0.5637590630505659,0.9588607594936709,1.0,1.0,7/38,17.57%,DAB2IP;EPC1;MAX;RYBP;APAF1;PHC3;EHMT1
prerank,peroxisome organization (GO:0007031),0.23592992443546662,0.5635322279929834,0.9619205298013245,1.0,1.0,5/25,14.09%,TMEM135;PLAAT3;ABCD4;ABCD1;PEX14
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.23233993660356125,-0.5633065627490795,0.9571428571428572,1.0,1.0,5/14,31.71%,U2AF2;PCBP4;SRSF6;C1QBP;SRSF9
prerank,tRNA methylation (GO:0030488),-0.1943676137792306,-0.5620561657642655,0.9740634005763689,1.0,1.0,34/34,80.61%,TARBP1;GTPBP3;MTO1;THUMPD3;BCDIN3D;METTL1;DALRD3;TRMT61A;METTL2A;METTL2B;TRMT13;THUMPD2;TRMT44;FTSJ1;HSD17B10;TRMT5;TRMT1;TRDMT1;THADA;TRMO;METTL6;WDR6;TYW3;TRMT112;TRMT10A;TRMT1L;NSUN2;TRMT12;LCMT2;TRMT10C;ALKBH8;TRMT61B;NSUN6;PRORP
prerank,double-strand break repair via break-induced replication (GO:0000727),0.26949152542372884,0.5611768122370002,0.9333333333333333,1.0,1.0,12/12,73.07%,GINS2;MCM6;MUS81;MCM2;MCM7;MCM4;MCM5;CDC7;CDC45;MCM3;MCMDC2;GINS4
prerank,mitochondrial transcription (GO:0006390),-0.24835246570140973,-0.5610298300266563,0.9663677130044843,1.0,1.0,3/10,20.12%,TFAM;SLC25A33;POLRMT
prerank,purine-containing compound biosynthetic process (GO:0072522),0.24025905483907525,0.5610262104247036,0.9674267100977199,1.0,1.0,3/25,9.67%,GMPR;ADSL;HPRT1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.25430621172524587,0.5609697740411042,0.9424083769633508,1.0,1.0,3/17,14.50%,HASPIN;RB1;BUB3
prerank,response to copper ion (GO:0046688),0.240905628847361,0.5604124790432522,0.9578207381370826,1.0,1.0,2/20,13.47%,ATP7B;AOC1
prerank,melanosome organization (GO:0032438),0.23461307836692769,0.5601614047337492,0.9626016260162602,1.0,1.0,5/26,17.39%,SHROOM2;RAB38;AP3B1;RAB32;BLOC1S5
prerank,purine nucleotide biosynthetic process (GO:0006164),0.26708256255700225,0.5597643706659504,0.924956369982548,1.0,1.0,4/12,19.88%,ADSL;HPRT1;GART;ADA
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.21874081754705146,0.5592053451745648,0.9748520710059172,1.0,1.0,10/38,25.32%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;NDUFS4;NDUFS6;NDUFB9;NDUFC1;NDUFS8;NDUFB7
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.1884405610997173,-0.5588612201022739,0.9941348973607038,1.0,1.0,14/38,27.03%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;CENPK;HIRA;CENPH;RBBP4;KNL1;CENPX;CENPA;CENPQ
prerank,acyl-CoA biosynthetic process (GO:0071616),0.2564582208581302,0.5586239070423007,0.9335664335664335,1.0,1.0,2/16,10.56%,FASN;SLC25A1
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.272772131718484,0.5568242657222156,0.9264150943396227,1.0,1.0,6/11,31.97%,FBLL1;TENT4B;EXOSC4;PARN;EXOSC5;EXOSC2
prerank,negative regulation of T cell proliferation (GO:0042130),0.22535493623319625,0.5565821771070912,0.9700996677740864,1.0,1.0,3/28,11.05%,PLA2G2D;BTN2A2;RC3H1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.19047141180288155,-0.5560758781956145,0.9914285714285714,1.0,1.0,8/34,24.98%,RBP4;STX4;PTPN22;LACC1;CLCF1;SPHK2;EPHB2;PTPRC
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.2661333525988383,0.5554843846057459,0.9263565891472868,1.0,1.0,3/12,23.99%,IL23A;CARD9;ZBTB1
prerank,aerobic respiration (GO:0009060),-0.21078046597835962,-0.555148098630533,0.9685990338164251,1.0,1.0,7/20,28.54%,SLC25A14;MTFR1L;SDHC;UQCRB;NDUFS7;UQCR10;MDH2
prerank,regulation of nuclear division (GO:0051783),0.24151857601704194,0.5549322367988158,0.9436860068259386,1.0,1.0,3/20,13.64%,CAV2;PDXP;CDC25C
prerank,transcription by RNA polymerase III (GO:0006383),-0.20132881501098904,-0.5544978141673793,0.9752066115702479,1.0,1.0,10/27,33.02%,ICE2;POLR3H;POLR2K;GTF3A;GTF3C4;POLR3K;ZC3H8;CRCP;TBP;SNAPC4
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.20599533602040923,-0.5537678825321727,0.982367758186398,1.0,1.0,4/22,13.84%,SMARCA4;EIF2AK3;SMARCB1;WDR43
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.27601765257066274,0.5531427667094871,0.9429590017825312,1.0,1.0,3/11,15.98%,MBTPS2;ATF6;DDIT3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.27211188237736683,0.5522267277061673,0.9178082191780822,1.0,1.0,2/10,12.26%,TFAP4;MUC1
prerank,cellular response to pH (GO:0071467),0.2538496749844724,0.5516826081719535,0.9511343804537522,1.0,1.0,5/17,20.04%,RAB11FIP5;RAB11B;CHP1;KCNK4;HVCN1
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.24624898002246193,-0.550846904038691,0.9405737704918032,1.0,1.0,2/10,18.39%,DDX39B;CRY1
prerank,positive regulation of phospholipid transport (GO:2001140),0.2744858798904808,0.54962863575373,0.9338235294117647,1.0,1.0,1/10,5.80%,ABCA3
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.25633961316124126,0.5488441789253067,0.9479553903345725,1.0,1.0,4/14,21.91%,NIFK;RPL7L1;URB1;RPL7
prerank,mitotic DNA replication (GO:1902969),-0.2522879437260954,-0.5477141631173782,0.9434389140271493,1.0,1.0,6/10,35.40%,GINS3;GINS1;LIG1;MCMDC2;MCM3;CDC45
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.21206151437741577,-0.5473467516262921,0.966183574879227,1.0,1.0,7/19,30.44%,POLR2B;POLR2K;TERF2;POLR2I;POLR2H;POLR2D;POLR2G
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.21206151437741577,-0.5473467516262921,0.966183574879227,1.0,1.0,7/19,30.44%,POLR2B;POLR2K;TERF2;POLR2I;POLR2H;POLR2D;POLR2G
prerank,mitochondrion disassembly (GO:0061726),0.22128578879976712,0.5472818399227015,0.9848714069591528,1.0,1.0,8/34,18.77%,ULK1;CTSK;BNIP3;GABARAPL1;ATG2A;ATG2B;ATG7;CISD2
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.2239022672614026,-0.5447876799842121,0.96875,1.0,1.0,4/14,20.88%,TFAM;SLC25A33;POLRMT;FASTKD5
prerank,replication fork processing (GO:0031297),0.2168806500726405,0.5440020853370596,0.9847560975609756,1.0,1.0,3/38,8.29%,SAMHD1;MMS22L;PRIMPOL
prerank,positive regulation of immunoglobulin production (GO:0002639),0.2189513081302151,0.5429909018275993,0.9702194357366771,1.0,1.0,7/31,21.89%,XBP1;SHLD1;MAD2L2;KMT5B;GPI;RIF1;DNAJB9
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.25372346560130715,0.5422726789310343,0.9382716049382716,1.0,1.0,3/13,17.45%,UBAC2;SVIP;YOD1
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.248963439953927,0.5417680492359628,0.9484902309058615,1.0,1.0,2/16,10.17%,RPA1;RECQL
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.23677350637047656,-0.5417420082086657,0.9596412556053812,1.0,1.0,5/13,25.49%,ANAPC15;LCMT1;GEN1;NDC80;XRCC3
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.22978564963175582,0.5411120790509304,0.9555921052631579,1.0,1.0,6/25,17.22%,ATXN3;LONP1;OMA1;UGGT1;RNF5;CUL3
prerank,male meiosis I (GO:0007141),-0.21241862453106958,-0.5405866280548174,0.9573991031390134,1.0,1.0,8/16,35.68%,BRDT;FOXJ3;HSF2BP;MYBL1;SYCP3;DDX4;TDRD9;SLC25A31
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.2361398310425623,0.5396423670445094,0.9505962521294719,1.0,1.0,7/20,23.33%,LONP1;HSP90AB1;CCT2;PSMG2;MKKS;HSPA4;CLU
prerank,regulation of centrosome duplication (GO:0010824),0.22193472959275984,0.5373571490798204,0.9745222929936306,1.0,1.0,6/29,17.88%,PLK2;CHMP2B;CHMP4B;NPM1;CEP295;CEP131
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.2214047659941542,-0.5371055439573081,0.9692671394799054,1.0,1.0,6/16,26.68%,HNRNPA2B1;RTEL1;TERF2;SLX4;ATM;SMG5
prerank,UV-damage excision repair (GO:0070914),0.2594204339838469,0.5363767973453918,0.9310344827586207,1.0,1.0,3/12,16.80%,POLA1;MC1R;ACTR5
prerank,positive regulation of rRNA processing (GO:2000234),0.2695636734039465,0.5357787289752286,0.935361216730038,1.0,1.0,4/10,21.82%,RIOK1;HEATR1;RIOK2;SIRT7
prerank,positive regulation of TOR signaling (GO:0032008),0.2055395351352133,0.5347305633955132,0.9816232771822359,1.0,1.0,7/40,16.52%,SIK3;RPTOR;RICTOR;LARS1;GAS6;PIH1D1;RHEB
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.23716001403237136,-0.5332562188111023,0.9617021276595744,1.0,1.0,3/11,21.40%,FGF2;PPIP5K2;IP6K1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.26125966400599776,0.5330487251197797,0.9294755877034359,1.0,1.0,2/13,10.89%,GLRX3;MMS19
prerank,microtubule nucleation (GO:0007020),-0.20990201356489274,-0.5326479396074628,0.9828850855745721,1.0,1.0,6/19,32.63%,TUBGCP5;CCDC57;TPX2;CLASP1;GOLGA2;TPPP
prerank,regulation of cholesterol metabolic process (GO:0090181),0.23243606198797387,0.5310771554727964,0.9556313993174061,1.0,1.0,7/20,24.80%,LPCAT3;MBTPS2;TTC39B;FMO5;KPNB1;SEC14L2;LDLRAP1
prerank,autophagy of mitochondrion (GO:0000422),0.2088797948139862,0.5285042135431007,0.98796992481203,1.0,1.0,8/38,18.77%,ULK1;CTSK;BNIP3;GABARAPL1;ATG2A;ATG2B;ATG7;CISD2
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.2277896976221397,-0.527581801181181,0.9615384615384616,1.0,1.0,4/13,20.30%,FUT9;ZDHHC21;MDK;ITGB2
prerank,phagosome acidification (GO:0090383),0.22077450757180647,0.5273168086311878,0.9752883031301482,1.0,1.0,6/26,20.06%,ATP6V0A1;RAB38;ATP6V1G2;RAB7A;ATP6V1F;ATP6V1D
prerank,prostanoid metabolic process (GO:0006692),0.2554936628949964,0.5262825498091535,0.954954954954955,1.0,1.0,2/13,12.71%,PTGS1;GSTP1
prerank,protein methylation (GO:0006479),-0.1730914450431407,-0.5260620114988116,0.9911504424778761,1.0,1.0,17/40,38.09%,EHMT2;LCMT1;CARM1;VCPKMT;EEF1AKMT1;PRMT8;METTL21A;PRMT2;EEF2KMT;EEF1AKMT3;PRMT7;NTMT1;PRMT6;PRMT1;GSPT1;EEF1AKMT2;NSD1
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.21284076453983097,-0.5243313548084704,0.9675925925925926,1.0,1.0,1/15,3.29%,CPEB2
prerank,cellular response to misfolded protein (GO:0071218),0.22949111482185236,0.5233600686184703,0.9684908789386402,1.0,1.0,5/20,18.20%,ATXN3;UGGT1;RNF5;CUL3;DNAJB12
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.20115668663212033,-0.5226175425974596,0.9803439803439803,1.0,1.0,6/18,30.07%,EIF2AK3;WDR43;POLR2K;MAF1;RASL11A;UTP15
prerank,mitochondrial genome maintenance (GO:0000002),0.2591745948422734,0.522609534174551,0.9444444444444444,1.0,1.0,3/11,14.03%,AKT3;LONP1;MEF2A
prerank,ncRNA catabolic process (GO:0034661),0.2141122979836701,0.5212715562067883,0.9834162520729685,1.0,1.0,13/28,31.97%,MTREX;NUDT16;TRIR;DIS3L;SND1;RBM7;TENT4B;EXOSC4;DIS3;PARN;DIS3L2;EXOSC5;EXOSC2
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.18498802764245953,0.5212666866547061,0.993455497382199,1.0,1.0,20/69,27.84%,NDUFA8;CYCS;NDUFA7;NDUFA10;NDUFS2;COX6C;UQCRQ;NDUFS4;SDHAF2;NDUFS6;UQCRC1;NDUFB9;UQCC3;NDUFC1;NDUFS8;NDUFB7;COX6A1;NDUFA6;UQCRC2;COX7C
prerank,aerobic electron transport chain (GO:0019646),0.18547227718772416,0.5210954818964418,0.9934123847167325,1.0,1.0,20/68,27.84%,NDUFA8;CYCS;NDUFA7;NDUFA10;NDUFS2;COX6C;UQCRQ;NDUFS4;SDHAF2;NDUFS6;UQCRC1;NDUFB9;UQCC3;NDUFC1;NDUFS8;NDUFB7;COX6A1;NDUFA6;UQCRC2;COX7C
prerank,regulation of biosynthetic process (GO:0009889),-0.2313801996111196,-0.5183813896713276,0.9582417582417583,1.0,1.0,4/11,30.94%,SNCA;SLC25A33;SPHK2;ALOX5
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.2262882848914349,0.5178764893718871,0.9744,1.0,1.0,8/21,26.95%,RPA1;ERCC4;GTF2H4;GTF2H1;CHD1L;CUL4B;GTF2H5;RPA3
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.2262882848914349,0.5178764893718871,0.9744,1.0,1.0,8/21,26.95%,RPA1;ERCC4;GTF2H4;GTF2H1;CHD1L;CUL4B;GTF2H5;RPA3
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.19204836197864825,0.5165407070297044,0.9930651872399445,1.0,1.0,21/58,27.03%,BABAM2;HERC2;POLA1;BRCC3;CYREN;ERCC4;DCLRE1C;NSMCE2;RIF1;XRCC4;UBE2V2;BABAM1;HMGB1;NSD2;ERCC6;LIG4;POLL;SUMO1;RNF168;UBE2N;UIMC1
prerank,regulation of T cell differentiation (GO:0045580),0.2038388973295433,0.5147714009559667,0.9906687402799378,1.0,1.0,4/33,11.15%,XBP1;ZMIZ1;IL7;CBFB
prerank,"base-excision repair, AP site formation (GO:0006285)",0.2330039547214899,0.5139261407310443,0.9640933572710951,1.0,1.0,4/17,16.46%,ACD;UNG;MPG;TERF1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.1779564554551021,0.5122439376927843,1.0,1.0,1.0,26/87,27.07%,IMMP2L;NDUFA8;NDUFA7;COA8;NDUFA10;OMA1;NDUFS2;COA3;SURF1;NDUFS4;SDHAF2;NDUFS6;SCO2;PET100;NDUFB9;COA5;UQCC3;NDUFC1;NUBPL;NDUFS8;SDHAF1;NDUFB7;SCO1;NDUFAF8;ECSIT;NDUFA6
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.25775020684559447,0.5119601552248392,0.9601518026565465,1.0,1.0,3/10,17.45%,UBAC2;SVIP;YOD1
prerank,DNA modification (GO:0006304),0.2162433493957605,0.5118409034186739,0.9743150684931506,1.0,1.0,5/22,16.46%,PARP2;ACD;UNG;MPG;TERF1
prerank,tryptophan metabolic process (GO:0006568),0.254911807168414,0.5109323415910787,0.9520153550863724,1.0,1.0,11/11,74.53%,ATP7A;IL4I1;IDO2;ACMSD;IDO1;KMO;TDO2;AADAT;KYNU;HAAO;KYAT1
prerank,regulation of glycogen metabolic process (GO:0070873),-0.22511929849424678,-0.5099487837074334,0.9694117647058823,1.0,1.0,3/12,20.04%,PPP1R3C;PPP1R3F;PPP1R3B
prerank,negative regulation of histone modification (GO:0031057),-0.21266077330942165,-0.5098160147707361,0.9856801909307876,1.0,1.0,5/14,24.34%,THAP7;SNCA;AASS;SPHK2;TWIST1
prerank,negative regulation of transposition (GO:0010529),0.2302442012468492,0.5097555257355951,0.977112676056338,1.0,1.0,6/16,27.12%,BTBD18;SPOCD1;TEX15;SIRT7;SMYD5;TUT7
prerank,peptidyl-methionine modification (GO:0018206),0.24316823191896914,0.5082975223439028,0.9655797101449275,1.0,1.0,4/12,28.84%,NAA16;NAA30;PDF;METAP1D
prerank,cilium movement (GO:0003341),0.18978898105156,0.5077366621404397,0.9955357142857143,1.0,1.0,6/47,13.50%,CFAP53;TEKT5;SPA17;CFAP73;DNAH17;CABYR
prerank,androgen metabolic process (GO:0008209),-0.194615126913039,-0.50759857879411,0.9907621247113164,1.0,1.0,1/18,5.83%,SPP1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.23413822528193834,0.5074098099019567,0.9602763385146805,1.0,1.0,4/15,22.50%,HUS1;CHEK2;RAD17;TIPIN
prerank,RNA splicing (GO:0008380),0.17604618222662932,0.5073686866837291,0.9986789960369881,1.0,1.0,27/95,26.38%,RSRC1;PPP1R9B;MBNL1;SF3B4;RNPS1;HNRNPC;DHX15;SMU1;SCAF11;SNRNP25;FUS;PRPF4;SRSF10;PPP2R1A;LSM1;DDX47;PRPF3;TRA2B;DBR1;SNRPD3;SRSF4;SYNCRIP;SLU7;PPIG;PPP2CA;RP9;DHX8
prerank,interstrand cross-link repair (GO:0036297),-0.15796212004176605,-0.5066910582244837,1.0,1.0,1.0,20/53,34.21%,NUCKS1;FANCI;FANCE;MSH6;NEIL3;ATR;SLX4;FANCA;UBC;ERCC6L2;CENPX;XRCC3;DCLRE1B;FANCB;ERCC1;RPA2;FAAP24;UBE2T;VCP;FANCF
prerank,maturation of LSU-rRNA (GO:0000470),0.20853311237905683,0.505990264599591,0.9836065573770492,1.0,1.0,8/26,22.49%,RPF1;NIFK;EIF6;RPL7L1;MAK16;URB1;RPL7;MRPL1
prerank,snRNA 3'-end processing (GO:0034472),-0.1972404865946084,-0.5059674901977793,0.9954954954954955,1.0,1.0,5/19,26.25%,EXOSC7;EXOSC3;EXOSC9;INTS7;INTS2
prerank,negative regulation of cell division (GO:0051782),-0.22524186625789339,-0.5058247713525704,0.9823399558498896,1.0,1.0,6/11,33.72%,ZFYVE19;VPS4A;SUSD2;BLM;MYC;E2F8
prerank,piRNA metabolic process (GO:0034587),0.21970194828687295,0.5007712276820326,0.969439728353141,1.0,1.0,3/19,17.85%,BTBD18;HENMT1;TEX15
prerank,glutathione derivative biosynthetic process (GO:1901687),0.22005485412195086,0.5002006285692507,0.9694915254237289,1.0,1.0,6/20,22.05%,GSTO2;GSTA4;GSTP1;ESD;MGST1;AKR1A1
prerank,glutathione derivative metabolic process (GO:1901685),0.22005485412195086,0.5002006285692507,0.9694915254237289,1.0,1.0,6/20,22.05%,GSTO2;GSTA4;GSTP1;ESD;MGST1;AKR1A1
prerank,positive regulation of lymphocyte activation (GO:0051251),0.2033474560552766,0.49975535605445437,0.9899665551839465,1.0,1.0,3/28,10.08%,LCK;IL23A;CYRIB
prerank,DNA replication checkpoint signaling (GO:0000076),0.23155239978601794,0.4991564360631771,0.968476357267951,1.0,1.0,6/16,27.37%,CDT1;HUS1;RAD17;TIPIN;TIMELESS;TICRR
prerank,sensory perception of smell (GO:0007608),-0.21630782750612013,-0.4984630566036173,0.9728506787330317,1.0,1.0,11/11,78.39%,ADCY3;BBS4;UBR3;SYT10;BEST2;OMP;GFY;OBP2B;DRD2;MKKS;SLC24A4
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.210930008908134,0.497324069550831,0.978405315614618,1.0,1.0,7/22,23.86%,ZDHHC18;ZDHHC9;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC8;ZDHHC2
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.210930008908134,0.497324069550831,0.978405315614618,1.0,1.0,7/22,23.86%,ZDHHC18;ZDHHC9;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC8;ZDHHC2
prerank,negative regulation of phagocytosis (GO:0050765),0.22459046855721349,0.4971312306835768,0.978688524590164,1.0,1.0,6/17,25.02%,SNX3;RACK1;PLSCR1;HMGB1;APPL1;CD47
prerank,negative regulation of immune effector process (GO:0002698),0.23411969414277578,0.4970841108732238,0.9698581560283688,1.0,1.0,2/13,11.05%,RPS19;RC3H1
prerank,telomere capping (GO:0016233),0.23415637604267775,0.4962027501534903,0.9591474245115453,1.0,1.0,4/16,21.00%,ACD;TERF1;DCLRE1C;TEN1
prerank,error-free translesion synthesis (GO:0070987),-0.18385087010044776,-0.4947856014801499,0.9922680412371134,1.0,1.0,8/22,34.62%,NPLOC4;POLDIP2;RFC1;UBC;POLD1;RPA2;VCP;RCHY1
prerank,eye photoreceptor cell development (GO:0042462),0.2188021794814864,0.4906690681138409,0.9772727272727273,1.0,1.0,3/15,15.60%,NRL;TOPORS;CEP290
prerank,cell differentiation in hindbrain (GO:0021533),0.2484503552996516,0.4904380842548388,0.955719557195572,1.0,1.0,1/11,5.74%,OPHN1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.18611520693003974,-0.4890150185663168,0.9955257270693513,1.0,1.0,3/17,13.56%,CXCL12;SERPINE1;CREB3
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.18967922114752717,-0.48699738848723667,0.9829268292682927,1.0,1.0,3/17,17.44%,AFG1L;COX6B1;COX7B
prerank,rRNA methylation (GO:0031167),0.2073928928577101,0.48611474946139294,0.985553772070626,1.0,1.0,4/22,15.53%,TFB2M;NSUN4;FBLL1;EMG1
prerank,negative regulation of secretion (GO:0051048),-0.22083092147192807,-0.48566688952249054,0.9829059829059829,1.0,1.0,5/10,31.06%,CD74;NR1H3;ERBB3;NRG1;EGF
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.215024336644912,0.4844933369083068,0.9808795411089866,1.0,1.0,5/16,20.69%,RC3H1;ZFP36;ZFP36L1;DHX36;TRIM71
prerank,response to zinc ion (GO:0010043),-0.1816265710190903,-0.48392092082042876,1.0,1.0,1.0,1/25,3.66%,P2RX4
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.21175491797873244,0.4795465762606026,0.9849498327759197,1.0,1.0,2/19,10.91%,TIRAP;NMI
prerank,isotype switching (GO:0045190),-0.22112758149470352,-0.4793799927027543,0.9775784753363229,1.0,1.0,2/10,17.64%,EXOSC3;MSH6
prerank,positive regulation of interferon-alpha production (GO:0032727),0.2112594210617385,0.47844573553084546,0.9835255354200988,1.0,1.0,4/19,18.99%,RIPK2;IFIH1;STAT1;DHX36
prerank,positive regulation of translational initiation (GO:0045948),0.2110022607385079,0.47729915444610505,0.9765765765765766,1.0,1.0,18/18,78.92%,EIF2B5;UHMK1;DAZL;YTHDF3;YTHDF1;DDX3X;LARP1;KHDRBS1;RPS6KB2;CDC123;YTHDF2;CCL5;POLR2G;BOLL;POLR2D;RPS6KB1;MTOR;HABP4
prerank,microtubule-based transport (GO:0099111),0.22333092116199588,0.47630297950628786,0.9752212389380531,1.0,1.0,2/12,13.50%,SPA17;CABYR
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.1966580451009854,0.4749164007599596,0.985,1.0,1.0,8/26,21.03%,NEK6;ANAPC7;RB1;CUL3;CDK5RAP2;PLK1;NSMCE2;RIOK2
prerank,peptidyl-amino acid modification (GO:0018193),-0.21875890955038535,-0.4734910974601679,0.978448275862069,1.0,1.0,4/10,37.20%,FKBP10;TTLL4;FKBP7;METAP1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.21705280341558347,0.47080424901079865,0.9840989399293286,1.0,1.0,15/15,78.32%,CCT7;CCT2;RUVBL1;RUVBL2;CCT8;CCT6A;NOP10;DKC1;CCT4;NAF1;CCT3;CCT5;TCP1;NHP2;SHQ1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.23492347351007012,0.47037796103178064,0.9726277372262774,1.0,1.0,7/10,33.40%,ACD;DCLRE1C;RIF1;APEX1;TFIP11;DCLRE1A;TERF2IP
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.2219850586979723,0.4676741685628369,0.9813432835820896,1.0,1.0,13/13,77.82%,CPSF1;CPSF6;CPSF2;TUT1;CSTF2T;CPSF4L;NUDT21;CPSF7;NCBP1;CSTF2;NCBP2;CPSF4;FIP1L1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.15449629039061594,0.4658099620460643,1.0,1.0,1.0,32/125,25.39%,PLK2;AURKA;PCNT;NEK6;XPO1;DYNLL1;DYNC1LI1;AURKC;RPS27;NUP98;MAD1L1;NDEL1;NUP133;BUB3;NUP43;PPP1CC;BCCIP;CLIP1;PLK1;TAOK1;KPNB1;KIF4A;SBDS;CENPN;KIF2A;CLASP2;MAP4;DCTN6;KIF18A;TNKS;NUP85;NSL1
prerank,mismatch repair (GO:0006298),0.19103901531926948,0.46549639014672206,0.993517017828201,1.0,1.0,6/27,22.39%,RNASEH2A;RPA1;MCM9;PMS1;MSH2;MSH5
prerank,pseudouridine synthesis (GO:0001522),-0.19316969050160085,-0.4650190781786803,0.9864559819413092,1.0,1.0,13/13,80.71%,PUS3;TRUB2;NHP2;GAR1;PUS1;DKC1;NOP10;PUS10;PUSL1;RPUSD2;PUS7;TRUB1;PUS7L
prerank,tRNA 5'-leader removal (GO:0001682),-0.1975080101727385,-0.4628360368589329,0.9954853273137697,1.0,1.0,7/13,33.50%,POP1;POP4;SSB;POP5;RPP25L;RPP40;RPP21
prerank,DNA biosynthetic process (GO:0071897),0.21179203817656672,0.46215577194467733,0.9774305555555556,1.0,1.0,16/16,78.84%,POLA1;RFC3;PPIA;TYMS;POLL;POLD4;POLH;WRNIP1;POLD3;SIRT1;WRN;POLD2;POLD1;CDKN2D;TERT;POLE
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.2300820187122587,0.4619712866164056,0.966789667896679,1.0,1.0,3/10,16.99%,FMR1;CALM1;CRHR1
prerank,inner dynein arm assembly (GO:0036159),-0.2146873247302926,-0.4606579351058844,0.9803063457330415,1.0,1.0,7/10,43.58%,CCDC39;DNAAF5;DNAAF4;CFAP100;DNAAF1;DNAI3;DNAH1
prerank,negative regulation of telomere maintenance (GO:0032205),-0.19050621347747182,-0.4566111136865732,0.9883449883449883,1.0,1.0,9/15,38.13%,RTEL1;RAD50;TERF2;SLX4;ATM;ERCC1;TNKS2;PARP1;NBN
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.17101294116409876,-0.45622247805768645,0.9973821989528796,1.0,1.0,5/22,23.75%,DDB2;XPC;DDB1;CUL4A;UBC
prerank,histone methylation (GO:0016571),0.1906794278477244,0.45507952063433305,0.9983525535420099,1.0,1.0,11/26,29.33%,SMYD3;FBLL1;EHMT1;SIRT7;SUV39H1;N6AMT1;CREBBP;PRMT5;EZH2;SMYD2;SMYD1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.16962411066516936,0.4538053191385945,0.9985486211901307,1.0,1.0,9/50,20.60%,CCNK;CDKN1B;HSP90AB1;CDC25C;CCNJ;CDC37;BCCIP;GTF2H1;CCNH
prerank,axoneme assembly (GO:0035082),-0.15833033885319375,-0.45304570261338706,1.0,1.0,1.0,9/30,29.39%,DNAI4;CCDC39;RSPH9;SPAG1;GAS8;DRC1;JHY;FOXJ1;TTC12
prerank,negative regulation of histone acetylation (GO:0035067),0.22362823630594786,0.45230191456152025,0.9811320754716981,1.0,1.0,4/11,27.27%,CTBP1;TAF7;SET;SIN3A
prerank,ncRNA 3'-end processing (GO:0043628),0.20920227889957527,0.45209646836501494,0.9841269841269841,1.0,1.0,4/14,24.19%,INTS12;INTS8;TOE1;INTS6L
prerank,natural killer cell mediated immunity (GO:0002228),-0.1815109593091197,-0.4457189909228327,0.9953379953379954,1.0,1.0,2/15,17.71%,PLEKHM2;RAET1E
prerank,B cell activation involved in immune response (GO:0002312),-0.18751961830623393,-0.440875038996279,0.9951456310679612,1.0,1.0,13/13,81.27%,EXOSC3;MSH6;FCGR2B;BATF;GPR183;CD19;GAPT;CD40LG;RNF8;RNF168;LIG4;MSH2;CD180
prerank,rRNA modification (GO:0000154),0.19275562581372158,0.4407617925340491,0.9950980392156863,1.0,1.0,3/21,13.29%,TFB2M;NSUN4;FBLL1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.17748220889456984,-0.4398766753191856,0.9952830188679245,1.0,1.0,8/16,43.56%,PLEKHM2;RAET1E;VAMP2;CORO1A;TUBB4B;SLAMF7;KIF5B;KLRK1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.17298384562197505,0.4393973869543906,0.9953271028037384,1.0,1.0,33/33,82.74%,WDR33;CPSF1;SETX;SNRPD3;TTF2;CPSF3;PCF11;CPSF2;LSM11;PAPOLA;CSTF3;CSTF2T;SNRPB;SCAF8;CLP1;LSM10;SLBP;SSU72;NUDT21;CPSF7;NCBP1;CSTF2;NCBP2;CSTF1;SNRPE;SYMPK;SNRPG;CPSF4;MAZ;MED18;FIP1L1;SNRPF;PABPN1
prerank,serine family amino acid catabolic process (GO:0009071),-0.19972369194688344,-0.43894772564800394,0.9958333333333333,1.0,1.0,6/10,45.01%,CBS;GLDC;THNSL2;AMT;SHMT2;GCSH
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.20630940582072282,0.438394067745018,0.9878472222222222,1.0,1.0,3/12,20.52%,HUS1;CHEK2;RAD17
prerank,DNA duplex unwinding (GO:0032508),-0.13823335680170407,-0.43755545846021177,1.0,1.0,1.0,7/50,16.79%,ANXA1;RECQL5;RTEL1;RAD50;DDB2;XPC;DDB1
prerank,regulation of DNA recombination (GO:0000018),0.17838764466331974,0.4366737178114659,0.9968944099378882,1.0,1.0,7/32,20.87%,IL7R;SIRT6;SPIDR;ALYREF;THOC1;KDM1A;MSH2
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.1608334382475135,0.43432267691780824,1.0,1.0,1.0,56/56,83.97%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;NDUFS4;NDUFS6;NDUFB9;NDUFC1;NUBPL;NDUFS8;NDUFB7;NDUFAF8;ECSIT;NDUFA6;NDUFA2;ACAD9;DMAC1;NDUFA5;NDUFB2;NDUFA3;NDUFAB1;NDUFAF4;TMEM126B;NDUFA13;NDUFS1;NDUFB4;NDUFB6;NDUFB8;NDUFAF5;TMEM126A;OXA1L;NDUFS5;NDUFB5;NDUFB3;NDUFS3;BCS1L;NDUFB11;NDUFA1;NDUFAF2;FOXRED1;TIMMDC1;NDUFAF3;NDUFV2;NDUFS7;NDUFB10;NDUFA9;NDUFC2;TIMM21;NDUFAF1;NDUFV1;NDUFAF6;NDUFA11;NDUFA12;NDUFV3;DMAC2;NDUFAF7
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.1608334382475135,0.43432267691780824,1.0,1.0,1.0,56/56,83.97%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;NDUFS4;NDUFS6;NDUFB9;NDUFC1;NUBPL;NDUFS8;NDUFB7;NDUFAF8;ECSIT;NDUFA6;NDUFA2;ACAD9;DMAC1;NDUFA5;NDUFB2;NDUFA3;NDUFAB1;NDUFAF4;TMEM126B;NDUFA13;NDUFS1;NDUFB4;NDUFB6;NDUFB8;NDUFAF5;TMEM126A;OXA1L;NDUFS5;NDUFB5;NDUFB3;NDUFS3;BCS1L;NDUFB11;NDUFA1;NDUFAF2;FOXRED1;TIMMDC1;NDUFAF3;NDUFV2;NDUFS7;NDUFB10;NDUFA9;NDUFC2;TIMM21;NDUFAF1;NDUFV1;NDUFAF6;NDUFA11;NDUFA12;NDUFV3;DMAC2;NDUFAF7
prerank,regulation of oxidoreductase activity (GO:0051341),0.20712624559456716,0.43299117095388295,0.9929577464788732,1.0,1.0,5/13,27.23%,ABL2;ATP7A;HDAC6;ECSIT;NOD2
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.1508375578320279,-0.43035317321552446,0.9973333333333333,0.999963606620673,1.0,10/29,33.27%,ACOT11;ACAT1;ACSF2;DBI;ACOT8;ACOT9;MLYCD;ACOT1;ACOT7;GPAT4
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.1508375578320279,-0.43035317321552446,0.9973333333333333,0.999963606620673,1.0,10/29,33.27%,ACOT11;ACAT1;ACSF2;DBI;ACOT8;ACOT9;MLYCD;ACOT1;ACOT7;GPAT4
prerank,ATP synthesis coupled proton transport (GO:0015986),0.19183673469387738,0.4284595209539146,0.9850746268656716,1.0,1.0,17/17,80.84%,ATP5PD;VPS9D1;ATP5MC2;STOML2;ATP5F1B;ATP5F1C;ATP5F1A;ATP5F1E;ATP5MC1;ATP5MF;ATP5F1D;ATP5MC3;DMAC2L;ATP5MG;ATP5PF;ATP5ME;ATP5PO
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.2156690285177254,0.4280225094708548,0.9751434034416826,1.0,1.0,4/10,26.08%,HSP90AB1;FN1;CDH3;FURIN
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.2018884821667121,0.42616731955114967,0.9874776386404294,1.0,1.0,3/16,12.88%,MEIOB;RMI1;ERCC4
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.19182468918749196,0.4244006798336275,0.9882154882154882,1.0,1.0,16/16,80.84%,ATP5PD;ATP5MC2;STOML2;ATP5F1B;ATP5F1C;ATP5F1A;ATP5F1E;ATP5MC1;ATP5MF;ATP5F1D;ATP5MC3;DMAC2L;ATP5MG;ATP5PF;ATP5ME;ATP5PO
prerank,N-terminal protein amino acid modification (GO:0031365),0.19504422741506985,0.42196656159075135,0.9944237918215614,1.0,1.0,5/14,24.44%,NAA11;NAA16;NAA35;PDF;NAA50
prerank,tRNA 5'-end processing (GO:0099116),0.19764997369683052,0.4208954211595245,1.0,1.0,1.0,6/15,28.17%,RPP30;RPP25;PRORP;TRMT10C;RPP14;RPP38
prerank,protein localization to microtubule organizing center (GO:1905508),-0.16805588501303867,-0.4113314829197784,0.9976580796252927,1.0,1.0,8/15,40.08%,CEP192;PCM1;C2CD3;STIL;DCTN2;SPAG5;HOOK3;BBS4
prerank,"base-excision repair, gap-filling (GO:0006287)",0.1613041138516159,0.4099913119302316,1.0,1.0,1.0,34/35,78.84%,RPA1;UNG;PARG;MPG;RFC3;RFC5;MBD4;POLL;RPA3;APEX1;RFC2;POLD4;RFC4;PNKP;PCNA;OGG1;XRCC1;POLD3;SMUG1;LIG3;PARP1;FEN1;RPA2;LIG1;NEIL1;ADPRS;POLD2;POLB;POLD1;NTHL1;POLG;TDG;MUTYH;POLE
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.15280720890595342,0.4089680041258049,1.0,1.0,1.0,14/53,25.54%,PSMA2;PSMA8;PSMA6;PSME1;PSMA4;PSMF1;PSMB1;PSMB7;PSMD2;PSMA5;BCKDK;PSMC3;PSMD3;PSMA3
prerank,anterograde synaptic vesicle transport (GO:0048490),0.19169936044452054,0.4066249556920921,0.9982935153583617,0.999838750088662,1.0,3/15,17.39%,AP3B1;AP3S1;BLOC1S5
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.19169936044452054,0.4066249556920921,0.9982935153583617,0.999838750088662,1.0,3/15,17.39%,AP3B1;AP3S1;BLOC1S5
prerank,peptidyl-lysine acetylation (GO:0018394),0.1972759226713532,0.40409684288628595,0.9981718464351006,0.999628718550114,1.0,10/10,80.28%,KAT2B;CREBBP;KAT7;EP300;KAT2A;ESCO1;SIRT1;BLOC1S1;BAG6;KAT5
prerank,positive regulation of cilium assembly (GO:0045724),-0.15352005060205587,-0.40297516876810674,1.0,1.0,1.0,7/18,35.29%,FUZ;HTT;ARHGAP35;SEPTIN9;CROCC;KCTD17;CCP110
prerank,regulation of cellular amine metabolic process (GO:0033238),0.1496872073997766,0.4019830152435739,1.0,0.999386819623975,1.0,13/50,25.54%,PSMA2;PSMA8;PSMA6;PSME1;PSMA4;PSMF1;PSMB1;PSMB7;PSMD2;PSMA5;PSMC3;PSMD3;PSMA3
prerank,negative regulation of inclusion body assembly (GO:0090084),0.20079086115992972,0.4007393861758158,0.9927272727272727,0.9990806472957386,1.0,10/10,79.93%,DNAJB1;DNAJB6;HSPA1B;DNAJA4;DNAJB8;HSPA1A;SORL1;SACS;HSPA2;DNAJB2
prerank,DNA packaging (GO:0006323),0.18420506331409287,0.3928210567628319,0.992831541218638,0.9992114903344504,1.0,2/16,15.37%,HAT1;KAT6A
prerank,regulation of RNA export from nucleus (GO:0046831),0.1965267983016077,0.3926883796814981,0.9925788497217068,0.998818903855063,1.0,4/11,27.24%,NUP153;CPSF6;IWS1;NSUN2
prerank,global genome nucleotide-excision repair (GO:0070911),0.1627547617416793,0.3866757765842237,0.9984251968503937,0.9987708861213406,1.0,8/26,25.66%,ERCC4;GTF2H4;CETN2;GTF2H1;CHD1L;RNF111;CUL4B;GTF2H5
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.16899177859819953,-0.3866625986304023,0.9955257270693513,0.9998955802077467,1.0,4/12,30.14%,PLK5;TP53;PRKDC;RPA2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.15788714794374692,0.379906939308838,0.9968798751950078,0.9987468856070113,1.0,9/29,26.95%,RPA1;GTF2H4;CETN2;GTF2H1;CHD1L;CCNH;CUL4B;GTF2H5;RPA3
prerank,regulation of protein acetylation (GO:1901983),0.1844004087399928,0.3753282717863344,0.9963031423290203,0.9985496532455976,1.0,4/12,25.88%,CEP295;RAPGEF3;TAOK1;GSK3B
prerank,tRNA modification (GO:0006400),-0.10824888125521248,-0.3613511365332599,1.0,0.9996644848540943,1.0,16/62,31.45%,TARBP1;PUS3;GTPBP3;DUS2;MTO1;ELP5;TPRKB;THUMPD3;SSB;ANKRD16;BCDIN3D;METTL1;ADAT2;QTRT1;TRMT61A;AARS1
